archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO MEMBRANE RAFT ASSEMBLY,8.4434e-05,2.5924,2.2935,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00069995,1.8651,1.6162,1,1
1,GO BLEB ASSEMBLY,0.0001525,1.8095,1.652,1,1
1,GO RESPONSE TO INTERFERON ALPHA,0.00014528,1.6755,1.4831,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00032527,1.5745,1.2828,1,1
1,GO HYALURONAN CATABOLIC PROCESS,5.3491e-05,1.5397,1.3309,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0017084,1.5211,1.3279,1,1
1,GO RESPONSE TO INTERFERON BETA,0.00017625,1.4894,1.2687,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00023453,1.4881,1.4512,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00040918,1.4655,1.261,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,5.9259e-05,1.4517,1.279,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,8.0303e-05,1.4498,1.377,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0012773,1.4343,1.2324,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,8.4434e-05,1.4262,1.2207,1,1
1,GO MEMBRANE RAFT ORGANIZATION,6.2359e-05,1.4236,1.3724,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0055117,1.3957,0.88721,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,5.3491e-05,1.3784,1.3531,1,1
1,GO NEUTROPHIL HOMEOSTASIS,4.5827e-05,1.3422,1.3629,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.5827e-05,1.3275,1.3414,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,6.5613e-05,1.32,1.2086,1,1
1,GO FIBRINOLYSIS,0.00010305,1.3132,1.1685,1,1
1,GO EPIBOLY,0.0002237,1.2934,0.96696,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,5.0811e-05,1.2854,1.3777,1,1
1,GO TROPHOBLAST CELL MIGRATION,0.00010828,1.2792,1.1271,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,8.0303e-05,1.2685,1.1258,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.00011376,1.2401,1.0649,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.0811e-05,1.2126,1.2126,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00034064,1.1932,1.0554,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00039093,1.1739,0.94452,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,0.00018491,1.1473,1.1521,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,8.4434e-05,1.144,1.1439,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00031055,1.1404,0.90456,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,5.3491e-05,1.1331,1.0905,1,1
1,GO ZYMOGEN INHIBITION,0.00011376,1.1273,1.0794,1,1
1,GO REGULATION OF PINOCYTOSIS,8.0303e-05,1.1266,0.95382,1,1
1,GO PINOCYTOSIS,0.00013179,1.1196,0.88113,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0001255,1.119,1.0328,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00016797,1.102,0.97849,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0011741,1.0948,0.98804,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,5.9259e-05,1.0905,1.186,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00034064,1.0858,0.88321,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00013179,1.0827,0.83533,1,1
1,GO REGULATION OF FIBRINOLYSIS,0.00028296,1.0778,0.93846,1,1
1,GO CD40 SIGNALING PATHWAY,4.8258e-05,1.0677,1.0204,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0039282,1.0654,0.90004,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,8.8765e-05,1.0586,0.9464,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00042822,1.0511,0.90788,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00010305,1.0483,1.046,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,3.9213e-05,1.0411,1.0094,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00058654,1.0321,0.80513,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00019396,1.0269,0.97969,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00094871,1.0108,0.97657,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,9.3306e-05,1.008,0.90174,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,7.6363e-05,1.0006,0.90581,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00023453,1.0002,0.95428,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00094871,0.99887,1.018,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00032527,0.9973,0.82842,1,1
1,GO APOPTOTIC CELL CLEARANCE,6.5613e-05,0.99701,0.95927,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,7.2607e-05,0.99055,1.0185,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,9.8065e-05,0.98832,0.94644,1,1
1,GO PLASMINOGEN ACTIVATION,0.0011741,0.98017,0.87137,1,1
1,GO ENDODERM FORMATION,5.9259e-05,0.9752,1.0473,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.00029645,0.97252,0.96951,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.9259e-05,0.97221,0.97595,1,1
1,GO HEMIDESMOSOME ASSEMBLY,0.00039093,0.97186,1.0607,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00014528,0.97139,0.87311,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,7.6363e-05,0.96717,1.0243,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0017084,0.96491,0.99984,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,6.2359e-05,0.96274,0.84669,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,5.3491e-05,0.96247,0.92304,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00073133,0.96119,0.84145,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00011376,0.95767,0.95712,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.0303e-05,0.953,0.92134,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,8.4434e-05,0.94705,0.9821,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,9.8065e-05,0.93354,0.92434,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0002237,0.92807,0.81185,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.3491e-05,0.92799,0.81471,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0009903,0.92777,0.93093,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.6305e-05,0.92582,1.0459,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00024585,0.92276,0.85794,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00014528,0.92226,0.80719,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.8065e-05,0.91385,0.86735,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.131e-05,0.91301,0.92367,1,1
1,GO ENTRY INTO HOST,0.00011949,0.91146,0.74356,1,1
1,GO TYPE 2 IMMUNE RESPONSE,9.3306e-05,0.90611,0.80152,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00025768,0.90442,1.0014,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0002237,0.90359,0.81639,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00016006,0.90231,0.75749,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00032527,0.90151,0.73726,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.3306e-05,0.89838,0.91558,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00011376,0.8978,0.82274,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00053648,0.88998,0.66434,1,1
1,GO T CELL EXTRAVASATION,0.00040918,0.8887,0.85155,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,8.0303e-05,0.88629,0.8921,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.9026e-05,0.88033,0.83782,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0001525,0.87738,0.83305,1,1
1,GO NUCLEOSIDE SALVAGE,0.00040918,0.87396,0.74722,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,6.5613e-05,0.87293,0.90074,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00027004,0.86982,0.71927,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.00017625,0.86582,0.92094,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00016797,0.86519,0.74483,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00034064,0.86409,0.78027,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,8.0303e-05,0.86011,0.72918,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,0.00010305,0.85987,0.84013,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0009903,0.85921,0.79355,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.9026e-05,0.85917,0.89496,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,5.6305e-05,0.85744,0.80823,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00049043,0.85608,0.81388,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00035669,0.85439,0.84345,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.00011376,0.85262,0.87132,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00027004,0.85151,0.88379,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00094871,0.84799,0.63499,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0051169,0.8478,0.77531,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00011376,0.84731,0.83195,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00013838,0.84589,0.89769,1,1
1,GO SKIN MORPHOGENESIS,0.00042822,0.84374,0.95062,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0002237,0.84349,0.81371,1,1
1,GO CELLULAR RESPONSE TO DSRNA,6.5613e-05,0.83951,0.74654,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,0.00013838,0.83903,0.77751,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00016797,0.83731,0.96249,1,1
1,GO DNA DEAMINATION,0.00042822,0.83587,0.74129,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0027694,0.83513,0.74168,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.3513e-05,0.83272,0.79253,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,8.8765e-05,0.83056,0.81228,1,1
1,GO LEUKOCYTE AGGREGATION,0.012053,0.8277,0.65722,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00017625,0.82768,0.67535,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.01857,0.82456,0.72882,1,1
1,GO REPLICATIVE SENESCENCE,0.0042393,0.82023,0.5859,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00016797,0.81584,0.79093,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0022699,0.81391,0.64233,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.00016006,0.81259,0.73881,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0012247,0.80826,0.61819,1,1
1,GO GAP JUNCTION ASSEMBLY,0.00016006,0.80756,0.76637,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00013179,0.80702,0.72358,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00051298,0.80148,0.66312,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,5.6305e-05,0.80127,0.80361,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,9.3306e-05,0.80016,0.87634,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.004403,0.79914,0.61494,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0073805,0.79857,0.58732,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0011254,0.79729,0.71107,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.00040918,0.79548,0.68214,1,1
1,GO BLOOD VESSEL REMODELING,6.5613e-05,0.79295,0.68156,1,1
1,GO VASCULOGENESIS,4.5827e-05,0.79137,0.73246,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,4.8258e-05,0.79125,0.79484,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00014528,0.78704,0.66826,1,1
1,GO MUCUS SECRETION,0.0066217,0.78557,0.61514,1,1
1,GO COPPER ION HOMEOSTASIS,8.0303e-05,0.78215,0.70441,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.2359e-05,0.78111,0.84018,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,3.9213e-05,0.7808,0.76899,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,9.8065e-05,0.77807,0.85357,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,5.3491e-05,0.77613,0.70331,1,1
1,GO ENDODERM DEVELOPMENT,0.00010828,0.77482,0.7914,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,0.00044809,0.77128,0.6259,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0012247,0.77099,0.60912,1,1
1,GO ANIMAL ORGAN REGENERATION,0.00013179,0.77078,0.62734,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00020344,0.77067,0.73147,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00017625,0.76672,0.68662,1,1
1,GO RESPONSE TO INTERFERON GAMMA,0.00058654,0.76497,0.62456,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0015095,0.76474,0.63833,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,0.00034064,0.76428,0.65424,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,0.00013838,0.76415,0.6336,1,1
1,GO LIVER REGENERATION,7.2607e-05,0.76385,0.70424,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,9.3306e-05,0.76107,0.68868,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.014755,0.75744,0.59411,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0018542,0.75517,0.55709,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.9259e-05,0.7541,0.85894,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,4.131e-05,0.75383,0.74928,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,3.9213e-05,0.75239,0.69292,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,4.8258e-05,0.75183,0.69153,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00046881,0.7512,0.6449,1,1
1,GO COLLAGEN METABOLIC PROCESS,5.3491e-05,0.75044,0.82088,1,1
1,GO SNRNA METABOLIC PROCESS,0.020453,0.74964,0.59015,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0001525,0.7475,0.72779,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.001448,0.74707,0.62852,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00079804,0.74645,0.73942,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00031055,0.74418,0.65223,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0071194,0.73787,0.57633,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00013838,0.73598,0.61996,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00020344,0.73527,0.73145,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.0082164,0.73492,0.65072,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00087036,0.73423,0.65127,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0023626,0.73197,0.57833,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00053648,0.72878,0.69671,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0017084,0.72542,0.60857,1,1
1,GO INTERLEUKIN 17 PRODUCTION,7.2607e-05,0.72335,0.69037,1,1
1,GO VAGINA DEVELOPMENT,0.00020344,0.72303,0.80446,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,0.0013889,0.72227,0.67032,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0002237,0.72194,0.70766,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.00040918,0.72059,0.6627,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00025768,0.71761,0.69358,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00035669,0.717,0.63565,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00018491,0.71496,0.86852,1,1
1,GO DEFENSE RESPONSE TO VIRUS,0.00083347,0.71471,0.51891,1,1
1,GO HYALURONAN METABOLIC PROCESS,6.5613e-05,0.71278,0.65362,1,1
1,GO IMMATURE T CELL PROLIFERATION,0.0011741,0.71269,0.62426,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0009903,0.70911,0.56621,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00014528,0.70663,0.73833,1,1
1,GO PIGMENT GRANULE MATURATION,0.0051169,0.70558,0.48731,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0013889,0.70535,0.48501,1,1
1,GO ZYMOGEN ACTIVATION,0.00049043,0.70525,0.63601,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,9.3306e-05,0.70346,0.69978,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,8.0303e-05,0.70322,0.82468,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00040918,0.70289,0.68188,1,1
1,GO T CELL CYTOKINE PRODUCTION,0.00023453,0.70192,0.57201,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,0.00024585,0.70093,0.6069,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.0013889,0.70057,0.58699,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00027004,0.69968,0.61692,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.00034064,0.6965,0.6515,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00010305,0.69629,0.70178,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0036381,0.69553,0.69358,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0011741,0.69535,0.51529,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00037344,0.6951,0.6265,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00037344,0.69404,0.7173,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0022699,0.69372,0.66265,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.023222,0.69174,0.62237,1,1
1,GO T CELL MEDIATED IMMUNITY,0.00023453,0.69064,0.60731,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0012247,0.68835,0.5563,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0039282,0.68777,0.61752,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00013179,0.68735,0.62726,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0001525,0.68693,0.63056,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,0.00049043,0.68581,0.62879,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.010874,0.68363,0.53081,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,6.5613e-05,0.68265,0.64168,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0001525,0.68184,0.61383,1,1
1,GO CYTOLYSIS,8.0303e-05,0.6781,0.65413,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0002237,0.67809,0.67772,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.015254,0.67688,0.49376,1,1
1,GO NUCLEOTIDE SALVAGE,0.0019312,0.67651,0.59641,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00061317,0.67322,0.71601,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00090875,0.67311,0.52463,1,1
1,GO REGULATION OF MYOBLAST FUSION,0.00023453,0.67256,0.80627,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0011741,0.67086,0.58356,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00032527,0.67079,0.58382,1,1
1,GO INTERACTION WITH HOST,0.00018491,0.6688,0.52959,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0027694,0.66858,0.79908,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.028854,0.6649,0.43225,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.00034064,0.66398,0.65613,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0025586,0.66359,0.5623,1,1
1,GO VIRAL GENOME REPLICATION,0.00044809,0.66322,0.53267,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0002237,0.66285,0.58172,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017084,0.66251,0.54754,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00035669,0.66175,0.65179,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00056099,0.66173,0.96094,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00035669,0.66117,0.62767,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00040918,0.65848,0.6069,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00039093,0.65737,0.71097,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00083347,0.65614,0.51404,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00023453,0.65555,0.58598,1,1
1,GO REGULATION OF COAGULATION,0.00028296,0.65549,0.586,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,6.9026e-05,0.65545,0.62472,1,1
1,GO GERMINAL CENTER FORMATION,0.0020943,0.65465,0.56181,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0016396,0.65279,0.62005,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0017799,0.65094,0.55894,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,9.8065e-05,0.65084,0.59576,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00035669,0.64773,0.5312,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,3.9213e-05,0.64733,0.65648,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00013838,0.64657,0.66029,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00032527,0.64625,0.54391,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.020453,0.64546,0.59246,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0013889,0.64419,0.51888,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,6.5613e-05,0.6438,0.77874,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00049043,0.6407,0.61523,1,1
1,GO AMYLOID BETA CLEARANCE,0.00016006,0.6402,0.57618,1,1
1,GO RESPONSE TO ANGIOTENSIN,0.0001255,0.6366,0.57175,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00034064,0.63589,0.48532,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010828,0.63446,0.55421,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.019808,0.63383,0.41636,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0013321,0.63318,0.48823,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00064092,0.63006,0.53025,1,1
1,GO NECROTIC CELL DEATH,0.00046881,0.62967,0.57798,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00025768,0.62966,0.54269,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00013838,0.62845,0.58377,1,1
1,GO NCRNA 3 END PROCESSING,0.027983,0.62753,0.49303,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00025768,0.62582,0.57254,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00023453,0.62566,0.5912,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.025507,0.62534,0.58313,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.2607e-05,0.62382,0.68455,1,1
1,GO INTERLEUKIN 1 PRODUCTION,0.00046881,0.62355,0.58654,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0019312,0.62335,0.49184,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,9.3306e-05,0.6221,0.58574,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00042822,0.62,0.69142,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00013179,0.61879,0.67091,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0009903,0.61814,0.58796,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00011376,0.61676,0.61835,1,1
1,GO PLATELET DEGRANULATION,0.00019396,0.61599,0.61401,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00076401,0.61413,0.51431,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00087036,0.61332,0.59147,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0018542,0.61273,0.57489,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0002237,0.61247,0.68181,1,1
1,GO VIRAL LIFE CYCLE,0.00016797,0.61217,0.50508,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,0.0001255,0.61055,0.55444,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00064092,0.60935,0.59059,1,1
1,GO NIK NF KAPPAB SIGNALING,0.0002237,0.60718,0.49743,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00028296,0.60716,0.52099,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0032392,0.60707,0.51135,1,1
1,GO RESPONSE TO PROGESTERONE,0.0010336,0.60681,0.46089,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00024585,0.60642,0.56206,1,1
1,GO P38MAPK CASCADE,0.00083347,0.60577,0.45911,1,1
1,GO VASCULAR TRANSPORT,0.010505,0.60558,0.61646,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.0012773,0.60433,0.61704,1,1
1,GO RESPONSE TO VIRUS,0.00042822,0.60406,0.45149,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0024588,0.60276,0.56571,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,8.8765e-05,0.60258,0.56078,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0047478,0.60088,0.55445,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00011949,0.60069,0.65484,1,1
1,GO RESPONSE TO INTERLEUKIN 1,0.00061317,0.59955,0.42717,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00046881,0.59696,0.48454,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.00020344,0.59681,0.6244,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00079804,0.59556,0.50496,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00018491,0.59551,0.55302,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00079804,0.5948,0.46443,1,1
1,GO INTERLEUKIN 2 PRODUCTION,0.0001525,0.59351,0.5637,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00053648,0.593,0.53435,1,1
1,GO EOSINOPHIL MIGRATION,0.0035004,0.59076,0.57577,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,0.00010305,0.59005,0.59968,1,1
1,GO RESPONSE TO DSRNA,0.00042822,0.58935,0.47914,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.011255,0.58832,0.4578,1,1
1,GO MULTI ORGANISM LOCALIZATION,0.00013179,0.58719,0.46667,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00051298,0.58444,0.49792,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,0.00034064,0.58321,0.50822,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.0001525,0.58163,0.61484,1,1
1,GO DETECTION OF BIOTIC STIMULUS,0.0011741,0.58074,0.52265,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0071194,0.58003,0.48029,1,1
1,GO RESPONSE TO HYPEROXIA,0.0018542,0.57991,0.59392,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00073133,0.57966,0.62509,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0001255,0.57902,0.5353,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00064092,0.57873,0.62673,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.0016396,0.57854,0.51284,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00031055,0.57815,0.52401,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00053648,0.57785,0.45467,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00011376,0.57692,0.52362,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.00023453,0.5768,0.55468,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00029645,0.57638,0.49419,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,0.00032527,0.57596,0.4724,1,1
1,GO MACROPHAGE PROLIFERATION,0.0025586,0.57557,0.58646,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0024588,0.5746,0.45702,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.010146,0.57406,0.40725,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0015095,0.57362,0.50066,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00044809,0.57299,0.51361,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00083347,0.57264,0.45434,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0023626,0.56952,0.52329,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00037344,0.56913,0.58956,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.6363e-05,0.56894,0.54079,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0047478,0.56872,0.47002,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00051298,0.56784,0.42164,1,1
1,GO RECEPTOR CATABOLIC PROCESS,0.00010828,0.56783,0.53945,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00017625,0.56771,0.58145,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.01247,0.56769,0.43415,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,8.4434e-05,0.56624,0.63007,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0047478,0.56584,0.40764,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.010505,0.56447,0.42171,1,1
1,GO HEME METABOLIC PROCESS,0.00083347,0.56367,0.5103,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0011741,0.5627,0.54843,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00031055,0.56066,0.54457,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0012773,0.56031,0.72093,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0010336,0.55968,0.55548,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.023222,0.5562,0.51908,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00069995,0.55421,0.42986,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010828,0.55287,0.51798,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00014528,0.55267,0.49563,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00051298,0.55226,0.51494,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00027004,0.55172,0.54712,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.01427,0.55168,0.47362,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.005311,0.55052,0.4842,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0039282,0.55041,0.59643,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00049043,0.54987,0.45687,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0029959,0.54977,0.50764,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00029645,0.54953,0.44783,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,7.2607e-05,0.54919,0.52223,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,6.5613e-05,0.5469,0.57795,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00042822,0.54666,0.42631,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00019396,0.54645,0.616,1,1
1,GO RESPONSE TO INTERLEUKIN 12,0.00056099,0.54625,0.46876,1,1
1,GO CYTOKINE METABOLIC PROCESS,0.00014528,0.54588,0.53461,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00069995,0.54401,0.42755,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0039282,0.54279,0.44995,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0022699,0.54269,0.48859,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00018491,0.54245,0.5298,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.8765e-05,0.54227,0.57369,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00040918,0.5419,0.65662,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.00011949,0.54148,0.57162,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.00031055,0.54139,0.46784,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0013889,0.54129,0.49506,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00069995,0.54079,0.3967,1,1
1,GO STEROL IMPORT,0.0091361,0.53938,0.55944,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00066983,0.53848,0.52184,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.0019312,0.53841,0.48873,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.00024585,0.5382,0.62204,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00025768,0.53801,0.52035,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0024588,0.53798,0.39866,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.131e-05,0.53781,0.63032,1,1
1,GO REGULATION OF TRANSPOSITION,0.0023626,0.53735,0.46728,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00051298,0.53734,0.47836,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0047478,0.53722,0.41593,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.00032527,0.53716,0.59222,1,1
1,GO PEPTIDE CROSS LINKING,0.0011254,0.5351,0.57715,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0045725,0.53497,0.52024,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.016296,0.53448,0.5041,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00013838,0.53437,0.50193,1,1
1,GO RESPONSE TO X RAY,0.00016797,0.53427,0.57988,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069995,0.53421,0.43641,1,1
1,GO EMBRYO IMPLANTATION,0.00034064,0.53386,0.61421,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00029645,0.53342,0.51383,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00023453,0.53283,0.54857,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00028296,0.5316,0.50334,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00014528,0.53105,0.52139,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.021117,0.52937,0.35821,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0047478,0.52853,0.5295,1,1
1,GO MRNA TRANSCRIPTION,0.00035669,0.52707,0.44435,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00044809,0.52649,0.47149,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0018542,0.52575,0.39935,1,1
1,GO EOSINOPHIL CHEMOTAXIS,0.0094624,0.52552,0.5936,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00079804,0.52545,0.44959,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0085133,0.52531,0.57323,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0082164,0.52509,0.37134,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0010786,0.52418,0.41584,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0063849,0.52276,0.51321,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00094871,0.52138,0.37297,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,0.00087036,0.52047,0.48711,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.004403,0.51975,0.48342,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0018542,0.51844,0.5841,1,1
1,GO VIRAL RNA GENOME REPLICATION,0.00016797,0.51778,0.43699,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,8.0303e-05,0.51777,0.79503,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00058654,0.51735,0.44116,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0091361,0.51676,0.42587,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.0009903,0.51674,0.52074,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00087036,0.51417,0.41692,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00076401,0.5138,0.48709,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00021334,0.51326,0.43235,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00094871,0.51315,0.39683,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00037344,0.51223,0.41403,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00044809,0.51206,0.43239,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00025768,0.50945,0.65161,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00034064,0.50822,0.4358,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00049043,0.50756,0.57259,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00017625,0.50748,0.4788,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0073805,0.50672,0.42925,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0019312,0.50628,0.47765,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0012247,0.50566,0.3649,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0035004,0.50515,0.34767,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.010505,0.50509,0.38692,1,1
1,GO RESPONSE TO PROTOZOAN,0.00079804,0.50495,0.4297,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00024585,0.50393,0.4906,1,1
1,GO REGULATION OF PROTEIN MATURATION,0.0001255,0.50366,0.47256,1,1
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0082164,0.50295,0.47615,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0012773,0.50265,0.5914,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,8.0303e-05,0.50233,0.44026,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.00066983,0.50199,0.51182,1,1
1,GO INTERLEUKIN 8 PRODUCTION,0.00040918,0.5016,0.48399,1,1
1,GO MACROPHAGE DIFFERENTIATION,0.00037344,0.50141,0.50744,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,0.00039093,0.50055,0.48365,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00028296,0.49975,0.48705,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.0022699,0.49907,0.48576,1,1
1,GO REGULATION OF PHAGOCYTOSIS,0.00016006,0.49893,0.48842,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,4.8258e-05,0.49872,0.47665,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.0020112,0.49814,0.41863,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00031055,0.49808,0.40676,1,1
1,GO RESPONSE TO CYTOKINE,0.0009903,0.49749,0.37269,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00090875,0.49709,0.39116,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00029645,0.49633,0.58091,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00061317,0.4958,0.48678,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0020112,0.49495,0.43932,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00020344,0.49471,0.4969,1,1
1,GO STORE OPERATED CALCIUM ENTRY,0.001448,0.49428,0.411,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00064092,0.49414,0.4455,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00073133,0.49399,0.52587,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0039282,0.49348,0.57758,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00021334,0.49339,0.45385,1,1
1,GO TYPE I INTERFERON PRODUCTION,0.0013321,0.49247,0.37551,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0010336,0.49192,0.4004,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00031055,0.49131,0.38069,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00037344,0.49106,0.42472,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,0.00024585,0.48949,0.4335,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.01247,0.48892,0.46599,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.0037806,0.48845,0.45807,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,5.3491e-05,0.48759,0.48092,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0002237,0.48759,0.50697,1,1
1,GO WOUND HEALING,0.00066983,0.48693,0.41064,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0023626,0.48605,0.45907,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00053648,0.48583,0.40373,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0002237,0.48536,0.42777,1,1
1,GO LYMPHANGIOGENESIS,0.00031055,0.48378,0.47699,1,1
1,GO MONOCYTE CHEMOTAXIS,0.0025586,0.4829,0.44426,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.01857,0.48263,0.38203,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0010336,0.48234,0.63833,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00064092,0.48182,0.50243,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,0.00035669,0.48095,0.438,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0023626,0.48013,0.34841,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00066983,0.47951,0.42546,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0010786,0.47947,0.42072,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.016296,0.47941,0.37924,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00031055,0.47914,0.4897,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.0031154,0.47817,0.39312,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00042822,0.4774,0.51749,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00090875,0.47657,0.48452,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0032392,0.47394,0.45485,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.00040918,0.47105,0.46829,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.0029959,0.47048,0.46777,1,1
1,GO VIRAL GENE EXPRESSION,0.0021804,0.46947,0.39299,1,1
1,GO COAGULATION,0.00025768,0.46905,0.39142,1,1
1,GO PROTEASOME ASSEMBLY,0.0012247,0.46838,0.39317,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0045725,0.46813,0.34986,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.019808,0.46785,0.49914,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.028854,0.46776,0.41904,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.00064092,0.46552,0.45273,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0020943,0.46464,0.44949,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0028806,0.46363,0.69146,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.011255,0.46325,0.36085,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010874,0.46315,0.34226,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0049293,0.46307,0.39904,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0071194,0.4629,0.37606,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.010874,0.46273,0.38399,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00040918,0.46202,0.41646,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.015254,0.46151,0.34261,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.014755,0.46091,0.35314,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00073133,0.4609,0.36641,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00042822,0.4604,0.38876,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00032527,0.46001,0.41035,1,1
1,GO CHYLOMICRON ASSEMBLY,0.028854,0.45996,0.3182,1,1
1,GO RIBOSOME ASSEMBLY,0.010505,0.4599,0.36866,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00058654,0.45937,0.48437,1,1
1,GO RIG I SIGNALING PATHWAY,0.0015095,0.45934,0.40897,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0045725,0.45914,0.31403,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0013321,0.45893,0.37541,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00040918,0.45814,0.41428,1,1
1,GO INTERACTION WITH SYMBIONT,0.010146,0.45783,0.32277,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00051298,0.45693,0.46945,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,0.00090875,0.45655,0.37828,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00037344,0.45639,0.35294,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00042822,0.45569,0.45194,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,0.00049043,0.45423,0.37139,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0012773,0.45273,0.39939,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.00029645,0.4525,0.42895,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00051298,0.45216,0.43556,1,1
1,GO PHAGOCYTOSIS,0.00013838,0.45162,0.41028,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.01427,0.45154,0.35001,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0019312,0.45073,0.33461,1,1
1,GO T CELL APOPTOTIC PROCESS,0.00058654,0.45067,0.38816,1,1
1,GO SPROUTING ANGIOGENESIS,0.00035669,0.45044,0.44187,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00018491,0.45022,0.39631,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00010828,0.44998,0.48883,1,1
1,GO PLATELET AGGREGATION,0.00011949,0.44988,0.463,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.0059338,0.44936,0.38606,1,1
1,GO RESPONSE TO ESTROGEN,0.00027004,0.44908,0.42437,1,1
1,GO REGULATION OF MRNA BINDING,0.00051298,0.44774,0.42282,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0066217,0.44592,0.39006,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00028296,0.44571,0.43741,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0039282,0.44564,0.4429,1,1
1,GO PRIMARY MIRNA PROCESSING,0.0019312,0.44529,0.44069,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0022699,0.44518,0.39826,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00018491,0.44474,0.41596,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00073133,0.44437,0.4055,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.022501,0.44414,0.3509,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00046881,0.44361,0.3882,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00016797,0.44269,0.46964,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00046881,0.44174,0.36486,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00010828,0.44157,0.42825,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.00017625,0.44095,0.41333,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.014755,0.44065,0.36377,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00010828,0.44048,0.39299,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0018542,0.43983,0.40423,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0028806,0.43974,0.37926,1,1
1,GO GLIAL CELL ACTIVATION,0.0001255,0.43917,0.54107,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00010828,0.43895,0.41422,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0026621,0.43854,0.37732,1,1
1,GO CYTOPLASMIC TRANSLATION,0.0051169,0.43836,0.35681,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0009903,0.43789,0.5894,1,1
1,GO T CELL MIGRATION,0.0037806,0.43589,0.34242,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.00094871,0.43492,0.48074,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0129,0.43466,0.3191,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.011255,0.43409,0.41014,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0094624,0.43321,0.42984,1,1
1,GO INACTIVATION OF MAPK ACTIVITY,0.0022699,0.43304,0.45587,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.0012773,0.43275,0.36205,1,1
1,GO INNATE IMMUNE RESPONSE,0.0009903,0.43268,0.32114,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00031055,0.43242,0.36713,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00053648,0.43198,0.38117,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0021804,0.43192,0.48034,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011741,0.43188,0.39814,1,1
1,GO RESPONSE TO MANGANESE ION,0.0018542,0.43162,0.36541,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00025768,0.43113,0.42125,1,1
1,GO VIRAL TRANSLATION,0.0015733,0.43111,0.40299,1,1
1,GO REGULATION OF WOUND HEALING,0.0013889,0.43075,0.39417,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00046881,0.43065,0.43211,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.00019396,0.43055,0.48711,1,1
1,GO RESPONSE TO CORTICOSTERONE,0.023222,0.43045,0.41623,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00046881,0.42881,0.3851,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0017084,0.42848,0.43963,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00053648,0.42816,0.36188,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00066983,0.42746,0.40228,1,1
1,GO ERBB SIGNALING PATHWAY,0.0011254,0.42674,0.33524,1,1
1,GO MYOBLAST FUSION,0.0020112,0.42641,0.45956,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.010146,0.42633,0.40849,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0015095,0.42568,0.5247,1,1
1,GO B CELL MEDIATED IMMUNITY,0.00053648,0.42519,0.39146,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.00053648,0.4238,0.44208,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00018491,0.42357,0.39972,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00031055,0.42343,0.36041,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013344,0.42283,0.47136,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0071194,0.42256,0.33969,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.01918,0.42223,0.31236,1,1
1,GO NATURAL KILLER CELL ACTIVATION,0.00016006,0.42148,0.43018,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00025768,0.42098,0.41094,1,1
1,GO INTERFERON BETA PRODUCTION,0.005311,0.42078,0.33844,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.01684,0.42015,0.30554,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0025586,0.41996,0.40186,1,1
1,GO TRNA 5 LEADER REMOVAL,0.0032392,0.41879,0.34525,1,1
1,GO MUSCLE FILAMENT SLIDING,0.00021334,0.41827,0.46918,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.00094871,0.41811,0.35979,1,1
1,GO TRACHEA MORPHOGENESIS,0.0020112,0.4177,0.37986,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0012247,0.4177,0.38502,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0061556,0.41749,0.4267,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0018542,0.4168,0.3207,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00053648,0.41676,0.3482,1,1
1,GO IMMUNE EFFECTOR PROCESS,0.00051298,0.41629,0.35218,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0059338,0.41615,0.36971,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0009903,0.41578,0.3754,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.02631,0.41564,0.37058,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00010828,0.415,0.39843,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0009903,0.41474,0.31511,1,1
1,GO REGULATION OF GASTRULATION,0.00025768,0.41303,0.41007,1,1
1,GO TRANSLATIONAL INITIATION,0.0025586,0.41207,0.36428,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0020112,0.4118,0.32979,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,0.00031055,0.41109,0.40812,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0020943,0.40944,0.37418,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0024588,0.40879,0.31307,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,9.3306e-05,0.40869,0.37223,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.012053,0.4086,0.58045,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0068665,0.40767,0.37594,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0049293,0.40758,0.3495,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00056099,0.40746,0.39931,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.022501,0.40699,0.27878,1,1
1,GO MEMBRANE INVAGINATION,0.00010305,0.40649,0.43823,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,6.5613e-05,0.40648,0.39548,1,1
1,GO REGULATION OF STEROL TRANSPORT,0.00064092,0.4059,0.39124,1,1
1,GO ASTROCYTE ACTIVATION,0.0017799,0.40537,0.46654,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.00061317,0.40461,0.37721,1,1
1,GO FOCAL ADHESION ASSEMBLY,0.0055117,0.40457,0.39931,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.021117,0.40439,0.31235,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0026621,0.40418,0.43,1,1
1,GO ASTROCYTE DEVELOPMENT,0.0010786,0.40389,0.40726,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0026621,0.40293,0.34788,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.0061556,0.40183,0.37784,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0020943,0.40117,0.3857,1,1
1,GO CAMP METABOLIC PROCESS,0.017977,0.40037,0.36797,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0063849,0.39996,0.34469,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,0.00020344,0.39954,0.38797,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.010146,0.39832,0.38289,1,1
1,GO HEPARIN METABOLIC PROCESS,0.0051169,0.39768,0.50358,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0035004,0.39744,0.47272,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00051298,0.39718,0.49481,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0015733,0.39637,0.51781,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0063849,0.39637,0.42019,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.010146,0.39629,0.38387,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.010505,0.39615,0.34507,1,1
1,GO REGULATION OF PROTEIN IMPORT,0.0085133,0.39603,0.35106,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00069995,0.39591,0.38297,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0055117,0.39358,0.43925,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.014755,0.39357,0.27012,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,0.00040918,0.39353,0.38065,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.0066217,0.39352,0.36678,1,1
1,GO OSTEOCLAST DEVELOPMENT,0.00035669,0.39351,0.5014,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00049043,0.39294,0.34639,1,1
1,GO GRANULOCYTE MIGRATION,0.0024588,0.39257,0.38999,1,1
1,GO RESPONSE TO BACTERIUM,0.0015095,0.39249,0.32603,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0035004,0.39237,0.40522,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0015095,0.39198,0.31918,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0079288,0.39161,0.35913,1,1
1,GO PROTEIN HYDROXYLATION,0.01918,0.39149,0.53655,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.001448,0.39148,0.32556,1,1
1,GO MUSCLE CELL MIGRATION,0.028854,0.39146,0.29647,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00090875,0.39112,0.32408,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00040918,0.391,0.37875,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0001255,0.39091,0.43223,1,1
1,GO COMPLEMENT ACTIVATION,0.00083347,0.3904,0.35327,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.028854,0.38944,0.29232,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0017084,0.38941,0.31388,1,1
1,GO MEMBRANE DISASSEMBLY,0.0059338,0.38928,0.30437,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00076401,0.38913,0.49302,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0031154,0.38897,0.31951,1,1
1,GO REGULATION OF CELL AGING,0.00010305,0.38878,0.37114,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00056099,0.38719,0.36904,1,1
1,GO VESICLE TARGETING,0.0020112,0.3871,0.28429,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.001448,0.38661,0.36219,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00061317,0.38626,0.42268,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,0.00021334,0.3856,0.32879,1,1
1,GO INFLAMMATORY RESPONSE,0.0013321,0.3855,0.33248,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00020344,0.3853,0.39612,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00046881,0.38507,0.37534,1,1
1,GO RESPONSE TO WOUNDING,0.00056099,0.38457,0.33816,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00025768,0.38413,0.39643,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0097991,0.38404,0.39425,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0129,0.38403,0.34692,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0039282,0.38393,0.47764,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,0.0012247,0.38358,0.29174,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00087036,0.38346,0.32555,1,1
1,GO REGULATION OF LIPASE ACTIVITY,0.00061317,0.38339,0.32146,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00061317,0.38224,0.35102,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0047478,0.38223,0.37608,1,1
1,GO PLATELET ACTIVATION,0.0015733,0.38116,0.31294,1,1
1,GO XENOBIOTIC TRANSPORT,0.001448,0.381,0.36599,1,1
1,GO LYMPHOCYTE MIGRATION,0.0026621,0.38089,0.27692,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0025586,0.38075,0.32894,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0020943,0.3806,0.33787,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0011741,0.38054,0.30549,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0076503,0.38,0.26832,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0059338,0.3798,0.29728,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00037344,0.37965,0.44055,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0031154,0.37874,0.42127,1,1
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.016296,0.37826,0.52144,1,1
1,GO SYMBIOTIC PROCESS,0.00023453,0.37805,0.31498,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.010146,0.37777,0.28304,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00049043,0.37775,0.42413,1,1
1,GO DEFENSE RESPONSE,0.0018542,0.37768,0.28068,1,1
1,GO CELL CELL RECOGNITION,0.0001255,0.37716,0.351,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0032392,0.37706,0.34642,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.00023453,0.37609,0.36376,1,1
1,GO ERAD PATHWAY,0.00011376,0.37557,0.36734,1,1
1,GO RESPONSE TO LEPTIN,0.02631,0.37499,0.27982,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0079288,0.37484,0.34578,1,1
1,GO CYTOKINE PRODUCTION,0.00083347,0.37384,0.3162,1,1
1,GO MATURATION OF SSU RRNA,0.01247,0.37335,0.31406,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0010786,0.37329,0.35556,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0079288,0.37298,0.30116,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0059338,0.3723,0.45851,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.0026621,0.37229,0.35305,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.005311,0.37204,0.47407,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0017084,0.37199,0.34378,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00061317,0.37197,0.31317,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00076401,0.3717,0.33145,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0040811,0.37165,0.28193,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011255,0.37163,0.50623,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00079804,0.37162,0.34971,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00037344,0.37102,0.44409,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00083347,0.36942,0.35105,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0016396,0.36827,0.28592,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0020112,0.36778,0.25846,1,1
1,GO ARGININE METABOLIC PROCESS,0.0068665,0.36755,0.4271,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00073133,0.36721,0.34945,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.00028296,0.3669,0.3205,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.0032392,0.36599,0.32921,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0059338,0.36592,0.34921,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0017084,0.36509,0.39445,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00034064,0.36464,0.42625,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0002237,0.3644,0.31027,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00064092,0.36359,0.30554,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.0013321,0.36304,0.38084,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.00058654,0.36251,0.36389,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0039282,0.36241,0.31414,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00094871,0.36237,0.32392,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.0011254,0.36235,0.30027,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0025586,0.3623,0.39893,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00044809,0.36216,0.34784,1,1
1,GO SPERM EGG RECOGNITION,0.00016797,0.36214,0.32423,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0059338,0.36145,0.30494,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00087036,0.36065,0.3602,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0051169,0.36061,0.3064,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,0.00090875,0.36031,0.33355,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0011741,0.35994,0.31856,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,6.2359e-05,0.35969,0.35741,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.014755,0.35965,0.29971,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.0015733,0.35951,0.32115,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.012053,0.35918,0.40869,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00046881,0.35869,0.37576,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,0.0015095,0.35825,0.32623,1,1
1,GO CYTOKINETIC PROCESS,0.00064092,0.35737,0.34156,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0013889,0.35702,0.28086,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.015767,0.35597,0.23264,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0020943,0.35527,0.29184,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0017084,0.35462,0.26268,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0097991,0.35453,0.32754,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.00083347,0.3532,0.34753,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.0013321,0.35299,0.34838,1,1
1,GO LIPID STORAGE,0.0068665,0.35141,0.29484,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,0.0015733,0.35123,0.39165,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0019312,0.34995,0.38893,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00064092,0.34956,0.39338,1,1
1,GO RESPONSE TO REDOX STATE,0.0076503,0.34927,0.37296,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0082164,0.34915,0.5239,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0033675,0.34912,0.31341,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,0.00023453,0.3483,0.37046,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00035669,0.34808,0.3261,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0019312,0.34785,0.33811,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0094624,0.3475,0.23835,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00039093,0.34693,0.31301,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.0011254,0.34531,0.31577,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,9.8065e-05,0.34502,0.36663,1,1
1,GO CELL ACTIVATION,0.00079804,0.3443,0.29381,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.02631,0.34407,0.29451,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0013321,0.34394,0.39007,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00049043,0.34361,0.31077,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00017625,0.34328,0.32258,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0039282,0.34303,0.541,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0017799,0.34267,0.28908,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00037344,0.34241,0.2983,1,1
1,GO HISTONE PHOSPHORYLATION,0.00079804,0.3421,0.32802,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.01247,0.34203,0.28374,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0049293,0.34168,0.3669,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0020943,0.34081,0.35649,1,1
1,GO COPII COATED VESICLE BUDDING,0.010505,0.34003,0.24916,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0037806,0.34,0.36982,1,1
1,GO CHONDROCYTE PROLIFERATION,0.027983,0.33994,0.37475,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0025586,0.33963,0.32079,1,1
1,GO REGULATION OF CELL KILLING,0.028854,0.3394,0.22562,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0066217,0.33896,0.31298,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0097991,0.33876,0.27814,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0071194,0.33686,0.28956,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0025586,0.33657,0.33372,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,0.0020943,0.33644,0.34864,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.0037806,0.33603,0.3018,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00024585,0.33421,0.35784,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.027136,0.33286,0.23411,1,1
1,GO TISSUE REMODELING,0.0025586,0.33247,0.34244,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0025586,0.33223,0.34625,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.02631,0.33221,0.13242,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.0017084,0.33168,0.29804,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0066217,0.33078,0.27428,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0047478,0.33068,0.26124,1,1
1,GO L GLUTAMATE IMPORT,0.019808,0.33051,0.34073,1,1
1,GO COPPER ION TRANSPORT,0.0020943,0.33028,0.33388,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.0057193,0.32981,0.32618,1,1
1,GO REGULATION OF IMMUNE RESPONSE,0.00090875,0.32969,0.26204,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.010874,0.32962,0.21464,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00061317,0.32912,0.25284,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0138,0.32903,0.29453,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.0029959,0.32869,0.32791,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00023453,0.32858,0.40787,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00019396,0.32843,0.3217,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.0039282,0.32698,0.26543,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0042393,0.32658,0.29943,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00051298,0.32642,0.28317,1,1
1,GO NCRNA PROCESSING,0.0094624,0.32556,0.24733,1,1
1,GO STEROL TRANSPORT,0.0029959,0.32555,0.26333,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.0010786,0.325,0.25927,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.029747,0.32459,0.2119,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0063849,0.32424,0.40546,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0011254,0.32411,0.29288,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00076401,0.32314,0.28882,1,1
1,GO MITOPHAGY,0.0010336,0.32296,0.29299,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0094624,0.32288,0.21907,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.027136,0.32272,0.16052,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.004403,0.32271,0.28436,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0029959,0.32261,0.30334,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0085133,0.32252,0.22439,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00090875,0.32217,0.27074,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0076503,0.32139,0.32341,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00083347,0.32135,0.30044,1,1
1,GO GOLGI VESICLE BUDDING,0.0057193,0.32101,0.24958,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.005311,0.32066,0.43585,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.0025586,0.32038,0.30483,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.015254,0.32038,0.27482,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.010146,0.31995,0.24603,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0019312,0.31899,0.32959,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.014755,0.3189,0.35713,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0051169,0.31862,0.27115,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.013344,0.31862,0.21856,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0138,0.31823,0.26349,1,1
1,GO CELL AGING,0.00046881,0.31791,0.26021,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0071194,0.31776,0.33175,1,1
1,GO ACUTE PHASE RESPONSE,0.0085133,0.31766,0.40774,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0094624,0.31764,0.31292,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0055117,0.31742,0.30091,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0068665,0.31733,0.23884,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.00076401,0.31703,0.39889,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.019808,0.3168,0.22678,1,1
1,GO TRNA 5 END PROCESSING,0.0047478,0.31655,0.29119,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0013889,0.31471,0.33839,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.023222,0.31459,0.24079,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0012773,0.31457,0.28729,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0061556,0.31418,0.30553,1,1
1,GO REGULATION OF RNA BINDING,0.00073133,0.31375,0.32072,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00029645,0.31338,0.36172,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,8.4434e-05,0.31284,0.32998,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,0.005311,0.31232,0.26524,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0017084,0.31229,0.24249,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.001448,0.31216,0.2855,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.004403,0.31205,0.23747,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0097991,0.31197,0.22498,1,1
1,GO BODY FLUID SECRETION,0.0033675,0.31181,0.26323,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00056099,0.31163,0.28695,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00039093,0.31157,0.33753,1,1
1,GO LACTATION,0.0045725,0.31133,0.27968,1,1
1,GO AUTOPHAGOSOME MATURATION,0.00087036,0.31082,0.30058,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0129,0.31038,0.24251,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.023222,0.31037,0.27464,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0024588,0.30984,0.37363,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0015095,0.30973,0.2724,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0026621,0.30957,0.22588,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0015095,0.30822,0.29969,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0012773,0.30779,0.29545,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0129,0.30749,0.24024,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,0.023963,0.30702,0.28634,1,1
1,GO LEUKOCYTE MIGRATION,0.0076503,0.30688,0.26329,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00037344,0.30647,0.28106,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0055117,0.30644,0.28128,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00051298,0.30595,0.28831,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0049293,0.30569,0.25587,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0061556,0.30559,0.27939,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,6.9026e-05,0.30536,0.32615,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00061317,0.30507,0.33102,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0097991,0.30486,0.28138,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.017977,0.30415,0.19985,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0071194,0.30389,0.25982,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0015733,0.30361,0.24802,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0051169,0.30316,0.2536,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00029645,0.3016,0.38517,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0073805,0.30151,0.3897,1,1
1,GO REGULATION OF URINE VOLUME,0.00044809,0.30144,0.35241,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0024588,0.30115,0.28485,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0009903,0.3005,0.269,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.0079288,0.30034,0.22481,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0035004,0.29987,0.22725,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0009903,0.2992,0.30744,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.01918,0.29916,0.26254,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00032527,0.29895,0.31396,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0027694,0.29891,0.26719,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0079288,0.29701,0.28459,1,1
1,GO CHOLESTEROL EFFLUX,0.0016396,0.29697,0.33768,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0174,0.29669,0.21228,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00061317,0.29592,0.27585,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0042393,0.29553,0.27341,1,1
1,GO SELECTIVE AUTOPHAGY,0.00017625,0.29535,0.34248,1,1
1,GO REGULATION OF PROTEOLYSIS,0.0019312,0.29529,0.22156,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.01247,0.29487,0.25092,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0017084,0.29471,0.26837,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,7.2607e-05,0.29408,0.35187,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0051169,0.29374,0.29096,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.0039282,0.2936,0.25027,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0016396,0.29353,0.2501,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,8.8765e-05,0.29303,0.2897,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00056099,0.29243,0.3214,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.0020943,0.2922,0.30517,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0082164,0.2916,0.24347,1,1
1,GO NCRNA METABOLIC PROCESS,0.016296,0.29148,0.20964,1,1
1,GO RNA CATABOLIC PROCESS,0.00042822,0.29119,0.27157,1,1
1,GO GTP METABOLIC PROCESS,0.004403,0.28994,0.31782,1,1
1,GO MIDBODY ABSCISSION,0.0174,0.2897,0.24604,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.012053,0.2889,0.33688,1,1
1,GO CELL CHEMOTAXIS,0.0091361,0.28811,0.26497,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0049293,0.28804,0.2858,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.011255,0.28752,0.34996,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0017799,0.28587,0.25445,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0026621,0.28586,0.29716,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0059338,0.28556,0.27242,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.01427,0.28538,0.25681,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00027004,0.28332,0.37209,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0026621,0.2822,0.33814,1,1
1,GO REGULATION OF GENE SILENCING,0.0027694,0.2818,0.23182,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0018542,0.28178,0.2459,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0042393,0.28114,0.24641,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0071194,0.28093,0.21947,1,1
1,GO VIRION ASSEMBLY,0.00019396,0.28007,0.27249,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,0.0017799,0.2798,0.20907,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00073133,0.27899,0.29091,1,1
1,GO ORGANELLE INHERITANCE,0.019808,0.27889,0.21529,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.022501,0.27884,0.2583,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00053648,0.27856,0.27318,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,6.9026e-05,0.27845,0.28497,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00010828,0.2779,0.29225,1,1
1,GO MEMBRANE BIOGENESIS,0.0045725,0.27719,0.32902,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00027004,0.27717,0.25113,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0017799,0.27711,0.41705,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.01247,0.27711,0.24824,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.00094871,0.27664,0.31612,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0057193,0.27657,0.32932,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,0.0010336,0.27624,0.33449,1,1
1,GO PROTEIN PROCESSING,0.0026621,0.27593,0.2474,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00034064,0.27492,0.3533,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0042393,0.27489,0.20211,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,0.00083347,0.27476,0.25819,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0018542,0.27411,0.25338,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.004403,0.2739,0.24977,1,1
1,GO T CELL ACTIVATION,0.0023626,0.27308,0.24388,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.022501,0.2729,0.20753,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0036381,0.27253,0.20606,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.010874,0.27246,0.24599,1,1
1,GO REGULATION OF CELL ACTIVATION,0.0020943,0.27187,0.23831,1,1
1,GO REGULATION OF LIPID STORAGE,0.025507,0.27126,0.28547,1,1
1,GO RESPONSE TO IONIZING RADIATION,0.005311,0.2712,0.21356,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.0045725,0.27118,0.2261,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0027694,0.27103,0.26473,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0011741,0.27079,0.24984,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,0.0023626,0.26971,0.20734,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0015733,0.26937,0.29176,1,1
1,GO REGULATION OF PROTON TRANSPORT,0.0097991,0.26936,0.25771,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.027136,0.26867,0.18375,1,1
1,GO PROTEIN FOLDING,0.00029645,0.26847,0.28862,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0024588,0.26767,0.25128,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,0.00076401,0.26656,0.25945,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0027694,0.2663,0.23862,1,1
1,GO TRANSLATIONAL ELONGATION,0.011648,0.26624,0.216,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0040811,0.26535,0.27514,1,1
1,GO RIBOSOME BIOGENESIS,0.024724,0.26484,0.24216,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0040811,0.2628,0.23031,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.001448,0.26259,0.23713,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0017084,0.26224,0.25738,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.00040918,0.26196,0.25943,1,1
1,GO SEQUESTERING OF METAL ION,0.023222,0.26194,0.18423,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0082164,0.26165,0.27544,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00032527,0.26148,0.22853,1,1
1,GO HYPEROSMOTIC RESPONSE,0.025507,0.26139,0.22188,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0094624,0.26086,0.25108,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.015767,0.26014,0.21252,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0017799,0.26013,0.2237,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.013344,0.26,0.23682,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.0088198,0.25975,0.19569,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0021804,0.2594,0.27036,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0082164,0.25863,0.25012,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00024585,0.25817,0.27398,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.01684,0.25789,0.21621,1,1
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.027983,0.25721,0.36819,1,1
1,GO PLATELET MORPHOGENESIS,0.0040811,0.25716,0.2636,1,1
1,GO MACROPHAGE ACTIVATION,0.0063849,0.25691,0.28122,1,1
1,GO LYMPHOCYTE ACTIVATION,0.0019312,0.25556,0.22743,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0023626,0.25505,0.27287,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.010874,0.25436,0.22413,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0037806,0.25416,0.24466,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.00087036,0.25333,0.24746,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0094624,0.25269,0.22555,1,1
1,GO INTEGRIN ACTIVATION,0.020453,0.25257,0.25153,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0015095,0.25215,0.28539,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0068665,0.25204,0.22466,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0129,0.25185,0.20688,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.0036381,0.25144,0.22353,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00073133,0.25136,0.29996,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0042393,0.25055,0.19723,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0028806,0.24996,0.24307,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.00083347,0.24943,0.30607,1,1
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0029959,0.24795,0.27387,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.028854,0.24586,0.23883,1,1
1,GO AGING,0.0015095,0.24574,0.21411,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.005311,0.24473,0.23492,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0029959,0.24273,0.25086,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0026621,0.24238,0.21356,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.00064092,0.24227,0.19747,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0021804,0.24139,0.23107,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00010828,0.2412,0.30523,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0055117,0.24119,0.19868,1,1
1,GO DNA DEALKYLATION,0.021799,0.24054,0.19106,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0011741,0.23908,0.23526,1,1
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.024724,0.23897,0.23996,1,1
1,GO CELL KILLING,0.01427,0.23874,0.18595,1,1
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0073805,0.23836,0.20507,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0031154,0.23768,0.21274,1,1
1,GO RUFFLE ORGANIZATION,0.0017084,0.23669,0.22833,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0040811,0.23648,0.18764,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0076503,0.23609,0.28528,1,1
1,GO RNA 3 END PROCESSING,0.012053,0.23579,0.18574,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0079288,0.23566,0.24546,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.020453,0.23353,0.18248,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.027983,0.23274,0.18503,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0015733,0.23237,0.24815,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.0049293,0.23193,0.17053,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0015733,0.23149,0.29234,1,1
1,GO EXOCYTOSIS,0.0036381,0.23039,0.19673,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.013344,0.23014,0.22094,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0068665,0.22792,0.23582,1,1
1,GO PROTEIN TARGETING,0.0013321,0.22771,0.20152,1,1
1,GO PROTEIN MATURATION,0.0032392,0.22761,0.17571,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.019808,0.22637,0.23223,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00040918,0.22625,0.2334,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.015767,0.22594,0.17314,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.01684,0.22555,0.15858,1,1
1,GO PEPTIDE METABOLIC PROCESS,0.0013321,0.22554,0.20414,1,1
1,GO RESPONSE TO PH,0.023222,0.2253,0.22174,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.021799,0.22468,0.18606,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.015767,0.22437,0.15934,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.010505,0.22429,0.19933,1,1
1,GO ALDITOL METABOLIC PROCESS,0.027983,0.22395,0.19779,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0061556,0.22316,0.16887,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.011648,0.22183,0.15504,1,1
1,GO PROTEIN KINASE A SIGNALING,0.0017799,0.22161,0.24221,1,1
1,GO VACUOLAR ACIDIFICATION,0.016296,0.22086,0.18386,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00064092,0.22045,0.22047,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0012247,0.22027,0.22859,1,1
1,GO REGULATION OF TUBE SIZE,0.023222,0.2201,0.1861,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0031154,0.21992,0.20298,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0013321,0.21918,0.22804,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.0138,0.21713,0.16838,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0040811,0.21641,0.26972,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0020943,0.21524,0.18149,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.02631,0.21328,0.14753,1,1
1,GO REGULATION OF CHEMOTAXIS,0.0055117,0.21321,0.19939,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.011648,0.21099,0.19799,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.010874,0.20667,0.18544,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0035004,0.20623,0.18574,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00051298,0.20563,0.20388,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0017799,0.2041,0.28011,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.0013321,0.20373,0.22173,1,1
1,GO RNA MODIFICATION,0.017977,0.20336,0.1457,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.0020112,0.20157,0.23836,1,1
1,GO OXALATE TRANSPORT,0.014755,0.20098,0.17931,1,1
1,GO B CELL ACTIVATION,0.011648,0.19989,0.15476,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.0023626,0.19821,0.22342,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0049293,0.19817,0.17224,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0085133,0.19795,0.19838,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0032392,0.19741,0.19865,1,1
1,GO RNA CAPPING,0.0023626,0.19701,0.19092,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00034064,0.19601,0.19197,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00037344,0.1947,0.17194,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.00027004,0.19467,0.17166,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.0013321,0.19442,0.20518,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00053648,0.19368,0.1637,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.011648,0.19346,0.22741,1,1
1,GO MAINTENANCE OF LOCATION,0.0009903,0.19344,0.20355,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0025586,0.19318,0.20813,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0088198,0.19238,0.14665,1,1
1,GO REGULATION OF ERAD PATHWAY,0.00019396,0.19199,0.2395,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.023963,0.19067,0.17276,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.011255,0.19027,0.20625,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.028854,0.1898,0.14222,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0011254,0.18873,0.19551,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0020112,0.18741,0.17289,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,0.00023453,0.18643,0.18397,1,1
1,GO PROTEOLYSIS,0.0037806,0.1852,0.14262,1,1
1,GO NOTCH RECEPTOR PROCESSING,0.01918,0.18437,0.34071,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0091361,0.18381,0.17211,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.010505,0.18337,0.1891,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0017799,0.18311,0.21622,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.0094624,0.18306,0.15584,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0057193,0.18235,0.15856,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,0.00056099,0.18168,0.16691,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.020453,0.1813,0.14213,1,1
1,GO SPINDLE LOCALIZATION,0.0042393,0.17909,0.18471,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0073805,0.17844,0.17058,1,1
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.015254,0.17293,0.1875,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.022501,0.17187,0.12369,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.012053,0.17137,0.11769,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.0051169,0.17077,0.14871,1,1
1,GO VIRAL BUDDING,0.0061556,0.16703,0.17834,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.00049043,0.16569,0.17353,1,1
1,GO REGULATION OF BINDING,0.01247,0.16435,0.14962,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0174,0.16337,0.13386,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,0.0039282,0.16139,0.15198,1,1
1,GO ACTIVATION OF MAPK ACTIVITY,0.021799,0.16133,0.12371,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0016396,0.15943,0.25471,1,1
1,GO MEMBRANE ORGANIZATION,0.0036381,0.15937,0.14085,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0011254,0.15931,0.18336,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.022501,0.15897,0.20624,1,1
1,GO SULFATE TRANSPORT,0.0033675,0.15822,0.16925,1,1
1,GO VACUOLE ORGANIZATION,0.0036381,0.1573,0.15543,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00083347,0.15591,0.16503,1,1
1,GO NUCLEUS ORGANIZATION,0.020453,0.15335,0.10748,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0061556,0.15315,0.16529,1,1
1,GO POSTREPLICATION REPAIR,0.028854,0.1519,0.12136,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0012247,0.15,0.14839,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.021799,0.14528,0.1296,1,1
1,GO RNA SURVEILLANCE,0.021117,0.14069,0.18646,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.027983,0.14058,0.12275,1,1
1,GO CELLULAR SENESCENCE,0.015767,0.14012,0.13919,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.013344,0.13726,0.16169,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0036381,0.13564,0.15424,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0009903,0.13326,0.14355,1,1
1,GO VESICLE ORGANIZATION,0.021799,0.13047,0.11341,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.010505,0.12903,0.10155,1,1
1,GO MRNA CLEAVAGE,0.020453,0.12477,0.12648,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00013179,1.0901,1.0674,1,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00079804,0.97801,0.99823,1,0
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0045725,0.85362,0.78609,1,0
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0071194,0.73421,0.61653,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00058654,0.71891,0.65512,1,0
1,GO LATERAL MESODERM DEVELOPMENT,0.00090875,0.65266,0.56371,1,0
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00035669,0.6522,0.66766,1,0
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.00018491,0.64919,0.65598,1,0
1,GO HIPPO SIGNALING,0.0019312,0.63876,0.53912,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0016396,0.63307,0.58163,1,0
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00087036,0.63094,0.59757,1,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0022699,0.62869,0.58372,1,0
1,GO NOTOCHORD DEVELOPMENT,0.00056099,0.60145,0.61508,1,0
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0022699,0.60034,0.46182,1,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0076503,0.58188,0.52039,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0002237,0.57822,0.73106,1,0
1,GO BONE TRABECULA FORMATION,0.019808,0.56872,0.74511,1,0
1,GO ELASTIC FIBER ASSEMBLY,0.0057193,0.55268,0.92306,1,0
1,GO CELLULAR RESPONSE TO X RAY,0.0082164,0.54477,0.40732,1,0
1,GO RESPONSE TO NITROSATIVE STRESS,0.0028806,0.5436,0.4747,1,0
1,GO SALIVARY GLAND DEVELOPMENT,0.00034064,0.54152,0.66429,1,0
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.029747,0.54054,0.55549,1,0
1,GO FORMATION OF PRIMARY GERM LAYER,0.00016006,0.54024,0.57107,1,0
1,GO TOLERANCE INDUCTION,0.0068665,0.5387,0.52327,1,0
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0049293,0.53081,0.49899,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00035669,0.52955,0.53075,1,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0036381,0.51367,0.53632,1,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0094624,0.50117,0.53437,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00010305,0.49924,0.57327,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00090875,0.48916,0.49096,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.0031154,0.48893,0.53089,1,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0073805,0.48865,0.44327,1,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.01684,0.48764,0.40633,1,0
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00066983,0.48701,0.55525,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0021804,0.48686,0.49288,1,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0091361,0.4819,0.59269,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.010505,0.48131,0.40596,1,0
1,GO AORTIC VALVE DEVELOPMENT,0.00076401,0.48023,0.55619,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0035004,0.47932,0.50968,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00053648,0.46563,0.50112,1,0
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00042822,0.46326,0.42727,1,0
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00094871,0.46105,0.4871,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0012773,0.45999,0.42229,1,0
1,GO COLLAGEN FIBRIL ORGANIZATION,0.00061317,0.45761,0.83631,1,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.012053,0.45761,0.3588,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0049293,0.45659,0.42552,1,0
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0011254,0.45535,0.41366,1,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.015767,0.45511,0.44213,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.021117,0.44894,0.42402,1,0
1,GO MESODERMAL CELL DIFFERENTIATION,0.0009903,0.44825,0.39872,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.0020943,0.44623,0.57209,1,0
1,GO REGULATION OF VASCULOGENESIS,0.0068665,0.44618,0.47487,1,0
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.020453,0.44485,0.34519,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0033675,0.44478,0.42416,1,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0021804,0.44328,0.56981,1,0
1,GO BASEMENT MEMBRANE ASSEMBLY,0.016296,0.43953,0.59215,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00090875,0.4365,0.44964,1,0
1,GO THYMOCYTE APOPTOTIC PROCESS,0.00090875,0.43217,0.42905,1,0
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0076503,0.42929,0.39924,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0037806,0.42826,0.44372,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0129,0.42655,0.36472,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0049293,0.42446,0.41632,1,0
1,GO PROTEIN ACTIVATION CASCADE,0.0011741,0.42385,0.43495,1,0
1,GO AMINOGLYCAN CATABOLIC PROCESS,0.0015095,0.42363,0.50179,1,0
1,GO PROTEIN TARGETING TO LYSOSOME,0.0009903,0.42211,0.40129,1,0
1,GO CELLULAR RESPONSE TO SALT STRESS,0.0020943,0.42199,0.44569,1,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.023222,0.41581,0.46892,1,0
1,GO BONE GROWTH,0.0020943,0.41499,0.48224,1,0
1,GO MAMMARY GLAND MORPHOGENESIS,0.00069995,0.41402,0.41253,1,0
1,GO CHONDROCYTE DEVELOPMENT,0.0024588,0.409,0.48751,1,0
1,GO MUSCLE CELL FATE COMMITMENT,0.012053,0.4067,0.36837,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0085133,0.40416,0.37836,1,0
1,GO FIBROBLAST MIGRATION,0.0013321,0.40377,0.44933,1,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.02631,0.40185,0.41075,1,0
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.013344,0.401,0.33155,1,0
1,GO I KAPPAB PHOSPHORYLATION,0.0027694,0.39919,0.32071,1,0
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0026621,0.39558,0.36844,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0037806,0.39389,0.40099,1,0
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.016296,0.39331,0.37846,1,0
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.021117,0.39138,0.26333,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0079288,0.39133,0.36291,1,0
1,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010146,0.39054,0.30659,1,0
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00083347,0.38964,0.33628,1,0
1,GO CELL SUBSTRATE ADHESION,0.00053648,0.38831,0.46403,1,0
1,GO REGULATION OF HIPPO SIGNALING,0.0129,0.38786,0.33859,1,0
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0017799,0.38779,0.41283,1,0
1,GO RESPONSE TO SALT STRESS,0.00029645,0.38733,0.39116,1,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0129,0.38507,0.31351,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.01427,0.38304,0.3658,1,0
1,GO FIBROBLAST PROLIFERATION,0.0037806,0.38263,0.34602,1,0
1,GO REGULATION OF RIBOSOME BIOGENESIS,0.0091361,0.38002,0.36968,1,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00031055,0.37909,0.42861,1,0
1,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00037344,0.37882,0.35985,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,0.0027694,0.37596,0.35589,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0031154,0.37568,0.32714,1,0
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0068665,0.37534,0.40114,1,0
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0020943,0.37409,0.33955,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0057193,0.37245,0.33196,1,0
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00083347,0.37174,0.36361,1,0
1,GO MATURATION OF LSU RRNA,0.011255,0.37094,0.37633,1,0
1,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0009903,0.36841,0.31463,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0085133,0.36432,0.35415,1,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.010146,0.36097,0.50409,1,0
1,GO ENDOTHELIAL CELL MIGRATION,0.00049043,0.36086,0.41701,1,0
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0071194,0.36035,0.38577,1,0
1,GO MUSCLE CELL PROLIFERATION,0.00094871,0.35924,0.34286,1,0
1,GO GLAND MORPHOGENESIS,0.0020112,0.35758,0.38207,1,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0091361,0.35654,0.35491,1,0
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.021799,0.35482,0.26695,1,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.025507,0.3548,0.30146,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.023963,0.35409,0.37419,1,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.004403,0.35371,0.45569,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0061556,0.35196,0.30244,1,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0066217,0.35185,0.35593,1,0
1,GO GASTRULATION,0.00049043,0.35122,0.37156,1,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.020453,0.35072,0.35316,1,0
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0097991,0.35034,0.32876,1,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0055117,0.35031,0.39707,1,0
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0013889,0.3455,0.4507,1,0
1,GO VASCULATURE DEVELOPMENT,0.0012247,0.34509,0.33449,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0076503,0.34427,0.30552,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.012053,0.34341,0.38086,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0057193,0.3427,0.35851,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0097991,0.34254,0.42431,1,0
1,GO BLOOD VESSEL MORPHOGENESIS,0.00087036,0.3422,0.34532,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0068665,0.3422,0.33217,1,0
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.01857,0.33966,0.35309,1,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0085133,0.33926,0.39214,1,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.023222,0.33866,0.35196,1,0
1,GO FOREGUT MORPHOGENESIS,0.01857,0.33715,0.26828,1,0
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.01427,0.33701,0.35211,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0020943,0.33657,0.30353,1,0
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0049293,0.3354,0.29862,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.013344,0.33516,0.39197,1,0
1,GO RESPONSE TO CORTICOSTEROID,0.0028806,0.33343,0.27085,1,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00058654,0.33104,0.41341,1,0
1,GO ACTIVATION OF MAPKK ACTIVITY,0.0037806,0.32904,0.3427,1,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0076503,0.32892,0.40716,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.019808,0.32852,0.33857,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.01684,0.32793,0.27282,1,0
1,GO TISSUE MIGRATION,0.0017799,0.32687,0.34786,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0015733,0.32682,0.53946,1,0
1,GO MATERNAL PLACENTA DEVELOPMENT,0.0055117,0.32606,0.38202,1,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.019808,0.3257,0.6049,1,0
1,GO SYNCYTIUM FORMATION,0.0016396,0.32509,0.4121,1,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028806,0.32473,0.33992,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.0055117,0.32218,0.35915,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.01684,0.32057,0.3544,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0066217,0.3195,0.45245,1,0
1,GO REGENERATION,0.00025768,0.31891,0.33182,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0068665,0.31874,0.29357,1,0
1,GO TISSUE REGENERATION,0.0020943,0.31861,0.34253,1,0
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0029959,0.31854,0.41136,1,0
1,GO MYOBLAST DIFFERENTIATION,0.00087036,0.3179,0.32258,1,0
1,GO CELL REDOX HOMEOSTASIS,0.0035004,0.31711,0.29156,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.01247,0.31677,0.32588,1,0
1,GO PIGMENT ACCUMULATION,0.023222,0.31572,0.24745,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0097991,0.31556,0.31832,1,0
1,GO MACROPHAGE MIGRATION,0.00044809,0.31458,0.43183,1,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0097991,0.31432,0.31367,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0010336,0.3141,0.34348,1,0
1,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0018542,0.313,0.34885,1,0
1,GO MACROPHAGE CHEMOTAXIS,0.0036381,0.31289,0.4087,1,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0097991,0.31253,0.26686,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0031154,0.31246,0.35739,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0066217,0.31066,0.33791,1,0
1,GO REGULATION OF PODOSOME ASSEMBLY,0.011648,0.31063,0.45858,1,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0042393,0.30863,0.39214,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0071194,0.30745,0.39064,1,0
1,GO CHONDROCYTE DIFFERENTIATION,0.0012247,0.30594,0.3623,1,0
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.013344,0.30553,0.28529,1,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0028806,0.3054,0.29726,1,0
1,GO LYMPH VESSEL DEVELOPMENT,0.0174,0.30457,0.2443,1,0
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.016296,0.30428,0.27657,1,0
1,GO TRANSLATIONAL TERMINATION,0.013344,0.30384,0.23268,1,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0066217,0.30363,0.36224,1,0
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.024724,0.30355,0.317,1,0
1,GO MESODERM MORPHOGENESIS,0.00064092,0.30256,0.32882,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0025586,0.30073,0.30526,1,0
1,GO ACTIN FILAMENT SEVERING,0.0174,0.30047,0.37963,1,0
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0011741,0.3004,0.36205,1,0
1,GO CELL MATRIX ADHESION,0.0028806,0.3002,0.38028,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0079288,0.3001,0.24649,1,0
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0036381,0.30001,0.34815,1,0
1,GO AUTOPHAGY OF NUCLEUS,0.0032392,0.29922,0.28385,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.016296,0.29794,0.34717,1,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.022501,0.29754,0.36076,1,0
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.017977,0.29566,0.38137,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0023626,0.29255,0.28507,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0045725,0.29243,0.27175,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.029747,0.29168,0.30141,1,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.00094871,0.29052,0.29954,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0019312,0.29008,0.31813,1,0
1,GO CELLULAR RESPONSE TO LIPID,0.0076503,0.28956,0.21513,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0019312,0.28753,0.2634,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0082164,0.28752,0.30992,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0129,0.2872,0.30314,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.023222,0.28688,0.39515,1,0
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.025507,0.28637,0.33977,1,0
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.022501,0.28637,0.55937,1,0
1,GO PROTEIN KINASE B SIGNALING,0.0012247,0.28635,0.24599,1,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0059338,0.28628,0.2883,1,0
1,GO IRON ION HOMEOSTASIS,0.0022699,0.28582,0.24625,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.011648,0.28377,0.24074,1,0
1,GO PLASMA MEMBRANE TUBULATION,0.00090875,0.28369,0.34035,1,0
1,GO SUPEROXIDE ANION GENERATION,0.01427,0.2827,0.32675,1,0
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0071194,0.28267,0.2989,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.024724,0.28158,0.27181,1,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0061556,0.28139,0.27172,1,0
1,GO PIGMENT METABOLIC PROCESS,0.0047478,0.28118,0.23424,1,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.023963,0.28114,0.24398,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.017977,0.28093,0.28951,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020453,0.28067,0.24487,1,0
1,GO REGULATION OF CELL MATRIX ADHESION,0.0049293,0.28015,0.40218,1,0
1,GO ERK1 AND ERK2 CASCADE,0.00069995,0.27998,0.2854,1,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0018542,0.27968,0.2703,1,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.013344,0.2775,0.27401,1,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0017084,0.27632,0.29912,1,0
1,GO LUNG MORPHOGENESIS,0.019808,0.27556,0.19221,1,0
1,GO MATURATION OF 5 8S RRNA,0.022501,0.27505,0.25242,1,0
1,GO CHEMOKINE PRODUCTION,0.0091361,0.27449,0.27651,1,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.021799,0.27326,0.24457,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0033675,0.27307,0.43475,1,0
1,GO CARTILAGE DEVELOPMENT,0.0035004,0.27281,0.28986,1,0
1,GO RNA 5 END PROCESSING,0.015767,0.27254,0.24496,1,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.01427,0.27086,0.34077,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00079804,0.27,0.35571,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.028854,0.2691,0.24815,1,0
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0051169,0.26857,0.35631,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0088198,0.26841,0.24213,1,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0079288,0.2673,0.29124,1,0
1,GO PODOSOME ASSEMBLY,0.011255,0.26618,0.38144,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0049293,0.26613,0.25936,1,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0059338,0.26561,0.27081,1,0
1,GO PROTEIN DEGLYCOSYLATION,0.017977,0.26522,0.29839,1,0
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.01247,0.26473,0.23032,1,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.022501,0.26451,0.21035,1,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.01684,0.26356,0.16948,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0027694,0.26307,0.27565,1,0
1,GO RESPONSE TO THYROID HORMONE,0.0097991,0.26129,0.31099,1,0
1,GO OSTEOBLAST DIFFERENTIATION,0.0018542,0.25945,0.29859,1,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0138,0.25848,0.23913,1,0
1,GO POSITIVE CHEMOTAXIS,0.01918,0.25823,0.28631,1,0
1,GO AMINO SUGAR METABOLIC PROCESS,0.0039282,0.25808,0.25325,1,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0071194,0.25716,0.27589,1,0
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0068665,0.25677,0.32001,1,0
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0055117,0.25624,0.25974,1,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0085133,0.25621,0.33379,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0071194,0.25585,0.23298,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0051169,0.25435,0.38252,1,0
1,GO INNER CELL MASS CELL PROLIFERATION,0.011648,0.25349,0.26394,1,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0051169,0.25143,0.247,1,0
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.027136,0.24808,0.31725,1,0
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0015095,0.24797,0.24672,1,0
1,GO REGULATION OF CELL ADHESION,0.019808,0.24772,0.20405,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.027983,0.24719,0.39161,1,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.01857,0.24664,0.23002,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.015767,0.24621,0.26285,1,0
1,GO REGULATION OF LIGASE ACTIVITY,0.0066217,0.24607,0.34787,1,0
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0019312,0.24527,0.27517,1,0
1,GO PHAGOCYTOSIS RECOGNITION,0.028854,0.2447,0.4962,1,0
1,GO FOAM CELL DIFFERENTIATION,0.01918,0.24429,0.32323,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0061556,0.24331,0.17013,1,0
1,GO CORONARY VASCULATURE DEVELOPMENT,0.016296,0.24293,0.25723,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0042393,0.24272,0.3169,1,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.020453,0.24228,0.24401,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0045725,0.24163,0.20656,1,0
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.011648,0.24154,0.27855,1,0
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0028806,0.24093,0.34304,1,0
1,GO RESPONSE TO STEROID HORMONE,0.010505,0.23976,0.1779,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.027983,0.23964,0.25336,1,0
1,GO BONE MORPHOGENESIS,0.01427,0.23858,0.23997,1,0
1,GO HYPOTONIC RESPONSE,0.025507,0.23837,0.28249,1,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.015254,0.23831,0.29989,1,0
1,GO TETRAPYRROLE METABOLIC PROCESS,0.01247,0.2381,0.20815,1,0
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.0032392,0.23752,0.22057,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0042393,0.23713,0.23487,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.01427,0.23677,0.23203,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0066217,0.23589,0.19308,1,0
1,GO REGULATION OF ORGAN GROWTH,0.0020943,0.23481,0.21476,1,0
1,GO OSTEOCLAST DIFFERENTIATION,0.0021804,0.23412,0.2263,1,0
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.01247,0.23341,0.19404,1,0
1,GO PROTEIN KINASE C SIGNALING,0.028854,0.233,0.1718,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0037806,0.23264,0.21269,1,0
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0071194,0.23145,0.26984,1,0
1,GO T CELL PROLIFERATION,0.0073805,0.23059,0.23307,1,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.011648,0.23055,0.23108,1,0
1,GO MESODERM DEVELOPMENT,0.0057193,0.23004,0.17313,1,0
1,GO AMINOGLYCAN METABOLIC PROCESS,0.0068665,0.22975,0.2788,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013344,0.22941,0.20802,1,0
1,GO RESPONSE TO TESTOSTERONE,0.011255,0.22919,0.20678,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.01684,0.2288,0.22285,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.0063849,0.22828,0.20666,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.011648,0.22781,0.21136,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY,0.00069995,0.22771,0.27079,1,0
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00090875,0.2257,0.44719,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.010146,0.22356,0.25569,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.016296,0.22337,0.16862,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0039282,0.22329,0.22273,1,0
1,GO POSITIVE REGULATION OF ORGAN GROWTH,0.017977,0.2225,0.25056,1,0
1,GO PROTEIN DENEDDYLATION,0.0091361,0.2209,0.22532,1,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.029747,0.22082,0.25622,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0174,0.22026,0.14924,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0016396,0.21852,0.25627,1,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.010874,0.21722,0.22505,1,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.021117,0.21694,0.24738,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,0.0068665,0.21681,0.27298,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0063849,0.2167,0.22127,1,0
1,GO LEUKOCYTE PROLIFERATION,0.012053,0.21373,0.20127,1,0
1,GO REGULATION OF HEMOPOIESIS,0.0019312,0.21332,0.20774,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0025586,0.2131,0.2066,1,0
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00069995,0.21232,0.24332,1,0
1,GO RESPONSE TO ISCHEMIA,0.01247,0.21144,0.19493,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,0.0055117,0.21043,0.22164,1,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0079288,0.20996,0.2806,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0020943,0.20982,0.18708,1,0
1,GO RESPONSE TO LIPID,0.0174,0.20952,0.17091,1,0
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.014755,0.20867,0.30952,1,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.013344,0.20853,0.24466,1,0
1,GO REGULATION OF HEART MORPHOGENESIS,0.021117,0.20823,0.27133,1,0
1,GO PLACENTA DEVELOPMENT,0.021799,0.20736,0.17936,1,0
1,GO LEUKOCYTE HOMEOSTASIS,0.0073805,0.20711,0.22393,1,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0057193,0.20596,0.24905,1,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.010146,0.2058,0.20974,1,0
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.01918,0.20498,0.17848,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0057193,0.20436,0.25466,1,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0029959,0.20431,0.23098,1,0
1,GO METANEPHROS DEVELOPMENT,0.023222,0.20399,0.17073,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.019808,0.20393,0.19566,1,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.023963,0.20383,0.16409,1,0
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0032392,0.2034,0.22874,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.021799,0.20337,0.18367,1,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0042393,0.20191,0.25729,1,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.01918,0.20178,0.15786,1,0
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0031154,0.20123,0.1875,1,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0063849,0.20065,0.24921,1,0
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.027136,0.20036,0.22157,1,0
1,GO TRANSLESION SYNTHESIS,0.021117,0.20032,0.16974,1,0
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.023222,0.19945,0.16472,1,0
1,GO NEGATIVE REGULATION OF CELL DEATH,0.0045725,0.19911,0.16617,1,0
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0028806,0.19882,0.20334,1,0
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.01857,0.19781,0.15605,1,0
1,GO BONE REMODELING,0.020453,0.19725,0.222,1,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0009903,0.1971,0.20212,1,0
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0068665,0.19618,0.21596,1,0
1,GO TUBE MORPHOGENESIS,0.0076503,0.19592,0.20839,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0029959,0.19562,0.19941,1,0
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00076401,0.19547,0.2272,1,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0051169,0.19493,0.21372,1,0
1,GO MITOCHONDRIAL DNA REPLICATION,0.019808,0.19382,0.16768,1,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.023963,0.19374,0.24066,1,0
1,GO MYELOID CELL HOMEOSTASIS,0.0017084,0.19355,0.22799,1,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.022501,0.19355,0.16304,1,0
1,GO NUCLEAR EXPORT,0.0129,0.19231,0.14203,1,0
1,GO SCHWANN CELL DIFFERENTIATION,0.019808,0.19017,0.1869,1,0
1,GO BLASTOCYST FORMATION,0.015767,0.19002,0.18189,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,0.013344,0.18883,0.1553,1,0
1,GO RNA DESTABILIZATION,0.024724,0.18796,0.18308,1,0
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.011648,0.18733,0.22767,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.020453,0.18713,0.19611,1,0
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.01684,0.18701,0.34716,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0129,0.18676,0.22092,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.027983,0.18664,0.16174,1,0
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.022501,0.18461,0.19581,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0071194,0.18374,0.25745,1,0
1,GO RESPONSE TO ATP,0.0039282,0.18291,0.2009,1,0
1,GO VESICLE CARGO LOADING,0.016296,0.18156,0.2255,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.021117,0.18026,0.15214,1,0
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0010336,0.17992,0.23173,1,0
1,GO REGULATION OF HEART GROWTH,0.021117,0.17971,0.16918,1,0
1,GO REGULATION OF BIOMINERALIZATION,0.021117,0.17939,0.27443,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.023222,0.17938,0.18307,1,0
1,GO SULFUR COMPOUND TRANSPORT,0.0021804,0.17924,0.19654,1,0
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.021117,0.17915,0.19177,1,0
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0063849,0.17909,0.1779,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.028854,0.17906,0.17515,1,0
1,GO MESENCHYME DEVELOPMENT,0.010874,0.17799,0.18239,1,0
1,GO LEUKOCYTE DIFFERENTIATION,0.0057193,0.17798,0.18761,1,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0063849,0.17772,0.19832,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.029747,0.17762,0.19249,1,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0073805,0.17755,0.2209,1,0
1,GO OSSIFICATION,0.011255,0.17745,0.21805,1,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.015767,0.17669,0.14654,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.0045725,0.17636,0.21111,1,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.028854,0.17607,0.23881,1,0
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.004403,0.17561,0.15611,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.022501,0.17549,0.13212,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0017799,0.17503,0.22395,1,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0061556,0.17501,0.15168,1,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0129,0.17387,0.1826,1,0
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0017799,0.17366,0.18501,1,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.0129,0.17285,0.15156,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.01684,0.17172,0.19567,1,0
1,GO CELLULAR EXTRAVASATION,0.01247,0.17118,0.23474,1,0
1,GO LYSOSOMAL TRANSPORT,0.0040811,0.17108,0.16711,1,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0021804,0.16889,0.1771,1,0
1,GO REGULATION OF MAPK CASCADE,0.0040811,0.16877,0.18318,1,0
1,GO GOLGI VESICLE TRANSPORT,0.0015095,0.16824,0.17442,1,0
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00046881,0.16756,0.17111,1,0
1,GO VACUOLAR TRANSPORT,0.0042393,0.16747,0.15532,1,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.01857,0.16632,0.14843,1,0
1,GO T CELL DIFFERENTIATION,0.01918,0.16585,0.1407,1,0
1,GO MYELOID CELL DIFFERENTIATION,0.0025586,0.16524,0.17407,1,0
1,GO EPITHELIAL CELL PROLIFERATION,0.027983,0.1635,0.17203,1,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.01918,0.16341,0.16295,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0097991,0.16297,0.15078,1,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.01684,0.16201,0.16804,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.010146,0.16201,0.16622,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.0023626,0.16082,0.20451,1,0
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0059338,0.15851,0.1672,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.017977,0.15717,0.20592,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.021799,0.15672,0.203,1,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.029747,0.1566,0.11836,1,0
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.00073133,0.1566,0.16938,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.02631,0.15635,0.13564,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.015767,0.15589,0.14781,1,0
1,GO RESPONSE TO HEAT,0.021117,0.15569,0.15967,1,0
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0091361,0.15554,0.14988,1,0
1,GO PROTEIN POLYUBIQUITINATION,0.011648,0.15482,0.12822,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.021799,0.15473,0.12655,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0174,0.15385,0.17133,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.027983,0.15227,0.15648,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0068665,0.15192,0.16214,1,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.021799,0.15135,0.1702,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0059338,0.15128,0.15867,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0071194,0.15044,0.1556,1,0
1,GO PROTEIN CATABOLIC PROCESS,0.00079804,0.14992,0.15073,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.011255,0.14985,0.14424,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.015254,0.14971,0.17886,1,0
1,GO GLOMERULUS DEVELOPMENT,0.016296,0.14969,0.32743,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0057193,0.14954,0.18088,1,0
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0032392,0.14809,0.2035,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.020453,0.14776,0.12993,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0042393,0.1463,0.15077,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.012053,0.14457,0.14622,1,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0031154,0.14423,0.13969,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0129,0.14411,0.12811,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.027983,0.14385,0.16741,1,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.010505,0.14356,0.16617,1,0
1,GO REGULATION OF PROTEIN BINDING,0.0042393,0.14346,0.17861,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.021799,0.14327,0.12552,1,0
1,GO T CELL CHEMOTAXIS,0.0138,0.14295,0.20078,1,0
1,GO REGULATION OF SENSORY PERCEPTION,0.025507,0.14236,0.15988,1,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.015767,0.14232,0.16515,1,0
1,GO BONE DEVELOPMENT,0.022501,0.1423,0.19098,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,0.0057193,0.14217,0.14433,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.011648,0.14201,0.12137,1,0
1,GO RESPONSE TO GAMMA RADIATION,0.025507,0.14111,0.15769,1,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.023963,0.14073,0.25248,1,0
1,GO REGULATION OF CATABOLIC PROCESS,0.0012773,0.14014,0.14995,1,0
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0088198,0.13967,0.1785,1,0
1,GO HEART VALVE DEVELOPMENT,0.020453,0.13959,0.27497,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.013344,0.13956,0.12082,1,0
1,GO REGULATION OF CELL DEATH,0.021799,0.13892,0.11721,1,0
1,GO APOPTOTIC PROCESS,0.01247,0.13862,0.12142,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0012773,0.13685,0.1516,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0076503,0.13666,0.19867,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.025507,0.13498,0.16241,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.028854,0.13473,0.12228,1,0
1,GO REGULATION OF PHOSPHORYLATION,0.027136,0.13315,0.11633,1,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.025507,0.13301,0.16842,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0091361,0.13269,0.14002,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0068665,0.13265,0.1307,1,0
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.01918,0.13202,0.1742,1,0
1,GO ENDOSOME ORGANIZATION,0.01247,0.13154,0.13716,1,0
1,GO ERYTHROCYTE HOMEOSTASIS,0.0063849,0.13151,0.17443,1,0
1,GO ENDOCYTOSIS,0.010874,0.13146,0.156,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.011255,0.13138,0.13313,1,0
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.011255,0.13089,0.14498,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.024724,0.13004,0.14276,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.011255,0.12998,0.11848,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.015767,0.12858,0.15409,1,0
1,GO DNA BIOSYNTHETIC PROCESS,0.0031154,0.12756,0.13344,1,0
1,GO RECEPTOR METABOLIC PROCESS,0.0088198,0.12621,0.16495,1,0
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.02631,0.12524,0.14158,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0047478,0.12475,0.14493,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01857,0.12298,0.21235,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.011648,0.12201,0.11407,1,0
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.015767,0.119,0.15975,1,0
1,GO MRNA METABOLIC PROCESS,0.020453,0.11822,0.11597,1,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0068665,0.11805,0.15437,1,0
1,GO NEGATIVE REGULATION OF SIGNALING,0.0057193,0.1141,0.13219,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0071194,0.11381,0.14011,1,0
1,GO GOLGI ORGANIZATION,0.014755,0.11255,0.11853,1,0
1,GO AUTOPHAGY OF MITOCHONDRION,0.0059338,0.11255,0.15128,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0020943,0.11252,0.13002,1,0
1,GO TISSUE MORPHOGENESIS,0.027983,0.11204,0.12705,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0174,0.10948,0.10227,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.010505,0.10842,0.10232,1,0
1,GO MACROAUTOPHAGY,0.0026621,0.10699,0.11518,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.013344,0.10681,0.12926,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0066217,0.1062,0.10705,1,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.021799,0.10498,0.1106,1,0
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.025507,0.10442,0.15869,1,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.004403,0.10406,0.12027,1,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0015733,0.10161,0.10099,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0138,0.10157,0.11338,1,0
1,GO REGULATION OF AUTOPHAGY,0.01918,0.093936,0.11388,1,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.01857,0.092237,0.099461,1,0
1,GO NUCLEOTIDE EXCISION REPAIR,0.024724,0.089241,0.11045,1,0
1,GO RESPONSE TO GROWTH FACTOR,0.028854,0.088923,0.14893,1,0
1,GO ORGANELLE DISASSEMBLY,0.0063849,0.088588,0.1237,1,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.02631,0.084882,0.098934,1,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.010874,0.082218,0.078971,1,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.027983,-0.077087,-0.069242,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.01684,-0.077779,-0.10184,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.025507,-0.083477,-0.088285,1,0
1,GO RESPONSE TO CARBOHYDRATE,0.01684,-0.083861,-0.10032,1,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0138,-0.085956,-0.10276,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.010505,-0.093447,-0.11718,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.01427,-0.095603,-0.095601,1,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.025507,-0.097059,-0.1011,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.014755,-0.098689,-0.15641,1,0
1,GO RESPONSE TO MONOSACCHARIDE,0.0066217,-0.099028,-0.11967,1,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.0047478,-0.10159,-0.10112,1,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.0059338,-0.10286,-0.12616,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.020453,-0.10458,-0.16258,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.01918,-0.10624,-0.14528,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.01857,-0.10661,-0.12806,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0028806,-0.1086,-0.18538,1,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.013344,-0.10864,-0.18813,1,0
1,GO CELL CYCLE DNA REPLICATION,0.01857,-0.10905,-0.19187,1,0
1,GO NUCLEOSOME ORGANIZATION,0.024724,-0.11014,-0.13943,1,0
1,GO METHYLATION,0.010505,-0.11097,-0.096683,1,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0063849,-0.11349,-0.10048,1,0
1,GO HETEROCHROMATIN ORGANIZATION,0.0073805,-0.11385,-0.11813,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0097991,-0.11541,-0.14557,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.021799,-0.11613,-0.10579,1,0
1,GO GERM CELL DEVELOPMENT,0.024724,-0.12051,-0.092002,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.014755,-0.12232,-0.10702,1,0
1,GO CHROMATIN ORGANIZATION,0.00017625,-0.12325,-0.13577,1,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.024724,-0.12334,-0.17036,1,0
1,GO COVALENT CHROMATIN MODIFICATION,0.00044809,-0.12347,-0.12237,1,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0066217,-0.124,-0.10872,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.011255,-0.12505,-0.14467,1,0
1,GO METAL ION TRANSPORT,0.0057193,-0.12531,-0.13025,1,0
1,GO RHYTHMIC PROCESS,0.01684,-0.12583,-0.10317,1,0
1,GO ION TRANSPORT,0.0039282,-0.12597,-0.13228,1,0
1,GO CELL MORPHOGENESIS,0.010505,-0.12606,-0.13717,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0031154,-0.12616,-0.14893,1,0
1,GO PEPTIDE SECRETION,0.0073805,-0.12704,-0.13094,1,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.0017084,-0.13027,-0.12396,1,0
1,GO DEMETHYLATION,0.017977,-0.13031,-0.11643,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.0037806,-0.13205,-0.15491,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0097991,-0.13292,-0.19747,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0174,-0.13364,-0.12501,1,0
1,GO SPLEEN DEVELOPMENT,0.020453,-0.13386,-0.17008,1,0
1,GO SEGMENTATION,0.0029959,-0.13641,-0.1825,1,0
1,GO NEURON APOPTOTIC PROCESS,0.0016396,-0.13737,-0.16345,1,0
1,GO PH REDUCTION,0.0129,-0.13766,-0.15056,1,0
1,GO MICROTUBULE BASED MOVEMENT,0.014755,-0.13775,-0.12411,1,0
1,GO WATER HOMEOSTASIS,0.021117,-0.13851,-0.16347,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.011255,-0.13863,-0.14329,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.0023626,-0.14183,-0.20991,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.01918,-0.14296,-0.12326,1,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.01918,-0.14306,-0.1437,1,0
1,GO REGULATION OF CELL CYCLE ARREST,0.0017799,-0.14407,-0.14874,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0068665,-0.14478,-0.14336,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.0055117,-0.14529,-0.13807,1,0
1,GO DETECTION OF STIMULUS,0.00031055,-0.14535,-0.15847,1,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.012053,-0.14567,-0.25659,1,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0079288,-0.14593,-0.17298,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0066217,-0.14598,-0.17994,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.001448,-0.14623,-0.18342,1,0
1,GO CELL CELL SIGNALING,0.00056099,-0.14646,-0.16365,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.024724,-0.14843,-0.13969,1,0
1,GO SENSORY ORGAN DEVELOPMENT,0.017977,-0.14857,-0.14766,1,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.010874,-0.14912,-0.13512,1,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0035004,-0.14932,-0.15001,1,0
1,GO MICROTUBULE BASED TRANSPORT,0.028854,-0.15112,-0.12445,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0017084,-0.15116,-0.21355,1,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0036381,-0.15141,-0.12916,1,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.019808,-0.15176,-0.16272,1,0
1,GO REGULATION OF HORMONE LEVELS,0.0020943,-0.15182,-0.18462,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0073805,-0.15187,-0.11419,1,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0073805,-0.15187,-0.23264,1,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.023222,-0.15199,-0.16994,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0076503,-0.15231,-0.14315,1,0
1,GO CHLORIDE TRANSPORT,0.012053,-0.15299,-0.14371,1,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0037806,-0.15323,-0.17933,1,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.0094624,-0.15341,-0.21606,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0035004,-0.15425,-0.17554,1,0
1,GO EATING BEHAVIOR,0.0085133,-0.15446,-0.18993,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.0047478,-0.15518,-0.14208,1,0
1,GO IMPORT INTO CELL,0.024724,-0.15556,-0.14399,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.020453,-0.15569,-0.13912,1,0
1,GO SPERMATID DIFFERENTIATION,0.022501,-0.1562,-0.11506,1,0
1,GO T CELL HOMEOSTASIS,0.011255,-0.15701,-0.15874,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0088198,-0.15854,-0.21376,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.011648,-0.1589,-0.17031,1,0
1,GO CELL JUNCTION ORGANIZATION,0.0066217,-0.15979,-0.15434,1,0
1,GO CATION TRANSPORT,0.0009903,-0.16002,-0.16597,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0051169,-0.16025,-0.18208,1,0
1,GO REGULATION OF APPETITE,0.015767,-0.16124,-0.16365,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0026621,-0.16239,-0.16047,1,0
1,GO REGULATION OF SYSTEM PROCESS,0.0032392,-0.16343,-0.15777,1,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.025507,-0.16431,-0.18809,1,0
1,GO REGULATION OF GLUCOSE IMPORT,0.0068665,-0.16625,-0.1857,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.00094871,-0.16675,-0.17906,1,0
1,GO REGULATION OF CELL DEVELOPMENT,0.0022699,-0.16677,-0.18465,1,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.015767,-0.16702,-0.17523,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0174,-0.16779,-0.17635,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.013344,-0.16868,-0.13353,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0017799,-0.16875,-0.22589,1,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0094624,-0.16925,-0.13874,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.001448,-0.16989,-0.23954,1,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0049293,-0.17014,-0.19236,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.012053,-0.17016,-0.15648,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0022699,-0.17029,-0.18966,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.023963,-0.17059,-0.13976,1,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0079288,-0.17156,-0.16827,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.0027694,-0.17313,-0.15926,1,0
1,GO REGULATION OF DNA METHYLATION,0.010505,-0.17418,-0.23518,1,0
1,GO CELL PROJECTION ORGANIZATION,0.0012773,-0.17469,-0.16445,1,0
1,GO CELL MATURATION,0.0017799,-0.17514,-0.17106,1,0
1,GO SODIUM ION TRANSPORT,0.0012247,-0.17567,-0.20542,1,0
1,GO CALCIUM ION IMPORT,0.013344,-0.17671,-0.16259,1,0
1,GO G0 TO G1 TRANSITION,0.005311,-0.17691,-0.18573,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0032392,-0.17705,-0.15768,1,0
1,GO CHROMATIN SILENCING,0.00056099,-0.17713,-0.18948,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.010874,-0.17726,-0.17731,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.0045725,-0.17758,-0.18417,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.00087036,-0.1786,-0.1804,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.015767,-0.17879,-0.16093,1,0
1,GO TRANSPORT ALONG MICROTUBULE,0.015767,-0.17903,-0.1722,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0023626,-0.1794,-0.17564,1,0
1,GO SLEEP,0.025507,-0.18005,-0.1496,1,0
1,GO CIRCADIAN RHYTHM,0.00079804,-0.1825,-0.1747,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.027136,-0.18258,-0.14042,1,0
1,GO PROTEIN ACETYLATION,0.00040918,-0.18338,-0.16898,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.0021804,-0.18383,-0.21821,1,0
1,GO RESPONSE TO AMINE,0.027983,-0.18401,-0.18682,1,0
1,GO MATING,0.0035004,-0.18407,-0.19304,1,0
1,GO REGULATION OF SECRETION,0.00039093,-0.18419,-0.18289,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0018542,-0.18456,-0.17392,1,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.027136,-0.18486,-0.16066,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.01918,-0.18577,-0.19063,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0026621,-0.18582,-0.2057,1,0
1,GO RESPONSE TO CATECHOLAMINE,0.0085133,-0.18725,-0.18301,1,0
1,GO PHOTOTRANSDUCTION,0.0015733,-0.1898,-0.20221,1,0
1,GO PROTEIN ACYLATION,9.8065e-05,-0.19,-0.18147,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0037806,-0.19015,-0.17909,1,0
1,GO REGULATION OF ION TRANSPORT,0.0010336,-0.19094,-0.19391,1,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0129,-0.19213,-0.23932,1,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.0174,-0.19335,-0.2162,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.00025768,-0.19362,-0.17809,1,0
1,GO SENSORY PERCEPTION,7.6363e-05,-0.19415,-0.20085,1,0
1,GO RESPONSE TO FOOD,0.0022699,-0.19442,-0.19718,1,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00073133,-0.19519,-0.20831,1,0
1,GO HINDBRAIN MORPHOGENESIS,0.0009903,-0.19554,-0.26274,1,0
1,GO PATTERN SPECIFICATION PROCESS,0.0129,-0.19691,-0.18161,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.015254,-0.197,-0.19482,1,0
1,GO STRIATED MUSCLE CONTRACTION,0.0039282,-0.19751,-0.19284,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00083347,-0.19753,-0.19661,1,0
1,GO RENAL WATER HOMEOSTASIS,0.0020112,-0.1978,-0.20524,1,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.0039282,-0.19863,-0.18053,1,0
1,GO MATING BEHAVIOR,0.0047478,-0.19884,-0.25402,1,0
1,GO DETECTION OF VISIBLE LIGHT,0.00079804,-0.19887,-0.21765,1,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0068665,-0.19941,-0.31546,1,0
1,GO DETECTION OF LIGHT STIMULUS,0.00039093,-0.19941,-0.23427,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0063849,-0.20026,-0.19121,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010146,-0.20125,-0.17778,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.01427,-0.20126,-0.16137,1,0
1,GO REGULATION OF GLIOGENESIS,0.012053,-0.20187,-0.16301,1,0
1,GO LIPID DROPLET ORGANIZATION,0.0032392,-0.20256,-0.24741,1,0
1,GO DNA STRAND ELONGATION,0.019808,-0.20266,-0.21845,1,0
1,GO CELLULAR RESPONSE TO CAMP,0.029747,-0.20397,-0.15192,1,0
1,GO INTESTINAL ABSORPTION,0.01427,-0.20424,-0.25867,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00083347,-0.20465,-0.23043,1,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.021117,-0.2049,-0.16239,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0040811,-0.20545,-0.19392,1,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0082164,-0.20557,-0.19808,1,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.0068665,-0.20576,-0.26145,1,0
1,GO NEURON PROJECTION EXTENSION,0.0076503,-0.20616,-0.22281,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0063849,-0.20619,-0.16659,1,0
1,GO HEART PROCESS,0.0040811,-0.20729,-0.19417,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.01918,-0.21055,-0.23066,1,0
1,GO RESPONSE TO DOPAMINE,0.0017799,-0.2106,-0.21649,1,0
1,GO NEUROGENESIS,0.00034064,-0.21078,-0.24106,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0035004,-0.21192,-0.29858,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.02631,-0.2126,-0.21741,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.00037344,-0.21424,-0.22731,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00053648,-0.21514,-0.26158,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.01684,-0.21546,-0.29039,1,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0071194,-0.21585,-0.29201,1,0
1,GO RESPONSE TO ETHER,0.01857,-0.21632,-0.29342,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0032392,-0.21699,-0.26251,1,0
1,GO PROTEIN DEMETHYLATION,0.0045725,-0.21728,-0.26741,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0011741,-0.21772,-0.21336,1,0
1,GO REGULATION OF BEHAVIOR,0.023222,-0.21843,-0.19183,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00018491,-0.21849,-0.24011,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0015733,-0.21853,-0.23925,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0076503,-0.21855,-0.23412,1,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0057193,-0.21856,-0.23066,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.01857,-0.22092,-0.24926,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0013889,-0.22119,-0.20399,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0010786,-0.22245,-0.27679,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.024724,-0.22347,-0.22612,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.010146,-0.2235,-0.23278,1,0
1,GO CARDIAC MUSCLE CONTRACTION,0.011648,-0.22367,-0.17846,1,0
1,GO EAR MORPHOGENESIS,0.0037806,-0.22385,-0.2647,1,0
1,GO SOMITOGENESIS,0.00020344,-0.22441,-0.22484,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.01684,-0.22442,-0.26446,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0013321,-0.22624,-0.21495,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0066217,-0.22925,-0.22582,1,0
1,GO AMINO ACID TRANSPORT,0.00090875,-0.22955,-0.22848,1,0
1,GO REGULATION OF ACTIN NUCLEATION,0.0029959,-0.2296,-0.26741,1,0
1,GO MEMORY,0.00094871,-0.22989,-0.2465,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0020943,-0.23022,-0.22342,1,0
1,GO RESPONSE TO AMPHETAMINE,0.0073805,-0.2308,-0.25023,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0088198,-0.23096,-0.21322,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.0068665,-0.23122,-0.21792,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.028854,-0.23161,-0.16164,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.004403,-0.23238,-0.21745,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.011255,-0.23245,-0.1903,1,0
1,GO NOREPINEPHRINE SECRETION,0.014755,-0.23395,-0.24667,1,0
1,GO REGULATION OF CHROMATIN BINDING,0.00066983,-0.23405,-0.31932,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00064092,-0.23416,-0.24282,1,0
1,GO DIGESTION,0.00087036,-0.23428,-0.24901,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.0017084,-0.23491,-0.34352,1,0
1,GO BRAIN MORPHOGENESIS,0.0068665,-0.23652,-0.23552,1,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0174,-0.23672,-0.22443,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.0020112,-0.23697,-0.25694,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0040811,-0.23789,-0.25507,1,0
1,GO HISTONE H3 K36 METHYLATION,0.005311,-0.23803,-0.27009,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.0091361,-0.23889,-0.20975,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0091361,-0.23932,-0.2807,1,0
1,GO SISTER CHROMATID COHESION,0.0018542,-0.23952,-0.25043,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.01857,-0.24159,-0.25043,1,0
1,GO NEUROMUSCULAR PROCESS,0.0015095,-0.2416,-0.26925,1,0
1,GO OXIDATIVE DEMETHYLATION,0.00076401,-0.24176,-0.23642,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.02631,-0.2427,-0.18335,1,0
1,GO GLUTAMINE METABOLIC PROCESS,0.0018542,-0.24312,-0.28649,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00028296,-0.24324,-0.27411,1,0
1,GO NEURON PROJECTION GUIDANCE,0.0017084,-0.24397,-0.28097,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.0091361,-0.24412,-0.20236,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00042822,-0.2442,-0.23161,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.019808,-0.24505,-0.22832,1,0
1,GO POLYOL CATABOLIC PROCESS,0.0025586,-0.24511,-0.23503,1,0
1,GO PHAGOSOME ACIDIFICATION,0.010505,-0.24534,-0.22318,1,0
1,GO REGIONALIZATION,0.010505,-0.24544,-0.21724,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00061317,-0.24611,-0.24813,1,0
1,GO RESPONSE TO ALKALOID,0.00025768,-0.24727,-0.25026,1,0
1,GO HEAD DEVELOPMENT,0.00032527,-0.24739,-0.24842,1,0
1,GO FEAR RESPONSE,0.0029959,-0.24762,-0.22785,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0091361,-0.24784,-0.28928,1,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0049293,-0.24818,-0.28161,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00039093,-0.24849,-0.27096,1,0
1,GO SOMITE DEVELOPMENT,0.0001525,-0.24862,-0.25277,1,0
1,GO CHROMATIN REMODELING,0.00014528,-0.24881,-0.22748,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0032392,-0.24896,-0.29509,1,0
1,GO REGULATION OF AXONOGENESIS,0.001448,-0.24902,-0.26927,1,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0076503,-0.24938,-0.17619,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00039093,-0.25136,-0.28471,1,0
1,GO HISTONE H3 K9 MODIFICATION,0.00021334,-0.25207,-0.25446,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,5.9259e-05,-0.25219,-0.27983,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.00027004,-0.25259,-0.25615,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.0045725,-0.25335,-0.24878,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.00076401,-0.25369,-0.30996,1,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.028854,-0.25453,-0.27254,1,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00025768,-0.25473,-0.25919,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0129,-0.25527,-0.29419,1,0
1,GO NERVOUS SYSTEM PROCESS,6.2359e-05,-0.25528,-0.25188,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0094624,-0.25538,-0.19767,1,0
1,GO CELL FATE COMMITMENT,0.0037806,-0.25551,-0.23258,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0066217,-0.2557,-0.22323,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.017977,-0.25655,-0.28362,1,0
1,GO ACID SECRETION,0.00090875,-0.25782,-0.26792,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0016396,-0.25826,-0.23277,1,0
1,GO NEURON DEVELOPMENT,0.00016006,-0.25891,-0.28652,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00017625,-0.25902,-0.25913,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0009903,-0.25955,-0.31775,1,0
1,GO NEURON DIFFERENTIATION,0.00010828,-0.26175,-0.29554,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0026621,-0.26241,-0.2133,1,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.0031154,-0.26335,-0.31427,1,0
1,GO AXON DEVELOPMENT,0.00056099,-0.26363,-0.29914,1,0
1,GO DEVELOPMENTAL MATURATION,0.00025768,-0.26406,-0.26128,1,0
1,GO HISTONE H4 ACETYLATION,7.6363e-05,-0.2645,-0.27695,1,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01427,-0.26502,-0.27332,1,0
1,GO REGULATION OF HEART RATE,0.0049293,-0.26581,-0.24785,1,0
1,GO CELL PART MORPHOGENESIS,0.00027004,-0.26699,-0.30598,1,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.023222,-0.268,-0.24558,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00035669,-0.26801,-0.31385,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.00090875,-0.27031,-0.29039,1,0
1,GO HISTONE METHYLATION,7.2607e-05,-0.27133,-0.25759,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0016396,-0.2715,-0.31755,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.00044809,-0.27151,-0.29781,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0059338,-0.27215,-0.26904,1,0
1,GO ORGANIC CATION TRANSPORT,0.0012247,-0.27244,-0.30497,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.0015733,-0.27275,-0.30315,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.029747,-0.27318,-0.25828,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.015767,-0.27457,-0.32894,1,0
1,GO PROTEIN METHYLATION,5.0811e-05,-0.27472,-0.25657,1,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0010786,-0.27478,-0.27199,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0040811,-0.27728,-0.26784,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00042822,-0.27766,-0.275,1,0
1,GO CELL AGGREGATION,0.011255,-0.27796,-0.28799,1,0
1,GO PEPTIDYL LYSINE METHYLATION,6.2359e-05,-0.27863,-0.2779,1,0
1,GO REGULATION OF HISTONE METHYLATION,8.4434e-05,-0.27894,-0.27834,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0015733,-0.27936,-0.29354,1,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.0015095,-0.27954,-0.2833,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,0.00073133,-0.27975,-0.25385,1,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.0040811,-0.28016,-0.25298,1,0
1,GO COGNITION,0.00011376,-0.28063,-0.27819,1,0
1,GO V D J RECOMBINATION,0.0042393,-0.28096,-0.3009,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0010336,-0.28131,-0.24305,1,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.017977,-0.28159,-0.41383,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.00069995,-0.2817,-0.28253,1,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00027004,-0.28278,-0.28508,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032527,-0.28287,-0.25973,1,0
1,GO EAR DEVELOPMENT,0.00039093,-0.2832,-0.32349,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0031154,-0.2832,-0.34444,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.0079288,-0.28443,-0.2991,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0009903,-0.28603,-0.24493,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00014528,-0.28638,-0.30458,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.013344,-0.28689,-0.35708,1,0
1,GO HISTONE H3 K9 METHYLATION,9.3306e-05,-0.28753,-0.31521,1,0
1,GO SECONDARY PALATE DEVELOPMENT,0.010874,-0.28797,-0.26086,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0001255,-0.29004,-0.30713,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00046881,-0.29064,-0.308,1,0
1,GO HORMONE TRANSPORT,6.9026e-05,-0.29135,-0.32931,1,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.02631,-0.29183,-0.32857,1,0
1,GO BILE ACID METABOLIC PROCESS,0.00039093,-0.29297,-0.33107,1,0
1,GO PANCREAS DEVELOPMENT,0.00066983,-0.29385,-0.31296,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00046881,-0.29386,-0.27564,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0002237,-0.29389,-0.27905,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00049043,-0.29411,-0.33007,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0023626,-0.29481,-0.25501,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.016296,-0.29514,-0.28709,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00083347,-0.29587,-0.37409,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00029645,-0.29605,-0.30005,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.0011254,-0.2962,-0.30809,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.028854,-0.29648,-0.25203,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0013321,-0.29671,-0.30136,1,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0010336,-0.29695,-0.24207,1,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.0021804,-0.29726,-0.26036,1,0
1,GO VISUAL BEHAVIOR,0.00032527,-0.29769,-0.27698,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00018491,-0.29796,-0.31807,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0174,-0.29801,-0.29728,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0035004,-0.29831,-0.26584,1,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00029645,-0.29957,-0.28274,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0017799,-0.29989,-0.32735,1,0
1,GO REGULATION OF HORMONE SECRETION,7.2607e-05,-0.30003,-0.31599,1,0
1,GO MULTICELLULAR ORGANISM AGING,0.00051298,-0.3008,-0.29884,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.01427,-0.30123,-0.25203,1,0
1,GO SIGNAL RELEASE,5.3491e-05,-0.30165,-0.33068,1,0
1,GO AXO DENDRITIC TRANSPORT,0.0049293,-0.30181,-0.28656,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0027694,-0.30209,-0.27222,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.0071194,-0.30319,-0.26633,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,0.00066983,-0.30369,-0.29655,1,0
1,GO FOREBRAIN DEVELOPMENT,0.00019396,-0.30379,-0.29782,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0059338,-0.30413,-0.23754,1,0
1,GO BEHAVIOR,6.2359e-05,-0.30494,-0.29192,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0055117,-0.30556,-0.36099,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.00035669,-0.30559,-0.27535,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0015733,-0.30582,-0.28157,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00034064,-0.30654,-0.26026,1,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0016396,-0.30686,-0.31066,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.00010828,-0.30903,-0.34152,1,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00027004,-0.30998,-0.28504,1,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.0039282,-0.31034,-0.33901,1,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.00079804,-0.31046,-0.33369,1,0
1,GO INNER EAR MORPHOGENESIS,0.0015733,-0.31089,-0.32781,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00031055,-0.31121,-0.31297,1,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.01247,-0.31143,-0.26035,1,0
1,GO AXIS SPECIFICATION,0.00020344,-0.31232,-0.34164,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00029645,-0.31284,-0.30564,1,0
1,GO ASSOCIATIVE LEARNING,0.00037344,-0.31285,-0.30973,1,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.010146,-0.3129,-0.31289,1,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0024588,-0.31312,-0.2998,1,0
1,GO PROTEIN POLYGLUTAMYLATION,0.0028806,-0.3136,-0.32676,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0097991,-0.3142,-0.29894,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.5827e-05,-0.31421,-0.30723,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0057193,-0.31446,-0.302,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.00051298,-0.31519,-0.31437,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0022699,-0.31528,-0.33814,1,0
1,GO RESPONSE TO FORSKOLIN,0.020453,-0.31683,-0.31768,1,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.01684,-0.31714,-0.35209,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00011949,-0.31747,-0.35009,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0021804,-0.31896,-0.3085,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00053648,-0.31912,-0.30212,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.00083347,-0.31949,-0.33116,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0047478,-0.31956,-0.42189,1,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.00024585,-0.31982,-0.3387,1,0
1,GO NEURAL CREST FORMATION,0.0061556,-0.32008,-0.3435,1,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00028296,-0.32062,-0.29866,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.022501,-0.32076,-0.27608,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.023963,-0.32259,-0.31389,1,0
1,GO SEX DETERMINATION,0.0010786,-0.32352,-0.36526,1,0
1,GO LIPOXYGENASE PATHWAY,0.021117,-0.32365,-0.37339,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0037806,-0.32453,-0.34935,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.00094871,-0.3246,-0.30931,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00021334,-0.3247,-0.28154,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0024588,-0.32607,-0.29936,1,0
1,GO SENSORY PERCEPTION OF PAIN,0.00016006,-0.32631,-0.30669,1,0
1,GO GENETIC IMPRINTING,0.00035669,-0.32649,-0.34483,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,7.6363e-05,-0.32651,-0.32598,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.01857,-0.32823,-0.22615,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.001448,-0.3286,-0.32596,1,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.00039093,-0.32978,-0.32334,1,0
1,GO THYMUS DEVELOPMENT,0.0009903,-0.33021,-0.28479,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0020943,-0.33031,-0.32273,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.00051298,-0.33059,-0.33564,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0022699,-0.33081,-0.31454,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,0.0012247,-0.33122,-0.34889,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00011376,-0.33263,-0.40148,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,0.00016006,-0.33265,-0.33022,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.015254,-0.33276,-0.22156,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.025507,-0.33379,-0.22135,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00031055,-0.33461,-0.32882,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0017084,-0.33645,-0.30615,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0049293,-0.3382,-0.29378,1,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.01918,-0.33989,-0.27138,1,0
1,GO PROTEIN DEPOLYMERIZATION,0.0036381,-0.34097,-0.27903,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0022699,-0.34146,-0.32587,1,0
1,GO CELL JUNCTION MAINTENANCE,0.0023626,-0.34218,-0.38156,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00035669,-0.34251,-0.33988,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.027983,-0.3439,-0.26602,1,0
1,GO POSTSYNAPSE ORGANIZATION,0.00046881,-0.34398,-0.33074,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,9.8065e-05,-0.3443,-0.36229,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02631,-0.34492,-0.25284,1,0
1,GO FOREBRAIN CELL MIGRATION,0.012053,-0.34639,-0.28645,1,0
1,GO MELANOCYTE DIFFERENTIATION,0.02631,-0.34665,-0.20788,1,0
1,GO SODIUM ION HOMEOSTASIS,0.00031055,-0.3469,-0.34732,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.011648,-0.34746,-0.31561,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.004403,-0.34758,-0.3173,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0049293,-0.34816,-0.41598,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0020112,-0.34886,-0.38417,1,0
1,GO CARDIAC CONDUCTION,0.00044809,-0.34972,-0.33349,1,0
1,GO UTERUS DEVELOPMENT,0.0085133,-0.35046,-0.34642,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.00016006,-0.35062,-0.34885,1,0
1,GO REGULATION OF MICROTUBULE BINDING,0.0036381,-0.3518,-0.29969,1,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0039282,-0.35235,-0.35842,1,0
1,GO NEURON PROJECTION ARBORIZATION,0.0042393,-0.35246,-0.33902,1,0
1,GO AXONAL TRANSPORT,0.0029959,-0.35279,-0.33501,1,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.0061556,-0.35634,-0.31601,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00028296,-0.35814,-0.30573,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.024724,-0.35927,-0.28697,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00083347,-0.3599,-0.33912,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0138,-0.36029,-0.48855,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.024724,-0.36078,-0.2502,1,0
1,GO SPINAL CORD DEVELOPMENT,0.00031055,-0.36147,-0.38445,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00034064,-0.36196,-0.35171,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00016006,-0.36238,-0.35009,1,0
1,GO PROTEIN PALMITOYLATION,0.00027004,-0.36247,-0.34339,1,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.00037344,-0.36249,-0.40886,1,0
1,GO SYNAPTIC VESICLE RECYCLING,0.0011254,-0.36367,-0.36742,1,0
1,GO LEARNING,0.00013179,-0.36393,-0.36354,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0036381,-0.36393,-0.3421,1,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.017977,-0.36463,-0.26588,1,0
1,GO HINDBRAIN DEVELOPMENT,6.2359e-05,-0.3654,-0.40621,1,0
1,GO NEUROBLAST PROLIFERATION,0.023222,-0.36564,-0.26129,1,0
1,GO REGULATION OF VESICLE FUSION,0.005311,-0.36571,-0.40254,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0073805,-0.36575,-0.37898,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.0040811,-0.36636,-0.38367,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,6.9026e-05,-0.36675,-0.39823,1,0
1,GO FEEDING BEHAVIOR,0.0001525,-0.3668,-0.31999,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0027694,-0.36779,-0.38477,1,0
1,GO MEMBRANE DEPOLARIZATION,0.00087036,-0.36923,-0.33916,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,0.0013321,-0.36938,-0.34705,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00079804,-0.36942,-0.35285,1,0
1,GO ADRENAL GLAND DEVELOPMENT,0.0037806,-0.37037,-0.40372,1,0
1,GO REGULATION OF CELL MATURATION,4.3513e-05,-0.37092,-0.41924,1,0
1,GO ACROSOME ASSEMBLY,0.00066983,-0.37134,-0.33703,1,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.0068665,-0.37186,-0.39503,1,0
1,GO PEPTIDE HORMONE SECRETION,5.3491e-05,-0.37199,-0.3904,1,0
1,GO NEUROTRANSMITTER REUPTAKE,0.0020112,-0.37251,-0.37333,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0068665,-0.37331,-0.32609,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.00051298,-0.37349,-0.42853,1,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0012247,-0.374,-0.29568,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,5.9259e-05,-0.37477,-0.40098,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.0001255,-0.37547,-0.38797,1,0
1,GO DENDRITE DEVELOPMENT,6.5613e-05,-0.37607,-0.39656,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,5.0811e-05,-0.37826,-0.38771,1,0
1,GO INSULIN SECRETION,5.0811e-05,-0.37847,-0.40161,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.01857,-0.37995,-0.37015,1,0
1,GO PALLIUM DEVELOPMENT,0.00066983,-0.38009,-0.30977,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0009903,-0.38063,-0.40039,1,0
1,GO KETONE BODY METABOLIC PROCESS,0.012053,-0.38076,-0.41838,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,8.4434e-05,-0.38093,-0.40974,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0042393,-0.38099,-0.32976,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0085133,-0.3826,-0.46434,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0010786,-0.38286,-0.39419,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00083347,-0.38308,-0.38668,1,0
1,GO CELL MIGRATION IN HINDBRAIN,0.0019312,-0.38311,-0.43106,1,0
1,GO CRANIAL NERVE DEVELOPMENT,0.00014528,-0.38438,-0.42053,1,0
1,GO RESPONSE TO HYDROXYUREA,0.00029645,-0.38543,-0.435,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,9.3306e-05,-0.38631,-0.38351,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.0033675,-0.38688,-0.37469,1,0
1,GO PRESYNAPSE ORGANIZATION,0.0026621,-0.387,-0.34922,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0071194,-0.38746,-0.28646,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0002237,-0.38808,-0.36557,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.0027694,-0.38849,-0.33078,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0035004,-0.39024,-0.42133,1,0
1,GO NERVE DEVELOPMENT,8.0303e-05,-0.39037,-0.43381,1,0
1,GO STRIATUM DEVELOPMENT,0.027136,-0.39074,-0.31689,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.0036381,-0.39143,-0.4132,1,0
1,GO FAT CELL PROLIFERATION,0.02631,-0.39241,-0.3767,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0026621,-0.39242,-0.3782,1,0
1,GO CLATHRIN COAT ASSEMBLY,0.01857,-0.39245,-0.3157,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,0.0002237,-0.39271,-0.43871,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0051169,-0.39288,-0.42106,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00064092,-0.39362,-0.45765,1,0
1,GO GROOMING BEHAVIOR,0.0039282,-0.39367,-0.3681,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.027983,-0.39373,-0.36465,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00046881,-0.39407,-0.38576,1,0
1,GO REGULATION OF INSULIN SECRETION,5.0811e-05,-0.39437,-0.39351,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0037806,-0.39461,-0.30032,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,6.5613e-05,-0.39484,-0.3854,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.027983,-0.39499,-0.24446,1,0
1,GO CATECHOLAMINE UPTAKE,0.022501,-0.39638,-0.31482,1,0
1,GO SYNAPTIC SIGNALING,6.9026e-05,-0.39681,-0.38549,1,0
1,GO REGULATION OF EXOCYTOSIS,9.8065e-05,-0.39804,-0.37271,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00010305,-0.39808,-0.43883,1,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00025768,-0.39837,-0.3762,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0039282,-0.40085,-0.30759,1,0
1,GO SYNAPSE ORGANIZATION,0.0001255,-0.4011,-0.38023,1,0
1,GO POTASSIUM ION TRANSPORT,8.8765e-05,-0.40143,-0.38377,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00058654,-0.40178,-0.36342,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.0129,-0.40243,-0.34994,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.011255,-0.40264,-0.36348,1,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.020453,-0.40292,-0.29146,1,0
1,GO FILOPODIUM ASSEMBLY,0.00028296,-0.40327,-0.36514,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0017799,-0.4039,-0.35526,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0036381,-0.40463,-0.3621,1,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0012773,-0.40528,-0.38762,1,0
1,GO N GLYCAN PROCESSING,0.00079804,-0.40531,-0.43508,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0012247,-0.40558,-0.35696,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0055117,-0.40639,-0.35336,1,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.004403,-0.40669,-0.45264,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,6.9026e-05,-0.40686,-0.39456,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0002237,-0.40698,-0.41573,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.011255,-0.40766,-0.39396,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.00039093,-0.40882,-0.41534,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00066983,-0.40914,-0.48261,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00039093,-0.41089,-0.37253,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0019312,-0.41147,-0.39896,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,0.0011741,-0.41166,-0.39791,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00029645,-0.41182,-0.42199,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00029645,-0.41241,-0.4278,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0023626,-0.41383,-0.47747,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0057193,-0.41493,-0.39146,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00013838,-0.41514,-0.37122,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.00044809,-0.41615,-0.40571,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,7.2607e-05,-0.41647,-0.4179,1,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.00029645,-0.41659,-0.36031,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00016797,-0.41786,-0.42767,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,0.0001525,-0.41798,-0.40982,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0040811,-0.41968,-0.3825,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00053648,-0.41973,-0.41123,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00020344,-0.42023,-0.42778,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.005311,-0.42161,-0.35804,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,6.9026e-05,-0.42213,-0.40766,1,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.0076503,-0.4223,-0.36313,1,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0068665,-0.42323,-0.42627,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00046881,-0.42383,-0.41232,1,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.02631,-0.42405,-0.33673,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,9.8065e-05,-0.42481,-0.40953,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.004403,-0.4256,-0.41706,1,0
1,GO RESPONSE TO NICOTINE,0.00011376,-0.42658,-0.44142,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0071194,-0.4266,-0.42121,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,8.4434e-05,-0.42951,-0.51193,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0076503,-0.4298,-0.46355,1,0
1,GO MITOCHONDRION LOCALIZATION,0.0011741,-0.43013,-0.38731,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00037344,-0.43076,-0.39848,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,9.3306e-05,-0.43242,-0.43625,1,0
1,GO LIPID DROPLET FORMATION,0.015254,-0.43266,-0.41842,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.0011254,-0.43486,-0.38014,1,0
1,GO DENDRITE MORPHOGENESIS,7.6363e-05,-0.43641,-0.44421,1,0
1,GO HAIR CELL DIFFERENTIATION,0.00073133,-0.43678,-0.43838,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0012773,-0.43697,-0.41861,1,0
1,GO TUBULIN DEACETYLATION,0.0025586,-0.43835,-0.42989,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0015095,-0.4385,-0.41989,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00016797,-0.43865,-0.45011,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00042822,-0.43919,-0.50078,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0068665,-0.44396,-0.42692,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.00039093,-0.4445,-0.47648,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00018491,-0.44463,-0.44356,1,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.01857,-0.44535,-0.33728,1,0
1,GO ENERGY HOMEOSTASIS,0.028854,-0.44672,-0.29193,1,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0068665,-0.44683,-0.45618,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,5.0811e-05,-0.44756,-0.45489,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0011741,-0.44889,-0.4589,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00079804,-0.45084,-0.45582,1,0
1,GO COCHLEA DEVELOPMENT,0.00051298,-0.45234,-0.41404,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0079288,-0.4528,-0.36716,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00011376,-0.45302,-0.41672,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00028296,-0.45351,-0.52849,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00020344,-0.4539,-0.44716,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.00018491,-0.45508,-0.38638,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0049293,-0.45537,-0.36129,1,0
1,GO PARENTAL BEHAVIOR,0.028854,-0.45609,-0.35194,1,0
1,GO EMBRYONIC AXIS SPECIFICATION,8.0303e-05,-0.4566,-0.47625,1,0
1,GO MALE SEX DETERMINATION,0.00049043,-0.45819,-0.48737,1,0
1,GO ACTION POTENTIAL,8.0303e-05,-0.4587,-0.43325,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00011376,-0.45944,-0.57561,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.0020112,-0.46082,-0.41766,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.01684,-0.46088,-0.39917,1,0
1,GO WALKING BEHAVIOR,0.00023453,-0.46095,-0.46429,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00028296,-0.46754,-0.46758,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,0.00027004,-0.46774,-0.46481,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0017084,-0.46817,-0.43489,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00046881,-0.46988,-0.47999,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0001525,-0.47015,-0.49886,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0032392,-0.4704,-0.44255,1,0
1,GO HISTONE H3 K4 METHYLATION,5.9259e-05,-0.47154,-0.43871,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0033675,-0.47209,-0.4383,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00046881,-0.47213,-0.42976,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0031154,-0.47322,-0.36566,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00037344,-0.47454,-0.43238,1,0
1,GO RESPONSE TO LIGHT INTENSITY,0.00018491,-0.47578,-0.48791,1,0
1,GO NEUROTRANSMITTER UPTAKE,0.00073133,-0.47626,-0.40744,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,0.00073133,-0.47653,-0.44103,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00083347,-0.47759,-0.41577,1,0
1,GO RESPONSE TO ACETYLCHOLINE,0.00056099,-0.47772,-0.46536,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0061556,-0.47791,-0.41651,1,0
1,GO RESPONSE TO INSECTICIDE,0.0017799,-0.47948,-0.46419,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00025768,-0.48066,-0.49942,1,0
1,GO SUBPALLIUM DEVELOPMENT,0.010146,-0.48166,-0.42533,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0025586,-0.48282,-0.52784,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,5.0811e-05,-0.48291,-0.51582,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0001525,-0.48479,-0.48138,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0094624,-0.48573,-0.48389,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0019312,-0.48574,-0.40213,1,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.010505,-0.4869,-0.40756,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00016006,-0.48825,-0.43916,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.01684,-0.48912,-0.38037,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,8.0303e-05,-0.48991,-0.45957,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0029959,-0.49019,-0.43381,1,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.0033675,-0.49034,-0.56047,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00076401,-0.49078,-0.46497,1,0
1,GO RESPONSE TO COCAINE,4.8258e-05,-0.49253,-0.56222,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0012773,-0.49263,-0.4572,1,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.0022699,-0.49334,-0.53359,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00011376,-0.49356,-0.46922,1,0
1,GO NEURON MIGRATION,0.00016797,-0.494,-0.49275,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0022699,-0.49449,-0.46228,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00018491,-0.49519,-0.54443,1,0
1,GO FOREBRAIN REGIONALIZATION,0.0024588,-0.49638,-0.45359,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00079804,-0.49639,-0.44519,1,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.0068665,-0.49662,-0.44683,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.019808,-0.49739,-0.31479,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00023453,-0.49776,-0.51751,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0011741,-0.49814,-0.50144,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,6.2359e-05,-0.49862,-0.5248,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0020943,-0.49887,-0.43162,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00044809,-0.50118,-0.4821,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0010336,-0.50221,-0.39015,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0047478,-0.50424,-0.55026,1,0
1,GO APICAL PROTEIN LOCALIZATION,0.01684,-0.50439,-0.31629,1,0
1,GO EXOCYTIC PROCESS,0.00010828,-0.50517,-0.48097,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00046881,-0.50559,-0.51685,1,0
1,GO HISTONE H4 K5 ACETYLATION,0.00020344,-0.50626,-0.42152,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00011376,-0.5076,-0.47202,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0066217,-0.5121,-0.39734,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00014528,-0.51213,-0.45014,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0020112,-0.51276,-0.53038,1,0
1,GO PITUITARY GLAND DEVELOPMENT,0.0002237,-0.51321,-0.55374,1,0
1,GO RESPONSE TO POTASSIUM ION,0.024724,-0.51329,-0.40006,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0010336,-0.51559,-0.47459,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00014528,-0.51582,-0.50431,1,0
1,GO DIENCEPHALON DEVELOPMENT,6.5613e-05,-0.51609,-0.51879,1,0
1,GO CGMP METABOLIC PROCESS,0.00073133,-0.51633,-0.52116,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00064092,-0.51686,-0.48426,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0026621,-0.51763,-0.43867,1,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00049043,-0.51765,-0.54968,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.00014528,-0.51788,-0.44372,1,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.0036381,-0.51794,-0.42738,1,0
1,GO METENCEPHALON DEVELOPMENT,5.6305e-05,-0.51829,-0.52489,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.00049043,-0.51863,-0.47136,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00024585,-0.51932,-0.56855,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00058654,-0.51988,-0.45011,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00027004,-0.52185,-0.54248,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.00031055,-0.52209,-0.46553,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0061556,-0.52398,-0.43847,1,0
1,GO GROWTH HORMONE SECRETION,0.0016396,-0.52471,-0.4612,1,0
1,GO LOCOMOTORY BEHAVIOR,5.3491e-05,-0.52655,-0.48255,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.00010305,-0.52695,-0.49801,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00016006,-0.52751,-0.5345,1,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.00042822,-0.5293,-0.60132,1,0
1,GO MRNA SPLICE SITE SELECTION,6.9026e-05,-0.53016,-0.50961,1,0
1,GO SHORT TERM MEMORY,0.00066983,-0.53172,-0.54654,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00056099,-0.53734,-0.53366,1,0
1,GO GLUTAMATE SECRETION,0.00016006,-0.54204,-0.53134,1,0
1,GO DETECTION OF CALCIUM ION,0.014755,-0.54378,-0.4195,1,0
1,GO SUCKLING BEHAVIOR,6.2359e-05,-0.54492,-0.64598,1,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.01427,-0.54535,-0.54941,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00046881,-0.54559,-0.49999,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00076401,-0.54943,-0.54903,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00014528,-0.551,-0.55474,1,0
1,GO NEURAL RETINA DEVELOPMENT,0.00010305,-0.55261,-0.57497,1,0
1,GO ENDOCARDIUM DEVELOPMENT,0.00090875,-0.55277,-0.52626,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0017084,-0.55362,-0.5763,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00025768,-0.55364,-0.62682,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0088198,-0.55529,-0.51246,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0009903,-0.55534,-0.4572,1,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.01684,-0.55561,-0.46805,1,0
1,GO SOMATIC STEM CELL DIVISION,0.021117,-0.55701,-0.45467,1,0
1,GO DOPAMINE METABOLIC PROCESS,0.00017625,-0.5584,-0.57253,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0001255,-0.56016,-0.51727,1,0
1,GO NEURON RECOGNITION,0.00040918,-0.56183,-0.55012,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00016006,-0.5654,-0.59006,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00079804,-0.56773,-0.6212,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,7.6363e-05,-0.5684,-0.55114,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,5.0811e-05,-0.56849,-0.55086,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00016006,-0.57129,-0.50874,1,0
1,GO CELL FATE SPECIFICATION,0.00016797,-0.57243,-0.52664,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00024585,-0.57327,-0.52334,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00031055,-0.57547,-0.59887,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.0012773,-0.57612,-0.52305,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.00049043,-0.58147,-0.55325,1,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.005311,-0.58186,-0.46293,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.00010305,-0.58194,-0.54739,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00044809,-0.58431,-0.50457,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0073805,-0.58476,-0.50221,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,6.5613e-05,-0.58841,-0.57659,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00037344,-0.58976,-0.544,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00018491,-0.59072,-0.54774,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,0.00027004,-0.59086,-0.58167,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.005311,-0.59315,-0.60016,1,0
1,GO SIALYLATION,0.00032527,-0.59669,-0.58086,1,0
1,GO DENDRITIC TRANSPORT,0.001448,-0.59723,-0.48739,1,0
1,GO LIMB BUD FORMATION,0.0051169,-0.59759,-0.63657,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00083347,-0.59966,-0.69087,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00016797,-0.59983,-0.55048,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0029959,-0.60055,-0.68821,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.9213e-05,-0.60081,-0.60805,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00037344,-0.60205,-0.52052,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00061317,-0.60305,-0.63017,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00056099,-0.60373,-0.59187,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00023453,-0.60546,-0.581,1,0
1,GO REGULATION OF GLUTAMATE SECRETION,0.00031055,-0.60624,-0.60127,1,0
1,GO SEROTONIN TRANSPORT,0.00010305,-0.60949,-0.69082,1,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.0015733,-0.61318,-0.53227,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,8.8765e-05,-0.61334,-0.56595,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0012247,-0.61374,-0.64623,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0027694,-0.61771,-0.49814,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,0.00018491,-0.61916,-0.54343,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00087036,-0.6221,-0.49782,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.017977,-0.62408,-0.65031,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0002237,-0.62473,-0.57527,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00016006,-0.62763,-0.67387,1,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0027694,-0.62824,-0.58196,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017625,-0.62825,-0.59519,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0011254,-0.62999,-0.64732,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,8.0303e-05,-0.63111,-0.60274,1,0
1,GO CARDIOBLAST PROLIFERATION,0.0037806,-0.63335,-0.62286,1,0
1,GO SYNAPSE ASSEMBLY,8.0303e-05,-0.63357,-0.55411,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00069995,-0.63836,-0.51099,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0138,-0.63928,-0.60716,1,0
1,GO NEURON MATURATION,0.00010828,-0.64042,-0.57467,1,0
1,GO ADULT BEHAVIOR,4.3513e-05,-0.64355,-0.6275,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,5.9259e-05,-0.64422,-0.6114,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,6.5613e-05,-0.64456,-0.62483,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.00025768,-0.64721,-0.57883,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00076401,-0.64741,-0.54979,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,9.3306e-05,-0.65004,-0.71779,1,0
1,GO REFLEX,7.6363e-05,-0.65008,-0.71127,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00019396,-0.65392,-0.58935,1,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00058654,-0.6549,-0.63634,1,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.0020112,-0.65594,-0.52375,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0012773,-0.65997,-0.7126,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,8.0303e-05,-0.66118,-0.64421,1,0
1,GO STARTLE RESPONSE,0.00056099,-0.66184,-0.57867,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,5.9259e-05,-0.66537,-0.63303,1,0
1,GO NEUROTRANSMITTER TRANSPORT,8.8765e-05,-0.66569,-0.65447,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.0010336,-0.66842,-0.61095,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,7.6363e-05,-0.67067,-0.64288,1,0
1,GO RESPONSE TO HISTAMINE,0.00079804,-0.67297,-0.66773,1,0
1,GO SEGMENT SPECIFICATION,8.0303e-05,-0.67797,-0.73136,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,8.0303e-05,-0.67872,-0.64095,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0024588,-0.68866,-0.70185,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.023222,-0.69198,-0.44614,1,0
1,GO EPITHELIAL CELL MATURATION,0.00049043,-0.6922,-0.65096,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0001525,-0.69518,-0.67133,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00027004,-0.69944,-0.68347,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,7.2607e-05,-0.70343,-0.6773,1,0
1,GO OTIC VESICLE DEVELOPMENT,0.00040918,-0.70969,-0.66878,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00094871,-0.71225,-0.56551,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00013179,-0.71571,-0.68653,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00011376,-0.71578,-0.69031,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042822,-0.71603,-0.71355,1,0
1,GO CEREBELLAR CORTEX FORMATION,7.6363e-05,-0.71858,-0.65513,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,5.3491e-05,-0.7218,-0.68096,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00028296,-0.72236,-0.89504,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,8.4434e-05,-0.72987,-0.75209,1,0
1,GO SPINAL CORD PATTERNING,0.00011376,-0.73553,-0.75084,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,6.2359e-05,-0.73871,-0.7021,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,6.5613e-05,-0.74074,-0.72567,1,0
1,GO NEUROTRANSMITTER SECRETION,0.00010828,-0.74358,-0.71384,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0001525,-0.74679,-0.71503,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0002237,-0.74763,-0.80145,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,9.3306e-05,-0.74808,-0.69347,1,0
1,GO REGULATION OF SYNAPSE MATURATION,0.00024585,-0.75036,-0.77169,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00010305,-0.75076,-0.74458,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.001448,-0.75335,-0.59873,1,0
1,GO AXONAL FASCICULATION,8.8765e-05,-0.75362,-0.73817,1,0
1,GO LUNG CELL DIFFERENTIATION,0.00073133,-0.75378,-0.66983,1,0
1,GO AMINE TRANSPORT,0.00011949,-0.75537,-0.68494,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00021334,-0.76134,-0.72844,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00016006,-0.76635,-0.77939,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00034064,-0.76868,-0.64549,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.00076401,-0.76885,-0.70487,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00020344,-0.7706,-0.73359,1,0
1,GO RESPONSE TO LEUCINE,0.00027004,-0.77866,-0.65801,1,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.01427,-0.78192,-0.56698,1,0
1,GO RESPONSE TO LITHIUM ION,0.00039093,-0.78599,-0.71527,1,0
1,GO OTIC VESICLE MORPHOGENESIS,0.00042822,-0.78952,-0.80457,1,0
1,GO RESPONSE TO L GLUTAMATE,8.4434e-05,-0.79154,-0.78402,1,0
1,GO SYNAPTIC VESICLE DOCKING,0.00037344,-0.79238,-0.82721,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0011254,-0.79338,-0.68082,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.00020344,-0.79369,-0.72179,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00029645,-0.79738,-0.84173,1,0
1,GO INNERVATION,0.00013179,-0.80773,-0.79431,1,0
1,GO SECRETORY GRANULE LOCALIZATION,0.00051298,-0.80838,-0.89982,1,0
1,GO REGULATION OF NEURON MATURATION,4.5827e-05,-0.81653,-0.82554,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0019312,-0.81868,-0.65319,1,0
1,GO THALAMUS DEVELOPMENT,4.3513e-05,-0.81996,-0.83047,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,8.8765e-05,-0.8204,-0.76525,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,5.9259e-05,-0.82797,-0.84058,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,8.8765e-05,-0.82862,-0.78463,1,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,0.0013321,-0.83013,-0.69978,1,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0068665,-0.83583,-0.6423,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00037344,-0.84217,-0.82609,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.9026e-05,-0.84262,-0.89701,1,0
1,GO DENTATE GYRUS DEVELOPMENT,7.6363e-05,-0.84465,-0.84715,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00016797,-0.84608,-0.73985,1,0
1,GO MONOAMINE TRANSPORT,9.8065e-05,-0.84952,-0.74819,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00010305,-0.84987,-0.87368,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,9.3306e-05,-0.85032,-0.77044,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0039282,-0.85231,-0.76833,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,7.2607e-05,-0.85565,-0.84888,1,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,0.00013838,-0.86535,-0.89245,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,9.8065e-05,-0.86883,-0.78513,1,0
1,GO SYNAPSE MATURATION,0.00010305,-0.87278,-0.93355,1,0
1,GO NEURONAL ACTION POTENTIAL,5.0811e-05,-0.87401,-0.85637,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,5.6305e-05,-0.8756,-0.81879,1,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.00034064,-0.87754,-0.78264,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00044809,-0.87879,-0.91807,1,0
1,GO SEROTONIN SECRETION,3.9213e-05,-0.89656,-0.88251,1,0
1,GO SYNAPTIC VESICLE PRIMING,0.00016797,-0.90627,-0.88276,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00014528,-0.90995,-0.89664,1,0
1,GO NEURON FATE COMMITMENT,0.00023453,-0.91162,-0.83647,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0021804,-0.91207,-0.78131,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00010305,-0.91329,-0.85003,1,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00016006,-0.9143,-0.8547,1,0
1,GO SYNAPTIC VESICLE MATURATION,0.00083347,-0.91513,-0.8767,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00042822,-0.9277,-0.8092,1,0
1,GO SEROTONIN METABOLIC PROCESS,5.0811e-05,-0.9309,-0.89029,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,6.2359e-05,-0.93646,-1.0244,1,0
1,GO PREPULSE INHIBITION,0.00017625,-0.93795,-0.87836,1,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0174,-0.94503,-0.69428,1,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00018491,-0.95333,-0.94525,1,0
1,GO RETINA LAYER FORMATION,5.0811e-05,-0.95687,-0.98534,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,5.9259e-05,-0.96834,-0.96154,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00064092,-0.97119,-0.94471,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00017625,-0.9712,-0.88215,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0002237,-0.98615,-0.90857,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.0033675,-1.0008,-0.81549,1,0
1,GO DOPAMINE TRANSPORT,0.00014528,-1.0052,-0.86136,1,0
1,GO DENDRITE EXTENSION,4.3513e-05,-1.0059,-0.95525,1,0
1,GO REGULATION OF DENDRITE EXTENSION,7.6363e-05,-1.0124,-1.0023,1,0
1,GO CATECHOLAMINE SECRETION,0.00014528,-1.0126,-0.8792,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0002237,-1.0231,-0.91991,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.0015095,-1.0438,-0.78809,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,4.3513e-05,-1.0573,-1.0325,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00014528,-1.0954,-0.9713,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.3513e-05,-1.0984,-1.0054,1,0
1,GO GANGLION DEVELOPMENT,0.00010305,-1.1086,-1.0154,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00011376,-1.1165,-1.0735,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,9.3306e-05,-1.1244,-1.1559,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,4.3513e-05,-1.1341,-1.1313,1,0
1,GO GABAERGIC NEURON DIFFERENTIATION,0.0010336,-1.1413,-0.94906,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00019396,-1.1475,-1.0915,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00028296,-1.1482,-0.91484,1,0
1,GO PROTEIN LOCALIZATION TO AXON,0.00014528,-1.1518,-1.193,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00051298,-1.1529,-0.87575,1,0
1,GO VOCALIZATION BEHAVIOR,0.00018491,-1.1692,-0.99762,1,0
1,GO MECHANOSENSORY BEHAVIOR,6.5613e-05,-1.2056,-1.2342,1,0
1,GO REGULATION OF DOPAMINE SECRETION,0.00014528,-1.2182,-1.0719,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,9.3306e-05,-1.2415,-1.1234,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00011949,-1.2478,-1.1426,1,0
1,GO DENSE CORE GRANULE TRANSPORT,0.00020344,-1.2538,-1.3333,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.0019312,-1.274,-1.054,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,9.3306e-05,-1.2897,-1.1659,1,0
1,GO NOSE DEVELOPMENT,0.0001525,-1.3362,-1.0554,1,0
1,GO NEURON CELL CELL ADHESION,0.00013838,-1.3467,-1.1506,1,0
1,GO NEURON FATE SPECIFICATION,5.9259e-05,-1.4613,-1.2284,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00011949,-1.5793,-1.4145,1,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.00023453,-1.8031,-1.4999,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00010828,-1.8113,-1.7625,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.037792,0.94156,0.64578,0,1
1,GO SNRNA PROCESSING,0.032572,0.90475,0.74226,0,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.042464,0.86615,0.78741,0,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.043706,0.72735,0.60679,0,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.09779,0.63402,0.46656,0,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.13699,0.62155,0.41158,0,1
1,GO PHOSPHOLIPID EFFLUX,0.15361,0.58803,0.33573,0,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047616,0.58281,0.41434,0,1
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.062834,0.56168,0.36654,0,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.041252,0.55697,0.38934,0,1
1,GO RESPONSE TO MUSCLE STRETCH,0.12771,0.53959,0.2887,0,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.056323,0.53487,0.45558,0,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.041252,0.5095,0.30017,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.031606,0.49295,0.44887,0,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.04007,0.48994,0.31574,0,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.030665,0.48415,0.37803,0,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.19971,0.48373,0.248,0,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.059504,0.47232,0.29287,0,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.042464,0.46935,0.48679,0,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.095374,0.46901,0.31052,0,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.07572,0.46727,0.30197,0,1
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.04007,0.46399,0.32666,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.09779,0.44775,0.29865,0,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.1794,0.44191,0.19976,0,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.030665,0.43014,0.37587,0,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.034581,0.42598,0.36868,0,1
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.064555,0.42477,0.30199,0,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.034581,0.42145,0.29826,0,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.042464,0.42086,0.28328,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.079775,0.42081,0.30381,0,1
1,GO DETECTION OF OTHER ORGANISM,0.030665,0.42063,0.39504,0,1
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.09779,0.41883,0.57541,0,1
1,GO AMP METABOLIC PROCESS,0.038917,0.41548,0.44859,0,1
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.051817,0.41249,0.29197,0,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.033564,0.40891,0.36812,0,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.11061,0.40507,0.29385,0,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.066316,0.39812,0.27626,0,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.10533,0.39157,0.22717,0,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.06115,0.38557,0.35436,0,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.069955,0.38447,0.26974,0,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.034581,0.38439,0.24767,0,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.059504,0.37811,0.38803,0,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.036694,0.37727,0.28877,0,1
1,GO RESPONSE TO INTERLEUKIN 7,0.081867,0.37255,0.25381,0,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20828,0.36432,0.21495,0,1
1,GO DECIDUALIZATION,0.071835,0.35708,0.38887,0,1
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.27056,0.3544,0.20482,0,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.073757,0.34922,0.23801,0,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.093006,0.33441,0.25518,0,1
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.07572,0.33159,0.21376,0,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.057895,0.32881,0.22512,0,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.056323,0.32678,0.21078,0,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.056323,0.32628,0.26899,0,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.059504,0.32246,0.29639,0,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.041252,0.31882,0.19447,0,1
1,GO RRNA MODIFICATION,0.04007,0.31742,0.20601,0,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.12771,0.31641,0.22174,0,1
1,GO RESPONSE TO CHEMOKINE,0.086186,0.31312,0.26706,0,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.032572,0.3099,0.31941,0,1
1,GO ADHESION OF SYMBIONT TO HOST,0.047616,0.30756,0.37915,0,1
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.046281,0.30466,0.20828,0,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.030665,0.30368,0.20478,0,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.031606,0.30269,0.29516,0,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.25516,0.30138,0.14413,0,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.079775,0.29527,0.2087,0,1
1,GO REGULATION OF MITOPHAGY,0.035624,0.29335,0.23375,0,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.095374,0.29271,0.51466,0,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.1402,0.28937,0.20343,0,1
1,GO NEUTROPHIL MIGRATION,0.032572,0.28375,0.34483,0,1
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.04007,0.27886,0.22456,0,1
1,GO MITOTIC CELL CYCLE ARREST,0.10794,0.27832,0.22047,0,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.064555,0.27769,0.24287,0,1
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.14347,0.27615,0.27834,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.064555,0.27437,0.19989,0,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.031606,0.27379,0.29534,0,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.051817,0.27278,0.20865,0,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.034581,0.26298,0.25091,0,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.054786,0.25794,0.21588,0,1
1,GO TOXIN TRANSPORT,0.14347,0.25443,0.12886,0,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.059504,0.25294,0.17216,0,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.038917,0.2506,0.23932,0,1
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.13384,0.2478,0.18736,0,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.19139,0.2473,0.27196,0,1
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.030665,0.24458,0.2113,0,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.068115,0.24341,0.21136,0,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.041252,0.24221,0.19259,0,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.14679,0.24217,0.1517,0,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.030665,0.24129,0.19485,0,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.17553,0.24064,0.09121,0,1
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.17553,0.23722,0.12729,0,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.1643,0.23582,0.11604,0,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.031606,0.23491,0.1432,0,1
1,GO RRNA METHYLATION,0.073757,0.23425,0.1463,0,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.053284,0.23324,0.18515,0,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.037792,0.23307,0.15058,0,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.13384,0.23196,0.087547,0,1
1,GO PROTEIN REFOLDING,0.073757,0.23153,0.18164,0,1
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050383,0.23008,0.17079,0,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.062834,0.22886,0.14621,0,1
1,GO CRISTAE FORMATION,0.20828,0.22656,0.1523,0,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.28658,0.22567,0.082184,0,1
1,GO DISACCHARIDE METABOLIC PROCESS,0.10025,0.22487,0.18507,0,1
1,GO LEUKOCYTE CHEMOTAXIS,0.07572,0.2223,0.21497,0,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.18334,0.22146,0.14858,0,1
1,GO RESPONSE TO INTERLEUKIN 6,0.090686,0.22016,0.1739,0,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.037792,0.2198,0.15991,0,1
1,GO OVULATION,0.062834,0.21677,0.32078,0,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.066316,0.21479,0.2179,0,1
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.1161,0.21274,0.20106,0,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.4445,0.21112,0.060753,0,1
1,GO REGULATION OF T CELL MIGRATION,0.14347,0.21062,0.15911,0,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.088413,0.20876,0.17887,0,1
1,GO REGULATION OF PROTEIN SUMOYLATION,0.1643,0.20697,0.16477,0,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.069955,0.20654,0.14608,0,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.062834,0.20445,0.15384,0,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.050383,0.20208,0.23911,0,1
1,GO TRNA PROCESSING,0.056323,0.20198,0.12107,0,1
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.048983,0.19959,0.12678,0,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.15017,0.19767,0.13552,0,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.37614,0.19683,0.11417,0,1
1,GO CHROMOSOME LOCALIZATION,0.059504,0.19679,0.12583,0,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.14679,0.19523,0.17105,0,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.038917,0.19411,0.1035,0,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.032572,0.19391,0.17651,0,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.15017,0.19321,0.13139,0,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.031606,0.19305,0.14929,0,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.059504,0.19007,0.1375,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.13074,0.18875,0.11941,0,1
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.10533,0.1859,0.1142,0,1
1,GO RESPONSE TO STEROL,0.044978,0.18429,0.18486,0,1
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.054786,0.18155,0.14549,0,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.18733,0.18067,0.11489,0,1
1,GO PEPTIDYL ARGININE METHYLATION,0.20828,0.17747,0.089642,0,1
1,GO NEUTROPHIL CHEMOTAXIS,0.26023,0.17459,0.28915,0,1
1,GO OVULATION CYCLE,0.044978,0.17203,0.20959,0,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12179,0.17107,0.14172,0,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.24525,0.17057,0.14391,0,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.062834,0.1696,0.097431,0,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.088413,0.16876,0.10139,0,1
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.06115,0.16713,0.16909,0,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.038917,0.16637,0.12227,0,1
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.1794,0.16621,0.14081,0,1
1,GO METAPHASE PLATE CONGRESSION,0.073757,0.16375,0.1017,0,1
1,GO POSITIVE REGULATION OF CELL AGING,0.14679,0.16333,0.25844,0,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.14679,0.16242,0.10933,0,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.036694,0.16025,0.10729,0,1
1,GO LYMPH NODE DEVELOPMENT,0.31468,0.16009,0.1165,0,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.053284,0.15994,0.084944,0,1
1,GO CELLULAR RESPONSE TO DRUG,0.086186,0.15988,0.14393,0,1
1,GO RECEPTOR RECYCLING,0.042464,0.15945,0.12655,0,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.056323,0.15834,0.1075,0,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.068115,0.15774,0.13093,0,1
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.20396,0.15525,0.13241,0,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.064555,0.15416,0.099474,0,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.034581,0.15385,0.12952,0,1
1,GO RESPONSE TO CAMP,0.041252,0.14962,0.17694,0,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11061,0.14688,0.094858,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16798,0.14331,0.091831,0,1
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.044978,0.14003,0.1126,0,1
1,GO CYTOKINESIS,0.17553,0.13714,0.082736,0,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.11333,0.13626,0.086646,0,1
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.047616,0.13448,0.13482,0,1
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.15361,0.13442,0.088706,0,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.035624,0.13358,0.098934,0,1
1,GO REGULATION OF SPINDLE CHECKPOINT,0.15361,0.13093,0.13644,0,1
1,GO HISTONE ARGININE METHYLATION,0.39593,0.12574,0.05968,0,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.13074,0.125,0.097859,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.58378,0.12488,0.034747,0,1
1,GO GENE SILENCING,0.062834,0.12199,0.068431,0,1
1,GO NEGATIVE REGULATION OF BINDING,0.06115,0.12077,0.1164,0,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.19552,0.12058,0.085022,0,1
1,GO SECRETION,0.073757,0.11634,0.090396,0,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.30892,0.11469,0.10365,0,1
1,GO RNA INTERFERENCE,0.67783,0.11313,0.030615,0,1
1,GO PROTEIN TETRAMERIZATION,0.034581,0.11147,0.10701,0,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.084004,0.11066,0.082806,0,1
1,GO MITOTIC NUCLEAR DIVISION,0.095374,0.11056,0.070675,0,1
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.21712,0.1046,0.10939,0,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.046281,0.09154,0.062926,0,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.073757,0.084049,0.078814,0,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.084004,0.055151,0.054647,0,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.031606,0.48598,0.42707,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.037792,0.48017,0.41934,0,0
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.13074,0.4531,0.29913,0,0
1,GO DISTAL TUBULE DEVELOPMENT,0.068115,0.43139,0.30064,0,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.032572,0.43048,0.37438,0,0
1,GO PROTEIN OXIDATION,0.06115,0.42696,0.44887,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.031606,0.42078,0.32906,0,0
1,GO STEROID ESTERIFICATION,0.035624,0.41292,0.32115,0,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.10025,0.40059,0.29866,0,0
1,GO NEGATIVE T CELL SELECTION,0.053284,0.39094,0.28155,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.11892,0.39057,0.26858,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.10277,0.37184,0.21691,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.15361,0.36473,0.18892,0,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.31468,0.36368,0.12157,0,0
1,GO TELOMERASE RNA LOCALIZATION,0.036694,0.36065,0.25373,0,0
1,GO PROGESTERONE METABOLIC PROCESS,0.035624,0.35898,0.2499,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.034581,0.35188,0.34352,0,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.16068,0.34725,0.20177,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.1643,0.34184,0.24088,0,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.034581,0.33803,0.23831,0,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.056323,0.33215,0.27456,0,0
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.38267,0.32969,0.14028,0,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.047616,0.32776,0.23957,0,0
1,GO REGULATION OF ANOIKIS,0.066316,0.32726,0.28459,0,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.047616,0.3245,0.31861,0,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.10025,0.32162,0.16844,0,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.054786,0.31652,0.36642,0,0
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.042464,0.31648,0.20235,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.095374,0.31487,0.22562,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.064555,0.31478,0.30097,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.093006,0.31458,0.21136,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.28658,0.31136,0.20304,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.084004,0.31054,0.25635,0,0
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.036694,0.30869,0.15715,0,0
1,GO CYCLOOXYGENASE PATHWAY,0.073757,0.30824,0.37707,0,0
1,GO BONE TRABECULA MORPHOGENESIS,0.11892,0.30755,0.36607,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.15712,0.30637,0.46214,0,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.071835,0.30427,0.18598,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.1402,0.30118,0.31457,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.45171,0.29987,0.13081,0,0
1,GO NADPH REGENERATION,0.046281,0.29871,0.22586,0,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.050383,0.29776,0.2958,0,0
1,GO CARNITINE METABOLIC PROCESS,0.06115,0.2968,0.30524,0,0
1,GO RENAL FILTRATION,0.035624,0.29621,0.30389,0,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.051817,0.29537,0.49282,0,0
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.28117,0.2945,0.1444,0,0
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.031606,0.2944,0.35444,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.6603,0.29438,0.085157,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.054786,0.29335,0.24997,0,0
1,GO OLIGOPEPTIDE TRANSPORT,0.037792,0.29201,0.29485,0,0
1,GO RESPONSE TO DEXAMETHASONE,0.056323,0.29168,0.18937,0,0
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.10025,0.29039,0.17653,0,0
1,GO RESPONSE TO CADMIUM ION,0.13699,0.29008,0.1897,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.16798,0.28794,0.27969,0,0
1,GO AMYLOID FIBRIL FORMATION,0.14347,0.2873,0.26504,0,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.042464,0.28664,0.26107,0,0
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.030665,0.28623,0.26323,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.21267,0.28606,0.17543,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.10794,0.28464,0.1841,0,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.033564,0.28106,0.19585,0,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.035624,0.27874,0.22345,0,0
1,GO CARDIOBLAST DIFFERENTIATION,0.047616,0.27762,0.26379,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.086186,0.27669,0.26747,0,0
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.033564,0.27558,0.31672,0,0
1,GO RETINAL METABOLIC PROCESS,0.24525,0.27544,0.16451,0,0
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.062834,0.27401,0.19865,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.1161,0.27356,0.17437,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.053284,0.27153,0.2597,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.084004,0.27144,0.31183,0,0
1,GO INTERFERON ALPHA PRODUCTION,0.069955,0.2644,0.16501,0,0
1,GO RRNA METABOLIC PROCESS,0.034581,0.26431,0.22976,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.093006,0.26318,0.25496,0,0
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.053284,0.26217,0.14355,0,0
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.04007,0.2589,0.24552,0,0
1,GO POSITIVE REGULATION OF COAGULATION,0.033564,0.25837,0.28431,0,0
1,GO SERTOLI CELL DEVELOPMENT,0.071835,0.25808,0.22296,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.10533,0.25701,0.15473,0,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.035624,0.25525,0.45956,0,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.034581,0.2542,0.24965,0,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.071835,0.25411,0.18589,0,0
1,GO TRABECULA FORMATION,0.073757,0.25318,0.37048,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.19552,0.25284,0.1983,0,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.050383,0.2528,0.23567,0,0
1,GO TRANSPOSITION,0.081867,0.25017,0.1934,0,0
1,GO PENTOSE METABOLIC PROCESS,0.071835,0.25014,0.19147,0,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.11892,0.25011,0.15121,0,0
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.11333,0.24957,0.23774,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.042464,0.24902,0.27398,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.093006,0.24873,0.19321,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.1643,0.24828,0.19333,0,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.088413,0.24793,0.25901,0,0
1,GO KERATINOCYTE MIGRATION,0.037792,0.24749,0.28158,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.17173,0.24744,0.13253,0,0
1,GO REGULATION OF PLATELET ACTIVATION,0.077726,0.24689,0.20583,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.051817,0.24613,0.25578,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.2356,0.24539,0.21431,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.26023,0.24491,0.11083,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.064555,0.24466,0.27944,0,0
1,GO CELL CELL JUNCTION MAINTENANCE,0.086186,0.24452,0.25037,0,0
1,GO ASTROCYTE DIFFERENTIATION,0.034581,0.2444,0.18556,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.22164,0.24416,0.13949,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.12771,0.2441,0.45878,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.10794,0.24245,0.23425,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.030665,0.24109,0.1867,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.11333,0.24043,0.19265,0,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.035624,0.24019,0.50931,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.27583,0.24009,0.12072,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.077726,0.23956,0.18028,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.36968,0.23934,0.12511,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.053284,0.23886,0.1825,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.044978,0.2375,0.2097,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.56735,0.23657,0.061213,0,0
1,GO MATURE B CELL DIFFERENTIATION,0.032572,0.23648,0.28185,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.13699,0.23603,0.28642,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.10794,0.23529,0.28441,0,0
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.27056,0.23495,0.11231,0,0
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.10277,0.23445,0.20424,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.1643,0.23399,0.18485,0,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.037792,0.23359,0.22086,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.21267,0.23324,0.10725,0,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.24039,0.23314,0.10451,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.29761,0.23226,0.10885,0,0
1,GO NEURAL CREST CELL MIGRATION,0.11333,0.23178,0.16599,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.081867,0.23115,0.24349,0,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.11061,0.23075,0.19018,0,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.037792,0.23064,0.19339,0,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.048983,0.23045,0.22324,0,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.030665,0.23029,0.2212,0,0
1,GO REGULATION OF CALCIUM ION IMPORT,0.10025,0.22951,0.15203,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.079775,0.22918,0.19983,0,0
1,GO KINETOCHORE ASSEMBLY,0.4445,0.22889,0.073421,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.10533,0.22888,0.17732,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17173,0.2282,0.27642,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.21712,0.22752,0.23849,0,0
1,GO RESPONSE TO UV B,0.23088,0.22707,0.18162,0,0
1,GO MITRAL VALVE DEVELOPMENT,0.55922,0.22611,0.065303,0,0
1,GO ENAMEL MINERALIZATION,0.10277,0.22509,0.25153,0,0
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.1643,0.22389,0.15125,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.038917,0.22366,0.21353,0,0
1,GO MYOBLAST PROLIFERATION,0.26536,0.22354,0.098406,0,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.31468,0.22268,0.20478,0,0
1,GO NAD METABOLIC PROCESS,0.11333,0.22244,0.17534,0,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.048983,0.22243,0.28255,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.10025,0.2217,0.20093,0,0
1,GO NUCLEAR PORE ORGANIZATION,0.086186,0.22138,0.15845,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.24039,0.22011,0.12787,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.13699,0.21953,0.19113,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.035624,0.2191,0.24497,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.10025,0.21898,0.30662,0,0
1,GO CELLULAR RESPONSE TO ETHANOL,0.068115,0.21887,0.29974,0,0
1,GO RESPONSE TO KETONE,0.071835,0.21875,0.1247,0,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.10025,0.21852,0.15073,0,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.057895,0.21732,0.1758,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.047616,0.2168,0.16,0,0
1,GO IMP METABOLIC PROCESS,0.28658,0.21656,0.14788,0,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.032572,0.2162,0.18627,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.21712,0.21618,0.30235,0,0
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.13699,0.21611,0.17389,0,0
1,GO RESPONSE TO COPPER ION,0.16068,0.21435,0.2409,0,0
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.40267,0.21406,0.091006,0,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.068115,0.21396,0.22065,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.14679,0.21297,0.19627,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.32642,0.21276,0.12762,0,0
1,GO ASYMMETRIC CELL DIVISION,0.053284,0.21271,0.19257,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.044978,0.21193,0.18381,0,0
1,GO URETER DEVELOPMENT,0.053284,0.21167,0.18847,0,0
1,GO FATTY ACID BETA OXIDATION,0.069955,0.20849,0.18897,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.21267,0.20819,0.14525,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.07572,0.20717,0.26965,0,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.10277,0.20706,0.18451,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.033564,0.20693,0.18093,0,0
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.038917,0.20652,0.18305,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.12771,0.20603,0.15929,0,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.036694,0.2059,0.15688,0,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.67783,0.20505,0.070853,0,0
1,GO MYOBLAST MIGRATION,0.12179,0.20427,0.2001,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.11892,0.20404,0.1498,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.42328,0.20345,0.36552,0,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.036694,0.20272,0.22079,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.068115,0.20263,0.25215,0,0
1,GO RESPONSE TO RETINOIC ACID,0.032572,0.2026,0.16547,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.041252,0.2024,0.1917,0,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.10533,0.20237,0.15985,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.16798,0.20202,0.14026,0,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.036694,0.20197,0.2402,0,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.050383,0.20156,0.18997,0,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.10533,0.20094,0.12945,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.27583,0.19916,0.1256,0,0
1,GO EXTRACELLULAR TRANSPORT,0.10277,0.19908,0.16317,0,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.034581,0.19875,0.19496,0,0
1,GO HISTONE H2B UBIQUITINATION,0.18733,0.19871,0.10666,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.17553,0.19865,0.22539,0,0
1,GO PARAXIAL MESODERM DEVELOPMENT,0.079775,0.19858,0.2058,0,0
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.14679,0.19788,0.21614,0,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.55115,0.19777,0.088128,0,0
1,GO REGULATION OF CELL CELL ADHESION,0.032572,0.19757,0.15161,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.10533,0.19719,0.075271,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.18334,0.19695,0.23659,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.61728,0.19691,-0.0072079,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.071835,0.19603,0.13785,0,0
1,GO PROTEIN ADP RIBOSYLATION,0.088413,0.19598,0.14986,0,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.064555,0.19457,0.19074,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.051817,0.19454,0.16188,0,0
1,GO REGULATION OF CENTRIOLE REPLICATION,0.35697,0.19444,0.080702,0,0
1,GO PROTEIN AUTOPROCESSING,0.093006,0.1944,0.12829,0,0
1,GO MITOTIC CYTOKINESIS,0.071835,0.19427,0.14301,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.24525,0.19348,0.10003,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.07572,0.19288,0.1444,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.43736,0.19285,0.066921,0,0
1,GO PROSTATIC BUD FORMATION,0.073757,0.19173,0.30316,0,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.19971,0.19169,0.1258,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.10533,0.19084,0.16034,0,0
1,GO LIPID IMPORT INTO CELL,0.25017,0.19032,0.14761,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.10794,0.19017,0.25296,0,0
1,GO GLIAL CELL APOPTOTIC PROCESS,0.09779,0.1901,0.19677,0,0
1,GO KINETOCHORE ORGANIZATION,0.58378,0.19007,0.026958,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.10794,0.18996,0.14784,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.45171,0.18901,0.064049,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.15017,0.18887,0.20635,0,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.034581,0.18885,0.17334,0,0
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.11061,0.18873,0.12453,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.10277,0.18849,0.11221,0,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.68667,0.1884,0.033925,0,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14679,0.18769,0.14178,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.23088,0.18765,0.10829,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.11892,0.18762,0.11756,0,0
1,GO TRACHEA DEVELOPMENT,0.062834,0.18599,0.22001,0,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.086186,0.18536,0.18544,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.6516,0.18536,0.14559,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.037792,0.18527,0.16296,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.041252,0.18518,0.22992,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.11892,0.18508,0.24163,0,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.15712,0.18483,0.20605,0,0
1,GO DENDRITIC CELL MIGRATION,0.35697,0.18442,0.10684,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.17173,0.1838,0.21821,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.079775,0.18329,0.1595,0,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.09779,0.18285,0.12592,0,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.29761,0.18276,0.080225,0,0
1,GO CELLULAR RESPONSE TO HEAT,0.043706,0.18276,0.14257,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.1643,0.18266,0.10921,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.14347,0.18219,0.24407,0,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.29761,0.18218,0.19294,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.19552,0.18189,0.075212,0,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.086186,0.18183,0.16952,0,0
1,GO TRNA METHYLATION,0.069955,0.18171,0.12075,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.20396,0.18147,0.12188,0,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.033564,0.18112,0.18348,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.31468,0.181,0.15741,0,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.036694,0.18085,0.19913,0,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.04007,0.18083,0.16722,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.12472,0.18076,0.2328,0,0
1,GO POSITIVE REGULATION OF HEART GROWTH,0.095374,0.18032,0.20306,0,0
1,GO MYOTUBE DIFFERENTIATION,0.066316,0.1797,0.1571,0,0
1,GO AXIS ELONGATION,0.11061,0.17968,0.13385,0,0
1,GO GONADOTROPIN SECRETION,0.21267,0.1781,0.18071,0,0
1,GO DNA LIGATION,0.04007,0.17806,0.20714,0,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.14679,0.17706,0.28322,0,0
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.33239,0.17694,0.1005,0,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.038917,0.17608,0.23879,0,0
1,GO TRNA METABOLIC PROCESS,0.13074,0.17587,0.099953,0,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.088413,0.17576,0.26748,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.35697,0.17573,0.079782,0,0
1,GO HEPATOCYTE DIFFERENTIATION,0.15017,0.17548,0.20277,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.24525,0.17512,0.12856,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.053284,0.17472,0.17628,0,0
1,GO RNA METHYLATION,0.041252,0.17425,0.12055,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.1794,0.17386,0.15895,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.14347,0.1734,0.24421,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.04007,0.17243,0.17258,0,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.046281,0.17184,0.12813,0,0
1,GO NADP METABOLIC PROCESS,0.26536,0.17113,0.12931,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.24525,0.17093,0.10679,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.10277,0.17027,0.22883,0,0
1,GO UV PROTECTION,0.30323,0.17021,0.16514,0,0
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.1161,0.17011,0.11399,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.45171,0.16993,0.13549,0,0
1,GO REGULATION OF BONE DEVELOPMENT,0.046281,0.16984,0.28031,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.24525,0.16925,0.35544,0,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.041252,0.16895,0.16731,0,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.050383,0.16829,0.14158,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.32052,0.16777,0.18618,0,0
1,GO RESPONSE TO DRUG,0.088413,0.16752,0.10599,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.11333,0.16746,0.22194,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.45171,0.16744,0.10904,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.051817,0.16728,0.17505,0,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.06115,0.16719,0.12672,0,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.036694,0.1669,0.18822,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.40267,0.16674,0.068271,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.67783,0.16657,0.018145,0,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.066316,0.16579,0.25994,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.093006,0.1656,0.12155,0,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.26023,0.16545,0.11186,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.069955,0.16413,0.16401,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.066316,0.16407,0.29282,0,0
1,GO FIBROBLAST ACTIVATION,0.1402,0.16345,0.14809,0,0
1,GO RESPONSE TO TUMOR CELL,0.13384,0.16335,0.16806,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.26536,0.16327,0.086659,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.12771,0.16325,0.15548,0,0
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.093006,0.16304,0.11262,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.1161,0.16298,0.22272,0,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.038917,0.16206,0.1385,0,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.068115,0.16194,0.17083,0,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.064555,0.16134,0.18771,0,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.6603,0.16105,0.035883,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.45171,0.16022,0.16203,0,0
1,GO MYELIN MAINTENANCE,0.093006,0.15995,0.2103,0,0
1,GO TOOTH MINERALIZATION,0.20396,0.15974,0.13003,0,0
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.04007,0.15951,0.1425,0,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.044978,0.15949,0.11953,0,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.073757,0.15937,0.15763,0,0
1,GO NCRNA EXPORT FROM NUCLEUS,0.29761,0.15869,0.097478,0,0
1,GO REGULATION OF GTP BINDING,0.32052,0.15858,0.14907,0,0
1,GO DNA DEMETHYLATION,0.28117,0.15801,0.080564,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.15361,0.15791,0.087987,0,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.41634,0.15787,0.11623,0,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.10025,0.15782,0.17182,0,0
1,GO TRANSEPITHELIAL TRANSPORT,0.043706,0.15731,0.19274,0,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.14347,0.15683,0.1678,0,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.032572,0.1568,0.15072,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.07572,0.15673,0.14445,0,0
1,GO ETHANOL METABOLIC PROCESS,0.17173,0.15584,0.138,0,0
1,GO PROSTATE GLAND DEVELOPMENT,0.06115,0.15553,0.16611,0,0
1,GO AMINE CATABOLIC PROCESS,0.079775,0.1555,0.21079,0,0
1,GO THYROID HORMONE METABOLIC PROCESS,0.032572,0.15526,0.20275,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.29761,0.15519,0.13796,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.13074,0.15487,0.15876,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.062834,0.1545,0.18086,0,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.044978,0.15439,0.11474,0,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.056323,0.15438,0.12616,0,0
1,GO MUSCLE ADAPTATION,0.084004,0.1542,0.11044,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.28117,0.15409,0.070157,0,0
1,GO PEROXISOMAL TRANSPORT,0.068115,0.15399,0.1643,0,0
1,GO MANGANESE ION TRANSPORT,0.19139,0.15367,0.16001,0,0
1,GO BIOLOGICAL PHASE,0.15361,0.15323,0.2839,0,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.21267,0.15302,0.093702,0,0
1,GO TRNA MODIFICATION,0.10794,0.15278,0.099501,0,0
1,GO REPLACEMENT OSSIFICATION,0.04007,0.15222,0.22992,0,0
1,GO ANIMAL ORGAN FORMATION,0.10025,0.15173,0.1372,0,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.062834,0.15146,0.12824,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.07572,0.15052,0.26397,0,0
1,GO SERTOLI CELL DIFFERENTIATION,0.10277,0.15033,0.16194,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.26023,0.15006,0.079319,0,0
1,GO OVULATION CYCLE PROCESS,0.13384,0.14988,0.14281,0,0
1,GO RRNA 3 END PROCESSING,0.048983,0.14953,0.1538,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.069955,0.14949,0.24053,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.33239,0.1489,0.076129,0,0
1,GO TONGUE DEVELOPMENT,0.17553,0.14858,0.15563,0,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.071835,0.14825,0.1818,0,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.032572,0.14825,0.16547,0,0
1,GO NADH METABOLIC PROCESS,0.13384,0.14811,0.14353,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.33843,0.14801,0.09007,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.30892,0.14794,0.059169,0,0
1,GO ENDODERMAL CELL FATE COMMITMENT,0.081867,0.14772,0.19339,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.088413,0.14742,0.11278,0,0
1,GO ENDOCRINE PROCESS,0.051817,0.147,0.15028,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20828,0.14698,0.09247,0,0
1,GO RESPONSE TO UV,0.068115,0.14679,0.090425,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.20396,0.14667,0.082428,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.19139,0.14648,0.12268,0,0
1,GO PEROXISOME ORGANIZATION,0.053284,0.14648,0.16096,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.88036,0.14565,0.0011309,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.24525,0.14561,0.091591,0,0
1,GO CELLULAR RESPONSE TO PH,0.29761,0.14534,0.080923,0,0
1,GO REGULATION OF DNA BINDING,0.18334,0.14534,0.069972,0,0
1,GO RRNA TRANSCRIPTION,0.12771,0.14506,0.12748,0,0
1,GO RESPONSE TO GONADOTROPIN,0.1402,0.14492,0.20454,0,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.11061,0.14461,0.12985,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.042464,0.14441,0.12858,0,0
1,GO ANION HOMEOSTASIS,0.30323,0.14414,0.070375,0,0
1,GO ENDOCARDIAL CUSHION FORMATION,0.28658,0.14409,0.16927,0,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.035624,0.14376,0.15415,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.26023,0.14353,0.072676,0,0
1,GO REGULATION OF LIPID TRANSPORT,0.037792,0.14339,0.11948,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.29761,0.14328,0.10363,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.15361,0.14293,0.1391,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.30892,0.14269,0.096001,0,0
1,GO EPOXYGENASE P450 PATHWAY,0.38267,0.14262,0.088141,0,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.064555,0.14259,0.14198,0,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.19971,0.14258,0.092368,0,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.27583,0.14239,0.1214,0,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.081867,0.14199,0.10224,0,0
1,GO UV DAMAGE EXCISION REPAIR,0.042464,0.14198,0.20356,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.090686,0.14186,0.18005,0,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.047616,0.14152,0.20695,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.20396,0.14115,0.10811,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.066316,0.14115,0.16063,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.25017,0.14101,0.12927,0,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.34454,0.14095,0.054463,0,0
1,GO STRESS FIBER ASSEMBLY,0.069955,0.14051,0.20464,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.84251,0.13999,-0.003494,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.081867,0.1391,0.22126,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.15361,0.13906,0.13345,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.046281,0.13858,0.10042,0,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.51944,0.13847,0.052791,0,0
1,GO RESPONSE TO LEAD ION,0.19552,0.13836,0.11027,0,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.55922,0.13831,0.056538,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.28117,0.13829,0.067748,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.11061,0.13761,0.1337,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.35072,0.1375,0.17526,0,0
1,GO PROTEIN TRIMERIZATION,0.14679,0.1372,0.17565,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.53518,0.13695,0.07449,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.07572,0.13685,0.22383,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.30323,0.13679,0.069078,0,0
1,GO CENTRIOLE ASSEMBLY,0.19552,0.13671,0.061082,0,0
1,GO SECRETION BY TISSUE,0.28658,0.13657,0.096918,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.071835,0.13651,0.21071,0,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.056323,0.13624,0.15042,0,0
1,GO TRNA CATABOLIC PROCESS,0.45898,0.13609,0.15895,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.45171,0.13608,0.15554,0,0
1,GO RESPONSE TO AMYLOID BETA,0.19971,0.13576,0.18386,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.69555,0.13555,0.024973,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037792,0.1355,0.11643,0,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.062834,0.13548,0.10265,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10277,0.13544,0.1643,0,0
1,GO RNA LOCALIZATION,0.041252,0.13543,0.13828,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.30892,0.13523,0.16222,0,0
1,GO TRABECULA MORPHOGENESIS,0.059504,0.13521,0.18959,0,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.053284,0.13514,0.10394,0,0
1,GO PORE COMPLEX ASSEMBLY,0.11061,0.135,0.11226,0,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.035624,0.13482,0.16422,0,0
1,GO NUCLEAR TRANSPORT,0.042464,0.13471,0.09063,0,0
1,GO STEROL HOMEOSTASIS,0.11892,0.13463,0.088097,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.18733,0.13452,0.14817,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.40947,0.13447,0.035235,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.030665,0.13438,0.12421,0,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077726,0.1343,0.18658,0,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.044978,0.13409,0.17736,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.4963,0.13379,0.10791,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.61728,0.1336,0.024161,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.042464,0.13359,0.1773,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.073757,0.13354,0.15041,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.068115,0.13347,0.096198,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.60883,0.13334,0.064748,0,0
1,GO REGULATION OF CELL DIVISION,0.19971,0.13329,0.058868,0,0
1,GO PROTEIN IMPORT,0.050383,0.13314,0.10479,0,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.032572,0.13313,0.20592,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.74054,0.13306,0.025887,0,0
1,GO HAIR FOLLICLE MATURATION,0.32052,0.13234,0.10199,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.084004,0.13233,0.13608,0,0
1,GO NEURAL TUBE PATTERNING,0.12771,0.13205,0.12385,0,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.10277,0.132,0.099255,0,0
1,GO INCLUSION BODY ASSEMBLY,0.55115,0.13195,0.05663,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.088413,0.13192,0.11339,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.090686,0.13185,0.18565,0,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.068115,0.13169,0.11362,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.34454,0.13137,0.085547,0,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.22622,0.13132,0.12965,0,0
1,GO RNA PROCESSING,0.044978,0.13103,0.10708,0,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.10533,0.13074,0.14793,0,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.030665,0.13071,0.14662,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.15361,0.13049,0.12356,0,0
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.10277,0.13046,0.20905,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.081867,0.13033,0.12558,0,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.17553,0.1303,0.1322,0,0
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.037792,0.13023,0.14593,0,0
1,GO RESPONSE TO SALT,0.64294,0.13022,-0.051935,0,0
1,GO RETINOL METABOLIC PROCESS,0.15712,0.13011,0.093047,0,0
1,GO ENDOTHELIUM DEVELOPMENT,0.38267,0.13006,0.0566,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.53518,0.13004,0.052932,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.081867,0.12967,0.088311,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.093006,0.129,0.11639,0,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.09779,0.12852,0.086376,0,0
1,GO B CELL PROLIFERATION,0.74966,0.1285,0.0083026,0,0
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.45171,0.12808,0.063637,0,0
1,GO REGULATION OF CELL SHAPE,0.081867,0.12802,0.13931,0,0
1,GO COPII COATED VESICLE CARGO LOADING,0.047616,0.12719,0.19728,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.033564,0.12692,0.17062,0,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.068115,0.12689,0.13157,0,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.095374,0.12688,0.11193,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.36968,0.12686,0.063438,0,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.034581,0.12647,0.12376,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.038917,0.12639,0.11621,0,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.26536,0.12616,0.18336,0,0
1,GO HUMORAL IMMUNE RESPONSE,0.046281,0.12614,0.1273,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.030665,0.1261,0.13999,0,0
1,GO DETOXIFICATION,0.23088,0.12577,0.083304,0,0
1,GO VASODILATION,0.53518,0.12572,0.040315,0,0
1,GO ESTROGEN METABOLIC PROCESS,0.084004,0.12571,0.13606,0,0
1,GO SPHINGOID METABOLIC PROCESS,0.066316,0.12559,0.11941,0,0
1,GO CELL CYCLE PHASE TRANSITION,0.15017,0.12537,0.055406,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.54313,0.12487,0.039494,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.19552,0.12479,0.083557,0,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.42328,0.12479,0.091734,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.053284,0.12456,0.17608,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.53518,0.12453,0.058848,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.18334,0.12449,0.079244,0,0
1,GO PLASMA MEMBRANE FUSION,0.1643,0.12432,0.21732,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.17553,0.12421,0.074838,0,0
1,GO AMYLOID BETA FORMATION,0.21267,0.12404,0.1417,0,0
1,GO REGULATION OF MITOTIC CELL CYCLE,0.086186,0.12382,0.076297,0,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.050383,0.12322,0.086404,0,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.030665,0.12318,0.10855,0,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038917,0.12313,0.11048,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.35697,0.12292,0.039052,0,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.051817,0.12281,0.23325,0,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.16068,0.1226,0.086566,0,0
1,GO PIRNA METABOLIC PROCESS,0.1402,0.12242,0.20603,0,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.23088,0.12228,0.069458,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.30892,0.12217,0.14984,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.26536,0.1218,0.074756,0,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.2356,0.1215,0.12512,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.40947,0.12118,0.049457,0,0
1,GO IMPORT INTO NUCLEUS,0.079775,0.12096,0.069425,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.34454,0.12082,0.081388,0,0
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.09779,0.12076,0.10366,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.28117,0.12066,0.088917,0,0
1,GO DRUG METABOLIC PROCESS,0.051817,0.12061,0.10164,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.29206,0.12061,0.083794,0,0
1,GO FACE DEVELOPMENT,0.04007,0.12045,0.20464,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.36329,0.12043,0.14062,0,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.64294,0.12003,0.10438,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.32052,0.11997,0.097538,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.19139,0.11983,0.12927,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.6603,0.11979,0.018333,0,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.054786,0.11971,0.14397,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.52728,0.11931,0.034665,0,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.15712,0.11921,0.21961,0,0
1,GO LIPID LOCALIZATION,0.14679,0.11912,0.067602,0,0
1,GO MAMMARY GLAND DEVELOPMENT,0.16798,0.11908,0.085663,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.4963,0.11892,0.18635,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.048983,0.11886,0.11578,0,0
1,GO REGULATION OF CHROMOSOME SEPARATION,0.084004,0.1186,0.13813,0,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.33239,0.11859,0.059021,0,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.40947,0.11828,0.075492,0,0
1,GO HEMOGLOBIN METABOLIC PROCESS,0.28117,0.11822,0.14416,0,0
1,GO NCRNA CATABOLIC PROCESS,0.35697,0.11801,0.1279,0,0
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.16798,0.11801,0.1505,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.20828,0.11797,0.115,0,0
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.20396,0.11779,0.18183,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.077726,0.11761,0.11207,0,0
1,GO TUBE DEVELOPMENT,0.034581,0.11736,0.14587,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.042464,0.11735,0.14197,0,0
1,GO REGULATION OF TISSUE REMODELING,0.18733,0.11725,0.10007,0,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.046281,0.11711,0.10479,0,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.16068,0.11687,0.086025,0,0
1,GO MITOTIC RECOMBINATION,0.048983,0.11684,0.14423,0,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.079775,0.11666,0.091506,0,0
1,GO CELLULAR RESPONSE TO RADIATION,0.07572,0.1166,0.089279,0,0
1,GO LIPID OXIDATION,0.2356,0.11649,0.099278,0,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.31468,0.11619,0.076445,0,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.036694,0.11596,0.096984,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.45171,0.11589,0.048562,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.25516,0.11581,0.11778,0,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.043706,0.1158,0.099006,0,0
1,GO BIOLOGICAL ADHESION,0.088413,0.11565,0.12042,0,0
1,GO REGULATION OF OSSIFICATION,0.031606,0.11558,0.18054,0,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.1794,0.1155,0.12627,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.11061,0.11518,0.075591,0,0
1,GO BLASTOCYST GROWTH,0.10533,0.11494,0.12355,0,0
1,GO ETHER METABOLIC PROCESS,0.39593,0.11484,0.051937,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.92804,0.11472,-0.034659,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.56735,0.1145,0.012218,0,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.1402,0.1142,0.068091,0,0
1,GO MEIOTIC SPINDLE ORGANIZATION,0.11333,0.11419,0.16455,0,0
1,GO HISTONE H4 DEACETYLATION,0.40947,0.1135,0.096932,0,0
1,GO ANOIKIS,0.29206,0.11343,0.13774,0,0
1,GO FLUID TRANSPORT,0.057895,0.11332,0.13348,0,0
1,GO VITAMIN D METABOLIC PROCESS,0.59207,0.1132,0.16755,0,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.064555,0.11316,0.088749,0,0
1,GO VITAMIN TRANSPORT,0.19139,0.11315,0.093277,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.17553,0.11296,0.085579,0,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.25017,0.11283,0.17385,0,0
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.037792,0.1127,0.15055,0,0
1,GO RESPONSE TO ACIDIC PH,0.27056,0.11211,0.11555,0,0
1,GO AMINE METABOLIC PROCESS,0.081867,0.11209,0.099276,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.50395,0.11203,0.030322,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.33843,0.11191,0.20166,0,0
1,GO ORGANELLE FISSION,0.10277,0.11178,0.055156,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.45898,0.11168,0.059878,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.6603,0.11164,0.034006,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.6516,0.11134,0.046809,0,0
1,GO CELLULAR RESPONSE TO UV,0.15017,0.11058,0.092001,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.12472,0.11035,0.085575,0,0
1,GO FATTY ACID CATABOLIC PROCESS,0.20828,0.1103,0.10142,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.1402,0.11013,0.16538,0,0
1,GO NEURAL CREST CELL DIFFERENTIATION,0.26536,0.11007,0.09805,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.51167,0.10997,0.13935,0,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.036694,0.10979,0.098698,0,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.079775,0.10972,0.11894,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.081867,0.10968,0.20131,0,0
1,GO SNORNA METABOLIC PROCESS,0.47371,0.10967,0.035188,0,0
1,GO ORGANIC ACID METABOLIC PROCESS,0.064555,0.10948,0.085566,0,0
1,GO CERAMIDE TRANSPORT,0.18334,0.10931,0.18537,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.11061,0.10922,0.13792,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.95679,0.10919,-0.021157,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.47371,0.10918,0.0029337,0,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.073757,0.10917,0.092371,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.22622,0.10912,0.12327,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.43736,0.10889,0.10785,0,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.11892,0.1087,0.15855,0,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.11333,0.10865,0.13325,0,0
1,GO RESPONSE TO HORMONE,0.053284,0.10859,0.099013,0,0
1,GO LIPID CATABOLIC PROCESS,0.18733,0.10856,0.059501,0,0
1,GO PROTEIN NEDDYLATION,0.079775,0.10839,0.15013,0,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.10533,0.10795,0.067792,0,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.23088,0.10787,0.048358,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.55115,0.10783,0.10851,0,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.079775,0.10779,0.10324,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35072,0.10771,0.10905,0,0
1,GO TRANSCYTOSIS,0.27583,0.10764,0.10976,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.22164,0.10746,0.11946,0,0
1,GO SNORNA 3 END PROCESSING,0.45171,0.10744,0.030194,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.36329,0.10736,0.10807,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.63434,0.10718,0.024628,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.47371,0.10714,0.063421,0,0
1,GO SULFATION,0.39593,0.10714,0.044465,0,0
1,GO FATTY ACID METABOLIC PROCESS,0.12771,0.10705,0.080973,0,0
1,GO REGULATION OF DNA REPLICATION,0.17553,0.10677,0.040007,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.13699,0.10665,0.061216,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.30323,0.10663,0.097582,0,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.06115,0.10649,0.10555,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.32052,0.10636,0.1073,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.30323,0.1062,0.15988,0,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.17553,0.10562,0.085418,0,0
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.062834,0.10543,0.068964,0,0
1,GO RUFFLE ASSEMBLY,0.042464,0.10528,0.14391,0,0
1,GO MESENCHYME MORPHOGENESIS,0.15712,0.10471,0.20644,0,0
1,GO COENZYME A METABOLIC PROCESS,0.54313,0.10436,0.042963,0,0
1,GO LIVER MORPHOGENESIS,0.32642,0.10422,0.1675,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.4445,0.10419,0.082033,0,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.28117,0.10416,0.079021,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.28117,0.10409,0.052537,0,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.33239,0.10401,0.1009,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.45898,0.10369,0.1058,0,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.19971,0.10365,0.082768,0,0
1,GO LIPID HOMEOSTASIS,0.14347,0.10337,0.057044,0,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.053284,0.10318,0.092008,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.28117,0.10315,0.064263,0,0
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.079775,0.10295,0.11379,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.43029,0.10267,0.077868,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.42328,0.10253,0.17431,0,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.43029,0.10251,0.10238,0,0
1,GO SPINDLE ORGANIZATION,0.24525,0.10237,0.05729,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.28117,0.10211,0.10579,0,0
1,GO MRNA TRANSPORT,0.030665,0.10202,0.12044,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.29761,0.10196,0.081762,0,0
1,GO BONE RESORPTION,0.069955,0.10167,0.16513,0,0
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.17553,0.10145,0.049418,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.19552,0.10139,0.12845,0,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.059504,0.10132,0.089909,0,0
1,GO GLYCINE METABOLIC PROCESS,0.43736,0.10121,0.12275,0,0
1,GO TRANSFERRIN TRANSPORT,0.46631,0.10118,0.032317,0,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.19971,0.10115,0.074821,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.39593,0.10108,0.038006,0,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.8331,0.10104,0.034455,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.34454,0.10096,0.071279,0,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.46631,0.10091,0.084733,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.70447,0.10084,0.047976,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.39593,0.10062,0.080619,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.40267,0.10051,0.071227,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.13699,0.10021,0.15912,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.10533,0.10003,0.10592,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.12771,0.099986,0.12613,0,0
1,GO NEPHRON TUBULE FORMATION,0.30323,0.099967,0.15759,0,0
1,GO INOSITOL METABOLIC PROCESS,0.82372,0.099535,0.0017734,0,0
1,GO RESPONSE TO ANTIBIOTIC,0.10025,0.099511,0.10247,0,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.11061,0.099415,0.05676,0,0
1,GO POSITIVE REGULATION OF URINE VOLUME,0.15712,0.099326,0.2036,0,0
1,GO NON RECOMBINATIONAL REPAIR,0.14347,0.099049,0.057227,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.15361,0.09859,0.10775,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.50395,0.098456,0.17165,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.8331,0.09836,-0.072889,0,0
1,GO REGULATION OF CELL CYCLE PROCESS,0.15361,0.098319,0.044182,0,0
1,GO RNA POLYADENYLATION,0.044978,0.098192,0.11851,0,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.053284,0.098182,0.10743,0,0
1,GO FEMALE GAMETE GENERATION,0.084004,0.09806,0.075616,0,0
1,GO AMELOGENESIS,0.8331,0.097885,0.021847,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.45171,0.097869,0.078425,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.42328,0.09774,0.15934,0,0
1,GO OOCYTE MATURATION,0.17173,0.097724,0.085489,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.12771,0.097647,0.16126,0,0
1,GO AMINO ACID IMPORT,0.47371,0.097544,0.051697,0,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.43736,0.097399,-0.0049616,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.031606,0.097132,0.096939,0,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.073757,0.097063,0.079683,0,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.073757,0.096942,0.12797,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.22622,0.096923,0.066132,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.24525,0.096667,0.080226,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.068115,0.096642,0.11319,0,0
1,GO STEM CELL DIFFERENTIATION,0.050383,0.096479,0.090736,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.1794,0.096442,0.12493,0,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.048983,0.096378,0.096695,0,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.74966,0.096346,-0.03334,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.40267,0.096074,0.097494,0,0
1,GO ETHANOL OXIDATION,0.35697,0.095844,0.17362,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.15017,0.09577,0.069509,0,0
1,GO MEMBRANE FUSION,0.093006,0.095636,0.07808,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27583,0.09549,0.11852,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.67783,0.095292,0.067108,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.38267,0.095161,0.048621,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.74054,0.095011,0.010364,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.071835,0.094926,0.13035,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.51167,0.094887,0.05731,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.30892,0.094375,0.11747,0,0
1,GO MITOTIC CELL CYCLE,0.18334,0.094195,0.051925,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.19552,0.094154,0.091626,0,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.19552,0.094135,0.074044,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.10794,0.093943,0.18026,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.54313,0.093941,0.030068,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.64294,0.093624,0.015532,0,0
1,GO ZINC ION TRANSPORT,0.28117,0.09349,0.09333,0,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.26536,0.093433,0.13778,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.12179,0.093287,0.15755,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.97598,0.093171,0.0062347,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.13384,0.092923,0.14934,0,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.20828,0.092793,0.078608,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.92804,0.092743,-0.018785,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.1643,0.09262,0.12189,0,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.30323,0.09245,0.053085,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.41634,0.092428,0.052813,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.53518,0.091817,0.10853,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.35697,0.091667,0.089981,0,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.030665,0.09147,0.096835,0,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.41634,0.091401,0.0567,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.4963,0.09134,0.061765,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.32642,0.091305,0.05974,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.30323,0.091303,0.0914,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.64294,0.091265,0.052536,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.29761,0.091248,0.11063,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.19971,0.091235,0.095194,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.74054,0.090993,0.040075,0,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.16798,0.090763,0.071365,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.11333,0.09031,0.064439,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.9472,0.090105,-0.011667,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12771,0.090019,0.14449,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.1643,0.08995,0.17829,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.33843,0.089857,0.093148,0,0
1,GO ATP METABOLIC PROCESS,0.1161,0.089709,0.072724,0,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.35697,0.089593,0.043741,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.55922,0.089528,0.046444,0,0
1,GO CELL MOTILITY,0.10533,0.089454,0.098725,0,0
1,GO CARDIAC SEPTUM DEVELOPMENT,0.06115,0.089106,0.15729,0,0
1,GO TELOMERE ORGANIZATION,0.17173,0.089017,0.051313,0,0
1,GO T CELL LINEAGE COMMITMENT,0.031606,0.088542,0.15649,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.45898,0.088446,0.047771,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.70447,0.088144,0.027765,0,0
1,GO OXIDATION REDUCTION PROCESS,0.1643,0.087767,0.067011,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.51944,0.087763,0.05791,0,0
1,GO PROTEIN STABILIZATION,0.035624,0.087716,0.093235,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.1161,0.087569,0.095913,0,0
1,GO CELL CYCLE PROCESS,0.27056,0.087299,0.029505,0,0
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.19552,0.087253,0.085527,0,0
1,GO LAMELLIPODIUM ASSEMBLY,0.26023,0.086916,0.10484,0,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.38267,0.086909,0.11213,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.17173,0.086857,0.10779,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.31468,0.086707,0.06152,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.10025,0.086646,0.072629,0,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.1402,0.086547,0.070272,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.31468,0.086318,0.06635,0,0
1,GO NEGATIVE REGULATION OF GROWTH,0.1161,0.086092,0.077788,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.6603,0.08595,0.047248,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.95679,0.08585,-0.025716,0,0
1,GO RESPONSE TO PEPTIDE,0.046281,0.085557,0.095201,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.050383,0.085332,0.14549,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.12771,0.085303,0.084992,0,0
1,GO EMBRYONIC MORPHOGENESIS,0.24525,0.084951,0.058265,0,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.057895,0.084708,0.085594,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.34454,0.084583,0.10056,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.11061,0.084541,0.23909,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.62578,0.084318,0.036842,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.16798,0.084205,0.06922,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.43736,0.084044,0.084374,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.56735,0.084039,0.087327,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.090686,0.083866,0.092365,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.11892,0.08385,0.073836,0,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.63434,0.083746,0.015779,0,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.24525,0.083578,0.057426,0,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.064555,0.08357,0.059152,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.39593,0.083201,0.053265,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.67783,0.082999,0.053745,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.98559,0.082817,-0.022666,0,0
1,GO VIRAL LATENCY,0.84251,0.082292,-0.0056642,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.87087,0.082289,0.038523,0,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.053284,0.082052,0.11168,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.69555,0.081862,0.048931,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.72243,0.081844,0.021491,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.19971,0.081738,0.10702,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.33843,0.081265,0.1303,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.45171,0.081181,0.10958,0,0
1,GO NEURAL TUBE DEVELOPMENT,0.34454,0.080949,0.060482,0,0
1,GO RESPONSE TO WATER,0.45898,0.080941,0.11456,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.59207,0.08067,0.022989,0,0
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.044978,0.080342,0.049939,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.069955,0.080231,0.10154,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.056323,0.080018,0.056038,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.10277,0.079881,0.10338,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.13699,0.079638,0.071816,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.26536,0.079496,0.068268,0,0
1,GO CENTROSOME DUPLICATION,0.43736,0.079334,0.018449,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27056,0.079248,0.058687,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.60042,0.07922,-0.01778,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.45171,0.078963,0.072174,0,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.22164,0.07896,0.073482,0,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.26536,0.078954,0.056444,0,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.069955,0.078798,0.055548,0,0
1,GO MICROVILLUS ASSEMBLY,0.63434,0.078632,0.025563,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.54313,0.07862,0.051636,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.12179,0.078577,0.10503,0,0
1,GO CELL DIVISION,0.25017,0.078427,0.037597,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.1794,0.078042,0.07683,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.63434,0.07802,0.095113,0,0
1,GO CANONICAL WNT SIGNALING PATHWAY,0.06115,0.077993,0.11637,0,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.55115,0.07789,0.070079,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.55115,0.0778,0.035117,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.13699,0.077777,0.068205,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.42328,0.077749,0.045135,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.63434,0.077666,0.089932,0,0
1,GO SNRNA TRANSCRIPTION,0.11333,0.077578,0.058386,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.13074,0.077431,0.092022,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.33239,0.077427,0.082604,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.29761,0.077336,0.028326,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.55115,0.077194,0.033445,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.48118,0.077045,0.06634,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.36968,0.077031,0.038225,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.26536,0.076703,0.069449,0,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.29206,0.076616,0.037616,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.47371,0.076562,0.045798,0,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.14347,0.076539,0.080093,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.33239,0.076511,0.095989,0,0
1,GO GENITALIA MORPHOGENESIS,0.36329,0.076461,0.10473,0,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.30892,0.076241,0.076628,0,0
1,GO MULTI ORGANISM PROCESS,0.06115,0.076025,0.05948,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.40267,0.075922,0.093117,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.8331,0.075821,0.03977,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.48871,0.075815,0.14341,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.43029,0.075809,0.09437,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.31468,0.075794,0.10331,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.59207,0.07555,0.020858,0,0
1,GO REGULATION OF CENTROSOME CYCLE,0.18334,0.075318,0.05944,0,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.090686,0.075275,0.094074,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.21267,0.075263,0.092243,0,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.086186,0.075064,0.082971,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.35697,0.074953,0.078135,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.36968,0.074769,0.063937,0,0
1,GO GLIAL CELL DEVELOPMENT,0.62578,0.074553,0.022236,0,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.11333,0.0743,0.080225,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.6603,0.074193,0.072657,0,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.10025,0.073945,0.051842,0,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.13699,0.073546,0.24372,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.74966,0.073296,-0.0064468,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.10025,0.07316,0.081825,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.19971,0.073154,0.12809,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.086186,0.073133,0.090263,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.19971,0.07296,0.055496,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.27056,0.072941,0.098346,0,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.26536,0.072883,0.099651,0,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.081867,0.07264,0.063638,0,0
1,GO RESPIRATORY BURST,0.57554,0.072495,0.015073,0,0
1,GO CHROMOSOME SEPARATION,0.23088,0.072379,0.075339,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.2356,0.072283,0.09811,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.97598,0.072125,-0.015816,0,0
1,GO ORGAN GROWTH,0.10533,0.071977,0.096773,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.13699,0.071957,0.059248,0,0
1,GO CELL VOLUME HOMEOSTASIS,0.36329,0.0719,0.056272,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1794,0.071788,0.08241,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.58378,0.071716,0.056933,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.48118,0.071494,0.036073,0,0
1,GO ORGANIC ACID CATABOLIC PROCESS,0.26023,0.071445,0.098993,0,0
1,GO GLIAL CELL MIGRATION,0.43736,0.071355,0.1149,0,0
1,GO RECEPTOR INTERNALIZATION,0.18334,0.071153,0.083642,0,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.51167,0.07115,0.023618,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.98559,0.071108,-0.036441,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.31468,0.07108,0.048421,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.96638,0.071063,-0.06235,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.2356,0.070832,0.057428,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24039,0.070765,0.12771,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.11892,0.070703,0.17606,0,0
1,GO BASE EXCISION REPAIR,0.53518,0.070649,0.047283,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.10533,0.070554,0.082676,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.32642,0.070447,0.18396,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.88036,0.070296,0.0052403,0,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.19971,0.070259,0.064111,0,0
1,GO ALCOHOL METABOLIC PROCESS,0.52728,0.069961,0.012952,0,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.40947,0.069925,0.1045,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.89939,0.069906,-0.028636,0,0
1,GO REGULATION OF PROTEIN STABILITY,0.11892,0.069803,0.064387,0,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.43736,0.069766,0.084353,0,0
1,GO HORMONE METABOLIC PROCESS,0.16798,0.069644,0.07112,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.42328,0.069632,0.064315,0,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.13384,0.069622,0.095315,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.30323,0.069616,0.14033,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.39593,0.06956,0.21044,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.45171,0.069552,0.05936,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.93762,0.069501,-0.023536,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,0.45898,0.069284,0.032124,0,0
1,GO TAXIS,0.36968,0.06918,0.034788,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.036694,0.069152,0.16279,0,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32052,0.068946,0.041174,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.56735,0.06868,0.018192,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.91848,0.068644,-0.012089,0,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.084004,0.068621,0.11462,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.51944,0.068451,0.044897,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.95679,0.068351,-0.013726,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.60042,0.068318,-0.13199,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.28658,0.068148,0.046544,0,0
1,GO FATTY ACID HOMEOSTASIS,0.64294,0.067963,0.039862,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.1794,0.067884,0.12414,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.40947,0.067667,0.10826,0,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.064555,0.067642,0.11336,0,0
1,GO TRNA TRANSPORT,0.55922,0.067476,0.043205,0,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.52728,0.067452,0.052344,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.15712,0.067409,0.063586,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.27056,0.067224,0.091801,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.90893,0.067178,0.0025343,0,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.1402,0.066818,0.089316,0,0
1,GO SPINDLE ASSEMBLY,0.42328,0.066776,0.020751,0,0
1,GO REGULATION OF GLIAL CELL MIGRATION,0.24039,0.066113,0.1495,0,0
1,GO ACTIN FILAMENT ORGANIZATION,0.25516,0.065829,0.080703,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.26536,0.065826,0.050599,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.92804,0.065672,-2.4424e-05,0,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.23088,0.065623,0.039997,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.25017,0.065403,0.05823,0,0
1,GO CELL CELL ADHESION,0.28658,0.065342,0.047954,0,0
1,GO CELLULAR RESPIRATION,0.1402,0.065296,0.085399,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.48871,0.06525,0.043218,0,0
1,GO PERICARDIUM DEVELOPMENT,0.40947,0.065245,0.054286,0,0
1,GO RESPONSE TO ESTRADIOL,0.19552,0.065103,0.092141,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.46631,0.065043,0.071148,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.45171,0.064972,0.063435,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.13074,0.064928,0.16635,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.10533,0.064778,0.12472,0,0
1,GO FAT CELL DIFFERENTIATION,0.28117,0.064674,0.045492,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.50395,0.064649,0.018807,0,0
1,GO MIRNA METABOLIC PROCESS,0.32642,0.064426,0.053667,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.45171,0.064407,0.04071,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.55922,0.06427,0.068006,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.19971,0.064138,0.072177,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.14347,0.063998,0.11993,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.80503,0.063811,0.082522,0,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.2356,0.063754,0.079598,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.67783,0.063729,0.033371,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.78645,0.063495,0.041566,0,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.45171,0.063317,0.058719,0,0
1,GO DIOL METABOLIC PROCESS,0.40267,0.063248,0.055611,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.72243,0.063115,0.010494,0,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.066316,0.06299,0.077536,0,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.10794,0.06294,0.13352,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.59207,0.062849,0.04451,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.18334,0.062751,0.063216,0,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.71343,0.062633,0.062471,0,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.22622,0.062602,0.060087,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.73147,0.062598,0.053293,0,0
1,GO REGULATION OF CELL CYCLE,0.28658,0.06254,0.025927,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.55115,0.062413,0.023881,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.81436,0.062128,0.037561,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.18334,0.061911,0.0841,0,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.88987,0.061845,0.058752,0,0
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.80503,0.061821,-0.087052,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.4963,0.06179,0.050295,0,0
1,GO AORTA DEVELOPMENT,0.51167,0.061666,0.14369,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.55922,0.061488,0.042766,0,0
1,GO REGULATION OF ATPASE ACTIVITY,0.20828,0.061486,0.067313,0,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.40947,0.061145,0.12654,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.27056,0.061091,0.088786,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.21267,0.060964,0.074486,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.89939,0.06095,-0.00044666,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.61728,0.060892,0.04434,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.6516,0.060887,0.00396,0,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.10794,0.060631,0.054293,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.35697,0.060621,0.03194,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.92804,0.060541,-0.046272,0,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.071835,0.060527,0.063173,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.33843,0.060508,0.042089,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.51167,0.060287,0.050677,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.47371,0.060224,0.12286,0,0
1,GO REGULATION OF MYELINATION,0.62578,0.060109,0.040226,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.56735,0.06009,0.028433,0,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.1161,0.060072,0.061688,0,0
1,GO GOLGI RIBBON FORMATION,0.66904,0.060013,0.072427,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.12472,0.05997,0.15055,0,0
1,GO REGULATION OF DNA METABOLIC PROCESS,0.14347,0.05976,0.037334,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.51944,0.059694,0.041599,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.25516,0.059637,0.080728,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.90893,0.059597,-0.045234,0,0
1,GO METAL ION HOMEOSTASIS,0.25516,0.059476,0.047375,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.27056,0.058941,0.049679,0,0
1,GO CELLULAR RESPONSE TO PEPTIDE,0.10533,0.058731,0.068201,0,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.35072,0.058579,0.10613,0,0
1,GO REGULATION OF EXCRETION,0.82372,0.05854,0.0097204,0,0
1,GO POSITIVE T CELL SELECTION,0.50395,0.058482,0.10061,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.51944,0.058412,0.098145,0,0
1,GO REGULATION OF ATP METABOLIC PROCESS,0.32052,0.058166,0.048284,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.72243,0.058132,0.14452,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.45171,0.058062,0.022588,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.43029,0.057996,0.056041,0,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.28658,0.057994,0.058034,0,0
1,GO MITOCHONDRION ORGANIZATION,0.050383,0.057745,0.060225,0,0
1,GO FATTY ACID TRANSPORT,0.46631,0.057559,0.033166,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.36968,0.057552,0.06423,0,0
1,GO PROTEIN MONOUBIQUITINATION,0.41634,0.057527,0.028615,0,0
1,GO SKELETAL SYSTEM DEVELOPMENT,0.16798,0.057492,0.11169,0,0
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.40267,0.057227,0.13208,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.41634,0.056836,0.039052,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.88036,0.056748,0.066043,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.34454,0.056636,0.13968,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.76799,0.05657,0.0069477,0,0
1,GO PROSTAGLANDIN SECRETION,0.20396,0.056519,0.10771,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.24525,0.056334,0.12557,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.45171,0.056046,0.017642,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.9952,0.056033,-0.025099,0,0
1,GO INTRACELLULAR TRANSPORT,0.068115,0.056015,0.050632,0,0
1,GO KETONE CATABOLIC PROCESS,0.98559,0.055929,-0.053171,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.15712,0.055777,0.10662,0,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.30892,0.055735,0.073357,0,0
1,GO CELL CYCLE ARREST,0.35697,0.055331,0.03217,0,0
1,GO MUSCLE HYPERTROPHY,0.9472,0.055109,0.0019737,0,0
1,GO DNA CATABOLIC PROCESS,0.19139,0.054884,0.051255,0,0
1,GO ARTERY DEVELOPMENT,0.15017,0.054875,0.19052,0,0
1,GO CELL CYCLE,0.33843,0.054833,0.015127,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.53518,0.054489,0.047673,0,0
1,GO MIDGUT DEVELOPMENT,0.84251,0.054461,0.020629,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.46631,0.054124,0.15024,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.48118,0.054065,0.12048,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.6516,0.054061,0.048083,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.19139,0.053838,0.11801,0,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.22622,0.053761,0.087016,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.88036,0.053627,-0.016523,0,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.24039,0.053611,0.098082,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.22164,0.053506,0.11622,0,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.45171,0.053264,0.061426,0,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.38927,0.05321,0.058918,0,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.34454,0.053179,0.046778,0,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.18733,0.053104,0.056753,0,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.053284,0.052732,0.13569,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.39593,0.052544,0.062807,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.50395,0.052294,0.038067,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.43029,0.052162,0.039493,0,0
1,GO RESPONSE TO COLD,0.88036,0.051972,-0.006655,0,0
1,GO REGULATION OF DNA REPAIR,0.73147,0.051613,0.0079471,0,0
1,GO RNA DECAPPING,0.21267,0.051431,0.03644,0,0
1,GO THYMIC T CELL SELECTION,0.70447,0.051129,0.013566,0,0
1,GO ION HOMEOSTASIS,0.47371,0.051128,0.031417,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.73147,0.051093,0.036601,0,0
1,GO CYTOKINE SECRETION,0.39593,0.050984,0.074265,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.35697,0.050807,0.17303,0,0
1,GO GENITALIA DEVELOPMENT,0.46631,0.0508,0.032808,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.21712,0.050396,0.061033,0,0
1,GO DNA METABOLIC PROCESS,0.18733,0.050394,0.027787,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.64294,0.050324,0.023327,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.95679,0.050246,-0.03075,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.46631,0.050143,0.078631,0,0
1,GO HISTONE DEACETYLATION,0.19971,0.049962,0.069188,0,0
1,GO HEART GROWTH,0.36329,0.049931,0.06102,0,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.74966,0.049864,0.023856,0,0
1,GO HISTONE H3 K27 METHYLATION,0.8331,0.049807,-0.048201,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.52728,0.049352,0.040919,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.43029,0.049348,0.04951,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.7772,0.049332,0.0090476,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.43736,0.049194,0.060419,0,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.19971,0.049007,0.043323,0,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.23088,0.04887,0.068759,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.66904,0.048864,0.061123,0,0
1,GO REGULATION OF CYTOKINESIS,0.66904,0.048664,0.023496,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.6603,0.048417,0.044409,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.93762,0.048383,-0.0076228,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.4963,0.048311,0.01776,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.73147,0.047564,0.022403,0,0
1,GO KERATINOCYTE PROLIFERATION,0.25017,0.047562,0.17771,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.56735,0.047491,0.043224,0,0
1,GO PLASMA MEMBRANE REPAIR,0.60042,0.047474,0.099878,0,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.53518,0.047151,0.025423,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.25516,0.047149,0.07061,0,0
1,GO AMMONIUM TRANSPORT,0.26023,0.047096,0.13113,0,0
1,GO STEROID METABOLIC PROCESS,0.6603,0.047094,-0.0062491,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.4963,0.047071,0.057018,0,0
1,GO SKIN DEVELOPMENT,0.43029,0.047054,0.036875,0,0
1,GO CHROMOSOME SEGREGATION,0.6516,0.047046,0.002694,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.4963,0.047019,0.092079,0,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.19552,0.046854,0.074949,0,0
1,GO HEAD MORPHOGENESIS,0.14347,0.046476,0.20076,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.24039,0.046461,0.052253,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.51944,0.046425,0.094033,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.30323,0.046315,0.046787,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.35072,0.046248,0.14824,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.98559,0.046233,-0.046401,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.38267,0.04578,0.023037,0,0
1,GO CHROMOSOME CONDENSATION,0.27056,0.045766,0.067446,0,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.35072,0.045601,0.028061,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.26536,0.045496,0.062413,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.60042,0.045492,0.023494,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.13699,0.045457,0.085044,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.78645,0.045301,-0.0023916,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.2356,0.045245,0.032219,0,0
1,GO CELLULAR PIGMENTATION,0.58378,0.045198,0.021466,0,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.32052,0.045062,0.036773,0,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.23088,0.044776,0.10657,0,0
1,GO ODONTOGENESIS,0.34454,0.044571,0.089157,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.35072,0.044563,0.045922,0,0
1,GO REGULATION OF MACROAUTOPHAGY,0.1402,0.044444,0.075942,0,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.15361,0.04443,0.059956,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.63434,0.044428,0.07373,0,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.20828,0.044266,0.068965,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.39593,0.044161,-0.13692,0,0
1,GO LIPID METABOLIC PROCESS,0.30323,0.044063,0.032087,0,0
1,GO EMBRYONIC EYE MORPHOGENESIS,0.6603,0.043635,0.033123,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.14679,0.043308,0.065014,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.48871,0.043,0.026651,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.35072,0.042937,0.10291,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.42328,0.04276,0.12713,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.98559,0.042747,-0.014263,0,0
1,GO BODY MORPHOGENESIS,0.24039,0.042434,0.12325,0,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.6603,0.042387,-0.0041916,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.53518,0.042333,0.0096136,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.43736,0.042332,0.055788,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.89939,0.041877,-0.016794,0,0
1,GO POSITIVE REGULATION OF CELL SIZE,0.90893,0.041856,0.050035,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.70447,0.041845,0.011525,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.78645,0.041723,0.047114,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.73147,0.041559,0.00028337,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.33239,0.041559,0.057468,0,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.96638,0.041437,-0.001731,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.51944,0.041264,0.062928,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.31468,0.041166,0.058277,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.84251,0.041155,-0.012148,0,0
1,GO NEURAL TUBE FORMATION,0.62578,0.041117,0.02746,0,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.41634,0.041014,0.014806,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.22164,0.040955,0.056992,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.38267,0.040516,0.050995,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.64294,0.040268,0.021464,0,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.15017,0.040089,0.055822,0,0
1,GO NEPHRON DEVELOPMENT,0.36968,0.039962,0.10095,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.33843,0.039919,0.045943,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.67783,0.039918,0.0033804,0,0
1,GO EPITHELIUM DEVELOPMENT,0.50395,0.03989,0.023824,0,0
1,GO RESPONSE TO ZINC ION,0.53518,0.03988,0.051406,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.55922,0.039746,0.028234,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.70447,0.039724,0.023008,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.21712,0.039644,0.066506,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.50395,0.039592,0.020086,0,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.45898,0.039556,0.036656,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.93762,0.039462,-0.044421,0,0
1,GO IRON ION TRANSPORT,0.1794,0.039368,0.055748,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.67783,0.039214,0.025541,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.37614,0.039129,0.096862,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.9952,0.039037,-0.021702,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.66904,0.038992,0.087968,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.88987,0.038979,-0.030775,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.72243,0.038977,-0.04421,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.20828,0.038902,0.078951,0,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.10025,0.038827,0.044754,0,0
1,GO NCRNA TRANSCRIPTION,0.4963,0.038825,0.032872,0,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.57554,0.03874,0.053731,0,0
1,GO RESPONSE TO UV C,0.33843,0.038684,0.093641,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.57554,0.038464,0.012086,0,0
1,GO RESPONSE TO ALCOHOL,0.91848,0.038277,-0.006396,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.57554,0.038167,0.037775,0,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.37614,0.038158,0.053126,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.57554,0.038122,0.015293,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.33239,0.038082,0.12752,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.51167,0.038068,0.0021832,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.67783,0.037917,0.007445,0,0
1,GO RESPONSE TO PEPTIDE HORMONE,0.18733,0.037644,0.058102,0,0
1,GO ORGANELLE ASSEMBLY,0.40947,0.037555,0.02498,0,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.095374,0.037554,0.070082,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.53518,0.037345,0.002141,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.53518,0.037131,0.047867,0,0
1,GO HEART DEVELOPMENT,0.10533,0.036941,0.11003,0,0
1,GO REGULATION OF CELL SIZE,0.71343,0.036909,0.01059,0,0
1,GO CELL CYCLE CHECKPOINT,0.56735,0.036797,0.00069922,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.89939,0.036684,-0.047443,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.8614,0.036617,0.035385,0,0
1,GO CENTROSOME SEPARATION,0.70447,0.036429,0.02999,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE,0.73147,0.0363,0.016857,0,0
1,GO RESPONSE TO ACID CHEMICAL,0.32052,0.036222,0.086516,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.69555,0.036168,0.010206,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.76799,0.036156,0.051118,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.92804,0.03604,0.09186,0,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.48871,0.035802,0.014479,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.51167,0.035714,0.095657,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.43029,0.035584,0.078305,0,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.12472,0.035379,0.095895,0,0
1,GO ESTABLISHMENT OF CELL POLARITY,0.48871,0.035327,0.033813,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56735,0.035105,0.041663,0,0
1,GO LIPID MODIFICATION,0.50395,0.035065,0.031896,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.6603,0.035002,0.10624,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.45171,0.034974,0.063354,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.67783,0.034951,0.00040286,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.6516,0.034657,0.026451,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.45171,0.034529,0.078971,0,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.43736,0.03452,0.019897,0,0
1,GO MRNA 3 END PROCESSING,0.51944,0.034196,0.04031,0,0
1,GO THIOESTER METABOLIC PROCESS,0.82372,0.034006,0.0031778,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.85194,0.033793,0.0051974,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.9952,0.033793,-0.0029803,0,0
1,GO VITAMIN METABOLIC PROCESS,0.42328,0.033735,0.044166,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.48118,0.033488,0.083628,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.64294,0.033449,0.087748,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.7588,0.033254,-0.053727,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.89939,0.032775,-0.046208,0,0
1,GO ENDOSOMAL TRANSPORT,0.27583,0.03276,0.036703,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.45898,0.032537,0.052125,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.52728,0.031875,0.040657,0,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.10277,0.031499,0.070952,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.63434,0.031389,0.014169,0,0
1,GO DRINKING BEHAVIOR,0.74966,0.031305,0.01092,0,0
1,GO RESPONSE TO RADIATION,0.59207,0.031099,0.00057538,0,0
1,GO NUCLEUS LOCALIZATION,0.95679,0.031071,0.0051113,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.60883,0.031014,0.035119,0,0
1,GO PEPTIDYL THREONINE MODIFICATION,0.38267,0.030985,0.05933,0,0
1,GO REPRODUCTION,0.73147,0.030888,0.0095405,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.50395,0.030837,0.048625,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.93762,0.030814,-0.022273,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.70447,0.030572,0.0094657,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.8331,0.030506,0.0025113,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.74054,0.030414,0.15383,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.96638,0.030383,-0.026137,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.97598,0.030259,0.019278,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.78645,0.030208,-0.067433,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.37614,0.030175,0.043306,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.45898,0.030103,0.090969,0,0
1,GO RESPONSE TO NUTRIENT,0.63434,0.030052,0.053395,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.8331,0.029951,-0.0028042,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.6516,0.029826,0.027452,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.62578,0.029789,0.013062,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.76799,0.029623,0.054149,0,0
1,GO RNA STABILIZATION,0.60883,0.029588,0.067221,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.71343,0.029442,-0.0005936,0,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,1,0.029427,-0.030567,0,0
1,GO STEROID CATABOLIC PROCESS,0.88036,0.029426,-0.010637,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.4963,0.029399,0.061585,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.48871,0.029367,0.073753,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.88036,0.029249,0.010277,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.67783,0.028772,-0.089862,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.61728,0.028534,0.01476,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.25516,0.028455,0.053478,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.7772,0.028081,0.028893,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.95679,0.027967,-0.0024864,0,0
1,GO CELLULAR HOMEOSTASIS,0.38267,0.027949,0.034641,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.98559,0.027909,-0.015983,0,0
1,GO HEART MORPHOGENESIS,0.24039,0.027577,0.088671,0,0
1,GO SMOOTHENED SIGNALING PATHWAY,0.26023,0.027571,0.07884,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,1,0.027413,0.018594,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.76799,0.027393,0.0082931,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.40947,0.027377,0.05375,0,0
1,GO NEURON PROJECTION REGENERATION,0.98559,0.027195,-0.00059435,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.51944,0.027117,0.031609,0,0
1,GO MUSCLE ATROPHY,0.7772,0.026889,0.010258,0,0
1,GO POLYOL METABOLIC PROCESS,0.4445,0.026578,0.03128,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.96638,0.026406,-0.0033543,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.40947,0.026336,0.065708,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.96638,0.026266,-0.016643,0,0
1,GO RNA EXPORT FROM NUCLEUS,0.59207,0.026136,0.023011,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.60883,0.026064,0.10381,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.98559,0.025966,-0.00037955,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.98559,0.025956,-0.037508,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.67783,0.025876,0.028553,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.35072,0.025856,0.12457,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.64294,0.025805,0.0097881,0,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.68667,0.025745,0.015446,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.45898,0.025682,0.010402,0,0
1,GO REGULATION OF STEM CELL PROLIFERATION,0.93762,0.025636,0.0075912,0,0
1,GO ACTIN FILAMENT BASED PROCESS,0.23088,0.025076,0.069547,0,0
1,GO PROTEIN DEMANNOSYLATION,0.4445,0.024994,0.098,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.6603,0.02478,-0.018343,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.30892,0.024764,0.13539,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.82372,0.02448,0.0044724,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.88987,0.024289,-0.018578,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.81436,0.024245,0.061514,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.9472,0.023952,-0.019549,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.7772,0.023612,0.018279,0,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.6516,0.023573,0.035843,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.2356,0.02357,0.041746,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.85194,0.023478,-0.080644,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.9952,0.023387,-0.009765,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.61728,0.023245,0.086254,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.91848,0.023176,-0.028084,0,0
1,GO B CELL DIFFERENTIATION,0.24039,0.022996,0.07132,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.55115,0.022951,0.01056,0,0
1,GO LIPID DIGESTION,0.63434,0.022482,0.029092,0,0
1,GO AMINO ACID ACTIVATION,0.60042,0.022337,0.040958,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.7772,0.022128,0.022914,0,0
1,GO DNA REPAIR,0.53518,0.022047,0.0046404,0,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.26023,0.022011,0.059995,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.98559,0.021961,-0.0058278,0,0
1,GO T CELL SELECTION,0.59207,0.021895,0.039688,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.73147,0.021361,0.022191,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.89939,0.021016,-0.034234,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.67783,0.020754,0.0082533,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.71343,0.02012,0.015037,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.43029,0.020025,0.076482,0,0
1,GO FUCOSE METABOLIC PROCESS,0.92804,0.019839,-0.016537,0,0
1,GO MICROTUBULE NUCLEATION,0.90893,0.019797,0.017914,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.9952,0.019768,-0.00035221,0,0
1,GO BIOMINERALIZATION,0.52728,0.019611,0.11548,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.71343,0.019545,0.030659,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.81436,0.019388,0.0039624,0,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.92804,0.019341,-0.013029,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.9952,0.019309,-0.0099838,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.8614,0.019234,-0.0035534,0,0
1,GO AEROBIC RESPIRATION,0.52728,0.019188,0.028391,0,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.36968,0.019039,0.065744,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.98559,0.018996,0.016562,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.62578,0.018789,0.083586,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.48118,0.018401,0.038611,0,0
1,GO ERYTHROCYTE MATURATION,0.56735,0.018306,0.024529,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.78645,0.01827,0.0053891,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.57554,0.01826,0.031579,0,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.40947,0.018237,0.054627,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.54313,0.018234,0.081109,0,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.35697,0.018188,0.062485,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.55115,0.018133,0.017328,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.56735,0.018092,0.057377,0,0
1,GO FOREBRAIN MORPHOGENESIS,0.78645,0.017966,0.022823,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.80503,0.017631,-0.040653,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.88036,0.017427,0.0005576,0,0
1,GO DNA RECOMBINATION,0.70447,0.01738,0.0012388,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.55115,0.017329,0.13378,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.55115,0.017127,0.038874,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.7772,0.016694,0.0082417,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.7772,0.016579,-0.053376,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.55922,0.016351,0.046011,0,0
1,GO RESPONSE TO METAL ION,0.90893,0.016216,0.0038644,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.56735,0.015724,0.04766,0,0
1,GO HISTONE EXCHANGE,0.85194,0.015696,-0.037894,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.96638,0.015654,-0.013123,0,0
1,GO NUCLEOTIDE TRANSPORT,0.61728,0.015554,-0.065565,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.97598,0.015315,-0.00094411,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.55922,0.014939,0.068603,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.61728,0.01488,-0.090535,0,0
1,GO DNA REPLICATION INITIATION,0.87087,0.014749,-0.059115,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.93762,0.014732,-0.017701,0,0
1,GO MUSCLE SYSTEM PROCESS,0.6516,0.014581,0.034573,0,0
1,GO RESPONSE TO IRON ION,0.48871,0.014547,0.060285,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.64294,0.014543,0.052688,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.85194,0.014513,0.017478,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.97598,0.014375,-0.028711,0,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.60883,0.014196,0.015383,0,0
1,GO ENSHEATHMENT OF NEURONS,0.88987,0.013889,0.0041389,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.40267,0.01378,0.061371,0,0
1,GO HOMEOSTATIC PROCESS,0.80503,0.013639,0.00163,0,0
1,GO GLYCOSYLATION,0.90893,0.013578,-0.030866,0,0
1,GO DOUBLE STRAND BREAK REPAIR,0.67783,0.013237,-0.007483,0,0
1,GO EPIDERMIS DEVELOPMENT,0.85194,0.013151,-0.032556,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.72243,0.012984,-0.048256,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.61728,0.012694,0.027712,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.63434,0.012436,0.024668,0,0
1,GO ERYTHROCYTE DEVELOPMENT,0.64294,0.012332,-0.031795,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.89939,0.012268,-0.028788,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.37614,0.012185,0.074795,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.85194,0.012163,0.012809,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.93762,0.012078,0.0038985,0,0
1,GO HINDLIMB MORPHOGENESIS,0.70447,0.011209,-0.045306,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.74966,0.011015,-0.039902,0,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.98559,0.010843,-0.006885,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.60883,0.010589,0.025064,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.68667,0.010342,0.017472,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.7772,0.010193,-0.0078855,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.70447,0.010122,0.0096212,0,0
1,GO TONGUE MORPHOGENESIS,0.66904,0.0097838,0.083832,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.95679,0.0096119,-0.027285,0,0
1,GO CYTOSKELETON ORGANIZATION,0.88036,0.009311,0.014795,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.61728,0.0092413,0.020711,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.7588,0.0091915,0.026665,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.73147,0.0090166,0.0070761,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.67783,0.0089746,0.02638,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.78645,0.0089286,0.014232,0,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.61728,0.0089127,0.013543,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.96638,0.0085383,0.052922,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.67783,0.0082949,0.078978,0,0
1,GO MYELIN ASSEMBLY,0.90893,0.0081881,0.010579,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.72243,0.0081579,0.01945,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.66904,0.0081352,0.056654,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.98559,0.0080602,0.0091798,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.43029,0.0080051,0.077805,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.88036,0.0079039,-0.0086985,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.37614,0.0078275,0.044703,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.90893,0.0074449,-0.019752,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.7772,0.0074075,0.010333,0,0
1,GO ORGANELLE FUSION,0.74966,0.0073212,0.0023438,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.69555,0.0072445,-0.03004,0,0
1,GO ORGAN INDUCTION,0.35072,0.0072145,0.085355,0,0
1,GO RESPONSE TO CALCIUM ION,0.85194,0.0071973,0.010824,0,0
1,GO ADAPTIVE THERMOGENESIS,0.73147,0.0071635,0.020534,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.78645,0.0070568,0.018206,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.85194,0.0066901,0.018641,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.60042,0.0065583,0.058231,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.7588,0.0063455,0.10788,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.9952,0.0062666,-0.0029753,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.60883,0.0059997,-0.050866,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.55922,0.0059591,0.071404,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.8331,0.00576,0.011357,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.38927,0.0057183,0.083947,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.8331,0.0056932,-0.035856,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,1,0.0056364,-0.0066678,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.8614,0.0056082,-0.025804,0,0
1,GO JNK CASCADE,0.71343,0.0055873,0.01423,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.74054,0.0054898,0.025558,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.72243,0.005408,-0.061467,0,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.97598,0.0052143,-0.010688,0,0
1,GO REGULATION OF GROWTH,0.46631,0.0047398,0.029518,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.79572,0.0044546,0.010181,0,0
1,GO SISTER CHROMATID SEGREGATION,0.87087,0.0044189,-0.031671,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.9952,0.0043713,-0.0020517,0,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.57554,0.0042686,0.059897,0,0
1,GO CELL CELL SIGNALING BY WNT,0.43029,0.0042604,0.042822,0,0
1,GO MALE SEX DIFFERENTIATION,0.8614,0.0037757,-0.023822,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.68667,0.0036023,0.026424,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.73147,0.0035699,0.016508,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.69555,0.0034253,0.019289,0,0
1,GO EMBRYO DEVELOPMENT,0.91848,0.003139,0.0086194,0,0
1,GO DNA MODIFICATION,0.97598,0.0029023,0.0010081,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.96638,0.0028631,0.021134,0,0
1,GO TISSUE HOMEOSTASIS,0.79572,0.0028135,-0.00018769,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.6603,0.0026466,0.040536,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.96638,0.0025268,0.023985,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.68667,0.0023943,0.023846,0,0
1,GO EXPLORATION BEHAVIOR,0.96638,0.0023743,-0.034707,0,0
1,GO FUCOSYLATION,0.62578,0.0022545,-0.045224,0,0
1,GO RESPONSE TO VITAMIN A,0.89939,0.0021597,-0.029477,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.67783,0.0020166,0.024076,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.9472,0.0019967,0.15516,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.7588,0.0017658,-0.035108,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.51167,0.0017137,0.039564,0,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.91848,0.0015635,-0.003317,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.7588,0.001487,-0.029456,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.96638,0.0013155,0.023442,0,0
1,GO STEROL METABOLIC PROCESS,0.90893,0.0010399,-0.018218,0,0
1,GO GMP METABOLIC PROCESS,0.8331,0.00079169,-0.040932,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.96638,0.00076696,-0.05523,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.8614,0.00071178,0.008472,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.96638,0.00069785,-0.022928,0,0
1,GO ESTROUS CYCLE,0.71343,0.00058529,0.05625,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.88987,0.00050662,0.012821,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.64294,0.00042838,-0.027011,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.96638,0.00021179,-0.0089361,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.96638,0.00017603,0.0093402,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.90893,8.9815e-05,0.00624,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.51944,8.9271e-05,0.019637,0,0
1,GO LYSOSOME LOCALIZATION,0.95679,-3.7736e-05,-0.0033519,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.48118,-0.00011307,-0.039831,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.80503,-0.00014449,0.039196,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.8331,-0.00021677,-0.021704,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.79572,-0.00027986,-0.0019575,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.97598,-0.00031436,0.029726,0,0
1,GO GLAND DEVELOPMENT,0.84251,-0.00078003,0.0049878,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.78645,-0.00083027,0.014463,0,0
1,GO INTRACELLULAR LIPID TRANSPORT,0.61728,-0.00084645,0.048174,0,0
1,GO CARBOHYDRATE TRANSPORT,0.93762,-0.0015082,-0.0095151,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.96638,-0.0017768,0.00263,0,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.88987,-0.0017858,-0.00061773,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.8331,-0.0018429,0.011776,0,0
1,GO DNA REPLICATION,0.97598,-0.0018466,-0.048399,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.80503,-0.0019027,-0.0021858,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.7772,-0.0020017,0.024853,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.82372,-0.0022212,0.021777,0,0
1,GO ISOPRENOID METABOLIC PROCESS,0.98559,-0.002255,0.011133,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.96638,-0.0024669,-0.0085782,0,0
1,GO ACTIN NUCLEATION,0.55922,-0.0025349,-0.084705,0,0
1,GO ALANINE TRANSPORT,0.7772,-0.0025644,-0.057854,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.72243,-0.0026595,-0.012839,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.84251,-0.0028032,-0.0086022,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.98559,-0.003122,-0.0020233,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.9472,-0.0034098,-0.017325,0,0
1,GO RESPONSE TO BMP,0.57554,-0.0036595,0.040649,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.95679,-0.0036788,0.0025896,0,0
1,GO BONE CELL DEVELOPMENT,0.88036,-0.0037316,0.019307,0,0
1,GO TUBE FORMATION,0.87087,-0.0039088,0.00063709,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.6603,-0.0040489,-0.025957,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.7772,-0.0040519,0.041682,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.9472,-0.0042723,-0.00056524,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62578,-0.0044206,-0.046212,0,0
1,GO HEART TRABECULA FORMATION,0.69555,-0.0052687,0.15258,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.76799,-0.0058853,0.021348,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.92804,-0.0060474,0.0067593,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.92804,-0.0061877,0.019937,0,0
1,GO RESPONSE TO EPINEPHRINE,0.62578,-0.0063898,-0.086629,0,0
1,GO ENDOCYTIC RECYCLING,0.81436,-0.0065822,0.0069058,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.63434,-0.0066348,-0.057995,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.51167,-0.0066986,-0.075813,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.84251,-0.0067889,0.04737,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.80503,-0.0068422,-0.012572,0,0
1,GO PROTEIN POLYMERIZATION,0.61728,-0.0069311,0.033293,0,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.60042,-0.0069623,0.17782,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.50395,-0.0069987,-0.0417,0,0
1,GO RESPONSE TO VITAMIN,0.71343,-0.0070167,0.064927,0,0
1,GO SPECIFICATION OF SYMMETRY,0.88987,-0.0070921,-0.0043712,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.73147,-0.0071062,-0.035269,0,0
1,GO CYTOPLASM ORGANIZATION,0.91848,-0.0071859,0.0083623,0,0
1,GO LACTATE METABOLIC PROCESS,0.88987,-0.0075469,-0.013533,0,0
1,GO METHIONINE METABOLIC PROCESS,0.61728,-0.0076831,-0.086858,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.69555,-0.0077469,0.10932,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.71343,-0.0081498,0.036688,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.43029,-0.0083394,0.041288,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.88987,-0.0088371,-0.03408,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.60883,-0.0092098,-0.089827,0,0
1,GO O GLYCAN PROCESSING,0.40947,-0.0093573,-0.10378,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.96638,-0.0094235,0.0049048,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.97598,-0.0097058,-0.010335,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.58378,-0.0097408,-0.048469,0,0
1,GO PROTEIN DESTABILIZATION,0.78645,-0.0097688,-0.023248,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.6516,-0.0097766,-0.082474,0,0
1,GO SARCOMERE ORGANIZATION,0.85194,-0.0097946,0.068513,0,0
1,GO EPITHELIAL TUBE FORMATION,0.68667,-0.0099039,-0.03016,0,0
1,GO L AMINO ACID TRANSPORT,0.98559,-0.0099714,-0.014032,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.69555,-0.010107,-0.032162,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.64294,-0.01028,-0.049746,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.41634,-0.010768,-0.057014,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.88036,-0.010872,0.01643,0,0
1,GO B CELL APOPTOTIC PROCESS,0.57554,-0.010926,-0.078517,0,0
1,GO RESPONSE TO INSULIN,0.72243,-0.010964,-0.023733,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.6516,-0.01108,0.077851,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.84251,-0.011235,0.075812,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.96638,-0.011339,0.00023794,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.48118,-0.011374,-0.12901,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.73147,-0.011381,0.033023,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.60883,-0.011482,-0.039682,0,0
1,GO SINGLE FERTILIZATION,0.42328,-0.011534,-0.039181,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.69555,-0.011549,-0.021106,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.85194,-0.011898,-0.027032,0,0
1,GO CHEMICAL HOMEOSTASIS,0.50395,-0.01199,-0.031505,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.97598,-0.012291,-0.021911,0,0
1,GO MACROMOLECULE DEACYLATION,0.89939,-0.012303,0.013268,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.70447,-0.012422,-0.016599,0,0
1,GO RESPONSE TO ACTIVITY,0.45898,-0.012498,-0.067685,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.88036,-0.012564,-0.0054992,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.7772,-0.012698,-0.046597,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.6603,-0.012836,0.021668,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.91848,-0.012862,-0.0012798,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.8614,-0.012895,0.018798,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.33239,-0.013039,-0.074846,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.91848,-0.013117,0.01734,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.85194,-0.013529,-0.0026685,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.78645,-0.013834,0.022954,0,0
1,GO BICARBONATE TRANSPORT,0.79572,-0.014094,-0.043142,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.96638,-0.014288,-0.029756,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.8331,-0.014473,0.017718,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.7588,-0.01458,0.0060858,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.82372,-0.015037,-0.015489,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.95679,-0.015088,0.0011916,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.64294,-0.015161,-0.026006,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.45171,-0.015655,-0.056225,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.61728,-0.015699,0.033037,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34454,-0.015792,-0.067997,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.97598,-0.015814,-0.014076,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.90893,-0.01585,-0.020594,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.53518,-0.016404,-0.076284,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,1,-0.016433,-0.0044261,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.92804,-0.016768,-0.0010304,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.70447,-0.016812,0.12866,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.93762,-0.016894,0.031813,0,0
1,GO GROWTH,0.66904,-0.017222,0.017114,0,0
1,GO REGULATION OF FERTILIZATION,0.7588,-0.017424,-0.049924,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.4963,-0.017487,-0.030002,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.9472,-0.017624,0.0041104,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.61728,-0.017773,0.031036,0,0
1,GO PIGMENT GRANULE ORGANIZATION,0.70447,-0.018075,0.070546,0,0
1,GO RENAL ABSORPTION,0.8614,-0.018212,0.010076,0,0
1,GO GLUCOSE IMPORT,0.37614,-0.018303,-0.067332,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.55115,-0.018367,-0.032314,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.90893,-0.018396,-0.0057453,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.84251,-0.018406,0.14208,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.63434,-0.018648,-0.029575,0,0
1,GO PHOTOPERIODISM,0.63434,-0.018771,-0.060646,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.43736,-0.018999,-0.060303,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.53518,-0.019096,-0.049694,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.51167,-0.019632,-0.032124,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42328,-0.01992,-0.075026,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.89939,-0.019945,-0.023967,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.67783,-0.020051,-0.039554,0,0
1,GO REGULATION OF HAIR CYCLE,0.74054,-0.020497,-0.03854,0,0
1,GO MITOCHONDRIAL FISSION,0.95679,-0.020622,0.0014685,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.6603,-0.020868,-0.052055,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.55115,-0.021699,-0.052517,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.76799,-0.021764,-0.062629,0,0
1,GO ARTERY MORPHOGENESIS,0.78645,-0.022125,0.09651,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.67783,-0.02217,-0.047058,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.36329,-0.022224,-0.039177,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.55922,-0.022577,-0.052923,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.69555,-0.022733,0.011997,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.87087,-0.022734,-0.023579,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.93762,-0.022777,-0.033083,0,0
1,GO MEIOTIC CELL CYCLE,0.56735,-0.022985,-0.02629,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.89939,-0.023276,-0.01736,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87087,-0.023334,0.013739,0,0
1,GO DNA GEOMETRIC CHANGE,0.90893,-0.023541,-0.00058283,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.40947,-0.023557,-0.052354,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.88036,-0.023936,-0.0052413,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.43029,-0.024066,-0.058233,0,0
1,GO REGULATION OF CELLULAR PH,0.68667,-0.024114,-0.027764,0,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.81436,-0.024135,-0.043021,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.74966,-0.024563,-0.03539,0,0
1,GO FERTILIZATION,0.89939,-0.024696,-0.0047511,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.98559,-0.024995,0.033802,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.45898,-0.025348,0.0039528,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.87087,-0.025755,0.0053423,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.66904,-0.026028,-0.016382,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.74966,-0.026223,0.013107,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.93762,-0.026275,-0.0021473,0,0
1,GO MALE MEIOSIS I,0.76799,-0.026295,0.040219,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.89939,-0.026557,-0.0025547,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.59207,-0.026821,-0.10592,0,0
1,GO ANION TRANSPORT,0.18733,-0.026823,-0.063877,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.90893,-0.027053,-0.021225,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.73147,-0.027229,-0.0048752,0,0
1,GO AXON EXTENSION,0.56735,-0.027503,-0.049304,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.88987,-0.027576,0.060277,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.59207,-0.027588,-0.066265,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.7772,-0.027632,-0.027329,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.47371,-0.027636,-0.043773,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.89939,-0.027665,0.020929,0,0
1,GO MIDBRAIN DEVELOPMENT,0.33843,-0.027756,-0.047331,0,0
1,GO MANNOSYLATION,0.62578,-0.027968,0.016942,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.79572,-0.028408,-0.0084971,0,0
1,GO RENAL SODIUM EXCRETION,0.82372,-0.028457,-0.014761,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.50395,-0.028604,-0.024232,0,0
1,GO MUSCLE CONTRACTION,0.8614,-0.028671,0.026768,0,0
1,GO ORGANIC ANION TRANSPORT,0.22164,-0.028891,-0.067862,0,0
1,GO SEXUAL REPRODUCTION,0.42328,-0.02909,-0.026427,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.59207,-0.029187,-0.029371,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.74054,-0.029371,-0.10594,0,0
1,GO DNA INTEGRITY CHECKPOINT,0.56735,-0.029568,-0.028077,0,0
1,GO TERPENOID METABOLIC PROCESS,0.80503,-0.029625,-0.014957,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.73147,-0.030021,0.031998,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.67783,-0.030023,-0.019094,0,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.80503,-0.030056,0.032583,0,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.60042,-0.030277,-0.04498,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.22164,-0.030471,-0.051228,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.66904,-0.030562,-0.0707,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.76799,-0.030614,0.071559,0,0
1,GO GLIOGENESIS,0.61728,-0.031016,-0.028911,0,0
1,GO ORGANELLE LOCALIZATION,0.15361,-0.031018,-0.054473,0,0
1,GO STEROID HORMONE SECRETION,0.60042,-0.031057,-0.071432,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.71343,-0.031084,-0.05746,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.8614,-0.031597,0.021366,0,0
1,GO CELL PROJECTION ASSEMBLY,0.87087,-0.03188,-0.0010696,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.4963,-0.032013,-0.1016,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.93762,-0.032159,-0.056699,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.95679,-0.032642,-0.041621,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.7772,-0.033024,0.020365,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.40947,-0.033026,-0.056312,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.9952,-0.033033,0.0053761,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.47371,-0.033621,-0.044627,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.93762,-0.034169,0.052137,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.43029,-0.034277,-0.094846,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.95679,-0.034334,0.019778,0,0
1,GO ATP TRANSPORT,0.80503,-0.034448,-0.042124,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.8614,-0.034468,0.011029,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.41634,-0.034706,-0.022378,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.39593,-0.034861,-0.10438,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.59207,-0.034872,-0.095558,0,0
1,GO RESPONSE TO INACTIVITY,0.71343,-0.035053,-0.055745,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.20396,-0.035175,-0.19746,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.27583,-0.035313,-0.095123,0,0
1,GO PHOSPHATE ION TRANSPORT,0.52728,-0.035323,-0.032497,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.97598,-0.035647,0.0095723,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.96638,-0.03597,0.019469,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.26023,-0.036098,-0.24236,0,0
1,GO RRNA CATABOLIC PROCESS,0.9472,-0.036139,0.0026035,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.69555,-0.036267,-0.03945,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.78645,-0.036312,0.015107,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.33239,-0.036421,-0.041714,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.90893,-0.036621,-0.0086079,0,0
1,GO CELL GROWTH,0.7588,-0.036691,-0.0014489,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60042,-0.036699,0.070588,0,0
1,GO NEUROBLAST DIVISION,0.48871,-0.03678,-0.10777,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.95679,-0.036839,-0.012807,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.82372,-0.036978,-0.024415,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.7772,-0.036998,-0.010266,0,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.23088,-0.037247,-0.083298,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.63434,-0.037509,-0.0066334,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.73147,-0.037542,0.19339,0,0
1,GO MRNA METHYLATION,0.36329,-0.037552,-0.098075,0,0
1,GO RNA SPLICING,0.41634,-0.03773,-0.042354,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.55922,-0.037773,-0.05871,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.43029,-0.037805,-0.062973,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.30323,-0.03798,-0.053258,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.63434,-0.038098,-0.054157,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.8331,-0.038147,0.02482,0,0
1,GO MEMBRANE DOCKING,0.33843,-0.038161,-0.052975,0,0
1,GO RESPONSE TO GLUCAGON,0.19139,-0.03818,-0.093398,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.24039,-0.038242,-0.061221,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.72243,-0.038286,-0.033732,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.97598,-0.03867,0.011785,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.79572,-0.038846,-0.013532,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.25017,-0.039076,-0.069768,0,0
1,GO INORGANIC ANION TRANSPORT,0.29761,-0.03929,-0.053918,0,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.55115,-0.039302,-0.021765,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.48118,-0.039472,-0.086019,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.80503,-0.039493,-0.0033117,0,0
1,GO DNA CONFORMATION CHANGE,0.35697,-0.039496,-0.053564,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22164,-0.039526,-0.068533,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.81436,-0.039536,0.052956,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.19139,-0.039785,-0.10476,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.70447,-0.040012,-0.068416,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.66904,-0.04031,-0.03265,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.34454,-0.040501,-0.048699,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.36329,-0.040541,-0.12758,0,0
1,GO MOLTING CYCLE,0.36968,-0.040613,-0.070003,0,0
1,GO SPERM CAPACITATION,0.71343,-0.040966,-0.028192,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.76799,-0.041259,-0.068704,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.42328,-0.041286,-0.039454,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.32052,-0.041356,-0.087276,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.15712,-0.041357,-0.097639,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.55115,-0.041778,-0.081454,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.32642,-0.041901,-0.090546,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.33843,-0.041917,-0.064716,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.24039,-0.042194,-0.11546,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.88987,-0.042497,-0.020909,0,0
1,GO REGULATION OF MRNA PROCESSING,0.1643,-0.042523,-0.098974,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.60883,-0.04258,-0.026278,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.79572,-0.042795,0.016824,0,0
1,GO REGULATION OF PH,0.58378,-0.042837,-0.031795,0,0
1,GO REGULATION OF OOGENESIS,0.48871,-0.043009,-0.024097,0,0
1,GO MISMATCH REPAIR,0.63434,-0.043122,-0.041704,0,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.60883,-0.043151,-0.040433,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.36968,-0.043217,-0.05015,0,0
1,GO GAMETE GENERATION,0.45898,-0.043246,-0.021236,0,0
1,GO NODAL SIGNALING PATHWAY,0.91848,-0.043425,0.00032195,0,0
1,GO CYTOSOLIC TRANSPORT,0.42328,-0.043464,-0.030781,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.64294,-0.043501,-0.056021,0,0
1,GO CHROMOSOME ORGANIZATION,0.057895,-0.043602,-0.0644,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.24525,-0.043675,-0.033036,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.51944,-0.043849,-0.015775,0,0
1,GO NEGATIVE CHEMOTAXIS,0.67783,-0.044054,0.055341,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.60042,-0.044495,-0.07593,0,0
1,GO PRE MIRNA PROCESSING,0.43029,-0.0448,-0.092395,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.4963,-0.045175,-0.065428,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.15017,-0.045191,-0.22882,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.89939,-0.045256,-0.019359,0,0
1,GO PROTEIN SUMOYLATION,0.31468,-0.045281,-0.031814,0,0
1,GO NEPHRON MORPHOGENESIS,0.41634,-0.04549,-0.031453,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.16798,-0.045491,-0.058298,0,0
1,GO MYELOID CELL DEVELOPMENT,0.95679,-0.04565,0.0031134,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.52728,-0.045884,0.066315,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.71343,-0.045914,-0.061141,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.33843,-0.046362,-0.067334,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.9472,-0.046515,-0.0078791,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.53518,-0.047062,-0.011888,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.4445,-0.047223,-0.10353,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.48118,-0.047361,-0.083305,0,0
1,GO SEX DIFFERENTIATION,0.10025,-0.047743,-0.075842,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.52728,-0.047795,-0.069213,0,0
1,GO HISTAMINE SECRETION,0.88987,-0.047847,-0.031651,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.93762,-0.048127,-0.0019907,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.80503,-0.048493,0.033622,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.33239,-0.048598,-0.059735,0,0
1,GO MALE GAMETE GENERATION,0.18334,-0.048611,-0.040743,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.8331,-0.049179,0.0077491,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.53518,-0.049379,-0.05536,0,0
1,GO STEM CELL DIVISION,0.6603,-0.049428,-0.030498,0,0
1,GO MRNA PROCESSING,0.35072,-0.049434,-0.043633,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.72243,-0.049645,-0.01905,0,0
1,GO HISTONE UBIQUITINATION,0.11892,-0.049677,-0.072152,0,0
1,GO DEVELOPMENTAL GROWTH,0.19971,-0.049892,-0.055126,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.43736,-0.05004,-0.072984,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.59207,-0.050058,-0.034645,0,0
1,GO BLASTOCYST DEVELOPMENT,0.084004,-0.050098,-0.079611,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.54313,-0.050371,-0.053421,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.40947,-0.050491,-0.14846,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.38927,-0.050499,-0.11083,0,0
1,GO GLIAL CELL PROLIFERATION,0.93762,-0.050526,0.02244,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.1161,-0.050588,-0.12286,0,0
1,GO DRUG CATABOLIC PROCESS,0.46631,-0.05061,-0.059872,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.7772,-0.050647,-0.006443,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.30892,-0.050733,-0.044927,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.30323,-0.05081,-0.068806,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.47371,-0.051076,-0.055534,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.46631,-0.051131,-0.042984,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.59207,-0.051256,-0.035613,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.25516,-0.051443,-0.073026,0,0
1,GO HISTONE H3 DEACETYLATION,0.80503,-0.051602,-0.01439,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.72243,-0.05194,-0.0034797,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.80503,-0.05228,0.032106,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.61728,-0.05236,-0.042591,0,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.29761,-0.052478,-0.036116,0,0
1,GO LIPID PHOSPHORYLATION,0.35072,-0.05312,-0.05257,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.33843,-0.053345,-0.09308,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.29761,-0.053429,-0.087704,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.61728,-0.053451,-0.032566,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.10533,-0.053721,-0.057899,0,0
1,GO GOLGI LOCALIZATION,0.58378,-0.053837,-0.038361,0,0
1,GO RESPONSE TO AXON INJURY,0.33239,-0.054102,-0.074439,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.55922,-0.05422,-0.056978,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.91848,-0.054256,0.055292,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.52728,-0.054545,-0.028695,0,0
1,GO MEMBRANE REPOLARIZATION,0.29761,-0.054649,-0.098944,0,0
1,GO DNA REPLICATION CHECKPOINT,0.28117,-0.055025,-0.13091,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.33843,-0.055139,-0.10382,0,0
1,GO BONE MINERALIZATION,0.84251,-0.055165,0.077004,0,0
1,GO RECOMBINATIONAL REPAIR,0.18334,-0.055239,-0.072458,0,0
1,GO QUINONE METABOLIC PROCESS,0.62578,-0.055289,-0.12424,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.19139,-0.055543,-0.052727,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.63434,-0.055671,-0.11856,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.45171,-0.056124,-0.024915,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.1643,-0.056379,-0.047627,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.51167,-0.056419,-0.13818,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.07572,-0.056455,-0.071013,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.91848,-0.056492,0.025506,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.35697,-0.056612,-0.088041,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.67783,-0.056701,-0.080242,0,0
1,GO LOCOMOTOR RHYTHM,0.96638,-0.057615,0.020569,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.27056,-0.057692,-0.082707,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.24039,-0.057844,-0.051525,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.10533,-0.057908,-0.1287,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.72243,-0.058058,-0.038663,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.27583,-0.058152,-0.10852,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.38927,-0.058155,-0.06819,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.19139,-0.058201,-0.13074,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.073757,-0.058206,-0.096894,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.39593,-0.058388,-0.088202,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.093006,-0.058502,-0.11782,0,0
1,GO B CELL HOMEOSTASIS,0.14679,-0.058544,-0.12661,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.29206,-0.058674,-0.084335,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.40267,-0.058778,-0.062795,0,0
1,GO PENILE ERECTION,0.29761,-0.058952,-0.11816,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.11892,-0.058996,-0.049119,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.25516,-0.059022,-0.10953,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.090686,-0.059027,-0.1323,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.74966,-0.05936,0.066749,0,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.70447,-0.059361,-0.042649,0,0
1,GO LONG TERM MEMORY,0.21267,-0.059365,-0.13117,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.31468,-0.059373,-0.16027,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.20828,-0.059638,-0.071396,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.96638,-0.0597,0.014645,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.26023,-0.060076,-0.096621,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.4963,-0.060148,-0.099456,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.19139,-0.060332,-0.07886,0,0
1,GO MAST CELL ACTIVATION,0.31468,-0.060463,-0.095758,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.68667,-0.060598,-0.086014,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.96638,-0.060605,-0.0050876,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.4445,-0.060693,-0.1471,0,0
1,GO ORGANIC ACID TRANSPORT,0.035624,-0.060705,-0.10188,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.28658,-0.060982,-0.14507,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.36329,-0.061001,-0.043428,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.28117,-0.061026,-0.094914,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.48871,-0.061182,-0.058075,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.56735,-0.06133,-0.063881,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.16068,-0.061369,-0.09519,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.13074,-0.061822,-0.11186,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.43736,-0.061863,-0.064954,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.34454,-0.061996,-0.10586,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.32052,-0.062081,-0.057451,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.7588,-0.062174,-0.020439,0,0
1,GO HEART VALVE FORMATION,0.62578,-0.062533,-0.10421,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.062584,-0.050682,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.10277,-0.063069,-0.09108,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.2356,-0.06327,-0.14635,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.54313,-0.06406,0.13124,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.36329,-0.064487,-0.14814,0,0
1,GO NEURON DEATH,0.16068,-0.0645,-0.064648,0,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.40267,-0.064601,-0.021138,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.62578,-0.064641,-0.0077538,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.11892,-0.06501,-0.043844,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.4445,-0.065054,-0.095876,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.42328,-0.065104,-0.060421,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.24039,-0.06542,-0.31877,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.69555,-0.065561,-0.027835,0,0
1,GO REGULATION OF RNA SPLICING,0.10025,-0.065665,-0.10962,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.27583,-0.065735,-0.091259,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.70447,-0.065934,-0.05437,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.29206,-0.066124,-0.066176,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.12179,-0.066415,-0.1081,0,0
1,GO EXIT FROM MITOSIS,0.36329,-0.066415,-0.045966,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.31468,-0.066638,-0.047561,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.19552,-0.066666,-0.058752,0,0
1,GO SPERM MOTILITY,0.10277,-0.066903,-0.074778,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.10533,-0.067078,-0.13317,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.19971,-0.06735,-0.14184,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.10277,-0.067645,-0.047266,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.48118,-0.067765,-0.055836,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.92804,-0.067967,0.021348,0,0
1,GO ZINC ION HOMEOSTASIS,0.88987,-0.068331,0.044671,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.91848,-0.06841,0.1342,0,0
1,GO DIVALENT METAL ION EXPORT,0.81436,-0.068692,-0.035852,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.18334,-0.069635,-0.10321,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.35072,-0.069644,-0.040145,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.32052,-0.069956,-0.15081,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.39593,-0.070328,-0.055472,0,0
1,GO TELOMERE CAPPING,0.21712,-0.070853,-0.053132,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.044978,-0.070939,-0.075602,0,0
1,GO PANCREATIC JUICE SECRETION,0.39593,-0.071049,-0.032044,0,0
1,GO DIET INDUCED THERMOGENESIS,0.34454,-0.071143,-0.12773,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.29761,-0.07172,-0.06496,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.64294,-0.071786,0.0070705,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.38267,-0.072021,-0.10298,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.27056,-0.072575,-0.11025,0,0
1,GO TOR SIGNALING,0.16798,-0.072712,-0.047522,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.33239,-0.072805,-0.064411,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.87087,-0.073294,0.020929,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.30892,-0.073374,-0.068973,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.2356,-0.073448,-0.16101,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.064555,-0.073708,-0.097602,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.68667,-0.073783,-0.032316,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.56735,-0.073825,-0.067074,0,0
1,GO HISTONE H2A ACETYLATION,0.54313,-0.073949,-0.052362,0,0
1,GO NUCLEOSOME ASSEMBLY,0.069955,-0.074131,-0.14971,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.21712,-0.074153,-0.065994,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.077726,-0.074159,-0.11135,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.34454,-0.074854,-0.050865,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.55922,-0.074996,-0.085022,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.74966,-0.075166,0.1634,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.30323,-0.075215,-0.071744,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.51167,-0.075225,-0.059673,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.28658,-0.07579,-0.047213,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.51944,-0.075819,-0.063139,0,0
1,GO CHOLESTEROL STORAGE,0.93762,-0.076541,0.056986,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.37614,-0.076779,-0.11561,0,0
1,GO DEPHOSPHORYLATION,0.086186,-0.076865,-0.071852,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.35072,-0.077019,-0.084511,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.29206,-0.077085,-0.06228,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.74054,-0.077093,0.049838,0,0
1,GO BLASTODERM SEGMENTATION,0.42328,-0.077133,-0.1058,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.10533,-0.077172,-0.09886,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.10794,-0.077237,-0.10948,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.15017,-0.077488,-0.096071,0,0
1,GO CELL RECOGNITION,0.41634,-0.077672,-0.048758,0,0
1,GO MITOCHONDRIAL FUSION,0.48871,-0.077676,-0.034814,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.69555,-0.07798,-0.0070995,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.66904,-0.078075,-0.013864,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.40267,-0.078153,-0.037922,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.13384,-0.078156,-0.15212,0,0
1,GO MAINTENANCE OF CELL NUMBER,0.20828,-0.07819,-0.068274,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.073757,-0.078244,-0.11159,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.40267,-0.078568,-0.13072,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.24039,-0.078816,-0.098335,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.28117,-0.078906,-0.074972,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.15712,-0.0793,-0.067003,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.057895,-0.079526,-0.11679,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.79572,-0.079827,-0.082769,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.27583,-0.080078,-0.099858,0,0
1,GO ECTODERM DEVELOPMENT,0.071835,-0.080402,-0.1083,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.43029,-0.080412,-0.078903,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.1794,-0.080587,-0.073159,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.050383,-0.080598,-0.093417,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.55115,-0.080655,-0.037519,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.36329,-0.081237,-0.11698,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.11333,-0.081682,-0.084019,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.26023,-0.081682,-0.044314,0,0
1,GO CELL JUNCTION ASSEMBLY,0.23088,-0.081732,-0.072572,0,0
1,GO HISTONE MONOUBIQUITINATION,0.19971,-0.08191,-0.079282,0,0
1,GO PARTURITION,0.52728,-0.081943,-0.08652,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.70447,-0.082109,-0.034539,0,0
1,GO SENSORY PERCEPTION OF SMELL,0.036694,-0.082194,-0.094422,0,0
1,GO REGULATION OF ACROSOME REACTION,0.36968,-0.082585,-0.15335,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20828,-0.082666,-0.22666,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.046281,-0.082875,-0.17914,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.33239,-0.083158,-0.0092762,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.27583,-0.083213,-0.056016,0,0
1,GO BONE MATURATION,0.33843,-0.08324,-0.14325,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.10025,-0.083308,-0.13179,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.19139,-0.083404,-0.12384,0,0
1,GO REGULATION OF TRANSPORT,0.036694,-0.083629,-0.075826,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.38267,-0.083993,-0.052496,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.10794,-0.084308,-0.13656,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.48871,-0.084513,-0.061956,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.45171,-0.084729,-0.045201,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.036694,-0.085379,-0.13608,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.32642,-0.085506,-0.20681,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.52728,-0.085585,-0.078945,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.47371,-0.085646,-0.073743,0,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.98559,-0.085724,0.0090048,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.13074,-0.085856,-0.086813,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.68667,-0.085925,-0.019444,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.51167,-0.086112,-0.023132,0,0
1,GO RESPONSE TO FUNGUS,0.25017,-0.086131,-0.14474,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.57554,-0.086166,-0.10717,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.086186,-0.086225,-0.14644,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.32642,-0.086261,-0.050505,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.85194,-0.086338,-0.0046337,0,0
1,GO OSTEOBLAST PROLIFERATION,0.71343,-0.086415,0.038971,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.073757,-0.086441,-0.097441,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.35697,-0.086454,-0.059894,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.25516,-0.086581,-0.10732,0,0
1,GO REPLICATION FORK PROCESSING,0.13384,-0.086694,-0.10553,0,0
1,GO PHAGOSOME MATURATION,0.32642,-0.086704,-0.06299,0,0
1,GO RECEPTOR CLUSTERING,0.09779,-0.086736,-0.18139,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.1643,-0.086782,-0.063876,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.18334,-0.086831,-0.10239,0,0
1,GO VASCULAR WOUND HEALING,0.78645,-0.087198,-0.060766,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.43029,-0.087349,-0.081239,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.40947,-0.087919,-0.049869,0,0
1,GO DNA PACKAGING,0.050383,-0.088221,-0.10966,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.52728,-0.088486,-0.058811,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.042464,-0.089109,-0.099196,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.41634,-0.089143,-0.099431,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.19971,-0.089152,-0.087662,0,0
1,GO PROTEIN MANNOSYLATION,0.60042,-0.089182,-0.04654,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.32642,-0.089566,-0.16658,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.19552,-0.089692,-0.067311,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.28117,-0.089988,-0.17907,0,0
1,GO PIGMENTATION,0.13699,-0.09018,-0.061846,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.34454,-0.090348,-0.077939,0,0
1,GO RENAL SYSTEM PROCESS,0.33843,-0.090364,-0.065802,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.88036,-0.09072,-0.0046689,0,0
1,GO HISTONE DEUBIQUITINATION,0.29761,-0.090754,-0.057452,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.60042,-0.090841,0.0095091,0,0
1,GO REGULATION OF TOR SIGNALING,0.032572,-0.090975,-0.092927,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.35072,-0.091054,-0.0015708,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.4963,-0.091308,-0.013716,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.032572,-0.091397,-0.10987,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.18733,-0.091485,-0.09594,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.15017,-0.091671,-0.053039,0,0
1,GO AUTOPHAGIC CELL DEATH,0.47371,-0.091679,-0.064198,0,0
1,GO RESPONSE TO FATTY ACID,0.1794,-0.091746,-0.098112,0,0
1,GO REGULATION OF ANION TRANSPORT,0.054786,-0.092026,-0.11934,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.41634,-0.092081,-0.063903,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.20396,-0.092304,-0.18399,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.13074,-0.092324,-0.10565,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.090686,-0.092693,-0.08167,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.21712,-0.092866,-0.20738,0,0
1,GO HORMONE CATABOLIC PROCESS,0.68667,-0.0929,-0.084028,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.32642,-0.093217,-0.12891,0,0
1,GO APPENDAGE DEVELOPMENT,0.26023,-0.093286,-0.094412,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.36329,-0.09357,-0.079859,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.55115,-0.093588,0.076995,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.069955,-0.093691,-0.092339,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.50395,-0.093719,-0.10474,0,0
1,GO REGULATION OF AXON GUIDANCE,0.47371,-0.093752,-0.063297,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.22164,-0.094487,-0.076907,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.30323,-0.094813,-0.11665,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.26023,-0.095061,-0.061114,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.32052,-0.095222,-0.11818,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.29761,-0.095299,-0.14091,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.33239,-0.095404,-0.094028,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.40947,-0.095404,-0.075542,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.71343,-0.095776,-0.026775,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.71343,-0.095827,0.022962,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.12179,-0.095895,-0.11098,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.068115,-0.095988,-0.094927,0,0
1,GO MYOFIBRIL ASSEMBLY,0.74054,-0.096186,0.053715,0,0
1,GO OOGENESIS,0.084004,-0.096281,-0.084708,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.46631,-0.096385,-0.055221,0,0
1,GO RHYTHMIC BEHAVIOR,0.1643,-0.096928,-0.16184,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.28658,-0.097292,-0.064801,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.054786,-0.097545,-0.099145,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.15017,-0.097556,-0.14883,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.31468,-0.097563,-0.10658,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.069955,-0.097942,-0.12177,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.57554,-0.098284,-0.016792,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.45171,-0.098331,-0.031479,0,0
1,GO HISTAMINE TRANSPORT,0.48118,-0.098574,-0.1165,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.036694,-0.099088,-0.14888,0,0
1,GO VESICLE LOCALIZATION,0.035624,-0.099119,-0.083787,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.25516,-0.099156,-0.07293,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.056323,-0.099381,-0.10023,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.42328,-0.099517,-0.031602,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.81436,-0.099639,0.078955,0,0
1,GO ARACHIDONIC ACID SECRETION,0.21712,-0.099647,-0.11833,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.15712,-0.1,-0.1233,0,0
1,GO HISTONE H3 ACETYLATION,0.15712,-0.10063,-0.063077,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.38267,-0.10072,-0.046479,0,0
1,GO MICROTUBULE ANCHORING,0.13074,-0.10076,-0.11711,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.98559,-0.10077,0.093477,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.26023,-0.10097,-0.1003,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.40947,-0.10147,-0.083416,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.19552,-0.10149,-0.19649,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.68667,-0.10154,-0.058011,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.55115,-0.10177,-0.052622,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.06115,-0.10181,-0.19988,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.030665,-0.10182,-0.095948,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.20828,-0.10233,-0.086587,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.43736,-0.10237,-0.087343,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.088413,-0.1025,-0.056611,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.61728,-0.10268,-0.017067,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.036694,-0.10287,-0.10293,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.066316,-0.10301,-0.1058,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.43029,-0.10305,-0.0034117,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.043706,-0.10305,-0.14016,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.35072,-0.10321,-0.06108,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.40947,-0.10348,-0.11906,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.19971,-0.10384,-0.22089,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.042464,-0.10415,-0.10104,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.18733,-0.10425,-0.1289,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.04007,-0.1044,-0.11083,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.1161,-0.10442,-0.090653,0,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.10025,-0.10498,-0.11629,0,0
1,GO HEART INDUCTION,0.89939,-0.10538,-0.024378,0,0
1,GO RETINA HOMEOSTASIS,0.1161,-0.10579,-0.095794,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.11061,-0.10592,-0.17331,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.048983,-0.10598,-0.096901,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.13699,-0.10616,-0.12552,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.14347,-0.10631,-0.095792,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.8614,-0.10639,0.051499,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.21267,-0.10671,-0.084513,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.19552,-0.10673,-0.073636,0,0
1,GO THYROID GLAND DEVELOPMENT,0.37614,-0.10675,-0.047463,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12472,-0.107,-0.098876,0,0
1,GO STRESS GRANULE ASSEMBLY,0.07572,-0.10714,-0.11707,0,0
1,GO SECONDARY METABOLIC PROCESS,0.27583,-0.10757,-0.12823,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.19971,-0.10759,-0.14327,0,0
1,GO MICROTUBULE BASED PROCESS,0.044978,-0.1076,-0.094104,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.30892,-0.10791,-0.18169,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.032572,-0.10794,-0.095849,0,0
1,GO ER OVERLOAD RESPONSE,0.7588,-0.10907,-0.027816,0,0
1,GO OOCYTE DIFFERENTIATION,0.034581,-0.10937,-0.1212,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.04007,-0.10988,-0.14883,0,0
1,GO EXCRETION,0.51944,-0.11012,-0.019555,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.42328,-0.11038,-0.078973,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.057895,-0.11051,-0.15231,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.35072,-0.11068,-0.10231,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.35072,-0.11136,-0.073823,0,0
1,GO CILIUM MOVEMENT,0.10277,-0.11137,-0.08257,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.47371,-0.11165,-0.16003,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.22622,-0.11192,-0.089786,0,0
1,GO REGULATION OF BONE REMODELING,0.56735,-0.11195,-0.025103,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.077726,-0.11249,-0.16557,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.06115,-0.11271,-0.15736,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.25017,-0.11295,-0.19788,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.25017,-0.11306,-0.073554,0,0
1,GO CILIUM ORGANIZATION,0.14679,-0.1132,-0.058286,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.1794,-0.1135,-0.12795,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.74054,-0.11359,-0.025507,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.21267,-0.11377,-0.15756,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.10277,-0.11449,-0.11349,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.037792,-0.11479,-0.19701,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.048983,-0.11497,-0.17666,0,0
1,GO HISTONE H2A UBIQUITINATION,0.064555,-0.11652,-0.11809,0,0
1,GO RESPONSE TO STARVATION,0.13384,-0.11689,-0.084602,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.20396,-0.1171,-0.11176,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.55922,-0.1173,-0.020383,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.84251,-0.1175,-0.020505,0,0
1,GO WATER TRANSPORT,0.084004,-0.1176,-0.12057,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.073757,-0.1176,-0.13531,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.43736,-0.11767,-0.11503,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.73147,-0.11772,-0.021627,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.14679,-0.11804,-0.19916,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.18334,-0.11826,-0.12532,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.035624,-0.11852,-0.16073,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.07572,-0.11856,-0.10044,0,0
1,GO MICROVILLUS ORGANIZATION,0.15017,-0.11874,-0.17976,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.21267,-0.11929,-0.049731,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.18334,-0.1194,-0.15194,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.40267,-0.11942,-0.066024,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.46631,-0.11956,-0.065192,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.056323,-0.1197,-0.10515,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.15017,-0.11986,-0.082443,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.26536,-0.11989,-0.078337,0,0
1,GO MEMBRANE FISSION,0.086186,-0.12028,-0.21651,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.084004,-0.12043,-0.10236,0,0
1,GO TORC1 SIGNALING,0.095374,-0.12044,-0.082067,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.35072,-0.12085,-0.06848,0,0
1,GO VESICLE DOCKING,0.030665,-0.12136,-0.13873,0,0
1,GO REGULATION OF NEURON MIGRATION,0.042464,-0.12209,-0.2246,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.1161,-0.12209,-0.13179,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.033564,-0.12235,-0.15644,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.29206,-0.12319,-0.12751,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.28658,-0.12347,-0.11134,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.68667,-0.12362,-0.018752,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.52728,-0.12363,-0.072894,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.34454,-0.12379,-0.040559,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.82372,-0.12391,0.018088,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.60883,-0.12393,-0.021337,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.60883,-0.124,-0.074473,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.054786,-0.12417,-0.15864,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.33843,-0.12447,-0.13087,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.61728,-0.12459,-0.040909,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.74966,-0.12495,0.10931,0,0
1,GO REGULATION OF ODONTOGENESIS,0.1794,-0.12519,-0.12942,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.059504,-0.12525,-0.18107,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.10025,-0.12581,-0.24605,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.13384,-0.12582,-0.11741,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.51944,-0.1259,-0.073415,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.084004,-0.12603,-0.20802,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.1643,-0.12621,-0.11059,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.041252,-0.12666,-0.12694,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.31468,-0.12683,-0.15825,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.13074,-0.12704,-0.18891,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.36329,-0.12813,-0.067103,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.34454,-0.129,-0.044111,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.60042,-0.1294,-0.027835,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.046281,-0.12949,-0.13689,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.25017,-0.12955,-0.098099,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.093006,-0.12972,-0.14608,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.31468,-0.12975,-0.073079,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.4445,-0.12979,-0.046985,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.12179,-0.12999,-0.095024,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.56735,-0.13036,-0.068591,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.090686,-0.13038,-0.096953,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.26536,-0.13056,-0.082291,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.12179,-0.13065,-0.16059,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.17553,-0.1307,-0.15951,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.037792,-0.13088,-0.10724,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.73147,-0.13102,-0.070704,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.32052,-0.13119,-0.10242,0,0
1,GO L SERINE METABOLIC PROCESS,0.66904,-0.13155,-0.1339,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.093006,-0.13221,-0.12666,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.27056,-0.13224,-0.10187,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20828,-0.13234,-0.073572,0,0
1,GO CGMP MEDIATED SIGNALING,0.33843,-0.1324,-0.07715,0,0
1,GO RESPONSE TO ETHANOL,0.064555,-0.13259,-0.11634,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.17553,-0.1335,-0.12335,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.48871,-0.13377,-0.11559,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.07572,-0.13409,-0.14638,0,0
1,GO MRNA MODIFICATION,0.28658,-0.13488,-0.093808,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.61728,-0.13493,-0.12101,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.07572,-0.13497,-0.1694,0,0
1,GO MESONEPHROS DEVELOPMENT,0.13074,-0.13567,-0.10736,0,0
1,GO ANIMAL ORGAN MATURATION,0.25017,-0.13578,-0.12776,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.45898,-0.13617,-0.07416,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.42328,-0.13621,-0.045284,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.095374,-0.13626,-0.16319,0,0
1,GO GAS TRANSPORT,0.55922,-0.13651,-0.11141,0,0
1,GO BRONCHUS DEVELOPMENT,0.93762,-0.13662,0.0046943,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.43029,-0.13664,-0.12212,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.054786,-0.13686,-0.14161,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.041252,-0.13688,-0.16043,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.077726,-0.13792,-0.10801,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.06115,-0.138,-0.1326,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.07572,-0.1382,-0.1403,0,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.10025,-0.13827,-0.24493,0,0
1,GO NOTCH SIGNALING PATHWAY,0.13074,-0.13861,-0.09666,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.1402,-0.1387,-0.11122,0,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.6516,-0.1387,0.019137,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.48118,-0.13871,-0.056095,0,0
1,GO APPENDAGE MORPHOGENESIS,0.1794,-0.13882,-0.13529,0,0
1,GO ADULT FEEDING BEHAVIOR,0.037792,-0.13962,-0.2202,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.11333,-0.13986,-0.1059,0,0
1,GO METANEPHROS MORPHOGENESIS,0.38267,-0.14022,-0.12922,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.086186,-0.1403,-0.10904,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.22622,-0.14075,-0.11703,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.13699,-0.14113,-0.14735,0,0
1,GO CHROMATIN DISASSEMBLY,0.19552,-0.14161,-0.16384,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.12179,-0.14197,-0.11803,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.079775,-0.14229,-0.12695,0,0
1,GO COCHLEA MORPHOGENESIS,0.15361,-0.14237,-0.22753,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.38927,-0.1429,-0.13398,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.96638,-0.14338,0.031734,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.037792,-0.14348,-0.14524,0,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.053284,-0.14353,-0.095358,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.04007,-0.14484,-0.19052,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.33239,-0.14507,-0.096693,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.066316,-0.14535,-0.10822,0,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.33843,-0.1455,-0.15159,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.16068,-0.14586,-0.19155,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.40947,-0.14681,-0.080642,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.031606,-0.14725,-0.19091,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.086186,-0.14844,-0.12914,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.048983,-0.14906,-0.15887,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.057895,-0.15073,-0.17387,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.14347,-0.15105,-0.1317,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.031606,-0.15122,-0.14935,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.15361,-0.15141,-0.099644,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.21267,-0.15157,-0.12464,0,0
1,GO P BODY ASSEMBLY,0.064555,-0.15158,-0.11141,0,0
1,GO NUCLEAR MIGRATION,0.1794,-0.15161,-0.14015,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.11061,-0.15202,-0.20387,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.06115,-0.15212,-0.137,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.071835,-0.15243,-0.24905,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.35697,-0.15256,-0.089264,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.038917,-0.15298,-0.27175,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.23088,-0.15315,-0.12693,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.1402,-0.15357,-0.087668,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.27056,-0.15361,-0.076484,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.26536,-0.15365,-0.15838,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.4963,-0.15491,-0.08106,0,0
1,GO RESPONSE TO INTERLEUKIN 2,0.10533,-0.15519,-0.17063,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.093006,-0.15569,-0.22573,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.12771,-0.1557,-0.16546,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.048983,-0.15617,-0.16502,0,0
1,GO PROTEIN NITROSYLATION,0.069955,-0.15642,-0.21229,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.050383,-0.15649,-0.13523,0,0
1,GO DOSAGE COMPENSATION,0.069955,-0.15653,-0.14439,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.043706,-0.15685,-0.11106,0,0
1,GO AORTA MORPHOGENESIS,0.20828,-0.15855,-0.029671,0,0
1,GO PROSTATE GLAND GROWTH,0.14679,-0.15941,-0.21211,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.39593,-0.15945,-0.10573,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.66904,-0.15965,0.055977,0,0
1,GO COPULATION,0.18334,-0.16004,-0.13956,0,0
1,GO MAGNESIUM ION TRANSPORT,0.29206,-0.16124,-0.064384,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.22164,-0.1615,-0.077622,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.11061,-0.16161,-0.13678,0,0
1,GO LYSINE METABOLIC PROCESS,0.51167,-0.16162,-0.092051,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.056323,-0.16197,-0.19804,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.093006,-0.1622,-0.11367,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.10025,-0.16308,-0.19002,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.095374,-0.16377,-0.14826,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.036694,-0.16384,-0.15185,0,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.042464,-0.16428,-0.18402,0,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.035624,-0.16473,-0.16015,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.13384,-0.1648,-0.15104,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.25516,-0.16482,-0.077204,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12771,-0.16508,-0.12612,0,0
1,GO CARNITINE SHUTTLE,0.90893,-0.16514,-0.00080036,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.047616,-0.16549,-0.16843,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.25516,-0.16555,-0.098939,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.36968,-0.16595,-0.13272,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.54313,-0.16601,-0.091949,0,0
1,GO STEM CELL PROLIFERATION,0.088413,-0.16621,-0.14011,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.041252,-0.16647,-0.1947,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.22622,-0.16696,-0.13973,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.044978,-0.16743,-0.13749,0,0
1,GO MICROTUBULE POLYMERIZATION,0.044978,-0.1682,-0.17738,0,0
1,GO LIPID EXPORT FROM CELL,0.1794,-0.16823,-0.10241,0,0
1,GO PRENYLATION,0.11892,-0.1687,-0.14677,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.18733,-0.16886,-0.18971,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.27056,-0.1691,-0.076713,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.056323,-0.16922,-0.21291,0,0
1,GO MITOTIC DNA REPLICATION,0.041252,-0.16943,-0.20006,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.06115,-0.17023,-0.12482,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.12472,-0.17055,-0.15171,0,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.093006,-0.17164,-0.15009,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.056323,-0.17196,-0.088831,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.19552,-0.17242,-0.07646,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.58378,-0.17268,-0.091665,0,0
1,GO DNA METHYLATION,0.035624,-0.17389,-0.13474,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.23088,-0.17394,-0.15727,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.11892,-0.17502,-0.18061,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.056323,-0.17522,-0.18297,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.15361,-0.17597,-0.1894,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.09779,-0.17713,-0.20466,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10794,-0.17745,-0.11829,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.079775,-0.17748,-0.11894,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.29761,-0.17815,-0.056863,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.093006,-0.17903,-0.22172,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.064555,-0.17936,-0.15579,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.28117,-0.17965,-0.1024,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.12472,-0.17978,-0.12532,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.033564,-0.18006,-0.15719,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.073757,-0.18095,-0.21227,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.55115,-0.18163,-0.14489,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.42328,-0.18322,-0.074273,0,0
1,GO KIDNEY MORPHOGENESIS,0.033564,-0.1834,-0.14964,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.29761,-0.18365,-0.10877,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.36329,-0.18371,-0.081522,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.12472,-0.18401,-0.22483,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.12472,-0.18468,-0.16786,0,0
1,GO SPERM AXONEME ASSEMBLY,0.11892,-0.18489,-0.13525,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.10794,-0.18546,-0.2557,0,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.081867,-0.18599,-0.16801,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.19971,-0.18608,-0.098739,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.55115,-0.18621,0.014266,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.35697,-0.18696,-0.14572,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.48118,-0.18714,-0.075958,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.15017,-0.18715,-0.17162,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.053284,-0.18723,-0.22039,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.62578,-0.18771,-0.064271,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.046281,-0.18854,-0.27411,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.07572,-0.1892,-0.1674,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.1161,-0.18985,-0.15906,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.10533,-0.18989,-0.12493,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.077726,-0.18997,-0.17924,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.079775,-0.19051,-0.20865,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.18334,-0.19241,-0.18144,0,0
1,GO EYE MORPHOGENESIS,0.038917,-0.19464,-0.12543,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.038917,-0.19471,-0.14651,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.30892,-0.19472,-0.14022,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.04007,-0.19489,-0.23136,0,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.041252,-0.19571,-0.25775,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.057895,-0.19888,-0.16768,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.19139,-0.19915,-0.1377,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.053284,-0.19919,-0.2139,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.10277,-0.2001,-0.12628,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.037792,-0.20124,-0.16324,0,0
1,GO KERATINIZATION,0.031606,-0.20154,-0.20813,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.48118,-0.20159,-0.10295,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.09779,-0.20391,-0.19785,0,0
1,GO DEVELOPMENTAL INDUCTION,0.032572,-0.20546,-0.18801,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.26536,-0.20603,-0.23215,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.06115,-0.20608,-0.15618,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.12771,-0.2067,-0.26048,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.031606,-0.20697,-0.22869,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.25516,-0.20701,-0.24083,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.10533,-0.20707,-0.20463,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.19139,-0.20737,-0.11439,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.38927,-0.20851,-0.12649,0,0
1,GO NEURON REMODELING,0.19139,-0.21029,-0.15401,0,0
1,GO LIPID TRANSLOCATION,0.038917,-0.21115,-0.18758,0,0
1,GO CORNIFICATION,0.059504,-0.21143,-0.21673,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.030665,-0.21172,-0.17474,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.1643,-0.21184,-0.1924,0,0
1,GO ACROSOME REACTION,0.081867,-0.21186,-0.16574,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.079775,-0.2122,-0.1522,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.1643,-0.21298,-0.20156,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.62578,-0.21318,-0.13868,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.26023,-0.21471,-0.09239,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.21712,-0.21625,-0.19762,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.054786,-0.21629,-0.1803,0,0
1,GO COLLATERAL SPROUTING,0.15017,-0.2173,-0.13228,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.19552,-0.21751,-0.10394,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.043706,-0.21892,-0.22806,0,0
1,GO DENDRITE SELF AVOIDANCE,0.40947,-0.21897,-0.065013,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.1643,-0.22122,-0.11456,0,0
1,GO NOREPINEPHRINE TRANSPORT,0.044978,-0.22179,-0.2212,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.11892,-0.22189,-0.13715,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.031606,-0.2234,-0.16272,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.11892,-0.2239,-0.22006,0,0
1,GO RESPONSE TO CAFFEINE,0.057895,-0.22395,-0.19991,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.12179,-0.22423,-0.2251,0,0
1,GO RESPONSE TO PAIN,0.030665,-0.22575,-0.22077,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.11892,-0.22594,-0.18128,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.18733,-0.22661,-0.11611,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.047616,-0.22712,-0.29253,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.071835,-0.22797,-0.27978,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.095374,-0.22904,-0.18304,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.66904,-0.23176,-0.0075269,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.19552,-0.23327,-0.13274,0,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.088413,-0.23329,-0.17093,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.09779,-0.23536,-0.25123,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.15712,-0.23726,-0.15827,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.27583,-0.23807,-0.14351,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.10794,-0.23812,-0.24046,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.088413,-0.2382,-0.26398,0,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.069955,-0.2391,-0.26506,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.054786,-0.23929,-0.31339,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.45898,-0.24119,-0.14636,0,0
1,GO POLYOL TRANSPORT,0.081867,-0.24137,-0.19341,0,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.062834,-0.24213,-0.1608,0,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.11892,-0.24273,-0.15275,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.18334,-0.24429,-0.19427,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.10025,-0.2443,-0.21464,0,0
1,GO RESPONSE TO VITAMIN D,0.27583,-0.24473,-0.14604,0,0
1,GO ADULT HEART DEVELOPMENT,0.07572,-0.24613,-0.21523,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.030665,-0.24636,-0.27533,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.056323,-0.24812,-0.26795,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.046281,-0.24905,-0.26835,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.030665,-0.25053,-0.25078,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.090686,-0.25071,-0.26155,0,0
1,GO OXYGEN TRANSPORT,0.36968,-0.25094,-0.19765,0,0
1,GO INTRACILIARY TRANSPORT,0.07572,-0.25219,-0.16062,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.13074,-0.25271,-0.18225,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.037792,-0.25316,-0.31857,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.10533,-0.25391,-0.27172,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.037792,-0.25606,-0.15196,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.032572,-0.25622,-0.29554,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.095374,-0.25722,-0.17369,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.077726,-0.26084,-0.2624,0,0
1,GO CELL FATE DETERMINATION,0.031606,-0.26168,-0.26826,0,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.041252,-0.26177,-0.30654,0,0
1,GO MICROTUBULE SEVERING,0.038917,-0.26235,-0.20124,0,0
1,GO HEAT GENERATION,0.24039,-0.26283,-0.14643,0,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.046281,-0.26354,-0.39406,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.046281,-0.26359,-0.16911,0,0
1,GO PRO B CELL DIFFERENTIATION,0.090686,-0.26434,-0.19983,0,0
1,GO GASTRIC ACID SECRETION,0.031606,-0.2652,-0.20752,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.19139,-0.26529,-0.1876,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.28658,-0.26858,-0.11251,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.043706,-0.27023,-0.27574,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.069955,-0.2708,-0.17751,0,0
1,GO RELAXATION OF MUSCLE,0.088413,-0.27209,-0.19091,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.038917,-0.27469,-0.19372,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.17173,-0.27498,-0.20582,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.28658,-0.27571,-0.12239,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.12472,-0.27747,-0.25148,0,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.034581,-0.27784,-0.25659,0,0
1,GO AXONEME ASSEMBLY,0.12179,-0.27802,-0.14591,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.26536,-0.27968,-0.16717,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.038917,-0.27977,-0.18912,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.10533,-0.28042,-0.24573,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.032572,-0.28048,-0.31574,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.044978,-0.28221,-0.34907,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.033564,-0.28332,-0.29232,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.14679,-0.28551,-0.19293,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.073757,-0.28731,-0.13503,0,0
1,GO CARTILAGE MORPHOGENESIS,0.090686,-0.29022,-0.28309,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.034581,-0.29172,-0.22061,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.044978,-0.29267,-0.36286,0,0
1,GO CONVERGENT EXTENSION,0.042464,-0.29707,-0.28945,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.09779,-0.2978,-0.29108,0,0
1,GO INSEMINATION,0.26023,-0.29883,-0.14313,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.081867,-0.29958,-0.24618,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.073757,-0.30334,-0.28429,0,0
1,GO GLYCINE TRANSPORT,0.088413,-0.30383,-0.27042,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.090686,-0.3048,-0.32866,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.16068,-0.30779,-0.18642,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.037792,-0.30831,-0.25462,0,0
1,GO FEVER GENERATION,0.14347,-0.31082,-0.00064739,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.033564,-0.31338,-0.19621,0,0
1,GO ACTIN CROSSLINK FORMATION,0.28658,-0.31357,-0.1266,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.11333,-0.31591,-0.32587,0,0
1,GO HEART FIELD SPECIFICATION,0.11892,-0.32119,-0.26787,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.1402,-0.32369,-0.19405,0,0
1,GO GDP METABOLIC PROCESS,0.062834,-0.32559,-0.30684,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.073757,-0.32673,-0.26857,0,0
1,GO HEART FORMATION,0.032572,-0.32922,-0.26281,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.044978,-0.33192,-0.31551,0,0
1,GO FORELIMB MORPHOGENESIS,0.036694,-0.33216,-0.22799,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.031606,-0.33258,-0.27418,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.04007,-0.33382,-0.43765,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.1643,-0.33391,-0.14967,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.053284,-0.33506,-0.23278,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.090686,-0.34186,-0.33851,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.13384,-0.34342,-0.28158,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.086186,-0.34919,-0.2473,0,0
1,GO TOXIN METABOLIC PROCESS,0.038917,-0.35405,-0.30616,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.21712,-0.35619,-0.25616,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.13074,-0.36465,-0.31536,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.043706,-0.36857,-0.27466,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.041252,-0.36958,-0.29517,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.13384,-0.37348,-0.26988,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.31468,-0.37359,-0.13197,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.035624,-0.37623,-0.36135,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.21267,-0.38878,-0.22318,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.050383,-0.39185,-0.33807,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.056323,-0.39537,-0.41616,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.043706,-0.40533,-0.36329,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.064555,-0.42509,-0.28941,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.13074,-0.42859,-0.43173,0,0
1,GO MAST CELL MIGRATION,0.071835,-0.44813,-0.37346,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.046281,-0.45921,-0.31101,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.17173,-0.46904,-0.2283,0,0
1,GO CARDIAC CHAMBER FORMATION,0.093006,-0.47906,-0.43651,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.041252,-0.49698,-0.44085,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.10794,-0.50421,-0.29959,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.033564,-0.55574,-0.52551,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.041252,-0.61383,-0.44894,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.26023,-0.64582,-0.38923,0,0
1,GO REGULATION OF HEAT GENERATION,0.033564,-0.69891,-0.41955,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.0013889,1.9428,1.3719,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,0.00013838,1.2385,1.0497,1,1
2,GO CELLULAR RESPONSE TO ZINC ION,0.001448,1.1883,0.89969,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00024585,0.97077,0.87314,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00024585,0.96578,0.89196,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00035669,0.87598,0.79772,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,9.8065e-05,0.8588,0.82233,1,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.0019312,0.85442,0.74844,1,1
2,GO ACTIN FILAMENT SEVERING,0.00011949,0.84121,0.7939,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00046881,0.82001,0.69368,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00011376,0.81686,0.71284,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.00037344,0.80283,0.8076,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,8.4434e-05,0.77123,0.77389,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,9.8065e-05,0.76158,0.72536,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00028296,0.75379,0.67129,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00090875,0.74202,0.67874,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00053648,0.71029,0.65917,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.0071194,0.69373,0.58949,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059338,0.67925,0.52959,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00053648,0.67247,0.52786,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0017799,0.67154,0.61574,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00016797,0.66374,0.56948,1,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.0009903,0.65991,0.56913,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.8065e-05,0.65188,0.62699,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012773,0.64502,0.59786,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0049293,0.64405,0.48471,1,1
2,GO ZINC ION HOMEOSTASIS,0.00090875,0.64219,0.57544,1,1
2,GO PENTOSE METABOLIC PROCESS,0.00044809,0.63909,0.51062,1,1
2,GO PROSTANOID METABOLIC PROCESS,0.00031055,0.63629,0.61516,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0033675,0.63574,0.55282,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0063849,0.63308,0.49942,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00023453,0.63134,0.60578,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.00021334,0.62489,0.63103,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00058654,0.62448,0.52416,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00042822,0.61304,0.45655,1,1
2,GO MYOBLAST MIGRATION,0.0174,0.61214,0.51829,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0085133,0.60372,0.50817,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0012247,0.59804,0.55401,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.023222,0.58274,0.36131,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,8.4434e-05,0.5762,0.52794,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0002237,0.56939,0.5287,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.01857,0.56315,0.37986,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00017625,0.55586,0.52727,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011648,0.55467,0.37282,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0011254,0.55207,0.52799,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.001448,0.54934,0.47823,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.012053,0.54709,0.3694,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00066983,0.54334,0.47522,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00087036,0.54241,0.54041,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0040811,0.54133,0.48519,1,1
2,GO RESPONSE TO COPPER ION,0.0045725,0.54041,0.47088,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.012053,0.5357,0.51831,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0027694,0.52754,0.44809,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.011648,0.52038,0.47856,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0042393,0.51561,0.38533,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.027983,0.51496,0.37504,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.016296,0.51255,0.49893,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.020453,0.51223,0.4171,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0017799,0.50258,0.37471,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0013321,0.5016,0.46795,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0037806,0.49984,0.42294,1,1
2,GO NEPHRON TUBULE FORMATION,0.0009903,0.49623,0.48483,1,1
2,GO ALDITOL METABOLIC PROCESS,0.0020943,0.49614,0.40521,1,1
2,GO RESPONSE TO CADMIUM ION,0.00044809,0.49556,0.45847,1,1
2,GO MICROVILLUS ORGANIZATION,0.010505,0.49485,0.459,1,1
2,GO LIPID DROPLET FORMATION,0.0059338,0.48999,0.51378,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0039282,0.48763,0.49057,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0063849,0.47828,0.48864,1,1
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.005311,0.47738,0.39497,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00039093,0.47579,0.4483,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0068665,0.4749,0.38247,1,1
2,GO PORE COMPLEX ASSEMBLY,0.00011949,0.47463,0.44183,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.01684,0.47377,0.35427,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00039093,0.47371,0.52195,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00013838,0.47051,0.43791,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0013889,0.46673,0.42157,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0013889,0.46566,0.43876,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.016296,0.46404,0.35146,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.0022699,0.45712,0.44138,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.019808,0.45478,0.39818,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0088198,0.4486,0.33091,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,5.3491e-05,0.44719,0.43702,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00061317,0.44716,0.4381,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.0063849,0.44513,0.36671,1,1
2,GO REGULATION OF CELL PROJECTION SIZE,0.0063849,0.44312,0.44447,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0010786,0.44169,0.42427,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00083347,0.43656,0.36777,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.028854,0.43627,0.37787,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.0013889,0.43482,0.34536,1,1
2,GO MICROVILLUS ASSEMBLY,0.015254,0.43368,0.40034,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0033675,0.42893,0.36511,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00046881,0.42651,0.43067,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.011648,0.42586,0.59359,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.021799,0.42418,0.50564,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0082164,0.42379,0.42092,1,1
2,GO AMP METABOLIC PROCESS,0.0017084,0.41848,0.40167,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.029747,0.41733,0.33212,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0076503,0.41651,0.42804,1,1
2,GO GASTRIC ACID SECRETION,0.0015095,0.41082,0.34152,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.00083347,0.41027,0.37594,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00051298,0.40904,0.40239,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00064092,0.40855,0.37123,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.00076401,0.40792,0.40225,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0029959,0.40665,0.31953,1,1
2,GO FEVER GENERATION,0.02631,0.40644,0.27865,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0079288,0.40308,0.29457,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00087036,0.40256,0.36638,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00053648,0.40155,0.37569,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.0017799,0.39952,0.35227,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.0026621,0.39944,0.37104,1,1
2,GO DETOXIFICATION,0.00053648,0.39679,0.35971,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.0020112,0.39586,0.4361,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0073805,0.39215,0.34471,1,1
2,GO REGULATION OF DNA METHYLATION,0.0049293,0.38729,0.27634,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00094871,0.3865,0.40153,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.00039093,0.38573,0.36627,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.017977,0.38529,0.30649,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0026621,0.38368,0.32813,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.0063849,0.38261,0.32466,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00053648,0.37958,0.36716,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0024588,0.37257,0.32015,1,1
2,GO IMP METABOLIC PROCESS,0.023222,0.36812,0.2765,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0020943,0.36751,0.29442,1,1
2,GO CARNITINE SHUTTLE,0.0015733,0.36662,0.36265,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.010505,0.36497,0.28195,1,1
2,GO RESPONSE TO ZINC ION,0.0129,0.3641,0.33627,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.022501,0.36394,0.34234,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0061556,0.36348,0.34549,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0017799,0.3617,0.30364,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0042393,0.36147,0.27491,1,1
2,GO TRANSLATIONAL TERMINATION,0.0031154,0.36088,0.30254,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0017084,0.36082,0.36104,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0033675,0.35905,0.35607,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0040811,0.35584,0.28714,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0032392,0.3548,0.32081,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.0021804,0.35441,0.31323,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0066217,0.35298,0.27417,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00042822,0.35125,0.34176,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0020112,0.35052,0.34774,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00019396,0.34947,0.34611,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0033675,0.34911,0.32284,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.00061317,0.34824,0.50631,1,1
2,GO NUCLEAR PORE ORGANIZATION,0.0009903,0.34733,0.38738,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.0076503,0.34576,0.27354,1,1
2,GO PLATELET MORPHOGENESIS,0.0027694,0.34543,0.28105,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.010146,0.3453,0.30387,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0020943,0.34413,0.36123,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.015254,0.34366,0.27094,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0001255,0.34326,0.33575,1,1
2,GO MATURATION OF SSU RRNA,0.0057193,0.34323,0.32067,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.0028806,0.34058,0.29765,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0091361,0.33987,0.22952,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011741,0.33862,0.29797,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00046881,0.33653,0.36035,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0037806,0.33635,0.31858,1,1
2,GO GTP METABOLIC PROCESS,0.0045725,0.33556,0.33178,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.010874,0.335,0.35731,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0066217,0.33474,0.30087,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00017625,0.33361,0.31564,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0085133,0.33321,0.28271,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0129,0.33276,0.28058,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.00039093,0.33181,0.3202,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0051169,0.33156,0.31089,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0049293,0.33094,0.32962,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0015095,0.32972,0.33832,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00034064,0.32922,0.32002,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0045725,0.32852,0.26034,1,1
2,GO CYTOPLASM ORGANIZATION,0.016296,0.32843,0.29112,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0073805,0.32641,0.31537,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00069995,0.32631,0.32951,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0032392,0.32548,0.31384,1,1
2,GO RNA DECAPPING,0.011255,0.32476,0.20461,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.014755,0.32382,0.23244,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.0031154,0.32355,0.25254,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0028806,0.32319,0.2909,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.01427,0.32295,0.35623,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0076503,0.32223,0.24601,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0068665,0.3217,0.31319,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.005311,0.32076,0.27093,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.0033675,0.31861,0.30475,1,1
2,GO MONOCYTE CHEMOTAXIS,0.0037806,0.31844,0.34016,1,1
2,GO ARACHIDONIC ACID SECRETION,0.005311,0.31824,0.31417,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.0029959,0.31809,0.26958,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0047478,0.31687,0.25656,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0013321,0.31641,0.29165,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.027983,0.31452,0.21451,1,1
2,GO VIRAL TRANSLATION,0.0068665,0.31432,0.30985,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0076503,0.31245,0.30787,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.014755,0.3107,0.26922,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0020112,0.30947,0.24201,1,1
2,GO OVULATION,0.0091361,0.30799,0.30124,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0039282,0.30764,0.25969,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.028854,0.30735,0.23023,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.01427,0.30654,0.23977,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.004403,0.30556,0.25759,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00044809,0.30288,0.28749,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00058654,0.30287,0.32518,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.024724,0.30154,0.21854,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0094624,0.30104,0.27604,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0031154,0.30064,0.29151,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,0.0012247,0.30056,0.2852,1,1
2,GO RNA 5 END PROCESSING,0.0037806,0.30049,0.26998,1,1
2,GO NAD BIOSYNTHETIC PROCESS,0.0082164,0.29913,0.2746,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0073805,0.29826,0.23587,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0051169,0.29731,0.27104,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.011648,0.29728,0.26234,1,1
2,GO RIG I SIGNALING PATHWAY,0.00058654,0.29707,0.31819,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0055117,0.29561,0.25465,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0010336,0.29528,0.29144,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.017977,0.29443,0.22577,1,1
2,GO HISTONE H3 K9 ACETYLATION,0.00069995,0.29413,0.27058,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.0057193,0.29342,0.29436,1,1
2,GO MONONUCLEAR CELL MIGRATION,0.0040811,0.29321,0.29736,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.010146,0.29301,0.30338,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0055117,0.29226,0.21131,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0055117,0.29183,0.2435,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.023222,0.29161,0.21275,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00094871,0.29096,0.27917,1,1
2,GO MRNA MODIFICATION,0.0039282,0.29005,0.24317,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0040811,0.28978,0.23845,1,1
2,GO MATURATION OF 5 8S RRNA,0.0076503,0.28916,0.31427,1,1
2,GO NAD METABOLIC PROCESS,0.011255,0.289,0.27174,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0063849,0.28787,0.19649,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.0091361,0.28781,0.25448,1,1
2,GO INTESTINAL ABSORPTION,0.011255,0.28774,0.25698,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00076401,0.28735,0.27855,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0012247,0.28625,0.26169,1,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0068665,0.28514,0.30246,1,1
2,GO GMP METABOLIC PROCESS,0.0018542,0.28385,0.3124,1,1
2,GO TRNA METHYLATION,0.0059338,0.28371,0.22957,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.010146,0.28316,0.27774,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0039282,0.282,0.31029,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0021804,0.27923,0.24131,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0138,0.27917,0.31645,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0097991,0.2786,0.24138,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0091361,0.27854,0.21662,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0036381,0.27827,0.27235,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0022699,0.27812,0.25191,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0057193,0.27746,0.27726,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.010874,0.27617,0.27015,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.010505,0.27575,0.21287,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0085133,0.27391,0.27317,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0026621,0.27299,0.23825,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00058654,0.27215,0.29962,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01247,0.27165,0.27106,1,1
2,GO CHROMATIN DISASSEMBLY,0.0082164,0.26947,0.24339,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0025586,0.26845,0.23664,1,1
2,GO THIOESTER METABOLIC PROCESS,0.021117,0.26755,0.24596,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0011741,0.26711,0.26635,1,1
2,GO MIRNA METABOLIC PROCESS,0.00094871,0.26689,0.2227,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0129,0.26568,0.18581,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001448,0.26535,0.22168,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.01857,0.26206,0.25946,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0042393,0.26133,0.23387,1,1
2,GO TRNA PROCESSING,0.0026621,0.26105,0.21021,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0035004,0.26073,0.22857,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0082164,0.26058,0.24173,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.01857,0.26057,0.19742,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0040811,0.25833,0.26753,1,1
2,GO CELL REDOX HOMEOSTASIS,0.0091361,0.25763,0.22162,1,1
2,GO NEGATIVE T CELL SELECTION,0.01247,0.25634,0.16856,1,1
2,GO TRNA METABOLIC PROCESS,0.0020112,0.25556,0.21804,1,1
2,GO NECROTIC CELL DEATH,0.0091361,0.25545,0.24613,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0063849,0.25466,0.23713,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.015767,0.25365,0.23496,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0129,0.25267,0.21633,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0082164,0.25142,0.26495,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.00056099,0.25138,0.34106,1,1
2,GO TRANSLATIONAL ELONGATION,0.0079288,0.25028,0.24459,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0010786,0.25016,0.25807,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.025507,0.24949,0.18584,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010146,0.24891,0.21566,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0057193,0.24845,0.23616,1,1
2,GO THYMUS DEVELOPMENT,0.0017084,0.24729,0.25797,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0037806,0.24687,0.27237,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.023222,0.24653,0.20888,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.01918,0.24644,0.20954,1,1
2,GO RNA STABILIZATION,0.00083347,0.24641,0.23331,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0047478,0.24605,0.22826,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.023963,0.24569,0.24615,1,1
2,GO ACTIN NUCLEATION,0.0028806,0.24478,0.22349,1,1
2,GO RIBOSOME BIOGENESIS,0.0063849,0.24449,0.24307,1,1
2,GO BLASTOCYST FORMATION,0.0010336,0.24418,0.25752,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.014755,0.24384,0.2606,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0021804,0.24354,0.2019,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.0037806,0.24319,0.21012,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00037344,0.2426,0.23498,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00037344,0.242,0.25516,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.029747,0.24135,0.18815,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0085133,0.24116,0.2249,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0071194,0.24089,0.24777,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0024588,0.24085,0.23153,1,1
2,GO RNA POLYADENYLATION,0.00069995,0.24027,0.21852,1,1
2,GO RESPONSE TO SALT,0.023222,0.24,0.25409,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0039282,0.23972,0.20687,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0027694,0.23957,0.23453,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.0091361,0.23936,0.22071,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0076503,0.23863,0.24832,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.0009903,0.23728,0.2154,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.022501,0.23608,0.23222,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0039282,0.23603,0.26085,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.0047478,0.23384,0.21497,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0036381,0.23288,0.23259,1,1
2,GO POLYOL METABOLIC PROCESS,0.0028806,0.23068,0.20568,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0018542,0.23059,0.22017,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0028806,0.23015,0.2296,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0097991,0.22983,0.18913,1,1
2,GO RESPONSE TO MANGANESE ION,0.019808,0.22825,0.24327,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0036381,0.22651,0.22599,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.015254,0.22608,0.2697,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0049293,0.22587,0.21965,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0174,0.22572,0.1756,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0068665,0.2254,0.17521,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0071194,0.22516,0.16459,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.004403,0.2246,0.18926,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.0174,0.22409,0.18789,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.015767,0.2231,0.1715,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.017977,0.22276,0.22616,1,1
2,GO HISTONE DEUBIQUITINATION,0.00061317,0.22217,0.20258,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0063849,0.22145,0.19043,1,1
2,GO B CELL HOMEOSTASIS,0.0066217,0.22105,0.20299,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.015767,0.22036,0.24024,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.027136,0.21959,0.13902,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0012247,0.2194,0.19415,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.011255,0.21914,0.2044,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.025507,0.21889,0.21246,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0013321,0.21847,0.20257,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0051169,0.21835,0.1908,1,1
2,GO BASE EXCISION REPAIR,0.0020112,0.21752,0.20283,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.015767,0.21402,0.15649,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0061556,0.21252,0.19868,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00087036,0.2123,0.20302,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0024588,0.21056,0.1837,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.005311,0.21024,0.22541,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0068665,0.20973,0.18777,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.013344,0.2092,0.18399,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.010874,0.20889,0.22284,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0088198,0.20878,0.19589,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.01918,0.20805,0.15964,1,1
2,GO NIK NF KAPPAB SIGNALING,0.012053,0.2076,0.17891,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0021804,0.20687,0.19678,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.025507,0.20675,0.16794,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.022501,0.20633,0.205,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.0015095,0.20631,0.19379,1,1
2,GO GOLGI RIBBON FORMATION,0.0138,0.20586,0.1721,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0017799,0.20567,0.181,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0019312,0.20415,0.17154,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0025586,0.20252,0.20797,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.016296,0.20251,0.17414,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.0042393,0.2013,0.22195,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0088198,0.20038,0.18786,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.004403,0.19992,0.18654,1,1
2,GO PHOTOPERIODISM,0.0040811,0.19917,0.2098,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0174,0.19855,0.15611,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0011254,0.19718,0.19869,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.027983,0.19679,0.13763,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0045725,0.19588,0.20045,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015767,0.19383,0.14565,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0013889,0.19374,0.17354,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0045725,0.19369,0.19663,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0024588,0.19317,0.16249,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.013344,0.19227,0.16034,1,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0068665,0.19167,0.18374,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.010146,0.18979,0.14982,1,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.01857,0.18799,0.13953,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.01427,0.18705,0.15328,1,1
2,GO TRNA TRANSPORT,0.0016396,0.18655,0.24885,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0039282,0.18645,0.21309,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0033675,0.18621,0.23838,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.01918,0.18482,0.30006,1,1
2,GO MRNA TRANSCRIPTION,0.027983,0.18331,0.1681,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0091361,0.18242,0.17972,1,1
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.027136,0.18215,0.16502,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.011255,0.18192,0.1683,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0129,0.18087,0.17288,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0071194,0.17943,0.17664,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0079288,0.1794,0.15869,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.0017799,0.17879,0.18579,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.005311,0.17822,0.14209,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.021117,0.17793,0.21184,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0023626,0.1772,0.20047,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.0055117,0.1767,0.18211,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.025507,0.17616,0.1259,1,1
2,GO RNA CATABOLIC PROCESS,0.0032392,0.17521,0.1714,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.024724,0.17452,0.1463,1,1
2,GO GOLGI VESICLE BUDDING,0.017977,0.17081,0.11331,1,1
2,GO FATTY ACID TRANSPORT,0.015767,0.17033,0.15093,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.023963,0.16807,0.17796,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0049293,0.16719,0.17475,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0129,0.16697,0.13271,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0129,0.16671,0.15559,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023963,0.16638,0.13318,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.011255,0.16616,0.15307,1,1
2,GO DIGESTION,0.024724,0.16373,0.1393,1,1
2,GO OXIDATIVE DEMETHYLATION,0.0027694,0.16265,0.16961,1,1
2,GO MRNA CLEAVAGE,0.00090875,0.16243,0.18043,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.013344,0.1624,0.147,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.025507,0.16138,0.13168,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.023222,0.16022,0.12292,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.023963,0.15719,0.13375,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0073805,0.15682,0.15358,1,1
2,GO RNA PROCESSING,0.0027694,0.15636,0.14948,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.017977,0.15563,0.13335,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.010505,0.15562,0.13018,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.019808,0.15395,0.13337,1,1
2,GO OXIDATION REDUCTION PROCESS,0.020453,0.15227,0.13855,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0032392,0.15215,0.19252,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.017977,0.15167,0.19483,1,1
2,GO COPII COATED VESICLE BUDDING,0.019808,0.15104,0.11398,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0085133,0.15019,0.13723,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0016396,0.1495,0.16484,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0037806,0.1478,0.16104,1,1
2,GO PROTEIN SUMOYLATION,0.0011741,0.14775,0.14108,1,1
2,GO MITOCHONDRIAL TRANSPORT,0.0066217,0.14756,0.13888,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0094624,0.14448,0.1298,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0029959,0.14272,0.178,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0129,0.14262,0.14982,1,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.025507,0.1419,0.18446,1,1
2,GO MRNA METABOLIC PROCESS,0.0021804,0.14185,0.14364,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.01427,0.14113,0.14213,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.01918,0.13917,0.16614,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.019808,0.13862,0.18073,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.014755,0.13832,0.10944,1,1
2,GO DNA GEOMETRIC CHANGE,0.00079804,0.13818,0.16033,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.0097991,0.13775,0.12524,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0049293,0.13645,0.12751,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0020943,0.13583,0.16964,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.01684,0.13541,0.13886,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0039282,0.13506,0.14426,1,1
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.023222,0.13378,0.11501,1,1
2,GO RNA SPLICING,0.0071194,0.13108,0.12277,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0174,0.13058,0.11397,1,1
2,GO MRNA 3 END PROCESSING,0.0027694,0.13052,0.15128,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.029747,0.13044,0.11913,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.014755,0.13031,0.11323,1,1
2,GO GENE SILENCING,0.0012773,0.13021,0.12496,1,1
2,GO TELOMERE ORGANIZATION,0.017977,0.12963,0.12113,1,1
2,GO MRNA PROCESSING,0.0063849,0.12732,0.11582,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011741,0.12682,0.13244,1,1
2,GO ORGANELLE INHERITANCE,0.02631,0.12536,0.10777,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0010786,0.12085,0.12429,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.010874,0.1204,0.092902,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0036381,0.12004,0.11275,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.011255,0.11979,0.10494,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.021799,0.11899,0.12146,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.027136,0.11623,0.13821,1,1
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.010146,0.11437,0.12336,1,1
2,GO REGULATION OF PROTEIN ACETYLATION,0.012053,0.11335,0.10858,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.0085133,0.11273,0.14387,1,1
2,GO MRNA TRANSPORT,0.011648,0.11104,0.12986,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0094624,0.10908,0.13773,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0036381,0.10871,0.12346,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.013344,0.10732,0.10347,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.015254,0.10337,0.11814,1,1
2,GO DNA CONFORMATION CHANGE,0.010146,0.092725,0.09002,1,1
2,GO CHROMATIN REMODELING,0.0045725,0.089255,0.11414,1,1
2,GO DNA MODIFICATION,0.0079288,0.084066,0.09804,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0042393,0.077602,0.076262,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.027983,0.074366,0.079573,1,1
2,GO DNA REPAIR,0.0174,0.053173,0.066964,1,1
2,GO ETHANOL OXIDATION,0.00056099,0.86794,0.84983,1,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.016296,0.68997,0.49778,1,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00046881,0.66982,0.57064,1,0
2,GO OXYGEN TRANSPORT,0.029747,0.63971,0.61295,1,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.0097991,0.63603,0.47154,1,0
2,GO BIOLOGICAL PHASE,0.0020943,0.63504,0.62125,1,0
2,GO RESPONSE TO INTERLEUKIN 18,0.01918,0.61145,0.43821,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.028854,0.59429,0.40377,1,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.015767,0.5879,0.41726,1,0
2,GO PROSTATE GLAND GROWTH,0.0022699,0.57682,0.44766,1,0
2,GO HAIR FOLLICLE MATURATION,0.00046881,0.55868,0.49372,1,0
2,GO MUCUS SECRETION,0.01918,0.55681,0.59407,1,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0061556,0.54831,0.4064,1,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.0040811,0.5412,0.4914,1,0
2,GO ETHER METABOLIC PROCESS,0.00049043,0.52264,0.53394,1,0
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0051169,0.51675,0.45254,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.00064092,0.51497,0.50115,1,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0085133,0.51418,0.43994,1,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.00016006,0.5107,0.54687,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.025507,0.49408,0.38349,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.012053,0.49315,0.3994,1,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0039282,0.49142,0.38714,1,0
2,GO OTIC VESICLE DEVELOPMENT,0.0017084,0.48572,0.51313,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0026621,0.4778,0.45035,1,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0076503,0.47543,0.41908,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0097991,0.45538,0.33857,1,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0094624,0.45388,0.41046,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.01427,0.45081,0.33066,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0079288,0.4468,0.47,1,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.01427,0.44647,0.61263,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.0068665,0.44352,0.49002,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0011741,0.44048,0.42101,1,0
2,GO ETHANOL METABOLIC PROCESS,0.0020112,0.43807,0.46465,1,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0082164,0.43511,0.36201,1,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.0013889,0.41669,0.40972,1,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0174,0.40185,0.38775,1,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.013344,0.39088,0.32117,1,0
2,GO HEME METABOLIC PROCESS,0.010505,0.38865,0.32856,1,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0129,0.38807,0.31058,1,0
2,GO DENDRITIC CELL MIGRATION,0.004403,0.38387,0.3816,1,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0082164,0.3817,0.33842,1,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0031154,0.38097,0.37061,1,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0027694,0.38001,0.4597,1,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.0028806,0.37846,0.32338,1,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.017977,0.37635,0.27845,1,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0097991,0.37568,0.27828,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.02631,0.37165,0.24512,1,0
2,GO NEURAL CREST FORMATION,0.013344,0.36589,0.30171,1,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.012053,0.36359,0.28981,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.012053,0.35988,0.31123,1,0
2,GO CYSTEINE METABOLIC PROCESS,0.028854,0.35851,0.31576,1,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.019808,0.3576,0.28289,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0035004,0.35145,0.2839,1,0
2,GO TYPE 2 IMMUNE RESPONSE,0.010505,0.34658,0.25236,1,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.014755,0.34655,0.2392,1,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.0085133,0.33946,0.34316,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.022501,0.33687,0.25493,1,0
2,GO MATURATION OF LSU RRNA,0.02631,0.33478,0.30135,1,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0024588,0.33474,0.27465,1,0
2,GO T CELL MEDIATED IMMUNITY,0.0174,0.3345,0.24457,1,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.015254,0.33387,0.2845,1,0
2,GO OTIC VESICLE MORPHOGENESIS,0.014755,0.33382,0.38602,1,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.015254,0.33207,0.28265,1,0
2,GO TONGUE MORPHOGENESIS,0.027983,0.33071,0.35311,1,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.022501,0.32983,0.24671,1,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.023222,0.32869,0.26559,1,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0029959,0.3286,0.42064,1,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.0049293,0.32782,0.3263,1,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.01857,0.32596,0.3096,1,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.019808,0.32585,0.2338,1,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.01918,0.32301,0.28186,1,0
2,GO RENAL VESICLE DEVELOPMENT,0.0059338,0.31973,0.31939,1,0
2,GO PRE MIRNA PROCESSING,0.019808,0.31793,0.21806,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0066217,0.316,0.33462,1,0
2,GO AMINO ACID ACTIVATION,0.0033675,0.31564,0.29879,1,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0129,0.31388,0.2375,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.013344,0.30987,0.24846,1,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0082164,0.30881,0.31684,1,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0037806,0.3046,0.2921,1,0
2,GO REGULATION OF B CELL PROLIFERATION,0.0026621,0.30453,0.26951,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.020453,0.30422,0.23388,1,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.029747,0.30188,0.25489,1,0
2,GO TELOMERASE RNA LOCALIZATION,0.029747,0.3002,0.24236,1,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0022699,0.29958,0.24768,1,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.01918,0.29955,0.33444,1,0
2,GO RETINOL METABOLIC PROCESS,0.0091361,0.29734,0.27832,1,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0020943,0.29706,0.2794,1,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.01857,0.29594,0.22861,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.022501,0.29484,0.2485,1,0
2,GO INTERLEUKIN 2 PRODUCTION,0.0018542,0.28843,0.26793,1,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.0091361,0.28832,0.28292,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.020453,0.28799,0.24761,1,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.0013321,0.28739,0.25495,1,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0040811,0.28599,0.3422,1,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.015254,0.28598,0.34962,1,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.010505,0.28567,0.25458,1,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.024724,0.28558,0.23128,1,0
2,GO FIBROBLAST ACTIVATION,0.0035004,0.28535,0.26287,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.005311,0.2834,0.29266,1,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.027136,0.28222,0.30942,1,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.00046881,0.28167,0.24386,1,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0012773,0.28094,0.31155,1,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.01857,0.27989,0.24531,1,0
2,GO RIBOSOME ASSEMBLY,0.029747,0.27876,0.2391,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0039282,0.27787,0.28119,1,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.025507,0.27282,0.20719,1,0
2,GO REGULATION OF LIPASE ACTIVITY,0.0049293,0.27195,0.20982,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.011255,0.27145,0.24771,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.019808,0.27109,0.218,1,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0020943,0.27044,0.32818,1,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.010874,0.27013,0.2361,1,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.01918,0.26855,0.22808,1,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0031154,0.26785,0.25152,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.010146,0.26703,0.32716,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.027983,0.26631,0.24762,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.027136,0.2642,0.17612,1,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0071194,0.26189,0.28089,1,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.02631,0.26136,0.20387,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.01427,0.25916,0.19286,1,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0036381,0.25895,0.2919,1,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0088198,0.25668,0.21942,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.021117,0.25527,0.31202,1,0
2,GO VIRAL GENE EXPRESSION,0.013344,0.25337,0.23416,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.02631,0.25211,0.25426,1,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.017977,0.25078,0.21143,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0063849,0.24902,0.28383,1,0
2,GO AEROBIC RESPIRATION,0.0055117,0.24881,0.25893,1,0
2,GO B CELL PROLIFERATION,0.0028806,0.24695,0.23443,1,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.012053,0.24641,0.20185,1,0
2,GO LAMELLIPODIUM ORGANIZATION,0.00049043,0.24546,0.27873,1,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.015254,0.24505,0.35313,1,0
2,GO RESPONSE TO INTERLEUKIN 15,0.0057193,0.24252,0.26483,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.025507,0.24053,0.18544,1,0
2,GO NADP METABOLIC PROCESS,0.01427,0.23947,0.24102,1,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0057193,0.23828,0.2164,1,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.011648,0.23688,0.24908,1,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.016296,0.2363,0.17972,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.016296,0.23617,0.27467,1,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.02631,0.23606,0.22561,1,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.029747,0.23533,0.16245,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.021799,0.23525,0.16565,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.029747,0.23518,0.2037,1,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0082164,0.23482,0.2113,1,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.0061556,0.23319,0.18431,1,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.021117,0.23317,0.20161,1,0
2,GO TRNA 5 LEADER REMOVAL,0.0068665,0.23191,0.26638,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.016296,0.23126,0.25993,1,0
2,GO RESPONSE TO X RAY,0.015767,0.23011,0.18737,1,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.02631,0.229,0.18175,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.019808,0.22878,0.1754,1,0
2,GO HISTONE H4 DEACETYLATION,0.005311,0.22849,0.25361,1,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0097991,0.22836,0.29105,1,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0097991,0.22823,0.21854,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.025507,0.22803,0.25896,1,0
2,GO RRNA METABOLIC PROCESS,0.0061556,0.22637,0.22577,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0138,0.22567,0.16436,1,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.010505,0.22402,0.2165,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.01427,0.22332,0.25196,1,0
2,GO CELLULAR RESPONSE TO DRUG,0.025507,0.22121,0.16004,1,0
2,GO NCRNA PROCESSING,0.0073805,0.22118,0.21247,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.02631,0.22113,0.19937,1,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.029747,0.22012,0.21789,1,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.020453,0.21999,0.19134,1,0
2,GO RESPONSE TO INTERLEUKIN 7,0.011255,0.21948,0.17855,1,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.0174,0.21851,0.19624,1,0
2,GO RRNA MODIFICATION,0.0085133,0.21777,0.23619,1,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.01427,0.21635,0.28405,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0094624,0.21609,0.1642,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.021117,0.21515,0.18584,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0174,0.21496,0.22597,1,0
2,GO B CELL APOPTOTIC PROCESS,0.01684,0.21381,0.21079,1,0
2,GO RNA INTERFERENCE,0.0037806,0.21381,0.27749,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0051169,0.2138,0.18995,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.01918,0.21367,0.38727,1,0
2,GO RESPONSE TO INTERLEUKIN 12,0.0174,0.21297,0.20986,1,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.023963,0.21262,0.17313,1,0
2,GO TRNA MODIFICATION,0.0094624,0.21239,0.17329,1,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0085133,0.20882,0.18236,1,0
2,GO NCRNA METABOLIC PROCESS,0.0051169,0.20631,0.2009,1,0
2,GO REGULATION OF PROTEIN IMPORT,0.0094624,0.20605,0.22704,1,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.015767,0.20557,0.24361,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.014755,0.20526,0.16626,1,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0045725,0.20503,0.22564,1,0
2,GO GOLGI LOCALIZATION,0.025507,0.20427,0.23214,1,0
2,GO REGULATION OF GENE SILENCING,0.0017084,0.20288,0.1804,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.015254,0.20234,0.22551,1,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0036381,0.2021,0.17116,1,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.029747,0.20137,0.30927,1,0
2,GO COBALAMIN METABOLIC PROCESS,0.010146,0.20125,0.18008,1,0
2,GO T CELL APOPTOTIC PROCESS,0.011648,0.2006,0.20275,1,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.024724,0.19965,0.33521,1,0
2,GO RNA MODIFICATION,0.0042393,0.19768,0.17354,1,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.010874,0.19641,0.20184,1,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.0073805,0.19636,0.1549,1,0
2,GO RESPONSE TO OXYGEN RADICAL,0.015767,0.19593,0.185,1,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.0026621,0.19579,0.23534,1,0
2,GO LEUKOCYTE PROLIFERATION,0.023222,0.19481,0.15235,1,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0097991,0.19435,0.19204,1,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.01918,0.19224,0.28445,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.01918,0.19119,0.16135,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.01684,0.191,0.15879,1,0
2,GO VESICLE CARGO LOADING,0.0061556,0.18998,0.223,1,0
2,GO RNA METHYLATION,0.0094624,0.18896,0.16184,1,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.028854,0.18892,0.22287,1,0
2,GO CELLULAR RESPIRATION,0.0094624,0.18853,0.21589,1,0
2,GO TRNA 5 END PROCESSING,0.0091361,0.18832,0.22521,1,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0174,0.1883,0.15841,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0036381,0.18689,0.15991,1,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0059338,0.18645,0.19399,1,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.01247,0.18347,0.15072,1,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0037806,0.18299,0.19511,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.022501,0.18262,0.15721,1,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02631,0.18176,0.12323,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0174,0.18135,0.19206,1,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.029747,0.18129,0.14127,1,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.011255,0.18043,0.16276,1,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.021799,0.17992,0.16925,1,0
2,GO ERBB SIGNALING PATHWAY,0.01857,0.1792,0.1565,1,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.015254,0.179,0.17883,1,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0097991,0.17863,0.15495,1,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0091361,0.17839,0.1843,1,0
2,GO LACTATION,0.024724,0.17805,0.16682,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.023222,0.17743,0.1939,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.027983,0.17597,0.1548,1,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.014755,0.17564,0.15181,1,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0129,0.17549,0.15403,1,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.010146,0.17533,0.19259,1,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.011255,0.17509,0.14969,1,0
2,GO T CELL CHEMOTAXIS,0.025507,0.17397,0.18262,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.011648,0.17322,0.21516,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.01918,0.1702,0.13833,1,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0045725,0.16804,0.17247,1,0
2,GO LAMELLIPODIUM ASSEMBLY,0.0018542,0.16714,0.22349,1,0
2,GO MULTI ORGANISM LOCALIZATION,0.017977,0.16649,0.13187,1,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0085133,0.16485,0.16951,1,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.0063849,0.16321,0.16425,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0082164,0.16081,0.19617,1,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.01427,0.16074,0.13553,1,0
2,GO STRESS GRANULE ASSEMBLY,0.0076503,0.15958,0.18913,1,0
2,GO PEPTIDE METABOLIC PROCESS,0.017977,0.1579,0.13384,1,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.023963,0.1555,0.13832,1,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.015254,0.15543,0.1587,1,0
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0059338,0.15478,0.18854,1,0
2,GO P BODY ASSEMBLY,0.0174,0.15159,0.13737,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.019808,0.15061,0.17774,1,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0031154,0.15015,0.1758,1,0
2,GO SYMBIOTIC PROCESS,0.01247,0.14781,0.13233,1,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.016296,0.14722,0.14069,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.022501,0.14486,0.14766,1,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0036381,0.14428,0.14163,1,0
2,GO HISTONE H3 K14 ACETYLATION,0.017977,0.14342,0.12104,1,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0032392,0.14102,0.13731,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.024724,0.14035,0.11663,1,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.011255,0.13935,0.1237,1,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.01427,0.13892,0.14138,1,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.023222,0.1388,0.11824,1,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.013344,0.13671,0.13398,1,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.015254,0.12956,0.18849,1,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0073805,0.12925,0.11234,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.012053,0.12912,0.11757,1,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.02631,0.12835,0.13956,1,0
2,GO INTERACTION WITH SYMBIONT,0.013344,0.1283,0.13989,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.021799,0.12781,0.13708,1,0
2,GO RNA 3 END PROCESSING,0.011255,0.12735,0.12431,1,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0138,0.12592,0.16882,1,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.029747,0.12416,0.11991,1,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.027983,0.12382,0.10128,1,0
2,GO RNA EXPORT FROM NUCLEUS,0.0049293,0.12116,0.15539,1,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.023963,0.1199,0.091678,1,0
2,GO RNA LOCALIZATION,0.0066217,0.11612,0.13538,1,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0071194,0.11602,0.12692,1,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.025507,0.11475,0.10276,1,0
2,GO DNA BIOSYNTHETIC PROCESS,0.027983,0.11375,0.081913,1,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.027136,0.11362,0.12951,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.01857,0.11244,0.11045,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.020453,0.11231,0.11501,1,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.025507,0.11089,0.11558,1,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.013344,0.1108,0.14265,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0024588,0.10938,0.12133,1,0
2,GO NUCLEAR EXPORT,0.0082164,0.10724,0.13606,1,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0094624,0.105,0.079805,1,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.023222,0.10249,0.079874,1,0
2,GO MITOCHONDRION ORGANIZATION,0.01684,0.10091,0.09878,1,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.011648,0.094035,0.099798,1,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.020453,0.087279,0.08821,1,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.027136,0.087235,0.070641,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01684,0.084747,0.070034,1,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0138,0.068945,0.078851,1,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.01918,0.066358,0.098617,1,0
2,GO METHYLATION,0.025507,0.052786,0.067266,1,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.010146,-0.067962,-0.14901,1,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.0040811,-0.078292,-0.11957,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.01918,-0.080136,-0.12934,1,0
2,GO POSITIVE REGULATION OF GROWTH,0.013344,-0.082114,-0.11553,1,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.022501,-0.086074,-0.11558,1,0
2,GO CELL GROWTH,0.029747,-0.086277,-0.11213,1,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0082164,-0.09118,-0.14037,1,0
2,GO CILIUM MOVEMENT,0.0076503,-0.091854,-0.1764,1,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.023963,-0.098318,-0.16629,1,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.0055117,-0.10016,-0.13833,1,0
2,GO REGULATION OF ANION TRANSPORT,0.010146,-0.10163,-0.16814,1,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0174,-0.10343,-0.16315,1,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.020453,-0.10855,-0.13049,1,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.019808,-0.10861,-0.11559,1,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.025507,-0.10925,-0.12748,1,0
2,GO CELL CELL SIGNALING,0.023222,-0.11163,-0.12643,1,0
2,GO MICROTUBULE BASED PROCESS,0.010146,-0.11365,-0.11378,1,0
2,GO NEURON PROJECTION GUIDANCE,0.0174,-0.11404,-0.18941,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.019808,-0.11423,-0.14542,1,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.010505,-0.11473,-0.16132,1,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.021117,-0.11488,-0.14457,1,0
2,GO GERM CELL DEVELOPMENT,0.0032392,-0.11785,-0.14903,1,0
2,GO REGULATION OF CELL DEVELOPMENT,0.0073805,-0.11928,-0.14724,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0051169,-0.11945,-0.13199,1,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.0057193,-0.1203,-0.14725,1,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.023963,-0.12091,-0.1443,1,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.01247,-0.12462,-0.15083,1,0
2,GO DEVELOPMENTAL CELL GROWTH,0.0082164,-0.12609,-0.18506,1,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.027983,-0.12743,-0.19219,1,0
2,GO CELL PROJECTION ORGANIZATION,0.011648,-0.12856,-0.13799,1,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.021799,-0.12956,-0.14834,1,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.021117,-0.13012,-0.13475,1,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.029747,-0.13199,-0.19104,1,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0061556,-0.13216,-0.14442,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0082164,-0.13272,-0.17771,1,0
2,GO ENDOTHELIUM DEVELOPMENT,0.029747,-0.13348,-0.17173,1,0
2,GO REGULATION OF AXONOGENESIS,0.0091361,-0.13464,-0.2249,1,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.027136,-0.13492,-0.13983,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.02631,-0.13512,-0.14741,1,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.010874,-0.13561,-0.16975,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0097991,-0.13666,-0.19701,1,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.017977,-0.13701,-0.19309,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.021799,-0.13718,-0.19132,1,0
2,GO TRANSPORT ALONG MICROTUBULE,0.005311,-0.13874,-0.15447,1,0
2,GO NEUROGENESIS,0.0066217,-0.13989,-0.15611,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0063849,-0.14017,-0.23406,1,0
2,GO MICROTUBULE BASED MOVEMENT,0.0012247,-0.14249,-0.16617,1,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.013344,-0.14484,-0.19182,1,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.01918,-0.14516,-0.21705,1,0
2,GO AXON DEVELOPMENT,0.01247,-0.14613,-0.19331,1,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.021117,-0.14669,-0.1268,1,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.028854,-0.14944,-0.19716,1,0
2,GO CELL MATURATION,0.02631,-0.15044,-0.1364,1,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.023963,-0.15051,-0.16342,1,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.014755,-0.15113,-0.14466,1,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.027983,-0.15135,-0.18016,1,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0033675,-0.15153,-0.16451,1,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.016296,-0.15238,-0.22363,1,0
2,GO RESPONSE TO CALCIUM ION,0.021117,-0.15262,-0.16588,1,0
2,GO MICROTUBULE BASED TRANSPORT,0.0018542,-0.15372,-0.17552,1,0
2,GO SPERMATID DIFFERENTIATION,0.0051169,-0.15374,-0.15638,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.01857,-0.15375,-0.21014,1,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.014755,-0.15394,-0.1801,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.01857,-0.15497,-0.1803,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0026621,-0.15551,-0.20423,1,0
2,GO SODIUM ION TRANSPORT,0.01247,-0.15609,-0.16344,1,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.021799,-0.1563,-0.1307,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.028854,-0.15678,-0.15848,1,0
2,GO PATTERN SPECIFICATION PROCESS,0.0088198,-0.15738,-0.14842,1,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.011255,-0.15869,-0.17148,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.027136,-0.15876,-0.18166,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.0097991,-0.15914,-0.18014,1,0
2,GO AMINO ACID TRANSPORT,0.0036381,-0.15954,-0.21982,1,0
2,GO REGULATION OF TUBE SIZE,0.010874,-0.1601,-0.16569,1,0
2,GO MEMBRANE DOCKING,0.00079804,-0.16099,-0.15536,1,0
2,GO MULTICELLULAR ORGANISM AGING,0.028854,-0.16166,-0.16573,1,0
2,GO REGULATION OF OOGENESIS,0.027136,-0.16182,-0.15908,1,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0068665,-0.16275,-0.15726,1,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.01918,-0.16352,-0.23758,1,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.0094624,-0.16397,-0.19197,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.017977,-0.16453,-0.34016,1,0
2,GO NEURON PROJECTION EXTENSION,0.0094624,-0.16557,-0.21132,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.025507,-0.1662,-0.20467,1,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.005311,-0.1663,-0.21144,1,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0037806,-0.16637,-0.16816,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.00064092,-0.16684,-0.20933,1,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.0063849,-0.16726,-0.20739,1,0
2,GO SIGNAL RELEASE,0.0174,-0.1676,-0.16134,1,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.021799,-0.16842,-0.1727,1,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.01427,-0.16844,-0.15568,1,0
2,GO HEAD DEVELOPMENT,0.0012773,-0.17014,-0.18459,1,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0051169,-0.17026,-0.21528,1,0
2,GO CELL PART MORPHOGENESIS,0.0085133,-0.17028,-0.18803,1,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.0042393,-0.17081,-0.20421,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0022699,-0.17095,-0.16577,1,0
2,GO MEMORY,0.010505,-0.17141,-0.21637,1,0
2,GO NEURON DIFFERENTIATION,0.0061556,-0.17146,-0.18152,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0033675,-0.17147,-0.19199,1,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.023222,-0.17187,-0.16449,1,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.021799,-0.1727,-0.16797,1,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.016296,-0.17302,-0.1839,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0057193,-0.17423,-0.18367,1,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0063849,-0.17788,-0.20913,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0073805,-0.17825,-0.18808,1,0
2,GO BEHAVIOR,0.0079288,-0.17842,-0.17919,1,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0174,-0.17848,-0.19976,1,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0097991,-0.17934,-0.15446,1,0
2,GO MICROTUBULE ANCHORING,0.022501,-0.17935,-0.14146,1,0
2,GO CILIUM ORGANIZATION,0.00066983,-0.17993,-0.19413,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0061556,-0.18135,-0.16997,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0020943,-0.18147,-0.23435,1,0
2,GO NEURON DEVELOPMENT,0.0049293,-0.18286,-0.19601,1,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.0138,-0.18315,-0.25492,1,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.024724,-0.18397,-0.21759,1,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0079288,-0.18409,-0.17806,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0082164,-0.18417,-0.18702,1,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.025507,-0.18541,-0.20704,1,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.01247,-0.1855,-0.20152,1,0
2,GO HINDBRAIN MORPHOGENESIS,0.010874,-0.18557,-0.20362,1,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.010505,-0.1858,-0.27698,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0042393,-0.18593,-0.21448,1,0
2,GO POTASSIUM ION TRANSPORT,0.0085133,-0.18655,-0.20795,1,0
2,GO DENDRITE DEVELOPMENT,0.021799,-0.1869,-0.17589,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.029747,-0.1891,-0.19796,1,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0061556,-0.18977,-0.2139,1,0
2,GO REGULATION OF GLUCOSE IMPORT,0.0068665,-0.18987,-0.18947,1,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0073805,-0.19075,-0.18283,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0013321,-0.1926,-0.20952,1,0
2,GO VESICLE DOCKING,0.01247,-0.19277,-0.23361,1,0
2,GO RESPONSE TO AXON INJURY,0.0033675,-0.19441,-0.23514,1,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.00042822,-0.19574,-0.24426,1,0
2,GO COGNITION,0.0088198,-0.19736,-0.20914,1,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.01684,-0.19748,-0.24249,1,0
2,GO REGULATION OF VASOCONSTRICTION,0.025507,-0.19753,-0.16202,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.023222,-0.19768,-0.17895,1,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.01684,-0.19768,-0.16183,1,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0025586,-0.19774,-0.19173,1,0
2,GO FIBROBLAST MIGRATION,0.027136,-0.19786,-0.1751,1,0
2,GO SPINAL CORD DEVELOPMENT,0.004403,-0.19892,-0.22007,1,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.023963,-0.19937,-0.19782,1,0
2,GO COCHLEA DEVELOPMENT,0.0051169,-0.19948,-0.22355,1,0
2,GO REGULATION OF FERTILIZATION,0.0017084,-0.1997,-0.27354,1,0
2,GO CELLULAR RESPONSE TO PH,0.0059338,-0.19994,-0.21129,1,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0088198,-0.2013,-0.21646,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.010505,-0.20196,-0.19859,1,0
2,GO BONE MATURATION,0.020453,-0.20296,-0.21836,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0023626,-0.20311,-0.23239,1,0
2,GO NEURON PROJECTION REGENERATION,0.0094624,-0.20317,-0.23074,1,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.005311,-0.2073,-0.23677,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.028854,-0.20741,-0.2293,1,0
2,GO HYALURONAN METABOLIC PROCESS,0.01857,-0.20746,-0.21946,1,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0079288,-0.20953,-0.20787,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0082164,-0.20965,-0.2654,1,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.01247,-0.21216,-0.26804,1,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0091361,-0.21416,-0.21485,1,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.02631,-0.21691,-0.25928,1,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.012053,-0.21822,-0.18155,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0063849,-0.2193,-0.21631,1,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.027136,-0.21932,-0.21128,1,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0017799,-0.22127,-0.25951,1,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0085133,-0.22171,-0.39088,1,0
2,GO ADULT HEART DEVELOPMENT,0.011648,-0.22283,-0.26182,1,0
2,GO PALLIUM DEVELOPMENT,0.0023626,-0.22288,-0.20165,1,0
2,GO RESPONSE TO FUNGUS,0.0129,-0.2238,-0.19377,1,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.024724,-0.22508,-0.28232,1,0
2,GO REGULATION OF DNA BINDING,0.005311,-0.22826,-0.17083,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.010146,-0.22905,-0.21566,1,0
2,GO MESENCHYME MORPHOGENESIS,0.013344,-0.23098,-0.26068,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.023222,-0.23113,-0.28262,1,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.011648,-0.23215,-0.17127,1,0
2,GO FOREBRAIN DEVELOPMENT,0.0011741,-0.23219,-0.21821,1,0
2,GO TELENCEPHALON DEVELOPMENT,0.0010336,-0.23592,-0.22742,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.0076503,-0.23808,-0.23542,1,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.012053,-0.23895,-0.2935,1,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.027983,-0.23972,-0.27334,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0024588,-0.24001,-0.23373,1,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.029747,-0.24132,-0.16618,1,0
2,GO DEVELOPMENTAL MATURATION,0.0049293,-0.24153,-0.20174,1,0
2,GO EXTRACELLULAR TRANSPORT,0.0085133,-0.24159,-0.25519,1,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.005311,-0.24225,-0.24222,1,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0076503,-0.24379,-0.24117,1,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014755,-0.24397,-0.27346,1,0
2,GO RESPONSE TO CATECHOLAMINE,0.0079288,-0.24402,-0.25728,1,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0032392,-0.24465,-0.31147,1,0
2,GO CALCIUM ION IMPORT,0.0011254,-0.24492,-0.28404,1,0
2,GO REGULATION OF NEURON MIGRATION,0.027983,-0.24779,-0.23435,1,0
2,GO SYNAPSE ASSEMBLY,0.021799,-0.24848,-0.20733,1,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.016296,-0.24897,-0.21067,1,0
2,GO MEMBRANE DEPOLARIZATION,0.013344,-0.25172,-0.27735,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.029747,-0.25237,-0.25373,1,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0063849,-0.25294,-0.22456,1,0
2,GO ACROSOME REACTION,0.0085133,-0.25384,-0.25077,1,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.015767,-0.25406,-0.24319,1,0
2,GO STRIATED MUSCLE ADAPTATION,0.0022699,-0.25534,-0.23752,1,0
2,GO SYNAPTIC SIGNALING,0.0045725,-0.25643,-0.25871,1,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0129,-0.25651,-0.23213,1,0
2,GO HINDBRAIN DEVELOPMENT,0.00044809,-0.25701,-0.28635,1,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.024724,-0.25889,-0.20471,1,0
2,GO CELL FATE DETERMINATION,0.0013889,-0.25975,-0.30918,1,0
2,GO REGULATION OF CILIUM MOVEMENT,0.00027004,-0.26029,-0.25561,1,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00087036,-0.26321,-0.26074,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0085133,-0.2658,-0.21613,1,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.00053648,-0.26689,-0.24641,1,0
2,GO NEURAL RETINA DEVELOPMENT,0.0082164,-0.26752,-0.26369,1,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.0017084,-0.26757,-0.22653,1,0
2,GO MICROTUBULE BUNDLE FORMATION,0.00019396,-0.26764,-0.3656,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.004403,-0.26797,-0.33371,1,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.016296,-0.26843,-0.22832,1,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.014755,-0.26878,-0.24259,1,0
2,GO SECRETORY GRANULE ORGANIZATION,0.00042822,-0.26889,-0.33957,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.011255,-0.26938,-0.35964,1,0
2,GO LOCOMOTORY BEHAVIOR,0.0049293,-0.26998,-0.26357,1,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0015095,-0.27011,-0.27447,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0024588,-0.27016,-0.29178,1,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0039282,-0.2704,-0.30946,1,0
2,GO NEURON MATURATION,0.028854,-0.2705,-0.21521,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0021804,-0.27123,-0.29663,1,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0017084,-0.2713,-0.31953,1,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.01427,-0.27257,-0.3659,1,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.0021804,-0.27259,-0.29704,1,0
2,GO FOREBRAIN CELL MIGRATION,0.0015733,-0.27353,-0.27092,1,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.028854,-0.27447,-0.22434,1,0
2,GO RESPONSE TO AMYLOID BETA,0.0085133,-0.27477,-0.25203,1,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.023222,-0.27501,-0.29302,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.001448,-0.27575,-0.30642,1,0
2,GO NEURON RECOGNITION,0.0068665,-0.27653,-0.33253,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.0047478,-0.27755,-0.23671,1,0
2,GO NOREPINEPHRINE TRANSPORT,0.0076503,-0.27871,-0.26997,1,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.01684,-0.28019,-0.27022,1,0
2,GO MALE MEIOSIS I,0.014755,-0.2802,-0.27929,1,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.016296,-0.28042,-0.28779,1,0
2,GO METENCEPHALON DEVELOPMENT,0.0011254,-0.28156,-0.30186,1,0
2,GO NERVE DEVELOPMENT,0.0010786,-0.28183,-0.33073,1,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0035004,-0.28275,-0.31734,1,0
2,GO ACROSOME ASSEMBLY,0.0068665,-0.28308,-0.2839,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.0091361,-0.28397,-0.37002,1,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.0020943,-0.28419,-0.30969,1,0
2,GO SECONDARY PALATE DEVELOPMENT,0.0174,-0.28449,-0.30908,1,0
2,GO PROTEIN PALMITOYLATION,0.010874,-0.28484,-0.23322,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.010874,-0.28659,-0.25502,1,0
2,GO REGULATION OF ACROSOME REACTION,0.0076503,-0.28797,-0.37438,1,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.017977,-0.28842,-0.33034,1,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.020453,-0.28846,-0.26031,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.011255,-0.28919,-0.342,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0035004,-0.29012,-0.36479,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0027694,-0.29046,-0.3129,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0129,-0.2908,-0.31425,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.0029959,-0.29083,-0.28028,1,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.0042393,-0.29128,-0.32594,1,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00021334,-0.29228,-0.32763,1,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0021804,-0.29241,-0.30939,1,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.027983,-0.29317,-0.28714,1,0
2,GO SKELETAL MUSCLE CONTRACTION,0.00053648,-0.29397,-0.31664,1,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0129,-0.29453,-0.36583,1,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.0018542,-0.29726,-0.27791,1,0
2,GO DIVALENT METAL ION EXPORT,0.0085133,-0.29811,-0.30688,1,0
2,GO RESPONSE TO DOPAMINE,0.0010786,-0.29887,-0.30797,1,0
2,GO NEUROBLAST PROLIFERATION,0.0020112,-0.30011,-0.2772,1,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0138,-0.30032,-0.29556,1,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.025507,-0.30185,-0.27778,1,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.022501,-0.30233,-0.27296,1,0
2,GO RESPONSE TO PH,0.0025586,-0.303,-0.28331,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.0016396,-0.3039,-0.30667,1,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.012053,-0.30565,-0.2579,1,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0025586,-0.30593,-0.30691,1,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0009903,-0.3061,-0.24993,1,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0021804,-0.30681,-0.39648,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00087036,-0.30768,-0.30691,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0051169,-0.30847,-0.31798,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0129,-0.3087,-0.30734,1,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.010874,-0.31142,-0.30132,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.0066217,-0.31282,-0.27439,1,0
2,GO RESPONSE TO FORSKOLIN,0.020453,-0.31329,-0.39204,1,0
2,GO RESPONSE TO MUSCLE STRETCH,0.0068665,-0.31397,-0.40339,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.0012247,-0.31466,-0.34629,1,0
2,GO COPULATION,0.0028806,-0.31469,-0.27515,1,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0049293,-0.31506,-0.28009,1,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.028854,-0.31882,-0.2861,1,0
2,GO EXOCYTIC PROCESS,0.013344,-0.31906,-0.25322,1,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.020453,-0.31974,-0.32541,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.01247,-0.32007,-0.32544,1,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00058654,-0.32022,-0.36704,1,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00087036,-0.32081,-0.32252,1,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.019808,-0.32103,-0.26081,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0094624,-0.32182,-0.46445,1,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.025507,-0.32279,-0.32094,1,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.01684,-0.32346,-0.29654,1,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0076503,-0.32439,-0.27218,1,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.010874,-0.32524,-0.29623,1,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.0059338,-0.32531,-0.27815,1,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.025507,-0.32714,-0.30659,1,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0088198,-0.32735,-0.392,1,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.01684,-0.32813,-0.32908,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.00046881,-0.3287,-0.32999,1,0
2,GO SYNAPTIC VESICLE RECYCLING,0.010505,-0.32876,-0.31888,1,0
2,GO ADULT BEHAVIOR,0.0032392,-0.32945,-0.28673,1,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00094871,-0.32949,-0.33642,1,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0024588,-0.33067,-0.35538,1,0
2,GO EXPLORATION BEHAVIOR,0.0011254,-0.33074,-0.47846,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0051169,-0.33095,-0.35594,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0042393,-0.33189,-0.43188,1,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.023222,-0.33202,-0.37097,1,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0037806,-0.3332,-0.33561,1,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.001448,-0.33343,-0.32443,1,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.005311,-0.33531,-0.31686,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.0033675,-0.33617,-0.37162,1,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.0021804,-0.33617,-0.35439,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.00079804,-0.33785,-0.33005,1,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.019808,-0.33825,-0.26992,1,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0028806,-0.3388,-0.33909,1,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0028806,-0.33955,-0.27518,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.01427,-0.33962,-0.39648,1,0
2,GO NOREPINEPHRINE SECRETION,0.0040811,-0.34036,-0.3842,1,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.0049293,-0.3415,-0.31145,1,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.029747,-0.34224,-0.25955,1,0
2,GO NEURON MIGRATION,0.0037806,-0.34241,-0.29835,1,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.020453,-0.34255,-0.33008,1,0
2,GO INTRACILIARY TRANSPORT,0.00064092,-0.34289,-0.37022,1,0
2,GO INSEMINATION,0.023222,-0.34292,-0.30939,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0057193,-0.34329,-0.31297,1,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0057193,-0.34353,-0.32002,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00090875,-0.34377,-0.32272,1,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.0026621,-0.34392,-0.36128,1,0
2,GO NEUROTRANSMITTER TRANSPORT,0.022501,-0.34394,-0.31436,1,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0033675,-0.34444,-0.29497,1,0
2,GO NEURONAL ACTION POTENTIAL,0.013344,-0.34474,-0.3671,1,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014755,-0.34602,-0.29323,1,0
2,GO NEURON PROJECTION ARBORIZATION,0.0033675,-0.34691,-0.37214,1,0
2,GO DIENCEPHALON DEVELOPMENT,0.0023626,-0.34693,-0.31959,1,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0032392,-0.34702,-0.32849,1,0
2,GO PROTEIN POLYGLUTAMYLATION,0.00034064,-0.34908,-0.41358,1,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.0079288,-0.35078,-0.29653,1,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0082164,-0.35105,-0.29594,1,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0012773,-0.35409,-0.34877,1,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.00083347,-0.35494,-0.36473,1,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0129,-0.35775,-0.32474,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.0024588,-0.35807,-0.34056,1,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.029747,-0.35828,-0.32124,1,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0129,-0.35895,-0.34296,1,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0017084,-0.3591,-0.44084,1,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.029747,-0.36062,-0.32335,1,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,0.00013179,-0.3608,-0.4035,1,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.0020112,-0.36161,-0.32821,1,0
2,GO CEREBELLAR CORTEX FORMATION,0.0016396,-0.36222,-0.37059,1,0
2,GO REGULATION OF MICROTUBULE BINDING,0.00083347,-0.36337,-0.39959,1,0
2,GO INCLUSION BODY ASSEMBLY,0.01918,-0.36339,-0.27741,1,0
2,GO COLLATERAL SPROUTING,0.004403,-0.36463,-0.34549,1,0
2,GO PRESYNAPSE ORGANIZATION,0.0029959,-0.3647,-0.35568,1,0
2,GO AXONEME ASSEMBLY,0.00034064,-0.36699,-0.42047,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0076503,-0.36733,-0.38761,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.00020344,-0.36739,-0.40574,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0029959,-0.3678,-0.39746,1,0
2,GO CAMP METABOLIC PROCESS,0.0011254,-0.36789,-0.34846,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0047478,-0.36796,-0.41318,1,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.010505,-0.36858,-0.35521,1,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,8.8765e-05,-0.36885,-0.38535,1,0
2,GO CATECHOLAMINE UPTAKE,0.027136,-0.36969,-0.27171,1,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.00094871,-0.37009,-0.37371,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00051298,-0.37048,-0.38236,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0076503,-0.37705,-0.33824,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.0037806,-0.37706,-0.35383,1,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.0055117,-0.3771,-0.49545,1,0
2,GO RETINA LAYER FORMATION,0.0047478,-0.37742,-0.45425,1,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.0049293,-0.37774,-0.39569,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.0055117,-0.37871,-0.40739,1,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0013321,-0.37909,-0.40511,1,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0061556,-0.37921,-0.30727,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.021117,-0.37935,-0.4082,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.0020943,-0.37992,-0.39352,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0025586,-0.38004,-0.37569,1,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0027694,-0.38222,-0.3969,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0016396,-0.38355,-0.3739,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.020453,-0.3842,-0.46867,1,0
2,GO DETECTION OF CALCIUM ION,0.0129,-0.38421,-0.35577,1,0
2,GO CELL MIGRATION IN HINDBRAIN,0.0027694,-0.38485,-0.42641,1,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.014755,-0.38501,-0.43656,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0076503,-0.38505,-0.46509,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0085133,-0.39009,-0.37471,1,0
2,GO MICROTUBULE SEVERING,0.010505,-0.39061,-0.31819,1,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.013344,-0.39201,-0.40629,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00025768,-0.39263,-0.46707,1,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0057193,-0.3929,-0.38891,1,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.0174,-0.39401,-0.42054,1,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.011255,-0.39424,-0.35489,1,0
2,GO MAINTENANCE OF CELL POLARITY,0.0040811,-0.39561,-0.39837,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.00037344,-0.39573,-0.41484,1,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.019808,-0.39578,-0.32429,1,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0013321,-0.39664,-0.34112,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0059338,-0.39683,-0.34941,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0088198,-0.39758,-0.28273,1,0
2,GO NEUROTRANSMITTER SECRETION,0.023963,-0.399,-0.34491,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0022699,-0.4041,-0.45577,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00049043,-0.40485,-0.39174,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0012773,-0.40662,-0.38998,1,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.00076401,-0.40805,-0.35296,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00037344,-0.41022,-0.40245,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00087036,-0.41048,-0.4153,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0037806,-0.41058,-0.36347,1,0
2,GO NOTCH RECEPTOR PROCESSING,0.004403,-0.41134,-0.40618,1,0
2,GO DORSAL AORTA DEVELOPMENT,0.0051169,-0.4136,-0.37845,1,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.0009903,-0.41385,-0.46151,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0059338,-0.41741,-0.48424,1,0
2,GO NEURON FATE COMMITMENT,0.010874,-0.42234,-0.34898,1,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.021117,-0.42376,-0.37607,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00042822,-0.43022,-0.46138,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0017084,-0.43296,-0.51133,1,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0040811,-0.43444,-0.4635,1,0
2,GO STRIATUM DEVELOPMENT,0.0022699,-0.43578,-0.38985,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.023963,-0.43613,-0.35633,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0028806,-0.43638,-0.40877,1,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.00073133,-0.43716,-0.40869,1,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.0035004,-0.43863,-0.47362,1,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0027694,-0.43896,-0.46115,1,0
2,GO SPERM AXONEME ASSEMBLY,0.0010786,-0.43908,-0.43741,1,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.0037806,-0.43933,-0.40466,1,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.011648,-0.43935,-0.4062,1,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.029747,-0.44002,-0.36689,1,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.029747,-0.44181,-0.43099,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0029959,-0.44202,-0.41783,1,0
2,GO SKELETAL MUSCLE ADAPTATION,0.00058654,-0.44247,-0.39151,1,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.0010336,-0.44309,-0.38872,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00056099,-0.44536,-0.46657,1,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.00083347,-0.44664,-0.46309,1,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00090875,-0.44742,-0.37914,1,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00061317,-0.45128,-0.45635,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.0001255,-0.45325,-0.48012,1,0
2,GO RESPONSE TO HISTAMINE,0.015254,-0.45409,-0.46163,1,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.027136,-0.45446,-0.4135,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.010146,-0.45585,-0.48945,1,0
2,GO PITUITARY GLAND DEVELOPMENT,0.00073133,-0.45643,-0.44701,1,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0027694,-0.45716,-0.51867,1,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.0020112,-0.45812,-0.45446,1,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00032527,-0.46096,-0.38343,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0020112,-0.46131,-0.41431,1,0
2,GO TELENCEPHALON REGIONALIZATION,0.0068665,-0.46325,-0.44288,1,0
2,GO CARDIOBLAST PROLIFERATION,0.029747,-0.46447,-0.47087,1,0
2,GO HEART FORMATION,0.00079804,-0.465,-0.4525,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.0018542,-0.46957,-0.49912,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0033675,-0.46961,-0.43494,1,0
2,GO SPINAL CORD PATTERNING,0.0013889,-0.46976,-0.51581,1,0
2,GO MOTILE CILIUM ASSEMBLY,0.00025768,-0.46986,-0.41373,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0011741,-0.47508,-0.58295,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0010336,-0.47729,-0.53691,1,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.0066217,-0.48095,-0.41846,1,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.028854,-0.48676,-0.35706,1,0
2,GO DOPAMINE METABOLIC PROCESS,0.0020943,-0.49018,-0.40403,1,0
2,GO FOREBRAIN REGIONALIZATION,0.0017799,-0.49121,-0.44491,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.005311,-0.49226,-0.44147,1,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0085133,-0.49357,-0.35675,1,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.01427,-0.49719,-0.37375,1,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.01427,-0.4975,-0.38289,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.010874,-0.49869,-0.52157,1,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.0073805,-0.49871,-0.56577,1,0
2,GO GLUTAMATE SECRETION,0.0009903,-0.50014,-0.51246,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0026621,-0.50084,-0.38965,1,0
2,GO PARENTAL BEHAVIOR,0.00079804,-0.5034,-0.50825,1,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.00032527,-0.50451,-0.48932,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00035669,-0.50476,-0.54648,1,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.029747,-0.50691,-0.37684,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.01918,-0.51126,-0.41384,1,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.016296,-0.51241,-0.40094,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0017799,-0.51347,-0.42918,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.00035669,-0.51459,-0.52994,1,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0059338,-0.51523,-0.48187,1,0
2,GO ADRENAL GLAND DEVELOPMENT,0.00058654,-0.51996,-0.49627,1,0
2,GO AMINE TRANSPORT,0.0022699,-0.5203,-0.44658,1,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0088198,-0.52436,-0.63858,1,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001448,-0.52792,-0.48441,1,0
2,GO PLASMA MEMBRANE REPAIR,0.0047478,-0.53219,-0.64871,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00094871,-0.53263,-0.61078,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.001448,-0.53279,-0.48708,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0017084,-0.53292,-0.55136,1,0
2,GO TOXIN METABOLIC PROCESS,0.00083347,-0.53317,-0.49561,1,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0061556,-0.53574,-0.5117,1,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0076503,-0.53598,-0.40302,1,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061556,-0.54526,-0.45002,1,0
2,GO MONOAMINE TRANSPORT,0.0024588,-0.54529,-0.45812,1,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.0039282,-0.54693,-0.49923,1,0
2,GO REFLEX,0.0020112,-0.55075,-0.52352,1,0
2,GO RESPONSE TO LITHIUM ION,0.004403,-0.55145,-0.44277,1,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00021334,-0.5528,-0.52774,1,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0071194,-0.55481,-0.50796,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0026621,-0.55952,-0.61372,1,0
2,GO NEURON CELL CELL ADHESION,0.0049293,-0.56515,-0.63913,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0013889,-0.56747,-0.57418,1,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.00046881,-0.57072,-0.54802,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0066217,-0.57204,-0.46091,1,0
2,GO STARTLE RESPONSE,0.0042393,-0.57663,-0.46595,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.0018542,-0.57783,-0.56699,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.015767,-0.58019,-0.60021,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00011949,-0.58119,-0.56658,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0017084,-0.58289,-0.61727,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0011741,-0.58421,-0.60396,1,0
2,GO DENDRITE EXTENSION,0.0017084,-0.59322,-0.48763,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0042393,-0.59454,-0.52608,1,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.00029645,-0.59496,-0.60216,1,0
2,GO POSTSYNAPSE ASSEMBLY,0.00083347,-0.59617,-0.63189,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00064092,-0.6063,-0.53521,1,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0037806,-0.60831,-0.6232,1,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00046881,-0.60865,-0.5591,1,0
2,GO DOPAMINE TRANSPORT,0.0057193,-0.61094,-0.50531,1,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00049043,-0.61222,-0.65574,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0047478,-0.61235,-0.56625,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00018491,-0.61239,-0.58794,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.027983,-0.61255,-0.57934,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0022699,-0.6126,-0.62415,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.0015095,-0.61615,-0.57449,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00029645,-0.61761,-0.59211,1,0
2,GO SUBPALLIUM DEVELOPMENT,0.00046881,-0.62051,-0.5904,1,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.005311,-0.62485,-0.54369,1,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0017799,-0.62588,-0.66433,1,0
2,GO PREPULSE INHIBITION,0.015767,-0.6288,-0.51284,1,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00037344,-0.62908,-0.5724,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0039282,-0.63228,-0.56959,1,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0024588,-0.63743,-0.60951,1,0
2,GO GROWTH HORMONE SECRETION,0.00046881,-0.63889,-0.57879,1,0
2,GO CATECHOLAMINE SECRETION,0.0085133,-0.64072,-0.50531,1,0
2,GO REGULATION OF DOPAMINE SECRETION,0.024724,-0.64538,-0.5043,1,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00053648,-0.64736,-0.68405,1,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00018491,-0.64808,-0.72451,1,0
2,GO REGULATION OF DENDRITE EXTENSION,0.00064092,-0.64832,-0.65471,1,0
2,GO SYNAPTIC VESICLE MATURATION,0.0031154,-0.64835,-0.74848,1,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00040918,-0.65095,-0.62427,1,0
2,GO SYNAPTIC VESICLE PRIMING,0.0091361,-0.65226,-0.55596,1,0
2,GO DENSE CORE GRANULE TRANSPORT,0.0020943,-0.654,-0.6852,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0016396,-0.6544,-0.59976,1,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00010305,-0.65882,-0.6879,1,0
2,GO RESPONSE TO INSECTICIDE,8.0303e-05,-0.66119,-0.69804,1,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0033675,-0.66186,-0.64664,1,0
2,GO SYNAPSE MATURATION,0.0085133,-0.66355,-0.55942,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00025768,-0.66424,-0.60984,1,0
2,GO GANGLION DEVELOPMENT,0.0012773,-0.67186,-0.70621,1,0
2,GO SYNAPTIC VESICLE DOCKING,0.01684,-0.67213,-0.58003,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0037806,-0.67531,-0.57417,1,0
2,GO GLIAL CELL FATE COMMITMENT,0.0020943,-0.67636,-0.59292,1,0
2,GO SYNAPTIC MEMBRANE ADHESION,0.00090875,-0.67795,-0.64866,1,0
2,GO VOCALIZATION BEHAVIOR,0.0023626,-0.67898,-0.66133,1,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00027004,-0.68066,-0.64882,1,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00083347,-0.6859,-0.57928,1,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0055117,-0.68592,-0.7176,1,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.00094871,-0.68753,-0.64327,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0011741,-0.71384,-0.68105,1,0
2,GO HEART FIELD SPECIFICATION,0.00076401,-0.72615,-0.63623,1,0
2,GO NOSE DEVELOPMENT,0.0082164,-0.74308,-0.60698,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.00044809,-0.74344,-0.65739,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00010828,-0.75648,-0.7762,1,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0002237,-0.76537,-0.77317,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00079804,-0.77391,-0.76606,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00064092,-0.77631,-0.80887,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0015733,-0.79059,-0.84209,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0020112,-0.79645,-0.69691,1,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0059338,-0.81489,-0.71377,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0071194,-0.82638,-0.68438,1,0
2,GO INNERVATION,0.00014528,-0.83258,-0.85856,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00083347,-0.87158,-0.75354,1,0
2,GO HEART INDUCTION,0.0035004,-0.95059,-0.73007,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00049043,-0.98284,-0.9726,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.001448,-1.002,-0.83629,1,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.0022699,-1.0794,-0.7815,1,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0028806,-1.0966,-0.96952,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.00073133,-1.3761,-1.2606,1,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0021804,-1.4579,-1.0661,1,0
2,GO BLASTODERM SEGMENTATION,0.041252,0.66128,0.41794,0,1
2,GO LYSINE METABOLIC PROCESS,0.064555,0.5691,0.49485,0,1
2,GO HEPATOCYTE DIFFERENTIATION,0.030665,0.55116,0.38093,0,1
2,GO PSEUDOPODIUM ORGANIZATION,0.034581,0.53093,0.39853,0,1
2,GO MUSCLE ATROPHY,0.11333,0.45862,0.31763,0,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.10533,0.45706,0.29639,0,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.16068,0.45153,0.31955,0,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.032572,0.44599,0.51186,0,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.054786,0.41333,0.27639,0,1
2,GO ACETYL COA METABOLIC PROCESS,0.068115,0.39942,0.25409,0,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.20396,0.34455,0.18245,0,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.04007,0.33055,0.30672,0,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.13384,0.32822,0.15689,0,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.054786,0.31174,0.46911,0,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.06115,0.30754,0.16789,0,1
2,GO MIDDLE EAR MORPHOGENESIS,0.053284,0.30752,0.24206,0,1
2,GO RENAL ABSORPTION,0.050383,0.30709,0.33736,0,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.037792,0.30616,0.30919,0,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.038917,0.29808,0.21117,0,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.12179,0.2954,0.22916,0,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.10794,0.28738,0.19657,0,1
2,GO MUSCLE CELL FATE COMMITMENT,0.07572,0.28682,0.32389,0,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.050383,0.2864,0.26171,0,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.093006,0.28589,0.15842,0,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.22622,0.28407,0.17587,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.095374,0.28031,0.16481,0,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.073757,0.27253,0.16022,0,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.032572,0.27035,0.25926,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.24039,0.26733,0.12461,0,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.15361,0.26662,0.13976,0,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.030665,0.25389,0.19309,0,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.064555,0.25378,0.20058,0,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.14679,0.25266,0.15015,0,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.047616,0.25176,0.16248,0,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.048983,0.2509,0.18458,0,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.11333,0.2453,0.22785,0,1
2,GO POSITIVE REGULATION OF MYELINATION,0.093006,0.24463,0.16556,0,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.030665,0.23852,0.19051,0,1
2,GO RESPONSE TO LIGHT INTENSITY,0.1643,0.23512,0.13452,0,1
2,GO HISTAMINE SECRETION,0.11333,0.23412,0.20642,0,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.06115,0.23394,0.28266,0,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.064555,0.23278,0.14534,0,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.068115,0.23238,0.17987,0,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.036694,0.23079,0.1868,0,1
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.27583,0.22564,0.1283,0,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.064555,0.22487,0.18396,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.2356,0.22278,0.079657,0,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.16068,0.22241,0.12775,0,1
2,GO SNARE COMPLEX ASSEMBLY,0.2356,0.21979,0.1615,0,1
2,GO GOLGI TO VACUOLE TRANSPORT,0.26023,0.21633,0.10535,0,1
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.21712,0.21473,0.136,0,1
2,GO REGULATION OF BONE DEVELOPMENT,0.031606,0.21177,0.13918,0,1
2,GO SEQUESTERING OF METAL ION,0.073757,0.20828,0.23327,0,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.1161,0.20761,0.15756,0,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.053284,0.20733,0.20707,0,1
2,GO PRIMARY MIRNA PROCESSING,0.034581,0.20652,0.17992,0,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.2356,0.20255,0.16316,0,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.10533,0.2004,0.18354,0,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.041252,0.19924,0.17996,0,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.07572,0.19859,0.15084,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.16068,0.19785,0.12916,0,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.031606,0.19732,0.17648,0,1
2,GO REGULATION OF SPINDLE ASSEMBLY,0.18733,0.19545,0.11376,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.046281,0.19541,0.15295,0,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.046281,0.19432,0.13623,0,1
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.090686,0.18775,0.14572,0,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.26536,0.18368,0.097927,0,1
2,GO APICAL JUNCTION ASSEMBLY,0.047616,0.18361,0.19498,0,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.12771,0.18359,0.11267,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.07572,0.1833,0.11779,0,1
2,GO REGULATION OF NUCLEASE ACTIVITY,0.17173,0.18171,0.13307,0,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.09779,0.18056,0.14592,0,1
2,GO T HELPER CELL LINEAGE COMMITMENT,0.068115,0.17787,0.18449,0,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.10277,0.17698,0.12667,0,1
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.050383,0.17531,0.14094,0,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.12179,0.17516,0.1144,0,1
2,GO MITOTIC SISTER CHROMATID COHESION,0.031606,0.17011,0.17286,0,1
2,GO VESICLE TARGETING,0.043706,0.16893,0.11364,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.10533,0.16629,0.13594,0,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.053284,0.16352,0.11827,0,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.037792,0.16352,0.11813,0,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.059504,0.16158,0.091618,0,1
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.1402,0.16157,0.077965,0,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.25516,0.15685,0.081433,0,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11333,0.15366,0.12926,0,1
2,GO REGULATION OF FEEDING BEHAVIOR,0.066316,0.15254,0.22979,0,1
2,GO RESPONSE TO GAMMA RADIATION,0.038917,0.15029,0.154,0,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.30323,0.14973,0.076887,0,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.09779,0.14927,0.096165,0,1
2,GO TRANSCYTOSIS,0.10533,0.14898,0.10586,0,1
2,GO LIPID METABOLIC PROCESS,0.04007,0.14816,0.10376,0,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.068115,0.14759,0.17681,0,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.84251,0.14674,-0.023211,0,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.06115,0.14672,0.085029,0,1
2,GO REGULATION OF DEFENSE RESPONSE,0.07572,0.14561,0.094479,0,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.10277,0.14363,0.16025,0,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.33843,0.14233,0.10529,0,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.037792,0.1415,0.10668,0,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.40947,0.13933,0.042867,0,1
2,GO CELL CELL RECOGNITION,0.09779,0.13826,0.090751,0,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.034581,0.13808,0.11339,0,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.12771,0.13807,0.10674,0,1
2,GO LIPID PHOSPHORYLATION,0.086186,0.13735,0.092975,0,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.059504,0.13719,0.12619,0,1
2,GO HISTONE MONOUBIQUITINATION,0.16798,0.13517,0.087418,0,1
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.24525,0.13291,0.099657,0,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.043706,0.13017,0.15039,0,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.033564,0.12988,0.13323,0,1
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.37614,0.12636,0.046572,0,1
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.18334,0.1247,0.088588,0,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.035624,0.12424,0.12542,0,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.064555,0.1242,0.093809,0,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.042464,0.12351,0.095639,0,1
2,GO PROTEIN DESTABILIZATION,0.031606,0.12304,0.13361,0,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.036694,0.12238,0.14146,0,1
2,GO GOLGI VESICLE TRANSPORT,0.088413,0.12055,0.068214,0,1
2,GO HISTONE UBIQUITINATION,0.23088,0.11564,0.055602,0,1
2,GO NON RECOMBINATIONAL REPAIR,0.15712,0.11489,0.066989,0,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.077726,0.10698,0.088833,0,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.043706,0.10511,0.106,0,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.19552,0.10267,0.055375,0,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.24039,0.099765,0.061411,0,1
2,GO PROTEIN MONOUBIQUITINATION,0.062834,0.098914,0.066674,0,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.044978,0.095639,0.090524,0,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.033564,0.089859,0.084017,0,1
2,GO PROTEIN POLYMERIZATION,0.31468,0.087785,0.051489,0,1
2,GO PROTEIN POLYUBIQUITINATION,0.064555,0.085051,0.062268,0,1
2,GO CELL CYCLE PHASE TRANSITION,0.031606,0.084988,0.061159,0,1
2,GO MACROAUTOPHAGY,0.13384,0.083782,0.048164,0,1
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.25516,0.08246,0.05244,0,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.086186,0.080403,0.071067,0,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.030665,0.080293,0.061335,0,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.086186,0.072491,0.069696,0,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.60883,0.063122,0.0112,0,1
2,GO NUCLEOSOME ORGANIZATION,0.20828,0.062741,0.060736,0,1
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.48871,0.051896,0.029121,0,1
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.1794,0.050245,0.035235,0,1
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.066316,0.05009,0.067421,0,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.050383,1.04,0.76385,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.047616,0.88358,0.63164,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.031606,0.7495,0.47521,0,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.077726,0.64408,0.44276,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.077726,0.58578,0.39281,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.09779,0.53192,0.35694,0,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.034581,0.50889,0.37313,0,0
2,GO GAS TRANSPORT,0.030665,0.50457,0.45805,0,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.10025,0.49379,0.3299,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.06115,0.4696,0.31491,0,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.10025,0.44221,0.30213,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.046281,0.43028,0.29541,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.48871,0.41884,0.12131,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.04007,0.41318,0.33493,0,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.034581,0.40921,0.32974,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.031606,0.40883,0.2576,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.031606,0.38487,0.37814,0,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.04007,0.37603,0.39636,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.047616,0.37509,0.36139,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.077726,0.3736,0.22918,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.10025,0.37348,0.25781,0,0
2,GO RESPONSE TO INTERFERON ALPHA,0.11061,0.37097,0.2109,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.086186,0.36748,0.28752,0,0
2,GO FATTY ACID HOMEOSTASIS,0.13074,0.36314,0.19129,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.086186,0.36157,0.28981,0,0
2,GO TOLERANCE INDUCTION,0.12472,0.35915,0.21696,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.18334,0.3578,0.14308,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.06115,0.35708,0.26612,0,0
2,GO RETINAL METABOLIC PROCESS,0.15712,0.35542,0.27711,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.041252,0.34884,0.3568,0,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.043706,0.34232,0.37394,0,0
2,GO LIMB BUD FORMATION,0.13074,0.34111,0.26369,0,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.043706,0.33532,0.19549,0,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.032572,0.33234,0.29578,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.038917,0.33002,0.28793,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.064555,0.32857,0.34473,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.073757,0.32684,0.24791,0,0
2,GO RESPONSE TO INTERFERON BETA,0.1161,0.3264,0.25155,0,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.04007,0.3256,0.20829,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.047616,0.32391,0.20087,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.034581,0.32271,0.25011,0,0
2,GO MATURE B CELL DIFFERENTIATION,0.030665,0.31858,0.22442,0,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.032572,0.31453,0.21303,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.13699,0.31186,0.19327,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.14679,0.30686,0.15484,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.21267,0.30341,0.17092,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.041252,0.30093,0.27153,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.21267,0.2987,0.27111,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.13074,0.29782,0.17439,0,0
2,GO MAST CELL ACTIVATION,0.12771,0.29669,0.15191,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.13074,0.2954,0.26663,0,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.069955,0.29314,0.2723,0,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.043706,0.29286,0.25895,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.071835,0.29151,0.16405,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.40267,0.2897,0.070808,0,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.084004,0.28934,0.19518,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.050383,0.28859,0.26077,0,0
2,GO MAST CELL MEDIATED IMMUNITY,0.10794,0.28857,0.18037,0,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.06115,0.28643,0.18933,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.030665,0.28586,0.25475,0,0
2,GO REGULATION OF TOLERANCE INDUCTION,0.25516,0.28534,0.13045,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041252,0.28286,0.25953,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.056323,0.28272,0.23666,0,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.047616,0.27955,0.21939,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.27056,0.27834,0.18195,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.19139,0.27824,0.20024,0,0
2,GO PEPTIDE CROSS LINKING,0.084004,0.27681,0.15222,0,0
2,GO LIPID DROPLET ORGANIZATION,0.064555,0.27612,0.18561,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.095374,0.27473,0.2043,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.11333,0.27216,0.18454,0,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.035624,0.27213,0.24214,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.069955,0.27119,0.28836,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.033564,0.27091,0.18763,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.059504,0.2699,0.17987,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.31468,0.26746,0.11519,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.037792,0.26717,0.18461,0,0
2,GO GLYCINE METABOLIC PROCESS,0.036694,0.26707,0.26522,0,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.050383,0.26648,0.2084,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.10277,0.26633,0.29471,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.071835,0.2651,0.14542,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.053284,0.26339,0.26348,0,0
2,GO GERMINAL CENTER FORMATION,0.21712,0.26285,0.11285,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.038917,0.2626,0.19633,0,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.042464,0.26174,0.18642,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.064555,0.26155,0.17427,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.10025,0.26089,0.3221,0,0
2,GO RESPONSE TO TYPE I INTERFERON,0.25017,0.26067,0.12492,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.15017,0.26014,0.16179,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.086186,0.25938,0.22505,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.11061,0.25917,0.13407,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.051817,0.25902,0.21438,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.088413,0.25897,0.20457,0,0
2,GO PHOSPHOLIPID EFFLUX,0.36329,0.25894,0.071515,0,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.1402,0.25733,0.13868,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.086186,0.25486,0.25262,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.13074,0.25447,0.21963,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.27056,0.25342,0.13697,0,0
2,GO CYTOPLASMIC TRANSLATION,0.066316,0.25308,0.18922,0,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.062834,0.25184,0.18534,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.032572,0.25075,0.18533,0,0
2,GO NUCLEOTIDE SALVAGE,0.29206,0.25074,0.11635,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.51167,0.25044,0.17668,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.17173,0.24972,0.17439,0,0
2,GO RESPONSE TO LEPTIN,0.088413,0.24969,0.14236,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.07572,0.24921,0.21727,0,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.036694,0.24904,0.19882,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.035624,0.24756,0.14783,0,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.032572,0.24477,0.19956,0,0
2,GO NEUTROPHIL HOMEOSTASIS,0.15017,0.24417,0.21748,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.11333,0.24392,0.18124,0,0
2,GO NOTOCHORD DEVELOPMENT,0.035624,0.24386,0.2314,0,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.084004,0.24385,0.20631,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.059504,0.24374,0.19486,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.12179,0.24337,0.27148,0,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.1402,0.24321,0.17377,0,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.1794,0.24313,0.17085,0,0
2,GO REGULATION OF CELL KILLING,0.13384,0.24244,0.12989,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.057895,0.24204,0.15933,0,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.18334,0.24159,0.13122,0,0
2,GO PROTEASOME ASSEMBLY,0.035624,0.2408,0.19543,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.062834,0.23995,0.21909,0,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.033564,0.23918,0.20407,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.051817,0.23852,0.19444,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.037792,0.23843,0.19357,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.031606,0.23817,0.26862,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.15361,0.23807,0.11079,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.1643,0.23769,0.17828,0,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.13384,0.23731,0.10239,0,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.28117,0.23708,0.12504,0,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.053284,0.23627,0.19947,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.16068,0.23584,0.14447,0,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.095374,0.23557,0.25301,0,0
2,GO ZYMOGEN INHIBITION,0.088413,0.23477,0.23348,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.13699,0.23452,0.19715,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.13699,0.23429,0.16923,0,0
2,GO CHONDROCYTE PROLIFERATION,0.11061,0.23217,0.16188,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.13384,0.23215,0.20128,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.11333,0.2321,0.20495,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.13384,0.23006,0.16412,0,0
2,GO GDP METABOLIC PROCESS,0.048983,0.22999,0.24548,0,0
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.1402,0.22999,0.17219,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.35697,0.22999,0.10038,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.050383,0.22992,0.20463,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.21267,0.22983,0.12369,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.10025,0.22974,0.20123,0,0
2,GO CRISTAE FORMATION,0.050383,0.22969,0.20012,0,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.28117,0.22967,0.070034,0,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.2356,0.22841,0.11992,0,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.10533,0.22744,0.13201,0,0
2,GO AMINE CATABOLIC PROCESS,0.30892,0.22732,0.1433,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.21267,0.22608,0.19154,0,0
2,GO EPITHELIAL CELL CELL ADHESION,0.079775,0.22492,0.25697,0,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.042464,0.22489,0.22922,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.06115,0.22357,0.15483,0,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.077726,0.22293,0.15876,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13384,0.22272,0.18049,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.26023,0.22242,0.11849,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.035624,0.22209,0.17806,0,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.12771,0.22109,0.17183,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.032572,0.22006,0.17156,0,0
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.39593,0.21954,0.13254,0,0
2,GO PIGMENT GRANULE MATURATION,0.24039,0.21832,0.17864,0,0
2,GO PODOSOME ASSEMBLY,0.15361,0.21778,0.17457,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.050383,0.21742,0.17301,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.36329,0.21726,0.084929,0,0
2,GO TRANSLATIONAL INITIATION,0.051817,0.21725,0.19499,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.051817,0.21655,0.2875,0,0
2,GO CD40 SIGNALING PATHWAY,0.086186,0.21647,0.12902,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.22164,0.21569,0.14752,0,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.034581,0.21561,0.13872,0,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.033564,0.2153,0.1621,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.19552,0.21497,0.11488,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.28658,0.21491,0.14578,0,0
2,GO RESPONSE TO GONADOTROPIN,0.15017,0.21417,0.13892,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.046281,0.21405,0.1917,0,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.10533,0.21319,0.11575,0,0
2,GO RESPONSE TO INTERFERON GAMMA,0.13699,0.21304,0.12027,0,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.14347,0.21261,0.20621,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.069955,0.21259,0.211,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.12771,0.21212,0.1484,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.054786,0.21203,0.29367,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.12179,0.21197,0.20892,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.79572,0.21174,-0.019722,0,0
2,GO ENTRY INTO HOST,0.081867,0.20989,0.12967,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.037792,0.20963,0.21932,0,0
2,GO INTERLEUKIN 10 PRODUCTION,0.086186,0.20905,0.14518,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.053284,0.20821,0.14346,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.15361,0.20708,0.119,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.031606,0.20661,0.2291,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.088413,0.20654,0.15153,0,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.048983,0.20633,0.24617,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.090686,0.2062,0.19303,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.89939,0.20617,-0.029062,0,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.07572,0.20571,0.14156,0,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.037792,0.20545,0.18011,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.053284,0.20541,0.13516,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.30323,0.20458,0.10713,0,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.048983,0.20458,0.14516,0,0
2,GO NADPH REGENERATION,0.081867,0.20394,0.22048,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.15712,0.20268,0.1494,0,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.066316,0.2026,0.14307,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.10533,0.20256,0.27376,0,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.043706,0.20249,0.15592,0,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.051817,0.20241,0.14879,0,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.12179,0.20212,0.15851,0,0
2,GO BLEB ASSEMBLY,0.48118,0.20093,0.013454,0,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.034581,0.2007,0.14558,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.1402,0.20064,0.1462,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.10794,0.20038,0.18074,0,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.1402,0.20017,0.09666,0,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.15361,0.20017,0.16737,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.081867,0.19934,0.19357,0,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.071835,0.19876,0.11503,0,0
2,GO COPPER ION TRANSPORT,0.14347,0.19818,0.12214,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.78645,0.19782,0.048014,0,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.053284,0.19762,0.18067,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.19139,0.19756,0.15199,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.11892,0.19718,0.11243,0,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.10533,0.19698,0.17979,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.095374,0.19676,0.17268,0,0
2,GO NUCLEUS LOCALIZATION,0.064555,0.19591,0.12705,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.38267,0.19559,0.16027,0,0
2,GO CARTILAGE MORPHOGENESIS,0.21712,0.19439,0.17654,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.17553,0.19402,0.15993,0,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.068115,0.19396,0.24209,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.38267,0.19345,0.10008,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.071835,0.19315,0.25506,0,0
2,GO TRACHEA DEVELOPMENT,0.1794,0.19313,0.1151,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.43736,0.19306,0.11757,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.042464,0.19304,0.15779,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.081867,0.19286,0.18478,0,0
2,GO MOVEMENT IN HOST ENVIRONMENT,0.071835,0.19263,0.1233,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.04007,0.19256,0.14621,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.054786,0.19251,0.14298,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.077726,0.19199,0.17373,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.26536,0.19191,0.11293,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.086186,0.1918,0.16693,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.071835,0.19165,0.14243,0,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.27056,0.19146,0.21477,0,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.10533,0.19114,0.18986,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.073757,0.19109,0.14701,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.43736,0.19107,0.11149,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.24525,0.19101,0.11763,0,0
2,GO COPPER ION HOMEOSTASIS,0.071835,0.191,0.15544,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.19552,0.19026,0.11061,0,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.048983,0.19024,0.10182,0,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.051817,0.19023,0.15081,0,0
2,GO LIPOXYGENASE PATHWAY,0.17173,0.18952,0.24132,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.079775,0.18937,0.20074,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.19971,0.18936,0.10559,0,0
2,GO DETECTION OF OTHER ORGANISM,0.4445,0.18798,0.036904,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.35697,0.18788,0.0629,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.48871,0.18787,0.10717,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.1794,0.18698,0.1229,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38267,0.18689,0.051576,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.031606,0.1868,0.13279,0,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.10794,0.18673,0.19281,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.057895,0.1867,0.27463,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.093006,0.18629,0.14528,0,0
2,GO RESPONSE TO TUMOR CELL,0.1161,0.18624,0.14402,0,0
2,GO NCRNA CATABOLIC PROCESS,0.04007,0.18591,0.1518,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.057895,0.18552,0.13636,0,0
2,GO LIPID IMPORT INTO CELL,0.33843,0.18546,0.082944,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.14347,0.18501,0.16289,0,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.073757,0.18481,0.13894,0,0
2,GO CHYLOMICRON ASSEMBLY,0.10025,0.1846,0.082946,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.45171,0.18453,0.091547,0,0
2,GO AXIS ELONGATION,0.034581,0.18446,0.19529,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.27056,0.1839,0.12772,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.077726,0.18387,0.12621,0,0
2,GO RESPONSE TO INTERLEUKIN 1,0.036694,0.18371,0.12191,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.06115,0.18365,0.13231,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.12179,0.18303,0.14847,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.12179,0.18299,0.21105,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.27583,0.18292,0.13225,0,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.046281,0.18276,0.12808,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.1402,0.18263,0.18961,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.21712,0.1826,0.10776,0,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.034581,0.18259,0.17988,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.16798,0.18256,0.16336,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.19552,0.18234,0.19166,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.16798,0.18221,0.11197,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.9952,0.18211,-0.034796,0,0
2,GO HYPEROSMOTIC RESPONSE,0.19139,0.18208,0.15074,0,0
2,GO T CELL PROLIFERATION,0.057895,0.18206,0.12802,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.2356,0.18185,0.085653,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.077726,0.18178,0.16717,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.050383,0.18165,0.12764,0,0
2,GO REGULATION OF B CELL ACTIVATION,0.047616,0.18124,0.10676,0,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.14679,0.18117,0.19257,0,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.1402,0.18114,0.21546,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.26536,0.18068,0.078268,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.086186,0.18068,0.12398,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.036694,0.18022,0.22889,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.34454,0.18016,0.11526,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.17553,0.17989,0.18498,0,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.064555,0.17967,0.15306,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.073757,0.17965,0.19942,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.053284,0.179,0.12548,0,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.056323,0.17896,0.1113,0,0
2,GO B CELL MEDIATED IMMUNITY,0.10794,0.17864,0.091997,0,0
2,GO HISTAMINE TRANSPORT,0.27056,0.17822,0.12049,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.35697,0.17797,0.0245,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.13384,0.17792,0.11855,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.13384,0.17746,0.11806,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.10025,0.1769,0.16588,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.27583,0.17671,0.078565,0,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.030665,0.17618,0.13951,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.084004,0.17611,0.11454,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.34454,0.17591,0.09133,0,0
2,GO URETER DEVELOPMENT,0.18334,0.17584,0.16882,0,0
2,GO REGULATION OF HEAT GENERATION,0.062834,0.17582,0.23228,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.28658,0.17537,0.12156,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.033564,0.17503,0.16319,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.042464,0.17485,0.20451,0,0
2,GO PIGMENT METABOLIC PROCESS,0.054786,0.17417,0.13939,0,0
2,GO NUCLEAR MIGRATION,0.07572,0.17406,0.13445,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.22164,0.17401,0.073986,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.081867,0.17394,0.21761,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.21712,0.17379,0.13107,0,0
2,GO CORNIFICATION,0.043706,0.17357,0.20996,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.084004,0.17333,0.15168,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.088413,0.17283,0.19748,0,0
2,GO STEROID ESTERIFICATION,0.40947,0.17282,0.029876,0,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.073757,0.17269,0.10929,0,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.13074,0.17192,0.090644,0,0
2,GO TYPE I INTERFERON PRODUCTION,0.07572,0.17192,0.1458,0,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.031606,0.17161,0.13083,0,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.059504,0.1715,0.17962,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.43736,0.17102,0.085403,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.079775,0.17062,0.11812,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.19971,0.1705,0.14189,0,0
2,GO APOPTOTIC CELL CLEARANCE,0.15712,0.17019,0.054688,0,0
2,GO METANEPHROS DEVELOPMENT,0.042464,0.16974,0.15322,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.18334,0.16948,0.1108,0,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.16798,0.16904,0.093984,0,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.081867,0.16833,0.13932,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.28658,0.16819,0.13003,0,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.10025,0.16766,0.13225,0,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.31468,0.16708,0.10567,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.09779,0.16685,0.11592,0,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.079775,0.16681,0.12845,0,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.079775,0.1668,0.10205,0,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.27056,0.16659,0.075253,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.4963,0.16621,0.061393,0,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.23088,0.16584,0.099708,0,0
2,GO LIPID OXIDATION,0.088413,0.16575,0.12511,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.064555,0.16556,0.12813,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.043706,0.16524,0.37634,0,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.044978,0.16521,0.16744,0,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.24525,0.16512,0.044256,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.20828,0.16495,0.14008,0,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.19971,0.16491,0.08032,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.37614,0.16487,0.12431,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.21267,0.16479,0.10557,0,0
2,GO L SERINE METABOLIC PROCESS,0.4963,0.16466,0.10741,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.13384,0.1645,0.20442,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.48871,0.16449,0.0951,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.71343,0.16445,0.025439,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.34454,0.16439,0.10077,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.084004,0.16438,0.11354,0,0
2,GO REGULATION OF NEURON MATURATION,0.13074,0.16402,0.24363,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.077726,0.16295,0.11797,0,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.18334,0.1625,0.142,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.081867,0.16238,0.13103,0,0
2,GO POSITIVE REGULATION OF WOUND HEALING,0.24039,0.1623,0.12053,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.064555,0.16209,0.11211,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.043706,0.16169,0.14262,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.19971,0.16157,0.13617,0,0
2,GO ENAMEL MINERALIZATION,0.36329,0.16127,0.14414,0,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.06115,0.16122,0.11338,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.10533,0.1612,0.10317,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.09779,0.16112,0.11475,0,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.062834,0.16097,0.14252,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.16068,0.1609,0.10923,0,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.11333,0.16089,0.13391,0,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.07572,0.16054,0.12785,0,0
2,GO PROTEIN NEDDYLATION,0.037792,0.1605,0.13232,0,0
2,GO GONADOTROPIN SECRETION,0.38927,0.16033,0.08926,0,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.056323,0.16014,0.26733,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.85194,0.16011,-0.014572,0,0
2,GO INTERACTION WITH HOST,0.051817,0.16005,0.11221,0,0
2,GO RRNA 3 END PROCESSING,0.071835,0.15953,0.13749,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.12771,0.15952,0.21528,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.050383,0.15946,0.1199,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.073757,0.15945,0.1368,0,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.36968,0.15907,0.075055,0,0
2,GO AMYLOID BETA CLEARANCE,0.33239,0.15885,0.053077,0,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.088413,0.15885,0.15,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.10794,0.15868,0.20457,0,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.090686,0.1584,0.11466,0,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.41634,0.15838,0.072368,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.14347,0.15815,0.089109,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.046281,0.15803,0.12371,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.064555,0.15803,0.1563,0,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.10533,0.15799,0.13516,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.06115,0.15794,0.10375,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.047616,0.15782,0.13088,0,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.093006,0.15762,0.11105,0,0
2,GO DNA LIGATION,0.086186,0.15745,0.15732,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.24039,0.1574,0.12217,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.24039,0.15708,0.097476,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.088413,0.15708,0.14633,0,0
2,GO POSITIVE REGULATION OF COAGULATION,0.10025,0.157,0.13253,0,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.11061,0.15693,0.12987,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.18334,0.15655,0.11576,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.21267,0.15639,0.1488,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.54313,0.15638,0.044951,0,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.29761,0.15619,0.13282,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.11061,0.1561,0.13155,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.31468,0.1559,0.084939,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.48871,0.15558,0.060772,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.95679,0.15543,-0.1222,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.09779,0.15523,0.1481,0,0
2,GO LIPID MODIFICATION,0.077726,0.15489,0.10792,0,0
2,GO MYELIN ASSEMBLY,0.48871,0.15478,0.10185,0,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.19552,0.15436,0.10297,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.034581,0.15412,0.13177,0,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.17173,0.15412,0.14454,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.057895,0.15384,0.21847,0,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.2356,0.15375,0.066722,0,0
2,GO REGULATION OF CELL CELL ADHESION,0.1161,0.15372,0.098677,0,0
2,GO POSITIVE CHEMOTAXIS,0.19971,0.15336,0.098342,0,0
2,GO REGULATION OF HAIR CYCLE,0.031606,0.15329,0.15267,0,0
2,GO DIOL METABOLIC PROCESS,0.56735,0.15324,0.067224,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.062834,0.1531,0.13452,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.33239,0.15282,0.17458,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.29761,0.15279,0.068697,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.73147,0.15276,-0.00074418,0,0
2,GO AXONAL FASCICULATION,0.47371,0.15271,0.064001,0,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.17553,0.15245,0.061183,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.079775,0.15203,0.1157,0,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.079775,0.152,0.11991,0,0
2,GO REGULATION OF CELL ACTIVATION,0.090686,0.15166,0.094474,0,0
2,GO CYTOKINE PRODUCTION,0.10533,0.15166,0.086728,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.14679,0.1513,0.10315,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.81436,0.15127,-0.0024226,0,0
2,GO REGULATION OF ANOIKIS,0.32642,0.15108,0.09678,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.30892,0.15107,0.093095,0,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.037792,0.151,0.15572,0,0
2,GO T CELL DIFFERENTIATION,0.037792,0.15089,0.12525,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.1161,0.15085,0.12972,0,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.35072,0.15075,0.092558,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.036694,0.15049,0.16393,0,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.15017,0.15041,0.072681,0,0
2,GO LIVER REGENERATION,0.32642,0.15036,0.059989,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.032572,0.15011,0.17422,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.079775,0.15003,0.1413,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.1402,0.15,0.092871,0,0
2,GO INNATE IMMUNE RESPONSE,0.093006,0.14984,0.093626,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.12771,0.14951,0.13553,0,0
2,GO PROTEIN TRIMERIZATION,0.12472,0.14949,0.15643,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.047616,0.1494,0.1122,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.053284,0.1491,0.1933,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.15361,0.14909,0.14896,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.19139,0.14904,0.083057,0,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.062834,0.14887,0.11861,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.16798,0.14868,0.13416,0,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.22164,0.14863,0.19443,0,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.19971,0.14861,0.059641,0,0
2,GO CELL AGGREGATION,0.2356,0.14859,0.10179,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.48871,0.14845,0.12197,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.073757,0.14728,0.14539,0,0
2,GO HIPPO SIGNALING,0.13384,0.14717,0.10862,0,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.07572,0.14716,0.13144,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.1794,0.14702,0.088528,0,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.27583,0.14685,0.16354,0,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.35697,0.1465,0.049241,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.10025,0.14632,0.20344,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.60042,0.14631,0.051769,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.37614,0.14614,0.1312,0,0
2,GO CELLULAR RESPONSE TO VIRUS,0.062834,0.14614,0.1187,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.41634,0.14611,0.12674,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.40947,0.14599,0.12185,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.10277,0.14583,0.13033,0,0
2,GO STEROL METABOLIC PROCESS,0.11333,0.14566,0.10537,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.40947,0.14535,0.093487,0,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.17553,0.14527,0.19351,0,0
2,GO KERATINOCYTE PROLIFERATION,0.27583,0.14502,0.15876,0,0
2,GO REGULATION OF IMMUNE RESPONSE,0.054786,0.1449,0.10514,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.14679,0.14485,0.10799,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.22164,0.14483,0.10629,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.19552,0.14455,0.1216,0,0
2,GO RESPONSE TO CYTOKINE,0.12179,0.14447,0.068287,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.15712,0.14435,0.11923,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.054786,0.14427,0.17019,0,0
2,GO MRNA METHYLATION,0.15712,0.14418,0.12835,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.069955,0.14412,0.18312,0,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.084004,0.14352,0.15729,0,0
2,GO ACTIN FILAMENT ORGANIZATION,0.056323,0.1435,0.10233,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.33843,0.14345,0.079969,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.73147,0.14341,0.014668,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.13384,0.14338,0.131,0,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.1402,0.14327,0.084702,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.50395,0.14284,0.10285,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.51167,0.14265,0.037834,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.10277,0.14261,0.076626,0,0
2,GO CHEMOKINE PRODUCTION,0.068115,0.14252,0.13218,0,0
2,GO T CELL ACTIVATION,0.10794,0.14234,0.095145,0,0
2,GO NEUROBLAST DIVISION,0.23088,0.14222,0.10025,0,0
2,GO STEROL HOMEOSTASIS,0.14679,0.1422,0.089458,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.1794,0.14215,0.097326,0,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.24039,0.14199,0.072339,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.36329,0.14178,0.10088,0,0
2,GO COCHLEA MORPHOGENESIS,0.13699,0.14172,0.12327,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.45171,0.14159,0.1182,0,0
2,GO SOMATIC STEM CELL DIVISION,0.48871,0.14148,0.089765,0,0
2,GO T CELL CYTOKINE PRODUCTION,0.090686,0.14146,0.092796,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.39593,0.14143,0.10876,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.43029,0.14115,0.048418,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.53518,0.14099,0.020283,0,0
2,GO HISTONE H2B UBIQUITINATION,0.050383,0.14094,0.12428,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.077726,0.14089,0.11409,0,0
2,GO MALE SEX DETERMINATION,0.2356,0.14078,0.1516,0,0
2,GO FOREGUT MORPHOGENESIS,0.21267,0.14065,0.17021,0,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.059504,0.14046,0.12164,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.24525,0.14039,0.1368,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.1402,0.14031,0.104,0,0
2,GO STEM CELL DIVISION,0.21712,0.14028,0.080689,0,0
2,GO AUTOPHAGIC CELL DEATH,0.43029,0.13983,0.063346,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.086186,0.13963,0.22308,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.28658,0.13959,0.094595,0,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.15712,0.13958,0.074778,0,0
2,GO INTERLEUKIN 17 PRODUCTION,0.1643,0.13938,0.088578,0,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.036694,0.13917,0.1441,0,0
2,GO PROTEIN DEMANNOSYLATION,0.31468,0.13914,0.081016,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.21712,0.1391,0.089243,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.050383,0.13887,0.13913,0,0
2,GO HEAT GENERATION,0.071835,0.13887,0.1845,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.38267,0.13878,0.076702,0,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.04007,0.13845,0.15934,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.13074,0.13841,0.12661,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.19552,0.13837,0.080769,0,0
2,GO REGULATION OF T CELL ACTIVATION,0.13699,0.1382,0.092519,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.29761,0.13818,0.054981,0,0
2,GO MALE SEX DIFFERENTIATION,0.073757,0.13817,0.1113,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.29761,0.138,0.050868,0,0
2,GO RESPONSE TO OSMOTIC STRESS,0.13384,0.13787,0.10555,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.4445,0.13785,0.09285,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.069955,0.13785,0.10031,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.068115,0.13784,0.12453,0,0
2,GO PINOCYTOSIS,0.12472,0.13745,0.097149,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.28117,0.13738,0.14343,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.25516,0.13729,0.10683,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.89939,0.13719,-0.014108,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.04007,0.1371,0.13723,0,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.088413,0.13704,0.10853,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.030665,0.13704,0.10642,0,0
2,GO POLYAMINE METABOLIC PROCESS,0.16068,0.13678,0.11562,0,0
2,GO RESPONSE TO EPINEPHRINE,0.4445,0.13596,0.12459,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.25516,0.13592,0.071673,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.22622,0.13587,0.14855,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.13074,0.13579,0.098777,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.48871,0.13577,0.059903,0,0
2,GO TRACHEA MORPHOGENESIS,0.26023,0.13557,0.076546,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.071835,0.13542,0.094786,0,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.14347,0.13532,0.089383,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.48118,0.13529,0.03437,0,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.12771,0.13522,0.14482,0,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.35072,0.13521,0.053444,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.1643,0.13513,0.091723,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.034581,0.1351,0.15105,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.58378,0.1351,0.028669,0,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.068115,0.13508,0.12745,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.40947,0.13501,0.039729,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.1643,0.13499,0.065679,0,0
2,GO PLASMA MEMBRANE FUSION,0.17553,0.13487,0.1177,0,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.11061,0.13476,0.085531,0,0
2,GO IRON ION HOMEOSTASIS,0.11333,0.13459,0.10236,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.10025,0.1342,0.10157,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.30323,0.13396,0.061174,0,0
2,GO MATING BEHAVIOR,0.69555,0.13391,0.021067,0,0
2,GO DRINKING BEHAVIOR,0.58378,0.13368,0.071622,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.35072,0.13359,0.11502,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.17553,0.13303,0.14142,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.16798,0.1329,0.082846,0,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.033564,0.13284,0.12773,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.13699,0.13282,0.22759,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.059504,0.13274,0.099305,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.068115,0.13232,0.12269,0,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.26023,0.13227,0.091068,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.22622,0.13212,0.10373,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.25516,0.1321,0.065604,0,0
2,GO REGULATION OF CELL MATURATION,0.13384,0.13204,0.15132,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.54313,0.132,0.048766,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.51944,0.13199,0.10405,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.032572,0.13195,0.13515,0,0
2,GO REGULATION OF HEMOPOIESIS,0.079775,0.13194,0.09485,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.084004,0.1319,0.10715,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.19971,0.13181,0.090698,0,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.050383,0.13176,0.10118,0,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.057895,0.13165,0.11595,0,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.32642,0.13144,0.065158,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.51167,0.13123,0.077937,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.11892,0.13109,0.23974,0,0
2,GO ALPHA BETA T CELL ACTIVATION,0.047616,0.13104,0.12778,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.11061,0.13099,0.093834,0,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.093006,0.13095,0.11783,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.43736,0.13075,0.067661,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.090686,0.13048,0.072575,0,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.27583,0.13045,0.092292,0,0
2,GO VIRAL LIFE CYCLE,0.062834,0.13018,0.094778,0,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.29761,0.13014,0.087863,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.1402,0.12977,0.09657,0,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.17553,0.12968,0.081322,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.086186,0.12944,0.12719,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.22164,0.12935,0.22495,0,0
2,GO ERYTHROCYTE MATURATION,0.11892,0.12927,0.20279,0,0
2,GO PROTEIN HYDROXYLATION,0.26023,0.12911,0.085349,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.066316,0.1291,0.11465,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.60042,0.12904,0.074134,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.054786,0.12883,0.17659,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10025,0.1284,0.12892,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.21712,0.12795,0.094983,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.095374,0.12779,0.08858,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.34454,0.12769,0.07459,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.35697,0.12757,0.089094,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.32642,0.12746,0.040548,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.32052,0.12726,0.086796,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.74054,0.12723,-0.0016253,0,0
2,GO IMMUNE EFFECTOR PROCESS,0.090686,0.12722,0.10014,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.21267,0.12714,0.084187,0,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.46631,0.12696,-0.012346,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.36329,0.12688,0.070102,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.48871,0.12669,0.032507,0,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.064555,0.12661,0.096072,0,0
2,GO INTERFERON BETA PRODUCTION,0.26023,0.12654,0.095591,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.069955,0.1265,0.081909,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.21712,0.12646,0.027979,0,0
2,GO STEROID HORMONE SECRETION,0.29206,0.12624,0.092397,0,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.33239,0.12621,0.085633,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.050383,0.12616,0.19636,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.09779,0.12613,0.081401,0,0
2,GO DEFENSE RESPONSE,0.18733,0.12611,0.048766,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.17173,0.12601,0.05912,0,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.28117,0.12586,0.10821,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.33843,0.12568,0.1219,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.15361,0.12547,0.12862,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.62578,0.12542,0.09552,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.36968,0.1254,0.069409,0,0
2,GO STEROID METABOLIC PROCESS,0.059504,0.12519,0.093659,0,0
2,GO RESPIRATORY BURST,0.21712,0.12514,0.13374,0,0
2,GO RNA DESTABILIZATION,0.095374,0.12512,0.096088,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.13384,0.12511,0.092181,0,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.29761,0.12506,0.024174,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.2356,0.12496,0.068767,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.26023,0.1249,0.10621,0,0
2,GO REGULATION OF MYELINATION,0.077726,0.12478,0.12636,0,0
2,GO VIRION ASSEMBLY,0.34454,0.12472,0.051216,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.40267,0.12456,0.17061,0,0
2,GO FUCOSE METABOLIC PROCESS,0.15712,0.12455,0.15552,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1643,0.1245,0.12322,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.038917,0.12445,0.098515,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.041252,0.12418,0.10988,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.062834,0.12416,0.13464,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.45898,0.12415,0.063729,0,0
2,GO RESPONSE TO IRON ION,0.12771,0.1241,0.21793,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.14347,0.1241,0.085879,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.45171,0.12405,0.089604,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.20828,0.12392,0.069539,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.20396,0.12383,0.090356,0,0
2,GO RESPONSE TO ETHANOL,0.11061,0.12373,0.11021,0,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.081867,0.12368,0.10361,0,0
2,GO RUFFLE ORGANIZATION,0.090686,0.12367,0.095693,0,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.28658,0.12351,0.1005,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.088413,0.12345,0.14253,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.41634,0.12316,0.054493,0,0
2,GO FATTY ACID BETA OXIDATION,0.17173,0.12309,0.082315,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.24039,0.12275,0.085708,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.1643,0.12267,0.089578,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.30323,0.12241,0.24125,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.12179,0.12218,0.098895,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.030665,0.12209,0.10768,0,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.66904,0.122,-0.0033615,0,0
2,GO RNA CAPPING,0.050383,0.12193,0.098768,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.36968,0.1219,0.1164,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.15017,0.12164,0.1342,0,0
2,GO PENILE ERECTION,0.66904,0.12159,0.016927,0,0
2,GO GENITALIA MORPHOGENESIS,0.28117,0.12151,0.069743,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.24525,0.12147,0.16109,0,0
2,GO PHAGOCYTOSIS,0.14347,0.1213,0.095036,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.35072,0.12124,0.13659,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.053284,0.12114,0.087137,0,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.044978,0.12108,0.11932,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.07572,0.12107,0.14506,0,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.12179,0.12104,0.086419,0,0
2,GO DNA REPLICATION INITIATION,0.059504,0.12089,0.11034,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.088413,0.12083,0.1571,0,0
2,GO LYMPHOCYTE ACTIVATION,0.13074,0.1207,0.077695,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.38267,0.1204,0.089945,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.40947,0.12032,0.066064,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60042,0.1199,-0.0038882,0,0
2,GO RENAL SYSTEM PROCESS,0.19552,0.11976,0.085331,0,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.18733,0.11966,0.1665,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.29761,0.11961,0.089509,0,0
2,GO CELL ACTIVATION,0.14347,0.11951,0.074672,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.90893,0.11945,-0.033116,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.43736,0.11942,0.067031,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.051817,0.1193,0.16622,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.10533,0.11922,0.090243,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.064555,0.11905,0.093842,0,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.043706,0.11904,0.093123,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.035624,0.11892,0.18209,0,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.23088,0.11877,0.1741,0,0
2,GO CYTOKINE METABOLIC PROCESS,0.10794,0.11865,0.075782,0,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.13074,0.11862,0.067955,0,0
2,GO SIGNAL PEPTIDE PROCESSING,0.084004,0.11859,0.18107,0,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.06115,0.1184,0.11301,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.1161,0.11804,0.15844,0,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.28658,0.1179,0.063334,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.047616,0.11787,0.13216,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18733,0.11779,0.073168,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.60883,0.11761,0.057613,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.095374,0.1176,0.10952,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.1643,0.11751,0.085375,0,0
2,GO PROTEIN IMPORT,0.066316,0.11743,0.094566,0,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.071835,0.11743,0.1604,0,0
2,GO CELL KILLING,0.11061,0.11743,0.11036,0,0
2,GO PEPTIDYL ARGININE N METHYLATION,0.16068,0.11698,0.16857,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.23088,0.11687,0.21643,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.068115,0.1168,0.098463,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.20396,0.11667,0.059335,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.52728,0.11665,0.094206,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.38927,0.11655,0.11377,0,0
2,GO B CELL ACTIVATION,0.054786,0.11643,0.089822,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.38927,0.11637,0.074869,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.6603,0.11611,0.0118,0,0
2,GO REGULATION OF CELL ADHESION,0.35697,0.11608,0.047106,0,0
2,GO HISTONE PHOSPHORYLATION,0.10533,0.11589,0.072544,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.19971,0.11583,0.090003,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.04007,0.1158,0.10277,0,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.27056,0.11577,0.058038,0,0
2,GO NEPHRON DEVELOPMENT,0.20828,0.11557,0.069346,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.72243,0.11549,0.004801,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.26023,0.11526,0.11376,0,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.077726,0.11511,0.094672,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.4445,0.11508,0.09267,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.6603,0.11502,0.039721,0,0
2,GO BODY FLUID SECRETION,0.041252,0.11499,0.13631,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.15017,0.11487,0.090608,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.17173,0.11486,0.11544,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.15017,0.11481,0.093456,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.74054,0.1148,0.027164,0,0
2,GO NEPHRON MORPHOGENESIS,0.090686,0.11469,0.11225,0,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.1794,0.11402,0.061477,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.40947,0.11394,0.058077,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.39593,0.11387,0.077598,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.4445,0.11385,0.062969,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.084004,0.11371,0.10068,0,0
2,GO ANIMAL ORGAN REGENERATION,0.32052,0.11355,0.044169,0,0
2,GO RESPONSE TO ESTROGEN,0.17553,0.11352,0.094355,0,0
2,GO PEROXISOMAL TRANSPORT,0.057895,0.11331,0.13373,0,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.15712,0.11331,0.071892,0,0
2,GO REGULATION OF SYMBIOTIC PROCESS,0.10025,0.11328,0.11884,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.43029,0.11307,0.076605,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.030665,0.11306,0.16872,0,0
2,GO PROTEIN KINASE B SIGNALING,0.54313,0.11302,0.027018,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.031606,0.11296,0.2016,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.077726,0.11287,0.12291,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.034581,0.11252,0.13713,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.12472,0.11245,0.070738,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.19971,0.11245,0.16338,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.20396,0.1124,0.09354,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.32642,0.11231,0.094066,0,0
2,GO TOXIN TRANSPORT,0.1161,0.11201,0.091758,0,0
2,GO STEROL IMPORT,0.16798,0.11176,0.081178,0,0
2,GO POSTREPLICATION REPAIR,0.057895,0.11174,0.08055,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.26536,0.11174,0.069078,0,0
2,GO KERATINOCYTE MIGRATION,0.59207,0.11155,0.027185,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.25516,0.11145,0.053504,0,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.40267,0.11135,0.060623,0,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.19139,0.11122,0.067456,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.041252,0.11109,0.12239,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.15361,0.1109,0.073878,0,0
2,GO LEUKOCYTE DIFFERENTIATION,0.10794,0.11087,0.079059,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.16798,0.1108,0.10008,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.19139,0.11076,0.10422,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.51167,0.11062,0.06822,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.45898,0.11053,0.053972,0,0
2,GO EPIDERMIS DEVELOPMENT,0.14679,0.11048,0.095426,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.038917,0.11046,0.1393,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.45898,0.1099,0.060146,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.042464,0.10989,0.096289,0,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19971,0.10971,0.08223,0,0
2,GO TONGUE DEVELOPMENT,0.24039,0.10962,0.12583,0,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.22622,0.10958,0.15757,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.28658,0.10957,0.074195,0,0
2,GO VIRAL GENOME REPLICATION,0.27056,0.10951,0.075616,0,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.16068,0.10944,0.071505,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.22622,0.10943,0.10106,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.74054,0.10937,0.0056733,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.58378,0.10913,0.004872,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.11892,0.10906,0.089739,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.32052,0.10896,0.085138,0,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.1402,0.10895,0.095403,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.55115,0.10885,0.030085,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.29206,0.10884,0.077884,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.19971,0.10878,0.13334,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.2356,0.10874,0.091811,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.13384,0.10873,0.11781,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.92804,0.10869,-0.031183,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.14347,0.10861,0.093301,0,0
2,GO RESPONSE TO ALCOHOL,0.1161,0.10848,0.091413,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.044978,0.10835,0.10311,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.35697,0.10827,0.074122,0,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.054786,0.10817,0.16441,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.21712,0.10816,0.16151,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.062834,0.10807,0.10793,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.35072,0.1079,0.095216,0,0
2,GO LIPID HOMEOSTASIS,0.22622,0.10785,0.060213,0,0
2,GO EAR MORPHOGENESIS,0.14347,0.10769,0.087006,0,0
2,GO LIPID CATABOLIC PROCESS,0.18334,0.10739,0.069233,0,0
2,GO REGULATION OF PHAGOCYTOSIS,0.29206,0.1073,0.065597,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.04007,0.10713,0.10032,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.85194,0.10707,-0.066927,0,0
2,GO PEROXISOME ORGANIZATION,0.064555,0.10701,0.11892,0,0
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.45898,0.10681,0.073569,0,0
2,GO MYELOID CELL HOMEOSTASIS,0.090686,0.10678,0.10091,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.11333,0.10675,0.077691,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.21712,0.10655,0.072965,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.33239,0.10653,0.058726,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.74054,0.10648,0.068046,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.066316,0.1064,0.067953,0,0
2,GO TRANSLESION SYNTHESIS,0.10794,0.10638,0.081797,0,0
2,GO B CELL DIFFERENTIATION,0.16068,0.10636,0.075631,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.19552,0.10634,0.1072,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.33843,0.10632,0.036493,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.062834,0.10632,0.083263,0,0
2,GO SPROUTING ANGIOGENESIS,0.14347,0.10622,0.082194,0,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.15017,0.10611,0.081274,0,0
2,GO V D J RECOMBINATION,0.33843,0.1061,0.080725,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.4445,0.10595,0.023618,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.31468,0.1059,0.054048,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.70447,0.10576,0.0073171,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.19139,0.10573,0.12476,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.54313,0.10572,0.065546,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.38267,0.10566,0.096246,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.97598,0.1056,-0.02055,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.10794,0.10545,0.095838,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.086186,0.10528,0.085927,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.35072,0.10521,0.081595,0,0
2,GO REGULATION OF PLATELET ACTIVATION,0.29206,0.10513,0.10035,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.29206,0.10504,0.055258,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.25516,0.10493,0.083145,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.12472,0.10491,0.13546,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.11061,0.1047,0.15108,0,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.13699,0.10468,0.086919,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.059504,0.10467,0.080605,0,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.056323,0.1046,0.11137,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.20396,0.10441,0.19664,0,0
2,GO LIPID LOCALIZATION,0.26023,0.10441,0.048438,0,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.15017,0.10433,0.080248,0,0
2,GO LEUKOCYTE CHEMOTAXIS,0.24525,0.10428,0.070796,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.19139,0.10415,0.069987,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.33239,0.10405,0.046368,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.13074,0.10399,0.11494,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.10025,0.10397,0.062351,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.071835,0.10379,0.08578,0,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.093006,0.10351,0.11189,0,0
2,GO CELL CHEMOTAXIS,0.26023,0.10341,0.072578,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.1402,0.10337,0.084914,0,0
2,GO SNRNA PROCESSING,0.062834,0.10329,0.042715,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.71343,0.10321,-0.003872,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.17173,0.10296,0.091802,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.16798,0.10295,0.077384,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.22622,0.1029,0.095692,0,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.20396,0.10288,0.069097,0,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.27583,0.10279,0.078568,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.53518,0.10268,0.022917,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.6516,0.10249,-0.00013836,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.50395,0.10246,0.023252,0,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.24039,0.10246,0.031078,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.29761,0.10244,0.077554,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.23088,0.10238,0.070876,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.37614,0.10232,0.14113,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.2356,0.1023,0.078321,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.031606,0.10226,0.086471,0,0
2,GO RRNA TRANSCRIPTION,0.068115,0.1022,0.18579,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.42328,0.10217,0.034666,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.1794,0.10217,0.054081,0,0
2,GO DEFENSE RESPONSE TO VIRUS,0.16068,0.10212,0.091939,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.033564,0.102,0.08129,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.6516,0.10197,-0.002754,0,0
2,GO RUFFLE ASSEMBLY,0.15361,0.10185,0.076444,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.28117,0.10167,0.059456,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.48118,0.10137,-0.001549,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.35697,0.10132,0.084482,0,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.28117,0.101,0.12155,0,0
2,GO EPIBOLY,0.67783,0.101,0.0054258,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.30892,0.10098,0.063156,0,0
2,GO NODAL SIGNALING PATHWAY,0.2356,0.10053,0.086574,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.047616,0.10019,0.07834,0,0
2,GO MACROPHAGE MIGRATION,0.19139,0.10012,0.088815,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.39593,0.099383,0.032731,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.40947,0.099242,0.033793,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.33843,0.099095,0.06533,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.057895,0.098978,0.2142,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.14679,0.098973,0.1039,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.52728,0.098957,0.027777,0,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.036694,0.098838,0.13062,0,0
2,GO EPOXYGENASE P450 PATHWAY,0.46631,0.098794,0.061174,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.032572,0.098735,0.14312,0,0
2,GO CELL AGING,0.053284,0.098701,0.093572,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.079775,0.09863,0.096361,0,0
2,GO KERATINIZATION,0.1402,0.098599,0.14362,0,0
2,GO EMBRYO IMPLANTATION,0.47371,0.098513,0.032744,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.71343,0.098487,-0.095953,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.038917,0.098358,0.097405,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068115,0.098049,0.086761,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.4445,0.098038,0.04073,0,0
2,GO MYOBLAST DIFFERENTIATION,0.15017,0.097849,0.095536,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.20828,0.097823,0.085118,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.13699,0.097631,0.094105,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.35697,0.097354,0.065651,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.38267,0.097334,0.062592,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.27056,0.097257,0.086317,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.4963,0.097028,0.10773,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.19971,0.096948,0.070997,0,0
2,GO CELLULAR SENESCENCE,0.15712,0.096655,0.081247,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.1161,0.096535,0.11618,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.45898,0.096517,0.058611,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.22622,0.096202,0.13896,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.36329,0.096015,0.06239,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.54313,0.095951,0.092723,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.32052,0.095743,0.075765,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.21712,0.095739,0.057532,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.19139,0.095613,0.10067,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.10794,0.095555,0.088761,0,0
2,GO HEART VALVE FORMATION,0.4963,0.095435,0.10956,0,0
2,GO POSITIVE REGULATION OF CELL SIZE,0.45171,0.095383,0.060029,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.36329,0.095309,0.10483,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.11333,0.095199,0.16118,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.33239,0.095092,0.095018,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.043706,0.09501,0.10795,0,0
2,GO THYROID GLAND DEVELOPMENT,0.47371,0.094914,0.076476,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.20828,0.0949,0.094,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.27583,0.094896,0.061396,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.19971,0.094827,0.0987,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.35072,0.094815,0.12021,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.1643,0.094758,0.064545,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.1161,0.094732,0.077816,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.33239,0.094612,0.10749,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.50395,0.094442,0.073017,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.11061,0.094252,0.0838,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.48871,0.094184,0.044384,0,0
2,GO PIGMENT ACCUMULATION,0.26536,0.094072,0.084824,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.43029,0.094069,0.047155,0,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.18733,0.093984,0.060071,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.28658,0.093855,0.069301,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.46631,0.09385,0.09007,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.45898,0.093847,0.044783,0,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.19971,0.093798,0.05417,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.89939,0.093431,-0.0081113,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.48871,0.093328,0.028974,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.46631,0.093266,0.062495,0,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.15712,0.093175,0.064116,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.53518,0.093147,-0.018161,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.093006,0.093116,0.096647,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.1402,0.093114,0.093531,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.18334,0.092941,0.17351,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.18334,0.092905,0.078884,0,0
2,GO TRNA CATABOLIC PROCESS,0.4445,0.092876,0.13939,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46631,0.092735,0.045983,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.37614,0.092668,0.05607,0,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.21712,0.092584,0.085618,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.030665,0.092487,0.16077,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.52728,0.092301,0.034263,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.68667,0.092287,0.030779,0,0
2,GO MESONEPHROS DEVELOPMENT,0.4445,0.092199,0.048961,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.51167,0.092159,0.028691,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.069955,0.091994,0.10078,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.095374,0.091928,0.058366,0,0
2,GO PLATELET ACTIVATION,0.19552,0.091876,0.075678,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.13074,0.091838,0.08299,0,0
2,GO STEM CELL DIFFERENTIATION,0.084004,0.091808,0.063876,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.1794,0.091732,0.083574,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.28658,0.091726,0.066048,0,0
2,GO TISSUE REGENERATION,0.40947,0.091633,0.054831,0,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.24525,0.091459,0.083809,0,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.24039,0.091392,0.13709,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.10794,0.091059,0.090581,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.32052,0.090843,0.059122,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.40947,0.090765,0.035212,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.57554,0.090757,0.024853,0,0
2,GO NEGATIVE REGULATION OF SECRETION,0.1794,0.090662,0.079176,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.38927,0.090639,0.01841,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.064555,0.09056,0.072184,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.046281,0.090429,0.10033,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.16068,0.090359,0.051997,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.28658,0.090306,0.077691,0,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.52728,0.090231,0.073139,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.28658,0.090216,0.13513,0,0
2,GO SPERM EGG RECOGNITION,0.30892,0.090137,0.057657,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.066316,0.08979,0.085561,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.43736,0.089778,0.034578,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.7588,0.089575,0.011767,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.1643,0.089518,0.126,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.21712,0.089454,0.11956,0,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.41634,0.089429,0.035772,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.21712,0.089421,0.086704,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.036694,0.08941,0.10067,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.10533,0.089407,0.12119,0,0
2,GO KERATINOCYTE DIFFERENTIATION,0.1161,0.089165,0.14948,0,0
2,GO RESPONSE TO HEAT,0.079775,0.089131,0.087642,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.33239,0.089053,0.054305,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.64294,0.088839,0.044641,0,0
2,GO NADH METABOLIC PROCESS,0.15017,0.088808,0.13894,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.34454,0.08873,0.084744,0,0
2,GO RESPONSE TO ISCHEMIA,0.27056,0.088728,0.07101,0,0
2,GO MOLTING CYCLE,0.48871,0.088722,0.018938,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.47371,0.088681,0.057219,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.40947,0.088665,0.1189,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.47371,0.088582,0.056626,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.27056,0.088377,0.095209,0,0
2,GO ANION HOMEOSTASIS,0.7772,0.088091,0.016546,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.8614,0.088076,0.017195,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.27056,0.087586,0.055716,0,0
2,GO CELL CELL ADHESION,0.62578,0.08758,0.014848,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.24039,0.087563,0.058075,0,0
2,GO NUCLEAR TRANSPORT,0.046281,0.087534,0.088738,0,0
2,GO ENDOSOME ORGANIZATION,0.36968,0.087511,0.049063,0,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.52728,0.087251,0.041979,0,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.28117,0.087197,0.082565,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.12472,0.087176,0.065196,0,0
2,GO SECRETION BY TISSUE,0.15017,0.087133,0.19694,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.33843,0.087069,0.075813,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.1402,0.087037,0.082309,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.21712,0.086879,0.075902,0,0
2,GO RESPONSE TO VIRUS,0.19552,0.086792,0.064969,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.45898,0.086744,0.044893,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24039,0.086725,0.058462,0,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.12179,0.086715,0.078623,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.079775,0.086695,0.082612,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.54313,0.086416,0.032802,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.66904,0.086403,0.0080212,0,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.1402,0.086385,0.064827,0,0
2,GO RESPONSE TO INACTIVITY,0.6603,0.085852,0.051924,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.2356,0.085723,0.060679,0,0
2,GO ATP METABOLIC PROCESS,0.090686,0.085703,0.10168,0,0
2,GO HISTONE H3 DEACETYLATION,0.33239,0.085519,0.055246,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.23088,0.085516,0.053807,0,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.33843,0.085479,0.044589,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.20396,0.085463,0.1262,0,0
2,GO PROTEIN AUTOPROCESSING,0.92804,0.085433,-0.049789,0,0
2,GO SISTER CHROMATID COHESION,0.15017,0.085384,0.07932,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.31468,0.085062,0.077174,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.51944,0.084963,0.038789,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.13699,0.084736,0.11137,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.34454,0.084539,0.031875,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.32052,0.084502,0.023991,0,0
2,GO RECEPTOR INTERNALIZATION,0.35072,0.084498,0.07166,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.13699,0.0844,0.049205,0,0
2,GO PLACENTA DEVELOPMENT,0.26536,0.084343,0.073306,0,0
2,GO TISSUE HOMEOSTASIS,0.33843,0.084306,0.03758,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.090686,0.084251,0.11049,0,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.26023,0.08422,0.044385,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.78645,0.084137,-0.010186,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.088413,0.084071,0.091281,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.57554,0.084058,0.054272,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.28117,0.083896,0.05834,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.63434,0.083865,0.08103,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.56735,0.083814,0.069841,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.069955,0.083741,0.050474,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.29761,0.083716,0.068856,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.032572,0.083713,0.063647,0,0
2,GO NCRNA 3 END PROCESSING,0.07572,0.083647,0.068486,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.066316,0.083579,0.092403,0,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.11333,0.083543,0.11778,0,0
2,GO INNER EAR MORPHOGENESIS,0.28117,0.083464,0.072065,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.09779,0.083325,0.05875,0,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.12771,0.083268,0.12018,0,0
2,GO REGULATION OF PINOCYTOSIS,0.43029,0.083237,0.068685,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.36329,0.083118,0.10532,0,0
2,GO DNA METHYLATION,0.034581,0.083082,0.099079,0,0
2,GO REGULATION OF RESPONSE TO STRESS,0.22622,0.083012,0.043009,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.16798,0.083008,0.092665,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.36968,0.082876,0.065384,0,0
2,GO DRUG CATABOLIC PROCESS,0.51944,0.082759,0.033564,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.63434,0.082646,0.063302,0,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.073757,0.082643,0.083171,0,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.050383,0.082627,0.070679,0,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.19139,0.082574,0.12589,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.74966,0.082388,-0.018094,0,0
2,GO HISTONE ARGININE METHYLATION,0.21712,0.082351,0.091087,0,0
2,GO MYOBLAST FUSION,0.42328,0.082319,0.0363,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.92804,0.082288,0.0055126,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.13074,0.082106,0.15221,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.56735,0.081828,0.074983,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.20396,0.081789,0.096953,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.35697,0.081724,0.060993,0,0
2,GO RESPONSE TO ACTIVITY,0.18334,0.081707,0.076212,0,0
2,GO INTERLEUKIN 13 PRODUCTION,0.17173,0.081656,0.21064,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.90893,0.081579,0.0015944,0,0
2,GO MYOTUBE DIFFERENTIATION,0.25017,0.08157,0.049996,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.93762,0.081464,-0.037068,0,0
2,GO RRNA METHYLATION,0.16068,0.081357,0.089879,0,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.26023,0.081288,0.21736,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.31468,0.081245,0.057801,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.1161,0.08121,0.089212,0,0
2,GO HISTONE H2A UBIQUITINATION,0.63434,0.081142,0.027268,0,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.51944,0.081083,0.048657,0,0
2,GO HISTONE H2A ACETYLATION,0.34454,0.080946,0.041068,0,0
2,GO GRANULOCYTE CHEMOTAXIS,0.34454,0.080872,0.057324,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.60042,0.080859,0.06748,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.43029,0.080829,0.092609,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.8331,0.080814,-0.016964,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.43029,0.080787,0.054026,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.43029,0.080589,0.041016,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.35072,0.080547,0.037077,0,0
2,GO BLASTOCYST DEVELOPMENT,0.17173,0.080442,0.051642,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.1794,0.080388,0.061812,0,0
2,GO ZINC ION TRANSPORT,0.24525,0.080358,0.089236,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.1161,0.080246,0.089922,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.70447,0.080215,0.044309,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.30323,0.08019,0.076769,0,0
2,GO MACROPHAGE ACTIVATION,0.31468,0.080174,0.041602,0,0
2,GO OOCYTE DIFFERENTIATION,0.6516,0.080086,0.016777,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.073757,0.079521,0.081251,0,0
2,GO MACROPHAGE CHEMOTAXIS,0.30892,0.079384,0.083134,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.59207,0.079358,0.0071174,0,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.63434,0.079197,0.036498,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.55922,0.079187,0.055368,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.42328,0.079154,0.034952,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.10277,0.079117,0.071737,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.034581,0.078994,0.11083,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.043706,0.078994,0.073533,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.55115,0.078934,0.1044,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.78645,0.078793,0.003994,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.35072,0.078723,0.11682,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.43029,0.078719,0.08895,0,0
2,GO CHOLESTEROL STORAGE,0.57554,0.078668,0.019295,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.59207,0.078539,0.0093593,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.52728,0.078437,0.023547,0,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.30892,0.078418,0.041573,0,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.34454,0.078397,0.11782,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.64294,0.078352,0.022307,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.081867,0.078287,0.062522,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.29761,0.078156,0.047332,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.30892,0.078149,0.040825,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.37614,0.078131,0.046599,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.11061,0.078013,0.07406,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.80503,0.078005,-0.003364,0,0
2,GO SKIN DEVELOPMENT,0.23088,0.07779,0.080466,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.42328,0.07774,0.063784,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.36329,0.077599,0.052587,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.24039,0.077471,0.049776,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.57554,0.077468,-0.0057778,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.47371,0.077417,0.036676,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.52728,0.077158,0.029252,0,0
2,GO NCRNA TRANSCRIPTION,0.14679,0.077102,0.067425,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.24039,0.077036,0.043769,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.22622,0.076899,0.051704,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.38927,0.076606,0.041549,0,0
2,GO ASTROCYTE DEVELOPMENT,0.53518,0.076436,0.060233,0,0
2,GO ANOIKIS,0.40267,0.076415,0.063124,0,0
2,GO RENAL FILTRATION,0.81436,0.076412,0.015035,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.47371,0.076318,0.0648,0,0
2,GO HISTONE H3 K9 METHYLATION,0.42328,0.076289,0.047795,0,0
2,GO RESPONSE TO THYROID HORMONE,0.62578,0.076281,0.045001,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.21712,0.076241,0.048198,0,0
2,GO REGULATION OF CELL DEATH,0.31468,0.07616,0.042583,0,0
2,GO CYTOKINETIC PROCESS,0.56735,0.075954,0.054251,0,0
2,GO VASCULOGENESIS,0.47371,0.07589,0.048643,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.4445,0.07578,0.1034,0,0
2,GO POSITIVE T CELL SELECTION,0.19552,0.075774,0.089348,0,0
2,GO LYMPHOCYTE COSTIMULATION,0.4963,0.075709,0.038531,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.74966,0.075669,0.0078373,0,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.54313,0.075631,0.024753,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.42328,0.075517,0.040931,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.33239,0.075504,0.034336,0,0
2,GO SELECTIVE AUTOPHAGY,0.15361,0.075458,0.071721,0,0
2,GO EPITHELIAL TUBE FORMATION,0.15361,0.075434,0.06297,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.67783,0.07537,0.031627,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.18733,0.07533,0.068832,0,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.10794,0.075106,0.090064,0,0
2,GO RESPONSE TO DRUG,0.51944,0.075098,0.033532,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.67783,0.075029,0.03615,0,0
2,GO MUSCLE CELL MIGRATION,0.28117,0.07497,0.075919,0,0
2,GO RNA SURVEILLANCE,0.29761,0.074909,0.071125,0,0
2,GO LYSOSOME LOCALIZATION,0.55922,0.07488,0.029159,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.12179,0.074828,0.06044,0,0
2,GO ENDOCRINE PROCESS,0.15017,0.07479,0.093793,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.19971,0.07472,0.048998,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.30892,0.074698,0.063486,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18334,0.07468,0.079988,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.30892,0.074656,0.091667,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.6603,0.074437,0.003671,0,0
2,GO ERAD PATHWAY,0.1794,0.074416,0.043353,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.67783,0.074333,0.023243,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.11061,0.07426,0.071446,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.9472,0.074224,-0.038749,0,0
2,GO REGULATION OF BODY FLUID LEVELS,0.58378,0.074193,0.022125,0,0
2,GO THYMIC T CELL SELECTION,0.69555,0.07418,0.020599,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.64294,0.074102,-0.13037,0,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.15017,0.074091,0.11827,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.090686,0.07398,0.093561,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.11061,0.073856,0.11044,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.74966,0.073851,0.0073313,0,0
2,GO GLYCOSYLATION,0.55115,0.073691,-0.0034827,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.73147,0.073247,0.010292,0,0
2,GO HUMORAL IMMUNE RESPONSE,0.2356,0.073155,0.028397,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.98559,0.073142,-0.052159,0,0
2,GO SNORNA 3 END PROCESSING,0.46631,0.07312,0.071508,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.40267,0.073008,0.02047,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.088413,0.072987,0.10862,0,0
2,GO SNRNA METABOLIC PROCESS,0.043706,0.072875,0.052343,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.45171,0.072556,0.11606,0,0
2,GO DNA STRAND ELONGATION,0.19552,0.072537,0.072551,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.36329,0.072339,0.034487,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.30892,0.07226,0.060983,0,0
2,GO KIDNEY MORPHOGENESIS,0.18334,0.072251,0.077284,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.55115,0.072228,0.00023743,0,0
2,GO BRONCHUS DEVELOPMENT,0.55115,0.072226,0.10092,0,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.55115,0.07221,-0.00077233,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.21712,0.072036,0.071755,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.17173,0.07185,0.054932,0,0
2,GO INTERLEUKIN 1 PRODUCTION,0.18733,0.071396,0.11733,0,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.41634,0.071356,0.016511,0,0
2,GO EXOCYTOSIS,0.70447,0.071276,0.012755,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.34454,0.071234,0.048556,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.4963,0.07117,0.020814,0,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.35072,0.070913,0.04924,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.59207,0.070847,0.01748,0,0
2,GO CHROMATIN SILENCING,0.40947,0.070825,0.064555,0,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.48871,0.070801,0.037381,0,0
2,GO QUINONE METABOLIC PROCESS,0.32052,0.070759,0.036635,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.29761,0.070719,0.07369,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.45898,0.070674,0.053239,0,0
2,GO PLATELET AGGREGATION,0.54313,0.070617,0.046676,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.6516,0.070566,0.099192,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.59207,0.070379,0.059703,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.047616,0.070275,0.080027,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.13384,0.070217,0.045461,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.20828,0.070135,0.10591,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.38927,0.070022,0.068194,0,0
2,GO CELLULAR RESPONSE TO DSRNA,0.67783,0.069923,-0.0080411,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.12771,0.069775,0.057964,0,0
2,GO FILOPODIUM ASSEMBLY,0.37614,0.069671,0.069392,0,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.60042,0.069625,0.042346,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.19971,0.069601,0.11533,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.4963,0.069319,0.02604,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.87087,0.069295,-0.0071589,0,0
2,GO REGULATION OF ORGAN GROWTH,0.51944,0.069188,0.027499,0,0
2,GO HISTONE DEACETYLATION,0.064555,0.069153,0.081467,0,0
2,GO SLEEP,0.24039,0.068987,0.12062,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.16798,0.068977,0.080667,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.57554,0.068906,0.087648,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.1161,0.068812,0.045702,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.42328,0.068805,0.01514,0,0
2,GO RESPONSE TO BACTERIUM,0.21267,0.068755,0.051566,0,0
2,GO INTERFERON ALPHA PRODUCTION,0.41634,0.068548,0.085901,0,0
2,GO SEGMENTATION,0.36329,0.068432,0.041651,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.41634,0.068376,0.066651,0,0
2,GO EXIT FROM MITOSIS,0.29206,0.068127,0.057088,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.36968,0.068022,0.055895,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.91848,0.068015,-0.0053059,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.13384,0.067958,0.11245,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.41634,0.067914,0.027004,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.25516,0.067854,0.081724,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.45898,0.067826,-0.0075409,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.50395,0.067798,0.039064,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.46631,0.067743,0.031495,0,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.63434,0.067561,0.071761,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.32642,0.067549,0.083088,0,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.50395,0.067253,0.023408,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.42328,0.067245,0.073851,0,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.6603,0.066983,0.020828,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.40947,0.066968,0.036298,0,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.32052,0.066754,0.056802,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.55922,0.066752,-0.00359,0,0
2,GO OSTEOBLAST PROLIFERATION,0.7588,0.066741,0.0056906,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.29761,0.066712,0.081814,0,0
2,GO POLYOL CATABOLIC PROCESS,0.21712,0.066672,0.064625,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.29761,0.066643,0.051943,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.53518,0.066615,0.02716,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.43736,0.066559,0.072312,0,0
2,GO RECEPTOR RECYCLING,0.69555,0.066543,0.02611,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.11892,0.066429,0.076355,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.18733,0.066426,0.12892,0,0
2,GO GLIAL CELL ACTIVATION,0.53518,0.066054,0.016974,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.74966,0.06589,0.020961,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.11892,0.06574,0.16906,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.8331,0.065632,-0.021202,0,0
2,GO MYELOID CELL DIFFERENTIATION,0.21712,0.065626,0.05795,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.35072,0.065527,0.064526,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.11892,0.065384,0.074514,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.40267,0.065356,0.034924,0,0
2,GO EATING BEHAVIOR,0.41634,0.065353,0.052473,0,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.55115,0.065317,0.06835,0,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.18733,0.06525,0.10516,0,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.45898,0.06523,0.026711,0,0
2,GO REGULATION OF CELL SHAPE,0.38927,0.065187,0.041205,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.46631,0.065091,0.011264,0,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.42328,0.065019,0.041272,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.54313,0.064908,0.033836,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.42328,0.064846,0.026312,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.34454,0.064788,0.052467,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.36329,0.064693,0.058085,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.4963,0.064636,0.019305,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.6516,0.064588,0.03676,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.46631,0.064447,0.015192,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.23088,0.064411,0.065904,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.76799,0.06425,0.024603,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.43029,0.064247,0.046728,0,0
2,GO RESPONSE TO CHEMOKINE,0.43029,0.064226,0.019722,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.27583,0.063945,0.069839,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.47371,0.063792,0.030867,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.96638,0.063688,-0.061127,0,0
2,GO HISTONE EXCHANGE,0.12179,0.063682,0.081165,0,0
2,GO RESPONSE TO DSRNA,0.42328,0.063631,0.037662,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.97598,0.063551,-0.011344,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.30323,0.063511,0.029234,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.61728,0.063498,0.034406,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.07572,0.063493,0.090799,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.042464,0.063421,0.077673,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.95679,0.063381,0.0028739,0,0
2,GO MANNOSYLATION,0.36329,0.063238,0.027504,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.43736,0.062923,0.057907,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.38267,0.062856,0.017652,0,0
2,GO LIPID EXPORT FROM CELL,0.13699,0.062818,0.10284,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.87087,0.062581,-0.01192,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.28658,0.062548,0.047887,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.06115,0.062485,0.061531,0,0
2,GO RESPONSE TO PROTOZOAN,0.36968,0.06241,0.061721,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.19971,0.062372,0.10594,0,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.55922,0.062335,0.1561,0,0
2,GO DNA METABOLIC PROCESS,0.032572,0.062177,0.052895,0,0
2,GO BILE ACID METABOLIC PROCESS,0.23088,0.062116,0.08466,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.22622,0.062085,0.076941,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.58378,0.062074,0.031235,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.10533,0.06198,0.053081,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.66904,0.06194,0.02027,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.4445,0.061798,0.056989,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.24525,0.061791,0.086765,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.46631,0.061791,0.024926,0,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.51167,0.061706,0.020763,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.23088,0.06165,0.063468,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.36329,0.061646,0.059909,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.35072,0.061632,0.03307,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.36329,0.061584,0.052134,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.4963,0.061521,0.053183,0,0
2,GO DE NOVO PROTEIN FOLDING,0.71343,0.061453,0.019309,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.11333,0.061345,0.066201,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.42328,0.06123,0.017781,0,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.57554,0.061147,0.012875,0,0
2,GO RHYTHMIC BEHAVIOR,0.61728,0.061115,0.035474,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.25516,0.061043,0.041157,0,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.96638,0.060871,-0.029916,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.37614,0.060831,0.029252,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.12771,0.060745,0.11548,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.33843,0.060158,0.029198,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.46631,0.060112,0.088636,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.11061,0.060099,0.12427,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.21267,0.060006,0.043426,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.17173,0.059957,0.078837,0,0
2,GO PHOTOTRANSDUCTION,0.1643,0.059907,0.051385,0,0
2,GO LIPID STORAGE,0.26536,0.059863,0.067525,0,0
2,GO VIRAL RELEASE FROM HOST CELL,0.13074,0.059818,0.090121,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.12179,0.059773,0.083915,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.40267,0.059666,0.057065,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.24039,0.059515,0.048979,0,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.32052,0.059482,0.037042,0,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.23088,0.059473,0.057477,0,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.29761,0.059372,0.04473,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.64294,0.059344,0.021653,0,0
2,GO CELL CYCLE DNA REPLICATION,0.19552,0.059321,0.058896,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.60042,0.059267,0.1224,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.56735,0.059053,0.0088047,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.4445,0.058981,0.10102,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.19552,0.058865,0.028976,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.50395,0.058422,0.016991,0,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.35072,0.058361,0.068072,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.081867,0.05824,0.073166,0,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.1402,0.058168,0.086882,0,0
2,GO GLOMERULUS DEVELOPMENT,0.59207,0.058167,0.031072,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.79572,0.05813,0.017181,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.93762,0.058055,-0.053985,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.19971,0.057997,0.07273,0,0
2,GO GENITALIA DEVELOPMENT,0.36968,0.057841,0.055052,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.1794,0.057734,0.10599,0,0
2,GO MAINTENANCE OF LOCATION,0.24039,0.057707,0.053042,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.97598,0.057652,-0.0091674,0,0
2,GO IMPORT INTO NUCLEUS,0.38267,0.057571,0.06256,0,0
2,GO ORGAN GROWTH,0.76799,0.057552,0.0098664,0,0
2,GO REGULATION OF DNA REPAIR,0.22622,0.057496,0.042898,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.88987,0.057495,0.030558,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.36329,0.057442,0.03222,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.16068,0.057413,0.0544,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.62578,0.057386,0.0081619,0,0
2,GO METHIONINE METABOLIC PROCESS,0.92804,0.057356,-0.043648,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.43029,0.057252,0.016268,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.33239,0.05714,0.084926,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.7772,0.05703,-0.11243,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.30323,0.057011,0.030017,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.87087,0.05701,0.01205,0,0
2,GO APOPTOTIC PROCESS,0.40947,0.056944,0.026905,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.69555,0.056872,-0.00012816,0,0
2,GO COAGULATION,0.66904,0.056795,0.010933,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.55922,0.056639,0.010809,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.68667,0.056581,0.014798,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.58378,0.056541,0.033071,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.081867,0.056488,0.065558,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.4963,0.056423,0.085239,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.80503,0.056355,0.0069963,0,0
2,GO MEMBRANE INVAGINATION,0.92804,0.056273,-0.018109,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.67783,0.056259,0.038759,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.33843,0.056184,0.020294,0,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.28117,0.056138,0.044309,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.96638,0.056047,0.03941,0,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.30323,0.055991,0.073759,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.26536,0.055947,0.069335,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.32642,0.055791,0.11437,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.74054,0.055628,0.091576,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.54313,0.055623,0.058205,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.51167,0.055606,0.024233,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.30323,0.055574,0.073416,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.43029,0.0554,0.040626,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.55922,0.055323,0.085351,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.78645,0.055234,0.0033669,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.7588,0.05523,0.0062875,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.69555,0.055169,-0.046161,0,0
2,GO UV PROTECTION,0.82372,0.055043,-0.0035673,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.050383,0.054975,0.055051,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.8614,0.05491,0.0071852,0,0
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.8614,0.0549,-0.003789,0,0
2,GO PROTEIN TARGETING,0.32052,0.054866,0.050086,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.91848,0.054866,-0.020368,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.7772,0.054854,-0.012534,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.85194,0.054847,0.0016767,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.56735,0.054803,0.03238,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.92804,0.054793,-0.031461,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.53518,0.054669,0.074758,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.63434,0.054627,0.020305,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.8614,0.054558,-0.032916,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.63434,0.054531,-0.0017363,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.17173,0.054493,0.059828,0,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.2356,0.054375,0.070826,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.28117,0.054331,0.071603,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.6516,0.054324,0.010453,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.43029,0.054298,0.027911,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.63434,0.054262,0.013062,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.56735,0.054235,0.028226,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.26536,0.054233,0.071825,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.54313,0.054024,0.026016,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.42328,0.053942,0.089421,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.22622,0.053894,0.021944,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.7772,0.053876,0.034411,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.79572,0.053678,0.0058822,0,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.40267,0.053628,0.073814,0,0
2,GO RESPONSE TO PAIN,0.96638,0.053608,-0.019493,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.51167,0.053526,0.079315,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.21712,0.053224,0.036746,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.52728,0.053212,0.034192,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.28658,0.053139,0.020693,0,0
2,GO BIOLOGICAL ADHESION,0.95679,0.052993,-0.019578,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.053284,0.052792,0.043993,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.91848,0.052786,-0.020141,0,0
2,GO ACUTE PHASE RESPONSE,0.47371,0.052761,0.056337,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.62578,0.052753,0.041873,0,0
2,GO VASCULAR WOUND HEALING,0.9472,0.052505,-0.0093311,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.31468,0.052463,0.089796,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.55115,0.052363,0.0079569,0,0
2,GO SNORNA METABOLIC PROCESS,0.20396,0.052227,0.10201,0,0
2,GO T CELL SELECTION,0.36968,0.052112,0.066526,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.95679,0.052036,-0.019228,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.73147,0.051952,-0.04676,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.8331,0.051942,0.0020452,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.88987,0.051915,-0.016126,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.29761,0.051805,0.053269,0,0
2,GO VITAMIN METABOLIC PROCESS,0.30323,0.051804,0.058556,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.73147,0.051789,-0.0080735,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.98559,0.051727,-0.040319,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.80503,0.051682,0.016167,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.93762,0.051597,-0.11283,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.47371,0.051382,0.02442,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.97598,0.051362,-0.027451,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.4963,0.051309,0.032391,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.76799,0.051238,-0.0021569,0,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.36968,0.05118,0.048657,0,0
2,GO REPLICATIVE SENESCENCE,0.92804,0.051087,0.0076832,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.82372,0.051053,0.0041508,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.88987,0.050909,0.024253,0,0
2,GO TERPENOID METABOLIC PROCESS,0.52728,0.05086,0.04097,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.71343,0.050815,0.029995,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.82372,0.050764,0.014114,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.71343,0.050757,0.0082416,0,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.28117,0.050596,0.048895,0,0
2,GO SNRNA TRANSCRIPTION,0.088413,0.050548,0.051608,0,0
2,GO RESPONSE TO HORMONE,0.87087,0.050492,-0.0024457,0,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.28658,0.050417,0.049364,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.98559,0.05041,-0.0091507,0,0
2,GO MITOCHONDRIAL FUSION,0.36329,0.050344,0.033314,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.32052,0.050338,0.08294,0,0
2,GO BONE GROWTH,0.66904,0.050304,0.030658,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.69555,0.050211,0.02366,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.30892,0.05021,0.047004,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.23088,0.050101,0.068791,0,0
2,GO REGENERATION,0.79572,0.050057,-0.0028989,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.11061,0.050048,0.053301,0,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.38267,0.050028,0.082821,0,0
2,GO HOMEOSTATIC PROCESS,0.64294,0.050001,0.00221,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.17553,0.049879,0.050238,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.68667,0.049757,0.040279,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.45171,0.049738,0.019104,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.72243,0.049677,0.017625,0,0
2,GO LEUKOCYTE MIGRATION,0.58378,0.049647,0.022645,0,0
2,GO MYOBLAST PROLIFERATION,0.97598,0.049606,-0.024133,0,0
2,GO FEMALE GAMETE GENERATION,0.72243,0.049552,0.0032359,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.28658,0.049542,0.071401,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.24039,0.049531,0.059793,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.61728,0.049421,0.028197,0,0
2,GO PROTEOLYSIS,0.62578,0.049363,0.010234,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.64294,0.049352,0.020369,0,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.59207,0.049276,0.052875,0,0
2,GO CELLULAR RESPONSE TO LIPID,0.33239,0.049241,0.037868,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.71343,0.049167,0.03627,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.069955,0.048966,0.043681,0,0
2,GO FUCOSYLATION,0.28117,0.048924,0.087674,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.30323,0.048694,0.030291,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.43029,0.048692,0.055331,0,0
2,GO CHROMOSOME SEPARATION,0.13699,0.04863,0.054902,0,0
2,GO RESPONSE TO NUTRIENT,0.60883,0.048578,-0.050837,0,0
2,GO GRANULOCYTE MIGRATION,0.4963,0.048463,0.0305,0,0
2,GO REPLACEMENT OSSIFICATION,0.56735,0.048461,-0.0041934,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.40267,0.048442,0.05308,0,0
2,GO RESPONSE TO STEROID HORMONE,0.43736,0.048418,0.0312,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.55922,0.048393,0.022937,0,0
2,GO RESPONSE TO INSULIN,0.4445,0.04838,0.021981,0,0
2,GO DNA RECOMBINATION,0.15017,0.048323,0.047251,0,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.46631,0.048267,0.024722,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.10277,0.048119,0.034396,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.92804,0.048065,-0.018469,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.30323,0.048039,0.022101,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.17553,0.047949,0.046318,0,0
2,GO RECOMBINATIONAL REPAIR,0.29761,0.047914,0.053687,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.76799,0.047858,-0.12698,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.36329,0.047738,0.039788,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.97598,0.047604,-0.015865,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.85194,0.047483,-0.02007,0,0
2,GO BONE MORPHOGENESIS,0.62578,0.047478,0.010745,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.18334,0.047444,0.081809,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.98559,0.047339,-0.019984,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.95679,0.047186,0.031739,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.56735,0.046931,0.016156,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.35072,0.04685,0.069892,0,0
2,GO REGULATION OF T CELL MIGRATION,0.64294,0.046781,0.024806,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.4963,0.046732,0.018912,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.28658,0.046639,0.052225,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.4445,0.046568,0.015035,0,0
2,GO RETINA HOMEOSTASIS,0.74054,0.046523,0.00063336,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.34454,0.046463,0.083927,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.52728,0.046378,0.034645,0,0
2,GO INTERLEUKIN 12 PRODUCTION,0.78645,0.046344,0.001258,0,0
2,GO HISTONE H3 ACETYLATION,0.2356,0.046311,0.037126,0,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.48871,0.046305,0.01792,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.7588,0.046152,0.041991,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.48118,0.046141,-0.0018561,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.33239,0.046119,0.030461,0,0
2,GO REGULATION OF PROTEOLYSIS,0.55115,0.045906,0.027204,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.60883,0.045863,0.062844,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.26023,0.04584,0.036352,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.79572,0.045787,0.032528,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.35697,0.045751,0.039299,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.8614,0.045635,0.0053587,0,0
2,GO REGULATION OF MRNA BINDING,0.42328,0.045617,0.049642,0,0
2,GO MITOTIC CELL CYCLE,0.33843,0.045536,0.020555,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91848,0.045498,-0.014733,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.7772,0.045474,0.0084182,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.55922,0.045272,0.030368,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.48118,0.045257,0.037118,0,0
2,GO VESICLE ORGANIZATION,0.73147,0.045192,-0.015227,0,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.97598,0.04504,-0.02248,0,0
2,GO GLIAL CELL DEVELOPMENT,0.82372,0.04497,0.0087244,0,0
2,GO TUBE FORMATION,0.22164,0.044966,0.045177,0,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.45171,0.044779,0.026202,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.40267,0.044746,0.056365,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.29206,0.044732,0.10293,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.47371,0.044723,0.011189,0,0
2,GO INTRACELLULAR TRANSPORT,0.36329,0.044644,0.017511,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.30323,0.044633,0.027562,0,0
2,GO RESPONSE TO UV C,0.76799,0.044534,0.058665,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.67783,0.044532,0.02079,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.71343,0.044501,0.028158,0,0
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.91848,0.044442,-0.02333,0,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.48871,0.044383,0.047897,0,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.4963,0.044291,0.02162,0,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.40267,0.044276,0.029464,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.6516,0.044232,0.014199,0,0
2,GO CYTIDINE TO URIDINE EDITING,0.39593,0.044095,0.18921,0,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.43029,0.044079,0.071777,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.31468,0.044033,0.057408,0,0
2,GO REGULATION OF MRNA PROCESSING,0.37614,0.043945,0.04018,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.42328,0.043913,0.034498,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.62578,0.043799,0.011491,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.22164,0.043622,0.064566,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.48871,0.043557,0.087388,0,0
2,GO CHROMOSOME ORGANIZATION,0.035624,0.043443,0.053062,0,0
2,GO PH REDUCTION,0.48118,0.043431,0.034353,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.48871,0.043422,0.026599,0,0
2,GO RRNA CATABOLIC PROCESS,0.52728,0.043402,0.04527,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.1794,0.043268,0.032606,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.33843,0.043095,0.058384,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.48118,0.043032,0.06086,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.58378,0.043027,0.026999,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.69555,0.043013,-0.091744,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.086186,0.042997,0.088066,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.50395,0.042883,0.054789,0,0
2,GO KINETOCHORE ASSEMBLY,0.55115,0.042692,-0.063399,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.32052,0.042668,0.068341,0,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.19552,0.042638,0.062207,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.26536,0.042552,0.043868,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.60042,0.042533,0.048055,0,0
2,GO REGULATION OF ERAD PATHWAY,0.42328,0.042245,0.032583,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.58378,0.042214,0.025406,0,0
2,GO RESPONSE TO TESTOSTERONE,0.7772,0.042189,0.01389,0,0
2,GO ASYMMETRIC CELL DIVISION,0.4963,0.042168,0.0451,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.54313,0.042021,0.011904,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.38927,0.041998,0.064467,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.93762,0.041944,-0.052112,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.9952,0.041878,-0.030661,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.38267,0.041845,0.069279,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.25516,0.041824,0.15857,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.6603,0.041568,0.021954,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.79572,0.041531,0.012689,0,0
2,GO G0 TO G1 TRANSITION,0.8614,0.041474,-0.013147,0,0
2,GO ERK1 AND ERK2 CASCADE,0.34454,0.041462,0.057625,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.1794,0.041417,0.0679,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.54313,0.04135,0.022371,0,0
2,GO REGULATION OF AUTOPHAGY,0.48871,0.041337,0.019557,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.79572,0.041209,0.007008,0,0
2,GO SECRETION,0.98559,0.041147,-0.019597,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.6603,0.041047,0.0091437,0,0
2,GO SISTER CHROMATID SEGREGATION,0.26023,0.041032,0.049255,0,0
2,GO CHROMOSOME CONDENSATION,0.37614,0.041026,0.040982,0,0
2,GO SYNCYTIUM FORMATION,0.50395,0.041024,0.02913,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.80503,0.040941,-0.0063502,0,0
2,GO VIRAL BUDDING,0.87087,0.040826,-0.0016445,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.33843,0.040716,0.053809,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.37614,0.040671,0.05775,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.40947,0.040563,0.026467,0,0
2,GO RESPONSE TO FOOD,0.79572,0.040528,0.012112,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.1794,0.040486,0.16065,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.37614,0.040418,0.069715,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.68667,0.040348,0.015052,0,0
2,GO DNA PACKAGING,0.27583,0.040335,0.040169,0,0
2,GO CYTOLYSIS,0.55115,0.040193,0.076431,0,0
2,GO GLIAL CELL PROLIFERATION,0.43736,0.040142,0.035235,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.92804,0.040132,0.021128,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.80503,0.040027,0.0020713,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.26536,0.039869,0.32547,0,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.35697,0.039804,0.043707,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.11061,0.039758,0.043119,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.95679,0.039667,-0.0066361,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.87087,0.039652,-0.010388,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.36968,0.039574,0.057355,0,0
2,GO MIDBODY ABSCISSION,0.6603,0.039436,0.046122,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.96638,0.03931,-0.023751,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.78645,0.039297,0.02096,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.29761,0.039261,0.039486,0,0
2,GO WOUND HEALING,0.73147,0.039183,0.0095926,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.40267,0.03912,0.040784,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.91848,0.039034,-0.044163,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.60883,0.039025,0.01612,0,0
2,GO SARCOMERE ORGANIZATION,0.82372,0.038797,0.01164,0,0
2,GO RESPONSE TO HYDROXYUREA,0.45171,0.038722,0.078925,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.98559,0.038697,-0.007515,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.84251,0.038662,-0.018218,0,0
2,GO TISSUE MIGRATION,0.30323,0.038647,0.052043,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.70447,0.038615,0.011721,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.98559,0.038324,0.0078083,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.90893,0.038277,-0.027014,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.38927,0.03826,0.010347,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.82372,0.038182,0.012981,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.9472,0.038127,-0.006307,0,0
2,GO AORTA MORPHOGENESIS,0.91848,0.03808,-0.0019581,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.89939,0.038058,0.048757,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.69555,0.038004,0.019222,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.60883,0.037996,0.028059,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.68667,0.037982,0.023817,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.8614,0.037911,-0.015726,0,0
2,GO INTERLEUKIN 6 PRODUCTION,0.73147,0.037904,0.017207,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.48118,0.037803,0.015764,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.58378,0.037718,0.064126,0,0
2,GO RESPONSE TO RADIATION,0.37614,0.037674,0.019774,0,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.98559,0.03756,-0.018794,0,0
2,GO HISTONE H3 K4 METHYLATION,0.62578,0.037532,0.048193,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.91848,0.037341,-0.00080879,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.85194,0.037304,0.018561,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.45171,0.037299,0.035004,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.45171,0.037287,0.009304,0,0
2,GO NATURAL KILLER CELL PROLIFERATION,0.50395,0.037257,0.080086,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.25017,0.037238,0.021904,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.42328,0.037136,0.012425,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.52728,0.036966,0.026485,0,0
2,GO LIVER MORPHOGENESIS,0.48871,0.036915,0.046374,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.32052,0.036914,0.0297,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.78645,0.036864,0.0050243,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.7588,0.036823,0.0065939,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.9472,0.03679,-0.0089203,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.63434,0.036751,0.076463,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.51944,0.036734,0.04164,0,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.50395,0.036683,0.030521,0,0
2,GO ARGININE METABOLIC PROCESS,0.37614,0.036646,0.10734,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.84251,0.036644,-0.020919,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.97598,0.036566,-0.011087,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.97598,0.036537,-0.028983,0,0
2,GO ENDOSOMAL TRANSPORT,0.4445,0.0363,0.028347,0,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.20828,0.036264,0.05685,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.76799,0.036186,0.021887,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.40267,0.036018,0.025953,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.60042,0.035923,0.020929,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.9472,0.035906,-0.01363,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.9952,0.035822,0.00098191,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.78645,0.035669,-0.0059519,0,0
2,GO XENOBIOTIC TRANSPORT,0.62578,0.035603,-0.069137,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.28658,0.035549,0.025035,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.6603,0.035458,-0.10097,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.4445,0.035411,0.018451,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.97598,0.035409,0.0035067,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.54313,0.035366,0.014725,0,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.29206,0.03533,0.14429,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.63434,0.035277,0.015688,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.66904,0.035234,-0.007818,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.80503,0.03519,-0.019187,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.27583,0.035017,0.038234,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.43736,0.034976,0.086359,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.84251,0.034867,-0.034913,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.9472,0.03483,-0.015812,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.87087,0.034726,-0.011459,0,0
2,GO MISMATCH REPAIR,0.67783,0.034702,0.011278,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.88987,0.034695,-0.032614,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.58378,0.03466,0.043073,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.58378,0.034552,0.030982,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.93762,0.034414,-0.031418,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.89939,0.034396,-0.029146,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.72243,0.034347,0.018296,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.7588,0.034344,0.0079303,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.84251,0.034336,-0.001231,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.26536,0.034313,0.034324,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.6603,0.03421,0.049137,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.12771,0.034114,0.034487,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.59207,0.034106,0.037094,0,0
2,GO RESPONSE TO FATTY ACID,0.68667,0.034103,0.0085643,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.6603,0.033934,0.013227,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.59207,0.033925,0.0049662,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.73147,0.03383,0.011396,0,0
2,GO DNA REPLICATION CHECKPOINT,0.36329,0.033755,0.064156,0,0
2,GO CELLULAR DEFENSE RESPONSE,0.72243,0.033727,-0.024708,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.68667,0.033724,0.021078,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.85194,0.033679,0.010155,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.89939,0.033629,-0.046725,0,0
2,GO PIRNA METABOLIC PROCESS,0.81436,0.033608,-0.027011,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.81436,0.033583,0.019299,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.7588,0.033511,0.0018942,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.47371,0.033455,0.041129,0,0
2,GO CHROMATIN ORGANIZATION,0.14347,0.033415,0.035949,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.35697,0.033379,0.041664,0,0
2,GO RESPONSE TO LIPID,0.53518,0.033339,0.018478,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.84251,0.03326,-0.011717,0,0
2,GO SPINDLE ASSEMBLY,0.89939,0.033219,-0.019254,0,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.61728,0.033215,0.0058781,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.96638,0.033162,-0.013587,0,0
2,GO EMBRYO DEVELOPMENT,0.84251,0.032976,-0.01814,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.80503,0.032898,0.024575,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.87087,0.032781,-0.03096,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.7772,0.032609,0.0065319,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.37614,0.032462,0.10801,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.73147,0.032367,-0.012554,0,0
2,GO PROTEIN MATURATION,0.63434,0.032287,0.017592,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.46631,0.032251,0.040036,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.52728,0.032237,0.021239,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.8614,0.032158,-0.0062289,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.95679,0.032155,-0.0029754,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.48118,0.032085,0.030453,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.80503,0.03208,0.0072156,0,0
2,GO METAL ION HOMEOSTASIS,0.88987,0.032038,0.00038966,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.48118,0.032008,0.051872,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.91848,0.031922,-0.00023913,0,0
2,GO HYPOTONIC RESPONSE,0.59207,0.031897,0.082224,0,0
2,GO DNA DEAMINATION,0.51167,0.031884,0.10848,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.74054,0.031658,0.013722,0,0
2,GO HORMONE METABOLIC PROCESS,0.69555,0.031652,0.0060904,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.35072,0.031616,0.18214,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.64294,0.0314,-0.043783,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.33239,0.031314,0.03178,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.19139,0.031297,0.05712,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.72243,0.031236,0.015756,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.64294,0.031191,0.054793,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.84251,0.031032,-0.0096344,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.7772,0.031023,0.0048292,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.78645,0.031018,-0.018852,0,0
2,GO MACROMOLECULE DEACYLATION,0.45898,0.030981,0.03041,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.95679,0.030973,-0.029133,0,0
2,GO INFLAMMATORY RESPONSE,0.54313,0.03097,0.008183,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.39593,0.030962,0.031717,0,0
2,GO VISUAL BEHAVIOR,0.92804,0.030877,-0.052168,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.6516,0.030844,0.022226,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.68667,0.030789,0.032565,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.40267,0.030704,0.065849,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.89939,0.030658,0.0038174,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.60042,0.030609,0.022853,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.29206,0.030564,0.028274,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.45171,0.030519,0.031103,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.48118,0.030447,0.014436,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.53518,0.030433,0.024582,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.8331,0.030301,-0.0053833,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.92804,0.03019,0.068992,0,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.8614,0.030154,-0.018529,0,0
2,GO RESPONSE TO KETONE,0.53518,0.030108,0.026316,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.76799,0.030098,0.0034486,0,0
2,GO HAIR CELL DIFFERENTIATION,0.90893,0.030085,-0.0056455,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.91848,0.029981,-0.033274,0,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.45898,0.029939,0.03219,0,0
2,GO RESPONSE TO UV,0.29761,0.029933,0.041039,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.7588,0.0298,0.027101,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.8331,0.029683,-0.014857,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.93762,0.029586,-0.040239,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.51167,0.029581,0.035012,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.56735,0.029578,0.012829,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.45171,0.029464,0.025315,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87087,0.029456,-0.001529,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.61728,0.029382,0.0037604,0,0
2,GO STRESS FIBER ASSEMBLY,0.74966,0.029194,0.012179,0,0
2,GO CELLULAR EXTRAVASATION,0.97598,0.029104,-0.016804,0,0
2,GO T CELL HOMEOSTASIS,0.98559,0.029021,-0.012878,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.67783,0.028973,0.012407,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.35697,0.028946,0.03433,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.7772,0.028904,-0.0015982,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.70447,0.028879,0.0090551,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.87087,0.028854,-0.00089394,0,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.28658,0.028817,0.074357,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.66904,0.028797,-0.0016603,0,0
2,GO T CELL LINEAGE COMMITMENT,0.45171,0.028778,0.079071,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.74966,0.028679,0.01012,0,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.60042,0.028665,0.049074,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.1794,0.028598,0.055893,0,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.48118,0.028569,0.034445,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.82372,0.028544,-0.011047,0,0
2,GO PROTEIN DEMETHYLATION,0.56735,0.028356,0.049547,0,0
2,GO RESPONSE TO HYPEROXIA,0.9472,0.028338,-0.040006,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.88987,0.028319,-0.010602,0,0
2,GO HINDLIMB MORPHOGENESIS,0.55922,0.028312,0.016828,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.64294,0.028269,0.050992,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.84251,0.02818,0.018915,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.60883,0.028129,0.03634,0,0
2,GO REPLICATION FORK PROCESSING,0.54313,0.027811,0.037183,0,0
2,GO RECEPTOR CLUSTERING,0.84251,0.027779,-0.022307,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.57554,0.027708,0.01327,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.43029,0.027701,0.047744,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.71343,0.027696,0.015239,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.50395,0.027651,0.037069,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.45898,0.027626,0.021209,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.45171,0.027589,0.014591,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.53518,0.02757,0.026619,0,0
2,GO MESODERM DEVELOPMENT,0.51944,0.02756,0.027445,0,0
2,GO CELL CYCLE PROCESS,0.41634,0.027517,0.013857,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.42328,0.027512,0.050801,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.73147,0.02743,-0.0067265,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.67783,0.027395,0.054777,0,0
2,GO CHOLESTEROL EFFLUX,0.78645,0.027359,-0.0062128,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.90893,0.027175,-0.0035971,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.64294,0.02715,0.01825,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.69555,0.026996,-0.053322,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.55115,0.02696,0.057315,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.73147,0.026949,-0.029567,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.92804,0.026834,-0.0039416,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.62578,0.026773,0.0035269,0,0
2,GO DECIDUALIZATION,0.88987,0.026771,-0.057344,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.63434,0.026755,-0.039653,0,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.51944,0.026697,0.021065,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.54313,0.026642,0.017548,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.88036,0.026516,-0.0010975,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.95679,0.026345,-0.0072092,0,0
2,GO RESPONSE TO VITAMIN D,0.4963,0.026294,-0.1227,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.36968,0.026259,0.095286,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.92804,0.026107,-0.001769,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.45898,0.026101,0.087186,0,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.6603,0.026052,0.052293,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.9952,0.025904,-0.0012522,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.9952,0.025901,-0.028612,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.64294,0.025795,0.008737,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.92804,0.025666,-0.0034396,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.91848,0.025597,-0.015552,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.55115,0.025503,0.01745,0,0
2,GO RESPONSE TO CORTICOSTEROID,0.47371,0.025437,0.043686,0,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.90893,0.025317,-0.024618,0,0
2,GO PERICARDIUM DEVELOPMENT,0.8614,0.025229,0.0029076,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.39593,0.025151,0.092066,0,0
2,GO CELLULAR HOMEOSTASIS,0.81436,0.025147,0.0010797,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.50395,0.025125,0.12229,0,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.51944,0.024979,0.03941,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.37614,0.024814,0.051387,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.74966,0.024813,-0.16311,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.79572,0.02477,-0.031585,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.87087,0.024692,-0.016598,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.4445,0.024481,0.02566,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.95679,0.024479,-0.010337,0,0
2,GO PIGMENTATION,0.87087,0.024369,0.0066155,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.73147,0.024119,0.011116,0,0
2,GO METANEPHROS MORPHOGENESIS,0.6516,0.024021,0.033176,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.81436,0.023861,-0.11409,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.74966,0.023752,-0.029878,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.60883,0.023626,0.062794,0,0
2,GO PROTEIN STABILIZATION,0.8614,0.0236,0.00010874,0,0
2,GO REGULATION OF CELL CYCLE,0.80503,0.023523,-0.0011544,0,0
2,GO ION HOMEOSTASIS,0.97598,0.023431,-0.0086359,0,0
2,GO REGULATION OF RNA SPLICING,0.27583,0.023371,0.079867,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.72243,0.023336,0.04831,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.48118,0.023288,0.033459,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.96638,0.023212,-0.0049243,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.9472,0.022939,-0.013673,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.90893,0.022922,-0.015595,0,0
2,GO CELLULAR PIGMENTATION,0.59207,0.022905,0.049257,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.66904,0.022872,0.008674,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.53518,0.022856,0.052303,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.66904,0.0226,0.019389,0,0
2,GO CELL CYCLE,0.59207,0.022449,0.0064073,0,0
2,GO TELOMERE CAPPING,0.64294,0.022361,0.020442,0,0
2,GO PROTEIN DENEDDYLATION,0.66904,0.022354,-0.052847,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.90893,0.022341,-0.0053438,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.7772,0.022251,-0.004998,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.93762,0.022176,-0.0094379,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.92804,0.022119,-0.031572,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.90893,0.022072,-0.028999,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.79572,0.022046,-0.045836,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.78645,0.022035,0.019148,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.55922,0.021891,0.02792,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.74054,0.021829,-0.0489,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.8331,0.021801,-0.0049357,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.68667,0.021762,-0.070071,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.92804,0.02168,0.029579,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.9472,0.021653,-0.0020404,0,0
2,GO METAPHASE PLATE CONGRESSION,0.52728,0.021428,0.032858,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.85194,0.021406,-0.0060866,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.96638,0.021399,-0.0083725,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.8614,0.021359,-0.056354,0,0
2,GO SPLEEN DEVELOPMENT,0.35697,0.021283,0.07831,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.80503,0.021194,-0.04944,0,0
2,GO CHROMOSOME SEGREGATION,0.55922,0.021176,0.019268,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.25017,0.020873,0.14662,0,0
2,GO SEX DETERMINATION,0.74966,0.020867,0.015651,0,0
2,GO ER OVERLOAD RESPONSE,0.8331,0.020835,0.0079727,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.78645,0.020828,-0.07867,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.97598,0.020772,-0.0046065,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.6603,0.020737,0.03352,0,0
2,GO REGULATION OF CELLULAR PH,0.85194,0.020648,0.0012236,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.48118,0.02061,0.027624,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.66904,0.02052,0.084304,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.95679,0.020306,-0.0015254,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.6603,0.020267,0.050146,0,0
2,GO CYTOSOLIC TRANSPORT,0.61728,0.020185,0.013966,0,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.47371,0.020125,0.041481,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.92804,0.020108,-0.021875,0,0
2,GO CELLULAR RESPONSE TO UV,0.48871,0.020045,0.027775,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.88036,0.020018,-0.011499,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.48118,0.020013,0.0086904,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.56735,0.020006,0.0047795,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.76799,0.019616,0.032642,0,0
2,GO VITAMIN TRANSPORT,0.8614,0.01943,-0.035862,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.67783,0.019266,0.010419,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.60042,0.019156,0.14616,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.68667,0.018993,0.028221,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.79572,0.018987,0.025786,0,0
2,GO PROTEIN TETRAMERIZATION,0.90893,0.018952,0.0018373,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.97598,0.01893,-0.0014847,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.74054,0.018886,0.064481,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57554,0.018883,0.018061,0,0
2,GO MEMBRANE ORGANIZATION,0.93762,0.018882,-0.015389,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.69555,0.018882,0.046335,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.8614,0.018743,-0.020766,0,0
2,GO RESPONSE TO LEAD ION,0.66904,0.018645,0.044477,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.9472,0.018599,-0.0089905,0,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.60042,0.018595,0.014104,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.7772,0.018576,0.020766,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.91848,0.018522,-0.014149,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.76799,0.018465,-0.016575,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.37614,0.018135,0.028552,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.95679,0.018028,-0.065241,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.89939,0.017951,-0.031837,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.42328,0.017842,0.06878,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.64294,0.017793,-0.032779,0,0
2,GO NEUTROPHIL MIGRATION,0.90893,0.017787,-0.032367,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.8331,0.017672,0.0095425,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.88036,0.017566,-0.0017949,0,0
2,GO LIPID TRANSLOCATION,0.91848,0.017406,-0.019054,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.74966,0.017387,0.030313,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.93762,0.017368,-0.0084204,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.59207,0.017148,0.033875,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.55922,0.017052,0.025718,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.91848,0.016941,-0.010378,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.98559,0.016897,-0.012655,0,0
2,GO GENETIC IMPRINTING,0.87087,0.016741,0.013381,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.82372,0.016703,-0.023104,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.8331,0.016675,-0.018665,0,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.96638,0.016645,-0.051799,0,0
2,GO PROTEIN REFOLDING,0.66904,0.016486,0.037181,0,0
2,GO L GLUTAMATE IMPORT,0.76799,0.016469,-0.10031,0,0
2,GO CERAMIDE TRANSPORT,0.8331,0.016218,0.063673,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.63434,0.016059,-0.10417,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.60042,0.015937,0.036403,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.43029,0.015746,0.034086,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.97598,0.015694,-0.0078234,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.88036,0.015615,-0.090793,0,0
2,GO CENTRIOLE ASSEMBLY,0.71343,0.015578,0.030241,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.98559,0.015467,0.013364,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.76799,0.015264,0.0094917,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.53518,0.01517,0.041941,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.6603,0.015163,-0.046991,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.6516,0.015121,0.024731,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.90893,0.015085,-0.02237,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.8331,0.014966,0.0096909,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.80503,0.014596,-0.054646,0,0
2,GO SEX DIFFERENTIATION,0.95679,0.01454,-0.0091282,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.6516,0.014539,-0.036757,0,0
2,GO NEURAL TUBE FORMATION,0.58378,0.01449,0.02429,0,0
2,GO ORGANELLE DISASSEMBLY,0.96638,0.014303,-0.0020567,0,0
2,GO GOLGI ORGANIZATION,0.90893,0.0143,-0.028905,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.76799,0.014234,0.01422,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.8614,0.014172,-0.084691,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.90893,0.014153,-0.02856,0,0
2,GO REGULATION OF LIPID STORAGE,0.53518,0.014023,0.032952,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.90893,0.01398,-0.010918,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.7772,0.013951,-0.019699,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.45171,0.013894,0.050404,0,0
2,GO REGULATION OF URINE VOLUME,0.82372,0.013728,0.066138,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.68667,0.013648,0.01571,0,0
2,GO CELL MOTILITY,0.68667,0.013634,-0.039446,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.82372,0.013504,-0.00079831,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.7772,0.013357,-0.029122,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.53518,0.013326,0.022736,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.8614,0.013309,-0.01229,0,0
2,GO NEURAL TUBE DEVELOPMENT,0.9472,0.013264,-0.011079,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.60042,0.013076,0.024358,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.91848,0.012969,-0.0043393,0,0
2,GO PROTEIN ACETYLATION,0.36968,0.012778,0.020056,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.9952,0.012732,0.0098127,0,0
2,GO INTERLEUKIN 4 PRODUCTION,0.89939,0.012714,-0.0056125,0,0
2,GO MITOTIC CYTOKINESIS,0.88036,0.012693,-0.0094282,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.74966,0.012637,-0.037918,0,0
2,GO PROTEIN ACYLATION,0.67783,0.012622,-0.010899,0,0
2,GO MYELOID CELL DEVELOPMENT,0.97598,0.012618,-0.000519,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.72243,0.012443,0.0077612,0,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.72243,0.012417,0.026518,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.72243,0.012363,0.028535,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.97598,0.012344,-0.071272,0,0
2,GO MUSCLE CELL PROLIFERATION,0.82372,0.012295,-0.0040246,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.93762,0.012162,-0.0041974,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.6603,0.01216,-0.073568,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.76799,0.012112,0.053226,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.7588,0.012041,-0.019172,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.56735,0.011931,0.050636,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.91848,0.01193,0.0050477,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.45171,0.011722,0.070954,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.84251,0.011615,0.010861,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.73147,0.011579,-0.020909,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.71343,0.01154,0.029879,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.91848,0.011512,0.01842,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.68667,0.011499,0.06216,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.68667,0.011473,-0.024191,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.87087,0.011464,0.020732,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.92804,0.011188,-0.044028,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.58378,0.0111,-0.037827,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.76799,0.011043,-0.011587,0,0
2,GO CHEMICAL HOMEOSTASIS,0.93762,0.011002,-0.018877,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.9952,0.010888,0.0062374,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.79572,0.010589,0.0030273,0,0
2,GO JNK CASCADE,0.85194,0.010579,-0.010564,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.96638,0.010518,-0.037223,0,0
2,GO DNA DEALKYLATION,0.51167,0.010484,0.070696,0,0
2,GO RESPONSE TO L GLUTAMATE,0.90893,0.01036,-0.03848,0,0
2,GO MYOFIBRIL ASSEMBLY,0.74966,0.010321,0.010913,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.84251,0.010229,-0.039143,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.50395,0.010189,-0.10249,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.40947,0.010143,0.080908,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.88987,0.010004,-0.0067655,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.71343,0.0099968,-0.051068,0,0
2,GO RESPONSE TO WOUNDING,0.93762,0.0099691,-0.027187,0,0
2,GO APPENDAGE DEVELOPMENT,0.97598,0.0099684,-0.023232,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.55922,0.0099116,-0.035397,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.9952,0.0098736,-0.046093,0,0
2,GO CELL CYCLE CHECKPOINT,0.46631,0.0098329,0.026016,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.71343,0.0096986,0.017973,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.74966,0.009694,0.0030555,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.7588,0.0095893,0.062048,0,0
2,GO CELL DIVISION,0.9952,0.0095324,-0.0078863,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.97598,0.0094649,-0.017872,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.95679,0.0094064,0.0029322,0,0
2,GO ORGANIC ACID TRANSPORT,0.55922,0.0093496,-0.046656,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.92804,0.009337,-0.026575,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.9952,0.0092594,-0.008525,0,0
2,GO RESPONSE TO METAL ION,0.80503,0.0091552,-0.021544,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.9472,0.0091224,-0.0020794,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.56735,0.0090698,-0.07062,0,0
2,GO VACUOLE ORGANIZATION,0.46631,0.0090443,-0.049955,0,0
2,GO T CELL MIGRATION,0.69555,0.00893,-0.045227,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.55922,0.0088429,-0.026417,0,0
2,GO HISTONE H3 K36 METHYLATION,0.69555,0.0086573,0.033393,0,0
2,GO MITOCHONDRIAL FISSION,0.98559,0.008547,-0.023064,0,0
2,GO RESPONSE TO SALT STRESS,0.92804,0.0082979,0.030049,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.87087,0.0082889,0.00033334,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.89939,0.0081355,-0.0361,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.79572,0.0081348,0.0055088,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.91848,0.0080755,0.0064158,0,0
2,GO RESPONSE TO ESTRADIOL,1,0.0080331,-0.01092,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.55115,0.0080104,0.048607,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.74966,0.007965,-0.028599,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.51944,0.0079044,-0.030212,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.51167,0.0078513,0.15945,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.60042,0.0078106,0.048956,0,0
2,GO INOSITOL METABOLIC PROCESS,0.73147,0.0077052,-0.040469,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.8331,0.0075504,0.0035869,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.88987,0.0074843,-0.010248,0,0
2,GO O GLYCAN PROCESSING,0.84251,0.0074622,0.012085,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.87087,0.0073751,0.014833,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.46631,0.0073388,0.048691,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.89939,0.0072475,-0.060297,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.88036,0.0069386,-0.012658,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.55922,0.0068333,0.043296,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.90893,0.0068223,-0.038795,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.84251,0.0068041,-0.022688,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.88987,0.0067765,0.0598,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.55115,0.0066481,0.036632,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.73147,0.0066367,0.054237,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.47371,0.0065931,-0.06026,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.71343,0.006548,0.048039,0,0
2,GO MACROPHAGE PROLIFERATION,0.9952,0.0065063,-0.045189,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.88036,0.0064989,-0.0095767,0,0
2,GO EPITHELIUM DEVELOPMENT,0.9952,0.0064559,-0.0075263,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.97598,0.00644,-0.0021832,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.68667,0.0062901,0.062892,0,0
2,GO REGULATION OF BEHAVIOR,0.9952,0.0062683,0.0005121,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.7772,0.0061597,0.032883,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.96638,0.006141,-0.0061786,0,0
2,GO ACID SECRETION,0.73147,0.0061308,0.032858,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.74054,0.0061007,-0.036053,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.95679,0.0058807,-0.00025599,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.6603,0.0058113,-0.036408,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.74054,0.0057181,-0.024402,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.95679,0.0056609,-0.011857,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.84251,0.0056445,-0.034303,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.7588,0.0056036,0.0032325,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.78645,0.0055793,0.016858,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.32642,0.0055366,0.095961,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.96638,0.0054756,0.0029323,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.36968,0.0054089,-0.066594,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.60883,0.005121,-0.11003,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.80503,0.0049633,0.0071861,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.53518,0.0049597,0.092836,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.84251,0.0049099,-0.036196,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.90893,0.0047193,-0.018066,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.89939,0.0046089,-0.00026273,0,0
2,GO PROTEIN KINASE A SIGNALING,0.61728,0.0044687,0.031827,0,0
2,GO REGULATION OF MAPK CASCADE,0.85194,0.0044105,-0.020491,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.98559,0.0042397,-0.0095074,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.55115,0.0042128,0.038977,0,0
2,GO AUTOPHAGOSOME MATURATION,0.88987,0.0042065,-0.0027673,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.9472,0.0041868,0.00025128,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.84251,0.0041543,0.004178,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.97598,0.0041235,-0.016272,0,0
2,GO NUCLEOSOME ASSEMBLY,0.78645,0.004092,-0.010084,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.60883,0.0040368,-0.027427,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.93762,0.0040364,0.018507,0,0
2,GO OOCYTE MATURATION,0.7588,0.0040174,-0.055811,0,0
2,GO DETECTION OF STIMULUS,0.70447,0.004015,-0.024545,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.7588,0.00398,0.044926,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1,0.003935,-0.028549,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.74966,0.0038125,-0.043172,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.68667,0.0037766,0.025805,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.6516,0.0037383,0.040676,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.93762,0.0037271,0.014061,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.84251,0.0035285,-0.06972,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.8614,0.0035051,-0.021074,0,0
2,GO HISTONE METHYLATION,0.92804,0.0031711,0.013295,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.91848,0.003086,0.018419,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.66904,0.003021,0.02523,0,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.6603,0.0028374,0.042835,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.60042,0.0028334,0.1333,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.98559,0.0027479,0.0092927,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.79572,0.0025152,-0.0081975,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.78645,0.002506,0.026452,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.90893,0.0023957,-0.0082609,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.97598,0.002365,-0.0084457,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.88987,0.0023615,-0.021815,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.69555,0.0022353,-0.083668,0,0
2,GO TOR SIGNALING,0.87087,0.0021755,-0.0097519,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.9472,0.0021654,-0.01733,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.54313,0.0021573,-0.069127,0,0
2,GO REGULATION OF GASTRULATION,0.85194,0.0020815,0.0018334,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.7772,0.0019425,-0.028047,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.68667,0.0019289,-0.032916,0,0
2,GO VIRAL RNA GENOME REPLICATION,0.85194,0.0017446,0.011383,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.57554,0.0016468,0.01854,0,0
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.96638,0.0016393,0.016489,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.71343,0.0014517,0.034879,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.97598,0.0014176,0.0016086,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.85194,0.0013934,-0.016254,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.67783,0.0013711,-0.026438,0,0
2,GO CARNITINE METABOLIC PROCESS,0.80503,0.0013352,-0.060857,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.74054,0.0013085,0.018111,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.71343,0.0011538,0.064897,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.85194,0.0010515,-0.037169,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.92804,0.00092343,-0.016015,0,0
2,GO ORGANIC ANION TRANSPORT,0.7588,0.00091399,-0.03275,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.74054,0.00081497,0.048307,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.55922,0.00069043,0.057268,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.4445,0.00066814,-0.046531,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.82372,0.0004934,-0.013932,0,0
2,GO REGULATION OF TOR SIGNALING,0.96638,0.00031246,-0.0047549,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.70447,0.00029992,-0.016406,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.48118,0.00029344,-0.10623,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.8614,0.00027485,-0.02154,0,0
2,GO ADAPTIVE THERMOGENESIS,0.38267,0.00026167,-0.065094,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.82372,0.00023422,-0.020833,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.63434,0.00014742,-0.035615,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.91848,8.4924e-05,-0.011005,0,0
2,GO TAXIS,0.41634,6.2914e-05,-0.062682,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.70447,-7.5092e-05,-0.043068,0,0
2,GO RESPONSE TO STEROL,0.91848,-0.00010687,-0.031351,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.80503,-0.00031266,0.021184,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.59207,-0.00032504,0.035455,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.72243,-0.0004,0.058137,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.68667,-0.00059637,-0.035781,0,0
2,GO RESPONSE TO PROGESTERONE,0.67783,-0.00064198,0.06398,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.79572,-0.00066009,-0.00098392,0,0
2,GO REGULATION OF RNA BINDING,0.79572,-0.00074754,0.0091705,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.81436,-0.0007684,0.056091,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.88036,-0.00078381,-0.025564,0,0
2,GO REGULATION OF VASCULOGENESIS,0.98559,-0.00078844,-0.023269,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.89939,-0.0011408,-0.0451,0,0
2,GO PRO B CELL DIFFERENTIATION,0.89939,-0.0011888,0.006237,0,0
2,GO FORELIMB MORPHOGENESIS,0.9952,-0.0011968,-0.0072928,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.60042,-0.0013098,0.027706,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.98559,-0.0013148,0.018475,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.50395,-0.0016183,0.054097,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.97598,-0.0019073,-0.0073537,0,0
2,GO PANCREATIC JUICE SECRETION,0.80503,-0.0019241,0.041995,0,0
2,GO RESPONSE TO PEPTIDE,0.90893,-0.0019485,-0.015486,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.80503,-0.0019642,0.018837,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.88987,-0.0021656,0.0090306,0,0
2,GO AMINE METABOLIC PROCESS,0.9952,-0.0022021,-0.0057814,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.97598,-0.0022205,-0.0063397,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.68667,-0.0022468,-0.033443,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.58378,-0.0022635,0.01779,0,0
2,GO ENDOCYTOSIS,0.95679,-0.0023516,-0.013856,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.80503,-0.0024212,0.052194,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.72243,-0.0025155,-0.065537,0,0
2,GO REGULATION OF CELL AGING,0.79572,-0.0026191,0.0043562,0,0
2,GO MICROTUBULE NUCLEATION,0.62578,-0.0026486,-0.097666,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.69555,-0.0026886,-0.08068,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.8331,-0.0028584,-0.0080227,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.7772,-0.0028913,-0.0020213,0,0
2,GO REGULATION OF WOUND HEALING,0.85194,-0.0029205,0.0096539,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1,-0.0029781,-0.015227,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.69555,-0.0029798,-0.030174,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.9952,-0.0030048,-0.018785,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.52728,-0.0030643,-0.046869,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.89939,-0.0031887,0.025331,0,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.67783,-0.0032441,0.0526,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.52728,-0.0032594,-0.056297,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.8614,-0.0032754,-0.036744,0,0
2,GO CELL CELL SIGNALING BY WNT,0.28117,-0.0032881,-0.053962,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.89939,-0.0033201,-0.036343,0,0
2,GO ENSHEATHMENT OF NEURONS,0.63434,-0.0033464,-0.047177,0,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.59207,-0.0034173,-0.10295,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.45171,-0.0034975,-0.097354,0,0
2,GO EAR DEVELOPMENT,0.74054,-0.0036099,-0.037162,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.59207,-0.0036282,-0.060595,0,0
2,GO SPECIFICATION OF SYMMETRY,0.59207,-0.0036579,-0.027583,0,0
2,GO PRENYLATION,0.42328,-0.003896,-0.091163,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.64294,-0.004128,-0.028347,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.55922,-0.0041596,-0.03731,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.41634,-0.0041916,0.046461,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.79572,-0.004204,-0.014113,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.96638,-0.0043603,-0.043816,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.79572,-0.0044385,-0.0096855,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.78645,-0.0045325,-0.061543,0,0
2,GO SULFATE TRANSPORT,0.9952,-0.0045515,0.021229,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.55922,-0.0045651,-0.041979,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.80503,-0.0046454,0.012506,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.55922,-0.0046601,0.078539,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.68667,-0.0047014,0.054866,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.87087,-0.004718,-0.029471,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.97598,-0.0047204,0.043278,0,0
2,GO DEMETHYLATION,0.81436,-0.0047309,0.013627,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.56735,-0.0047692,-0.02875,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.92804,-0.0047946,0.0013913,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.4963,-0.0049775,-0.05146,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.59207,-0.0050846,-0.076598,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.70447,-0.0050905,0.01486,0,0
2,GO GROWTH,0.30892,-0.0055105,-0.052281,0,0
2,GO SENSORY PERCEPTION,0.46631,-0.005735,-0.035179,0,0
2,GO ARTERY MORPHOGENESIS,0.88987,-0.0057573,-0.013284,0,0
2,GO BLASTOCYST GROWTH,0.72243,-0.0058712,0.0081237,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.41634,-0.0059027,-0.067748,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.60042,-0.0062983,0.030919,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.78645,-0.0063981,-0.081625,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.79572,-0.0064267,-0.015519,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.9472,-0.0064801,0.0025124,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.26023,-0.0064937,-0.13925,0,0
2,GO REGULATION OF PH,0.78645,-0.0065612,-0.035728,0,0
2,GO MUSCLE FILAMENT SLIDING,0.57554,-0.006673,-0.088669,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.89939,-0.0068799,-0.0030263,0,0
2,GO MEMBRANE FUSION,0.78645,-0.0068899,-0.029785,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.71343,-0.0070967,-0.027433,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.51944,-0.0071163,-0.035479,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,1,-0.0072134,-0.016037,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.40947,-0.0072625,-0.047148,0,0
2,GO LACTATE METABOLIC PROCESS,0.56735,-0.0072825,0.068422,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.35072,-0.0074846,-0.053733,0,0
2,GO ORGANELLE FISSION,0.72243,-0.0074995,-0.014641,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.87087,-0.0075487,-0.0022228,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.93762,-0.007601,-0.028813,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.48871,-0.0076913,-0.031743,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.74966,-0.0077362,0.0086079,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.60042,-0.0078008,-0.029355,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.82372,-0.0078439,-0.030805,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.80503,-0.0079668,-0.021423,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.98559,-0.0080095,-0.01472,0,0
2,GO BONE TRABECULA FORMATION,0.88036,-0.0080774,-0.095144,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.8331,-0.0081123,-0.013089,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.55115,-0.0081972,-0.05871,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.56735,-0.0082039,-0.042244,0,0
2,GO LYMPHANGIOGENESIS,0.82372,-0.0082046,-0.047226,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.60883,-0.0082055,0.095645,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.60042,-0.0082381,-0.07394,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.28658,-0.0082823,-0.063037,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.80503,-0.0084404,-0.038782,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.95679,-0.0085009,-0.0068009,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.69555,-0.0085898,0.027137,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.8331,-0.008671,-0.029253,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.90893,-0.0086868,0.0018326,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.63434,-0.0087471,-0.023778,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.45171,-0.0087503,-0.054132,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.60883,-0.0087706,-0.030799,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.79572,-0.0088163,-0.03326,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.76799,-0.008819,0.023085,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.7772,-0.0091454,-0.056797,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.92804,-0.0091558,0.0025259,0,0
2,GO BICARBONATE TRANSPORT,0.91848,-0.0091801,0.012563,0,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.80503,-0.0092591,-0.035717,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.8331,-0.0096106,-0.021165,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.59207,-0.00975,-0.10878,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,1,-0.0099775,0.0053468,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.96638,-0.010076,-0.0090673,0,0
2,GO VACUOLAR TRANSPORT,0.64294,-0.010383,-0.029201,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.46631,-0.010425,-0.046533,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.95679,-0.010426,-0.0047582,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.69555,-0.010529,-0.045506,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.88987,-0.010568,-0.025924,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.58378,-0.010632,-0.081225,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.45898,-0.010828,-0.047251,0,0
2,GO MAST CELL MIGRATION,0.89939,-0.010835,0.067524,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.47371,-0.010882,-0.059366,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.7588,-0.010946,-0.025981,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.88987,-0.01095,-0.034167,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.35697,-0.010957,-0.14191,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.70447,-0.010963,-0.045147,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.68667,-0.011023,-0.029718,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.7588,-0.011024,-0.0345,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.72243,-0.01122,-0.045966,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.71343,-0.011289,0.048406,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.8614,-0.011331,-0.0076388,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.98559,-0.011383,-0.0095087,0,0
2,GO NUCLEUS ORGANIZATION,0.8614,-0.011413,-0.014872,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.74966,-0.011441,0.027336,0,0
2,GO REGULATION OF AXON GUIDANCE,0.81436,-0.011535,-0.07211,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.91848,-0.011633,0.0025962,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.58378,-0.011647,-0.038932,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.63434,-0.011649,0.1114,0,0
2,GO DOSAGE COMPENSATION,0.88987,-0.011678,0.031678,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.9472,-0.011822,-0.0072101,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.88987,-0.01189,-0.010445,0,0
2,GO RESPONSE TO ATP,0.80503,-0.011891,-0.026469,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.89939,-0.011962,-0.033335,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.28117,-0.012096,-0.040028,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.88987,-0.012178,-0.012259,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.89939,-0.012193,-0.038733,0,0
2,GO STEROL TRANSPORT,0.79572,-0.01226,-0.033791,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.9952,-0.012318,-0.038555,0,0
2,GO DIET INDUCED THERMOGENESIS,0.80503,-0.012351,-0.043027,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.82372,-0.012383,-0.037359,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.53518,-0.012438,-0.23611,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.38267,-0.012528,-0.070661,0,0
2,GO CYTOSKELETON ORGANIZATION,0.69555,-0.012649,-0.031104,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.43736,-0.012735,-0.041704,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.39593,-0.01274,-0.049705,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.85194,-0.012799,-0.014098,0,0
2,GO DEPHOSPHORYLATION,0.72243,-0.012967,-0.018016,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.81436,-0.012998,-0.011389,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.36329,-0.013061,-0.051146,0,0
2,GO AMYLOID BETA FORMATION,0.96638,-0.013384,-0.010776,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.88036,-0.013592,-0.0055329,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.4963,-0.013646,-0.099564,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.93762,-0.013686,0.014238,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.55922,-0.013713,-0.033028,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.32642,-0.013762,-0.088438,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.55115,-0.013857,-0.029799,0,0
2,GO REGULATION OF ODONTOGENESIS,0.93762,-0.013859,-0.043624,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.88987,-0.013944,-0.035076,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.89939,-0.014024,-0.023017,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.62578,-0.014029,-0.052922,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.88987,-0.014186,-0.039957,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.42328,-0.014303,-0.063976,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.48871,-0.014514,-0.052737,0,0
2,GO CELL JUNCTION ASSEMBLY,0.4445,-0.014533,-0.055772,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.52728,-0.014781,-0.052891,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.4445,-0.014922,-0.051172,0,0
2,GO AGING,0.9952,-0.015094,-0.0086964,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.73147,-0.015094,0.0093538,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.78645,-0.015157,-0.025477,0,0
2,GO PROTEIN METHYLATION,0.85194,-0.015194,0.0071642,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.88987,-0.015223,0.0051269,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.85194,-0.015259,0.0061467,0,0
2,GO MEMBRANE DISASSEMBLY,0.87087,-0.015353,-0.0098578,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.97598,-0.015466,-0.00048504,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,1,-0.015717,-0.01277,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.9952,-0.015778,0.022735,0,0
2,GO VESICLE LOCALIZATION,0.62578,-0.016024,-0.035884,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.87087,-0.016103,-0.030293,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.55115,-0.016108,-0.030397,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.72243,-0.016218,-0.047662,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.81436,-0.016223,-0.020721,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.9952,-0.01623,-0.014342,0,0
2,GO AMELOGENESIS,0.55115,-0.016261,0.066978,0,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.96638,-0.016276,0.026149,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.62578,-0.016478,-0.037195,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.93762,-0.016573,-0.035677,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.98559,-0.016877,0.003707,0,0
2,GO ORGANELLE FUSION,0.9952,-0.017014,-0.013842,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.70447,-0.017036,-0.037566,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.34454,-0.01706,-0.10436,0,0
2,GO ANION TRANSPORT,0.55922,-0.017114,-0.047411,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.79572,-0.017133,-0.080803,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.87087,-0.017361,0.0038698,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.88987,-0.017515,-9.4139e-05,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.93762,-0.017592,0.004246,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.84251,-0.017596,0.022086,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.88987,-0.017839,-0.0041615,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.71343,-0.017845,-0.052275,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.70447,-0.017911,-0.026204,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.76799,-0.017931,-0.052677,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.67783,-0.017992,0.068604,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.84251,-0.018035,-0.0056966,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.89939,-0.018065,-0.0095539,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.55922,-0.018274,-0.078507,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.37614,-0.01842,-0.094111,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.66904,-0.018517,-0.020723,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.73147,-0.018518,-0.01414,0,0
2,GO EXCRETION,0.90893,-0.018544,-0.0097313,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.70447,-0.018579,-0.029755,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.8331,-0.018834,-0.028267,0,0
2,GO GLAND DEVELOPMENT,0.45898,-0.018886,-0.044422,0,0
2,GO DNA REPLICATION,0.93762,-0.018949,0.015539,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.85194,-0.019063,0.0068141,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.85194,-0.01909,-0.023615,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.8614,-0.019128,-0.013856,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.36968,-0.019163,-0.05313,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1,-0.01924,1.1695e-05,0,0
2,GO MESODERM MORPHOGENESIS,0.71343,-0.019291,-0.030567,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.52728,-0.019302,-0.040409,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.66904,-0.01936,-0.049331,0,0
2,GO WATER HOMEOSTASIS,0.58378,-0.019473,-0.047981,0,0
2,GO NEURON DEATH,0.23088,-0.019549,-0.055029,0,0
2,GO TISSUE MORPHOGENESIS,0.68667,-0.019739,-0.036759,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.45171,-0.01989,-0.083108,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.91848,-0.019891,-0.039902,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.87087,-0.019903,0.015012,0,0
2,GO SHORT TERM MEMORY,0.72243,-0.019992,-0.048234,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.90893,-0.02,-0.020069,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.98559,-0.020002,0.02451,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.29761,-0.020054,-0.056835,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.81436,-0.020214,0.017384,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.80503,-0.020294,-0.011608,0,0
2,GO REGULATION OF CELL DIVISION,0.61728,-0.020543,-0.033085,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.91848,-0.020864,-0.027082,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.8614,-0.021,-0.027497,0,0
2,GO REGULATION OF PROTEIN BINDING,0.89939,-0.02113,-0.010657,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.71343,-0.021385,-0.010241,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.38927,-0.021438,-0.044406,0,0
2,GO CHROMOSOME LOCALIZATION,0.52728,-0.021541,-0.028009,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.98559,-0.021588,-0.0083226,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.71343,-0.021672,-0.032967,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.73147,-0.021687,-0.033394,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.53518,-0.021786,-0.11107,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.93762,-0.021825,-0.010799,0,0
2,GO ZYMOGEN ACTIVATION,0.6516,-0.021858,0.06261,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.71343,-0.021948,-0.056366,0,0
2,GO NEURON APOPTOTIC PROCESS,0.36329,-0.022066,-0.041765,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.54313,-0.022074,-0.098456,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.9472,-0.022205,-0.019711,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.57554,-0.022392,-0.019182,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.8614,-0.022409,-0.016906,0,0
2,GO ACTIN CROSSLINK FORMATION,0.76799,-0.02252,-0.067882,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.36329,-0.022564,-0.096632,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.30323,-0.022721,-0.15483,0,0
2,GO TRABECULA FORMATION,1,-0.022752,-0.033791,0,0
2,GO RESPONSE TO ETHER,0.80503,-0.023198,0.025207,0,0
2,GO REPRODUCTION,0.25017,-0.023233,-0.052069,0,0
2,GO SPINDLE ORGANIZATION,0.33843,-0.023448,-0.055863,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.45171,-0.023602,-0.10783,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.81436,-0.023643,-0.0017281,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.55115,-0.023647,-0.096874,0,0
2,GO APPENDAGE MORPHOGENESIS,0.55115,-0.024059,-0.055908,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.9472,-0.024078,0.0032911,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.79572,-0.024191,-0.0366,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.76799,-0.024573,-0.036456,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.39593,-0.025084,-0.0959,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.45898,-0.025136,-0.03997,0,0
2,GO CENTROSOME DUPLICATION,0.29206,-0.025401,-0.049849,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.97598,-0.025468,0.010651,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.96638,-0.025562,-0.010449,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.7588,-0.02563,-0.023076,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.71343,-0.025746,0.034618,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.60883,-0.02584,0.030774,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.6603,-0.025968,-0.018855,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.7588,-0.025978,-0.018095,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.60883,-0.026107,-0.055919,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.64294,-0.02615,-0.037161,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.71343,-0.02619,-0.025727,0,0
2,GO FLUID TRANSPORT,0.36968,-0.026393,-0.074129,0,0
2,GO COENZYME A METABOLIC PROCESS,0.97598,-0.026441,-0.0080561,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.88036,-0.02694,-0.026263,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.66904,-0.026957,-0.045291,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.96638,-0.027132,-0.011782,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.38927,-0.027139,-0.06136,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.88036,-0.027176,-0.0087515,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.53518,-0.027262,-0.11938,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.41634,-0.027329,-0.038429,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.24525,-0.027343,-0.065651,0,0
2,GO FIBROBLAST PROLIFERATION,0.9952,-0.027567,-0.015257,0,0
2,GO RESPONSE TO VITAMIN,0.60042,-0.027638,-0.067409,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.81436,-0.027639,-0.0097932,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.74054,-0.027713,-0.030934,0,0
2,GO LEUKOCYTE AGGREGATION,0.91848,-0.027752,-0.042877,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.48118,-0.027861,-0.084421,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.54313,-0.028049,-0.050798,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.97598,-0.028239,0.0015371,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.71343,-0.028252,-0.0036589,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.50395,-0.028282,-0.034454,0,0
2,GO COMPLEMENT ACTIVATION,0.53518,-0.028397,-0.074513,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.89939,-0.028405,0.021904,0,0
2,GO BONE DEVELOPMENT,0.50395,-0.028591,-0.056121,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.4963,-0.028638,-0.052766,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.53518,-0.02871,-0.044449,0,0
2,GO CYTOKINE SECRETION,0.8331,-0.029007,-0.013309,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.30323,-0.029008,-0.093048,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.64294,-0.02906,-0.042207,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.87087,-0.029065,-0.040164,0,0
2,GO HEART TRABECULA FORMATION,0.70447,-0.029148,-0.046317,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.51944,-0.029292,-0.039898,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.63434,-0.029331,-0.022144,0,0
2,GO TRANSFERRIN TRANSPORT,0.62578,-0.029401,-0.062283,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.89939,-0.029606,0.011786,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.4963,-0.029708,-0.079394,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.14347,-0.030053,-0.071146,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.32642,-0.030076,-0.07725,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.39593,-0.030079,-0.039843,0,0
2,GO BLOOD VESSEL REMODELING,0.84251,-0.030235,-0.070729,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.62578,-0.030249,-0.060564,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.32642,-0.030335,-0.055281,0,0
2,GO LUNG MORPHOGENESIS,0.69555,-0.030387,0.017846,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.33843,-0.030451,-0.071337,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.85194,-0.030471,0.011696,0,0
2,GO LYMPHOCYTE MIGRATION,0.45898,-0.030492,-0.062736,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.52728,-0.030569,-0.03348,0,0
2,GO TUBE MORPHOGENESIS,0.74966,-0.030578,-0.026514,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.82372,-0.030614,0.00042433,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.29761,-0.030696,-0.051386,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.91848,-0.030718,-0.037714,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.54313,-0.030802,-0.091699,0,0
2,GO OOGENESIS,0.26536,-0.030863,-0.089398,0,0
2,GO ENDOCYTIC RECYCLING,0.91848,-0.03092,0.0092942,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.92804,-0.030978,-0.014339,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.36329,-0.03101,-0.088907,0,0
2,GO PLASMINOGEN ACTIVATION,0.9952,-0.031116,-0.045302,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.97598,-0.031142,-0.003493,0,0
2,GO NEURAL CREST CELL MIGRATION,0.64294,-0.031206,-0.064156,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.53518,-0.031273,-0.036128,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.90893,-0.031339,-0.011609,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.43029,-0.031472,-0.061704,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.27056,-0.031521,-0.058732,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.41634,-0.031561,-0.079122,0,0
2,GO MRNA SPLICE SITE SELECTION,0.58378,-0.031631,-0.06209,0,0
2,GO GLAND MORPHOGENESIS,0.81436,-0.031838,-0.053321,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.54313,-0.031911,-0.047576,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.68667,-0.031967,-0.0088432,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.76799,-0.032143,-0.01928,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.33239,-0.032245,-0.13787,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.34454,-0.032516,-0.064786,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.88987,-0.032553,-0.0056827,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.91848,-0.032669,-0.016571,0,0
2,GO RESPONSE TO UV B,0.6603,-0.032683,-0.071104,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.18334,-0.032702,-0.053168,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.68667,-0.032712,0.016455,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.39593,-0.032745,-0.062899,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.92804,-0.032796,0.015842,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.6516,-0.032879,-0.048274,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.40267,-0.032946,-0.06354,0,0
2,GO VASCULATURE DEVELOPMENT,0.92804,-0.032997,-0.022382,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.19139,-0.033004,-0.077052,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.63434,-0.033198,-0.057914,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.60883,-0.033381,-0.051294,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.37614,-0.033444,-0.13378,0,0
2,GO ARTERY DEVELOPMENT,0.33239,-0.033474,-0.083794,0,0
2,GO RESPONSE TO VITAMIN A,0.7772,-0.033568,0.012191,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.20828,-0.033652,-0.077722,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.78645,-0.0338,-0.067399,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.36968,-0.033846,-0.047937,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.90893,-0.033886,0.025222,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.78645,-0.034077,-0.050652,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.57554,-0.034116,-0.0559,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.43029,-0.034449,-0.046363,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.43029,-0.03453,-0.046335,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.60042,-0.034626,-0.063072,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.37614,-0.034665,-0.080028,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.92804,-0.034964,-0.023224,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.55922,-0.034964,-0.049956,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.7772,-0.035029,-0.047912,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.15361,-0.035071,-0.094713,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.55115,-0.035105,-0.051419,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.4963,-0.035117,-0.078439,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.73147,-0.035132,-0.040085,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.36968,-0.035191,-0.070346,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.45171,-0.035415,-0.06546,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.7772,-0.035443,-0.018467,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.36329,-0.035676,-0.075166,0,0
2,GO FERTILIZATION,0.70447,-0.035769,-0.032107,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.55922,-0.035853,-0.056571,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.61728,-0.035996,0.055026,0,0
2,GO MICROTUBULE POLYMERIZATION,0.38267,-0.036006,-0.11508,0,0
2,GO REGULATION OF DNA REPLICATION,0.60883,-0.036096,-0.015136,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67783,-0.036111,-0.041841,0,0
2,GO CELL CYCLE ARREST,0.73147,-0.036188,-0.011384,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.6603,-0.036244,-0.03495,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.38267,-0.036336,-0.045994,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.42328,-0.036341,-0.077567,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.27056,-0.036423,-0.058737,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.50395,-0.036451,-0.051968,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.51944,-0.036486,-0.14238,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.69555,-0.036506,-0.020775,0,0
2,GO RESPONSE TO STARVATION,0.26536,-0.036537,-0.071789,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.78645,-0.036547,-0.024525,0,0
2,GO FAT CELL DIFFERENTIATION,0.52728,-0.036553,-0.048879,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.31468,-0.036553,-0.053644,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.7772,-0.036785,0.065369,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.88036,-0.037027,-0.035006,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.73147,-0.037113,-0.03794,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.25017,-0.037261,-0.056547,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.89939,-0.037336,-0.029748,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.66904,-0.037354,-0.049807,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.64294,-0.037533,-0.056861,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.93762,-0.037705,0.010382,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.31468,-0.037736,-0.051069,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.59207,-0.037755,-0.080878,0,0
2,GO AMINO ACID IMPORT,0.79572,-0.03786,-0.039269,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.8331,-0.038066,-0.055031,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.9952,-0.038145,-0.011039,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.58378,-0.038313,-0.045459,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.72243,-0.038394,-0.063946,0,0
2,GO REGULATION OF GROWTH,0.1643,-0.03842,-0.060445,0,0
2,GO DEVELOPMENTAL GROWTH,0.13074,-0.038458,-0.074296,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.9472,-0.038481,-0.018197,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.28117,-0.038524,-0.048258,0,0
2,GO MITOTIC RECOMBINATION,0.82372,-0.038599,-0.0078367,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.30323,-0.038675,-0.082273,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.89939,-0.038765,0.035531,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.8614,-0.038964,-0.064552,0,0
2,GO MITOPHAGY,0.92804,-0.038976,-0.001584,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.69555,-0.03903,-0.034589,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.45898,-0.039056,-0.077297,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.59207,-0.039146,-0.098204,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.37614,-0.039176,-0.045084,0,0
2,GO SOMITOGENESIS,0.66904,-0.039205,-0.040338,0,0
2,GO DENTATE GYRUS DEVELOPMENT,1,-0.039213,-0.026976,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.38267,-0.039214,-0.06535,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.35697,-0.039397,-0.07769,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,1,-0.039406,0.019575,0,0
2,GO MEIOTIC CELL CYCLE,0.088413,-0.039409,-0.064191,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.18334,-0.03948,-0.072826,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.26023,-0.039487,-0.048838,0,0
2,GO SUPEROXIDE ANION GENERATION,0.80503,-0.039506,-0.036499,0,0
2,GO PROTEIN PROCESSING,0.7588,-0.039507,-0.023462,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.12771,-0.039749,-0.068821,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.8614,-0.039751,-0.010538,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.70447,-0.039797,-0.040276,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48118,-0.039799,-0.094981,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.89939,-0.039973,-0.018904,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.74054,-0.040316,0.031223,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.33239,-0.040409,-0.05682,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.9952,-0.040496,0.0278,0,0
2,GO FOAM CELL DIFFERENTIATION,0.95679,-0.040717,-0.040024,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.71343,-0.040888,-0.052575,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.7772,-0.040904,-0.017911,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.96638,-0.040977,0.019912,0,0
2,GO MANGANESE ION TRANSPORT,0.55922,-0.041356,-0.060067,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.55115,-0.041419,-0.048821,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.28658,-0.041421,-0.12787,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.8331,-0.041476,-0.030468,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.19971,-0.04153,-0.048507,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.58378,-0.041641,-0.040174,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.63434,-0.041714,-0.029228,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.41634,-0.041776,-0.10347,0,0
2,GO POSITIVE REGULATION OF BINDING,0.40947,-0.041813,-0.04218,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.98559,-0.041928,-0.095783,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.76799,-0.042048,-0.021806,0,0
2,GO CELL JUNCTION ORGANIZATION,0.19139,-0.042187,-0.082075,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.96638,-0.042196,-0.006442,0,0
2,GO WATER TRANSPORT,0.23088,-0.042454,-0.1005,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.30323,-0.042536,-0.1366,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.40267,-0.042619,-0.03694,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.32052,-0.042681,-0.16015,0,0
2,GO RENAL SODIUM EXCRETION,0.8331,-0.042704,0.028025,0,0
2,GO MULTI ORGANISM PROCESS,0.10277,-0.042746,-0.070158,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.43029,-0.042813,-0.058435,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.33843,-0.042877,-0.15788,0,0
2,GO ION TRANSPORT,0.26536,-0.042957,-0.059274,0,0
2,GO PROTEIN FOLDING,0.50395,-0.042976,-0.052958,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.38927,-0.043089,-0.054182,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.38267,-0.043126,-0.064007,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.51167,-0.043143,-0.043788,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.6603,-0.043674,-0.087291,0,0
2,GO HISTONE H4 ACETYLATION,0.4963,-0.04369,-0.028936,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.55115,-0.04377,-0.045283,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.4445,-0.043778,-0.053477,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.59207,-0.043797,-0.046479,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.84251,-0.044015,-0.010703,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.61728,-0.044048,-0.095952,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.15017,-0.0441,-0.059416,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.9952,-0.044103,-0.0029663,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.66904,-0.044436,-0.026246,0,0
2,GO INORGANIC ANION TRANSPORT,0.16068,-0.044521,-0.080693,0,0
2,GO NOTCH SIGNALING PATHWAY,0.2356,-0.044714,-0.083219,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.67783,-0.044916,-0.03348,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.068115,-0.044977,-0.082482,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.76799,-0.045023,-0.058644,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.97598,-0.045026,-0.0012974,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68667,-0.045283,-0.035081,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.32642,-0.045315,-0.084309,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.73147,-0.045343,-0.033886,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.29206,-0.045366,-0.090639,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.64294,-0.045497,-0.043583,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.8614,-0.045588,-0.033181,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.55115,-0.045709,-0.036462,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.22622,-0.045717,-0.077591,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.59207,-0.045754,-0.060517,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.80503,-0.045758,-0.019704,0,0
2,GO SINGLE FERTILIZATION,0.40947,-0.046016,-0.057763,0,0
2,GO ORGANELLE ASSEMBLY,0.12472,-0.046249,-0.053383,0,0
2,GO REGULATION OF MITOPHAGY,0.50395,-0.046367,-0.052793,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.64294,-0.046456,-0.054454,0,0
2,GO DNA CATABOLIC PROCESS,0.28117,-0.046524,-0.043458,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.32642,-0.04659,-0.066482,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.9472,-0.04676,-0.01374,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.14347,-0.047093,-0.074176,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.43029,-0.047153,-0.046557,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.2356,-0.047182,-0.097213,0,0
2,GO DRUG METABOLIC PROCESS,0.55115,-0.047336,-0.062433,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.32642,-0.047347,-0.08877,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.66904,-0.047408,-0.044892,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.7588,-0.047461,-0.034216,0,0
2,GO RESPONSE TO RETINOIC ACID,0.93762,-0.047742,-0.0052,0,0
2,GO SULFATION,0.4963,-0.047815,-0.061364,0,0
2,GO CIRCADIAN RHYTHM,0.064555,-0.04807,-0.070406,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.10277,-0.048235,-0.10111,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.36968,-0.048345,-0.055131,0,0
2,GO SPINDLE LOCALIZATION,0.20828,-0.048732,-0.090109,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.97598,-0.048738,0.03645,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.38927,-0.048779,-0.042789,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.54313,-0.048969,-0.050985,0,0
2,GO REGULATION OF HEART GROWTH,0.41634,-0.049141,-0.06878,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.74966,-0.049192,-0.0028896,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.14679,-0.049316,-0.13753,0,0
2,GO REGULATION OF GTP BINDING,0.87087,-0.049574,-0.022926,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.79572,-0.04961,-0.07078,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.6603,-0.049637,-0.067137,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.7772,-0.049846,-0.015972,0,0
2,GO AXIS SPECIFICATION,0.1402,-0.049935,-0.087505,0,0
2,GO CELL MATRIX ADHESION,0.62578,-0.050029,-0.052479,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.13074,-0.050282,-0.07592,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.63434,-0.05029,-0.10118,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.51944,-0.05031,-0.039697,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.93762,-0.050598,-0.0024125,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.76799,-0.050604,-0.014579,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.090686,-0.050822,-0.07946,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.12771,-0.050934,-0.064852,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.52728,-0.050952,-0.065264,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.13699,-0.051253,-0.19202,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.62578,-0.051592,-0.027662,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.39593,-0.05169,-0.080258,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.64294,-0.051853,-0.053012,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.85194,-0.051928,-0.016682,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.88036,-0.052019,-0.024347,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.48871,-0.052307,-0.07816,0,0
2,GO MALE GAMETE GENERATION,0.2356,-0.052468,-0.06235,0,0
2,GO REGULATION OF TRANSPORT,0.25017,-0.052506,-0.060843,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.1794,-0.052669,-0.075926,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.60883,-0.052738,-0.060593,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.36329,-0.052759,-0.11772,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.87087,-0.052972,0.02976,0,0
2,GO NEURON REMODELING,0.30892,-0.053072,-0.11596,0,0
2,GO CELL PROJECTION ASSEMBLY,0.095374,-0.053415,-0.066119,0,0
2,GO SPERM MOTILITY,0.038917,-0.053545,-0.14132,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.1794,-0.053695,-0.067112,0,0
2,GO CELL SUBSTRATE ADHESION,0.73147,-0.053745,-0.049721,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.45171,-0.054076,-0.028316,0,0
2,GO OXALATE TRANSPORT,0.43029,-0.05419,-0.062984,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.50395,-0.05422,-0.058997,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.43029,-0.0545,-0.047638,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.96638,-0.054515,0.0043135,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.6516,-0.054615,-0.17206,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.91848,-0.054659,-0.033443,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.31468,-0.054845,-0.038727,0,0
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.97598,-0.054876,0.026799,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.41634,-0.054922,-0.060712,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.63434,-0.055083,-0.081741,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.51944,-0.05509,-0.07071,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.58378,-0.055228,-0.041072,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.45171,-0.05523,-0.068999,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.47371,-0.055323,-0.097194,0,0
2,GO SEXUAL REPRODUCTION,0.13699,-0.055341,-0.069305,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.27583,-0.055388,-0.077519,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.6516,-0.055641,-0.016773,0,0
2,GO ORGANELLE LOCALIZATION,0.32052,-0.055824,-0.044146,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.36329,-0.05583,-0.028501,0,0
2,GO VIRAL LATENCY,0.57554,-0.056008,-0.036774,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.61728,-0.056143,-0.049107,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.34454,-0.056197,-0.063684,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.26536,-0.056273,-0.070681,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.28117,-0.056293,-0.059895,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.12771,-0.056319,-0.082271,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.52728,-0.056448,-0.044115,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.87087,-0.056626,-0.061626,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.55115,-0.056668,-0.10547,0,0
2,GO PROTEIN MANNOSYLATION,0.46631,-0.056751,-0.05613,0,0
2,GO MEMBRANE REPOLARIZATION,0.23088,-0.056824,-0.11619,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.25017,-0.056906,-0.070071,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.32642,-0.056986,-0.1023,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.81436,-0.057153,-0.04986,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.10794,-0.057237,-0.074699,0,0
2,GO PHAGOSOME ACIDIFICATION,0.47371,-0.05727,-0.073827,0,0
2,GO MUSCLE SYSTEM PROCESS,0.14347,-0.057402,-0.076762,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.19971,-0.057405,-0.073567,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.1643,-0.057454,-0.072717,0,0
2,GO PROSTAGLANDIN SECRETION,0.8331,-0.057526,0.022082,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.55115,-0.057533,-0.10075,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.37614,-0.057815,-0.073754,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.39593,-0.057829,-0.056616,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.46631,-0.057916,-0.14371,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.31468,-0.058,-0.055849,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.46631,-0.058038,-0.10783,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.93762,-0.058207,-0.0019424,0,0
2,GO MATING,0.14347,-0.058318,-0.11247,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21712,-0.058595,-0.15752,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.46631,-0.058754,-0.073808,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.18733,-0.059028,-0.07718,0,0
2,GO HISTONE H3 K27 METHYLATION,0.25516,-0.059294,-0.072957,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.21267,-0.0593,-0.13081,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.38267,-0.059438,-0.060993,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.40267,-0.059486,-0.056297,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.32642,-0.059605,-0.058164,0,0
2,GO RESPONSE TO REDOX STATE,0.7772,-0.059838,-0.040575,0,0
2,GO ENDODERM DEVELOPMENT,0.72243,-0.06016,-0.074402,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.088413,-0.060175,-0.080559,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.66904,-0.060256,-0.019663,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.17553,-0.060329,-0.082857,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.34454,-0.060527,-0.047666,0,0
2,GO REGULATION OF HORMONE LEVELS,0.26023,-0.060586,-0.084804,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.48118,-0.060781,-0.06292,0,0
2,GO CYTOKINESIS,0.09779,-0.060797,-0.080256,0,0
2,GO GAMETE GENERATION,0.16068,-0.060817,-0.066438,0,0
2,GO GLIOGENESIS,0.13699,-0.060827,-0.090619,0,0
2,GO REGULATION OF CYTOKINESIS,0.11061,-0.060901,-0.0755,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.32052,-0.06091,-0.059317,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.51944,-0.061182,-0.094359,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.64294,-0.061364,-0.0319,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.24525,-0.061477,-0.086182,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.33843,-0.061671,-0.1093,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.32052,-0.061739,-0.058536,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.4445,-0.061935,-0.085187,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.4963,-0.062237,-0.045297,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58378,-0.062272,-0.035864,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.55922,-0.06239,-0.074053,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.76799,-0.062469,-0.024766,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.36968,-0.062678,-0.095103,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.31468,-0.062742,-0.076106,0,0
2,GO IRON ION TRANSPORT,0.48118,-0.062794,-0.038192,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.26536,-0.062861,-0.15026,0,0
2,GO L AMINO ACID TRANSPORT,0.20828,-0.063159,-0.11451,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.45171,-0.063308,-0.14452,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.51167,-0.063605,-0.065788,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.88036,-0.063828,-0.035786,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.4445,-0.063894,-0.035709,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.26023,-0.063982,-0.070697,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.12472,-0.064111,-0.101,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.34454,-0.064141,-0.085804,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.85194,-0.064149,0.052392,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.1161,-0.064151,-0.12065,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.71343,-0.064181,-0.0047973,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.32642,-0.064328,-0.11682,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.1643,-0.064389,-0.095714,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.79572,-0.064419,-0.039802,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.15712,-0.06446,-0.19604,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.36968,-0.064617,-0.095333,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.6603,-0.064736,-0.065448,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.1161,-0.064738,-0.094912,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.66904,-0.064985,-0.067063,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.74966,-0.065224,-0.01935,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.55115,-0.065315,-0.09191,0,0
2,GO SODIUM ION HOMEOSTASIS,0.47371,-0.065383,-0.061126,0,0
2,GO CELLULAR RESPONSE TO ATP,0.29206,-0.065455,-0.099801,0,0
2,GO INTEGRIN ACTIVATION,0.58378,-0.065462,-0.071603,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.42328,-0.065463,-0.12278,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.43736,-0.065584,-0.049421,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.23088,-0.065935,-0.18157,0,0
2,GO REGULATION OF BONE REMODELING,0.43029,-0.06596,-0.095535,0,0
2,GO VACUOLAR ACIDIFICATION,0.55922,-0.066007,-0.032535,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.39593,-0.066071,-0.15355,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.97598,-0.06614,0.023013,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.09779,-0.066348,-0.086641,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.95679,-0.066906,0.010746,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.45898,-0.066982,-0.048818,0,0
2,GO MUSCLE HYPERTROPHY,0.25017,-0.067167,-0.07971,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.56735,-0.067211,-0.06153,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.28117,-0.067262,-0.080035,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.25017,-0.067268,-0.19536,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.88987,-0.067284,0.054444,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.081867,-0.067328,-0.077267,0,0
2,GO RHYTHMIC PROCESS,0.10025,-0.067975,-0.057759,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.48118,-0.067997,-0.098775,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.55922,-0.068232,-0.037823,0,0
2,GO TORC1 SIGNALING,0.50395,-0.068257,-0.048263,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.8614,-0.068735,-0.038536,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.50395,-0.068803,-0.11891,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.27056,-0.068848,-0.090105,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.046281,-0.068945,-0.091726,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.14679,-0.069238,-0.070946,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.37614,-0.069289,-0.12873,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.69555,-0.069358,-0.15721,0,0
2,GO P38MAPK CASCADE,0.48871,-0.069474,-0.070712,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.51944,-0.069483,-0.052159,0,0
2,GO SOMITE DEVELOPMENT,0.1402,-0.069539,-0.083184,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.04007,-0.069871,-0.10442,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.084004,-0.06989,-0.10963,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.64294,-0.070069,-0.033081,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.66904,-0.070153,-0.062357,0,0
2,GO CELL FATE COMMITMENT,0.07572,-0.070384,-0.08382,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.11892,-0.070424,-0.084437,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.62578,-0.070467,-0.060119,0,0
2,GO RESPONSE TO GLUCAGON,0.16068,-0.070471,-0.086182,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.20396,-0.070596,-0.078626,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.26536,-0.070687,-0.12149,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.37614,-0.07085,-0.15334,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.53518,-0.071164,-0.083073,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.4445,-0.071309,-0.060801,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.80503,-0.071337,0.023457,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.71343,-0.071353,-0.026094,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.26536,-0.07136,-0.10537,0,0
2,GO HEART DEVELOPMENT,0.16798,-0.071424,-0.069295,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.20396,-0.071935,-0.087564,0,0
2,GO AORTA DEVELOPMENT,0.1402,-0.072025,-0.16325,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.11333,-0.072244,-0.09643,0,0
2,GO CARBOHYDRATE TRANSPORT,0.071835,-0.072381,-0.11145,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.047616,-0.072418,-0.10205,0,0
2,GO PLATELET DEGRANULATION,0.31468,-0.072682,-0.12416,0,0
2,GO BONE REMODELING,0.4963,-0.072687,-0.075955,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.50395,-0.072696,-0.04088,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.55115,-0.072707,-0.035257,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.4963,-0.072792,-0.086898,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.15361,-0.072827,-0.096053,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.10794,-0.07314,-0.090512,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.051817,-0.07383,-0.10246,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.54313,-0.073864,-0.11098,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.69555,-0.073921,-0.042727,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.1161,-0.073981,-0.17195,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.12771,-0.074008,-0.093647,0,0
2,GO FEEDING BEHAVIOR,0.36968,-0.07401,-0.064259,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.54313,-0.074016,-0.072295,0,0
2,GO CATION TRANSPORT,0.12179,-0.074089,-0.084139,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.55922,-0.074169,-0.030736,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.7588,-0.074465,-0.084252,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.10794,-0.074501,-0.11403,0,0
2,GO MUSCLE CONTRACTION,0.10533,-0.074732,-0.091027,0,0
2,GO PROTEIN OXIDATION,0.20396,-0.074897,-0.19086,0,0
2,GO AMMONIUM TRANSPORT,0.53518,-0.07491,-0.075976,0,0
2,GO GAP JUNCTION ASSEMBLY,0.8614,-0.074996,-0.056931,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.12771,-0.075184,-0.070647,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.87087,-0.075286,-0.0052483,0,0
2,GO OVULATION CYCLE PROCESS,0.18733,-0.075298,-0.099913,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.55115,-0.075774,-0.092524,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.042464,-0.076325,-0.15712,0,0
2,GO TUBE DEVELOPMENT,0.33843,-0.076395,-0.058582,0,0
2,GO REGULATION OF CHEMOTAXIS,0.60042,-0.076448,-0.035953,0,0
2,GO LYSOSOMAL TRANSPORT,0.30323,-0.07652,-0.067243,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.66904,-0.076614,-0.024373,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.32642,-0.076622,-0.10193,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.15017,-0.076744,-0.079355,0,0
2,GO METAL ION TRANSPORT,0.077726,-0.077164,-0.094312,0,0
2,GO EOSINOPHIL MIGRATION,0.64294,-0.07722,-0.095597,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.20396,-0.07736,-0.10946,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.20828,-0.07738,-0.11266,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.45898,-0.077589,-0.042138,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.60883,-0.077632,-0.034315,0,0
2,GO MIDBRAIN DEVELOPMENT,0.26536,-0.077708,-0.051287,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.37614,-0.077817,-0.071052,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.26023,-0.077911,-0.08535,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.55922,-0.078033,-0.046762,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.88987,-0.078203,0.0017844,0,0
2,GO RESPONSE TO AMINE,0.42328,-0.078235,-0.070284,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.28117,-0.078314,-0.10943,0,0
2,GO MUSCLE ADAPTATION,0.27583,-0.078472,-0.065753,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.18733,-0.078738,-0.081961,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.20396,-0.07883,-0.083076,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.76799,-0.078849,-0.025991,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.25017,-0.078957,-0.14042,0,0
2,GO ASTROCYTE ACTIVATION,0.32642,-0.07915,-0.099758,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.31468,-0.079302,-0.042346,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.84251,-0.079368,-0.0092604,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.1161,-0.079449,-0.10287,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.090686,-0.079867,-0.089678,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.73147,-0.079878,-0.056496,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.1794,-0.079997,-0.20906,0,0
2,GO AXON EXTENSION,0.088413,-0.080086,-0.16572,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.27056,-0.080309,-0.12133,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.13384,-0.080394,-0.10267,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.36968,-0.080508,-0.077239,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.041252,-0.080511,-0.13341,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.36968,-0.080591,-0.087506,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.38267,-0.08095,-0.068862,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.36329,-0.080957,-0.10152,0,0
2,GO REGULATION OF ION TRANSPORT,0.077726,-0.081242,-0.10943,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.8614,-0.081256,-0.0078418,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.51167,-0.081413,-0.066591,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.23088,-0.081527,-0.065439,0,0
2,GO REGULATION OF HEART RATE,0.32642,-0.081576,-0.072787,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.38927,-0.081585,-0.1026,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.071835,-0.081679,-0.083258,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.34454,-0.081709,-0.0446,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.095374,-0.081802,-0.078677,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12179,-0.081907,-0.1107,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.8614,-0.081918,-0.076282,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.30323,-0.082,-0.066827,0,0
2,GO REGULATION OF BINDING,0.13384,-0.082052,-0.067417,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.090686,-0.08215,-0.10135,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.54313,-0.082179,-0.050523,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.40267,-0.082303,-0.063137,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.12771,-0.082361,-0.16957,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.56735,-0.082435,-0.081434,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.17173,-0.082563,-0.11736,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.61728,-0.082782,-0.081164,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.081867,-0.082806,-0.21253,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.14347,-0.082996,-0.088761,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.044978,-0.083008,-0.12537,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.47371,-0.083122,-0.093628,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.45898,-0.083162,-0.10142,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.084004,-0.083348,-0.15272,0,0
2,GO NEGATIVE CHEMOTAXIS,0.31468,-0.08353,-0.14786,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.37614,-0.083608,-0.074277,0,0
2,GO GLIAL CELL MIGRATION,0.29761,-0.083688,-0.10542,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.52728,-0.083854,-0.076319,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.27583,-0.084172,-0.075153,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.28117,-0.084229,-0.11827,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.34454,-0.084348,-0.085294,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.27056,-0.084424,-0.075188,0,0
2,GO MESENCHYME DEVELOPMENT,0.1643,-0.084677,-0.09303,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.54313,-0.084729,-0.051047,0,0
2,GO HEART PROCESS,0.14347,-0.08482,-0.10297,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.18334,-0.084877,-0.10623,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.088413,-0.084967,-0.10298,0,0
2,GO GASTRULATION,0.52728,-0.08498,-0.056641,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.21267,-0.0853,-0.086112,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.46631,-0.085512,-0.076079,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.21712,-0.085744,-0.095931,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.29761,-0.085821,-0.081816,0,0
2,GO IMPORT INTO CELL,0.12771,-0.085916,-0.10575,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.21712,-0.085998,-0.10998,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.19552,-0.086277,-0.075627,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.33843,-0.086567,-0.06763,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.086186,-0.086607,-0.29216,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.1794,-0.0868,-0.082077,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.48118,-0.086923,-0.07774,0,0
2,GO ENERGY HOMEOSTASIS,0.11892,-0.087048,-0.14524,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.78645,-0.087118,-0.040088,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.15361,-0.08734,-0.076519,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.72243,-0.08748,-0.049065,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.43736,-0.08758,-0.05221,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.8331,-0.087748,-0.031606,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.07572,-0.087801,-0.080085,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.21712,-0.087872,-0.11552,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.60883,-0.087918,-0.035217,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.19139,-0.088018,-0.1433,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.7588,-0.088399,-0.04647,0,0
2,GO SPERM CAPACITATION,0.088413,-0.08857,-0.17586,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.11333,-0.088655,-0.092407,0,0
2,GO LIPID DIGESTION,0.55922,-0.089152,-0.085666,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.041252,-0.089157,-0.10187,0,0
2,GO SKIN MORPHOGENESIS,0.74966,-0.08923,-0.12699,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.64294,-0.089361,-0.043893,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.82372,-0.089363,-0.015181,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.31468,-0.089571,-0.14811,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.2356,-0.089684,-0.26234,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.042464,-0.089855,-0.092736,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.59207,-0.090197,-0.040432,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.29761,-0.09023,-0.074918,0,0
2,GO RESPONSE TO WATER,0.6516,-0.090261,-0.064277,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.14679,-0.090391,-0.099307,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.48118,-0.090649,-0.061794,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.071835,-0.090663,-0.096327,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.69555,-0.090706,-0.037011,0,0
2,GO HEART GROWTH,0.12472,-0.090852,-0.096907,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.40947,-0.090981,-0.060771,0,0
2,GO CELL RECOGNITION,0.054786,-0.091005,-0.11278,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.32052,-0.091234,-0.088161,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.4445,-0.091303,-0.055772,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.50395,-0.09133,-0.040851,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.12179,-0.091354,-0.08475,0,0
2,GO REGULATION OF GLIOGENESIS,0.42328,-0.091735,-0.050231,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.095374,-0.092017,-0.11147,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.22164,-0.09205,-0.10474,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.43029,-0.09211,-0.098464,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.46631,-0.092348,-0.076603,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.084004,-0.092458,-0.091808,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.25017,-0.092524,-0.086487,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.073757,-0.092648,-0.10783,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.71343,-0.092653,-0.090434,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.15017,-0.092822,-0.10413,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.4445,-0.092926,-0.081525,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.10025,-0.092993,-0.11741,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.12472,-0.093027,-0.12652,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.10533,-0.093039,-0.1116,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.34454,-0.093101,-0.070212,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.090686,-0.093194,-0.12531,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.36329,-0.093229,-0.11433,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.52728,-0.093681,-0.14719,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.12179,-0.093891,-0.091165,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.73147,-0.093902,-0.03979,0,0
2,GO CELL JUNCTION MAINTENANCE,0.073757,-0.093957,-0.15239,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.33239,-0.094098,-0.070862,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.18733,-0.094118,-0.21991,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26536,-0.094152,-0.078769,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.24525,-0.094228,-0.12077,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.13384,-0.094448,-0.09181,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.39593,-0.094465,-0.059914,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.053284,-0.09501,-0.12315,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.031606,-0.095039,-0.15709,0,0
2,GO RESPONSE TO NICOTINE,0.64294,-0.095084,-0.033717,0,0
2,GO PROSTATIC BUD FORMATION,0.40947,-0.09524,-0.19446,0,0
2,GO BRAIN MORPHOGENESIS,0.15361,-0.095357,-0.11518,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.51167,-0.095387,-0.10168,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.12771,-0.095392,-0.094075,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.11061,-0.095758,-0.11716,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.037792,-0.09586,-0.15116,0,0
2,GO FEAR RESPONSE,0.19552,-0.095985,-0.11237,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.12771,-0.096046,-0.1483,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.13074,-0.096055,-0.11431,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.25516,-0.096225,-0.084548,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.36329,-0.096238,-0.0777,0,0
2,GO REGULATION OF CELL SIZE,0.043706,-0.096333,-0.12747,0,0
2,GO PEPTIDE SECRETION,0.046281,-0.096336,-0.12123,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.09779,-0.096398,-0.11403,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.32642,-0.096791,-0.13396,0,0
2,GO ACTION POTENTIAL,0.15712,-0.097148,-0.12417,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.34454,-0.097161,-0.11382,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.27056,-0.097335,-0.099001,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.43736,-0.097338,-0.17757,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.51944,-0.097416,-0.17694,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.10025,-0.097421,-0.13595,0,0
2,GO CHLORIDE TRANSPORT,0.053284,-0.097681,-0.13082,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.34454,-0.097685,-0.07099,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.17173,-0.097705,-0.093382,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.73147,-0.097808,-0.065629,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.30323,-0.09784,-0.10968,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.048983,-0.098017,-0.13822,0,0
2,GO CGMP MEDIATED SIGNALING,0.15017,-0.098155,-0.16358,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.27056,-0.098185,-0.08859,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.19139,-0.09824,-0.11395,0,0
2,GO REGULATION OF TISSUE REMODELING,0.55115,-0.098328,-0.06814,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.054786,-0.098393,-0.13949,0,0
2,GO EPITHELIAL CELL MATURATION,0.21267,-0.098472,-0.13129,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.55115,-0.098865,-0.18389,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.073757,-0.099239,-0.11327,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.63434,-0.099335,-0.029363,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.10277,-0.099451,-0.13895,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.43029,-0.099604,-0.12623,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.053284,-0.099693,-0.11123,0,0
2,GO FACE DEVELOPMENT,0.24039,-0.099983,-0.11094,0,0
2,GO SEGMENT SPECIFICATION,0.27056,-0.099986,-0.15294,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.36329,-0.10002,-0.099393,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.56735,-0.10044,-0.081704,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.1402,-0.10089,-0.1389,0,0
2,GO BONE RESORPTION,0.43736,-0.10098,-0.080271,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.24039,-0.101,-0.11145,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.22164,-0.1011,-0.088923,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.030665,-0.10119,-0.13114,0,0
2,GO PHOSPHATE ION TRANSPORT,0.12472,-0.10121,-0.10181,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.51167,-0.10129,-0.029233,0,0
2,GO TRABECULA MORPHOGENESIS,0.19139,-0.10147,-0.10891,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.1643,-0.10159,-0.18457,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.15361,-0.10163,-0.15522,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.43736,-0.10169,-0.068111,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.07572,-0.10194,-0.10762,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.056323,-0.10198,-0.14549,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.38927,-0.10213,-0.10595,0,0
2,GO REGULATION OF SECRETION,0.093006,-0.10244,-0.10548,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.20828,-0.10245,-0.16041,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.064555,-0.10256,-0.13329,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.10794,-0.10262,-0.105,0,0
2,GO MAGNESIUM ION TRANSPORT,0.14347,-0.10322,-0.16253,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.064555,-0.10326,-0.10364,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.10794,-0.10332,-0.11305,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.59207,-0.10334,-0.086199,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.76799,-0.10349,-0.047082,0,0
2,GO CELL FATE SPECIFICATION,0.45898,-0.10361,-0.053873,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.07572,-0.10367,-0.14061,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.31468,-0.10369,-0.087765,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.064555,-0.10377,-0.1155,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.030665,-0.10382,-0.13329,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.11333,-0.10422,-0.10891,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.51944,-0.10429,-0.072341,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.51167,-0.1044,-0.12621,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.093006,-0.10453,-0.19437,0,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.20396,-0.10472,-0.11267,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.42328,-0.10481,-0.043621,0,0
2,GO OSSIFICATION,0.069955,-0.1049,-0.11988,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.17173,-0.10491,-0.1206,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.30323,-0.10526,-0.087736,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.11333,-0.10526,-0.15419,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.081867,-0.10526,-0.14912,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.66904,-0.10529,-0.030488,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.086186,-0.10548,-0.11493,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.53518,-0.10575,-0.084287,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.068115,-0.1062,-0.15382,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.22164,-0.10623,-0.14006,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.13074,-0.10635,-0.080823,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.030665,-0.10654,-0.13056,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.1402,-0.10661,-0.11022,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.22164,-0.10667,-0.10568,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.1643,-0.10698,-0.16583,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.1643,-0.10698,-0.10137,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.048983,-0.10747,-0.11337,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.042464,-0.10765,-0.11375,0,0
2,GO CARTILAGE DEVELOPMENT,0.25017,-0.10773,-0.084677,0,0
2,GO MITOCHONDRION LOCALIZATION,0.14347,-0.10775,-0.092635,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.25516,-0.10785,-0.12185,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.12771,-0.10791,-0.11089,0,0
2,GO EYE MORPHOGENESIS,0.077726,-0.10791,-0.10513,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.13384,-0.108,-0.10678,0,0
2,GO NERVOUS SYSTEM PROCESS,0.071835,-0.10841,-0.11543,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.086186,-0.10857,-0.14461,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.17553,-0.10893,-0.10903,0,0
2,GO ECTODERM DEVELOPMENT,0.077726,-0.10924,-0.1381,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.71343,-0.10938,-0.029839,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.47371,-0.10959,-0.074062,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.084004,-0.10975,-0.09816,0,0
2,GO WALKING BEHAVIOR,0.35072,-0.10993,-0.09519,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.047616,-0.10997,-0.12928,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.1794,-0.11,-0.13179,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.14347,-0.11028,-0.1124,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.25516,-0.11037,-0.17081,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.73147,-0.1105,-0.10515,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.093006,-0.11069,-0.18106,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.16798,-0.11095,-0.19863,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.71343,-0.11101,-0.018087,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.11333,-0.11108,-0.14038,0,0
2,GO LYMPH NODE DEVELOPMENT,0.11061,-0.11115,-0.1833,0,0
2,GO CELLULAR ANION HOMEOSTASIS,0.48118,-0.11148,-0.071409,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.062834,-0.11153,-0.1225,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.35697,-0.11169,-0.026965,0,0
2,GO RESPONSE TO ALKALOID,0.031606,-0.11191,-0.16761,0,0
2,GO ATP TRANSPORT,0.17173,-0.11196,-0.091064,0,0
2,GO NEURAL TUBE PATTERNING,0.11333,-0.112,-0.17165,0,0
2,GO HEART MORPHOGENESIS,0.12179,-0.11231,-0.092496,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.41634,-0.11253,-0.13175,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.16798,-0.11287,-0.1424,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.079775,-0.11291,-0.18527,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.16798,-0.11301,-0.13064,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.038917,-0.11301,-0.1339,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13384,-0.11343,-0.15306,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.1643,-0.11358,-0.12296,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.30892,-0.11375,-0.10255,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.12179,-0.11389,-0.16851,0,0
2,GO DNA DEMETHYLATION,0.28117,-0.11419,-0.041123,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.041252,-0.11448,-0.10061,0,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.054786,-0.11463,-0.1123,0,0
2,GO CARDIAC CONDUCTION,0.10533,-0.11476,-0.14277,0,0
2,GO REGULATION OF OSSIFICATION,0.26536,-0.11476,-0.081778,0,0
2,GO BONE CELL DEVELOPMENT,0.18334,-0.11495,-0.090292,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.36329,-0.11517,-0.11345,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.29206,-0.11531,-0.1356,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.20396,-0.11536,-0.13892,0,0
2,GO HORMONE TRANSPORT,0.10533,-0.11553,-0.11833,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.031606,-0.11565,-0.18293,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.11333,-0.11575,-0.1477,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.22164,-0.11577,-0.11221,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.67783,-0.11614,-0.048821,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.090686,-0.11617,-0.13721,0,0
2,GO MITOTIC DNA REPLICATION,0.20828,-0.11624,-0.099803,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.11333,-0.11633,-0.13237,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.22622,-0.11635,-0.18135,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.22622,-0.11647,-0.12854,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.24525,-0.11649,-0.18933,0,0
2,GO RESPONSE TO LEUCINE,0.1794,-0.11662,-0.21074,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.51944,-0.11665,-0.10201,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.12472,-0.1168,-0.16883,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.45171,-0.11701,-0.045995,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.088413,-0.11707,-0.18435,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.12771,-0.11712,-0.14203,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.095374,-0.1172,-0.087135,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.066316,-0.11721,-0.10825,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.13699,-0.11723,-0.11298,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.21712,-0.11725,-0.091491,0,0
2,GO PANCREAS DEVELOPMENT,0.11333,-0.1173,-0.13653,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.25516,-0.11752,-0.088431,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.048983,-0.11758,-0.16223,0,0
2,GO ODONTOGENESIS,0.26023,-0.11782,-0.098471,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.093006,-0.11796,-0.2869,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.76799,-0.11835,-0.041381,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.053284,-0.11884,-0.17304,0,0
2,GO REGULATION OF INSULIN SECRETION,0.11892,-0.11886,-0.11273,0,0
2,GO RESPONSE TO BMP,0.037792,-0.11891,-0.14858,0,0
2,GO PHAGOSOME MATURATION,0.084004,-0.11937,-0.14982,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.19552,-0.11942,-0.14693,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.1402,-0.11962,-0.11935,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.037792,-0.1199,-0.083854,0,0
2,GO ANIMAL ORGAN FORMATION,0.1161,-0.11995,-0.1218,0,0
2,GO AXO DENDRITIC TRANSPORT,0.079775,-0.12059,-0.11539,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.26536,-0.12137,-0.087565,0,0
2,GO NUCLEOSIDE SALVAGE,0.11333,-0.12145,-0.13039,0,0
2,GO GLUCOSE IMPORT,0.043706,-0.12157,-0.13612,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.2356,-0.12167,-0.11526,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.33239,-0.12173,-0.12382,0,0
2,GO REGULATION OF COAGULATION,0.48871,-0.12173,-0.081444,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.45898,-0.12197,-0.11588,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.21712,-0.12229,-0.17199,0,0
2,GO PROTEIN KINASE C SIGNALING,0.09779,-0.1223,-0.21567,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.60883,-0.1224,-0.064321,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.4963,-0.12244,-0.10223,0,0
2,GO REGULATION OF HORMONE SECRETION,0.051817,-0.12248,-0.12127,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.062834,-0.12254,-0.1623,0,0
2,GO CELL MORPHOGENESIS,0.030665,-0.12258,-0.13167,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.19139,-0.12259,-0.07727,0,0
2,GO SEROTONIN TRANSPORT,0.36968,-0.12283,-0.1041,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.11892,-0.12307,-0.1195,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.20828,-0.12331,-0.10881,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.10025,-0.12334,-0.10795,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.56735,-0.12356,-0.13526,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.34454,-0.1239,-0.075362,0,0
2,GO STEM CELL PROLIFERATION,0.11892,-0.12411,-0.094543,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.33239,-0.12485,-0.19577,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.095374,-0.12514,-0.11895,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.33239,-0.12517,-0.10597,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.15361,-0.12541,-0.13651,0,0
2,GO KINETOCHORE ORGANIZATION,0.17173,-0.12558,-0.12865,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.29206,-0.12567,-0.085516,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.26536,-0.12574,-0.1968,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.29206,-0.126,-0.10058,0,0
2,GO REGULATION OF EXCRETION,0.60042,-0.12608,0.00018877,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.1794,-0.12633,-0.11843,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.21267,-0.12636,-0.073363,0,0
2,GO ADULT FEEDING BEHAVIOR,0.10533,-0.12649,-0.15442,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.17173,-0.12678,-0.19563,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.29761,-0.1269,-0.075015,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.72243,-0.12697,-0.022181,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.09779,-0.12701,-0.11402,0,0
2,GO RESPONSE TO AMPHETAMINE,0.35072,-0.12736,-0.067988,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.2356,-0.12741,-0.074268,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.35697,-0.12755,-0.061715,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.14347,-0.12766,-0.14445,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.084004,-0.12777,-0.15281,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.1643,-0.12863,-0.097599,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.042464,-0.12866,-0.14383,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.27583,-0.12877,-0.14288,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.18334,-0.12881,-0.11204,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.1794,-0.12922,-0.18521,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.06115,-0.12931,-0.11994,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.12179,-0.12991,-0.1307,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.079775,-0.12996,-0.15781,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.2356,-0.13008,-0.17706,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.15361,-0.13093,-0.12828,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.13074,-0.13094,-0.12706,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.077726,-0.13117,-0.089033,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.064555,-0.13122,-0.11601,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16068,-0.13169,-0.10553,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.037792,-0.13184,-0.11225,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.030665,-0.13228,-0.1562,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.088413,-0.13249,-0.13438,0,0
2,GO RELAXATION OF MUSCLE,0.26023,-0.13269,-0.12814,0,0
2,GO RESPONSE TO CAMP,0.071835,-0.13271,-0.12947,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.33239,-0.13274,-0.0934,0,0
2,GO PROTEIN NITROSYLATION,0.55922,-0.13289,-0.010312,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.059504,-0.13289,-0.21583,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.70447,-0.13327,-0.049402,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.27583,-0.13375,-0.12392,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.066316,-0.13381,-0.14897,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.11061,-0.13398,-0.11727,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.038917,-0.13415,-0.15241,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.10533,-0.13423,-0.13665,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.4963,-0.13424,-0.060376,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.4445,-0.13432,-0.1671,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.088413,-0.13451,-0.16967,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.13699,-0.13498,-0.15099,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.10794,-0.13536,-0.11924,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.14679,-0.13554,-0.13836,0,0
2,GO ORGANIC CATION TRANSPORT,0.39593,-0.13565,-0.064719,0,0
2,GO RENAL WATER HOMEOSTASIS,0.07572,-0.13578,-0.12273,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.33843,-0.13593,-0.075734,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.28658,-0.13608,-0.10773,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.30892,-0.1361,-0.10112,0,0
2,GO CENTROSOME SEPARATION,0.10533,-0.13618,-0.11141,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10533,-0.13669,-0.18536,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.21267,-0.13682,-0.098835,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.10025,-0.13694,-0.13077,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.069955,-0.13722,-0.11993,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.24039,-0.13727,-0.13636,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.26023,-0.13752,-0.085277,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.059504,-0.13824,-0.22282,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.13074,-0.13827,-0.18549,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.31468,-0.13832,-0.13639,0,0
2,GO TISSUE REMODELING,0.36329,-0.13846,-0.093853,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.88036,-0.1387,0.033997,0,0
2,GO BONE MINERALIZATION,0.1161,-0.13872,-0.11801,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.20396,-0.13919,-0.072681,0,0
2,GO REGIONALIZATION,0.033564,-0.13929,-0.12211,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.057895,-0.13953,-0.16638,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.062834,-0.13962,-0.14442,0,0
2,GO REGULATION OF APPETITE,0.088413,-0.14027,-0.12438,0,0
2,GO INSULIN SECRETION,0.14347,-0.14044,-0.11562,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.1402,-0.14054,-0.15346,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.084004,-0.14063,-0.13083,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.053284,-0.14129,-0.14729,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.046281,-0.14182,-0.13753,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.088413,-0.14201,-0.14025,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.057895,-0.14204,-0.17281,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.10533,-0.14218,-0.14171,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.12771,-0.14232,-0.24883,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.1643,-0.14282,-0.12033,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.15017,-0.14304,-0.115,0,0
2,GO ENDODERM FORMATION,0.39593,-0.14305,-0.12657,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.37614,-0.1431,-0.10617,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.35697,-0.14316,-0.090211,0,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.18733,-0.14336,-0.19872,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.12179,-0.1438,-0.11084,0,0
2,GO MEMBRANE FISSION,0.33843,-0.14421,-0.085618,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.066316,-0.14423,-0.12633,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.031606,-0.14433,-0.15332,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.066316,-0.14435,-0.1476,0,0
2,GO AXONAL TRANSPORT,0.048983,-0.14492,-0.14951,0,0
2,GO NEUROMUSCULAR PROCESS,0.068115,-0.14574,-0.16598,0,0
2,GO STEROID CATABOLIC PROCESS,0.10277,-0.14589,-0.15066,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.056323,-0.14641,-0.13281,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.28658,-0.14684,-0.12436,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.064555,-0.14745,-0.13613,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.15017,-0.14765,-0.12654,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.22622,-0.14782,-0.18412,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.17173,-0.14786,-0.23146,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.12179,-0.14789,-0.16669,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.086186,-0.14801,-0.12066,0,0
2,GO BIOMINERALIZATION,0.1161,-0.14806,-0.11201,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.28117,-0.1486,-0.19196,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.071835,-0.14866,-0.13702,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.053284,-0.14899,-0.20851,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.48118,-0.14911,-0.12165,0,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.036694,-0.14913,-0.14224,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.33239,-0.14954,-0.096919,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.32052,-0.14956,-0.096102,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.031606,-0.1496,-0.16413,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.25017,-0.14987,-0.11977,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.10533,-0.15004,-0.094087,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.11061,-0.15055,-0.1684,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.22622,-0.15061,-0.1219,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.20828,-0.15063,-0.18411,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.19971,-0.15065,-0.089529,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.1643,-0.1507,-0.095928,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.14347,-0.15115,-0.20966,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.16798,-0.15127,-0.15345,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.07572,-0.15139,-0.15594,0,0
2,GO ASSOCIATIVE LEARNING,0.064555,-0.15174,-0.17647,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.033564,-0.15204,-0.13226,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.27056,-0.15312,-0.11075,0,0
2,GO TOOTH MINERALIZATION,0.47371,-0.15321,-0.07147,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.10025,-0.15336,-0.2815,0,0
2,GO OVULATION CYCLE,0.047616,-0.15398,-0.14002,0,0
2,GO FAT CELL PROLIFERATION,0.18733,-0.15412,-0.156,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.22622,-0.15429,-0.14518,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.04007,-0.15507,-0.1371,0,0
2,GO POLYOL TRANSPORT,0.32052,-0.15517,-0.094948,0,0
2,GO MEMBRANE BIOGENESIS,0.095374,-0.1553,-0.18703,0,0
2,GO UTERUS DEVELOPMENT,0.14679,-0.15573,-0.19731,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.46631,-0.15588,-0.059585,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.22622,-0.15608,-0.11098,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.033564,-0.15642,-0.2712,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.054786,-0.15742,-0.13866,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.062834,-0.15746,-0.18447,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.09779,-0.15763,-0.19687,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.1402,-0.15786,-0.12994,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.050383,-0.15801,-0.16785,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.15712,-0.15802,-0.17633,0,0
2,GO AMYLOID FIBRIL FORMATION,0.07572,-0.15813,-0.2389,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.095374,-0.15822,-0.17923,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.11892,-0.15832,-0.15346,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.8331,-0.15856,0.072611,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.12472,-0.15888,-0.13021,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.033564,-0.15916,-0.222,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.054786,-0.15937,-0.13799,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.073757,-0.15956,-0.26424,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.12179,-0.16033,-0.13605,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.062834,-0.16063,-0.17791,0,0
2,GO NUCLEOTIDE TRANSPORT,0.046281,-0.1618,-0.14711,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.15712,-0.1618,-0.052517,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.041252,-0.1619,-0.19231,0,0
2,GO DENDRITE MORPHOGENESIS,0.044978,-0.16194,-0.16638,0,0
2,GO GLYCINE TRANSPORT,0.25017,-0.16206,-0.18687,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.051817,-0.16218,-0.17979,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.051817,-0.16245,-0.14483,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.084004,-0.16253,-0.13125,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.20396,-0.16271,-0.15995,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.21267,-0.16307,-0.083361,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.42328,-0.16363,-0.10448,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.10025,-0.16402,-0.19053,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.18334,-0.16464,-0.14288,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.046281,-0.16502,-0.12517,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.037792,-0.16599,-0.23183,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.07572,-0.16606,-0.25337,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.057895,-0.16638,-0.17059,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.069955,-0.16681,-0.13657,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.28117,-0.16683,-0.18947,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.073757,-0.16883,-0.14716,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.13074,-0.16926,-0.21954,0,0
2,GO PEPTIDE HORMONE SECRETION,0.033564,-0.16954,-0.16103,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.4963,-0.16962,-0.077197,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.11061,-0.17014,-0.15436,0,0
2,GO DEVELOPMENTAL INDUCTION,0.088413,-0.17014,-0.16424,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.090686,-0.17071,-0.12396,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.34454,-0.17074,-0.15539,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.10277,-0.17084,-0.2028,0,0
2,GO CONVERGENT EXTENSION,0.21712,-0.17145,-0.10859,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.10794,-0.17187,-0.12577,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.12472,-0.17256,-0.13255,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.17173,-0.17303,-0.23561,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.12472,-0.17339,-0.15149,0,0
2,GO SUCKLING BEHAVIOR,0.077726,-0.17346,-0.21984,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.079775,-0.17355,-0.18098,0,0
2,GO KETONE CATABOLIC PROCESS,0.1794,-0.17397,-0.13514,0,0
2,GO SYNAPSE ORGANIZATION,0.04007,-0.17424,-0.17277,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.10025,-0.17428,-0.096954,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.033564,-0.17429,-0.23143,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.11892,-0.17443,-0.15022,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.13074,-0.17503,-0.17225,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.19552,-0.17522,-0.15271,0,0
2,GO ORGAN INDUCTION,0.073757,-0.17524,-0.18355,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.046281,-0.17581,-0.16536,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.056323,-0.17603,-0.20578,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.057895,-0.17609,-0.18643,0,0
2,GO RESPONSE TO COCAINE,0.034581,-0.17609,-0.1947,0,0
2,GO RESPONSE TO COLD,0.071835,-0.17639,-0.18959,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.21267,-0.17655,-0.18226,0,0
2,GO TUBULIN DEACETYLATION,0.32642,-0.17659,-0.17098,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.26536,-0.17825,-0.11143,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.068115,-0.17855,-0.20799,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.1161,-0.17866,-0.1681,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.04007,-0.17871,-0.18973,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.18334,-0.17876,-0.10186,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.4963,-0.17895,-0.087785,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.030665,-0.18014,-0.18181,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.043706,-0.18054,-0.3673,0,0
2,GO LEARNING,0.050383,-0.18058,-0.19168,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.18334,-0.18061,-0.20054,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.40267,-0.18092,-0.067394,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.059504,-0.18108,-0.28496,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.1794,-0.18138,-0.14684,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.21712,-0.18151,-0.17193,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.15017,-0.18237,-0.28459,0,0
2,GO VASODILATION,0.22622,-0.18367,-0.16286,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.35697,-0.18368,-0.081811,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.1402,-0.18394,-0.13851,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.26023,-0.18413,-0.099354,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.086186,-0.1844,-0.17539,0,0
2,GO REGULATION OF TRANSPOSITION,0.52728,-0.18442,-0.11517,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.22622,-0.18482,-0.065146,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.27583,-0.18487,-0.16569,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.041252,-0.18509,-0.23328,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.34454,-0.18534,-0.12822,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.095374,-0.18562,-0.20666,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.10025,-0.18591,-0.16122,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.21267,-0.18643,-0.12678,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.10025,-0.18684,-0.16672,0,0
2,GO LONG TERM MEMORY,0.044978,-0.18688,-0.19721,0,0
2,GO HEPARIN METABOLIC PROCESS,0.13074,-0.18691,-0.22971,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.29206,-0.18745,-0.14775,0,0
2,GO HEART VALVE DEVELOPMENT,0.059504,-0.18867,-0.16325,0,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.06115,-0.18907,-0.18142,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.038917,-0.18917,-0.15737,0,0
2,GO MYELIN MAINTENANCE,0.095374,-0.19007,-0.23686,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.064555,-0.19018,-0.16904,0,0
2,GO THALAMUS DEVELOPMENT,0.12472,-0.19058,-0.20745,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.26536,-0.19083,-0.16518,0,0
2,GO RESPONSE TO CAFFEINE,0.066316,-0.19098,-0.18785,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.044978,-0.19103,-0.20968,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.059504,-0.19169,-0.14908,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.042464,-0.19173,-0.22379,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15361,-0.19218,-0.16774,0,0
2,GO VAGINA DEVELOPMENT,0.10794,-0.19219,-0.21029,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.030665,-0.19239,-0.17686,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1,-0.19261,0.0098397,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.13699,-0.19365,-0.15467,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.056323,-0.19389,-0.17748,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.068115,-0.19424,-0.19286,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.043706,-0.19448,-0.20533,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.15712,-0.19504,-0.14248,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.17173,-0.19532,-0.1271,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.32052,-0.19557,-0.066762,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.079775,-0.19581,-0.16441,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.25516,-0.1965,-0.14488,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.27583,-0.19667,-0.093799,0,0
2,GO ALANINE TRANSPORT,0.046281,-0.19708,-0.26056,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.15712,-0.19737,-0.14278,0,0
2,GO HEAD MORPHOGENESIS,0.068115,-0.19762,-0.18678,0,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.37614,-0.19819,-0.16142,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.037792,-0.19875,-0.18158,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.29206,-0.19891,-0.10983,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.046281,-0.19964,-0.23499,0,0
2,GO REGULATION OF EXOCYTOSIS,0.16798,-0.20021,-0.18369,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.1402,-0.20036,-0.22545,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.036694,-0.20049,-0.17946,0,0
2,GO RESPONSE TO ACIDIC PH,0.077726,-0.20115,-0.17611,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.071835,-0.20126,-0.19142,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.33239,-0.20143,-0.098103,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.054786,-0.20171,-0.21828,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.35072,-0.20191,-0.16119,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.45171,-0.20244,-0.13646,0,0
2,GO DENDRITIC TRANSPORT,0.16798,-0.20263,-0.15947,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.041252,-0.20273,-0.21079,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.053284,-0.20565,-0.31857,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.084004,-0.20575,-0.20303,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.38267,-0.20577,-0.10121,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.051817,-0.20585,-0.24984,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11333,-0.20612,-0.20613,0,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.2356,-0.20622,-0.19226,0,0
2,GO ANIMAL ORGAN MATURATION,0.032572,-0.20633,-0.18885,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.30892,-0.2066,-0.16812,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.088413,-0.20708,-0.16811,0,0
2,GO VASCULAR TRANSPORT,0.35697,-0.20758,-0.15337,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.057895,-0.20789,-0.17839,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.09779,-0.20807,-0.19482,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.043706,-0.209,-0.20847,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.30323,-0.2092,-0.10434,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.032572,-0.20958,-0.19749,0,0
2,GO N GLYCAN PROCESSING,0.07572,-0.20964,-0.26072,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.059504,-0.20973,-0.28664,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.030665,-0.20987,-0.17926,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.56735,-0.20999,-0.053925,0,0
2,GO SECONDARY METABOLIC PROCESS,0.1402,-0.21112,-0.15465,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.084004,-0.2113,-0.19377,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.079775,-0.21169,-0.26634,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.088413,-0.21206,-0.2302,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.12771,-0.21302,-0.19907,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.030665,-0.21337,-0.21933,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.55922,-0.21373,0.011966,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.048983,-0.21473,-0.18389,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.057895,-0.21485,-0.19059,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.069955,-0.21492,-0.18574,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.17173,-0.21551,-0.14577,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.1161,-0.21589,-0.14809,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.050383,-0.21591,-0.24102,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.035624,-0.21693,-0.18197,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.034581,-0.21699,-0.24012,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.056323,-0.21766,-0.24095,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.079775,-0.21805,-0.22145,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.048983,-0.21942,-0.22871,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.07572,-0.2196,-0.20075,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.034581,-0.21984,-0.36092,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.030665,-0.22046,-0.23657,0,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.042464,-0.22118,-0.16501,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.068115,-0.22348,-0.18699,0,0
2,GO RESPONSE TO POTASSIUM ION,0.042464,-0.22452,-0.23391,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.050383,-0.22545,-0.16381,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.4963,-0.22637,-0.17872,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.13074,-0.2264,-0.23964,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.13384,-0.22653,-0.20416,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.062834,-0.22686,-0.20079,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.090686,-0.22701,-0.23156,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.041252,-0.2286,-0.21421,0,0
2,GO BODY MORPHOGENESIS,0.086186,-0.22908,-0.15454,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.10025,-0.23255,-0.21619,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.12179,-0.2327,-0.15638,0,0
2,GO SIALYLATION,0.1402,-0.23276,-0.1802,0,0
2,GO TRANSPOSITION,0.077726,-0.23353,-0.22303,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.093006,-0.23418,-0.34379,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.04007,-0.2345,-0.27033,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.09779,-0.23474,-0.24883,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.25516,-0.23479,-0.18982,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.084004,-0.23485,-0.25244,0,0
2,GO LOCOMOTOR RHYTHM,0.43029,-0.2349,-0.072538,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.12179,-0.2351,-0.18308,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.044978,-0.23663,-0.35545,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.11333,-0.23759,-0.23155,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.14347,-0.23915,-0.17215,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.090686,-0.23953,-0.34064,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.054786,-0.24039,-0.18057,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.15017,-0.24115,-0.27471,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.22164,-0.24204,-0.20254,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.044978,-0.24241,-0.19052,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.030665,-0.24248,-0.19759,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.12179,-0.24258,-0.21273,0,0
2,GO DENDRITE SELF AVOIDANCE,0.071835,-0.24582,-0.26961,0,0
2,GO CARDIAC CHAMBER FORMATION,0.26536,-0.24958,-0.15902,0,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.079775,-0.25108,-0.27192,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.093006,-0.25268,-0.26834,0,0
2,GO FIBRINOLYSIS,0.077726,-0.25559,-0.24537,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.044978,-0.25673,-0.27861,0,0
2,GO ESTROUS CYCLE,0.10025,-0.25696,-0.21165,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.047616,-0.25812,-0.23958,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.030665,-0.25947,-0.31727,0,0
2,GO PARTURITION,0.11892,-0.26243,-0.1904,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.035624,-0.26353,-0.2658,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.12179,-0.26527,-0.24716,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.050383,-0.26582,-0.3599,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.17173,-0.26707,-0.21273,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.038917,-0.26745,-0.33283,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.16798,-0.26815,-0.18332,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.069955,-0.27054,-0.24238,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.095374,-0.27156,-0.26333,0,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.057895,-0.27534,-0.26048,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.084004,-0.27666,-0.24387,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.11061,-0.27754,-0.18171,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.14679,-0.2783,-0.17712,0,0
2,GO GROOMING BEHAVIOR,0.077726,-0.28155,-0.2017,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.068115,-0.28245,-0.31635,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.030665,-0.28293,-0.32497,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.090686,-0.29109,-0.22066,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.033564,-0.29698,-0.29509,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.10025,-0.29853,-0.30575,0,0
2,GO HORMONE CATABOLIC PROCESS,0.035624,-0.30186,-0.34556,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.93762,-0.30193,0.042002,0,0
2,GO CGMP METABOLIC PROCESS,0.054786,-0.30218,-0.28532,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.034581,-0.30404,-0.24712,0,0
2,GO SEROTONIN SECRETION,0.18733,-0.3053,-0.20805,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.07572,-0.30698,-0.31163,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.33239,-0.311,-0.1574,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.030665,-0.3113,-0.21743,0,0
2,GO T CELL EXTRAVASATION,0.059504,-0.31253,-0.33726,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.044978,-0.31476,-0.30134,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.035624,-0.31536,-0.24418,0,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.1161,-0.31727,-0.23574,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.11061,-0.31866,-0.18524,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.032572,-0.31867,-0.28776,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.06115,-0.32396,-0.30229,0,0
2,GO MIDGUT DEVELOPMENT,0.066316,-0.32793,-0.25915,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.043706,-0.32845,-0.2954,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.038917,-0.33481,-0.33604,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.042464,-0.33657,-0.23486,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.030665,-0.33706,-0.30526,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.043706,-0.33743,-0.24312,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.057895,-0.33897,-0.38764,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.057895,-0.34683,-0.28819,0,0
2,GO REGULATION OF VESICLE FUSION,0.10533,-0.35399,-0.23212,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.064555,-0.35615,-0.32092,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.088413,-0.37142,-0.23507,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.068115,-0.37416,-0.23781,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.033564,-0.3766,-0.28483,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.035624,-0.37893,-0.33423,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.081867,-0.40595,-0.33292,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.12179,-0.40718,-0.14866,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.044978,-0.41222,-0.33248,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.066316,-0.43322,-0.36423,0,0
2,GO LUNG CELL DIFFERENTIATION,0.12179,-0.45432,-0.29295,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.11333,-0.46965,-0.22799,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.041252,-0.48901,-0.34051,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.077726,-0.48973,-0.4136,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.10794,-0.49335,-0.27538,0,0
2,GO NEURON FATE SPECIFICATION,0.037792,-0.50518,-0.34452,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.037792,-0.53173,-0.49945,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.10794,-0.54338,-0.2718,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.038917,-0.64586,-0.44906,0,0
2,GO PROTEIN LOCALIZATION TO AXON,0.041252,-0.70616,-0.60984,0,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.12472,-0.76048,-0.70458,0,0
3,GO OXYGEN TRANSPORT,0.0040811,0.8675,0.77952,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00027004,0.83121,0.77358,1,1
3,GO SYNAPSE MATURATION,0.00034064,0.77455,0.80651,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00042822,0.77283,0.89328,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.0022699,0.72964,0.56695,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.0029959,0.69604,0.61754,1,1
3,GO RESPONSE TO L GLUTAMATE,0.00021334,0.68537,0.65875,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00042822,0.6536,0.61363,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.0026621,0.65247,0.52975,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0138,0.60791,0.47238,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.01427,0.58703,0.39307,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00031055,0.58098,0.51074,1,1
3,GO DIVALENT METAL ION EXPORT,0.001448,0.57873,0.59369,1,1
3,GO GAS TRANSPORT,0.0047478,0.56905,0.58773,1,1
3,GO SYNAPTIC VESICLE MATURATION,0.00040918,0.56182,0.63652,1,1
3,GO DENTATE GYRUS DEVELOPMENT,0.0025586,0.54713,0.56776,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.00087036,0.54382,0.53079,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0031154,0.52942,0.45939,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0059338,0.52778,0.45842,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00044809,0.51975,0.46755,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0094624,0.51722,0.4404,1,1
3,GO PLASMA MEMBRANE REPAIR,0.00035669,0.50871,0.51391,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0037806,0.50267,0.58237,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.012053,0.50159,0.3419,1,1
3,GO L GLUTAMATE IMPORT,0.023222,0.5007,0.33418,1,1
3,GO RIBOSOME ASSEMBLY,0.0051169,0.49309,0.41595,1,1
3,GO SIALYLATION,0.0055117,0.48618,0.45042,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.022501,0.4846,0.43673,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0066217,0.46895,0.36929,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.0021804,0.46486,0.53256,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0025586,0.46456,0.42258,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00058654,0.46312,0.51212,1,1
3,GO CYTOPLASMIC TRANSLATION,0.0091361,0.45969,0.39628,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0079288,0.45754,0.35283,1,1
3,GO IMP METABOLIC PROCESS,0.0016396,0.45506,0.4645,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.00014528,0.45088,0.45091,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0019312,0.44867,0.39839,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0039282,0.44716,0.50639,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0047478,0.44393,0.38214,1,1
3,GO PARENTAL BEHAVIOR,0.0063849,0.43864,0.37214,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.027136,0.43788,0.38925,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0016396,0.42891,0.41905,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0016396,0.42826,0.43472,1,1
3,GO MATURATION OF LSU RRNA,0.0026621,0.42724,0.41498,1,1
3,GO SNORNA METABOLIC PROCESS,0.012053,0.42686,0.42547,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00051298,0.42628,0.43504,1,1
3,GO CGMP METABOLIC PROCESS,0.0071194,0.42498,0.37015,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0138,0.41706,0.38494,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0027694,0.41304,0.38854,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0010786,0.40994,0.46557,1,1
3,GO TRANSLATIONAL INITIATION,0.011255,0.40981,0.33448,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0059338,0.40844,0.41467,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00069995,0.40638,0.42768,1,1
3,GO SNORNA 3 END PROCESSING,0.0019312,0.40532,0.48902,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.01684,0.40502,0.33797,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0031154,0.4014,0.40308,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.011648,0.40086,0.34795,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0031154,0.39869,0.3841,1,1
3,GO MYOBLAST PROLIFERATION,0.0028806,0.39223,0.35033,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.0015733,0.39181,0.43283,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.021117,0.38782,0.38618,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0015095,0.3853,0.34963,1,1
3,GO EXPLORATION BEHAVIOR,0.0045725,0.38512,0.42758,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.0024588,0.38304,0.36441,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.011648,0.37985,0.24894,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0040811,0.37944,0.30495,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0061556,0.37885,0.29322,1,1
3,GO REGULATION OF TUBULIN DEACETYLATION,0.0059338,0.37596,0.34555,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.023963,0.37064,0.28822,1,1
3,GO NEGATIVE CHEMOTAXIS,0.016296,0.36832,0.28658,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0047478,0.36223,0.34032,1,1
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0076503,0.3593,0.51113,1,1
3,GO L SERINE METABOLIC PROCESS,0.027136,0.35742,0.33857,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.004403,0.3507,0.38823,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.00064092,0.34906,0.37872,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0061556,0.34895,0.25231,1,1
3,GO MATURATION OF SSU RRNA,0.0037806,0.34825,0.3433,1,1
3,GO TUBULIN DEACETYLATION,0.0066217,0.34728,0.30236,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.005311,0.34675,0.30142,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.0029959,0.33981,0.32444,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00066983,0.33356,0.32047,1,1
3,GO PROTEIN NITROSYLATION,0.0022699,0.33142,0.34666,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0071194,0.32824,0.35013,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0174,0.32594,0.27093,1,1
3,GO FEAR RESPONSE,0.024724,0.32562,0.22046,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0085133,0.32336,0.31703,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.01247,0.31975,0.28374,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.0032392,0.31849,0.37895,1,1
3,GO MITOCHONDRIAL TRNA PROCESSING,0.023963,0.31316,0.2635,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0068665,0.30555,0.25517,1,1
3,GO ALANINE TRANSPORT,0.01427,0.30123,0.31982,1,1
3,GO MRNA METHYLATION,0.0017799,0.29978,0.26495,1,1
3,GO RIBOSOME BIOGENESIS,0.0055117,0.29696,0.29512,1,1
3,GO CRISTAE FORMATION,0.0040811,0.29585,0.28298,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.005311,0.29496,0.22146,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0055117,0.2934,0.23823,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0024588,0.29206,0.28544,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.001448,0.29182,0.25033,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.010146,0.29107,0.29156,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.021799,0.28902,0.21549,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.01427,0.28761,0.26157,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.023222,0.28604,0.21892,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.021117,0.2847,0.26766,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0047478,0.28394,0.27529,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0055117,0.28374,0.27221,1,1
3,GO REGULATION OF LYASE ACTIVITY,0.00073133,0.28311,0.27031,1,1
3,GO MRNA MODIFICATION,0.0020943,0.28289,0.27451,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.010505,0.28156,0.24041,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.0012247,0.28047,0.27661,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0097991,0.27621,0.24661,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0082164,0.27497,0.25589,1,1
3,GO RRNA METABOLIC PROCESS,0.0066217,0.27437,0.2642,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0045725,0.27215,0.26053,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.0073805,0.27123,0.23323,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.027983,0.2709,0.21396,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.010146,0.27028,0.25506,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0031154,0.26887,0.24761,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0059338,0.26767,0.19899,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0037806,0.26767,0.2363,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.015767,0.26694,0.27224,1,1
3,GO TRANSLATIONAL ELONGATION,0.0063849,0.2652,0.24012,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0068665,0.26463,0.26924,1,1
3,GO MITOCHONDRION LOCALIZATION,0.00061317,0.26434,0.25731,1,1
3,GO REGULATION OF RNA BINDING,0.0024588,0.26344,0.33633,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.021799,0.26192,0.22008,1,1
3,GO NEURON REMODELING,0.0082164,0.26135,0.34268,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.023963,0.26134,0.24122,1,1
3,GO HISTONE ARGININE METHYLATION,0.0049293,0.25979,0.26979,1,1
3,GO ASSOCIATIVE LEARNING,0.00037344,0.25888,0.2758,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.022501,0.25629,0.1792,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00061317,0.24966,0.31791,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.023963,0.24957,0.21691,1,1
3,GO RRNA TRANSCRIPTION,0.0071194,0.24934,0.23756,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,0.0011741,0.24685,0.25362,1,1
3,GO RNA SURVEILLANCE,0.01247,0.24609,0.20218,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.019808,0.24514,0.24215,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.0021804,0.2394,0.29155,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.014755,0.23906,0.24111,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0055117,0.23644,0.23546,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.027983,0.23614,0.1972,1,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.01427,0.23448,0.23742,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0012773,0.23363,0.20707,1,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.023222,0.23193,0.22239,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0055117,0.22842,0.20377,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0010336,0.22171,0.23884,1,1
3,GO TRNA MODIFICATION,0.0031154,0.22093,0.24635,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00056099,0.21958,0.20918,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.005311,0.21927,0.23431,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0029959,0.2152,0.27323,1,1
3,GO AEROBIC RESPIRATION,0.021799,0.21212,0.16595,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.012053,0.21109,0.17653,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0094624,0.20737,0.18132,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.015254,0.2063,0.17977,1,1
3,GO EXCRETION,0.0073805,0.20509,0.18363,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.015254,0.20465,0.16675,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0042393,0.19829,0.17733,1,1
3,GO RNA POLYADENYLATION,0.0051169,0.19606,0.16207,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0027694,0.19595,0.17048,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0076503,0.19405,0.19935,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.010146,0.18775,0.26449,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.027983,0.1799,0.23715,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.01918,0.17976,0.14459,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.015767,0.17668,0.15649,1,1
3,GO DRUG CATABOLIC PROCESS,0.023963,0.17579,0.1798,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0066217,0.17302,0.1916,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.022501,0.1712,0.12865,1,1
3,GO NEUROMUSCULAR PROCESS,0.0088198,0.1711,0.1889,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.024724,0.16823,0.12831,1,1
3,GO NUCLEUS LOCALIZATION,0.021799,0.16772,0.17356,1,1
3,GO TRNA PROCESSING,0.0085133,0.16095,0.19158,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0082164,0.15663,0.1406,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0097991,0.15235,0.13539,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.01247,0.14328,0.13299,1,1
3,GO REPLICATION FORK PROCESSING,0.020453,0.14309,0.14927,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.0138,0.13978,0.12068,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.015254,0.13798,0.12308,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.01684,0.13622,0.16806,1,1
3,GO REGULATION OF MRNA PROCESSING,0.0091361,0.1247,0.1153,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0068665,0.12033,0.16342,1,1
3,GO MRNA 3 END PROCESSING,0.015254,0.12028,0.098966,1,1
3,GO NCRNA TRANSCRIPTION,0.0085133,0.12009,0.11394,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0129,0.11548,0.11031,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.021799,0.1154,0.10792,1,1
3,GO RNA 3 END PROCESSING,0.021117,0.10808,0.10111,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.011648,0.10742,0.11407,1,1
3,GO MRNA METABOLIC PROCESS,0.013344,0.10456,0.12068,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.023963,0.10303,0.094177,1,1
3,GO RNA LOCALIZATION,0.0174,0.096759,0.11955,1,1
3,GO RNA PROCESSING,0.0071194,0.092217,0.12808,1,1
3,GO RNA SPLICING,0.0097991,0.085868,0.097554,1,1
3,GO MRNA PROCESSING,0.0071194,0.079722,0.10192,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0018542,0.91325,0.85989,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00076401,0.86237,0.82526,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00024585,0.78455,0.79598,1,0
3,GO RESPONSE TO HISTAMINE,0.0009903,0.69497,0.65203,1,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0066217,0.58085,0.50513,1,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.00019396,0.57684,0.57128,1,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0068665,0.57156,0.54328,1,0
3,GO REGULATION OF SYNAPSE MATURATION,0.0009903,0.57081,0.66282,1,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.024724,0.54624,0.45236,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0049293,0.54591,0.57775,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.01247,0.54273,0.49749,1,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0066217,0.52652,0.47025,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.0020943,0.51696,0.5638,1,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0010786,0.51344,0.52011,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0042393,0.48885,0.49973,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.0020112,0.46908,0.46314,1,0
3,GO GLYCINE TRANSPORT,0.029747,0.46604,0.36952,1,0
3,GO ARGININE METABOLIC PROCESS,0.0036381,0.45906,0.44967,1,0
3,GO ELASTIC FIBER ASSEMBLY,0.014755,0.45581,0.38387,1,0
3,GO SECRETORY GRANULE LOCALIZATION,0.0031154,0.44726,0.51027,1,0
3,GO CORPUS CALLOSUM DEVELOPMENT,0.00051298,0.44662,0.47465,1,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00083347,0.44648,0.43972,1,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0059338,0.44191,0.50435,1,0
3,GO PROTEIN LOCALIZATION TO AXON,0.029747,0.43455,0.47427,1,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.013344,0.42953,0.37012,1,0
3,GO UV PROTECTION,0.0039282,0.42901,0.37326,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.025507,0.41795,0.33656,1,0
3,GO SUCKLING BEHAVIOR,0.0029959,0.40846,0.37279,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0012773,0.40803,0.4807,1,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0068665,0.40144,0.44354,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0174,0.3936,0.38338,1,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00061317,0.39288,0.39979,1,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0022699,0.38969,0.50863,1,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0045725,0.38272,0.42886,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.022501,0.38185,0.35882,1,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.025507,0.38066,0.36663,1,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0129,0.38033,0.50224,1,0
3,GO BASIC AMINO ACID TRANSPORT,0.01857,0.36916,0.3326,1,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.010505,0.36841,0.37238,1,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0091361,0.36737,0.28081,1,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.022501,0.36406,0.29917,1,0
3,GO REGULATION OF VESICLE FUSION,0.0066217,0.35671,0.3435,1,0
3,GO PYRAMIDAL NEURON DIFFERENTIATION,0.010874,0.3538,0.55588,1,0
3,GO HEART VALVE FORMATION,0.017977,0.35276,0.35778,1,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0055117,0.35218,0.39627,1,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.0097991,0.35136,0.51512,1,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.01684,0.3495,0.34193,1,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0063849,0.3454,0.30061,1,0
3,GO DENSE CORE GRANULE TRANSPORT,0.01918,0.34184,0.45333,1,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.020453,0.33597,0.2684,1,0
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0031154,0.33357,0.38256,1,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0025586,0.33161,0.33396,1,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.010505,0.32795,0.35002,1,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0061556,0.32746,0.37247,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.029747,0.32723,0.38934,1,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.012053,0.32583,0.3227,1,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.023963,0.32443,0.30722,1,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0073805,0.32409,0.3489,1,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.0019312,0.32383,0.33986,1,0
3,GO NEURON PROJECTION ORGANIZATION,0.00083347,0.31514,0.31263,1,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0012247,0.31497,0.34958,1,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0017084,0.31175,0.35427,1,0
3,GO ADULT HEART DEVELOPMENT,0.011255,0.30564,0.34726,1,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.016296,0.30561,0.32114,1,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0085133,0.30345,0.36556,1,0
3,GO REGULATION OF MRNA BINDING,0.005311,0.30244,0.38521,1,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0020112,0.30039,0.28242,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0021804,0.30012,0.31959,1,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.010505,0.29666,0.27536,1,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.029747,0.29507,0.28122,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.01247,0.29156,0.26336,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0138,0.29155,0.26019,1,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0019312,0.28758,0.32454,1,0
3,GO PENTOSE METABOLIC PROCESS,0.021799,0.28645,0.24555,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0029959,0.28636,0.32663,1,0
3,GO LONG TERM MEMORY,0.0042393,0.28365,0.28857,1,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.010146,0.2836,0.30551,1,0
3,GO MATING BEHAVIOR,0.0073805,0.28242,0.28568,1,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0021804,0.27906,0.33225,1,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.028854,0.27552,0.25138,1,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0068665,0.27522,0.35362,1,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0023626,0.2746,0.24916,1,0
3,GO LEARNING,0.00090875,0.2737,0.28508,1,0
3,GO REGULATION OF NEURON MIGRATION,0.019808,0.26567,0.245,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.02631,0.26404,0.29403,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0094624,0.26328,0.359,1,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.0021804,0.26145,0.27323,1,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.011255,0.26054,0.29515,1,0
3,GO ADULT FEEDING BEHAVIOR,0.028854,0.26032,0.18576,1,0
3,GO NEUROTRANSMITTER REUPTAKE,0.020453,0.25832,0.25566,1,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.01857,0.25732,0.27454,1,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0091361,0.25557,0.22798,1,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.021799,0.25478,0.20031,1,0
3,GO GLUTAMATE SECRETION,0.012053,0.25282,0.29366,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.021799,0.25245,0.20159,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0051169,0.2474,0.31754,1,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0025586,0.24509,0.23625,1,0
3,GO URONIC ACID METABOLIC PROCESS,0.0045725,0.24182,0.20897,1,0
3,GO RRNA METHYLATION,0.02631,0.24175,0.2198,1,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0063849,0.24165,0.26355,1,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.011648,0.24124,0.25264,1,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0097991,0.24072,0.26944,1,0
3,GO POSTSYNAPSE ORGANIZATION,0.0066217,0.23769,0.22717,1,0
3,GO MEMORY,0.012053,0.23386,0.1804,1,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.017977,0.23341,0.20723,1,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0012247,0.23337,0.25375,1,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.024724,0.23243,0.2747,1,0
3,GO MOTOR NEURON AXON GUIDANCE,0.0068665,0.23179,0.25731,1,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0029959,0.22931,0.26871,1,0
3,GO WALKING BEHAVIOR,0.0091361,0.22453,0.25147,1,0
3,GO SKELETAL MUSCLE CONTRACTION,0.0174,0.22311,0.19161,1,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.027983,0.22218,0.2627,1,0
3,GO TRNA METHYLATION,0.01857,0.21703,0.20179,1,0
3,GO NADH METABOLIC PROCESS,0.0138,0.21658,0.22683,1,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0036381,0.21656,0.28032,1,0
3,GO MATURATION OF 5 8S RRNA,0.029747,0.21598,0.24214,1,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0068665,0.21391,0.27983,1,0
3,GO MITOCHONDRIAL TRANSLATION,0.027136,0.21382,0.21113,1,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.015254,0.2108,0.27694,1,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0040811,0.20978,0.24624,1,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0174,0.2092,0.21804,1,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0057193,0.20891,0.21448,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.029747,0.20884,0.21086,1,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.011648,0.20841,0.22327,1,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.027983,0.20665,0.27177,1,0
3,GO CELLULAR RESPONSE TO PH,0.0068665,0.20599,0.21198,1,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.011648,0.20318,0.35452,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0174,0.20252,0.26539,1,0
3,GO SYNAPSE ORGANIZATION,0.0076503,0.20219,0.19892,1,0
3,GO FOLIC ACID METABOLIC PROCESS,0.0138,0.20154,0.27582,1,0
3,GO RESPONSE TO INTERLEUKIN 7,0.0088198,0.19971,0.18514,1,0
3,GO STRESS GRANULE ASSEMBLY,0.0051169,0.19756,0.1888,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.021799,0.19726,0.22807,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.021799,0.19573,0.21247,1,0
3,GO NCRNA PROCESSING,0.010874,0.19435,0.2048,1,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0037806,0.19188,0.26422,1,0
3,GO CARDIAC CONDUCTION,0.021799,0.18919,0.18644,1,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.022501,0.18877,0.21145,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0097991,0.1887,0.2033,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.021799,0.18844,0.18683,1,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0045725,0.18785,0.30043,1,0
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.022501,0.1858,0.15981,1,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.0026621,0.18535,0.19918,1,0
3,GO ONE CARBON METABOLIC PROCESS,0.01427,0.18186,0.18622,1,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0063849,0.18082,0.19392,1,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.01684,0.18061,0.19951,1,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.01427,0.1804,0.2022,1,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.028854,0.1793,0.12309,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.015254,0.17535,0.15889,1,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.011255,0.16894,0.1297,1,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.01247,0.16734,0.16613,1,0
3,GO STRIATUM DEVELOPMENT,0.021799,0.16617,0.22763,1,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.027136,0.16525,0.17976,1,0
3,GO FOREBRAIN CELL MIGRATION,0.0138,0.16457,0.19873,1,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.01427,0.16437,0.23702,1,0
3,GO DNA REPLICATION INITIATION,0.013344,0.16397,0.17045,1,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0085133,0.16287,0.15963,1,0
3,GO NCRNA METABOLIC PROCESS,0.016296,0.16285,0.17212,1,0
3,GO L AMINO ACID TRANSPORT,0.0094624,0.15903,0.24234,1,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010505,0.15816,0.16211,1,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.013344,0.157,0.18143,1,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.012053,0.15522,0.1774,1,0
3,GO NEUROTRANSMITTER TRANSPORT,0.01857,0.15237,0.21218,1,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.01684,0.15031,0.17405,1,0
3,GO COGNITION,0.0061556,0.14852,0.18418,1,0
3,GO TRNA METABOLIC PROCESS,0.01684,0.14843,0.16212,1,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.01684,0.14779,0.14492,1,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.01857,0.14398,0.16685,1,0
3,GO MATING,0.021117,0.14361,0.13969,1,0
3,GO IMPORT INTO CELL,0.0082164,0.14332,0.17165,1,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.021799,0.14249,0.13853,1,0
3,GO NEURON PROJECTION EXTENSION,0.022501,0.13968,0.1572,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.019808,0.13822,0.16081,1,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.017977,0.13724,0.15997,1,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.015254,0.13713,0.19881,1,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.025507,0.13393,0.13202,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.017977,0.13226,0.1488,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.01427,0.13008,0.10394,1,0
3,GO METENCEPHALON DEVELOPMENT,0.020453,0.12916,0.16384,1,0
3,GO NEUROTRANSMITTER SECRETION,0.024724,0.12748,0.21979,1,0
3,GO RNA METHYLATION,0.028854,0.12683,0.15197,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.021117,0.12652,0.12673,1,0
3,GO PROTEIN TETRAMERIZATION,0.023963,0.12591,0.11883,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.028854,0.12589,0.20118,1,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.022501,0.12376,0.14008,1,0
3,GO RNA MODIFICATION,0.01857,0.12198,0.15005,1,0
3,GO SYNAPTIC SIGNALING,0.023222,0.12108,0.15765,1,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.028854,0.12028,0.14009,1,0
3,GO ATP METABOLIC PROCESS,0.027983,0.11992,0.10029,1,0
3,GO DEVELOPMENTAL CELL GROWTH,0.023222,0.11869,0.11782,1,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.029747,0.11502,0.098111,1,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0129,0.11073,0.16029,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.02631,0.10757,0.1137,1,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0073805,0.10711,0.15568,1,0
3,GO AMINO ACID TRANSPORT,0.027983,0.10387,0.17621,1,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0071194,0.095788,0.12034,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0061556,0.094576,0.11718,1,0
3,GO MALE GAMETE GENERATION,0.021117,-0.055035,-0.085391,1,0
3,GO SEXUAL REPRODUCTION,0.023222,-0.057819,-0.071312,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.019808,-0.058319,-0.12531,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.029747,-0.059139,-0.079011,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.02631,-0.063132,-0.086088,1,0
3,GO MACROAUTOPHAGY,0.027983,-0.068644,-0.086268,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.027983,-0.069882,-0.11574,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.01918,-0.070797,-0.12198,1,0
3,GO SECRETION,0.020453,-0.071212,-0.095909,1,0
3,GO CELL CYCLE CHECKPOINT,0.021117,-0.072704,-0.083714,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.022501,-0.074492,-0.10292,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.01857,-0.075867,-0.094144,1,0
3,GO GAMETE GENERATION,0.010146,-0.078301,-0.092444,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.023222,-0.078726,-0.13675,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.023222,-0.079218,-0.089553,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0138,-0.081535,-0.11378,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.025507,-0.082369,-0.14751,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.02631,-0.082438,-0.1003,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.025507,-0.08313,-0.098303,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.011648,-0.083399,-0.10029,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.012053,-0.084517,-0.12704,1,0
3,GO MEIOTIC CELL CYCLE,0.015254,-0.086455,-0.093065,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0129,-0.086888,-0.097266,1,0
3,GO ENDOSOMAL TRANSPORT,0.01857,-0.087931,-0.095774,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.027136,-0.088115,-0.15888,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.027983,-0.089577,-0.127,1,0
3,GO LYMPHOCYTE ACTIVATION,0.027136,-0.090349,-0.12147,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.0129,-0.090539,-0.14393,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.01918,-0.090628,-0.13577,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.022501,-0.091394,-0.11232,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.02631,-0.091761,-0.092675,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.015254,-0.092351,-0.12225,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.015767,-0.092426,-0.14563,1,0
3,GO CELL CELL ADHESION,0.021117,-0.093463,-0.13258,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.023963,-0.09379,-0.14483,1,0
3,GO PROTEIN POLYUBIQUITINATION,0.011648,-0.093837,-0.10654,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.010505,-0.094169,-0.12927,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.02631,-0.095726,-0.1192,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.005311,-0.09585,-0.14376,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.023963,-0.096318,-0.20498,1,0
3,GO VACUOLAR TRANSPORT,0.027136,-0.096555,-0.11688,1,0
3,GO MALE SEX DIFFERENTIATION,0.022501,-0.0967,-0.12797,1,0
3,GO EXOCYTOSIS,0.0138,-0.098091,-0.12613,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.005311,-0.098389,-0.12692,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.021799,-0.098637,-0.1468,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.010505,-0.098861,-0.17314,1,0
3,GO METAPHASE PLATE CONGRESSION,0.021799,-0.099705,-0.11354,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0129,-0.10082,-0.12726,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.028854,-0.10124,-0.11439,1,0
3,GO REGULATION OF CELL ADHESION,0.014755,-0.10141,-0.16044,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0039282,-0.10157,-0.13602,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.027136,-0.10357,-0.12196,1,0
3,GO REPRODUCTION,0.011255,-0.10374,-0.090735,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.02631,-0.1044,-0.11505,1,0
3,GO DEFENSE RESPONSE,0.029747,-0.10491,-0.13604,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.021799,-0.10564,-0.16392,1,0
3,GO REGULATION OF CELL ACTIVATION,0.02631,-0.10618,-0.12675,1,0
3,GO TISSUE HOMEOSTASIS,0.0017084,-0.10628,-0.17441,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.023222,-0.10706,-0.11042,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0068665,-0.10956,-0.1536,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0061556,-0.11036,-0.16186,1,0
3,GO CELL ACTIVATION,0.010505,-0.11137,-0.15205,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.028854,-0.11151,-0.15657,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.01247,-0.11186,-0.16215,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.023963,-0.11189,-0.12495,1,0
3,GO SENSORY PERCEPTION OF TASTE,0.029747,-0.11201,-0.13967,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.015254,-0.11256,-0.14918,1,0
3,GO NEURAL TUBE DEVELOPMENT,0.01857,-0.11278,-0.13629,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.025507,-0.11296,-0.12242,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.010874,-0.11419,-0.156,1,0
3,GO PROTEIN KINASE B SIGNALING,0.01684,-0.11424,-0.14413,1,0
3,GO INFLAMMATORY RESPONSE,0.015254,-0.1157,-0.14901,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.010874,-0.11578,-0.17172,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.021799,-0.11613,-0.12304,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.022501,-0.11633,-0.17566,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0071194,-0.11653,-0.20759,1,0
3,GO HISTONE MONOUBIQUITINATION,0.0129,-0.11675,-0.12506,1,0
3,GO REGULATION OF NUCLEAR DIVISION,0.010146,-0.11696,-0.098414,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.010874,-0.11713,-0.14839,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.01247,-0.1175,-0.11235,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.02631,-0.11818,-0.12804,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.012053,-0.11821,-0.12578,1,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.029747,-0.11855,-0.12848,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.01857,-0.11862,-0.17466,1,0
3,GO RESPONSE TO CYTOKINE,0.01684,-0.11908,-0.15248,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.022501,-0.11935,-0.17097,1,0
3,GO T CELL ACTIVATION,0.0061556,-0.11979,-0.1682,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0047478,-0.1199,-0.1249,1,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.022501,-0.12006,-0.15017,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.021799,-0.12016,-0.18144,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.029747,-0.1212,-0.14683,1,0
3,GO CHROMOSOME LOCALIZATION,0.0091361,-0.1213,-0.12889,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.01918,-0.12136,-0.1395,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.01247,-0.12189,-0.17538,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0076503,-0.12202,-0.16831,1,0
3,GO VIRAL LIFE CYCLE,0.0129,-0.12234,-0.18273,1,0
3,GO EMBRYONIC MORPHOGENESIS,0.014755,-0.12237,-0.13763,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.019808,-0.12251,-0.15754,1,0
3,GO EAR MORPHOGENESIS,0.0066217,-0.12276,-0.18397,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.010505,-0.12301,-0.18346,1,0
3,GO T CELL PROLIFERATION,0.01427,-0.12353,-0.16692,1,0
3,GO LIPID LOCALIZATION,0.017977,-0.12355,-0.14096,1,0
3,GO CYTOKINE PRODUCTION,0.0066217,-0.12393,-0.1728,1,0
3,GO MITOTIC CYTOKINESIS,0.022501,-0.12414,-0.14425,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02631,-0.12454,-0.12087,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0037806,-0.12463,-0.16743,1,0
3,GO COAGULATION,0.011255,-0.1247,-0.17061,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.014755,-0.12478,-0.20624,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.023222,-0.12482,-0.16452,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.0024588,-0.12622,-0.16492,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.01918,-0.12644,-0.14661,1,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.02631,-0.12662,-0.13461,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.027983,-0.12679,-0.10135,1,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.021799,-0.12705,-0.16126,1,0
3,GO VESICLE TARGETING,0.015254,-0.12717,-0.1577,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.010874,-0.12749,-0.15496,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.0129,-0.12762,-0.18057,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.011255,-0.12842,-0.19431,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.010505,-0.12862,-0.15672,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.01918,-0.12908,-0.19188,1,0
3,GO SPECIFICATION OF SYMMETRY,0.015767,-0.12908,-0.11759,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.022501,-0.12944,-0.15806,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.0091361,-0.12985,-0.15419,1,0
3,GO CHEMOKINE PRODUCTION,0.011648,-0.12989,-0.19833,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.01684,-0.13021,-0.17833,1,0
3,GO PROTEIN DESTABILIZATION,0.0061556,-0.1305,-0.15674,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.028854,-0.13059,-0.17661,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01427,-0.13061,-0.19235,1,0
3,GO GOLGI ORGANIZATION,0.0031154,-0.13073,-0.15159,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0031154,-0.13115,-0.12185,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.0020112,-0.13143,-0.14917,1,0
3,GO WOUND HEALING,0.01857,-0.13163,-0.18368,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.013344,-0.13175,-0.15684,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.01918,-0.13185,-0.21129,1,0
3,GO RESPONSE TO WOUNDING,0.023222,-0.13245,-0.1677,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.01247,-0.13297,-0.17748,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.021799,-0.13304,-0.15767,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0068665,-0.13376,-0.13488,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.011255,-0.13391,-0.19275,1,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.025507,-0.13407,-0.20067,1,0
3,GO CYTOKINE SECRETION,0.017977,-0.13507,-0.14484,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0085133,-0.13511,-0.14658,1,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.0013321,-0.13648,-0.17459,1,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.01427,-0.13661,-0.14048,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0085133,-0.13669,-0.1937,1,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.020453,-0.13673,-0.16607,1,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0174,-0.13675,-0.15516,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0085133,-0.13682,-0.16311,1,0
3,GO INNER EAR MORPHOGENESIS,0.0174,-0.13789,-0.18232,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.01684,-0.138,-0.16123,1,0
3,GO EPITHELIAL TUBE FORMATION,0.0061556,-0.13839,-0.16137,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0174,-0.13866,-0.14461,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.01247,-0.13924,-0.14287,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.010146,-0.1393,-0.15124,1,0
3,GO CELL PROJECTION ASSEMBLY,0.0045725,-0.13934,-0.12204,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.013344,-0.14009,-0.14632,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.004403,-0.14059,-0.15618,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.010505,-0.14065,-0.19165,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.010505,-0.14069,-0.1299,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0061556,-0.14069,-0.18446,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.023963,-0.14078,-0.15359,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.014755,-0.14126,-0.21649,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0015095,-0.14139,-0.15268,1,0
3,GO LEUKOCYTE PROLIFERATION,0.0039282,-0.1414,-0.1819,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.021117,-0.1416,-0.17071,1,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.0042393,-0.14195,-0.14223,1,0
3,GO EPITHELIUM DEVELOPMENT,0.0018542,-0.14233,-0.1672,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.023222,-0.1426,-0.18109,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.017977,-0.14319,-0.16129,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.015767,-0.14366,-0.157,1,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.0091361,-0.14373,-0.1557,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.023963,-0.14389,-0.2185,1,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.017977,-0.14417,-0.13676,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.016296,-0.14459,-0.15506,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0042393,-0.14484,-0.15712,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0055117,-0.14488,-0.17803,1,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.02631,-0.1451,-0.18065,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,0.0040811,-0.14513,-0.18069,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.028854,-0.14515,-0.1432,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.016296,-0.14536,-0.17545,1,0
3,GO LEUKOCYTE MIGRATION,0.0138,-0.14583,-0.16096,1,0
3,GO B CELL ACTIVATION,0.0013321,-0.14586,-0.17258,1,0
3,GO CENTROSOME DUPLICATION,0.0051169,-0.14588,-0.18892,1,0
3,GO LUNG MORPHOGENESIS,0.01684,-0.14594,-0.23758,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0055117,-0.14659,-0.21019,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.023963,-0.14731,-0.1494,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0076503,-0.14773,-0.13175,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0017799,-0.14823,-0.23035,1,0
3,GO REGULATION OF CHEMOTAXIS,0.0066217,-0.14834,-0.16097,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0063849,-0.14895,-0.16756,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.01684,-0.14952,-0.19556,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.012053,-0.15001,-0.18893,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.027136,-0.15004,-0.15014,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.019808,-0.15011,-0.19692,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.023222,-0.15018,-0.15284,1,0
3,GO RESPONSE TO VIRUS,0.0042393,-0.15064,-0.21612,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.022501,-0.15073,-0.13555,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.01918,-0.15075,-0.15953,1,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.021117,-0.15078,-0.20941,1,0
3,GO SECONDARY METABOLIC PROCESS,0.02631,-0.1508,-0.21389,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0059338,-0.15144,-0.17414,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.016296,-0.1515,-0.18583,1,0
3,GO PROTEIN PROCESSING,0.01427,-0.15185,-0.16135,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.011255,-0.15216,-0.19134,1,0
3,GO RESPONSE TO ISCHEMIA,0.028854,-0.1523,-0.16364,1,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0020943,-0.15235,-0.15417,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.017977,-0.15236,-0.16509,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.013344,-0.15268,-0.19658,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023222,-0.1533,-0.15283,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.0035004,-0.15363,-0.17791,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0066217,-0.15366,-0.20317,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.029747,-0.15426,-0.22735,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.004403,-0.15429,-0.20608,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.022501,-0.15488,-0.14824,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.01427,-0.15552,-0.15843,1,0
3,GO ACTIN NUCLEATION,0.00042822,-0.15558,-0.18981,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.023963,-0.15641,-0.21035,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.012053,-0.15661,-0.20231,1,0
3,GO RIG I SIGNALING PATHWAY,0.0174,-0.15674,-0.20436,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0068665,-0.15685,-0.20555,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.0094624,-0.15686,-0.16397,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.023222,-0.15703,-0.19615,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0073805,-0.15726,-0.16624,1,0
3,GO VIRION ASSEMBLY,0.0055117,-0.15742,-0.17038,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.027136,-0.15767,-0.20091,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.0037806,-0.15785,-0.19713,1,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.01857,-0.15791,-0.18207,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0023626,-0.15829,-0.16387,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00069995,-0.1584,-0.17673,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.0016396,-0.15847,-0.26167,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.023963,-0.15871,-0.18614,1,0
3,GO ALPHA BETA T CELL ACTIVATION,0.0010786,-0.15885,-0.23424,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.021799,-0.1592,-0.24308,1,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.0012247,-0.15934,-0.18075,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0094624,-0.1596,-0.17797,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0082164,-0.15974,-0.13799,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.02631,-0.15987,-0.33035,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0051169,-0.16031,-0.2329,1,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.016296,-0.16036,-0.13182,1,0
3,GO IMMUNOGLOBULIN SECRETION,0.0071194,-0.16039,-0.30756,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0059338,-0.16045,-0.24319,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.012053,-0.161,-0.21499,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.01247,-0.16119,-0.16497,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.021799,-0.16147,-0.22865,1,0
3,GO TELOMERE CAPPING,0.01247,-0.16168,-0.12604,1,0
3,GO B CELL PROLIFERATION,0.023222,-0.16208,-0.15477,1,0
3,GO INTERLEUKIN 12 PRODUCTION,0.0059338,-0.16261,-0.19804,1,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.0085133,-0.16271,-0.16525,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0042393,-0.1632,-0.21476,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.01247,-0.16357,-0.24127,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.015254,-0.16388,-0.14826,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0036381,-0.16418,-0.20791,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,0.0079288,-0.16492,-0.16433,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0085133,-0.1654,-0.23678,1,0
3,GO ENDOCYTIC RECYCLING,0.0029959,-0.16597,-0.17426,1,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.01857,-0.16601,-0.20434,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0076503,-0.16613,-0.22572,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0017084,-0.16693,-0.24375,1,0
3,GO GOLGI LOCALIZATION,0.02631,-0.16716,-0.18361,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.017977,-0.16718,-0.16577,1,0
3,GO REGULATION OF CELL CELL ADHESION,0.004403,-0.1673,-0.19273,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0079288,-0.16761,-0.1713,1,0
3,GO EYE MORPHOGENESIS,0.0042393,-0.16812,-0.18041,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0082164,-0.16815,-0.23784,1,0
3,GO REGULATION OF OSSIFICATION,0.019808,-0.16863,-0.16442,1,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.019808,-0.16968,-0.14628,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0024588,-0.16974,-0.23593,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0020943,-0.17011,-0.18117,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.015767,-0.17015,-0.22054,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.016296,-0.17016,-0.17066,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0024588,-0.1705,-0.19156,1,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.0016396,-0.17056,-0.17848,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0059338,-0.17084,-0.20757,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.01918,-0.17085,-0.21728,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0049293,-0.17102,-0.21296,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.0129,-0.17145,-0.16745,1,0
3,GO REGULATION OF CELL KILLING,0.0059338,-0.1721,-0.23501,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0045725,-0.17219,-0.18678,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0073805,-0.17263,-0.27114,1,0
3,GO REGULATION OF CELL SHAPE,0.0042393,-0.17273,-0.19063,1,0
3,GO RENAL TUBULE DEVELOPMENT,0.0032392,-0.17303,-0.21118,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.029747,-0.17354,-0.22228,1,0
3,GO MYELOID CELL HOMEOSTASIS,0.0037806,-0.17383,-0.18222,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.01427,-0.17484,-0.19758,1,0
3,GO PHOSPHOLIPID TRANSPORT,0.0010336,-0.17485,-0.21331,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0017084,-0.17505,-0.20182,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.01684,-0.17526,-0.22946,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0011741,-0.17527,-0.2049,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0012247,-0.17527,-0.2151,1,0
3,GO MESONEPHROS DEVELOPMENT,0.0063849,-0.17544,-0.21287,1,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.010505,-0.17545,-0.1635,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0040811,-0.17582,-0.21838,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.011648,-0.17583,-0.23462,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.021117,-0.17584,-0.18945,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0174,-0.17589,-0.16834,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0097991,-0.17622,-0.21768,1,0
3,GO CELLULAR RESPONSE TO VIRUS,0.0031154,-0.17622,-0.21187,1,0
3,GO ENDOSOME ORGANIZATION,0.00066983,-0.17682,-0.19276,1,0
3,GO VIRAL GENOME REPLICATION,0.0076503,-0.17683,-0.25338,1,0
3,GO EXIT FROM MITOSIS,0.029747,-0.17721,-0.14016,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,0.0049293,-0.17742,-0.22656,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0032392,-0.17766,-0.22822,1,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.0138,-0.17847,-0.17094,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.027983,-0.17881,-0.17441,1,0
3,GO RNA DESTABILIZATION,0.0073805,-0.17885,-0.17446,1,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.021799,-0.17888,-0.23461,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0068665,-0.17946,-0.22526,1,0
3,GO NEPHRON DEVELOPMENT,0.0017084,-0.17951,-0.22136,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0082164,-0.17987,-0.26736,1,0
3,GO REGULATION OF TELOMERE CAPPING,0.015767,-0.17996,-0.15337,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,0.001448,-0.17996,-0.169,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0071194,-0.18003,-0.19977,1,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.025507,-0.18011,-0.14393,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.025507,-0.18058,-0.175,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.019808,-0.18105,-0.21035,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.021799,-0.18109,-0.26014,1,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.023222,-0.18114,-0.23052,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,0.0059338,-0.18114,-0.22768,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.005311,-0.18146,-0.27536,1,0
3,GO INTERACTION WITH HOST,0.0059338,-0.18169,-0.21018,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.021799,-0.18174,-0.23449,1,0
3,GO MYOBLAST DIFFERENTIATION,0.021117,-0.18174,-0.20516,1,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.017977,-0.18223,-0.21399,1,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.0040811,-0.1825,-0.18419,1,0
3,GO HISTONE H4 DEACETYLATION,0.029747,-0.18287,-0.19901,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0085133,-0.18315,-0.25047,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.025507,-0.18354,-0.25996,1,0
3,GO ENDOTHELIUM DEVELOPMENT,0.0051169,-0.18372,-0.19233,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025586,-0.18374,-0.18525,1,0
3,GO B CELL DIFFERENTIATION,0.00058654,-0.18488,-0.22416,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.0073805,-0.18555,-0.30438,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.014755,-0.18573,-0.21361,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0129,-0.18628,-0.17471,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00066983,-0.18665,-0.25918,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.019808,-0.18667,-0.19023,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.028854,-0.18685,-0.16992,1,0
3,GO B CELL APOPTOTIC PROCESS,0.019808,-0.1872,-0.22412,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.01247,-0.18788,-0.23685,1,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.0040811,-0.18848,-0.1955,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0085133,-0.18899,-0.25125,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0025586,-0.18978,-0.18962,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.017977,-0.18981,-0.22271,1,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.024724,-0.19009,-0.18636,1,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0057193,-0.19018,-0.16412,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0174,-0.19062,-0.18599,1,0
3,GO APPENDAGE MORPHOGENESIS,0.019808,-0.19062,-0.18578,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0009903,-0.19067,-0.23081,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0033675,-0.19081,-0.19224,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0023626,-0.1911,-0.24234,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.027136,-0.19122,-0.16506,1,0
3,GO KERATINOCYTE PROLIFERATION,0.027983,-0.19136,-0.23339,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.001448,-0.19184,-0.23565,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,0.0035004,-0.19202,-0.29407,1,0
3,GO B CELL MEDIATED IMMUNITY,0.0088198,-0.19206,-0.22046,1,0
3,GO V D J RECOMBINATION,0.019808,-0.19229,-0.24667,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0012247,-0.1924,-0.20367,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.010505,-0.1927,-0.18932,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.02631,-0.19284,-0.28807,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.004403,-0.19345,-0.23739,1,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.029747,-0.19346,-0.16626,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.0033675,-0.19349,-0.1865,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,0.0031154,-0.19366,-0.20218,1,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.016296,-0.19404,-0.18088,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.01427,-0.19413,-0.27928,1,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.012053,-0.19417,-0.18636,1,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0059338,-0.19441,-0.17508,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0091361,-0.19442,-0.28033,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.0020943,-0.19446,-0.19435,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00083347,-0.19463,-0.26232,1,0
3,GO PLATELET ACTIVATION,0.00066983,-0.19484,-0.24142,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.015254,-0.19502,-0.2059,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0027694,-0.19534,-0.18652,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.028854,-0.19536,-0.19761,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.013344,-0.19615,-0.21287,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0138,-0.19644,-0.18861,1,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.00061317,-0.19682,-0.17685,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0032392,-0.19687,-0.24491,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00061317,-0.19708,-0.25779,1,0
3,GO CELL CHEMOTAXIS,0.0035004,-0.19724,-0.20228,1,0
3,GO MONOCYTE CHEMOTAXIS,0.010874,-0.19739,-0.25658,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0051169,-0.19822,-0.23348,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.016296,-0.19857,-0.2191,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.013344,-0.19879,-0.22704,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.015767,-0.1989,-0.19143,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0051169,-0.19928,-0.25056,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.015254,-0.19978,-0.22386,1,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.013344,-0.20117,-0.16513,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0023626,-0.20119,-0.24871,1,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0073805,-0.20165,-0.20475,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.019808,-0.20203,-0.16744,1,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0088198,-0.20249,-0.20743,1,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.014755,-0.20273,-0.19257,1,0
3,GO T CELL MEDIATED IMMUNITY,0.0138,-0.20282,-0.26645,1,0
3,GO ENTRY INTO HOST,0.0049293,-0.20288,-0.27521,1,0
3,GO EPIDERMIS DEVELOPMENT,0.0033675,-0.20322,-0.22393,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0035004,-0.20379,-0.24115,1,0
3,GO PLATELET MORPHOGENESIS,0.0094624,-0.20396,-0.30821,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.028854,-0.20419,-0.31693,1,0
3,GO REGULATION OF TISSUE REMODELING,0.0032392,-0.20437,-0.23932,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00056099,-0.20443,-0.27807,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0023626,-0.20477,-0.21244,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.01247,-0.2048,-0.25074,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.005311,-0.20481,-0.29911,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.01857,-0.20488,-0.27695,1,0
3,GO BONE RESORPTION,0.0023626,-0.2053,-0.25138,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0020112,-0.20558,-0.24874,1,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.025507,-0.20578,-0.25504,1,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.021117,-0.20609,-0.24114,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0129,-0.20638,-0.19837,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.0066217,-0.20719,-0.21122,1,0
3,GO REGULATION OF CENTROSOME CYCLE,0.0010786,-0.20738,-0.20146,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0047478,-0.20764,-0.27005,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0035004,-0.20766,-0.22318,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0085133,-0.20774,-0.19526,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0009903,-0.20782,-0.2285,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.024724,-0.20796,-0.31474,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00079804,-0.20798,-0.23717,1,0
3,GO DEFENSE RESPONSE TO VIRUS,0.00083347,-0.20812,-0.29003,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0057193,-0.20863,-0.27857,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0059338,-0.209,-0.26799,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.013344,-0.20925,-0.30725,1,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0057193,-0.21002,-0.19124,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.004403,-0.21068,-0.25649,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0085133,-0.21086,-0.23571,1,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0025586,-0.21119,-0.23132,1,0
3,GO RUFFLE ASSEMBLY,0.00021334,-0.2117,-0.25616,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.00027004,-0.21173,-0.19737,1,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.014755,-0.21182,-0.22123,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.0001525,-0.21184,-0.2262,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0026621,-0.21185,-0.21366,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0036381,-0.21212,-0.25825,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.0025586,-0.2126,-0.23423,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.0045725,-0.2127,-0.21616,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079804,-0.21276,-0.2722,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.011255,-0.21334,-0.23915,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0032392,-0.21357,-0.25187,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,0.0019312,-0.21364,-0.26677,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0027694,-0.21378,-0.23139,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0085133,-0.21392,-0.25642,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0012773,-0.21412,-0.21288,1,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.00053648,-0.21451,-0.22521,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0023626,-0.21452,-0.21095,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.004403,-0.21458,-0.23639,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0049293,-0.21464,-0.1875,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.027983,-0.21465,-0.18053,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00061317,-0.21479,-0.29557,1,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.015254,-0.21615,-0.22273,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0055117,-0.21618,-0.19604,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0085133,-0.21641,-0.2445,1,0
3,GO BONE REMODELING,0.01684,-0.21711,-0.22202,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0015733,-0.21753,-0.2758,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.005311,-0.21753,-0.20033,1,0
3,GO SPINDLE LOCALIZATION,0.0037806,-0.21767,-0.19866,1,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.029747,-0.21855,-0.24861,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.015767,-0.21867,-0.28547,1,0
3,GO NEURAL TUBE FORMATION,0.0010336,-0.21895,-0.21783,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.001448,-0.21931,-0.24477,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0066217,-0.21951,-0.23084,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.013344,-0.2208,-0.2227,1,0
3,GO ADRENAL GLAND DEVELOPMENT,0.029747,-0.22119,-0.25332,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0026621,-0.22123,-0.25911,1,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0082164,-0.2222,-0.22788,1,0
3,GO CELLULAR DEFENSE RESPONSE,0.00094871,-0.22226,-0.28036,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0045725,-0.223,-0.19625,1,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0047478,-0.22307,-0.24284,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.017977,-0.22314,-0.22075,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0066217,-0.22338,-0.23912,1,0
3,GO PROTEIN ADP RIBOSYLATION,0.0059338,-0.22363,-0.24956,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.012053,-0.22393,-0.34583,1,0
3,GO POSITIVE T CELL SELECTION,0.0049293,-0.22412,-0.20556,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0071194,-0.22436,-0.33118,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.027136,-0.22444,-0.1793,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0057193,-0.2245,-0.22798,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.015767,-0.2246,-0.27386,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0029959,-0.22464,-0.27585,1,0
3,GO CELL FATE DETERMINATION,0.0129,-0.22513,-0.24374,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014755,-0.22599,-0.2589,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.010505,-0.2266,-0.19944,1,0
3,GO REGULATION OF ACTIN NUCLEATION,0.0017084,-0.22758,-0.25361,1,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.004403,-0.22849,-0.19967,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0010786,-0.22872,-0.23561,1,0
3,GO CYTOKINETIC PROCESS,0.0016396,-0.2288,-0.25866,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.010146,-0.22882,-0.28095,1,0
3,GO TISSUE REMODELING,0.0021804,-0.22946,-0.25174,1,0
3,GO BILE ACID METABOLIC PROCESS,0.0063849,-0.22949,-0.24132,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.004403,-0.22971,-0.27428,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00083347,-0.23092,-0.26114,1,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0055117,-0.23143,-0.26337,1,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.0076503,-0.23143,-0.2135,1,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.010505,-0.23218,-0.26613,1,0
3,GO PLACENTA DEVELOPMENT,0.0015095,-0.23239,-0.23313,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0061556,-0.23304,-0.20794,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.024724,-0.23333,-0.323,1,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.011648,-0.23334,-0.21229,1,0
3,GO LIPID STORAGE,0.0047478,-0.23402,-0.22941,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0037806,-0.23426,-0.25286,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.015767,-0.23482,-0.23512,1,0
3,GO SKIN DEVELOPMENT,0.0033675,-0.23489,-0.23279,1,0
3,GO INTERFERON BETA PRODUCTION,0.00064092,-0.23497,-0.26323,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0021804,-0.235,-0.28687,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00076401,-0.23502,-0.30408,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0082164,-0.23506,-0.37987,1,0
3,GO ERBB2 SIGNALING PATHWAY,0.0042393,-0.23523,-0.23201,1,0
3,GO REGULATION OF WOUND HEALING,0.0033675,-0.23553,-0.28703,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0037806,-0.23599,-0.24298,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.019808,-0.23604,-0.29899,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00079804,-0.23604,-0.27534,1,0
3,GO VIRAL RELEASE FROM HOST CELL,0.00064092,-0.23621,-0.25634,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0040811,-0.23623,-0.2873,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.001448,-0.23631,-0.24964,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0047478,-0.23669,-0.23665,1,0
3,GO INTERLEUKIN 8 PRODUCTION,0.0021804,-0.2367,-0.2708,1,0
3,GO REPLICATIVE SENESCENCE,0.0088198,-0.23699,-0.2856,1,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.01427,-0.23722,-0.28949,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0059338,-0.23761,-0.24743,1,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.024724,-0.23808,-0.23384,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,0.0049293,-0.23966,-0.24314,1,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.015254,-0.23978,-0.2245,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,0.0057193,-0.24039,-0.3375,1,0
3,GO O GLYCAN PROCESSING,0.0066217,-0.24069,-0.28501,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0063849,-0.24113,-0.27123,1,0
3,GO EMBRYONIC HEMOPOIESIS,0.02631,-0.24114,-0.19532,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0094624,-0.24174,-0.27869,1,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.0174,-0.24206,-0.19489,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019396,-0.24231,-0.29341,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0027694,-0.24246,-0.26106,1,0
3,GO INTERLEUKIN 10 PRODUCTION,0.0019312,-0.24255,-0.27419,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0011254,-0.24261,-0.26653,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0047478,-0.24278,-0.29616,1,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.013344,-0.24296,-0.30784,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.0085133,-0.24306,-0.31383,1,0
3,GO CELL FATE SPECIFICATION,0.010505,-0.24307,-0.21027,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00076401,-0.24317,-0.2982,1,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0091361,-0.24324,-0.24978,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0017799,-0.24338,-0.2386,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0015733,-0.24369,-0.2554,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.025507,-0.24448,-0.40036,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015767,-0.24467,-0.27526,1,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.01918,-0.24499,-0.24504,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.021117,-0.24499,-0.30635,1,0
3,GO SIGNAL PEPTIDE PROCESSING,0.01247,-0.24501,-0.29595,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0138,-0.2454,-0.24699,1,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0061556,-0.24628,-0.22795,1,0
3,GO AMYLOID BETA CLEARANCE,0.0033675,-0.24644,-0.26782,1,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.0035004,-0.2465,-0.23612,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0079288,-0.24678,-0.19156,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0042393,-0.24717,-0.4328,1,0
3,GO PANCREAS DEVELOPMENT,0.0071194,-0.24725,-0.23902,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0011254,-0.2475,-0.24979,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.029747,-0.24842,-0.32028,1,0
3,GO AXONEME ASSEMBLY,0.0097991,-0.25028,-0.27087,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032392,-0.25047,-0.31537,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0129,-0.25092,-0.28214,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0012247,-0.25101,-0.24184,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0066217,-0.25146,-0.32983,1,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.023963,-0.25156,-0.30312,1,0
3,GO RUFFLE ORGANIZATION,0.00016006,-0.25169,-0.27834,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0028806,-0.25195,-0.26097,1,0
3,GO SEROTONIN SECRETION,0.023963,-0.25215,-0.23201,1,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.016296,-0.25278,-0.27778,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.0012773,-0.25291,-0.27649,1,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0049293,-0.25308,-0.2294,1,0
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.027136,-0.25313,-0.26437,1,0
3,GO LIPID DROPLET ORGANIZATION,0.0036381,-0.25384,-0.27811,1,0
3,GO AUTOPHAGOSOME MATURATION,0.00076401,-0.25384,-0.26018,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.0032392,-0.25387,-0.25533,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0059338,-0.25493,-0.24157,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00064092,-0.2552,-0.30579,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.01427,-0.2554,-0.30788,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0024588,-0.25635,-0.31391,1,0
3,GO GERMINAL CENTER FORMATION,0.027136,-0.25681,-0.35303,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00094871,-0.25682,-0.26437,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0017084,-0.25703,-0.33176,1,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.0138,-0.25736,-0.33822,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.010146,-0.25757,-0.27073,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0018542,-0.25803,-0.29839,1,0
3,GO INTERLEUKIN 6 PRODUCTION,0.00034064,-0.25856,-0.25683,1,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.028854,-0.25907,-0.24004,1,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.013344,-0.25916,-0.35427,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,0.0020943,-0.25942,-0.27409,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,0.00073133,-0.26136,-0.25346,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0015095,-0.26196,-0.30213,1,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.013344,-0.26358,-0.26097,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0012773,-0.26376,-0.32394,1,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00061317,-0.26422,-0.27088,1,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0129,-0.26475,-0.23131,1,0
3,GO NECROTIC CELL DEATH,0.0063849,-0.2657,-0.27411,1,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.023963,-0.26578,-0.25087,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0016396,-0.26681,-0.29471,1,0
3,GO T CELL SELECTION,0.011255,-0.26681,-0.18751,1,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.017977,-0.26707,-0.30594,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00094871,-0.26725,-0.2497,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.015254,-0.26747,-0.25693,1,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.014755,-0.2678,-0.30369,1,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0061556,-0.2678,-0.2585,1,0
3,GO REGULATION OF RECEPTOR BINDING,0.0129,-0.26814,-0.2915,1,0
3,GO REGULATION OF BONE REMODELING,0.0059338,-0.26898,-0.25993,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0029959,-0.26918,-0.2799,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00058654,-0.26971,-0.29567,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0036381,-0.26979,-0.28972,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.01857,-0.27057,-0.32947,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0009903,-0.2707,-0.31133,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.010505,-0.27204,-0.38102,1,0
3,GO GLOMERULUS DEVELOPMENT,0.0047478,-0.27245,-0.30637,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00040918,-0.2725,-0.31138,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0035004,-0.27264,-0.27426,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0082164,-0.27391,-0.46756,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0088198,-0.2741,-0.24793,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0018542,-0.2743,-0.28059,1,0
3,GO VIRAL BUDDING,0.0020112,-0.27431,-0.2356,1,0
3,GO ICOSANOID METABOLIC PROCESS,0.00090875,-0.27448,-0.30939,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0013321,-0.27462,-0.29216,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0020943,-0.2752,-0.28779,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0039282,-0.27543,-0.27817,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0082164,-0.2757,-0.22627,1,0
3,GO TOLERANCE INDUCTION,0.023963,-0.27788,-0.40441,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,0.0057193,-0.27833,-0.31005,1,0
3,GO EXTRACELLULAR TRANSPORT,0.0039282,-0.27904,-0.30891,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0097991,-0.27984,-0.33722,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0066217,-0.2812,-0.2608,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0097991,-0.28222,-0.32154,1,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.015767,-0.28223,-0.30429,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00079804,-0.28321,-0.29664,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.024724,-0.28334,-0.27023,1,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.023222,-0.28334,-0.221,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0085133,-0.28447,-0.33384,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0059338,-0.28485,-0.34369,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.01247,-0.28513,-0.22209,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.010146,-0.28598,-0.28914,1,0
3,GO INTESTINAL ABSORPTION,0.0020943,-0.286,-0.35706,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.012053,-0.28611,-0.28129,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00028296,-0.28728,-0.31199,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0040811,-0.2876,-0.26259,1,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.025507,-0.28785,-0.3118,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.025507,-0.28817,-0.25124,1,0
3,GO PLATELET AGGREGATION,0.0009903,-0.28877,-0.32162,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0020112,-0.2888,-0.29524,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.02631,-0.28895,-0.44613,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0066217,-0.28969,-0.29399,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0073805,-0.29052,-0.32575,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0042393,-0.29197,-0.32645,1,0
3,GO HISTAMINE TRANSPORT,0.021117,-0.29243,-0.33216,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00069995,-0.29292,-0.27602,1,0
3,GO EPOXYGENASE P450 PATHWAY,0.02631,-0.29393,-0.2707,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0057193,-0.29421,-0.25353,1,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0068665,-0.2954,-0.37934,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0082164,-0.29545,-0.37007,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0023626,-0.29547,-0.3018,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0045725,-0.29567,-0.3637,1,0
3,GO MICROVILLUS ORGANIZATION,0.0036381,-0.29592,-0.34302,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0016396,-0.29637,-0.26304,1,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.010874,-0.29703,-0.30756,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.028854,-0.29756,-0.28259,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00056099,-0.29767,-0.29671,1,0
3,GO SPLEEN DEVELOPMENT,0.00040918,-0.298,-0.28676,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00046881,-0.29848,-0.29359,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,0.0009903,-0.29911,-0.35248,1,0
3,GO ETHER METABOLIC PROCESS,0.024724,-0.29925,-0.26098,1,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.00083347,-0.30022,-0.34494,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0016396,-0.30146,-0.41967,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0097991,-0.30254,-0.34894,1,0
3,GO ACTIN FILAMENT SEVERING,0.02631,-0.30291,-0.36883,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.0042393,-0.30363,-0.24253,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.029747,-0.30407,-0.32007,1,0
3,GO OSTEOBLAST PROLIFERATION,0.0040811,-0.30415,-0.31081,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.017977,-0.30447,-0.36367,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0015095,-0.30573,-0.28926,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.004403,-0.30589,-0.33344,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.01684,-0.30618,-0.23091,1,0
3,GO SUPEROXIDE ANION GENERATION,0.0082164,-0.30691,-0.30893,1,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.0011254,-0.30694,-0.34464,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.023222,-0.30719,-0.3333,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00031055,-0.30811,-0.36166,1,0
3,GO MAGNESIUM ION TRANSPORT,0.00027004,-0.30875,-0.36688,1,0
3,GO T CELL LINEAGE COMMITMENT,0.0012773,-0.30952,-0.29642,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.015254,-0.3096,-0.36217,1,0
3,GO ZYMOGEN INHIBITION,0.0047478,-0.31024,-0.42949,1,0
3,GO REGULATION OF PLATELET ACTIVATION,0.0027694,-0.31039,-0.3579,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.01857,-0.31049,-0.36103,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,0.00076401,-0.31139,-0.32139,1,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0129,-0.31156,-0.25574,1,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.010146,-0.31206,-0.29684,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.0027694,-0.31312,-0.35492,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0010336,-0.3143,-0.30548,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,0.00079804,-0.31443,-0.28731,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0040811,-0.31643,-0.2969,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00023453,-0.31647,-0.37283,1,0
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0073805,-0.31719,-0.30004,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.017977,-0.3175,-0.28754,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0036381,-0.31878,-0.30484,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0073805,-0.31973,-0.4359,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.00016006,-0.31986,-0.37115,1,0
3,GO HEART FIELD SPECIFICATION,0.020453,-0.32078,-0.29815,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,0.00024585,-0.32134,-0.3195,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.001448,-0.32217,-0.37434,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00031055,-0.32221,-0.33559,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.016296,-0.32263,-0.37156,1,0
3,GO MUSCLE CELL MIGRATION,0.00029645,-0.3229,-0.35592,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.0028806,-0.32297,-0.31093,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,0.00039093,-0.32353,-0.37242,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0035004,-0.32508,-0.36018,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0059338,-0.3255,-0.3615,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00073133,-0.3255,-0.29204,1,0
3,GO POSITIVE REGULATION OF COAGULATION,0.0033675,-0.3262,-0.29754,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00076401,-0.32636,-0.40544,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,0.0025586,-0.32749,-0.29437,1,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066217,-0.32772,-0.32676,1,0
3,GO REGULATION OF COAGULATION,0.0020112,-0.32785,-0.34523,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.0029959,-0.32805,-0.35063,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0023626,-0.32831,-0.3778,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.0055117,-0.32837,-0.33189,1,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.010505,-0.32844,-0.35042,1,0
3,GO DETECTION OF OTHER ORGANISM,0.0040811,-0.32849,-0.38902,1,0
3,GO KERATINOCYTE DIFFERENTIATION,0.0029959,-0.32895,-0.3068,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.0066217,-0.32941,-0.26238,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0040811,-0.32973,-0.39951,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0076503,-0.33054,-0.41077,1,0
3,GO RESPONSE TO TYPE I INTERFERON,0.0073805,-0.33152,-0.45491,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.022501,-0.33267,-0.30141,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.014755,-0.33396,-0.43957,1,0
3,GO HETEROTYPIC CELL CELL ADHESION,0.00039093,-0.33408,-0.37357,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0073805,-0.33465,-0.53739,1,0
3,GO LEFT RIGHT PATTERN FORMATION,0.0071194,-0.33602,-0.28251,1,0
3,GO INTERLEUKIN 1 PRODUCTION,0.00017625,-0.33673,-0.38086,1,0
3,GO NATURAL KILLER CELL PROLIFERATION,0.012053,-0.3369,-0.34571,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00037344,-0.33761,-0.36907,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.021799,-0.33831,-0.38241,1,0
3,GO REGULATION OF ANOIKIS,0.0020943,-0.3389,-0.44254,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.011255,-0.33904,-0.46844,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0042393,-0.33961,-0.32396,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.015767,-0.3409,-0.36649,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.016296,-0.34115,-0.37881,1,0
3,GO LIPID TRANSLOCATION,0.0020943,-0.34157,-0.28925,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045725,-0.3419,-0.45831,1,0
3,GO GDP METABOLIC PROCESS,0.0088198,-0.34201,-0.32762,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0174,-0.34214,-0.27033,1,0
3,GO ANOIKIS,0.0010336,-0.34292,-0.35227,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0085133,-0.34329,-0.35415,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0063849,-0.34408,-0.38176,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0015733,-0.34565,-0.34219,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00027004,-0.3458,-0.36326,1,0
3,GO GONADOTROPIN SECRETION,0.0040811,-0.34636,-0.38755,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0029959,-0.3467,-0.36928,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00066983,-0.34714,-0.44568,1,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.021799,-0.34717,-0.31969,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.00014528,-0.3473,-0.36289,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00094871,-0.35208,-0.3716,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0088198,-0.35222,-0.34658,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0097991,-0.35293,-0.43196,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00044809,-0.35505,-0.34924,1,0
3,GO RESPONSE TO WATER,0.015254,-0.35681,-0.37332,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00049043,-0.35704,-0.39089,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0018542,-0.35875,-0.51039,1,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0085133,-0.35933,-0.40544,1,0
3,GO NOTCH RECEPTOR PROCESSING,0.012053,-0.35995,-0.30551,1,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.01427,-0.36009,-0.32624,1,0
3,GO VASCULAR TRANSPORT,0.011648,-0.3601,-0.40425,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0040811,-0.36056,-0.40671,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,0.0040811,-0.3613,-0.42255,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,0.0035004,-0.36139,-0.44322,1,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.012053,-0.36285,-0.3333,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0020112,-0.36551,-0.40001,1,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.015767,-0.36554,-0.37189,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.014755,-0.36581,-0.32866,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0129,-0.36632,-0.31966,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0013889,-0.36698,-0.36721,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0174,-0.37224,-0.2981,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0018542,-0.3729,-0.38717,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.01684,-0.37577,-0.35287,1,0
3,GO REGULATION OF TRANSPOSITION,0.0018542,-0.37579,-0.50804,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0017084,-0.37637,-0.44577,1,0
3,GO TOXIN METABOLIC PROCESS,0.027136,-0.37675,-0.3254,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.01857,-0.37749,-0.40852,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.014755,-0.37805,-0.33836,1,0
3,GO KERATINIZATION,0.005311,-0.37909,-0.32243,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00094871,-0.38018,-0.39436,1,0
3,GO CENTROSOME SEPARATION,0.00053648,-0.38112,-0.35214,1,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0076503,-0.3832,-0.37596,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0017084,-0.38706,-0.40124,1,0
3,GO TRANSPOSITION,0.00094871,-0.38722,-0.48203,1,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.010146,-0.38748,-0.37154,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.027136,-0.38763,-0.31631,1,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.021117,-0.39081,-0.32105,1,0
3,GO PROSTANOID METABOLIC PROCESS,0.00034064,-0.39124,-0.51932,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.0016396,-0.39154,-0.49961,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00024585,-0.39332,-0.48504,1,0
3,GO GAP JUNCTION ASSEMBLY,0.00032527,-0.39539,-0.54867,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00066983,-0.39647,-0.41695,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0018542,-0.39661,-0.45285,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00066983,-0.39694,-0.39687,1,0
3,GO PSEUDOPODIUM ORGANIZATION,0.024724,-0.39698,-0.36852,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00025768,-0.39712,-0.38064,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.0057193,-0.3978,-0.37277,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.020453,-0.39851,-0.3349,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.0071194,-0.4011,-0.36709,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.01247,-0.40118,-0.30025,1,0
3,GO RESPONSE TO FORSKOLIN,0.0068665,-0.40169,-0.36423,1,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.022501,-0.4017,-0.51516,1,0
3,GO CORNIFICATION,0.0073805,-0.402,-0.35124,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00051298,-0.40284,-0.42996,1,0
3,GO INTERFERON ALPHA PRODUCTION,0.00016797,-0.4095,-0.43101,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010786,-0.41,-0.50873,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.0059338,-0.41271,-0.37108,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.023963,-0.41347,-0.29611,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00056099,-0.41543,-0.42084,1,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.010874,-0.41728,-0.40405,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00016797,-0.41788,-0.45721,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0017084,-0.41797,-0.38108,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0023626,-0.42044,-0.45773,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00051298,-0.42064,-0.40096,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,0.00083347,-0.42357,-0.41973,1,0
3,GO RESPONSE TO LITHIUM ION,0.024724,-0.42473,-0.28304,1,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.0015733,-0.4258,-0.55655,1,0
3,GO MIDBODY ABSCISSION,0.00066983,-0.42637,-0.411,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0017084,-0.42688,-0.46678,1,0
3,GO MUCUS SECRETION,0.015254,-0.42798,-0.5397,1,0
3,GO RETINA LAYER FORMATION,0.0059338,-0.42818,-0.39751,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0059338,-0.42886,-0.43491,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0001255,-0.42986,-0.45792,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0018542,-0.43512,-0.41202,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.011255,-0.43513,-0.44231,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.00051298,-0.43641,-0.51215,1,0
3,GO KERATINOCYTE DEVELOPMENT,0.01684,-0.43797,-0.4356,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0032392,-0.43875,-0.47861,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.017977,-0.44501,-0.35399,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00040918,-0.44604,-0.40899,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0024588,-0.44827,-0.49451,1,0
3,GO HISTAMINE SECRETION,0.0138,-0.45113,-0.42696,1,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.010505,-0.45176,-0.54376,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.016296,-0.45349,-0.31181,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.00064092,-0.45551,-0.42564,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0020112,-0.46341,-0.64257,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0073805,-0.46353,-0.46565,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00061317,-0.46383,-0.4284,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00083347,-0.4678,-0.50782,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00046881,-0.46912,-0.49397,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.021117,-0.46946,-0.42296,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0138,-0.47203,-0.39593,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.014755,-0.47274,-0.47895,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0061556,-0.48252,-0.46942,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00073133,-0.4852,-0.5071,1,0
3,GO RESPONSE TO INTERLEUKIN 18,0.0174,-0.48521,-0.44838,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00064092,-0.48528,-0.49495,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.010874,-0.48756,-0.51142,1,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.00090875,-0.49085,-0.48202,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00020344,-0.49091,-0.54485,1,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.027136,-0.49203,-0.39453,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0031154,-0.49274,-0.46694,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0010786,-0.50176,-0.46856,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.021799,-0.5056,-0.41475,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,0.001448,-0.51163,-0.60299,1,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0129,-0.52583,-0.59132,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00049043,-0.53206,-0.48208,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.00094871,-0.53426,-0.56593,1,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00037344,-0.53692,-0.5595,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00053648,-0.53885,-0.5651,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0047478,-0.54124,-0.46244,1,0
3,GO APICAL JUNCTION ASSEMBLY,0.0001525,-0.55125,-0.51193,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00046881,-0.55185,-0.57292,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00056099,-0.56013,-0.6137,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0040811,-0.56599,-0.52307,1,0
3,GO REGULATION OF PLATELET AGGREGATION,0.0015733,-0.5694,-0.55158,1,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00011949,-0.57037,-0.56195,1,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0059338,-0.57241,-0.49709,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0138,-0.5734,-0.57475,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.023222,-0.57821,-0.60455,1,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.0020112,-0.58334,-0.54496,1,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0047478,-0.58352,-0.63693,1,0
3,GO CARDIAC CELL FATE COMMITMENT,0.0057193,-0.59882,-0.5229,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,0.0012247,-0.60581,-0.54072,1,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.0091361,-0.61061,-0.65189,1,0
3,GO LUNG CELL DIFFERENTIATION,0.0039282,-0.61208,-0.53488,1,0
3,GO LIPID DROPLET FORMATION,0.00073133,-0.63678,-0.711,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00031055,-0.64546,-0.67039,1,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0033675,-0.65038,-0.49608,1,0
3,GO GAMMA DELTA T CELL ACTIVATION,0.00051298,-0.65822,-0.59382,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00076401,-0.6664,-0.56948,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00021334,-0.66829,-0.72756,1,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0031154,-0.67435,-0.61006,1,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.00024585,-0.67447,-0.70124,1,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0018542,-0.70426,-0.65518,1,0
3,GO EPITHELIAL CELL CELL ADHESION,0.00016006,-0.70635,-0.76178,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00044809,-0.79062,-0.66064,1,0
3,GO NOSE DEVELOPMENT,0.01857,-0.85904,-0.57233,1,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0001525,-0.91957,-0.88063,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00056099,-0.94492,-0.76676,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00016006,-0.99466,-0.95617,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00061317,-1.0949,-1.0018,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.00024585,-1.1116,-1.0686,1,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.13074,0.48281,0.27108,0,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.15361,0.45549,0.25433,0,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.042464,0.45517,0.26352,0,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.07572,0.42163,0.22546,0,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.032572,0.41152,0.29158,0,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.15361,0.39895,0.22906,0,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.035624,0.37445,0.31348,0,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.14679,0.3476,0.25701,0,1
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.04007,0.32242,0.19061,0,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.064555,0.30894,0.25366,0,1
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.041252,0.30864,0.23767,0,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.12179,0.30693,0.21593,0,1
3,GO SYNAPTIC VESICLE DOCKING,0.16068,0.29332,0.22281,0,1
3,GO VIRAL GENE EXPRESSION,0.035624,0.29146,0.25389,0,1
3,GO RRNA MODIFICATION,0.069955,0.28576,0.22836,0,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.041252,0.26838,0.28819,0,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.035624,0.26768,0.27047,0,1
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.035624,0.26279,0.26049,0,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.030665,0.25692,0.21589,0,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.041252,0.2566,0.21092,0,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.054786,0.25582,0.15169,0,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.030665,0.2439,0.25975,0,1
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.073757,0.2395,0.19635,0,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.16798,0.2224,0.19608,0,1
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.030665,0.22161,0.20661,0,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.043706,0.22006,0.21759,0,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.081867,0.21626,0.14462,0,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.057895,0.21227,0.12846,0,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.10025,0.21011,0.18076,0,1
3,GO RESPONSE TO GLUCAGON,0.06115,0.20934,0.1125,0,1
3,GO HORMONE BIOSYNTHETIC PROCESS,0.041252,0.20801,0.15551,0,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.086186,0.20658,0.18907,0,1
3,GO T CELL HOMEOSTASIS,0.037792,0.20556,0.11793,0,1
3,GO BRAIN MORPHOGENESIS,0.034581,0.20535,0.20371,0,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.24525,0.19834,0.16886,0,1
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.088413,0.19565,0.13868,0,1
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.064555,0.18199,0.11796,0,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.043706,0.17538,0.23274,0,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.17173,0.17369,0.12765,0,1
3,GO MITOTIC RECOMBINATION,0.15712,0.172,0.1317,0,1
3,GO RNA CATABOLIC PROCESS,0.04007,0.17042,0.13529,0,1
3,GO PYRUVATE METABOLIC PROCESS,0.046281,0.16775,0.1165,0,1
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.25516,0.16547,0.097471,0,1
3,GO PROTEIN TARGETING,0.048983,0.15992,0.11331,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.043706,0.15794,0.14978,0,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.051817,0.14957,0.15342,0,1
3,GO RNA STABILIZATION,0.12179,0.14794,0.10852,0,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.054786,0.14759,0.14124,0,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.12472,0.1468,0.12688,0,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.15361,0.1465,0.11397,0,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.038917,0.14376,0.12293,0,1
3,GO REGULATION OF HEART RATE,0.24039,0.14256,0.085183,0,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.073757,0.13945,0.094682,0,1
3,GO PEPTIDYL ARGININE MODIFICATION,0.068115,0.13776,0.12991,0,1
3,GO PHOSPHATE ION TRANSPORT,0.090686,0.13754,0.098056,0,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.10025,0.13707,0.10455,0,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.1402,0.13418,0.10858,0,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.10277,0.13362,0.12177,0,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.04007,0.13293,0.13232,0,1
3,GO DEFENSE RESPONSE TO FUNGUS,0.047616,0.12852,0.11703,0,1
3,GO REGULATION OF ATPASE ACTIVITY,0.10794,0.12837,0.069813,0,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.1794,0.12321,0.08812,0,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.056323,0.11911,0.088778,0,1
3,GO NCRNA 3 END PROCESSING,0.086186,0.11658,0.12691,0,1
3,GO TRNA TRANSPORT,0.09779,0.1164,0.10873,0,1
3,GO TELOMERE ORGANIZATION,0.032572,0.10666,0.10831,0,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.050383,0.10143,0.10844,0,1
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.27056,0.10142,0.048811,0,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.15712,0.1014,0.081686,0,1
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.095374,0.097678,0.092882,0,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.056323,0.096874,0.094383,0,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.09779,0.081288,0.12303,0,1
3,GO OXIDATIVE DEMETHYLATION,0.20828,0.076509,0.088883,0,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.14679,0.40148,0.23509,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.09779,0.39077,0.31028,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.031606,0.38596,0.27996,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.057895,0.3817,0.25272,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.10533,0.37611,0.2098,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.14679,0.37084,0.33523,0,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.09779,0.36663,0.23766,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.22622,0.33723,0.20519,0,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.044978,0.33319,0.33982,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.086186,0.33095,0.23415,0,0
3,GO LIMB BUD FORMATION,0.16068,0.32433,0.26822,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.046281,0.32253,0.24349,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.046281,0.32013,0.26798,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.035624,0.31595,0.23778,0,0
3,GO PREPULSE INHIBITION,0.041252,0.3141,0.34027,0,0
3,GO INNERVATION,0.064555,0.31016,0.31008,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.06115,0.29875,0.30568,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.090686,0.29565,0.23938,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.06115,0.29471,0.21504,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.077726,0.29361,0.27839,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.19552,0.29329,0.090605,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.16798,0.29147,0.1562,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.038917,0.2905,0.33408,0,0
3,GO CARDIAC VENTRICLE FORMATION,0.086186,0.28731,0.37785,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.057895,0.28399,0.23373,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.057895,0.28308,0.20388,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.032572,0.28006,0.26366,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.25017,0.27877,0.13058,0,0
3,GO VOCALIZATION BEHAVIOR,0.088413,0.27859,0.35731,0,0
3,GO PHAGOCYTOSIS RECOGNITION,0.18334,0.27784,0.14845,0,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.057895,0.27708,0.26978,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.064555,0.27427,0.31022,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.032572,0.27112,0.23036,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.041252,0.26893,0.24154,0,0
3,GO MYELIN MAINTENANCE,0.10025,0.26111,0.19686,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.25017,0.25807,0.14562,0,0
3,GO NAD METABOLIC PROCESS,0.06115,0.25769,0.19417,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.081867,0.25741,0.1818,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.051817,0.25464,0.19985,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.051817,0.25456,0.18074,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.048983,0.24867,0.30305,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.059504,0.24847,0.29649,0,0
3,GO SHORT TERM MEMORY,0.054786,0.24776,0.28689,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.035624,0.24687,0.21459,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.10025,0.24534,0.16629,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.11333,0.24473,0.18003,0,0
3,GO GLYCINE METABOLIC PROCESS,0.39593,0.24301,0.14783,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.31468,0.24298,0.1166,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.24525,0.24292,0.21817,0,0
3,GO THALAMUS DEVELOPMENT,0.2356,0.24186,0.18588,0,0
3,GO LIPID IMPORT INTO CELL,0.15017,0.2413,0.1263,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.064555,0.24118,0.20792,0,0
3,GO PROTEIN DENEDDYLATION,0.038917,0.23784,0.19317,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.059504,0.23709,0.15553,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.073757,0.23519,0.1853,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.030665,0.23499,0.24989,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.033564,0.23446,0.22256,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.34454,0.23344,0.1366,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.042464,0.23149,0.18944,0,0
3,GO MIDGUT DEVELOPMENT,0.43736,0.23134,0.10525,0,0
3,GO VIRAL TRANSLATION,0.042464,0.23097,0.28037,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.066316,0.23034,0.18283,0,0
3,GO TRANSLATIONAL TERMINATION,0.032572,0.23004,0.20067,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.4445,0.22965,0.0852,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.062834,0.22634,0.21025,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.044978,0.22614,0.19962,0,0
3,GO SEQUESTERING OF METAL ION,0.054786,0.22581,0.15519,0,0
3,GO CGMP MEDIATED SIGNALING,0.036694,0.2253,0.17137,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.10533,0.22497,0.23709,0,0
3,GO BONE GROWTH,0.15712,0.22438,0.16634,0,0
3,GO AMP METABOLIC PROCESS,0.051817,0.22402,0.19487,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.33843,0.22361,0.10204,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.059504,0.22301,0.23823,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.093006,0.22219,0.18053,0,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.33843,0.22196,0.05702,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.23088,0.22055,0.12987,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.054786,0.22052,0.21621,0,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.30892,0.21954,0.13435,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.036694,0.21839,0.23778,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.068115,0.21712,0.15258,0,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.15361,0.21563,0.13447,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.048983,0.21478,0.20114,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.32642,0.21329,0.23529,0,0
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.033564,0.21218,0.23523,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.050383,0.21213,0.16267,0,0
3,GO CARDIAC CHAMBER FORMATION,0.13074,0.21185,0.30147,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.28117,0.21164,0.11479,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.33843,0.21131,0.14654,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.16798,0.21034,0.14344,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.038917,0.20952,0.16359,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.21267,0.20904,0.09887,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.27583,0.20891,0.098536,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.11333,0.20864,0.14941,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.056323,0.20859,0.26443,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.57554,0.20538,0.05926,0,0
3,GO GTP METABOLIC PROCESS,0.10277,0.20372,0.17256,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.053284,0.2024,0.14268,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.38267,0.20208,0.13518,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.19971,0.20198,0.1289,0,0
3,GO CAMP METABOLIC PROCESS,0.22164,0.20165,0.10787,0,0
3,GO NEUROBLAST DIVISION,0.36329,0.20113,0.081297,0,0
3,GO POLYOL TRANSPORT,0.056323,0.19889,0.18954,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.16068,0.19885,0.15032,0,0
3,GO RESPONSE TO CAFFEINE,0.12472,0.19851,0.16336,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.27583,0.19833,0.1378,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.1161,0.19797,0.17277,0,0
3,GO RESPONSE TO PROTOZOAN,0.2356,0.19756,0.084249,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.04007,0.19738,0.15221,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.1402,0.19631,0.14851,0,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.030665,0.19494,0.28504,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.1161,0.19483,0.15082,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.33843,0.19414,0.12651,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.11892,0.19335,0.18272,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.29761,0.19302,0.19246,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.037792,0.19292,0.23177,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.24039,0.19289,0.15437,0,0
3,GO NUCLEOTIDE SALVAGE,0.1643,0.19259,0.1519,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.09779,0.19249,0.2707,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.19552,0.1914,0.15712,0,0
3,GO REGULATION OF DOPAMINE SECRETION,0.19971,0.19117,0.24928,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.28658,0.19037,0.16225,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.12179,0.18978,0.30568,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.031606,0.18977,0.19846,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.25017,0.18914,0.18711,0,0
3,GO BONE TRABECULA FORMATION,0.15712,0.1889,0.22562,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.38267,0.18863,0.068359,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.42328,0.18821,0.11679,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.14347,0.1882,0.15055,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.06115,0.18755,0.19961,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.39593,0.1869,0.1041,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.069955,0.18637,0.16687,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2356,0.18585,0.14288,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.030665,0.18581,0.19734,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.081867,0.18545,0.18061,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.10277,0.18354,0.17758,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.2356,0.18351,0.13461,0,0
3,GO RESPONSE TO MANGANESE ION,0.30892,0.1834,0.062418,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.064555,0.1833,0.18666,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.19552,0.18227,0.11051,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.030665,0.18226,0.30617,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.13384,0.1822,0.099159,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.081867,0.18142,0.18805,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.11333,0.18118,0.16624,0,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.18334,0.18096,0.18185,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.14679,0.18031,0.094564,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.084004,0.18022,0.15965,0,0
3,GO DENDRITE SELF AVOIDANCE,0.1161,0.17998,0.15232,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.12179,0.17953,0.10518,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.26536,0.17908,0.077077,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.13074,0.17895,0.16856,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.16068,0.17881,0.16028,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.044978,0.17837,0.16167,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.10794,0.17798,0.15872,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.1643,0.17796,0.13106,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.41634,0.17731,0.13885,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.4963,0.17729,0.12696,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.084004,0.17698,0.18954,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.19139,0.17657,0.19016,0,0
3,GO TELENCEPHALON REGIONALIZATION,0.26023,0.17646,0.24692,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.15361,0.17639,0.14153,0,0
3,GO VASODILATION,0.19552,0.17564,0.10824,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.037792,0.17488,0.20715,0,0
3,GO COPPER ION HOMEOSTASIS,0.088413,0.17436,0.15248,0,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11061,0.17426,0.12184,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.78645,0.17394,-0.013025,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.10794,0.17331,0.12689,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.077726,0.17325,0.17394,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.26536,0.17249,0.1079,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.33843,0.17238,0.15534,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.2356,0.17192,0.14273,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.12472,0.17186,0.15915,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.31468,0.1715,0.077628,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.10025,0.17123,0.1861,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.043706,0.17092,0.19145,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.032572,0.17065,0.15702,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.26536,0.16935,0.094216,0,0
3,GO DENDRITIC TRANSPORT,0.036694,0.16934,0.27224,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.43029,0.16901,0.16169,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.43029,0.16876,0.050894,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.10277,0.16857,0.11678,0,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.093006,0.16857,0.13885,0,0
3,GO AMINO ACID ACTIVATION,0.13384,0.16834,0.12804,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13074,0.16823,0.19119,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.036694,0.16808,0.13691,0,0
3,GO PROTEIN TRIMERIZATION,0.057895,0.16793,0.28793,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.093006,0.16758,0.1101,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.32642,0.16757,0.037845,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.043706,0.16755,0.1593,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.40267,0.16748,0.11368,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.088413,0.16675,0.13413,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.033564,0.16661,0.17356,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.14679,0.16658,0.12348,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.04007,0.16625,0.1424,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.04007,0.16614,0.16584,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.25017,0.16609,0.13392,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.038917,0.16553,0.15902,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.11892,0.16535,0.13209,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.22164,0.16453,0.13776,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.038917,0.16398,0.15654,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.051817,0.16353,0.17234,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.041252,0.16342,0.14826,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.064555,0.16286,0.16801,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.1161,0.16256,0.11046,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.13384,0.16251,0.1676,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.041252,0.16232,0.14705,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.059504,0.16197,0.12293,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.038917,0.16158,0.20206,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.13384,0.161,0.19511,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.084004,0.16087,0.13109,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.19139,0.16017,0.19557,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.35072,0.16007,0.25913,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.037792,0.15992,0.14983,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.057895,0.15968,0.12328,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.48118,0.15956,0.020891,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.034581,0.15934,0.14997,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.084004,0.15868,0.15062,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.1402,0.15863,0.14954,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.071835,0.15863,0.16942,0,0
3,GO FOREBRAIN REGIONALIZATION,0.22622,0.15842,0.22175,0,0
3,GO RELAXATION OF MUSCLE,0.22164,0.15829,0.12052,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.042464,0.15805,0.11998,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.062834,0.15802,0.15692,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.090686,0.15751,0.096175,0,0
3,GO FATTY ACID HOMEOSTASIS,0.22164,0.15726,0.20473,0,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.28117,0.15702,0.083454,0,0
3,GO CELLULAR RESPIRATION,0.069955,0.15652,0.1176,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.62578,0.15645,0.11396,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.2356,0.15628,0.15127,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.071835,0.15623,0.15731,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.23088,0.15601,0.12422,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.066316,0.15587,0.17168,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25516,0.15578,0.10689,0,0
3,GO XENOBIOTIC TRANSPORT,0.34454,0.15541,0.045654,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.66904,0.15527,0.021102,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.61728,0.15489,0.023058,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.095374,0.15416,0.14463,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.09779,0.15351,0.12723,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.48118,0.15345,0.029327,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.10277,0.15333,0.1638,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.20396,0.1532,0.1214,0,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.084004,0.15292,0.15113,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.10533,0.15289,0.11183,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.10025,0.15271,0.1598,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.22164,0.15243,0.11573,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.10025,0.15185,0.29205,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.1794,0.15184,0.13069,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.13074,0.15167,0.15189,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.10025,0.15129,0.14545,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.15017,0.15126,0.23201,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.047616,0.151,0.15471,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.081867,0.15055,0.17924,0,0
3,GO BASE EXCISION REPAIR,0.069955,0.15038,0.10999,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.32642,0.15009,0.10605,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.042464,0.14965,0.23469,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.23088,0.14947,0.088866,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.36968,0.14919,0.080743,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.27056,0.14916,0.095435,0,0
3,GO STEROID CATABOLIC PROCESS,0.40947,0.14912,0.051138,0,0
3,GO RESPONSE TO AMINE,0.062834,0.14903,0.19542,0,0
3,GO TONGUE MORPHOGENESIS,0.60042,0.14894,0.10678,0,0
3,GO RESPONSE TO AMYLOID BETA,0.048983,0.14893,0.13608,0,0
3,GO REGULATION OF DNA METHYLATION,0.60883,0.14881,0.030556,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.095374,0.14849,0.11292,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.7588,0.14827,0.025415,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.8331,0.14797,-0.024041,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.044978,0.1475,0.16584,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.15017,0.14705,0.15448,0,0
3,GO RESPONSE TO AMPHETAMINE,0.06115,0.14696,0.16462,0,0
3,GO BICARBONATE TRANSPORT,0.073757,0.14687,0.11005,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.72243,0.14671,0.0080067,0,0
3,GO NUCLEAR MIGRATION,0.066316,0.14619,0.15952,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.035624,0.14611,0.16648,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.28117,0.14595,0.08362,0,0
3,GO TOXIN TRANSPORT,0.046281,0.1459,0.1208,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.053284,0.14589,0.13336,0,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.038917,0.1457,0.13099,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.24525,0.14565,0.076248,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.077726,0.14556,0.11395,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.036694,0.14549,0.13484,0,0
3,GO NOREPINEPHRINE TRANSPORT,0.10794,0.14529,0.14718,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.26536,0.14528,0.072323,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.29761,0.14484,0.084908,0,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.43736,0.14405,0.081074,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.1643,0.14334,0.10842,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.51944,0.14306,0.10682,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.13074,0.14287,0.092381,0,0
3,GO PRENYLATION,0.069955,0.14276,0.12696,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.28658,0.14262,0.15921,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.60042,0.14243,0.053166,0,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.046281,0.14239,0.1451,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.1161,0.14231,0.15276,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.046281,0.14201,0.18818,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.40267,0.14178,0.16696,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.084004,0.14071,0.13382,0,0
3,GO COLLATERAL SPROUTING,0.095374,0.14047,0.15748,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.40267,0.14042,0.089636,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.70447,0.13976,0.01138,0,0
3,GO DENDRITE MORPHOGENESIS,0.043706,0.13957,0.15437,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26023,0.13953,0.12231,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.047616,0.13913,0.16129,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.037792,0.13906,0.10373,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.52728,0.13839,-0.01464,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.053284,0.13797,0.12518,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.28658,0.13762,0.061464,0,0
3,GO NEURON RECOGNITION,0.27583,0.1374,0.10591,0,0
3,GO CAMP BIOSYNTHETIC PROCESS,0.29761,0.13739,0.12159,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.069955,0.13736,0.14813,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.18334,0.13722,0.08087,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.038917,0.13703,0.12832,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.24525,0.13699,0.073969,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.095374,0.13659,0.13972,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.04007,0.13657,0.1369,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21712,0.13657,0.16229,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.033564,0.13654,0.16127,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.53518,0.13649,0.02059,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.36329,0.13646,0.027359,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.21712,0.13637,0.13133,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.057895,0.13629,0.1546,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.35697,0.13613,0.07781,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.069955,0.13604,0.091163,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.032572,0.13586,0.14232,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.56735,0.13568,0.050494,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.25516,0.13562,0.14762,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.19552,0.13553,0.10568,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.035624,0.1344,0.14327,0,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.047616,0.13432,0.14122,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.10794,0.13403,0.18007,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.46631,0.13388,0.0046849,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.37614,0.13387,0.03962,0,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.12771,0.1334,0.099387,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.10794,0.1331,0.036014,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.19139,0.13303,0.1154,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.12771,0.13292,0.11508,0,0
3,GO STARTLE RESPONSE,0.24039,0.13284,0.14485,0,0
3,GO AXON EXTENSION,0.057895,0.13215,0.13816,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.051817,0.13191,0.17451,0,0
3,GO MUSCLE ATROPHY,0.96638,0.13179,-0.062744,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.10533,0.13154,0.212,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.068115,0.13139,0.18226,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.14679,0.13137,0.12062,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.090686,0.13106,0.18292,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.069955,0.13102,0.13107,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.25017,0.13093,0.073248,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.088413,0.13077,0.1804,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.1402,0.13052,0.070016,0,0
3,GO ANION HOMEOSTASIS,0.18733,0.13033,0.089023,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.095374,0.13022,0.14621,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.32642,0.12984,0.061401,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.6516,0.12974,0.0058143,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.50395,0.12972,0.047506,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.24525,0.12947,0.101,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.52728,0.12931,0.12025,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.43029,0.12921,0.067628,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.29206,0.12916,0.11811,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.12472,0.1291,0.11748,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12179,0.12888,0.14161,0,0
3,GO MEMBRANE DISASSEMBLY,0.19139,0.12884,0.074617,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.32052,0.12873,0.057007,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093006,0.12873,0.17998,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.1402,0.12858,0.14527,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.19552,0.12808,0.097956,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.12472,0.12794,0.12741,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.27583,0.1276,0.07991,0,0
3,GO ALDITOL METABOLIC PROCESS,0.18334,0.12758,0.12153,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.095374,0.12686,0.11335,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.057895,0.12658,0.10881,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.11892,0.12658,0.12976,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.27583,0.12657,0.14505,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.064555,0.12609,0.0874,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.36968,0.12598,0.060165,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.18334,0.12573,0.14033,0,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.24525,0.12569,0.075448,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.079775,0.12564,0.1352,0,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.13384,0.12559,0.11874,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.15017,0.1255,0.14512,0,0
3,GO PROTEIN KINASE A SIGNALING,0.093006,0.12549,0.096381,0,0
3,GO PRESYNAPSE ORGANIZATION,0.10794,0.12511,0.16736,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.041252,0.12507,0.12036,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.24525,0.12497,0.10165,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.60042,0.12491,0.043924,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.047616,0.12448,0.11819,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.42328,0.12445,0.066475,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.10533,0.1244,0.098119,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.33239,0.12392,0.093645,0,0
3,GO ENDODERM DEVELOPMENT,0.55115,0.12377,0.024291,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.30323,0.12367,0.14656,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.17553,0.12362,0.17086,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.21712,0.12362,0.15137,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.88036,0.12347,-0.017289,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.61728,0.12345,0.066477,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.40267,0.12293,0.13431,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.35697,0.12284,0.045736,0,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.38927,0.12277,0.093115,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.52728,0.12242,0.019175,0,0
3,GO MRNA SPLICE SITE SELECTION,0.068115,0.12204,0.16138,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.25017,0.12189,0.082241,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.095374,0.12178,0.12657,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.26023,0.12177,0.060369,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.12179,0.12163,0.10489,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.21267,0.12155,0.15252,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.22164,0.12148,0.30534,0,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.40947,0.12128,0.073548,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.064555,0.12124,0.10366,0,0
3,GO LOCOMOTORY BEHAVIOR,0.048983,0.12116,0.16722,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.24039,0.12108,0.089553,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.046281,0.12094,0.14033,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.19971,0.12074,0.13,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.80503,0.12066,0.0075912,0,0
3,GO SYNAPSE ASSEMBLY,0.15017,0.12046,0.13835,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.053284,0.12036,0.14197,0,0
3,GO DENDRITE DEVELOPMENT,0.042464,0.12027,0.14453,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.084004,0.12009,0.090495,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.21267,0.12006,0.085935,0,0
3,GO HEME METABOLIC PROCESS,0.28658,0.11992,0.10026,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.059504,0.11984,0.10937,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.95679,0.1195,-0.0084451,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4963,0.11945,0.061836,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.031606,0.11898,0.13505,0,0
3,GO MEMBRANE DEPOLARIZATION,0.28658,0.11844,0.098823,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.095374,0.11837,0.11424,0,0
3,GO METAL ION TRANSPORT,0.064555,0.11836,0.081344,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.1794,0.11822,0.090115,0,0
3,GO RNA CAPPING,0.053284,0.1179,0.108,0,0
3,GO L PHENYLALANINE METABOLIC PROCESS,0.58378,0.1178,0.021003,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.29206,0.11767,0.1068,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.15712,0.11753,0.10892,0,0
3,GO REGULATION OF GTP BINDING,0.60042,0.11752,0.064885,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.27056,0.11738,0.09451,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.71343,0.11702,0.018754,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.40267,0.11688,0.018985,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.36329,0.11674,0.14721,0,0
3,GO RESPONSE TO LEAD ION,0.20828,0.11663,0.084425,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.17173,0.11652,0.11635,0,0
3,GO LIVER REGENERATION,0.13384,0.11555,0.09058,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.035624,0.11543,0.10937,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.47371,0.11539,0.11153,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.04007,0.11536,0.11517,0,0
3,GO NEURON PROJECTION GUIDANCE,0.14679,0.11534,0.1188,0,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.06115,0.11515,0.12847,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34454,0.1151,0.064575,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.25017,0.11483,0.11428,0,0
3,GO POTASSIUM ION TRANSPORT,0.090686,0.11472,0.13005,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.33843,0.1147,0.09224,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.18733,0.11446,0.12594,0,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.047616,0.11438,0.098318,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.13074,0.11424,0.11371,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.24039,0.11423,0.09789,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.14679,0.11401,0.091978,0,0
3,GO COCHLEA DEVELOPMENT,0.10794,0.11401,0.10708,0,0
3,GO INSEMINATION,0.58378,0.11374,0.030501,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.06115,0.1129,0.091959,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.38927,0.11264,0.069441,0,0
3,GO COCHLEA MORPHOGENESIS,0.51167,0.11248,0.046854,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.1643,0.11228,0.10473,0,0
3,GO MUSCLE FILAMENT SLIDING,0.38267,0.11182,0.056411,0,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.34454,0.11164,0.056459,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.10794,0.11138,0.15579,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.45171,0.11135,0.067773,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.090686,0.11132,0.083474,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.90893,0.11105,0.010094,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.33843,0.11085,0.1074,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36329,0.1108,0.10261,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.22164,0.1107,0.15905,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.10794,0.11068,0.093887,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.088413,0.11051,0.18922,0,0
3,GO PROTEIN REFOLDING,0.27056,0.11045,0.16181,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.68667,0.11021,0.085259,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.14679,0.1102,0.10896,0,0
3,GO ADULT BEHAVIOR,0.057895,0.10984,0.18078,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.079775,0.1098,0.11091,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.041252,0.1098,0.14216,0,0
3,GO THYROID GLAND DEVELOPMENT,0.38927,0.10961,0.10868,0,0
3,GO HISTONE H3 K27 METHYLATION,0.13699,0.10944,0.10375,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.6516,0.10937,0.070718,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.47371,0.10921,0.058806,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.36968,0.10901,0.042431,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.073757,0.10894,0.087342,0,0
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.12179,0.10887,0.12,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.054786,0.1087,0.14597,0,0
3,GO ZINC ION TRANSPORT,0.40947,0.10854,0.051984,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.32642,0.10842,0.13853,0,0
3,GO PLASMINOGEN ACTIVATION,0.42328,0.10823,-0.021871,0,0
3,GO HISTONE H3 K36 METHYLATION,0.34454,0.1082,0.058669,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.038917,0.10804,0.17386,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.047616,0.10783,0.14289,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.73147,0.10772,-0.022185,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.17553,0.10747,0.085085,0,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.046281,0.10746,0.10788,0,0
3,GO RNA 5 END PROCESSING,0.15712,0.10736,0.1213,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.07572,0.1073,0.090317,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.47371,0.10711,0.010754,0,0
3,GO COPPER ION TRANSPORT,0.35072,0.10674,0.071839,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.21267,0.10672,0.0535,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.16068,0.10656,0.066539,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.96638,0.10647,-0.073475,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.044978,0.10639,0.11353,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.82372,0.10624,-0.0084581,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.32642,0.10622,0.082652,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.50395,0.1062,0.12645,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.11333,0.10602,0.13111,0,0
3,GO CELL PART MORPHOGENESIS,0.053284,0.10585,0.11828,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.057895,0.10579,0.099047,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.73147,0.10562,0.031995,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.13384,0.10561,0.069013,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.25516,0.10553,0.062676,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.047616,0.10542,0.096248,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.84251,0.10536,0.018161,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.29206,0.1053,0.074741,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.38927,0.10528,0.05919,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.32052,0.10513,0.067495,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.28658,0.10513,0.15899,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.14679,0.10511,0.082817,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.16068,0.10498,0.13628,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.38927,0.10492,0.21985,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.057895,0.10472,0.11009,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.55922,0.10468,0.019329,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.40267,0.10449,0.027765,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.10794,0.10432,0.10931,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.18733,0.10431,0.13449,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.32052,0.10389,0.093354,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.035624,0.1038,0.10704,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.43029,0.10378,0.062097,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.17173,0.10377,0.065973,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.07572,0.10365,0.086009,0,0
3,GO RESPONSE TO ACIDIC PH,0.4445,0.10352,0.032608,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.084004,0.10352,0.12576,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.35697,0.10348,0.054312,0,0
3,GO BEHAVIOR,0.043706,0.10333,0.12191,0,0
3,GO CALCIUM ION IMPORT,0.28117,0.10328,0.06328,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.56735,0.10304,0.062951,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.071835,0.1028,0.098008,0,0
3,GO REGULATION OF AXON GUIDANCE,0.45171,0.10272,0.052607,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.76799,0.10258,0.031483,0,0
3,GO DNA REPLICATION CHECKPOINT,0.037792,0.10214,0.13094,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.22622,0.10203,0.077809,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.43736,0.10202,0.097939,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.35072,0.10192,0.088783,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.88036,0.10143,0.021876,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47371,0.10136,0.059136,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.7588,0.10126,0.054164,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.22622,0.10119,0.051306,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.76799,0.10104,0.014536,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.064555,0.10096,0.18137,0,0
3,GO GROWTH HORMONE SECRETION,0.29206,0.10086,0.10698,0,0
3,GO REGULATION OF ODONTOGENESIS,0.68667,0.10002,0.04103,0,0
3,GO DOPAMINE TRANSPORT,0.68667,0.099896,0.12491,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.19971,0.099839,0.090309,0,0
3,GO TRNA 5 END PROCESSING,0.32642,0.099827,0.064786,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.069955,0.099787,0.21286,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.37614,0.099626,0.080085,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.037792,0.09943,0.10491,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.32052,0.099283,0.10212,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.11333,0.098941,0.12179,0,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.27583,0.098768,0.097697,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.25516,0.098737,0.069076,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.090686,0.098654,0.088427,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.12472,0.098497,0.12403,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.46631,0.098467,0.042881,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.23088,0.098237,0.064828,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.15361,0.098113,0.09893,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.11333,0.098101,0.097434,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.32642,0.097986,0.086828,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.36329,0.097973,0.06824,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.11333,0.097733,0.10007,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.093006,0.097732,0.071644,0,0
3,GO HEART PROCESS,0.14347,0.097719,0.083305,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.10277,0.09768,0.11309,0,0
3,GO GROOMING BEHAVIOR,0.26536,0.09765,0.11757,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.04007,0.097332,0.099285,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32052,0.097188,0.12472,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.073757,0.096966,0.10192,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.13699,0.096875,0.25471,0,0
3,GO RESPONSE TO CALCIUM ION,0.07572,0.096872,0.11566,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67783,0.096769,0.059762,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.066316,0.096736,0.12408,0,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.11892,0.096577,0.069405,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.086186,0.096346,0.13297,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.046281,0.096319,0.086712,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.23088,0.096166,0.07802,0,0
3,GO DNA LIGATION,0.53518,0.095875,0.060729,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.10025,0.095835,0.12025,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.22622,0.095579,0.1726,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.4963,0.095458,0.017029,0,0
3,GO CATION TRANSPORT,0.077726,0.09525,0.075765,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.053284,0.095238,0.1121,0,0
3,GO PLASMA MEMBRANE FUSION,0.8614,0.09506,0.019047,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.32052,0.095058,0.047617,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.26023,0.095053,0.082708,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.30892,0.094651,0.030161,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.74054,0.094364,0.019234,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.60042,0.094364,0.065284,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.43736,0.09395,0.077586,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.16798,0.09389,0.069809,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.24039,0.093815,0.094275,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.6516,0.09376,0.045743,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.16798,0.093728,0.1276,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.09779,0.093439,0.1165,0,0
3,GO REGULATION OF AXONOGENESIS,0.17173,0.093407,0.097114,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.4963,0.093291,0.046025,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.17173,0.093241,0.079447,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.068115,0.093107,0.1401,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.19139,0.093061,0.055407,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.20828,0.092966,0.10392,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.30323,0.092927,0.082081,0,0
3,GO AXON DEVELOPMENT,0.090686,0.092887,0.11308,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.55922,0.09265,0.042484,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.50395,0.092404,0.084678,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.57554,0.092388,0.031336,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.69555,0.092316,-0.052073,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.15361,0.092106,0.1065,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.46631,0.092081,0.058154,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.29206,0.091928,0.29771,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.48118,0.091918,0.048337,0,0
3,GO AMINO ACID IMPORT,0.059504,0.091913,0.18316,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.66904,0.091592,0.014789,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.46631,0.091473,0.083542,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.35697,0.091368,0.066517,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.12771,0.091356,0.089984,0,0
3,GO PROTEIN PALMITOYLATION,0.15361,0.091353,0.11474,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.11333,0.091032,0.072143,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.048983,0.091008,0.072185,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.27056,0.090923,0.10083,0,0
3,GO IRON ION HOMEOSTASIS,0.20396,0.090872,0.076462,0,0
3,GO NERVE DEVELOPMENT,0.98559,0.090835,-0.0090258,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.15017,0.090772,0.082311,0,0
3,GO KERATINOCYTE MIGRATION,0.45898,0.09072,0.048809,0,0
3,GO CONVERGENT EXTENSION,0.32052,0.09057,0.093476,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.50395,0.09056,0.03469,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.38927,0.090291,0.17848,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.43029,0.090194,0.12979,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.30323,0.090188,0.066599,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.22164,0.090146,0.071136,0,0
3,GO METHYLATION,0.042464,0.089999,0.074348,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.10025,0.089924,0.092153,0,0
3,GO AMINE CATABOLIC PROCESS,0.90893,0.08992,-0.030364,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.093006,0.08971,0.10922,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.1794,0.089423,0.12179,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.50395,0.089125,-0.067797,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.50395,0.089021,0.06895,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.16798,0.088941,0.10931,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.64294,0.088755,0.053462,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.90893,0.088717,-0.031682,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.2356,0.088684,0.11361,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.88036,0.088592,0.037373,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.038917,0.088482,0.11522,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.20396,0.088441,0.067606,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.15712,0.088436,0.072689,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.38927,0.08809,0.061747,0,0
3,GO RESPONSE TO POTASSIUM ION,0.71343,0.087889,0.041242,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.030665,0.087671,0.14614,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.042464,0.087645,0.10162,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.28658,0.087601,0.066985,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.60042,0.087586,-0.16075,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.55922,0.087533,0.048933,0,0
3,GO PROTEIN KINASE C SIGNALING,0.45171,0.087416,0.052114,0,0
3,GO REGULATION OF ION TRANSPORT,0.28658,0.087269,0.059417,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.13384,0.08705,0.11508,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.19139,0.086989,0.062755,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.17553,0.086777,0.084054,0,0
3,GO CELL RECOGNITION,0.35697,0.086101,0.04347,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.15017,0.085995,0.073121,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.10277,0.085982,0.1137,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.09779,0.085826,0.11887,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.18733,0.085608,0.10987,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.45171,0.085318,0.062698,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.1794,0.085016,0.072154,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.45171,0.084877,0.036585,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42328,0.084738,0.036551,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.15361,0.084731,0.071699,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.28658,0.08469,0.053811,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.24039,0.08459,0.088259,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.43736,0.084326,0.055098,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.12179,0.084324,0.068005,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.93762,0.084123,-0.010855,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.081867,0.084102,0.08795,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.53518,0.083987,0.042277,0,0
3,GO BLASTOCYST FORMATION,0.22164,0.083906,0.078586,0,0
3,GO RECEPTOR INTERNALIZATION,0.16068,0.083875,0.073533,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.1643,0.083796,0.070934,0,0
3,GO RESPONSE TO ZINC ION,0.51167,0.083487,0.042719,0,0
3,GO HEART TRABECULA FORMATION,0.6516,0.08338,0.041016,0,0
3,GO NEPHRON TUBULE FORMATION,0.87087,0.083319,0.021782,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.73147,0.083113,0.029433,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.088413,0.082804,0.10958,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.09779,0.082755,0.15437,0,0
3,GO MISMATCH REPAIR,0.35697,0.082706,0.048442,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17553,0.082579,0.058576,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35697,0.082543,0.045831,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.14347,0.082419,0.11775,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.76799,0.082149,-0.054236,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.95679,0.082036,-0.04559,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1161,0.082021,0.11696,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.53518,0.081998,0.035436,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.32052,0.08193,0.20232,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.16798,0.081859,0.096661,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.39593,0.081663,0.070893,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.39593,0.081563,0.051612,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.35072,0.08154,0.043829,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.2356,0.081372,0.063773,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.050383,0.081366,0.11687,0,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.28117,0.081344,0.052443,0,0
3,GO PROTEIN FOLDING,0.14347,0.081268,0.075005,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.76799,0.081239,-0.069875,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.50395,0.08111,0.071428,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.6603,0.08096,0.016636,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.26536,0.080935,0.11072,0,0
3,GO FIBROBLAST ACTIVATION,0.40267,0.080625,0.059378,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.60883,0.080552,0.048238,0,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.07572,0.080207,0.09898,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,1,0.080144,-0.00083572,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.60883,0.080003,0.019624,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.36329,0.07977,0.086317,0,0
3,GO RESPONSE TO SALT,0.57554,0.079682,0.030704,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.60883,0.079473,0.043795,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.35697,0.079301,0.058246,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.7588,0.079177,0.0085554,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.4445,0.079107,0.038282,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.9952,0.078962,-0.011137,0,0
3,GO RESPONSE TO HEAT,0.12472,0.07885,0.070453,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.15361,0.078662,0.096402,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.27583,0.078554,0.070584,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.27056,0.078448,0.053813,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.26536,0.07802,0.085168,0,0
3,GO PROSTAGLANDIN SECRETION,0.33843,0.077907,0.085629,0,0
3,GO RESPONSE TO VITAMIN A,0.8614,0.077713,0.045013,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.54313,0.077566,0.031427,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.43736,0.077528,0.044218,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.90893,0.077481,-0.01761,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.26536,0.077452,0.054659,0,0
3,GO MEMBRANE REPOLARIZATION,0.2356,0.077409,0.081682,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.28117,0.077314,0.037841,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.6603,0.077227,0.025719,0,0
3,GO NEUROBLAST PROLIFERATION,0.62578,0.077137,0.022078,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.20396,0.076983,0.12425,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.43736,0.076861,0.059648,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.24525,0.076843,0.049503,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.11333,0.076821,0.097047,0,0
3,GO SODIUM ION TRANSPORT,0.21712,0.076792,0.063669,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.15712,0.076727,0.11157,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.32642,0.076714,0.05006,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.10025,0.076541,0.076518,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.14679,0.076487,0.092561,0,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.15361,0.076392,0.088809,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.43029,0.076369,0.069639,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.47371,0.076151,0.090529,0,0
3,GO MICROTUBULE POLYMERIZATION,0.11333,0.076011,0.1168,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.27583,0.075879,0.069271,0,0
3,GO VISUAL BEHAVIOR,0.25516,0.075839,0.079491,0,0
3,GO RESPONSE TO NICOTINE,0.6603,0.075795,0.015802,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.33843,0.075762,0.090462,0,0
3,GO RRNA CATABOLIC PROCESS,0.19971,0.07564,0.13829,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.52728,0.075401,0.048127,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.18334,0.075397,0.075993,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.40947,0.074849,0.05928,0,0
3,GO FEEDING BEHAVIOR,0.18733,0.074259,0.07466,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.16068,0.074229,0.11777,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.33239,0.074216,0.055441,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.52728,0.074022,0.027763,0,0
3,GO RECOMBINATIONAL REPAIR,0.10025,0.073986,0.061415,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.036694,0.073824,0.079963,0,0
3,GO DNA GEOMETRIC CHANGE,0.073757,0.073763,0.082534,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.11333,0.07371,0.13047,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.093006,0.073622,0.076584,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.22622,0.073371,0.063099,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.086186,0.073094,0.1342,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.38267,0.073051,0.087682,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.13699,0.072986,0.099669,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.071835,0.072973,0.1205,0,0
3,GO METHIONINE METABOLIC PROCESS,0.56735,0.072881,0.0073705,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.96638,0.072638,0.039833,0,0
3,GO AXO DENDRITIC TRANSPORT,0.20396,0.07239,0.095336,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.88987,0.072193,-0.018331,0,0
3,GO AXONAL FASCICULATION,0.87087,0.072137,0.0044412,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.57554,0.071986,0.019611,0,0
3,GO REGULATION OF DNA BINDING,0.40947,0.071852,0.037578,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.036694,0.071819,0.1074,0,0
3,GO BONE MORPHOGENESIS,0.63434,0.071459,0.017501,0,0
3,GO MUSCLE CONTRACTION,0.15017,0.07138,0.070759,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.28117,0.071005,0.052767,0,0
3,GO GLIAL CELL MIGRATION,0.29206,0.070989,0.11003,0,0
3,GO HISTONE METHYLATION,0.10025,0.070909,0.057877,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.27056,0.070905,0.060819,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.069955,0.070873,0.10274,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.55922,0.070866,0.056628,0,0
3,GO PROSTATE GLAND GROWTH,0.78645,0.070825,-0.043755,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.59207,0.07078,0.029652,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.36968,0.070542,0.065987,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.21712,0.070409,0.093999,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.29206,0.070001,0.0841,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.85194,0.069893,-0.04471,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.26023,0.069772,0.02895,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.37614,0.069672,0.056669,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.48118,0.069519,0.048953,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.96638,0.069503,-0.056384,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.96638,0.069334,-0.018243,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.66904,0.069277,0.036834,0,0
3,GO PROTEIN NEDDYLATION,0.16798,0.069194,0.095599,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.29761,0.06903,0.10226,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.6603,0.069001,0.026489,0,0
3,GO MEMBRANE BIOGENESIS,0.42328,0.068975,0.062393,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.32642,0.068813,0.067805,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.25516,0.068521,0.059045,0,0
3,GO NEURON MATURATION,0.19971,0.068454,0.17035,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.56735,0.068429,0.071501,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.40947,0.068341,0.03371,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.48871,0.068027,0.046857,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.27583,0.067983,0.078373,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.63434,0.067643,0.026031,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.48118,0.067585,0.021645,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.52728,0.067545,0.046535,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.38927,0.067462,0.043748,0,0
3,GO TOOTH MINERALIZATION,0.74054,0.067321,0.043812,0,0
3,GO CATECHOLAMINE UPTAKE,0.58378,0.067065,0.07176,0,0
3,GO MITOCHONDRIAL FISSION,0.20828,0.066962,0.097037,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.12472,0.066922,0.085056,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.40947,0.066824,0.025327,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.30323,0.066616,0.066193,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.15712,0.066608,0.071548,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.76799,0.066556,-0.014793,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.53518,0.066416,0.083385,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.7588,0.066329,0.016448,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.21267,0.066211,0.07448,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.96638,0.06618,-0.044197,0,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.054786,0.066156,0.14491,0,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.17553,0.066121,0.066812,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.32052,0.066044,0.061506,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.69555,0.065995,0.0020663,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.7772,0.065844,-0.014783,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,1,0.065744,0.0061819,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.66904,0.06549,0.020336,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.46631,0.065402,0.038672,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.20828,0.065332,0.079305,0,0
3,GO URETER DEVELOPMENT,0.73147,0.065314,0.048828,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12472,0.065165,0.11872,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.14679,0.065059,0.049018,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.58378,0.064788,0.015601,0,0
3,GO PALLIUM DEVELOPMENT,0.16068,0.064737,0.090119,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.20396,0.064603,0.070105,0,0
3,GO NUCLEOSOME ORGANIZATION,0.12771,0.064533,0.069738,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.069955,0.064501,0.072347,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.33843,0.064273,0.054381,0,0
3,GO CHROMATIN DISASSEMBLY,0.40947,0.064089,0.10863,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.24525,0.064024,0.079275,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.050383,0.064006,0.05279,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.48871,0.063926,0.079457,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.13699,0.063856,0.12705,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.50395,0.063856,0.037719,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.2356,0.063716,0.049826,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.68667,0.063672,0.021947,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.6603,0.063575,0.01446,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.31468,0.06355,0.072622,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.36968,0.063149,0.039918,0,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.11892,0.06291,0.049506,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.40267,0.06287,0.033987,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.51167,0.062735,0.050172,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.74966,0.062703,0.0064623,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.21267,0.062508,0.1249,0,0
3,GO CELL AGGREGATION,0.60883,0.062465,0.027905,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.79572,0.062426,0.013742,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.7772,0.062233,-0.015124,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.54313,0.0622,0.089188,0,0
3,GO SEROTONIN TRANSPORT,0.89939,0.062171,-0.029788,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.88036,0.062015,-0.034429,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.10794,0.061926,0.099127,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.55922,0.061837,0.0086868,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.28658,0.061453,0.050814,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.4445,0.061165,0.059791,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.59207,0.061021,0.022676,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.18334,0.060885,0.14553,0,0
3,GO CELL CYCLE DNA REPLICATION,0.20828,0.060818,0.087937,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.93762,0.060531,-0.060566,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.60042,0.060501,-0.10917,0,0
3,GO RRNA 3 END PROCESSING,0.43736,0.060427,0.078925,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.97598,0.0604,-0.025003,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.1643,0.060374,0.083222,0,0
3,GO NUCLEAR EXPORT,0.12771,0.060373,0.060397,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.40947,0.060355,0.044153,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.66904,0.060279,0.012192,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.55922,0.060215,0.019666,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.35697,0.059919,0.04456,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.45898,0.059655,0.14388,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.22622,0.059611,0.081408,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.55115,0.059537,0.028127,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.72243,0.059483,0.0053729,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.41634,0.059408,0.071768,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.26023,0.05925,0.045456,0,0
3,GO REGULATION OF EXOCYTOSIS,0.19971,0.059169,0.083901,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.12179,0.059107,0.062317,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.41634,0.059088,0.07718,0,0
3,GO AMYLOID BETA FORMATION,0.56735,0.059064,0.041299,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.32642,0.058691,0.09298,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.38927,0.058663,0.039327,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.10277,0.058549,0.079325,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.30323,0.058523,0.048168,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.1643,0.058486,0.06911,0,0
3,GO DE NOVO PROTEIN FOLDING,0.45171,0.058087,0.084147,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.92804,0.057963,-0.018429,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.073757,0.057958,0.1096,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.29761,0.057684,0.067639,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.42328,0.057621,0.057422,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.71343,0.057601,0.037555,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.25017,0.057544,0.066364,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.53518,0.057184,0.020478,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.39593,0.057172,0.04974,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.68667,0.056776,0.019422,0,0
3,GO ACTION POTENTIAL,0.60883,0.056769,0.049574,0,0
3,GO CATECHOLAMINE SECRETION,0.36329,0.056582,0.1689,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.14679,0.056472,0.060801,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.58378,0.056458,0.038406,0,0
3,GO METAL ION HOMEOSTASIS,0.6516,0.056235,0.018906,0,0
3,GO RESPONSE TO DOPAMINE,0.84251,0.056228,0.018317,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.22622,0.056227,0.099684,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.79572,0.056139,0.016963,0,0
3,GO ION HOMEOSTASIS,0.48118,0.056044,0.030178,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.6603,0.056006,0.027099,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.96638,0.055987,-0.0034994,0,0
3,GO CHLORIDE TRANSPORT,0.4963,0.055824,0.037328,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.6516,0.055793,0.016154,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.42328,0.055716,0.050804,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.036694,0.055626,0.080498,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.43736,0.055602,0.077112,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.59207,0.055398,0.071974,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.053284,0.055291,0.082246,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.8614,0.055206,-0.036738,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.82372,0.055144,0.011535,0,0
3,GO ENDODERM FORMATION,0.48871,0.05494,0.031184,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.46631,0.054921,0.066571,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.51167,0.054812,0.03677,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.42328,0.054738,0.032439,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.61728,0.054737,0.033256,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.40267,0.054698,0.068082,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.78645,0.054432,0.029352,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.67783,0.054112,0.011456,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.19971,0.053955,0.058058,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.35697,0.053804,0.034796,0,0
3,GO PROTEASOME ASSEMBLY,0.090686,0.053773,0.11672,0,0
3,GO PIGMENT METABOLIC PROCESS,0.29761,0.053691,0.081009,0,0
3,GO BLASTOCYST GROWTH,0.51167,0.053688,0.026695,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.081867,0.053629,0.076211,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.6516,0.053521,0.035528,0,0
3,GO DEVELOPMENTAL MATURATION,0.12771,0.053509,0.088935,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.10277,0.053405,0.08725,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.21267,0.05328,0.097984,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.90893,0.053206,-0.033934,0,0
3,GO AORTA DEVELOPMENT,0.25017,0.053188,0.070931,0,0
3,GO MRNA TRANSPORT,0.079775,0.053117,0.083479,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.54313,0.053114,0.01951,0,0
3,GO VITAMIN TRANSPORT,0.54313,0.052987,0.099798,0,0
3,GO MACROMOLECULE DEACYLATION,0.53518,0.052901,0.024584,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.45898,0.052691,0.10542,0,0
3,GO RESPONSE TO CAMP,0.2356,0.052682,0.070972,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.81436,0.05267,0.025957,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.30892,0.052458,0.051545,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.95679,0.052443,-0.0018088,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.36329,0.052433,0.052678,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.27583,0.052352,0.056172,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.61728,0.05231,-0.12018,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.33843,0.052076,0.068448,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.31468,0.051943,0.0078519,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.40267,0.051851,0.045209,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.68667,0.051724,0.025339,0,0
3,GO NUCLEOSOME ASSEMBLY,0.23088,0.051694,0.06275,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.89939,0.051633,-0.017035,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.25017,0.051436,0.098127,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.45898,0.051393,0.055154,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.13074,0.05135,0.096983,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.26023,0.051249,0.064047,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.80503,0.051141,0.0099498,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.37614,0.051108,0.072718,0,0
3,GO MUSCLE SYSTEM PROCESS,0.24525,0.051011,0.051317,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.66904,0.050928,0.021431,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.82372,0.050771,-0.010453,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.45898,0.050767,0.051905,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.78645,0.050591,-0.097532,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.16068,0.050566,0.051301,0,0
3,GO RESPONSE TO ATP,0.2356,0.050431,0.063696,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.55115,0.050372,0.0148,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.38267,0.050369,0.067085,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.88036,0.050326,0.0064567,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.63434,0.049974,0.034072,0,0
3,GO LYMPH NODE DEVELOPMENT,0.51167,0.049918,0.025122,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.96638,0.049895,-0.030862,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.2356,0.049849,0.05599,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.12179,0.049738,0.058229,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.64294,0.049719,0.0082147,0,0
3,GO PORE COMPLEX ASSEMBLY,0.84251,0.049691,-0.044136,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.90893,0.049537,-0.0111,0,0
3,GO RESPONSE TO DRUG,0.57554,0.049347,0.027999,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.17173,0.049166,0.056035,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.36329,0.049071,0.034409,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.88036,0.049039,-0.010421,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.45898,0.049018,0.036377,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.31468,0.048942,0.055965,0,0
3,GO G0 TO G1 TRANSITION,0.87087,0.048842,0.014138,0,0
3,GO DNA CONFORMATION CHANGE,0.1643,0.048823,0.056167,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.64294,0.048665,0.026445,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.9952,0.048616,-0.024469,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.38267,0.048609,0.071429,0,0
3,GO NEURON DEVELOPMENT,0.18334,0.048565,0.075487,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.84251,0.04845,-0.049752,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.26536,0.048323,0.057955,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.34454,0.048308,0.067,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.33843,0.048236,0.081776,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.41634,0.04814,0.06955,0,0
3,GO ION TRANSPORT,0.26023,0.048095,0.044209,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.64294,0.048072,0.0042332,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.1643,0.048056,0.056592,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.89939,0.047979,-0.010737,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.59207,0.047806,0.015591,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.30323,0.047734,0.050643,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.7588,0.047703,0.063811,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.52728,0.04765,0.03587,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.81436,0.047556,-0.049736,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.71343,0.047496,0.016847,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.9952,0.047473,-0.012856,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.31468,0.047089,0.039599,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.64294,0.046908,0.032882,0,0
3,GO RESPONSE TO GONADOTROPIN,0.54313,0.046811,0.023318,0,0
3,GO PIGMENT GRANULE MATURATION,0.54313,0.046535,0.03977,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.8614,0.046481,3.2455e-05,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.52728,0.04646,0.033059,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.96638,0.046459,-0.060889,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.33239,0.04637,0.081041,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.27056,0.046343,0.073921,0,0
3,GO SNRNA PROCESSING,0.24039,0.046317,0.010174,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.21267,0.046181,0.16436,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.96638,0.04609,-0.017543,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.59207,0.04604,0.059433,0,0
3,GO PROTEIN OXIDATION,0.96638,0.046034,-0.078537,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.23088,0.045935,0.085081,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.69555,0.04592,0.016602,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.39593,0.045821,0.086206,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.12179,0.045627,0.057035,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.96638,0.045453,-0.032211,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.55115,0.045311,0.029101,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.68667,0.045085,0.062153,0,0
3,GO REGULATION OF RNA SPLICING,0.16068,0.04501,0.051842,0,0
3,GO REGULATION OF CELL SIZE,0.31468,0.044906,0.048066,0,0
3,GO ENAMEL MINERALIZATION,0.9472,0.044903,0.0080509,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.38267,0.04476,0.052535,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.96638,0.044742,0.0085396,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.18733,0.044679,0.041147,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.84251,0.044672,0.0079646,0,0
3,GO REGULATION OF CELL AGING,0.9472,0.044663,-0.031456,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.48118,0.044644,0.031802,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.25516,0.044546,0.085483,0,0
3,GO CHYLOMICRON ASSEMBLY,0.88036,0.044372,-0.030924,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.47371,0.044325,0.017908,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.87087,0.044231,-0.018793,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.36968,0.044225,0.067865,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.95679,0.044204,-0.010584,0,0
3,GO ORGANELLE FUSION,0.50395,0.044182,0.012641,0,0
3,GO NEURON DIFFERENTIATION,0.28658,0.044137,0.062674,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.64294,0.044106,-0.011099,0,0
3,GO PROTEIN HYDROXYLATION,0.7588,0.044073,-0.057206,0,0
3,GO IRON ION TRANSPORT,0.55922,0.044071,0.00047698,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.7772,0.043989,0.004178,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.31468,0.043955,0.11113,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.9472,0.043943,-0.0082278,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.1161,0.043942,0.078206,0,0
3,GO NEURON MIGRATION,0.29206,0.043933,0.11091,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.74966,0.043745,0.025418,0,0
3,GO POLYOL METABOLIC PROCESS,0.18733,0.04373,0.05863,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.30323,0.043609,0.065211,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.81436,0.043502,-0.036775,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.20396,0.04349,0.093412,0,0
3,GO RESPONSE TO PAIN,0.76799,0.043198,-0.0059695,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.55115,0.042822,0.026247,0,0
3,GO TERPENOID METABOLIC PROCESS,0.51167,0.042665,0.032968,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.57554,0.042515,0.021221,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.38927,0.042438,0.06543,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.64294,0.042241,0.091202,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.23088,0.042214,0.049464,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.8331,0.042139,0.016092,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.55922,0.042127,-0.14569,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.17173,0.042119,0.075737,0,0
3,GO SNRNA TRANSCRIPTION,0.17553,0.042057,0.044954,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.76799,0.041943,-0.0056719,0,0
3,GO ACROSOME ASSEMBLY,0.51944,0.04188,0.098257,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.8331,0.041783,-0.012306,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.90893,0.041758,-0.023667,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.71343,0.041739,0.020377,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.84251,0.0417,-0.016533,0,0
3,GO CELLULAR HOMEOSTASIS,0.28658,0.041694,0.039364,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.4963,0.041592,0.064865,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.84251,0.041544,-0.039701,0,0
3,GO EPIBOLY,0.47371,0.041503,-0.13342,0,0
3,GO CERAMIDE TRANSPORT,0.47371,0.041502,0.016441,0,0
3,GO THIOESTER METABOLIC PROCESS,0.54313,0.041429,0.038181,0,0
3,GO VASCULOGENESIS,0.72243,0.041407,0.0025865,0,0
3,GO ZINC ION HOMEOSTASIS,0.97598,0.041385,-0.037825,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.36329,0.041184,0.035239,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.67783,0.041112,0.0048662,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.48118,0.041062,0.046393,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.98559,0.040627,-0.0066987,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.7588,0.0402,-0.0008591,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.91848,0.040178,-0.035114,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.55922,0.039983,0.027582,0,0
3,GO NERVOUS SYSTEM PROCESS,0.31468,0.039816,0.049264,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.6603,0.039769,0.017569,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.48118,0.039571,0.10488,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.11333,0.039502,0.13836,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.43029,0.039434,0.052724,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.88987,0.039233,-0.01564,0,0
3,GO PROTEIN METHYLATION,0.24525,0.039089,0.036645,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42328,0.038868,0.031018,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.6603,0.038819,0.059617,0,0
3,GO HISTONE DEACETYLATION,0.92804,0.038698,0.0002989,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.7772,0.038685,0.041219,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.15712,0.03864,0.11333,0,0
3,GO NEURAL CREST FORMATION,0.7772,0.038363,0.05372,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.56735,0.03829,0.033389,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.72243,0.038247,0.0063533,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.50395,0.03818,0.03645,0,0
3,GO SOMITE DEVELOPMENT,0.31468,0.038173,0.061267,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.56735,0.038121,0.027056,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.74966,0.037954,-0.058328,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.46631,0.037931,0.045343,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.14679,0.037929,0.057512,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47371,0.03787,0.036662,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.95679,0.037826,0.0055317,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.87087,0.037635,-0.025492,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.47371,0.037618,0.084881,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.92804,0.037495,-0.024796,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.67783,0.037397,0.017058,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.87087,0.037391,0.0041303,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.97598,0.037188,-0.040995,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.47371,0.037182,0.048125,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.31468,0.037136,0.12326,0,0
3,GO CELL JUNCTION ORGANIZATION,0.54313,0.03705,0.028008,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.36329,0.036903,0.12223,0,0
3,GO TRABECULA FORMATION,0.4445,0.036891,0.059726,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.80503,0.036869,0.033928,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.59207,0.036778,0.016449,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.63434,0.036678,0.018189,0,0
3,GO RECEPTOR CLUSTERING,0.48118,0.036482,0.041356,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.32052,0.036179,0.038978,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.28658,0.036171,0.10273,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.74054,0.036055,0.012608,0,0
3,GO CELL GROWTH,0.38267,0.036016,0.024814,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.32642,0.036011,0.0433,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.74054,0.036,0.016358,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.90893,0.035989,-0.027445,0,0
3,GO REGULATION OF ACROSOME REACTION,0.51167,0.035938,0.069975,0,0
3,GO CELL CELL SIGNALING,0.27056,0.035857,0.038968,0,0
3,GO DNA RECOMBINATION,0.31468,0.035736,0.031613,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.9952,0.035633,-0.0006832,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.8331,0.035616,-0.0080549,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.35072,0.035599,0.072099,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.9472,0.035561,-0.029406,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.64294,0.035523,0.046213,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.88036,0.035506,-0.019375,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.74966,0.035425,0.0053343,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.92804,0.035374,0.0050612,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.8614,0.03537,-0.029571,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.79572,0.035308,0.021281,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.51167,0.035245,0.03791,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.67783,0.035223,0.029433,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.62578,0.035106,0.050939,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.55115,0.03495,0.020939,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.63434,0.034948,0.041591,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.97598,0.034919,-0.025026,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.90893,0.034917,-0.0059354,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.51944,0.0348,0.039946,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.69555,0.034779,-0.012111,0,0
3,GO BONE DEVELOPMENT,0.82372,0.034611,-0.0094426,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.48871,0.034362,0.08542,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.57554,0.034287,0.037307,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.61728,0.034189,0.031965,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.43736,0.034148,0.072795,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.82372,0.034027,-0.021259,0,0
3,GO REGULATION OF EXCRETION,0.42328,0.034016,0.097262,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.70447,0.033925,0.0054558,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.76799,0.033874,-0.047481,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.27056,0.033748,0.028076,0,0
3,GO CHOLESTEROL EFFLUX,0.73147,0.033532,-0.0010002,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.4963,0.033433,0.014388,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.66904,0.033422,0.058071,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.85194,0.033364,-0.00026476,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.63434,0.033189,0.028615,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.87087,0.033175,0.0025865,0,0
3,GO MAST CELL MIGRATION,0.70447,0.03315,0.026722,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.90893,0.033037,0.0027586,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.97598,0.032854,-0.0046221,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.89939,0.032797,0.014885,0,0
3,GO CELLULAR RESPONSE TO UV,0.36329,0.032764,0.047967,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.13384,0.032559,0.068963,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.82372,0.032557,0.0094611,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.91848,0.032357,-0.024408,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.59207,0.032237,0.0056916,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.55115,0.032152,0.022659,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.87087,0.032092,0.0010566,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.51944,0.032042,0.023412,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.40947,0.031976,0.046718,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.84251,0.031778,-0.01206,0,0
3,GO DETOXIFICATION,0.74054,0.031614,-0.039166,0,0
3,GO ORGANIC CATION TRANSPORT,0.40267,0.031537,0.056325,0,0
3,GO DENDRITE EXTENSION,0.37614,0.031485,0.15807,0,0
3,GO NADP METABOLIC PROCESS,0.7588,0.03131,-0.0050058,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.63434,0.03126,0.010936,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.8331,0.031161,-0.051095,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.55115,0.030811,0.059248,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.73147,0.030805,-0.0034069,0,0
3,GO HYPEROSMOTIC RESPONSE,0.88987,0.030663,0.0049358,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.24525,0.030535,0.059721,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.27056,0.030525,0.030273,0,0
3,GO NUCLEAR TRANSPORT,0.32052,0.030453,0.031358,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.23088,0.030365,0.054274,0,0
3,GO LYSOSOME LOCALIZATION,0.68667,0.030349,0.019173,0,0
3,GO REGULATION OF FERTILIZATION,0.60883,0.030341,0.022213,0,0
3,GO REGULATION OF GLIOGENESIS,0.8614,0.030011,0.0051385,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.27583,0.029925,0.045869,0,0
3,GO DIET INDUCED THERMOGENESIS,0.57554,0.029453,0.07788,0,0
3,GO CELLULAR ANION HOMEOSTASIS,0.39593,0.029416,0.10429,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.45171,0.029398,0.081237,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.40947,0.029328,0.061152,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.60883,0.029215,0.020358,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.88987,0.029159,-0.025676,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.78645,0.029087,-0.0332,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.7772,0.029032,0.010158,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.7772,0.029008,0.025471,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.1643,0.028809,0.069377,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.69555,0.028512,0.0067364,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.80503,0.028448,-0.0057837,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.32642,0.028231,0.049662,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.88036,0.028176,-0.033165,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.48871,0.02816,0.046616,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.95679,0.028144,-0.0055451,0,0
3,GO DNA PACKAGING,0.32052,0.028112,0.040466,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.4445,0.028087,0.040379,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.81436,0.028063,-0.0011835,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.95679,0.02799,-0.0021442,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.80503,0.027868,-0.056133,0,0
3,GO RNA INTERFERENCE,0.60042,0.027476,0.024471,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.52728,0.027439,0.055015,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.56735,0.027315,0.020124,0,0
3,GO HISTONE H3 K4 METHYLATION,0.81436,0.027216,-0.015962,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.95679,0.027205,-0.0095389,0,0
3,GO RHYTHMIC BEHAVIOR,0.9952,0.027198,-0.015447,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.52728,0.027055,0.05306,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.59207,0.027027,0.027987,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.92804,0.026977,-0.0039292,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.63434,0.026953,0.016416,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.33843,0.026855,0.066595,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.36968,0.026707,0.039317,0,0
3,GO HISTONE EXCHANGE,0.70447,0.026465,0.016445,0,0
3,GO PHOSPHOLIPID EFFLUX,0.68667,0.02639,0.028617,0,0
3,GO MRNA CLEAVAGE,0.78645,0.026367,0.018564,0,0
3,GO DNA REPAIR,0.18733,0.02636,0.0401,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.78645,0.026357,-0.028803,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.88036,0.026325,0.0034884,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.48871,0.026315,0.15529,0,0
3,GO MIDBRAIN DEVELOPMENT,0.98559,0.026276,-0.025169,0,0
3,GO POSITIVE REGULATION OF BINDING,0.66904,0.026257,0.018344,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.35697,0.026197,0.047083,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.96638,0.026042,-0.039463,0,0
3,GO CHROMATIN SILENCING,0.81436,0.026018,0.013998,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.88987,0.025837,-0.019827,0,0
3,GO NEUROGENESIS,0.41634,0.025809,0.045494,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.43029,0.025797,0.038009,0,0
3,GO TRNA 5 LEADER REMOVAL,0.89939,0.025561,-0.012906,0,0
3,GO DNA METABOLIC PROCESS,0.27583,0.02541,0.028903,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.84251,0.025299,-0.013731,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.56735,0.025276,0.061623,0,0
3,GO AXONAL TRANSPORT,0.34454,0.025209,0.080183,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.59207,0.025151,0.094229,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.58378,0.025109,-0.067601,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.84251,0.025055,-0.057282,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.79572,0.024998,0.029325,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.62578,0.024942,0.025667,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.76799,0.024847,-0.028381,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.88036,0.024598,-0.013577,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.58378,0.024481,0.11115,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.61728,0.024393,-0.07654,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.46631,0.024368,0.058863,0,0
3,GO REGULATION OF OOGENESIS,0.85194,0.02433,-0.031245,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,1,0.024273,-0.013507,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.56735,0.024272,0.014044,0,0
3,GO INORGANIC ANION TRANSPORT,0.6603,0.024155,0.014164,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.19139,0.024033,0.062548,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.8614,0.023677,-0.0025564,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.76799,0.023597,-0.0080559,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.69555,0.02359,0.042115,0,0
3,GO DNA METHYLATION,0.93762,0.023535,0.006346,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.69555,0.023477,0.019447,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.55115,0.023423,0.05697,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.56735,0.023391,-0.063962,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.40947,0.023251,0.062223,0,0
3,GO NCRNA CATABOLIC PROCESS,0.88987,0.023243,0.012561,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.74054,0.023167,0.025872,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.79572,0.023052,0.015505,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.58378,0.023052,-0.11141,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.85194,0.022902,-0.018893,0,0
3,GO CHROMATIN REMODELING,0.4445,0.022867,0.027537,0,0
3,GO SOMITOGENESIS,0.60042,0.02286,0.032872,0,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.45171,0.022847,-0.11457,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.9472,0.022843,-0.0085994,0,0
3,GO WATER TRANSPORT,0.98559,0.022676,-0.024054,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.6516,0.022673,0.063347,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.78645,0.022637,-0.00046365,0,0
3,GO LYMPHANGIOGENESIS,0.40947,0.022556,0.061379,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.78645,0.022452,-0.040335,0,0
3,GO SNRNA METABOLIC PROCESS,0.36968,0.022447,0.0090173,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.7588,0.022443,0.063933,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.98559,0.022376,0.0012091,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.74966,0.022358,0.041713,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.33239,0.022301,0.040676,0,0
3,GO FOREBRAIN DEVELOPMENT,0.42328,0.022236,0.047844,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.4963,0.02205,0.043214,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.61728,0.021988,0.033128,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.57554,0.021963,0.044019,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.39593,0.021945,0.043095,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.7588,0.021814,0.012577,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.6516,0.021748,-0.099296,0,0
3,GO DRUG METABOLIC PROCESS,0.67783,0.021738,0.013152,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.59207,0.021316,0.018404,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.61728,0.021141,0.03873,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.55922,0.021134,0.019841,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.7588,0.02094,-0.040242,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.68667,0.020932,0.04127,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.70447,0.020862,-0.046104,0,0
3,GO CHROMOSOME CONDENSATION,0.88036,0.020808,0.0079982,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.82372,0.020801,0.024379,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.72243,0.020751,0.013786,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.89939,0.020664,0.014737,0,0
3,GO MONOAMINE TRANSPORT,1,0.020526,0.07116,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.51944,0.020416,0.040345,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.36968,0.020389,0.037615,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.70447,0.020221,0.015867,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.79572,0.020113,0.008504,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.96638,0.020112,-0.043143,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.71343,0.020064,0.0111,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.51167,0.020038,0.043443,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.72243,0.019865,0.035432,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.53518,0.019838,0.035856,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.7588,0.019723,-0.025987,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.71343,0.019687,0.0052467,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.4963,0.019646,0.058682,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.88036,0.019584,-0.029615,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.4963,0.019472,0.026764,0,0
3,GO INTERACTION WITH SYMBIONT,0.71343,0.019409,-0.010021,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.95679,0.019393,-0.0061685,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.92804,0.019152,-0.0043185,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.79572,0.019064,-0.0033956,0,0
3,GO REGULATION OF MYELINATION,0.71343,0.019049,0.038177,0,0
3,GO DNA MODIFICATION,0.9472,0.018973,-0.010138,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.53518,0.018874,0.12608,0,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.9952,0.018867,-0.066661,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.92804,0.018855,-0.0044353,0,0
3,GO SULFATION,0.82372,0.018796,-0.048772,0,0
3,GO RENAL WATER HOMEOSTASIS,0.9472,0.018673,-0.0039358,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.70447,0.018623,0.030763,0,0
3,GO PROTEIN DEMETHYLATION,0.42328,0.018539,0.063708,0,0
3,GO ASTROCYTE DEVELOPMENT,0.7772,0.018503,-0.051163,0,0
3,GO LEUKOCYTE AGGREGATION,0.4445,0.018458,0.067487,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.91848,0.018415,1.0864e-07,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.92804,0.018283,-0.014821,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.81436,0.018229,-0.0054355,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.39593,0.018224,0.021138,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.93762,0.01822,-0.010015,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.50395,0.018168,0.050564,0,0
3,GO CELLULAR RESPONSE TO ATP,0.42328,0.018144,0.059093,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.33239,0.018048,0.03774,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.88987,0.017898,-0.015716,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.63434,0.017886,0.033626,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.85194,0.01786,0.17629,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.74054,0.017842,-0.046703,0,0
3,GO MITOCHONDRION ORGANIZATION,0.50395,0.017813,0.019755,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.85194,0.017781,0.009605,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.95679,0.017768,-0.014021,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.60042,0.017561,0.059464,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.67783,0.017559,0.039754,0,0
3,GO DNA STRAND ELONGATION,0.37614,0.017512,0.089128,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.85194,0.017441,-0.040154,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.74054,0.017351,0.0034665,0,0
3,GO SEGMENTATION,0.71343,0.017206,0.01626,0,0
3,GO HISTONE DEUBIQUITINATION,0.54313,0.017001,0.031907,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.69555,0.016977,0.020643,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.60883,0.016976,0.060638,0,0
3,GO PROTEIN ACYLATION,0.24039,0.016969,0.031488,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.72243,0.016963,0.018286,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.28658,0.016899,0.0759,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.93762,0.016749,-0.018306,0,0
3,GO HEPARIN METABOLIC PROCESS,0.45898,0.01674,0.083141,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.90893,0.016718,-0.038812,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.89939,0.016706,0.012441,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.88036,0.016623,-0.087391,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.81436,0.016238,0.0058032,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.68667,0.016078,0.01722,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.74054,0.016033,0.0095203,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71343,0.016011,0.047802,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.71343,0.015984,0.022109,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.48118,0.015869,0.0468,0,0
3,GO RENAL SODIUM EXCRETION,0.41634,0.015721,0.05034,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.46631,0.015712,0.032714,0,0
3,GO NODAL SIGNALING PATHWAY,0.92804,0.015654,-0.018013,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.90893,0.01559,-0.017077,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.91848,0.015541,-0.041943,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.37614,0.015513,0.050207,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.73147,0.0155,-0.035965,0,0
3,GO ENSHEATHMENT OF NEURONS,0.6603,0.015249,0.021821,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.43736,0.01523,0.032028,0,0
3,GO REGULATION OF TUBE SIZE,0.67783,0.015191,-0.04699,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.7772,0.015082,0.013738,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.43029,0.015035,0.040815,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.90893,0.014982,-0.011846,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.43736,0.014967,0.12393,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.46631,0.014958,0.078731,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.9952,0.014846,-0.008098,0,0
3,GO SODIUM ION HOMEOSTASIS,0.82372,0.014829,0.0074896,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.7772,0.014794,-0.035973,0,0
3,GO COMPLEMENT ACTIVATION,0.73147,0.014705,-0.074409,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.85194,0.014628,-0.042378,0,0
3,GO NUCLEOSIDE SALVAGE,0.26536,0.014533,0.081108,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.89939,0.014439,-0.015352,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.8331,0.014435,-0.054816,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.50395,0.014364,0.037582,0,0
3,GO REGULATION OF GENE SILENCING,0.96638,0.014259,-0.012874,0,0
3,GO CELL REDOX HOMEOSTASIS,0.63434,0.014237,0.02076,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.52728,0.014054,-0.056156,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.96638,0.014054,0.0011068,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.76799,0.014016,0.0007868,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.87087,0.013995,-0.026689,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.70447,0.013916,-0.055884,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.72243,0.013798,0.0028988,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.76799,0.013752,-0.094289,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.88987,0.013743,-0.054026,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.95679,0.013741,-0.0013765,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.90893,0.013701,0.015038,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.90893,0.013673,-0.051689,0,0
3,GO STEROID HORMONE SECRETION,0.74966,0.013582,-0.030146,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.33843,0.013561,-0.14321,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.87087,0.013514,-0.021539,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.56735,0.013491,0.056757,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.88036,0.013487,-0.013446,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.67783,0.013438,0.0079964,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.85194,0.013295,0.022299,0,0
3,GO CELL MORPHOGENESIS,0.71343,0.013133,0.019967,0,0
3,GO FIBRINOLYSIS,1,0.013023,-0.093698,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.88036,0.012963,-8.0766e-05,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.8331,0.012865,-0.025524,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.81436,0.012689,-0.020712,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.88987,0.012563,-0.0079732,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.82372,0.012477,-0.0051614,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.88987,0.012377,0.077462,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.66904,0.012341,0.01721,0,0
3,GO DEVELOPMENTAL GROWTH,0.45898,0.012239,0.029486,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.31468,0.01208,0.025404,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.85194,0.012018,0.01405,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.92804,0.011797,0.00016109,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.73147,0.011715,0.016991,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.9472,0.011693,0.010068,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.89939,0.011678,0.015931,0,0
3,GO MANNOSYLATION,0.79572,0.01166,-0.0098868,0,0
3,GO REGULATION OF BINDING,0.7588,0.011599,-0.015161,0,0
3,GO ATP TRANSPORT,0.56735,0.011471,0.056143,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.80503,0.011466,0.01267,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.90893,0.011342,-0.010548,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.8331,0.011311,0.011172,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.87087,0.01125,-0.019366,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.51944,0.011208,0.013783,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.89939,0.011197,-0.01331,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.4445,0.010932,-0.033886,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.92804,0.010758,-0.013641,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.78645,0.010714,0.0011834,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.84251,0.010495,0.010654,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.90893,0.010456,-0.016219,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.8614,0.010346,-0.036187,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.82372,0.010177,0.015598,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.80503,0.0099745,0.035152,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.63434,0.0098726,0.034326,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.95679,0.0098012,-0.016654,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.64294,0.00979,-0.021649,0,0
3,GO LACTATION,0.29761,0.0097833,0.11228,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.71343,0.0097683,-0.044966,0,0
3,GO CELL CYCLE ARREST,0.9952,0.0095918,0.00017029,0,0
3,GO VAGINA DEVELOPMENT,0.80503,0.0095358,-0.059581,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.85194,0.0095202,0.0036027,0,0
3,GO REGULATION OF ORGAN GROWTH,0.82372,0.0094019,0.0043808,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.89939,0.0093583,0.0037539,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.91848,0.0093476,-0.020865,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.88036,0.0091934,-0.017709,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.70447,0.0091872,0.061277,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.51944,0.0091101,-0.12039,0,0
3,GO PROTEIN ACETYLATION,0.60883,0.009087,0.010135,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.55922,0.0090306,0.045572,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.55115,0.008908,0.027548,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.85194,0.0086724,0.0019577,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.85194,0.0086352,0.03321,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.98559,0.0085806,0.0070293,0,0
3,GO HYPOTONIC RESPONSE,0.55922,0.0084752,0.056592,0,0
3,GO TORC1 SIGNALING,0.87087,0.0083629,-0.014306,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.89939,0.0083539,-0.058067,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.57554,0.0083131,-0.041868,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.36968,0.0082356,0.047634,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.81436,0.0082337,-0.027999,0,0
3,GO RESPONSE TO ACTIVITY,0.72243,0.0081774,-0.02752,0,0
3,GO CHROMOSOME ORGANIZATION,0.85194,0.0081241,0.0090173,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.73147,0.0081164,0.017946,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.68667,0.0079215,-0.019747,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.92804,0.0078709,-0.0094262,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.40947,0.0078482,0.029849,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.98559,0.0077626,0.0055878,0,0
3,GO CHROMATIN ORGANIZATION,0.89939,0.0076606,-0.00057803,0,0
3,GO RESPONSE TO PH,0.9472,0.007641,-0.014583,0,0
3,GO ANIMAL ORGAN REGENERATION,0.82372,0.0075719,-0.048969,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.8614,0.0075612,-0.000713,0,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.78645,0.007443,-0.1121,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82372,0.0074377,0.0084997,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.93762,0.0073875,-0.0060553,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.62578,0.007308,0.0091336,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.51944,0.007136,0.024699,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.73147,0.0070853,0.017376,0,0
3,GO REGULATION OF GROWTH,0.88036,0.0069389,-0.011646,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.60042,0.0068418,-0.046132,0,0
3,GO ENDOCYTOSIS,0.92804,0.0065263,-0.0076394,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.70447,0.0065098,0.0067221,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.8614,0.0062978,0.0071645,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.45898,0.0062535,-0.078794,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.85194,0.0062241,0.016276,0,0
3,GO CD40 SIGNALING PATHWAY,0.8614,0.0061849,-0.056135,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.8331,0.0061437,-0.00163,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.92804,0.0061248,-0.0057818,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.48118,0.0060685,0.08237,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.40267,0.0060577,0.045344,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.88036,0.0060164,-0.043377,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.6516,0.0059216,0.0022544,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.67783,0.0058414,-0.079305,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.87087,0.0057643,0.035364,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.95679,0.005704,-0.0092224,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.60883,0.0055685,-0.041344,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.79572,0.0055329,-0.0095829,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.88036,0.0055042,-0.012592,0,0
3,GO GROWTH,0.90893,0.0054979,0.00033653,0,0
3,GO RESPONSE TO ESTROGEN,0.92804,0.0053598,-0.015551,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.91848,0.0053581,0.005952,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.7588,0.0053223,0.018644,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.6603,0.0051905,0.0603,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.85194,0.0051676,0.0098287,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35072,0.0051045,-0.13368,0,0
3,GO VESICLE DOCKING,0.7588,0.0044676,0.021921,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.78645,0.0044672,0.090581,0,0
3,GO CHEMICAL HOMEOSTASIS,0.92804,0.0044574,-0.0049145,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.79572,0.0044452,-0.031341,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.74054,0.0044171,0.023181,0,0
3,GO VITAMIN METABOLIC PROCESS,0.40947,0.0043568,0.06819,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.61728,0.0043337,-0.049932,0,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.67783,0.0041387,-0.032594,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.80503,0.0040841,-0.013437,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1,0.0038896,-0.0091291,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.97598,0.0037598,-0.010331,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.74054,0.003633,0.00090728,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.90893,0.0035807,-0.035206,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.98559,0.0035398,0.0023109,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.97598,0.0034822,0.0008195,0,0
3,GO MEMBRANE FUSION,0.72243,0.003444,-0.029749,0,0
3,GO BLASTOCYST DEVELOPMENT,0.9472,0.0033764,0.0045624,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.98559,0.003339,-0.0029182,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.61728,0.0033183,0.040826,0,0
3,GO NIK NF KAPPAB SIGNALING,0.71343,0.0032748,-0.058474,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.92804,0.0032388,-0.037883,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.80503,0.003226,-0.025052,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.64294,0.0031076,-0.029287,0,0
3,GO ODONTOGENESIS,0.88987,0.003081,-0.02477,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.9952,0.0030231,0.015926,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.8614,0.0029387,0.0062895,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.93762,0.0029104,-0.0027419,0,0
3,GO HINDBRAIN DEVELOPMENT,0.7772,0.0029095,0.027292,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.52728,0.0027824,-0.058555,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.66904,0.0027076,-0.037633,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.50395,0.0026022,-0.061959,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.81436,0.002548,0.011119,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.60042,0.0025009,-0.062284,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.56735,0.002356,0.061823,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.93762,0.0021971,-0.0049861,0,0
3,GO PROTEIN STABILIZATION,0.9472,0.0020254,-0.00094669,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.92804,0.0019705,-0.030206,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.82372,0.0019426,0.00044321,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.66904,0.0019395,-0.041326,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.7772,0.0018658,-0.013976,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.88987,0.0018531,-0.012921,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.9472,0.0017781,0.0031906,0,0
3,GO ACROSOME REACTION,0.74054,0.0017747,0.022161,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.89939,0.0017719,0.0062425,0,0
3,GO RESPONSE TO UV,0.6603,0.0016796,0.020223,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.9952,0.0016792,-0.0014474,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.88036,0.0016772,-0.037696,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.95679,0.0015985,-0.0080642,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.88987,0.0015516,-0.067157,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.9472,0.0015013,-0.0083144,0,0
3,GO CELL CELL SIGNALING BY WNT,0.90893,0.0013252,-0.002404,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.62578,0.0012126,-0.025892,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.9472,0.0011699,-0.0018591,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.8614,0.001009,-0.019211,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.60883,0.00090121,-0.09514,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.67783,0.00082385,-0.06402,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.85194,0.00081474,-0.048216,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.80503,0.00076801,-0.0011263,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.92804,0.00058772,-0.0013872,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.9472,0.00056174,-0.024689,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.71343,0.00048888,0.0095437,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.6516,0.00043637,-0.02839,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.88987,0.00042688,-0.0063631,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.85194,0.00031554,-0.0012996,0,0
3,GO RESPONSE TO FUNGUS,0.63434,0.00030307,0.036823,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.88987,0.00027894,0.0022744,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.93762,0.00021422,-0.016052,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.88036,0.00020692,0.02719,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.87087,0.00013118,0.0042565,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.63434,7.4538e-05,-0.020916,0,0
3,GO HEART MORPHOGENESIS,0.88036,3.2388e-05,-0.033936,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.90893,2.1395e-05,0.005496,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.76799,-5.7752e-05,-0.084962,0,0
3,GO MAINTENANCE OF LOCATION,0.93762,-6.148e-05,0.0041326,0,0
3,GO DNA REPLICATION,0.7588,-0.00014459,0.01102,0,0
3,GO PROTEIN AUTOPROCESSING,0.96638,-0.00016379,-0.025697,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.87087,-0.00021438,-0.004097,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.92804,-0.00022713,0.0012321,0,0
3,GO PIRNA METABOLIC PROCESS,0.39593,-0.0002303,-0.13693,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.74054,-0.0002409,-0.0091159,0,0
3,GO ORGAN GROWTH,0.85194,-0.00033556,-0.017624,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.71343,-0.00041911,0.020994,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.53518,-0.00044849,-0.046225,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.66904,-0.00049962,-0.029897,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.96638,-0.00055466,-0.0042589,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.74054,-0.00060735,-0.026466,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.7772,-0.00069125,-0.11863,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.51944,-0.0007256,0.094079,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.90893,-0.00084003,-0.023735,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.87087,-0.00085644,0.014835,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.76799,-0.00090543,-0.015925,0,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.58378,-0.0009331,-0.054131,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.98559,-0.0010061,-0.0016565,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.55115,-0.0011103,0.021599,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.82372,-0.0013027,0.0086682,0,0
3,GO MICROTUBULE NUCLEATION,0.80503,-0.0013533,0.030399,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.8331,-0.001415,-0.030111,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.81436,-0.0014274,0.012922,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.9952,-0.0014734,-0.005164,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.64294,-0.0014845,-0.034022,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.96638,-0.0015098,-0.0049546,0,0
3,GO MYELIN ASSEMBLY,0.6516,-0.0017178,0.042298,0,0
3,GO RECEPTOR METABOLIC PROCESS,1,-0.0018568,0.0020747,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.80503,-0.0018844,-0.027983,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.74966,-0.0018994,-0.051282,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.40947,-0.0019049,-0.068781,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.70447,-0.001926,0.036477,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.50395,-0.0019744,-0.077048,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.96638,-0.0020666,-0.00083923,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.87087,-0.0020953,-0.068357,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.92804,-0.0023056,-0.0047924,0,0
3,GO INTRACELLULAR TRANSPORT,0.9952,-0.0023142,-0.00090288,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.8331,-0.0023924,0.05401,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.73147,-0.0026231,-0.025143,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.90893,-0.0026649,-0.0044097,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.68667,-0.002906,-0.0032816,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.62578,-0.0030686,-0.059308,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.6516,-0.0032292,0.020292,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.60883,-0.0032816,0.012693,0,0
3,GO RESPONSE TO METAL ION,0.93762,-0.0033387,-0.0067606,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.69555,-0.0034172,0.03198,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.88987,-0.0034363,-0.01026,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.69555,-0.0035164,-0.015842,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.87087,-0.003649,-0.03685,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.82372,-0.0036787,-0.022693,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.92804,-0.0037034,-0.018188,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.69555,-0.0037221,-0.060642,0,0
3,GO INTEGRIN ACTIVATION,0.63434,-0.0037557,-0.060378,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.9952,-0.0038033,-0.013686,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.82372,-0.0038524,-0.010154,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.71343,-0.0040079,-0.05201,0,0
3,GO FATTY ACID TRANSPORT,0.95679,-0.0040282,-0.0055085,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.7588,-0.0041167,-0.044249,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.89939,-0.0041488,-0.01498,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.76799,-0.0042399,0.062244,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.57554,-0.0043698,-0.033498,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.92804,-0.0046546,-0.0059873,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.89939,-0.0047831,-0.011373,0,0
3,GO SPINAL CORD DEVELOPMENT,0.9952,-0.0049518,0.0024082,0,0
3,GO REGULATION OF HEART GROWTH,0.85194,-0.0050349,0.0016675,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.85194,-0.0051497,-0.017623,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.98559,-0.0051757,-0.016302,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.80503,-0.0052126,-0.068343,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.32642,-0.0052584,-0.046332,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.76799,-0.0053239,-0.043611,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.88036,-0.0053496,-0.030009,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.81436,-0.0054989,0.011716,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.39593,-0.0056814,-0.045865,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.91848,-0.0056968,-0.0020271,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.69555,-0.0056993,-0.021446,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.84251,-0.005766,-0.0024087,0,0
3,GO EXOCYTIC PROCESS,0.95679,-0.0059077,0.039116,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.68667,-0.0059794,-0.033331,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.47371,-0.0060414,-0.046746,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.84251,-0.0061494,-0.062601,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.45898,-0.006358,-0.098422,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.90893,-0.0064252,-0.01261,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.7588,-0.0064839,0.018671,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.76799,-0.0064848,-0.026952,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.53518,-0.0065986,-0.064157,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.84251,-0.0067006,-0.032666,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.97598,-0.0069512,-0.0088415,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.8614,-0.0070207,0.051374,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.88987,-0.0070533,0.0042189,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.70447,-0.0071673,-0.054497,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.88036,-0.007211,-0.016463,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.56735,-0.0073873,-0.07097,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.71343,-0.0075343,-0.01537,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.7588,-0.0076999,0.021803,0,0
3,GO HEAD MORPHOGENESIS,0.37614,-0.0078274,-0.13082,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.60042,-0.0080234,-0.035919,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.92804,-0.0080842,-0.0036226,0,0
3,GO RESPONSE TO FATTY ACID,0.93762,-0.0081579,-0.024936,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.59207,-0.0081736,-0.061862,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.74966,-0.0082289,-0.025463,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.60042,-0.0082482,0.089583,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.95679,-0.0083158,-0.021603,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.81436,-0.0083852,-0.0085906,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.50395,-0.0084447,0.059921,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.6603,-0.0084642,-0.027156,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.60883,-0.0086369,-0.055176,0,0
3,GO HIPPO SIGNALING,1,-0.0087675,-0.054114,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.72243,-0.0088048,0.021847,0,0
3,GO ERK1 AND ERK2 CASCADE,0.56735,-0.0089105,-0.052161,0,0
3,GO RESPONSE TO RETINOIC ACID,0.6516,-0.0091794,-0.072081,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.54313,-0.009239,0.023422,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.88036,-0.0092514,-0.054744,0,0
3,GO POLYOL CATABOLIC PROCESS,0.98559,-0.0093672,-0.00013574,0,0
3,GO HEART GROWTH,0.87087,-0.0094319,-0.0097515,0,0
3,GO HOMEOSTATIC PROCESS,0.56735,-0.0095007,-0.024136,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.43736,-0.0097277,0.0571,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.31468,-0.010011,-0.044983,0,0
3,GO ARTERY DEVELOPMENT,0.9472,-0.010045,-0.03444,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.58378,-0.010146,-0.044304,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.53518,-0.010235,0.15063,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.88987,-0.010257,-0.01845,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.74966,-0.01028,-0.049689,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.78645,-0.010309,-0.036908,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.67783,-0.010416,-0.05531,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.96638,-0.010477,-0.011088,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.90893,-0.010508,-0.011881,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.95679,-0.010544,-0.015738,0,0
3,GO NOREPINEPHRINE SECRETION,0.52728,-0.01066,0.057834,0,0
3,GO HINDLIMB MORPHOGENESIS,0.64294,-0.010736,-0.065079,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.51944,-0.010749,-0.072787,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.82372,-0.010963,-0.058786,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.97598,-0.011136,-0.0086736,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.8614,-0.011149,-0.0059382,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.4445,-0.011172,-0.028001,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.70447,-0.011183,-0.039033,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.70447,-0.011265,-0.043157,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.8331,-0.011452,-0.028578,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.6516,-0.01149,0.022942,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.96638,-0.011545,0.018349,0,0
3,GO RESPONSE TO AXON INJURY,0.82372,-0.011778,-0.027427,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.66904,-0.011797,-0.047241,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.59207,-0.011904,0.028622,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.73147,-0.012111,-0.047055,0,0
3,GO BONE MATURATION,0.8331,-0.012243,-0.030767,0,0
3,GO DOSAGE COMPENSATION,0.6603,-0.012247,-0.025252,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.8614,-0.012251,-0.022518,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.9952,-0.012281,-0.0069909,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.90893,-0.012362,-0.039287,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.9952,-0.012451,-0.021431,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.48871,-0.012499,-0.042622,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.52728,-0.012501,0.031685,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.6603,-0.012717,-0.080816,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.93762,-0.012797,0.012407,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.54313,-0.013024,-0.029098,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.59207,-0.013041,-0.016384,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.88036,-0.013174,-0.02193,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.72243,-0.01325,-0.008557,0,0
3,GO AXIS SPECIFICATION,0.73147,-0.013276,0.044207,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.92804,-0.013277,-0.010718,0,0
3,GO STEM CELL DIFFERENTIATION,0.38267,-0.013323,-0.044146,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.91848,-0.013371,-0.016225,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.78645,-0.013418,-0.015463,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.93762,-0.013427,-0.021481,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.87087,-0.01343,0.0092412,0,0
3,GO CELL PROJECTION ORGANIZATION,0.87087,-0.013441,0.00086458,0,0
3,GO RENAL SYSTEM PROCESS,0.36329,-0.013461,-0.064922,0,0
3,GO OOGENESIS,0.45171,-0.013505,-0.055159,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.80503,-0.013527,-0.015983,0,0
3,GO MICROTUBULE ANCHORING,0.80503,-0.013549,-0.020838,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.55922,-0.013557,0.034584,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.63434,-0.013705,-0.087971,0,0
3,GO BODY FLUID SECRETION,0.91848,-0.013747,-0.0084214,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.43736,-0.013819,-0.040838,0,0
3,GO VESICLE CARGO LOADING,0.28117,-0.013856,-0.13452,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.60883,-0.013869,-0.046306,0,0
3,GO GMP METABOLIC PROCESS,0.87087,-0.01408,-0.0081757,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58378,-0.01413,-0.075524,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.74966,-0.014168,0.03758,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.79572,-0.014253,0.045935,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.9952,-0.014318,-0.042704,0,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.53518,-0.014327,-0.040819,0,0
3,GO MITOPHAGY,0.53518,-0.014368,-0.05834,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.60883,-0.014471,-0.037692,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.66904,-0.014475,0.021785,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.78645,-0.014627,-0.0035206,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.55115,-0.014719,0.026992,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.91848,-0.014721,-0.023063,0,0
3,GO HEAD DEVELOPMENT,0.8331,-0.014849,0.014258,0,0
3,GO OXIDATION REDUCTION PROCESS,0.8614,-0.014897,0.0082814,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.31468,-0.015176,-0.29434,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.71343,-0.015185,-0.045445,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.89939,-0.015459,-0.017213,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.62578,-0.015491,-0.020186,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.66904,-0.015562,-0.013281,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.95679,-0.015791,0.01825,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.62578,-0.015947,0.021225,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.51944,-0.016086,-0.056281,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.43736,-0.016107,-0.037465,0,0
3,GO GLIOGENESIS,0.81436,-0.016142,-0.02326,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.88987,-0.016142,0.0030763,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.98559,-0.016201,0.016238,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.97598,-0.01627,-0.0088973,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.79572,-0.016326,-0.01793,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.61728,-0.016467,-0.028844,0,0
3,GO CHROMOSOME SEPARATION,0.9472,-0.016631,0.0034921,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.57554,-0.016681,0.073008,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.66904,-0.016704,-0.039915,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.89939,-0.016713,-0.048031,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.36968,-0.016728,-0.05912,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.7772,-0.016803,0.03751,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.95679,-0.016814,-0.0057081,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.87087,-0.016916,-0.018954,0,0
3,GO RESPONSE TO VITAMIN D,0.80503,-0.017029,0.10751,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.6603,-0.017076,-0.02828,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.59207,-0.017121,-0.016451,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.58378,-0.017136,-0.025197,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.6516,-0.017189,-0.036255,0,0
3,GO PROTEIN POLYMERIZATION,0.92804,-0.017221,-0.0076684,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.40267,-0.017338,-0.091711,0,0
3,GO AUTOPHAGIC CELL DEATH,0.70447,-0.017344,-0.045514,0,0
3,GO REGULATION OF TRANSPORT,0.51944,-0.017377,-0.024961,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.56735,-0.017379,-0.035236,0,0
3,GO STEROL TRANSPORT,0.40267,-0.01743,-0.076359,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.42328,-0.017485,-0.027563,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.55115,-0.017534,-0.033464,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.58378,-0.017537,-0.067207,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.6516,-0.017578,-0.021391,0,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.60883,-0.017655,-0.077256,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.92804,-0.017671,-0.011256,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.97598,-0.017681,-0.034266,0,0
3,GO PHOTOPERIODISM,0.85194,-0.01784,0.014531,0,0
3,GO CHOLESTEROL STORAGE,0.82372,-0.018,-0.022645,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9472,-0.018133,-0.026131,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.55922,-0.018237,-0.059752,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.90893,-0.018284,-0.012964,0,0
3,GO RESPONSE TO SALT STRESS,0.55922,-0.018293,-0.063642,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.68667,-0.018359,0.039357,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.74054,-0.018488,-0.0093845,0,0
3,GO MAST CELL MEDIATED IMMUNITY,0.4445,-0.018679,-0.082522,0,0
3,GO PEROXISOME ORGANIZATION,0.72243,-0.018787,-0.021655,0,0
3,GO REGULATION OF URINE VOLUME,0.68667,-0.018867,-0.032178,0,0
3,GO LOCOMOTOR RHYTHM,0.79572,-0.018869,0.029774,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.88987,-0.018922,-0.0077525,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.4963,-0.018989,-0.055398,0,0
3,GO PROTEIN IMPORT,0.71343,-0.019131,-0.020653,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.18733,-0.019163,-0.053402,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.70447,-0.019342,-0.016568,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.36329,-0.01937,-0.028554,0,0
3,GO MEMBRANE ORGANIZATION,0.46631,-0.019382,-0.03203,0,0
3,GO ORGANELLE INHERITANCE,0.36329,-0.019439,-0.056687,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.7588,-0.019517,-0.029796,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.79572,-0.019559,-0.052735,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.56735,-0.019589,-0.041608,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.50395,-0.019661,-0.066085,0,0
3,GO RESPONSE TO STEROL,0.53518,-0.019669,-0.05112,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.96638,-0.019758,0.0083121,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.40267,-0.019789,-0.015899,0,0
3,GO REGULATION OF DNA REPAIR,0.8614,-0.019793,-0.011805,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.43029,-0.019845,-0.042981,0,0
3,GO NEURON CELL CELL ADHESION,0.97598,-0.019854,0.025313,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.64294,-0.019885,-0.01947,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.59207,-0.019969,-0.027777,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.98559,-0.020005,0.0012099,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.91848,-0.020039,0.0091939,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.68667,-0.020235,-0.098044,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.53518,-0.020305,-0.026618,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.62578,-0.02033,-0.039404,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.89939,-0.020583,-0.013097,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.59207,-0.020691,-0.043265,0,0
3,GO RESPONSE TO ETHANOL,0.52728,-0.020748,-0.033395,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.93762,-0.020811,-0.026852,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.78645,-0.021053,-0.032582,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.9952,-0.021131,-0.003074,0,0
3,GO FILOPODIUM ASSEMBLY,0.93762,-0.02115,-0.013213,0,0
3,GO SISTER CHROMATID COHESION,0.90893,-0.0212,0.01701,0,0
3,GO ORGANIC ACID TRANSPORT,0.74966,-0.021283,0.027986,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.96638,-0.021317,0.044883,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.87087,-0.021446,0.00042411,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.4963,-0.021715,-0.022762,0,0
3,GO MEMBRANE INVAGINATION,0.35697,-0.021751,-0.076792,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.38927,-0.021787,-0.073679,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.51944,-0.021794,-0.077386,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.63434,-0.021862,-0.021735,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.69555,-0.021931,-0.062605,0,0
3,GO FERTILIZATION,0.39593,-0.021983,-0.031102,0,0
3,GO REGULATION OF VASCULOGENESIS,0.59207,-0.021997,-0.063538,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.61728,-0.022108,-0.028292,0,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.30323,-0.022269,-0.044738,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.41634,-0.022288,-0.10857,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.67783,-0.022332,-0.091813,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.73147,-0.022368,-0.022473,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.81436,-0.022417,-0.018458,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.76799,-0.022595,-0.08144,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.17173,-0.022613,-0.08271,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.55922,-0.022615,-0.046908,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.30892,-0.02268,-0.099084,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.96638,-0.022751,0.027127,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.42328,-0.022816,-0.039827,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.6603,-0.02287,-0.031581,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.91848,-0.022918,0.0026822,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.4963,-0.022921,-0.048455,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.85194,-0.023078,-0.039086,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.52728,-0.023205,-0.03569,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.48871,-0.023292,-0.062885,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.62578,-0.023301,-0.03055,0,0
3,GO VESICLE ORGANIZATION,0.21267,-0.023316,-0.065221,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.8331,-0.023346,-0.014151,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.42328,-0.023425,-0.10317,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.7588,-0.02365,0.031491,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.7772,-0.023683,-0.065981,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.50395,-0.023767,-0.04176,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.66904,-0.023905,-0.10378,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.87087,-0.023933,0.0088634,0,0
3,GO OXALATE TRANSPORT,0.69555,-0.023979,-0.033051,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.25516,-0.024087,-0.05576,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.60042,-0.024356,-0.020457,0,0
3,GO OVULATION CYCLE,0.67783,-0.024394,-0.031397,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.62578,-0.024416,-0.040592,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.63434,-0.024421,-0.053377,0,0
3,GO CELL CYCLE PROCESS,0.81436,-0.02462,-0.010091,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.41634,-0.024792,-0.046506,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.87087,-0.024966,-0.019679,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.2356,-0.024986,-0.058398,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.63434,-0.024992,-0.097956,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.9952,-0.02503,-0.013227,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.52728,-0.025049,-0.040315,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.2356,-0.025142,-0.041376,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.51167,-0.025198,-0.069948,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.55115,-0.025215,-0.015396,0,0
3,GO ANIMAL ORGAN MATURATION,0.74966,-0.025261,-0.040154,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.4963,-0.025455,-0.046967,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.85194,-0.025467,0.044008,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.43029,-0.025489,-0.028137,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.89939,-0.025502,-0.048223,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.4963,-0.025523,-0.048472,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.98559,-0.025547,0.0019309,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.46631,-0.02557,0.031893,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.35072,-0.025639,-0.16975,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.51167,-0.025644,-0.091663,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.45171,-0.025697,-0.11598,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.90893,-0.02574,0.01675,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.55115,-0.025826,-0.054778,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.93762,-0.025858,0.01155,0,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.26023,-0.02589,-0.064073,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.81436,-0.025918,0.01136,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.58378,-0.026048,-0.033332,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.76799,-0.026156,-0.02806,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.51944,-0.026257,-0.089572,0,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.68667,-0.026271,-0.078449,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.66904,-0.026471,-0.01495,0,0
3,GO VESICLE LOCALIZATION,0.59207,-0.026509,-0.026131,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.55922,-0.026509,-0.031903,0,0
3,GO TRABECULA MORPHOGENESIS,0.88987,-0.026512,-0.030213,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.89939,-0.026555,0.01589,0,0
3,GO BLEB ASSEMBLY,0.32642,-0.026684,-0.31461,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.35697,-0.026922,-0.05547,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.37614,-0.027007,-0.040875,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.67783,-0.027151,-0.066696,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.32642,-0.027178,-0.096252,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.87087,-0.02722,-0.0093287,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.63434,-0.027311,0.032389,0,0
3,GO NEURON DEATH,0.40267,-0.027318,-0.029719,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.8614,-0.027561,0.028762,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.41634,-0.027712,-0.063066,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.72243,-0.027793,-0.030792,0,0
3,GO GLIAL CELL PROLIFERATION,0.43736,-0.027852,-0.085132,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.38927,-0.027864,-0.075813,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.54313,-0.028099,-0.039222,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.29761,-0.028103,-0.1351,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.96638,-0.028107,-0.015624,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.98559,-0.028139,-0.0070104,0,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.32642,-0.028152,-0.069746,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.21267,-0.028309,-0.032221,0,0
3,GO CELL CELL RECOGNITION,0.4963,-0.028337,-0.04974,0,0
3,GO IMPORT INTO NUCLEUS,0.32052,-0.028387,-0.044582,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.6516,-0.02839,-0.1132,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11333,-0.028438,-0.063549,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.74054,-0.028455,-0.038653,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.51944,-0.028492,-0.046837,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.22622,-0.028561,-0.092549,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.62578,-0.028562,-0.031692,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.6603,-0.028648,0.1123,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.15017,-0.028676,-0.069383,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.62578,-0.028739,-0.053012,0,0
3,GO SISTER CHROMATID SEGREGATION,0.37614,-0.02877,-0.027983,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.92804,-0.028846,0.0088442,0,0
3,GO AMINE METABOLIC PROCESS,0.91848,-0.028968,-0.0027351,0,0
3,GO SOMATIC STEM CELL DIVISION,0.81436,-0.029217,0.047783,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.27056,-0.029268,-0.034218,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,1,-0.029336,-0.019436,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.7772,-0.029338,-0.02564,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.33239,-0.029403,-0.19768,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.8331,-0.029407,0.019597,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.6516,-0.029514,-0.04022,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.55115,-0.029525,-0.064481,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.51167,-0.029565,-0.050912,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.64294,-0.029673,-0.033325,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.26536,-0.029775,-0.13319,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.7588,-0.029799,0.018845,0,0
3,GO EMBRYO IMPLANTATION,0.85194,-0.029883,-0.037598,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.88036,-0.029916,0.0033411,0,0
3,GO VACUOLAR ACIDIFICATION,0.73147,-0.029967,-0.054508,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.43736,-0.030004,-0.062978,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.51167,-0.030196,-0.052415,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.14679,-0.030285,-0.064681,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.38267,-0.030291,-0.038231,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.59207,-0.030352,-0.088046,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.56735,-0.030369,-0.053627,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.52728,-0.030406,-0.028097,0,0
3,GO GLIAL CELL DEVELOPMENT,0.7772,-0.030443,-0.029974,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.46631,-0.030465,-0.051824,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.79572,-0.030506,-0.059727,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.39593,-0.030537,-0.027637,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.28658,-0.03056,-0.078337,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.41634,-0.030594,-0.065913,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.17553,-0.030611,-0.09966,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.36968,-0.030703,-0.059666,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.52728,-0.030781,-0.036092,0,0
3,GO NEURAL CREST CELL MIGRATION,0.9952,-0.030891,-0.023143,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.58378,-0.031025,-0.097151,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.93762,-0.031175,-0.0091181,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.29761,-0.031261,-0.057316,0,0
3,GO NADPH REGENERATION,0.52728,-0.031308,-0.069819,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.78645,-0.031319,-0.021144,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.39593,-0.031397,-0.08681,0,0
3,GO RESPONSE TO UV B,0.42328,-0.03147,-0.13127,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.48118,-0.031606,-0.093822,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.56735,-0.031646,-0.047261,0,0
3,GO MITOTIC DNA REPLICATION,0.88036,-0.031672,-0.012278,0,0
3,GO ENERGY HOMEOSTASIS,0.88036,-0.031676,0.043727,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.2356,-0.031766,-0.086179,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.9952,-0.031851,-0.023514,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.43029,-0.031873,-0.051126,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.82372,-0.031911,-0.018686,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.70447,-0.032087,0.021666,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.72243,-0.032117,0.044921,0,0
3,GO CARNITINE METABOLIC PROCESS,0.81436,-0.032139,-0.029162,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27056,-0.032141,-0.042586,0,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.26023,-0.032291,-0.072804,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.4963,-0.032308,-0.031355,0,0
3,GO RESPONSE TO VITAMIN,0.62578,-0.032309,-0.058493,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.70447,-0.03233,-0.051035,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.29761,-0.032352,-0.032817,0,0
3,GO OOCYTE DIFFERENTIATION,0.54313,-0.032364,-0.062821,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.54313,-0.032388,-0.053721,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.48118,-0.032449,-0.067651,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.27056,-0.032473,-0.077486,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.48871,-0.03252,-0.050326,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.6603,-0.03259,-0.028527,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.47371,-0.032637,-0.062251,0,0
3,GO MOLTING CYCLE,0.45171,-0.032639,-0.067056,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.29206,-0.032671,-0.038891,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.95679,-0.032935,0.026833,0,0
3,GO REGULATION OF PROTEIN BINDING,0.39593,-0.03295,-0.043368,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.62578,-0.032984,-0.020534,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.63434,-0.033011,-0.028284,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.43736,-0.033053,-0.058324,0,0
3,GO OOCYTE MATURATION,0.81436,-0.033079,-0.020695,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.61728,-0.033105,-0.022292,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.9472,-0.033118,0.021539,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.47371,-0.033189,-0.014098,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.51944,-0.033235,-0.063207,0,0
3,GO SIGNAL RELEASE,0.55115,-0.033387,-0.0093027,0,0
3,GO MICROTUBULE BASED PROCESS,0.34454,-0.033529,-0.024928,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.79572,-0.033534,-0.046416,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.71343,-0.033558,-0.10924,0,0
3,GO PEROXISOMAL TRANSPORT,0.70447,-0.03357,-0.024499,0,0
3,GO HAIR FOLLICLE MATURATION,0.50395,-0.033638,-0.074367,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.6516,-0.033667,-0.060971,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.64294,-0.033721,-0.048855,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13384,-0.033748,-0.049891,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.45898,-0.033887,-0.054924,0,0
3,GO REGULATION OF ANION TRANSPORT,0.43029,-0.033929,-0.059657,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.68667,-0.033941,-0.034801,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.76799,-0.033966,-0.0091812,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.14347,-0.034014,-0.083888,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.87087,-0.034071,-0.014773,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.19971,-0.034193,-0.037508,0,0
3,GO PIGMENTATION,0.43029,-0.034231,-0.053958,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.79572,-0.034231,-0.0068522,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.67783,-0.034258,-0.051983,0,0
3,GO REGULATION OF CELL CYCLE,0.36968,-0.034293,-0.024513,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.48871,-0.03441,-0.025451,0,0
3,GO CIRCADIAN RHYTHM,0.2356,-0.034414,-0.045267,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.97598,-0.034465,-0.031977,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.64294,-0.034546,-0.04082,0,0
3,GO CELLULAR EXTRAVASATION,0.34454,-0.034561,-0.070349,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.66904,-0.034604,-0.095214,0,0
3,GO FIBROBLAST PROLIFERATION,0.60883,-0.03461,-0.072506,0,0
3,GO FOAM CELL DIFFERENTIATION,0.51944,-0.034648,-0.093764,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.42328,-0.034858,-0.060598,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.24039,-0.034873,-0.050793,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.89939,-0.034896,-0.014387,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.21267,-0.034921,-0.062671,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.54313,-0.034976,-0.061215,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.27583,-0.035016,-0.05032,0,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.48118,-0.035144,-0.096116,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.48118,-0.035228,-0.029486,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.28117,-0.035363,-0.036806,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.74966,-0.035375,-0.048758,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.51944,-0.035455,-0.087603,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.35697,-0.035619,-0.051362,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.55115,-0.035659,-0.027469,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.40947,-0.035865,-0.043283,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.84251,-0.036053,-0.0066179,0,0
3,GO GLUCOSE IMPORT,0.50395,-0.036244,-0.038261,0,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.21267,-0.036301,-0.067227,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.69555,-0.036343,-0.064885,0,0
3,GO RHYTHMIC PROCESS,0.47371,-0.036382,-0.026375,0,0
3,GO RESPONSE TO NUTRIENT,0.55115,-0.036399,-0.050501,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.85194,-0.03649,-0.0089089,0,0
3,GO NEURON APOPTOTIC PROCESS,0.55115,-0.036593,-0.023613,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.50395,-0.036714,-0.043419,0,0
3,GO P BODY ASSEMBLY,0.17553,-0.036822,-0.066709,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.95679,-0.036833,-0.017293,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.20828,-0.036979,-0.049448,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.41634,-0.037089,-0.070825,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.58378,-0.03711,-0.033612,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.19971,-0.037167,-0.062163,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.89939,-0.037175,0.013598,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.34454,-0.037225,-0.10271,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.6603,-0.03729,-0.020696,0,0
3,GO PHAGOSOME MATURATION,0.8614,-0.037398,-0.029905,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.9952,-0.037419,-0.02079,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,1,-0.037444,0.0098691,0,0
3,GO ORGANELLE LOCALIZATION,0.24039,-0.037452,-0.027474,0,0
3,GO QUINONE METABOLIC PROCESS,0.30892,-0.037561,-0.17169,0,0
3,GO SPERM MOTILITY,0.29761,-0.037767,-0.04629,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.58378,-0.037824,0.032152,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32642,-0.037969,-0.0706,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.40267,-0.03798,-0.041601,0,0
3,GO T CELL MIGRATION,0.42328,-0.03801,-0.082798,0,0
3,GO TONGUE DEVELOPMENT,0.36968,-0.038072,-0.12436,0,0
3,GO HISTONE H4 ACETYLATION,0.51944,-0.038351,-0.025492,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.18334,-0.038436,-0.044132,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.1794,-0.038505,-0.065924,0,0
3,GO PROTEIN AUTOUBIQUITINATION,0.19971,-0.038516,-0.054847,0,0
3,GO CHROMOSOME SEGREGATION,0.48871,-0.038519,-0.024956,0,0
3,GO ASTROCYTE ACTIVATION,0.45171,-0.038523,-0.084492,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.8331,-0.038558,-0.028876,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.32052,-0.038592,-0.052761,0,0
3,GO REGULATION OF NEURON MATURATION,0.91848,-0.038666,0.0026596,0,0
3,GO TRANSLESION SYNTHESIS,0.24039,-0.038812,-0.070897,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.42328,-0.038857,-0.069747,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.45171,-0.038904,-0.041181,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.50395,-0.038922,-0.040329,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.48871,-0.038943,-0.072422,0,0
3,GO MITOTIC CELL CYCLE,0.48118,-0.039037,-0.022505,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.32052,-0.039049,-0.038036,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.7772,-0.039061,-0.024214,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.32052,-0.039154,-0.078258,0,0
3,GO RESPONSE TO LEPTIN,0.63434,-0.039215,-0.082751,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.88987,-0.039266,-0.026023,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.67783,-0.039312,-0.10287,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.59207,-0.039373,-0.028439,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.25516,-0.039383,-0.10738,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.29206,-0.039415,-0.030668,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.1794,-0.039428,-0.036813,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.93762,-0.039454,-0.031323,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.15361,-0.039466,-0.079273,0,0
3,GO CARTILAGE MORPHOGENESIS,0.95679,-0.039492,0.0056344,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.64294,-0.039567,-0.021019,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.25516,-0.039616,-0.066865,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.32642,-0.039639,-0.047324,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.69555,-0.039674,-0.019538,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.74966,-0.039688,-0.050116,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.41634,-0.039743,-0.056363,0,0
3,GO REGULATION OF SECRETION,0.22622,-0.039761,-0.050485,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.27583,-0.03995,-0.053273,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.42328,-0.040292,-0.043582,0,0
3,GO SENSORY PERCEPTION,0.41634,-0.040329,-0.027557,0,0
3,GO PROTEIN SUMOYLATION,0.10794,-0.040416,-0.066979,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.48118,-0.040426,-0.052694,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.54313,-0.040435,-0.047941,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.69555,-0.040462,-0.10085,0,0
3,GO LYSINE METABOLIC PROCESS,0.79572,-0.040549,-0.065442,0,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.1794,-0.040608,-0.10746,0,0
3,GO GENE SILENCING,0.18733,-0.040704,-0.047551,0,0
3,GO ORGANELLE ASSEMBLY,0.1161,-0.040851,-0.047245,0,0
3,GO LIPID CATABOLIC PROCESS,0.60042,-0.04097,-0.037155,0,0
3,GO REGULATION OF DNA REPLICATION,0.67783,-0.041193,-0.019139,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.30892,-0.041194,-0.045227,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.28117,-0.041214,-0.12582,0,0
3,GO REGULATION OF CELL MATURATION,0.34454,-0.041302,-0.056067,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.51167,-0.041328,-0.032397,0,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.062834,-0.041385,-0.059211,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.62578,-0.041494,-0.057359,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.88036,-0.041506,-0.014808,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.2356,-0.041596,-0.045709,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.18334,-0.041613,-0.07288,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.6516,-0.041695,-0.057829,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.14347,-0.041798,-0.043471,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.59207,-0.041814,-0.050638,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.10794,-0.041848,-0.042742,0,0
3,GO HEART DEVELOPMENT,0.21712,-0.041944,-0.064563,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.30892,-0.041961,-0.063504,0,0
3,GO HEART VALVE DEVELOPMENT,0.70447,-0.041967,-0.036308,0,0
3,GO RESPONSE TO KETONE,0.35072,-0.042098,-0.07239,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.63434,-0.04214,-0.018264,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.84251,-0.042144,-0.022397,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.35072,-0.04221,-0.047454,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.31468,-0.042254,-0.030842,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.79572,-0.042347,-0.027906,0,0
3,GO JNK CASCADE,0.25017,-0.042386,-0.050916,0,0
3,GO FOREGUT MORPHOGENESIS,0.7772,-0.042389,-0.048881,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.96638,-0.042469,0.0037112,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.48118,-0.042474,-0.024028,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.80503,-0.042581,-0.048163,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.81436,-0.042672,0.050051,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.27583,-0.042748,-0.039349,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.58378,-0.042794,-0.031176,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.36329,-0.0428,-0.059603,0,0
3,GO T CELL CHEMOTAXIS,0.6516,-0.042889,-0.043755,0,0
3,GO TAXIS,0.43736,-0.043021,-0.037082,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.41634,-0.043055,-0.046715,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.38927,-0.043117,-0.10435,0,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.13384,-0.043132,-0.088175,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.80503,-0.043405,0.0128,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.26023,-0.043515,-0.14015,0,0
3,GO ANION TRANSPORT,0.7772,-0.043528,-0.004624,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.20396,-0.043597,-0.14422,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.41634,-0.043629,-0.13841,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.73147,-0.043655,-0.025397,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.50395,-0.043724,-0.079444,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.20828,-0.043757,-0.047761,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.1402,-0.043882,-0.08372,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.45898,-0.043992,-0.023135,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.30892,-0.04402,-0.099356,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.92804,-0.044044,0.002688,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.36329,-0.044062,-0.085425,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.61728,-0.044097,-0.043681,0,0
3,GO MESENCHYME DEVELOPMENT,0.26536,-0.044106,-0.084254,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.27583,-0.044118,-0.048643,0,0
3,GO ORGANIC ANION TRANSPORT,0.6516,-0.044119,-0.014629,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.11892,-0.044205,-0.10598,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.55115,-0.044223,-0.05339,0,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.33843,-0.044284,-0.086777,0,0
3,GO REGULATION OF PH,0.2356,-0.044329,-0.067374,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.43736,-0.044405,-0.063015,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.45898,-0.044425,-0.033956,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46631,-0.044507,-0.055802,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.1643,-0.044553,-0.15261,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.55115,-0.044707,-0.083798,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.30323,-0.044728,-0.17723,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.37614,-0.044735,-0.078657,0,0
3,GO MACROPHAGE DIFFERENTIATION,0.28117,-0.044805,-0.11054,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.69555,-0.044865,-0.012845,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.51167,-0.044934,-0.068792,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.25516,-0.044959,-0.10474,0,0
3,GO LYMPHOCYTE MIGRATION,0.41634,-0.044977,-0.07679,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.55922,-0.045057,-0.021493,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.15361,-0.045184,-0.064528,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.45898,-0.045271,-0.028674,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.35072,-0.045286,-0.10595,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.9952,-0.045293,-0.010826,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.6516,-0.045331,-0.09958,0,0
3,GO FEVER GENERATION,0.52728,-0.045353,-0.090849,0,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.18733,-0.045372,-0.080404,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.10025,-0.045383,-0.057737,0,0
3,GO CELL FATE COMMITMENT,0.23088,-0.045435,-0.068904,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.32052,-0.04544,-0.096343,0,0
3,GO T CELL APOPTOTIC PROCESS,0.35072,-0.045481,-0.088468,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.18733,-0.045546,-0.052272,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.12771,-0.045619,-0.053361,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.7772,-0.045714,-0.029681,0,0
3,GO OSSIFICATION,0.1643,-0.045726,-0.09867,0,0
3,GO RESPONSE TO REDOX STATE,0.35072,-0.045965,-0.099407,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.044978,-0.046114,-0.069977,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.60042,-0.046135,-0.077529,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.74054,-0.046324,0.036024,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.59207,-0.046391,-0.02181,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.54313,-0.046394,-0.052102,0,0
3,GO RESPONSE TO CHEMOKINE,0.69555,-0.046506,-0.042485,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.43736,-0.04652,-0.05718,0,0
3,GO RESPONSE TO PEPTIDE,0.18733,-0.046551,-0.051247,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.14347,-0.046578,-0.088455,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.57554,-0.046606,-0.036663,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.30892,-0.046704,-0.036096,0,0
3,GO CELL SUBSTRATE ADHESION,0.32642,-0.046717,-0.08635,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.34454,-0.046825,-0.03645,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.60883,-0.046845,-0.048773,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.43029,-0.046858,-0.025657,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.29761,-0.046964,-0.073195,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.40267,-0.047051,-0.038937,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.15361,-0.047158,-0.10297,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.55922,-0.047223,-0.03316,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.2356,-0.047229,-0.046106,0,0
3,GO BIOLOGICAL ADHESION,0.14679,-0.047273,-0.091727,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.35697,-0.047306,-0.061602,0,0
3,GO HISTONE H2B UBIQUITINATION,0.46631,-0.047451,-0.050811,0,0
3,GO SPINDLE ASSEMBLY,0.095374,-0.047544,-0.071593,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.60042,-0.04755,-0.031004,0,0
3,GO DRINKING BEHAVIOR,0.89939,-0.047763,-0.036292,0,0
3,GO RESPONSE TO RADIATION,0.6516,-0.047799,-0.0058534,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.23088,-0.047874,-0.052932,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.12472,-0.047946,-0.054875,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.35697,-0.048031,-0.10146,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.38927,-0.048038,-0.081394,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.54313,-0.048061,-0.099401,0,0
3,GO LACTATE METABOLIC PROCESS,0.45898,-0.048096,-0.089598,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.54313,-0.048153,-0.023525,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.18334,-0.048207,-0.10968,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.16798,-0.048209,-0.084189,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.10277,-0.048263,-0.10462,0,0
3,GO MEMBRANE DOCKING,0.21712,-0.048356,-0.042613,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.64294,-0.048357,-0.1124,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.87087,-0.048361,0.030051,0,0
3,GO LIPID HOMEOSTASIS,0.32052,-0.048384,-0.066452,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.38927,-0.048424,-0.070291,0,0
3,GO MUSCLE ADAPTATION,0.1643,-0.048426,-0.092007,0,0
3,GO PENILE ERECTION,0.41634,-0.048522,-0.11322,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.35697,-0.048667,-0.11211,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.26536,-0.048744,-0.083449,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.52728,-0.048763,-0.049823,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.6516,-0.048799,-0.072302,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.35697,-0.048821,-0.031092,0,0
3,GO ACID SECRETION,0.78645,-0.048845,-0.010388,0,0
3,GO ACTIN FILAMENT BASED PROCESS,0.069955,-0.048887,-0.087824,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.24039,-0.04889,-0.084479,0,0
3,GO GASTRULATION,0.59207,-0.048963,-0.061143,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.12472,-0.048991,-0.042826,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.60042,-0.049076,0.043132,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.61728,-0.049124,-0.080071,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.57554,-0.049188,-0.052256,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.1161,-0.049196,-0.062892,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.67783,-0.049205,-0.039991,0,0
3,GO REGULATION OF BEHAVIOR,0.45898,-0.049283,-0.057846,0,0
3,GO POSTREPLICATION REPAIR,0.35072,-0.049322,-0.059161,0,0
3,GO POSITIVE REGULATION OF SIGNALING,0.081867,-0.049374,-0.069337,0,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.15017,-0.049411,-0.1153,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.1794,-0.049419,-0.052949,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.16068,-0.049512,-0.10663,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.29206,-0.049557,-0.063468,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.15361,-0.0496,-0.096189,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.67783,-0.049685,-0.071703,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.62578,-0.049791,-0.091664,0,0
3,GO REGULATION OF CELL DEATH,0.13384,-0.049794,-0.068624,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.24039,-0.049837,-0.057698,0,0
3,GO ERYTHROCYTE MATURATION,0.79572,-0.049846,0.00070907,0,0
3,GO ACTIN FILAMENT ORGANIZATION,0.10794,-0.049924,-0.091679,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.22164,-0.049933,-0.067366,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.15361,-0.050016,-0.059476,0,0
3,GO CYTOSOLIC TRANSPORT,0.18733,-0.050078,-0.051278,0,0
3,GO OVULATION CYCLE PROCESS,0.37614,-0.050163,-0.079835,0,0
3,GO CELL CYCLE,0.24039,-0.050172,-0.028524,0,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.22164,-0.050181,-0.11077,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.98559,-0.050213,-0.003122,0,0
3,GO GASTRIC ACID SECRETION,0.88036,-0.050238,0.0089832,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.40947,-0.050265,-0.046449,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.30323,-0.050266,-0.05956,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.11892,-0.050302,-0.10479,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.90893,-0.050421,0.022412,0,0
3,GO BIOMINERALIZATION,0.31468,-0.050447,-0.077655,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.90893,-0.050476,-0.010297,0,0
3,GO MACROPHAGE ACTIVATION,0.54313,-0.050509,-0.048597,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.40947,-0.050614,-0.057782,0,0
3,GO MIRNA METABOLIC PROCESS,0.17553,-0.05069,-0.073751,0,0
3,GO RESPONSE TO HORMONE,0.31468,-0.050715,-0.049392,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.85194,-0.050779,-0.01998,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.1794,-0.050804,-0.047856,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.43736,-0.050841,-0.064616,0,0
3,GO REGULATION OF INSULIN SECRETION,0.43736,-0.050887,-0.042394,0,0
3,GO COENZYME A METABOLIC PROCESS,0.27583,-0.050949,-0.12606,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.084004,-0.051069,-0.065202,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.1794,-0.051203,-0.10038,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.15361,-0.051217,-0.053258,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.28658,-0.051241,-0.15743,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.14347,-0.051266,-0.075136,0,0
3,GO RESPONSE TO INACTIVITY,0.33239,-0.051296,-0.077523,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.27583,-0.051313,-0.12169,0,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.19139,-0.051329,-0.067733,0,0
3,GO VACUOLE ORGANIZATION,0.17173,-0.051359,-0.077008,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.35072,-0.051506,-0.095109,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.46631,-0.051612,-0.10135,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.68667,-0.051848,-0.030439,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.1402,-0.05186,-0.041641,0,0
3,GO TISSUE MORPHOGENESIS,0.081867,-0.051954,-0.093136,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.56735,-0.051964,-0.068572,0,0
3,GO MYOBLAST FUSION,0.73147,-0.05197,-0.033899,0,0
3,GO TRANSFERRIN TRANSPORT,0.40267,-0.052003,-0.064282,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.43736,-0.052036,-0.056104,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.48871,-0.052058,-0.042797,0,0
3,GO CYTOSKELETON ORGANIZATION,0.068115,-0.052099,-0.067248,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.1794,-0.052317,-0.050119,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.60042,-0.052357,-0.042609,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.20396,-0.052424,-0.060059,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.4963,-0.052468,-0.073892,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.27056,-0.052499,-0.076459,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.63434,-0.052584,-0.066667,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.36329,-0.052585,-0.073641,0,0
3,GO APOPTOTIC PROCESS,0.12472,-0.052605,-0.068259,0,0
3,GO SYMBIOTIC PROCESS,0.23088,-0.052623,-0.075012,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.45171,-0.052701,-0.053278,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.89939,-0.052805,-0.015415,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.56735,-0.052913,-0.038171,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.98559,-0.052971,0.0089583,0,0
3,GO RECEPTOR RECYCLING,0.16798,-0.052985,-0.090349,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.40947,-0.052989,-0.10463,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.51944,-0.053002,-0.052199,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.20828,-0.053015,-0.049471,0,0
3,GO MANGANESE ION TRANSPORT,0.29761,-0.05359,-0.08757,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.47371,-0.053698,-0.08611,0,0
3,GO DETECTION OF STIMULUS,0.036694,-0.053818,-0.079425,0,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.27056,-0.053873,-0.080532,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.57554,-0.054123,-0.083327,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.21267,-0.054136,-0.067493,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.6603,-0.054139,-0.026185,0,0
3,GO REGULATION OF AUTOPHAGY,0.23088,-0.054203,-0.048659,0,0
3,GO INOSITOL METABOLIC PROCESS,0.6516,-0.054253,-0.025042,0,0
3,GO MESODERM DEVELOPMENT,0.17173,-0.054259,-0.089162,0,0
3,GO HISTONE H3 K9 METHYLATION,0.38267,-0.054297,-0.051255,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.24525,-0.054337,-0.063067,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.20828,-0.054394,-0.078408,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.70447,-0.054403,-0.049,0,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.16068,-0.054464,-0.061844,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.42328,-0.054605,-0.079921,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.34454,-0.054624,-0.043054,0,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.053284,-0.05466,-0.053768,0,0
3,GO T CELL EXTRAVASATION,0.32642,-0.054728,-0.21801,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2356,-0.054948,-0.13106,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.09779,-0.055058,-0.10162,0,0
3,GO REGULATION OF PROTEOLYSIS,0.073757,-0.055063,-0.10018,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.26023,-0.055121,-0.065703,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.1402,-0.055243,-0.053572,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.42328,-0.055402,-0.042697,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.38927,-0.055443,-0.053809,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.20396,-0.05555,-0.062013,0,0
3,GO AGING,0.10533,-0.055637,-0.093348,0,0
3,GO GOLGI VESICLE TRANSPORT,0.16068,-0.055758,-0.067188,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.27056,-0.055831,-0.089573,0,0
3,GO DEMETHYLATION,0.25516,-0.055847,-0.050039,0,0
3,GO STRESS FIBER ASSEMBLY,0.30323,-0.055864,-0.080161,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.19552,-0.055869,-0.16264,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.40267,-0.05587,-0.042287,0,0
3,GO REGULATION OF APPETITE,0.33843,-0.055979,-0.073805,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.07572,-0.056026,-0.060915,0,0
3,GO SPERM AXONEME ASSEMBLY,0.24525,-0.056041,-0.094079,0,0
3,GO SPINDLE ORGANIZATION,0.1402,-0.056086,-0.057838,0,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.55922,-0.056106,-0.084845,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.34454,-0.056232,-0.065761,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.47371,-0.056234,-0.072621,0,0
3,GO ECTODERM DEVELOPMENT,0.27056,-0.05632,-0.079319,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.22622,-0.056322,-0.075994,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.29206,-0.056353,-0.090474,0,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.057895,-0.056386,-0.091801,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.43736,-0.056501,-0.064742,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.55115,-0.056867,-0.10342,0,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.22164,-0.056972,-0.13091,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.11892,-0.057182,-0.10345,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24039,-0.05719,-0.057475,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.55922,-0.057198,-0.055924,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.081867,-0.057266,-0.064847,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.7772,-0.057268,-0.021925,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.26536,-0.057276,-0.045157,0,0
3,GO SYNCYTIUM FORMATION,0.74966,-0.057355,-0.036983,0,0
3,GO GLIAL CELL ACTIVATION,0.55922,-0.057362,-0.064668,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.14679,-0.057374,-0.086216,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.13699,-0.057412,-0.073221,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.55922,-0.057444,-0.040526,0,0
3,GO RESPONSE TO TESTOSTERONE,0.53518,-0.057452,-0.061262,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.81436,-0.05749,-0.010607,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.1794,-0.057531,-0.13635,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.031606,-0.057546,-0.1052,0,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.057895,-0.057558,-0.10342,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.2356,-0.057596,-0.046249,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.59207,-0.057596,-0.081305,0,0
3,GO EMBRYO DEVELOPMENT,0.12771,-0.057604,-0.067145,0,0
3,GO RESPONSE TO THYROID HORMONE,0.50395,-0.057627,-0.083079,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.7588,-0.057676,-0.081695,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.11333,-0.05796,-0.084809,0,0
3,GO CARTILAGE DEVELOPMENT,0.30892,-0.058054,-0.079127,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.27583,-0.058065,-0.11374,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.29761,-0.058163,-0.073572,0,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.41634,-0.058176,-0.060863,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.073757,-0.058212,-0.061129,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.15361,-0.058405,-0.071828,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.33239,-0.058431,-0.068696,0,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.16068,-0.058486,-0.095654,0,0
3,GO DENDRITIC CELL MIGRATION,0.41634,-0.058547,-0.10776,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.45171,-0.058552,-0.056116,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.40267,-0.058574,-0.070352,0,0
3,GO REGENERATION,0.19971,-0.058636,-0.09906,0,0
3,GO PROTEIN MANNOSYLATION,0.73147,-0.058695,-0.023232,0,0
3,GO NEPHRON MORPHOGENESIS,0.1402,-0.058745,-0.11192,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.36329,-0.058806,-0.17984,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.23088,-0.058835,-0.069341,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.7772,-0.058836,-0.034436,0,0
3,GO FATTY ACID BETA OXIDATION,0.31468,-0.058862,-0.08866,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.72243,-0.058868,-0.14898,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.29761,-0.058929,-0.068935,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.24525,-0.058934,-0.086656,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.095374,-0.059015,-0.08508,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.45171,-0.059044,-0.044522,0,0
3,GO NEURONAL ACTION POTENTIAL,0.35697,-0.059138,-0.087119,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.35072,-0.059154,-0.086438,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.55115,-0.059271,-0.04946,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.31468,-0.059379,-0.10468,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.30892,-0.059488,-0.048023,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.14347,-0.059509,-0.074258,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.15361,-0.059569,-0.15309,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.41634,-0.05963,-0.048031,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.38927,-0.059755,-0.074585,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.090686,-0.059786,-0.16073,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.64294,-0.059801,-0.072709,0,0
3,GO HISTONE H3 ACETYLATION,0.2356,-0.059828,-0.046184,0,0
3,GO CENTRIOLE ASSEMBLY,0.21267,-0.059853,-0.090612,0,0
3,GO HISTONE H2A ACETYLATION,0.25516,-0.059878,-0.082931,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.24039,-0.059886,-0.12382,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.35072,-0.059887,-0.060015,0,0
3,GO LIPID PHOSPHORYLATION,0.40267,-0.059889,-0.031383,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.68667,-0.059928,-0.049873,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.27583,-0.060168,-0.10272,0,0
3,GO NUCLEUS ORGANIZATION,0.16068,-0.060168,-0.05251,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56735,-0.060173,-0.041976,0,0
3,GO CELLULAR PIGMENTATION,0.19971,-0.060191,-0.086983,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.27583,-0.060192,-0.062272,0,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.095374,-0.060242,-0.065599,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.15712,-0.060279,-0.15322,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.24525,-0.060338,-0.077451,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.40267,-0.060352,-0.039351,0,0
3,GO LIPID OXIDATION,0.22164,-0.060459,-0.096975,0,0
3,GO VASCULATURE DEVELOPMENT,0.14347,-0.060488,-0.10435,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.81436,-0.060506,-0.077862,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.42328,-0.060562,-0.10161,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.35697,-0.060566,-0.075564,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.67783,-0.060632,-0.034928,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.27583,-0.060708,-0.061239,0,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.25516,-0.060716,-0.078982,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.80503,-0.060762,-0.016216,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.27583,-0.060787,-0.083403,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.12472,-0.060799,-0.059273,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.42328,-0.061006,-0.049724,0,0
3,GO NEUTROPHIL MIGRATION,0.28658,-0.061042,-0.09083,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.72243,-0.061101,-0.002157,0,0
3,GO SULFATE TRANSPORT,0.19139,-0.06113,-0.068673,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.14679,-0.061238,-0.062636,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.034581,-0.061272,-0.097577,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.7588,-0.06129,-0.01757,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.18733,-0.061381,-0.13003,0,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.034581,-0.061438,-0.11085,0,0
3,GO RESPONSE TO INSULIN,0.1402,-0.061474,-0.0615,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.36968,-0.061488,-0.067567,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.22164,-0.061492,-0.092308,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.55115,-0.061543,-0.047217,0,0
3,GO NEURON PROJECTION REGENERATION,0.35072,-0.061715,-0.076721,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.1402,-0.06182,-0.078029,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.1643,-0.06184,-0.097742,0,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.1794,-0.061852,-0.086602,0,0
3,GO RENAL FILTRATION,0.62578,-0.061867,-0.053099,0,0
3,GO SEX DIFFERENTIATION,0.069955,-0.061878,-0.075633,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.38927,-0.06193,-0.05943,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.30323,-0.061933,-0.040208,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.32052,-0.061949,-0.10164,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51167,-0.062005,-0.045385,0,0
3,GO ETHANOL METABOLIC PROCESS,0.33239,-0.062035,-0.13683,0,0
3,GO STEM CELL DIVISION,0.33239,-0.062077,-0.10003,0,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.38927,-0.062116,-0.099708,0,0
3,GO REGULATION OF HORMONE LEVELS,0.34454,-0.062138,-0.053772,0,0
3,GO PHAGOCYTOSIS,0.27583,-0.062194,-0.08304,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.4963,-0.062217,-0.11607,0,0
3,GO SINGLE FERTILIZATION,0.13384,-0.062238,-0.061452,0,0
3,GO REGULATION OF CELLULAR PH,0.10533,-0.062252,-0.084082,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.64294,-0.062334,-0.016803,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.52728,-0.062452,-0.063311,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.40947,-0.062477,-0.044267,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.48118,-0.062493,-0.05793,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.26536,-0.062609,-0.077855,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.55115,-0.062775,-0.054066,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.15712,-0.062779,-0.15983,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.2356,-0.062807,-0.089973,0,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.084004,-0.062856,-0.10428,0,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.069955,-0.062883,-0.10082,0,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.051817,-0.06289,-0.071616,0,0
3,GO OVULATION,0.40947,-0.062928,-0.11239,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.34454,-0.062997,-0.082632,0,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.19552,-0.063035,-0.093553,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.079775,-0.063225,-0.073849,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.19552,-0.063242,-0.16277,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.1794,-0.063307,-0.067893,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.60883,-0.063386,-0.032499,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.82372,-0.063387,-0.0099595,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.32642,-0.063437,-0.10493,0,0
3,GO ERAD PATHWAY,0.28658,-0.063487,-0.077842,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.050383,-0.063596,-0.063536,0,0
3,GO EATING BEHAVIOR,0.45898,-0.063634,-0.05093,0,0
3,GO REGULATION OF HEMOPOIESIS,0.057895,-0.06367,-0.11109,0,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.13699,-0.063766,-0.089434,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.2356,-0.0638,-0.099443,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.28658,-0.063807,-0.055774,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.20396,-0.063808,-0.14072,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.31468,-0.063842,-0.10854,0,0
3,GO ARACHIDONIC ACID SECRETION,0.52728,-0.063976,-0.062728,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11333,-0.06407,-0.12466,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.51944,-0.064082,-0.068043,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.17553,-0.064098,-0.13446,0,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.10025,-0.064172,-0.16169,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.04007,-0.064201,-0.079772,0,0
3,GO REGULATION OF T CELL MIGRATION,0.25516,-0.064207,-0.080746,0,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.046281,-0.064216,-0.082203,0,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.10794,-0.064357,-0.078233,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.90893,-0.064426,-0.021201,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.8614,-0.064485,0.059274,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.28658,-0.064497,-0.095143,0,0
3,GO AMINE TRANSPORT,0.63434,-0.064512,0.020749,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.059504,-0.064634,-0.081116,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.26023,-0.064758,-0.051277,0,0
3,GO HISTONE PHOSPHORYLATION,0.15017,-0.064861,-0.10156,0,0
3,GO ORGANELLE FISSION,0.064555,-0.065034,-0.05714,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.33239,-0.065069,-0.12203,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.056323,-0.065092,-0.054448,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.30892,-0.065145,-0.086944,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.27583,-0.065203,-0.12224,0,0
3,GO RESPONSE TO COCAINE,0.39593,-0.065279,-0.052996,0,0
3,GO RESPONSE TO FOOD,0.43029,-0.065378,-0.051185,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.8614,-0.065398,0.020347,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.60883,-0.065435,-0.047555,0,0
3,GO HORMONE METABOLIC PROCESS,0.87087,-0.065462,-0.026337,0,0
3,GO HEAT GENERATION,0.60042,-0.065467,-0.075937,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.59207,-0.065487,-0.090258,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.38927,-0.065494,-0.057761,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.7772,-0.065535,-0.031763,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.45171,-0.065943,-0.12862,0,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.20828,-0.066028,-0.073671,0,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.069955,-0.066065,-0.089356,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.29761,-0.066119,-0.081346,0,0
3,GO MALE MEIOSIS I,0.9472,-0.066163,0.022867,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.53518,-0.066167,-0.038839,0,0
3,GO RESPONSE TO STEROID HORMONE,0.20828,-0.066195,-0.083558,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.31468,-0.066242,-0.051195,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.14347,-0.066269,-0.21582,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.38267,-0.066321,-0.21042,0,0
3,GO CELL MATURATION,0.33843,-0.066583,-0.040349,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.59207,-0.066599,-0.060487,0,0
3,GO REGULATION OF ERAD PATHWAY,0.34454,-0.066608,-0.045241,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.40947,-0.066742,-0.089416,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.22164,-0.06683,-0.075095,0,0
3,GO CELL JUNCTION ASSEMBLY,0.1794,-0.06687,-0.0775,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.39593,-0.066932,-0.051431,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.61728,-0.066944,-0.054629,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.16068,-0.067075,-0.064358,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.38927,-0.06725,-0.044593,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.34454,-0.06729,-0.09624,0,0
3,GO HISTONE UBIQUITINATION,0.10533,-0.067335,-0.067931,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.6516,-0.067345,-0.069191,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.26023,-0.067429,-0.053694,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.73147,-0.06745,-0.01943,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.68667,-0.067591,-0.018249,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.081867,-0.067603,-0.083253,0,0
3,GO GOLGI RIBBON FORMATION,0.52728,-0.067706,-0.073375,0,0
3,GO MUSCLE CELL PROLIFERATION,0.12472,-0.067716,-0.1134,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.21712,-0.067775,-0.063334,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.38927,-0.067799,-0.064136,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.17173,-0.067857,-0.064951,0,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.43736,-0.067985,-0.081027,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.27583,-0.068072,-0.1101,0,0
3,GO GLYCOSYLATION,0.13384,-0.068078,-0.085657,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.28658,-0.068099,-0.048215,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.22622,-0.068111,-0.09495,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.67783,-0.068185,-0.065342,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.39593,-0.068308,-0.089549,0,0
3,GO RESPONSE TO ANTIBIOTIC,0.17173,-0.06837,-0.10825,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.40947,-0.068382,-0.10259,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.19139,-0.068439,-0.064501,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.24039,-0.068471,-0.073786,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.50395,-0.06864,-0.032885,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.55922,-0.06866,-0.072183,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.24039,-0.068791,-0.12783,0,0
3,GO TOR SIGNALING,0.10533,-0.068797,-0.052241,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.4445,-0.068955,-0.028187,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.31468,-0.068963,-0.13512,0,0
3,GO KINETOCHORE ORGANIZATION,0.4963,-0.068978,-0.065643,0,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.041252,-0.069164,-0.084454,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.32052,-0.069168,-0.085172,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.09779,-0.069297,-0.079196,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.22622,-0.069304,-0.051302,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.35072,-0.069337,-0.059058,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.31468,-0.069382,-0.11597,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.20828,-0.069399,-0.18309,0,0
3,GO SPERM EGG RECOGNITION,0.8331,-0.06947,-0.00085321,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.90893,-0.069665,-0.0081642,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.59207,-0.069679,0.029742,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.038917,-0.069754,-0.085404,0,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.093006,-0.069764,-0.07697,0,0
3,GO CELL MOTILITY,0.053284,-0.069771,-0.095062,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.37614,-0.06978,-0.084003,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.36329,-0.069816,-0.080816,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.31468,-0.069948,-0.069529,0,0
3,GO ETHANOL OXIDATION,0.4963,-0.069971,-0.19694,0,0
3,GO REGULATION OF MITOPHAGY,0.34454,-0.07004,-0.074007,0,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.062834,-0.07011,-0.074258,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.14679,-0.07015,-0.065118,0,0
3,GO CELL DIVISION,0.095374,-0.070256,-0.056865,0,0
3,GO AMMONIUM TRANSPORT,0.57554,-0.070443,-0.042066,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.88036,-0.070659,-0.033737,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.11061,-0.070662,-0.068439,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.51167,-0.070706,-0.068008,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.35697,-0.070721,-0.10713,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.09779,-0.070898,-0.088327,0,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.050383,-0.070904,-0.12737,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.72243,-0.070971,-0.057448,0,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.24039,-0.071056,-0.1054,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.50395,-0.071077,-0.068564,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.39593,-0.071109,-0.048543,0,0
3,GO AMELOGENESIS,0.80503,-0.071117,-0.045273,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.059504,-0.071184,-0.12244,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.41634,-0.071224,-0.045813,0,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.22622,-0.071245,-0.1311,0,0
3,GO MULTI ORGANISM PROCESS,0.053284,-0.071273,-0.065893,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.34454,-0.071279,-0.035095,0,0
3,GO SLEEP,0.84251,-0.071527,0.002749,0,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.043706,-0.07157,-0.067355,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.16798,-0.071696,-0.08659,0,0
3,GO NEGATIVE T CELL SELECTION,0.044978,-0.071713,-0.14578,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.059504,-0.071766,-0.12814,0,0
3,GO REGULATION OF HORMONE SECRETION,0.1402,-0.071821,-0.080859,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.41634,-0.071899,-0.10224,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.24039,-0.071952,-0.058847,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.55115,-0.072046,-0.031279,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.22622,-0.072174,-0.10981,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.47371,-0.07218,-0.10823,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.066316,-0.072246,-0.17705,0,0
3,GO RETINA HOMEOSTASIS,0.14347,-0.072301,-0.083666,0,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.07572,-0.072365,-0.10645,0,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.057895,-0.072443,-0.08466,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.077726,-0.072511,-0.074656,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.21712,-0.072538,-0.12006,0,0
3,GO RESPONSE TO STARVATION,0.48871,-0.072622,-0.040412,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.64294,-0.072675,-0.09619,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.47371,-0.072737,-0.056321,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.24039,-0.07278,-0.055675,0,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.28658,-0.072793,-0.12565,0,0
3,GO FEMALE GAMETE GENERATION,0.32052,-0.073147,-0.053638,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.24039,-0.073158,-0.09298,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.26023,-0.073301,-0.10043,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.64294,-0.073365,-0.090515,0,0
3,GO RESPONSE TO COLD,0.47371,-0.07338,-0.088374,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.15017,-0.073457,-0.1143,0,0
3,GO CILIUM MOVEMENT,0.064555,-0.073585,-0.098303,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.19139,-0.073636,-0.13023,0,0
3,GO PEPTIDE SECRETION,0.079775,-0.07373,-0.088246,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.62578,-0.073749,-0.082803,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.038917,-0.073781,-0.072422,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.090686,-0.073848,-0.064993,0,0
3,GO PH REDUCTION,0.14679,-0.07385,-0.086758,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031606,-0.073878,-0.12226,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.12179,-0.07399,-0.15322,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.88987,-0.074113,0.018696,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.29206,-0.074123,-0.10705,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.22164,-0.074192,-0.087629,0,0
3,GO LYSOSOMAL TRANSPORT,0.17553,-0.074645,-0.085257,0,0
3,GO PEPTIDE HORMONE SECRETION,0.43029,-0.074712,-0.041762,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.32642,-0.074732,-0.079844,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.50395,-0.074751,-0.073726,0,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.34454,-0.074971,-0.10453,0,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.09779,-0.075,-0.12186,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.47371,-0.075012,-0.1717,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.50395,-0.075119,-0.058173,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.06115,-0.075188,-0.07862,0,0
3,GO REGULATION OF MAPK CASCADE,0.1643,-0.075245,-0.073187,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.37614,-0.075374,-0.094547,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.19139,-0.075527,-0.070458,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.28117,-0.07553,-0.10639,0,0
3,GO REGULATION OF IMMUNE RESPONSE,0.056323,-0.075564,-0.11241,0,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.51944,-0.075682,-0.055467,0,0
3,GO POSITIVE REGULATION OF SECRETION,0.069955,-0.0757,-0.080864,0,0
3,GO CYTOKINESIS,0.035624,-0.075733,-0.099965,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.43029,-0.075805,-0.10763,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.9472,-0.076037,0.0020654,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.20828,-0.076056,-0.1992,0,0
3,GO CELL AGING,0.10794,-0.076072,-0.093604,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.34454,-0.076119,-0.20875,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.58378,-0.0762,-0.060589,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.38267,-0.076242,-0.085432,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.35072,-0.076307,-0.0568,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.36968,-0.076411,-0.074926,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.038917,-0.076431,-0.079049,0,0
3,GO REGIONALIZATION,0.29206,-0.076433,-0.053013,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.043706,-0.076494,-0.10745,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.046281,-0.076523,-0.1033,0,0
3,GO NATURAL KILLER CELL ACTIVATION,0.13074,-0.076574,-0.12046,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.037792,-0.076667,-0.093777,0,0
3,GO FAT CELL DIFFERENTIATION,0.071835,-0.07679,-0.10454,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.26023,-0.076856,-0.058537,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.10533,-0.076929,-0.11683,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.088413,-0.076945,-0.08846,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.33843,-0.077099,-0.10074,0,0
3,GO BODY MORPHOGENESIS,0.11061,-0.077119,-0.14926,0,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.093006,-0.077158,-0.089096,0,0
3,GO HORMONE TRANSPORT,0.20396,-0.077206,-0.071999,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.78645,-0.077208,-0.04119,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.45171,-0.077227,-0.10908,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.93762,-0.077312,0.0339,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.91848,-0.077423,-0.039169,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.41634,-0.077645,-0.076173,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.10794,-0.07767,-0.073034,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.43029,-0.077678,-0.05157,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.22622,-0.077713,-0.093093,0,0
3,GO PEPTIDE CROSS LINKING,0.39593,-0.077749,-0.13083,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.19971,-0.077769,-0.071951,0,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.15712,-0.077892,-0.11145,0,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.09779,-0.07796,-0.13051,0,0
3,GO EAR DEVELOPMENT,0.064555,-0.077967,-0.13091,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.19552,-0.078047,-0.11258,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.22164,-0.078167,-0.11217,0,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.33239,-0.078221,-0.12278,0,0
3,GO B CELL HOMEOSTASIS,0.37614,-0.078256,-0.074147,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.45898,-0.078261,-0.13905,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.1161,-0.078268,-0.079186,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.11061,-0.078341,-0.15032,0,0
3,GO DNA CATABOLIC PROCESS,0.18733,-0.078412,-0.091741,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.81436,-0.078418,-0.039983,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.25017,-0.078438,-0.24127,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.31468,-0.078512,-0.076298,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.45898,-0.078874,-0.060471,0,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.056323,-0.078892,-0.096245,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.15712,-0.078939,-0.12936,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.42328,-0.079124,-0.059591,0,0
3,GO GENITALIA DEVELOPMENT,0.15712,-0.07927,-0.10676,0,0
3,GO SELECTIVE AUTOPHAGY,0.14347,-0.079287,-0.10013,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.14679,-0.079346,-0.12257,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.71343,-0.079439,-0.080046,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.78645,-0.079452,0.038818,0,0
3,GO LIPID METABOLIC PROCESS,0.1643,-0.079621,-0.065954,0,0
3,GO GLUCOSE METABOLIC PROCESS,0.10025,-0.079635,-0.074481,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.33239,-0.079642,-0.061305,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.15361,-0.079664,-0.14707,0,0
3,GO ANIMAL ORGAN FORMATION,0.07572,-0.079704,-0.15018,0,0
3,GO MAST CELL ACTIVATION,0.28658,-0.079811,-0.097735,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29206,-0.079886,-0.14824,0,0
3,GO PRIMARY MIRNA PROCESSING,0.13699,-0.079914,-0.12365,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23088,-0.079938,-0.11847,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.48871,-0.07996,-0.15641,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.16798,-0.08005,-0.10126,0,0
3,GO ADAPTIVE THERMOGENESIS,0.18334,-0.080158,-0.07706,0,0
3,GO FLUID TRANSPORT,0.13384,-0.080255,-0.11129,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.23088,-0.08038,-0.15747,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.74966,-0.080412,-0.019608,0,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.2356,-0.080483,-0.12376,0,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.24525,-0.080505,-0.068226,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.30323,-0.080577,-0.070069,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.25516,-0.080584,-0.12879,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.073757,-0.080623,-0.064861,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.63434,-0.080671,-0.03149,0,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.1643,-0.080823,-0.069984,0,0
3,GO REGULATION OF CYTOKINESIS,0.042464,-0.08091,-0.096942,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.25017,-0.080952,-0.069971,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.14679,-0.081163,-0.066137,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.044978,-0.081336,-0.09097,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.069955,-0.08135,-0.094226,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.57554,-0.081438,-0.033577,0,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.043706,-0.081443,-0.096518,0,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.12771,-0.081527,-0.11033,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.09779,-0.081544,-0.07249,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.39593,-0.081612,-0.13398,0,0
3,GO NEURAL TUBE PATTERNING,0.7588,-0.081659,-0.021913,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.24525,-0.081679,-0.081173,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.53518,-0.081723,-0.054551,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.036694,-0.081733,-0.092115,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.22164,-0.081737,-0.12197,0,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.29761,-0.081815,-0.11883,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.04007,-0.081815,-0.080324,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.31468,-0.081867,-0.15146,0,0
3,GO TRACHEA DEVELOPMENT,0.47371,-0.081894,-0.099805,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.20396,-0.08191,-0.1004,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.15361,-0.082014,-0.16648,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.89939,-0.082031,-0.0020346,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.093006,-0.082385,-0.11734,0,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.071835,-0.082597,-0.12394,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.27583,-0.082707,-0.08808,0,0
3,GO RESPONSE TO EPINEPHRINE,0.9472,-0.082913,0.0043875,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.10025,-0.083019,-0.086945,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.15712,-0.083025,-0.075904,0,0
3,GO RESPONSE TO INSECTICIDE,0.90893,-0.083188,-0.010298,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.36968,-0.083207,-0.059627,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.2356,-0.083243,-0.078081,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.18334,-0.083246,-0.12717,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.095374,-0.083311,-0.10491,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.17173,-0.083321,-0.076966,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.35697,-0.083365,-0.097749,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.48118,-0.083386,-0.072196,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.15712,-0.083457,-0.10237,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.37614,-0.083482,-0.12918,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.15017,-0.083555,-0.17157,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.073757,-0.083645,-0.085227,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.044978,-0.083653,-0.079232,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.2356,-0.083773,-0.11968,0,0
3,GO BLOOD VESSEL REMODELING,0.24039,-0.083783,-0.16055,0,0
3,GO CELLULAR SENESCENCE,0.048983,-0.083922,-0.12311,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.14679,-0.083938,-0.12,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.2356,-0.083938,-0.11414,0,0
3,GO GERM CELL DEVELOPMENT,0.10533,-0.08397,-0.065106,0,0
3,GO PROTEIN MATURATION,0.086186,-0.083996,-0.098123,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.28658,-0.084014,-0.14335,0,0
3,GO DEPHOSPHORYLATION,0.046281,-0.084177,-0.066267,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.12179,-0.084224,-0.093951,0,0
3,GO RESPONSE TO LIPID,0.13384,-0.084276,-0.08295,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.33239,-0.084316,-0.10144,0,0
3,GO BONE CELL DEVELOPMENT,0.1643,-0.084508,-0.11088,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.4445,-0.084527,-0.083709,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.90893,-0.084577,-0.031355,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.19971,-0.08461,-0.12519,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.34454,-0.084663,-0.063229,0,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.17553,-0.08475,-0.1129,0,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.10533,-0.084859,-0.083201,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.29206,-0.084868,-0.085283,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.45171,-0.084877,-0.049264,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.037792,-0.084903,-0.11543,0,0
3,GO ORGANELLE DISASSEMBLY,0.056323,-0.084934,-0.091441,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.25516,-0.084941,-0.10878,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.27056,-0.08502,-0.12515,0,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.10025,-0.085054,-0.13335,0,0
3,GO TISSUE REGENERATION,0.086186,-0.085055,-0.16258,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.17553,-0.085161,-0.088822,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.041252,-0.085189,-0.11763,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.084004,-0.085243,-0.16983,0,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.068115,-0.085625,-0.081237,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.043706,-0.085627,-0.13716,0,0
3,GO TUBE DEVELOPMENT,0.038917,-0.085643,-0.11292,0,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.21267,-0.085909,-0.11206,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.22622,-0.085998,-0.090189,0,0
3,GO PODOSOME ASSEMBLY,0.20828,-0.086137,-0.19383,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.68667,-0.08614,-0.062862,0,0
3,GO CYTOKINE METABOLIC PROCESS,0.048983,-0.086209,-0.17183,0,0
3,GO SKIN MORPHOGENESIS,0.31468,-0.08622,-0.20136,0,0
3,GO MYOFIBRIL ASSEMBLY,0.12771,-0.086239,-0.10736,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.28658,-0.086279,-0.058168,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.74054,-0.086381,-0.029627,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.52728,-0.086396,-0.047118,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.16798,-0.086397,-0.14444,0,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.048983,-0.086632,-0.083008,0,0
3,GO INTERLEUKIN 17 PRODUCTION,0.28117,-0.086716,-0.10652,0,0
3,GO PROTEOLYSIS,0.031606,-0.086757,-0.091196,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.062834,-0.086778,-0.15662,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.22164,-0.086912,-0.078597,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.54313,-0.086986,-0.048859,0,0
3,GO MITOCHONDRIAL FUSION,0.24039,-0.087018,-0.065286,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.34454,-0.087144,-0.1224,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.21712,-0.087157,-0.058821,0,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.14347,-0.087195,-0.1664,0,0
3,GO REGULATION OF TOR SIGNALING,0.069955,-0.087327,-0.07319,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.16068,-0.087346,-0.098493,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.21267,-0.087374,-0.078714,0,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.18334,-0.087459,-0.097789,0,0
3,GO ERBB SIGNALING PATHWAY,0.086186,-0.08776,-0.11436,0,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.050383,-0.087853,-0.10377,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.17173,-0.087878,-0.14089,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.18733,-0.087931,-0.082951,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.70447,-0.08796,-0.089777,0,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.048983,-0.088157,-0.14745,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.84251,-0.088164,-0.0020553,0,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.25516,-0.088179,-0.13098,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.42328,-0.088307,-0.078613,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.45171,-0.088338,-0.17646,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.42328,-0.088433,-0.087831,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.090686,-0.088463,-0.093453,0,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.036694,-0.088474,-0.11555,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.1643,-0.088588,-0.089031,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.14347,-0.088639,-0.06883,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.09779,-0.088645,-0.16476,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.68667,-0.08866,-0.019178,0,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.12771,-0.088789,-0.12251,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.13074,-0.088804,-0.083865,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.60042,-0.089594,-0.028316,0,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.16068,-0.089599,-0.11673,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.04007,-0.089649,-0.079055,0,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.11333,-0.089708,-0.13069,0,0
3,GO COPII COATED VESICLE BUDDING,0.053284,-0.089801,-0.10563,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.40267,-0.089826,-0.15128,0,0
3,GO NOTOCHORD DEVELOPMENT,0.51167,-0.089861,-0.13069,0,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.21712,-0.090097,-0.12241,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.20396,-0.090348,-0.076688,0,0
3,GO METANEPHROS DEVELOPMENT,0.10794,-0.090421,-0.14764,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.13384,-0.09062,-0.10607,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.20396,-0.09075,-0.11701,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.17553,-0.090946,-0.12041,0,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.06115,-0.091146,-0.14694,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.10794,-0.091218,-0.15412,0,0
3,GO REGULATION OF CELL DIVISION,0.038917,-0.091271,-0.089053,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.19971,-0.091382,-0.12165,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.13699,-0.091389,-0.13973,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.28658,-0.091449,-0.11339,0,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.18334,-0.09152,-0.15316,0,0
3,GO INSULIN SECRETION,0.25516,-0.091613,-0.068338,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.19971,-0.091751,-0.12659,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.20396,-0.091885,-0.11826,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60042,-0.091944,-0.069236,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.17553,-0.092118,-0.13012,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.13699,-0.092168,-0.11529,0,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.32052,-0.092178,-0.092122,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.27583,-0.092496,-0.085031,0,0
3,GO TUBE MORPHOGENESIS,0.042464,-0.092497,-0.123,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.11061,-0.092499,-0.13157,0,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.34454,-0.092711,-0.089662,0,0
3,GO INCLUSION BODY ASSEMBLY,0.66904,-0.092796,0.00089438,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.057895,-0.093069,-0.12074,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.1402,-0.093213,-0.10485,0,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.069955,-0.093226,-0.11403,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.32052,-0.093233,-0.076129,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.064555,-0.093433,-0.12637,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.090686,-0.093487,-0.091076,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.031606,-0.093501,-0.13312,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.10533,-0.093543,-0.0966,0,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.068115,-0.093546,-0.16252,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.10794,-0.093581,-0.12688,0,0
3,GO THYMIC T CELL SELECTION,0.09779,-0.093721,-0.089589,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.66904,-0.093799,-0.046767,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.68667,-0.093954,-0.031509,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.21712,-0.09401,-0.069991,0,0
3,GO CHONDROCYTE PROLIFERATION,0.61728,-0.094077,-0.068302,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.064555,-0.094114,-0.16799,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.090686,-0.094245,-0.11646,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.11333,-0.094409,-0.11311,0,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.15017,-0.094463,-0.18603,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.19971,-0.094489,-0.2589,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.39593,-0.094539,-0.091188,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.1161,-0.094576,-0.098629,0,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.12179,-0.094751,-0.10699,0,0
3,GO SPROUTING ANGIOGENESIS,0.15361,-0.094943,-0.11336,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.89939,-0.095031,-0.030848,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.28117,-0.095174,-0.1136,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.057895,-0.095186,-0.11941,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.20396,-0.095195,-0.078063,0,0
3,GO THYMUS DEVELOPMENT,0.34454,-0.095208,-0.063844,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.37614,-0.095274,-0.073238,0,0
3,GO RESPONSE TO ALCOHOL,0.051817,-0.095276,-0.10092,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.12179,-0.095423,-0.091033,0,0
3,GO CELL KILLING,0.054786,-0.095452,-0.13645,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.19971,-0.095468,-0.16886,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.24525,-0.095493,-0.09922,0,0
3,GO STEROL HOMEOSTASIS,0.17173,-0.095581,-0.1204,0,0
3,GO GOLGI VESICLE BUDDING,0.057895,-0.095597,-0.11304,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.27056,-0.095668,-0.095031,0,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.038917,-0.095713,-0.10231,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.23088,-0.095776,-0.13464,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.1794,-0.095881,-0.082586,0,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.086186,-0.095887,-0.14583,0,0
3,GO STEM CELL PROLIFERATION,0.093006,-0.095965,-0.11902,0,0
3,GO TRACHEA MORPHOGENESIS,0.2356,-0.096012,-0.14309,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.90893,-0.096027,-0.023591,0,0
3,GO NUCLEOTIDE TRANSPORT,0.37614,-0.096066,-0.059216,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.85194,-0.096145,0.02667,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.40267,-0.09627,-0.098716,0,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.059504,-0.096289,-0.11748,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.17553,-0.096318,-0.17821,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.78645,-0.096358,-0.056975,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.21267,-0.096592,-0.096317,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.30323,-0.096607,-0.067622,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.40947,-0.096619,-0.10986,0,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.062834,-0.096625,-0.13739,0,0
3,GO TUBE FORMATION,0.081867,-0.096675,-0.10217,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.24039,-0.096723,-0.073181,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.27583,-0.096729,-0.092788,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.73147,-0.096803,-0.020727,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.044978,-0.096814,-0.077345,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.068115,-0.096824,-0.092883,0,0
3,GO GLAND DEVELOPMENT,0.041252,-0.09697,-0.11253,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.11061,-0.096982,-0.097878,0,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.034581,-0.097005,-0.13402,0,0
3,GO INNATE IMMUNE RESPONSE,0.048983,-0.097014,-0.14693,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.19139,-0.097048,-0.085819,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.18733,-0.097056,-0.069343,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.26023,-0.09707,-0.10714,0,0
3,GO ORGAN INDUCTION,0.079775,-0.097096,-0.19288,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.16068,-0.0971,-0.1364,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.31468,-0.097144,-0.080293,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.61728,-0.097157,-0.10415,0,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.034581,-0.097205,-0.12628,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.12179,-0.097225,-0.1062,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.45898,-0.097441,-0.098212,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.088413,-0.097474,-0.17621,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.046281,-0.097528,-0.087054,0,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.069955,-0.097564,-0.14356,0,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.21712,-0.097617,-0.16381,0,0
3,GO DNA DEALKYLATION,0.32642,-0.097664,-0.081762,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.12472,-0.097764,-0.11591,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.18334,-0.097833,-0.17803,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.9472,-0.09784,2.953e-05,0,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.088413,-0.09798,-0.12785,0,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.45171,-0.098027,-0.09311,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.24039,-0.098031,-0.09277,0,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.054786,-0.098085,-0.15474,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.39593,-0.098106,-0.11932,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.1402,-0.098246,-0.10371,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.51167,-0.098303,-0.084793,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.054786,-0.09833,-0.11066,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.11333,-0.098384,-0.21374,0,0
3,GO LIPID MODIFICATION,0.033564,-0.098445,-0.10823,0,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.033564,-0.098465,-0.12569,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.10025,-0.098488,-0.076791,0,0
3,GO BLASTODERM SEGMENTATION,0.7588,-0.098511,-0.026477,0,0
3,GO T CELL DIFFERENTIATION,0.034581,-0.098526,-0.12825,0,0
3,GO MUSCLE HYPERTROPHY,0.1402,-0.098812,-0.097638,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.054786,-0.09889,-0.11584,0,0
3,GO TISSUE MIGRATION,0.13074,-0.098939,-0.11061,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.10794,-0.099038,-0.1302,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.27056,-0.099117,-0.10792,0,0
3,GO STEROID METABOLIC PROCESS,0.081867,-0.099245,-0.1102,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.1402,-0.099311,-0.20384,0,0
3,GO RESPONSE TO BMP,0.073757,-0.099354,-0.13272,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.23088,-0.099511,-0.12498,0,0
3,GO BONE MINERALIZATION,0.15361,-0.099662,-0.1095,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.79572,-0.099782,-0.032428,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.057895,-0.09984,-0.11583,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.31468,-0.099917,-0.096787,0,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.069955,-0.099938,-0.19201,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.04007,-0.099953,-0.13223,0,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.15361,-0.10003,-0.14099,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.13699,-0.10012,-0.10704,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.07572,-0.10017,-0.15941,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.036694,-0.10019,-0.11349,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1161,-0.10024,-0.088158,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.34454,-0.10028,-0.10997,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.048983,-0.10029,-0.14106,0,0
3,GO DEVELOPMENTAL INDUCTION,0.084004,-0.1003,-0.1884,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.1402,-0.10032,-0.18218,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.090686,-0.10059,-0.17591,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.053284,-0.10059,-0.091788,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.17173,-0.10077,-0.099642,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.12472,-0.10084,-0.084159,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.14679,-0.10093,-0.13838,0,0
3,GO REGULATION OF HEAT GENERATION,0.60042,-0.10096,-0.088874,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.081867,-0.10113,-0.097973,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.30892,-0.10118,-0.11544,0,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.40267,-0.10118,-0.10788,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.086186,-0.10126,-0.13799,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.034581,-0.10137,-0.11634,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.38267,-0.10149,-0.074758,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.13384,-0.10172,-0.12711,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.14679,-0.10179,-0.12003,0,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.37614,-0.10181,-0.11647,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.55115,-0.10185,-0.0070361,0,0
3,GO SEX DETERMINATION,0.11333,-0.10188,-0.136,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.78645,-0.1021,-0.017394,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.47371,-0.10226,-0.053065,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.088413,-0.10234,-0.093876,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.071835,-0.10238,-0.11672,0,0
3,GO GLAND MORPHOGENESIS,0.15017,-0.10247,-0.1799,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.11061,-0.1025,-0.16465,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.61728,-0.10253,-0.22426,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.10025,-0.10269,-0.091874,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.1643,-0.10271,-0.16843,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.04007,-0.10276,-0.10139,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.32642,-0.10282,-0.1117,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.059504,-0.10284,-0.12651,0,0
3,GO RESPONSE TO HYDROXYUREA,0.14679,-0.10292,-0.12482,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.34454,-0.10295,-0.11334,0,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.077726,-0.10303,-0.13376,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.064555,-0.10308,-0.10078,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.073757,-0.10312,-0.09941,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1,-0.10313,-0.0040732,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.38927,-0.10318,-0.072452,0,0
3,GO DIGESTIVE SYSTEM PROCESS,0.1161,-0.10319,-0.12417,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.095374,-0.10321,-0.18504,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.76799,-0.10321,-0.060417,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.16068,-0.10329,-0.075216,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.1402,-0.10333,-0.18259,0,0
3,GO REPLACEMENT OSSIFICATION,0.14347,-0.10335,-0.15066,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.55115,-0.10355,-0.050372,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.18334,-0.10361,-0.092243,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.17553,-0.10363,-0.10327,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.073757,-0.10379,-0.12196,0,0
3,GO RNA DECAPPING,0.071835,-0.10384,-0.10255,0,0
3,GO LYMPHOCYTE COSTIMULATION,0.077726,-0.10388,-0.12155,0,0
3,GO CARBOHYDRATE TRANSPORT,0.073757,-0.10401,-0.097014,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.48118,-0.10402,-0.11868,0,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.064555,-0.10404,-0.20005,0,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.038917,-0.10425,-0.1833,0,0
3,GO PANCREATIC JUICE SECRETION,0.51944,-0.10426,-0.048584,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.088413,-0.1043,-0.13827,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.82372,-0.10434,-0.042448,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.29206,-0.10445,-0.13329,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.48118,-0.10446,-0.096037,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.1161,-0.10449,-0.1206,0,0
3,GO RESPONSE TO BACTERIUM,0.038917,-0.10451,-0.13852,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.43029,-0.10453,-0.082969,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.18334,-0.10464,-0.12303,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.22622,-0.10465,-0.12349,0,0
3,GO REGULATION OF PEPTIDE SECRETION,0.034581,-0.10467,-0.10871,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.60883,-0.10474,-0.049113,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.24525,-0.10479,-0.12674,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.25516,-0.10492,-0.068991,0,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.14679,-0.10495,-0.17287,0,0
3,GO SPERMATID DIFFERENTIATION,0.14347,-0.10497,-0.070468,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.077726,-0.10512,-0.1649,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.054786,-0.10525,-0.10809,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.1161,-0.10557,-0.12262,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.16798,-0.10596,-0.11517,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.4445,-0.10598,-0.16041,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.10533,-0.10599,-0.13979,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.38927,-0.10622,-0.067378,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.079775,-0.10646,-0.10931,0,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.032572,-0.10655,-0.11167,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.29206,-0.10666,-0.13583,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.52728,-0.10673,-0.078193,0,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.04007,-0.10688,-0.21564,0,0
3,GO RESPONSE TO ALKALOID,0.1794,-0.10691,-0.083173,0,0
3,GO CELL MATRIX ADHESION,0.090686,-0.10699,-0.1304,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.78645,-0.10723,-0.0029498,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.19552,-0.10727,-0.12701,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.14347,-0.10728,-0.20222,0,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.4445,-0.10754,-0.078643,0,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.10533,-0.1077,-0.13177,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.035624,-0.10789,-0.12678,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.09779,-0.10792,-0.084772,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.069955,-0.10795,-0.14942,0,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.051817,-0.108,-0.14708,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.48871,-0.10832,-0.085273,0,0
3,GO STEROL METABOLIC PROCESS,0.086186,-0.10833,-0.11558,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.041252,-0.10841,-0.16938,0,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.033564,-0.10843,-0.17215,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.081867,-0.1085,-0.16592,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.4445,-0.10855,-0.027968,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.07572,-0.10863,-0.099539,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.1643,-0.1089,-0.13169,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.35072,-0.10924,-0.14913,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.1402,-0.10931,-0.10213,0,0
3,GO REGULATION OF HAIR CYCLE,0.22622,-0.10947,-0.11864,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.31468,-0.10954,-0.14823,0,0
3,GO FAT CELL PROLIFERATION,0.58378,-0.11001,-0.051204,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.086186,-0.11007,-0.10617,0,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.071835,-0.1101,-0.12445,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.27056,-0.11063,-0.138,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.10533,-0.11075,-0.10576,0,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.032572,-0.11085,-0.19489,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.19139,-0.11096,-0.11769,0,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.27583,-0.11114,-0.21488,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.044978,-0.11116,-0.19459,0,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.06115,-0.11118,-0.14525,0,0
3,GO CARNITINE SHUTTLE,0.51167,-0.11128,-0.068232,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.04007,-0.11139,-0.10097,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.42328,-0.11149,-0.060644,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.1402,-0.11158,-0.14851,0,0
3,GO CILIUM ORGANIZATION,0.030665,-0.11189,-0.11627,0,0
3,GO FACE DEVELOPMENT,0.090686,-0.11193,-0.17542,0,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.048983,-0.11203,-0.099752,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.47371,-0.11212,-0.032965,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.51944,-0.11238,-0.03965,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.1161,-0.11249,-0.16124,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.16068,-0.11272,-0.11422,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.24039,-0.11286,-0.12943,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.48118,-0.1129,-0.11006,0,0
3,GO MACROPHAGE CHEMOTAXIS,0.12771,-0.11313,-0.14416,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.095374,-0.11321,-0.12009,0,0
3,GO RESPONSE TO OSMOTIC STRESS,0.090686,-0.11328,-0.12055,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.85194,-0.11349,0.038529,0,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.093006,-0.11357,-0.10397,0,0
3,GO RESPONSE TO UV C,0.14347,-0.11408,-0.10933,0,0
3,GO DIGESTION,0.031606,-0.11415,-0.15691,0,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.18733,-0.1144,-0.15739,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.13384,-0.11443,-0.10662,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.29206,-0.11443,-0.077978,0,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.036694,-0.11444,-0.18506,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.36329,-0.11449,-0.056026,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.04007,-0.11457,-0.17342,0,0
3,GO RETINOL METABOLIC PROCESS,0.41634,-0.11462,-0.11058,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.13384,-0.11477,-0.088049,0,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.13384,-0.11487,-0.15635,0,0
3,GO KETONE CATABOLIC PROCESS,0.062834,-0.11487,-0.22997,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.064555,-0.11498,-0.12507,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.61728,-0.11498,-0.026167,0,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.030665,-0.11505,-0.17182,0,0
3,GO VIRAL RNA GENOME REPLICATION,0.086186,-0.11509,-0.14561,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.09779,-0.11514,-0.1394,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.064555,-0.11516,-0.19967,0,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.1161,-0.11517,-0.12296,0,0
3,GO PHAGOSOME ACIDIFICATION,0.11061,-0.11525,-0.13779,0,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.077726,-0.11535,-0.15172,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.2356,-0.11557,-0.14101,0,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.11061,-0.11563,-0.1838,0,0
3,GO NOTCH SIGNALING PATHWAY,0.033564,-0.11579,-0.12964,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.084004,-0.11594,-0.097016,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.35072,-0.11621,-0.12849,0,0
3,GO FATTY ACID METABOLIC PROCESS,0.051817,-0.11642,-0.12159,0,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.11892,-0.11644,-0.153,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.032572,-0.11649,-0.13827,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.050383,-0.11665,-0.14894,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.030665,-0.11692,-0.13545,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.41634,-0.11699,-0.20185,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.19552,-0.11747,-0.11374,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.046281,-0.11748,-0.16207,0,0
3,GO KINETOCHORE ASSEMBLY,0.52728,-0.11749,-0.071338,0,0
3,GO RESPIRATORY BURST,0.062834,-0.11749,-0.20854,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.38927,-0.11759,-0.11213,0,0
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.32642,-0.11774,-0.24807,0,0
3,GO TRNA CATABOLIC PROCESS,0.39593,-0.11784,-0.15215,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.13074,-0.11793,-0.086057,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.06115,-0.11802,-0.14075,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.7772,-0.11828,-0.038415,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.36329,-0.11849,-0.09397,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.74966,-0.11854,-0.047904,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.13074,-0.11889,-0.10829,0,0
3,GO DECIDUALIZATION,0.22164,-0.1191,-0.20376,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.45898,-0.1191,-0.072351,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.61728,-0.11935,-0.099936,0,0
3,GO REGULATION OF PINOCYTOSIS,0.079775,-0.11941,-0.1947,0,0
3,GO RESPONSE TO PROGESTERONE,0.057895,-0.11942,-0.19732,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.92804,-0.11965,0.031361,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.17553,-0.11967,-0.14857,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.7588,-0.11979,0.00090646,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.25516,-0.11983,-0.066335,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.095374,-0.12,-0.16205,0,0
3,GO VIRAL LATENCY,0.07572,-0.12001,-0.13235,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.13699,-0.12002,-0.15416,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.10533,-0.1201,-0.18503,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.050383,-0.12017,-0.1306,0,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.084004,-0.12028,-0.15151,0,0
3,GO RESPONSE TO CADMIUM ION,0.33843,-0.12029,-0.091378,0,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.079775,-0.1203,-0.15739,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.19552,-0.12098,-0.13773,0,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.10025,-0.1212,-0.34281,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.079775,-0.1213,-0.11103,0,0
3,GO KIDNEY MORPHOGENESIS,0.034581,-0.12134,-0.14318,0,0
3,GO RESPONSE TO INTERLEUKIN 6,0.042464,-0.12158,-0.16864,0,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.36329,-0.12159,-0.08273,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.71343,-0.1216,-0.15419,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.088413,-0.12165,-0.16293,0,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.056323,-0.12184,-0.11498,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.071835,-0.12217,-0.092257,0,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.042464,-0.12224,-0.17774,0,0
3,GO RESPONSE TO HYPEROXIA,0.6516,-0.12225,-0.074611,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.45171,-0.12237,-0.1043,0,0
3,GO MACROPHAGE MIGRATION,0.13699,-0.12241,-0.13544,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.22622,-0.12241,-0.27591,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.22622,-0.12244,-0.11378,0,0
3,GO MEMBRANE FISSION,0.13074,-0.12246,-0.12977,0,0
3,GO AXIS ELONGATION,0.43736,-0.12252,-0.11471,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.20828,-0.12274,-0.19949,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.4963,-0.1229,-0.13072,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.15361,-0.12305,-0.22173,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.34454,-0.1231,-0.17364,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.26536,-0.12317,-0.22467,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.16798,-0.12329,-0.27945,0,0
3,GO INTRACILIARY TRANSPORT,0.10025,-0.12342,-0.15583,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.081867,-0.12348,-0.11157,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.21267,-0.12348,-0.095495,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.25516,-0.12356,-0.13017,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.084004,-0.12361,-0.16638,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.069955,-0.12365,-0.13344,0,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.077726,-0.12375,-0.21057,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.032572,-0.12402,-0.13833,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.38267,-0.12427,-0.08586,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.050383,-0.12432,-0.22667,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.10794,-0.12442,-0.11408,0,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.051817,-0.12462,-0.13053,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.050383,-0.125,-0.11166,0,0
3,GO EPITHELIAL CELL MATURATION,0.17553,-0.1251,-0.1577,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.09779,-0.1251,-0.1423,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.090686,-0.12514,-0.13859,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.10533,-0.12516,-0.17533,0,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.031606,-0.12523,-0.11756,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.45898,-0.12523,-0.15121,0,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.066316,-0.12524,-0.15804,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.066316,-0.12524,-0.23338,0,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.15712,-0.12596,-0.10699,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.032572,-0.12598,-0.11413,0,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.042464,-0.12622,-0.173,0,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.041252,-0.1263,-0.12986,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.084004,-0.12664,-0.16949,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.67783,-0.12669,-0.23863,0,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.043706,-0.12677,-0.15508,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.24039,-0.12686,-0.15914,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.1794,-0.12686,-0.15082,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.70447,-0.12689,-0.070349,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.25017,-0.12701,-0.16956,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.28658,-0.12714,-0.17246,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.20828,-0.12759,-0.12568,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.55922,-0.12764,-0.052257,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.35072,-0.12796,-0.15339,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.10277,-0.12803,-0.1311,0,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.033564,-0.1281,-0.15469,0,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.057895,-0.12818,-0.21761,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.36329,-0.12838,-0.19331,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.07572,-0.12864,-0.16976,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.13699,-0.12871,-0.14267,0,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.088413,-0.12872,-0.15904,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.31468,-0.12894,-0.15544,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.21712,-0.12898,-0.22911,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.32052,-0.129,-0.093794,0,0
3,GO AORTA MORPHOGENESIS,0.28117,-0.12908,-0.11515,0,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.14347,-0.12908,-0.16008,0,0
3,GO HISTONE H3 DEACETYLATION,0.20828,-0.12912,-0.069736,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.89939,-0.12934,0.030587,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.60883,-0.12937,-0.016391,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.030665,-0.12939,-0.10166,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.20396,-0.12951,-0.074888,0,0
3,GO LIPID EXPORT FROM CELL,0.34454,-0.12952,-0.076279,0,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.15361,-0.12967,-0.10602,0,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.034581,-0.12968,-0.14838,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.037792,-0.12982,-0.16137,0,0
3,GO MESENCHYME MORPHOGENESIS,0.050383,-0.13016,-0.1916,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.17553,-0.13017,-0.17166,0,0
3,GO STEROID ESTERIFICATION,0.21267,-0.13022,-0.19485,0,0
3,GO ARTERY MORPHOGENESIS,0.033564,-0.13048,-0.16173,0,0
3,GO DIOL METABOLIC PROCESS,0.62578,-0.13049,-0.059441,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.1643,-0.13085,-0.16358,0,0
3,GO ENDOTHELIAL CELL MIGRATION,0.086186,-0.13092,-0.13503,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.1402,-0.13094,-0.11594,0,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.093006,-0.13124,-0.16293,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.10533,-0.13144,-0.22109,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.42328,-0.13149,0.0049402,0,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.12771,-0.13227,-0.1967,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.50395,-0.1324,-0.043922,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.084004,-0.13256,-0.16135,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.11333,-0.1327,-0.22473,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.37614,-0.13271,-0.072367,0,0
3,GO MYELOID CELL DEVELOPMENT,0.041252,-0.13276,-0.10969,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.030665,-0.13277,-0.15091,0,0
3,GO RESPONSE TO X RAY,0.42328,-0.13278,-0.081545,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.036694,-0.1329,-0.13041,0,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.19139,-0.13298,-0.099927,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.18334,-0.1336,-0.12034,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.59207,-0.1337,-0.11025,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.10025,-0.13372,-0.18602,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.032572,-0.1338,-0.15917,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.11061,-0.13385,-0.13257,0,0
3,GO INTERLEUKIN 4 PRODUCTION,0.041252,-0.13395,-0.17133,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.042464,-0.13407,-0.13458,0,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.084004,-0.13422,-0.15557,0,0
3,GO REGULATION OF LIPID STORAGE,0.10025,-0.13457,-0.11958,0,0
3,GO PRE MIRNA PROCESSING,0.09779,-0.13464,-0.14589,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.13384,-0.13485,-0.13181,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.40267,-0.1354,-0.075272,0,0
3,GO PROSTATIC BUD FORMATION,0.33239,-0.13554,-0.20242,0,0
3,GO RESPONSE TO IRON ION,0.073757,-0.13577,-0.19788,0,0
3,GO MYOTUBE DIFFERENTIATION,0.066316,-0.13577,-0.13001,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.35072,-0.13596,-0.12911,0,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.033564,-0.13602,-0.19876,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.11333,-0.13603,-0.11257,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.059504,-0.13606,-0.14727,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.043706,-0.13627,-0.12421,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.45171,-0.13647,-0.14419,0,0
3,GO PHOTOTRANSDUCTION,0.09779,-0.13656,-0.1156,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.090686,-0.13667,-0.17288,0,0
3,GO PROTEIN DEMANNOSYLATION,0.33239,-0.13669,-0.11933,0,0
3,GO GRANULOCYTE MIGRATION,0.059504,-0.13675,-0.14308,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.056323,-0.13693,-0.17318,0,0
3,GO P38MAPK CASCADE,0.07572,-0.1371,-0.1569,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.10794,-0.13721,-0.203,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.19971,-0.13736,-0.17749,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.38927,-0.13739,-0.11035,0,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.29761,-0.13764,-0.11356,0,0
3,GO HISTONE H2A UBIQUITINATION,0.033564,-0.13782,-0.11951,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.26023,-0.13787,-0.069739,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.23088,-0.13795,-0.072829,0,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.053284,-0.13805,-0.12837,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.50395,-0.13829,-0.14554,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.04007,-0.13853,-0.15771,0,0
3,GO ERYTHROCYTE DEVELOPMENT,0.18334,-0.13864,-0.093294,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.88987,-0.1388,-0.069898,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.51944,-0.13894,-0.15697,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.038917,-0.13899,-0.11536,0,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.037792,-0.13905,-0.20116,0,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.056323,-0.13942,-0.14256,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.37614,-0.13949,-0.098516,0,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.056323,-0.13989,-0.44357,0,0
3,GO RESPONSE TO DSRNA,0.054786,-0.14013,-0.14665,0,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.051817,-0.14034,-0.10685,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.069955,-0.14038,-0.11059,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.036694,-0.14043,-0.22853,0,0
3,GO PIGMENT ACCUMULATION,0.24039,-0.14051,-0.11628,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.048983,-0.14063,-0.13122,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.13699,-0.14076,-0.15039,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.093006,-0.14077,-0.17904,0,0
3,GO MESODERM MORPHOGENESIS,0.042464,-0.14148,-0.17959,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.077726,-0.14153,-0.23078,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26023,-0.14157,-0.12218,0,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.1643,-0.14167,-0.11578,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.34454,-0.14169,-0.11492,0,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.04007,-0.14171,-0.19397,0,0
3,GO N GLYCAN PROCESSING,0.1643,-0.14193,-0.18442,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.047616,-0.14227,-0.156,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.038917,-0.14248,-0.1375,0,0
3,GO MICROTUBULE SEVERING,0.15712,-0.14298,-0.13903,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.066316,-0.14312,-0.19439,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.1794,-0.14358,-0.14623,0,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.057895,-0.14374,-0.21439,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.066316,-0.14377,-0.13936,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.24525,-0.14406,-0.17558,0,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.077726,-0.14414,-0.15756,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.13699,-0.14416,-0.1596,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.48118,-0.1442,-0.12014,0,0
3,GO GENETIC IMPRINTING,0.034581,-0.14443,-0.15864,0,0
3,GO COPULATION,0.28117,-0.14445,-0.10541,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.18334,-0.14501,-0.14244,0,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.047616,-0.14512,-0.18808,0,0
3,GO WATER HOMEOSTASIS,0.10794,-0.14513,-0.14897,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.1161,-0.14536,-0.19279,0,0
3,GO PINOCYTOSIS,0.093006,-0.14545,-0.17482,0,0
3,GO ACUTE PHASE RESPONSE,0.047616,-0.14547,-0.18347,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.10025,-0.14551,-0.13974,0,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.24039,-0.14658,-0.17003,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.20396,-0.1468,-0.098142,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.12472,-0.14726,-0.16224,0,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.048983,-0.14736,-0.20109,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.30892,-0.14757,-0.17823,0,0
3,GO FIBROBLAST MIGRATION,0.10277,-0.1476,-0.19275,0,0
3,GO RESPONSE TO ETHER,0.030665,-0.14769,-0.13977,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.036694,-0.14773,-0.25855,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.11333,-0.14775,-0.16265,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.084004,-0.14794,-0.15723,0,0
3,GO MRNA TRANSCRIPTION,0.1402,-0.14811,-0.12521,0,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.054786,-0.14814,-0.27507,0,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.10025,-0.14818,-0.17636,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.12472,-0.14826,-0.14838,0,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.054786,-0.14833,-0.16355,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.17553,-0.14847,-0.10651,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.55115,-0.14893,-0.064276,0,0
3,GO SARCOMERE ORGANIZATION,0.11333,-0.14918,-0.13047,0,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.12472,-0.14939,-0.23582,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.50395,-0.14951,-0.093931,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.15017,-0.14958,-0.19245,0,0
3,GO ACTIVATED T CELL PROLIFERATION,0.046281,-0.14971,-0.1527,0,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.10277,-0.14973,-0.13511,0,0
3,GO DETECTION OF CALCIUM ION,0.24039,-0.14974,-0.17088,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.084004,-0.14977,-0.15252,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.036694,-0.14981,-0.23589,0,0
3,GO RESPONSE TO TUMOR CELL,0.16068,-0.15021,-0.16664,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.084004,-0.15029,-0.15481,0,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.04007,-0.15047,-0.19717,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.088413,-0.15053,-0.16052,0,0
3,GO RESPONSE TO ESTRADIOL,0.17173,-0.15053,-0.094888,0,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.35072,-0.15082,-0.10786,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.053284,-0.15128,-0.13498,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.10533,-0.15142,-0.16936,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.29761,-0.15162,-0.14273,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.035624,-0.15166,-0.16755,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.064555,-0.15168,-0.18911,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.13699,-0.15187,-0.12242,0,0
3,GO REGULATION OF ICOSANOID SECRETION,0.36329,-0.15188,-0.087497,0,0
3,GO ENDOCRINE PROCESS,0.079775,-0.15241,-0.1452,0,0
3,GO NEURON FATE COMMITMENT,0.37614,-0.15257,-0.071154,0,0
3,GO MALE GENITALIA DEVELOPMENT,0.13074,-0.1528,-0.16346,0,0
3,GO GRANULOCYTE CHEMOTAXIS,0.056323,-0.15341,-0.13544,0,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.034581,-0.15358,-0.21541,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.050383,-0.15402,-0.20885,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.41634,-0.15414,-0.15009,0,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.047616,-0.15489,-0.20379,0,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.38267,-0.15497,-0.12714,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.04007,-0.15499,-0.21035,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.73147,-0.1553,-0.048604,0,0
3,GO PLATELET DEGRANULATION,0.06115,-0.15552,-0.206,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.13384,-0.15567,-0.15426,0,0
3,GO CYTOLYSIS,0.037792,-0.15573,-0.23296,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.47371,-0.15612,-0.21818,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.054786,-0.15674,-0.14172,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.038917,-0.15693,-0.24994,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.042464,-0.15764,-0.15983,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.25017,-0.15808,-0.13583,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.63434,-0.15848,-0.023094,0,0
3,GO DNA DEMETHYLATION,0.071835,-0.1589,-0.14158,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.58378,-0.15902,-0.03328,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.14679,-0.15903,-0.16594,0,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.04007,-0.15921,-0.2495,0,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.069955,-0.15945,-0.15102,0,0
3,GO HORMONE CATABOLIC PROCESS,0.044978,-0.15953,-0.2504,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.73147,-0.1596,-0.03764,0,0
3,GO STEROL IMPORT,0.10025,-0.15963,-0.16355,0,0
3,GO CELLULAR RESPONSE TO DSRNA,0.035624,-0.15965,-0.22189,0,0
3,GO TRANSCYTOSIS,0.054786,-0.15981,-0.14831,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.19971,-0.16033,-0.10403,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.1643,-0.1614,-0.13775,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.12472,-0.1621,-0.11304,0,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.10277,-0.16211,-0.15966,0,0
3,GO POSITIVE CHEMOTAXIS,0.066316,-0.16265,-0.17708,0,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.12472,-0.16279,-0.19074,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.30323,-0.16299,-0.093623,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.093006,-0.16302,-0.24705,0,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.14347,-0.16314,-0.29221,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.10025,-0.16326,-0.11461,0,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.20396,-0.16328,-0.18587,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.06115,-0.16346,-0.16647,0,0
3,GO HEART FORMATION,0.069955,-0.16413,-0.17749,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.1643,-0.16418,-0.10731,0,0
3,GO REGULATION OF RESPIRATORY BURST,0.035624,-0.16445,-0.19598,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.084004,-0.16462,-0.19408,0,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.13074,-0.16478,-0.12573,0,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.050383,-0.16499,-0.22155,0,0
3,GO RETINAL METABOLIC PROCESS,0.27583,-0.16517,-0.18848,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.11333,-0.16563,-0.16811,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.6516,-0.16607,-0.035391,0,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.066316,-0.16643,-0.14266,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.26536,-0.16643,-0.088955,0,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.032572,-0.16661,-0.15083,0,0
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.27056,-0.1668,-0.29849,0,0
3,GO RESPONSE TO INTERLEUKIN 2,0.057895,-0.16731,-0.18584,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.24039,-0.16788,-0.17285,0,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.056323,-0.16822,-0.28577,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.037792,-0.16824,-0.19117,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.095374,-0.16839,-0.13967,0,0
3,GO ASYMMETRIC CELL DIVISION,0.47371,-0.16844,-0.12451,0,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.035624,-0.16861,-0.27036,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.1402,-0.1691,-0.15239,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.40267,-0.16978,-0.12073,0,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.033564,-0.16993,-0.17351,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.051817,-0.1701,-0.2343,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.17173,-0.171,-0.15474,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.046281,-0.17108,-0.21049,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.27056,-0.17124,-0.10225,0,0
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.16068,-0.17154,-0.16929,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.55115,-0.17155,-0.077717,0,0
3,GO RESPONSE TO INTERFERON GAMMA,0.057895,-0.17158,-0.23249,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.31468,-0.1718,-0.18731,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.084004,-0.17184,-0.18058,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.081867,-0.17186,-0.19642,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.46631,-0.17207,-0.11439,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.26536,-0.1723,-0.069485,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.25516,-0.17249,-0.16964,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.10794,-0.17263,-0.18191,0,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.079775,-0.17263,-0.16891,0,0
3,GO CYTOPLASM ORGANIZATION,0.12472,-0.17267,-0.1439,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.38267,-0.17331,-0.11262,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.22164,-0.17344,-0.12756,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.069955,-0.17357,-0.17312,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.63434,-0.17358,-0.026907,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.36329,-0.1738,-0.076311,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.09779,-0.17394,-0.14445,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.1643,-0.17468,-0.18301,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.073757,-0.17469,-0.17449,0,0
3,GO ZYMOGEN ACTIVATION,0.04007,-0.17509,-0.27197,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.044978,-0.17525,-0.36611,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.40947,-0.17552,-0.11851,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.088413,-0.17553,-0.23429,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.63434,-0.17579,-0.03512,0,0
3,GO APPENDAGE DEVELOPMENT,0.032572,-0.17581,-0.16072,0,0
3,GO PRO B CELL DIFFERENTIATION,0.15017,-0.17685,-0.16055,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.48118,-0.17689,-0.092462,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.14679,-0.17698,-0.24213,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.11333,-0.17715,-0.1834,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.11333,-0.17752,-0.1912,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.16798,-0.17778,-0.15966,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.34454,-0.178,-0.22245,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.07572,-0.17822,-0.17022,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.077726,-0.17837,-0.13829,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.06115,-0.17849,-0.19465,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.1161,-0.1787,-0.23705,0,0
3,GO MACROPHAGE PROLIFERATION,0.079775,-0.17915,-0.26598,0,0
3,GO FUCOSYLATION,0.064555,-0.17931,-0.17012,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.046281,-0.17934,-0.17334,0,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.1794,-0.17958,-0.17189,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.081867,-0.17975,-0.1549,0,0
3,GO RESPONSE TO LEUCINE,0.38927,-0.17976,-0.073097,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.29206,-0.17993,-0.12959,0,0
3,GO SPERM CAPACITATION,0.053284,-0.18016,-0.14042,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.050383,-0.18057,-0.19137,0,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.042464,-0.18066,-0.22705,0,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.1643,-0.18162,-0.16304,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.056323,-0.1818,-0.23579,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.21267,-0.18204,-0.1592,0,0
3,GO UTERUS DEVELOPMENT,0.12179,-0.18205,-0.16962,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.073757,-0.18226,-0.20545,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.10025,-0.18253,-0.18806,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.2356,-0.18253,-0.086227,0,0
3,GO GENITALIA MORPHOGENESIS,0.24525,-0.18286,-0.16517,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.13699,-0.18365,-0.18988,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.062834,-0.1848,-0.22979,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.069955,-0.18501,-0.1805,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.09779,-0.1854,-0.14749,0,0
3,GO REGULATION OF GASTRULATION,0.044978,-0.18599,-0.17124,0,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.053284,-0.18744,-0.22506,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.093006,-0.18766,-0.18549,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.1643,-0.18823,-0.20185,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.07572,-0.18859,-0.24123,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.51167,-0.18863,-0.044445,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.53518,-0.18883,-0.094523,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.38267,-0.18884,-0.069096,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.38267,-0.189,-0.090938,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.066316,-0.18916,-0.17891,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.27056,-0.18954,-0.17819,0,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.037792,-0.19098,-0.18393,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.066316,-0.19114,-0.15698,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.1161,-0.19135,-0.13024,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.20396,-0.19138,-0.14066,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.27583,-0.19156,-0.087381,0,0
3,GO METANEPHROS MORPHOGENESIS,0.2356,-0.19207,-0.11502,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.051817,-0.19216,-0.25637,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.55115,-0.19225,-0.0025349,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.084004,-0.1932,-0.20567,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.1161,-0.19322,-0.13859,0,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.07572,-0.19341,-0.17476,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.038917,-0.19349,-0.23087,0,0
3,GO ACTIN CROSSLINK FORMATION,0.07572,-0.19445,-0.1623,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.079775,-0.19457,-0.23355,0,0
3,GO MICROVILLUS ASSEMBLY,0.073757,-0.19495,-0.25995,0,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.034581,-0.19616,-0.19704,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.27583,-0.1962,-0.17654,0,0
3,GO VASCULAR WOUND HEALING,0.13699,-0.19675,-0.15439,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.064555,-0.19678,-0.14641,0,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.038917,-0.19686,-0.18526,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.1643,-0.1974,-0.21346,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.043706,-0.19766,-0.21176,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.11061,-0.19807,-0.29619,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.077726,-0.19915,-0.29092,0,0
3,GO CELL JUNCTION MAINTENANCE,0.048983,-0.19956,-0.20579,0,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.047616,-0.19966,-0.16718,0,0
3,GO SEGMENT SPECIFICATION,0.04007,-0.19969,-0.26159,0,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.14679,-0.20052,-0.20882,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.35072,-0.20076,-0.12208,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.4445,-0.20085,-0.046275,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.13074,-0.20096,-0.13789,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.093006,-0.20139,-0.13117,0,0
3,GO MALE SEX DETERMINATION,0.033564,-0.20182,-0.26271,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,0.047616,-0.20191,-0.22224,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.044978,-0.2021,-0.16481,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.17553,-0.20309,-0.23224,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.056323,-0.20355,-0.16091,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.056323,-0.204,-0.23807,0,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.050383,-0.20415,-0.17482,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.33239,-0.20475,-0.10281,0,0
3,GO SECRETION BY TISSUE,0.07572,-0.2054,-0.16751,0,0
3,GO ESTROUS CYCLE,0.037792,-0.20577,-0.2519,0,0
3,GO ER OVERLOAD RESPONSE,0.18733,-0.20578,-0.19998,0,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.042464,-0.20585,-0.21761,0,0
3,GO LIVER MORPHOGENESIS,0.09779,-0.20587,-0.2296,0,0
3,GO FORELIMB MORPHOGENESIS,0.086186,-0.20695,-0.18098,0,0
3,GO PARTURITION,0.35697,-0.20727,-0.12751,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.032572,-0.2075,-0.17782,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.056323,-0.20831,-0.20494,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.079775,-0.20876,-0.22043,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.062834,-0.20921,-0.26491,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.06115,-0.20926,-0.18546,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.093006,-0.21006,-0.23302,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.64294,-0.21007,0.0039734,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.4445,-0.21047,0.022302,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.10794,-0.21281,-0.16515,0,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.15017,-0.21311,-0.34046,0,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.035624,-0.21411,-0.20735,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.11333,-0.21432,-0.1635,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.14347,-0.21498,-0.15327,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.04007,-0.21601,-0.26997,0,0
3,GO FUCOSE METABOLIC PROCESS,0.090686,-0.21605,-0.20176,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.068115,-0.21619,-0.25437,0,0
3,GO HAIR CELL DIFFERENTIATION,0.037792,-0.21623,-0.27064,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.088413,-0.2171,-0.26482,0,0
3,GO BRONCHUS DEVELOPMENT,0.11333,-0.21745,-0.23395,0,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.044978,-0.21789,-0.23671,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19552,-0.2185,-0.25013,0,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.16068,-0.21981,-0.16967,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.35697,-0.21986,-0.069936,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.038917,-0.22005,-0.18213,0,0
3,GO PERICARDIUM DEVELOPMENT,0.10533,-0.22067,-0.16625,0,0
3,GO RENAL ABSORPTION,0.1402,-0.22085,-0.24109,0,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.04007,-0.22199,-0.22082,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.27056,-0.22199,-0.11281,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.037792,-0.22274,-0.22373,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.079775,-0.2234,-0.28194,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.31468,-0.22503,-0.18684,0,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.066316,-0.22558,-0.20902,0,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.12472,-0.22576,-0.19637,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.069955,-0.22587,-0.2291,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.29206,-0.22613,-0.18169,0,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.034581,-0.22719,-0.29096,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.1402,-0.22751,-0.15995,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.033564,-0.2278,-0.2347,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.047616,-0.22783,-0.30959,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.12771,-0.22859,-0.20343,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.071835,-0.22888,-0.31109,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.042464,-0.22906,-0.17277,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.062834,-0.23268,-0.16965,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.24039,-0.23319,-0.17809,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.12179,-0.23789,-0.40634,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.053284,-0.23866,-0.24582,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.22622,-0.2406,-0.17092,0,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.081867,-0.24199,-0.20529,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.038917,-0.24253,-0.20662,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.1794,-0.24289,-0.16176,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.13699,-0.24306,-0.20909,0,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.051817,-0.24318,-0.28961,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.32052,-0.24434,-0.079261,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.1161,-0.24506,-0.38183,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.14347,-0.24532,-0.12066,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.056323,-0.2471,-0.22732,0,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.13699,-0.24725,-0.23297,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.062834,-0.24801,-0.28075,0,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.095374,-0.25168,-0.24876,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.043706,-0.25392,-0.22125,0,0
3,GO EOSINOPHIL CHEMOTAXIS,0.071835,-0.25401,-0.34132,0,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.1794,-0.25452,-0.39933,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.1161,-0.25488,-0.18065,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.043706,-0.25491,-0.18835,0,0
3,GO AMYLOID FIBRIL FORMATION,0.12179,-0.25515,-0.23666,0,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.038917,-0.25542,-0.20665,0,0
3,GO MYOBLAST MIGRATION,0.086186,-0.25638,-0.2734,0,0
3,GO HEART INDUCTION,0.068115,-0.25719,-0.25463,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.062834,-0.25723,-0.23062,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.28117,-0.25966,-0.19238,0,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.044978,-0.26029,-0.23886,0,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.086186,-0.26194,-0.19945,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.23088,-0.26264,-0.17093,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.041252,-0.26336,-0.23486,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.18733,-0.26408,-0.20399,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.041252,-0.26811,-0.30824,0,0
3,GO REFLEX,0.066316,-0.26824,-0.29042,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.47371,-0.2686,-0.19584,0,0
3,GO EOSINOPHIL MIGRATION,0.030665,-0.26876,-0.34607,0,0
3,GO RESPONSE TO COPPER ION,0.068115,-0.26989,-0.27406,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.064555,-0.27005,-0.25209,0,0
3,GO MEMBRANE RAFT ORGANIZATION,0.042464,-0.27525,-0.33572,0,0
3,GO SPINAL CORD PATTERNING,0.06115,-0.27593,-0.24519,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.10025,-0.27616,-0.24094,0,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.079775,-0.27635,-0.27542,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.18733,-0.27987,-0.12477,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.13074,-0.28047,-0.2457,0,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.038917,-0.28069,-0.29848,0,0
3,GO LIPID DIGESTION,0.053284,-0.28154,-0.31663,0,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.033564,-0.28193,-0.29137,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.084004,-0.28331,-0.34515,0,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.10533,-0.286,-0.30941,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.10794,-0.28609,-0.22328,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.19971,-0.28652,-0.22521,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.07572,-0.28685,-0.24568,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.12179,-0.28946,-0.24096,0,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.079775,-0.29194,-0.28421,0,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.095374,-0.29427,-0.24965,0,0
3,GO INTERLEUKIN 13 PRODUCTION,0.062834,-0.29473,-0.24868,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.051817,-0.29604,-0.28181,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.2356,-0.29652,-0.15494,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.036694,-0.29957,-0.37758,0,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.090686,-0.30316,-0.37596,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.1161,-0.3067,-0.29413,0,0
3,GO LIPOXYGENASE PATHWAY,0.047616,-0.31164,-0.33231,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.29761,-0.31217,-0.12566,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.13384,-0.31251,-0.26662,0,0
3,GO DNA DEAMINATION,0.1161,-0.31622,-0.25987,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.031606,-0.31636,-0.49047,0,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.077726,-0.31679,-0.20462,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.073757,-0.31788,-0.29421,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.081867,-0.31802,-0.24494,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.10025,-0.32882,-0.3614,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.038917,-0.32983,-0.36135,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.036694,-0.3307,-0.31776,0,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.030665,-0.34176,-0.49687,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.037792,-0.34419,-0.32081,0,0
3,GO BIOLOGICAL PHASE,0.18733,-0.35204,-0.31721,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.054786,-0.35634,-0.32025,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.059504,-0.35793,-0.27859,0,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.073757,-0.36143,-0.26214,0,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.031606,-0.3634,-0.40974,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.053284,-0.36534,-0.27643,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.10794,-0.38056,-0.33138,0,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.068115,-0.38631,-0.34014,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.032572,-0.39007,-0.36755,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.29206,-0.39184,-0.21687,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.041252,-0.39567,-0.33038,0,0
3,GO CARDIOBLAST PROLIFERATION,0.28117,-0.39607,-0.23833,0,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.031606,-0.40661,-0.31902,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.1402,-0.41576,-0.21678,0,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.044978,-0.41947,-0.30462,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.15361,-0.4201,-0.29267,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.088413,-0.42512,-0.29688,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.053284,-0.43645,-0.32204,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.034581,-0.49198,-0.71969,0,0
3,GO NEURON FATE SPECIFICATION,0.034581,-0.49249,-0.32859,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.053284,-0.49584,-0.45034,0,0
3,GO SEROTONIN METABOLIC PROCESS,0.11061,-0.49938,-0.27819,0,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.036694,-0.50205,-0.28599,0,0
3,GO LEYDIG CELL DIFFERENTIATION,0.059504,-0.5185,-0.38819,0,0
3,GO CYTIDINE TO URIDINE EDITING,0.031606,-0.57556,-0.51645,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.042464,-0.57939,-0.36633,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.041252,-0.58661,-0.87502,0,0
3,GO GANGLION DEVELOPMENT,0.053284,-0.60324,-0.38307,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0015095,1.2651,1.1755,1,1
4,GO LIPID DROPLET FORMATION,0.00014528,0.7548,0.80322,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00094871,0.71616,0.6793,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0027694,0.71125,0.53364,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.011648,0.70207,0.60347,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,0.00090875,0.69263,0.77693,1,1
4,GO HISTAMINE SECRETION,0.00027004,0.68356,0.74019,1,1
4,GO SEROTONIN METABOLIC PROCESS,5.9259e-05,0.68329,0.8364,1,1
4,GO DETECTION OF OTHER ORGANISM,0.00040918,0.68042,0.64054,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00042822,0.67596,0.62187,1,1
4,GO RESPONSE TO COPPER ION,0.0010336,0.66978,0.65659,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00037344,0.66854,0.67785,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.0018542,0.66019,0.55103,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,9.8065e-05,0.65865,0.71551,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0025586,0.65828,0.68547,1,1
4,GO TOLERANCE INDUCTION,0.0057193,0.65655,0.60386,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00035669,0.64717,0.60213,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,0.0002237,0.64569,0.57742,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.0002237,0.63649,0.61107,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0025586,0.63479,0.49251,1,1
4,GO EOSINOPHIL MIGRATION,0.0025586,0.63379,0.51321,1,1
4,GO HISTAMINE TRANSPORT,0.00024585,0.62554,0.73044,1,1
4,GO RESPONSE TO EPINEPHRINE,0.0017084,0.61791,0.51562,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00051298,0.6176,0.59097,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.0009903,0.61671,0.53335,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00079804,0.61082,0.57754,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0085133,0.60757,0.49547,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0129,0.60377,0.46359,1,1
4,GO ADRENAL GLAND DEVELOPMENT,0.001448,0.60219,0.5357,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.0040811,0.60018,0.48617,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0018542,0.59685,0.60466,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0021804,0.59671,0.52155,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00016797,0.5965,0.66058,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0066217,0.59541,0.52545,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0068665,0.59044,0.50391,1,1
4,GO LIVER MORPHOGENESIS,0.0049293,0.58011,0.45188,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0061556,0.57229,0.48743,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00027004,0.56833,0.57045,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.014755,0.55864,0.45061,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,0.00023453,0.55827,0.49603,1,1
4,GO O GLYCAN PROCESSING,0.00028296,0.55803,0.52929,1,1
4,GO LIPOXYGENASE PATHWAY,0.0055117,0.54679,0.44649,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.0010786,0.54441,0.56462,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.0009903,0.54122,0.48744,1,1
4,GO RESPONSE TO COLD,0.00039093,0.53636,0.46701,1,1
4,GO REGULATION OF ANOIKIS,0.0017084,0.5339,0.56989,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0037806,0.53385,0.48409,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.021799,0.52494,0.40626,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0022699,0.52362,0.39561,1,1
4,GO REGULATION OF PLATELET AGGREGATION,0.0028806,0.52314,0.47735,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00024585,0.52194,0.46386,1,1
4,GO INSEMINATION,0.0035004,0.52086,0.47076,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0088198,0.51547,0.45362,1,1
4,GO RESPONSE TO REDOX STATE,0.00034064,0.51455,0.45696,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0035004,0.50835,0.43491,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0017799,0.50826,0.52015,1,1
4,GO PARTURITION,0.0011254,0.50747,0.47454,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00031055,0.50499,0.53129,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0029959,0.50304,0.43165,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0061556,0.50051,0.39483,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00019396,0.50001,0.49585,1,1
4,GO DETECTION OF CALCIUM ION,0.0019312,0.49795,0.5021,1,1
4,GO TOXIN METABOLIC PROCESS,0.0011741,0.49288,0.48021,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0063849,0.49282,0.38575,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0055117,0.49035,0.50273,1,1
4,GO RENAL ABSORPTION,0.01427,0.48303,0.41324,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0026621,0.48086,0.46438,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0085133,0.47833,0.35726,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0032392,0.47832,0.42511,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0138,0.47709,0.38886,1,1
4,GO RESPONSE TO MAGNESIUM ION,0.0015733,0.47561,0.50605,1,1
4,GO REGULATION OF PLATELET ACTIVATION,0.00094871,0.47354,0.43216,1,1
4,GO REGULATION OF B CELL PROLIFERATION,0.00042822,0.47293,0.40867,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.005311,0.46773,0.39279,1,1
4,GO HEART TRABECULA FORMATION,0.0025586,0.46733,0.45932,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00039093,0.46445,0.43721,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0012773,0.46264,0.4973,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0025586,0.45926,0.51602,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0039282,0.45741,0.44784,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0010336,0.45735,0.56528,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.013344,0.45582,0.39471,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.00037344,0.45535,0.49126,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0024588,0.45208,0.44016,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.01427,0.45177,0.38198,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0076503,0.45174,0.47726,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00040918,0.4498,0.4556,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0021804,0.44927,0.50105,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.0023626,0.44903,0.37877,1,1
4,GO REGULATION OF BONE REMODELING,0.00076401,0.44732,0.39472,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00049043,0.44683,0.42721,1,1
4,GO GLIAL CELL FATE COMMITMENT,0.01247,0.44622,0.44697,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.0094624,0.44454,0.43929,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012053,0.4444,0.34763,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.0085133,0.44408,0.40761,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.00051298,0.44243,0.50431,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0022699,0.44152,0.40259,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00094871,0.44108,0.39727,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0033675,0.44013,0.46907,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00039093,0.44005,0.39019,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.021117,0.43917,0.31576,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.011648,0.43724,0.33967,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0022699,0.43718,0.46058,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0018542,0.43691,0.40971,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0020112,0.43681,0.40221,1,1
4,GO REGULATION OF GASTRIC ACID SECRETION,0.0082164,0.43371,0.32822,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.001448,0.42837,0.56663,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0031154,0.42757,0.38101,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017799,0.42651,0.50207,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0039282,0.42631,0.42854,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0010786,0.42629,0.3465,1,1
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0057193,0.42517,0.3914,1,1
4,GO REGULATION OF NEURON MATURATION,0.00094871,0.42455,0.42683,1,1
4,GO SEGMENT SPECIFICATION,0.010146,0.42388,0.377,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0082164,0.42286,0.43051,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0076503,0.42245,0.42448,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0032392,0.42231,0.34317,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0033675,0.42162,0.42773,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0013889,0.4209,0.38608,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.01247,0.42069,0.34165,1,1
4,GO LUNG CELL DIFFERENTIATION,0.0076503,0.41774,0.45869,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00083347,0.41704,0.37382,1,1
4,GO REGULATION OF TISSUE REMODELING,0.00076401,0.41607,0.3625,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0138,0.41497,0.32606,1,1
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0094624,0.41442,0.32932,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.01427,0.41414,0.34178,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.02631,0.41363,0.31053,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00058654,0.4117,0.37698,1,1
4,GO B CELL APOPTOTIC PROCESS,0.00051298,0.41083,0.4856,1,1
4,GO INTESTINAL ABSORPTION,0.00044809,0.41055,0.42417,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0028806,0.40664,0.37644,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0022699,0.40638,0.41014,1,1
4,GO REGULATION OF CELL KILLING,0.0037806,0.40579,0.3227,1,1
4,GO RESPONSE TO CAFFEINE,0.00079804,0.40499,0.38235,1,1
4,GO ANOIKIS,0.001448,0.40394,0.44849,1,1
4,GO KERATINOCYTE DEVELOPMENT,0.015254,0.40367,0.39149,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.0029959,0.40238,0.29678,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015095,0.4007,0.33286,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0020112,0.40051,0.32906,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.020453,0.40029,0.30271,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0045725,0.39988,0.33699,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0025586,0.39927,0.33657,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0174,0.39743,0.25278,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0016396,0.39681,0.36806,1,1
4,GO REGULATION OF ACROSOME REACTION,0.015254,0.39623,0.31227,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0051169,0.39485,0.48919,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.024724,0.39466,0.30746,1,1
4,GO MAGNESIUM ION TRANSPORT,0.00087036,0.39251,0.33529,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.0036381,0.38993,0.33617,1,1
4,GO REGULATION OF T CELL MIGRATION,0.001448,0.38839,0.33501,1,1
4,GO PROTEIN KINASE C SIGNALING,0.0045725,0.38766,0.3474,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.011648,0.38529,0.39253,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.023222,0.38326,0.2801,1,1
4,GO BONE RESORPTION,0.0010336,0.38277,0.32616,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0066217,0.38237,0.40311,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0040811,0.38049,0.37101,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.017977,0.38039,0.26188,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.010146,0.37913,0.40556,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0033675,0.37767,0.32901,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.0023626,0.37661,0.38365,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0022699,0.37648,0.40288,1,1
4,GO RESPONSE TO PAIN,0.0073805,0.37613,0.32143,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0025586,0.37485,0.33303,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0027694,0.3735,0.29222,1,1
4,GO NEURONAL ACTION POTENTIAL,0.0129,0.37243,0.4286,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0025586,0.372,0.35514,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0057193,0.37162,0.32114,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.00046881,0.37124,0.36071,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.013344,0.37054,0.3112,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0085133,0.36663,0.35136,1,1
4,GO MATURE B CELL DIFFERENTIATION,0.015254,0.36598,0.34379,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.01684,0.3657,0.33188,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.0035004,0.36333,0.32452,1,1
4,GO VASCULAR WOUND HEALING,0.0068665,0.36245,0.44852,1,1
4,GO B CELL PROLIFERATION,0.00029645,0.35973,0.32766,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.01247,0.35919,0.4774,1,1
4,GO LIPID TRANSLOCATION,0.00073133,0.35887,0.32305,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.017977,0.35848,0.263,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0012773,0.35837,0.36918,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0012247,0.3573,0.34922,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00040918,0.35721,0.31247,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0049293,0.35562,0.30779,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010786,0.35506,0.36345,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,0.0027694,0.35404,0.38663,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.012053,0.3539,0.25804,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0029959,0.35293,0.36946,1,1
4,GO INTERLEUKIN 12 PRODUCTION,0.0019312,0.35177,0.31898,1,1
4,GO TISSUE REMODELING,0.0025586,0.35167,0.28471,1,1
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00069995,0.35152,0.37205,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.014755,0.34963,0.29616,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0024588,0.34835,0.30268,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,0.0020943,0.34793,0.33595,1,1
4,GO VASODILATION,0.0057193,0.34758,0.29524,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.011648,0.34617,0.2464,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0018542,0.34506,0.34071,1,1
4,GO WHITE FAT CELL DIFFERENTIATION,0.0032392,0.34281,0.30536,1,1
4,GO PARENTAL BEHAVIOR,0.029747,0.34215,0.30093,1,1
4,GO RESPONSE TO INTERLEUKIN 2,0.00090875,0.34214,0.34549,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.010146,0.34074,0.319,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.004403,0.3402,0.29755,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0020943,0.33918,0.27254,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0076503,0.33891,0.32083,1,1
4,GO LIPID DROPLET ORGANIZATION,0.0021804,0.33762,0.27775,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0017084,0.33762,0.32008,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00024585,0.3367,0.34447,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.014755,0.33509,0.25652,1,1
4,GO REGULATION OF FERTILIZATION,0.0049293,0.33461,0.26202,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.024724,0.33435,0.2999,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.028854,0.33388,0.36505,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0036381,0.33383,0.31594,1,1
4,GO REGULATION OF ICOSANOID SECRETION,0.00066983,0.33334,0.34416,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0076503,0.33327,0.28895,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0040811,0.3328,0.32054,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0018542,0.33193,0.30089,1,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.01857,0.33178,0.28423,1,1
4,GO FOAM CELL DIFFERENTIATION,0.0035004,0.33166,0.30274,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0016396,0.33059,0.32796,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0020112,0.33029,0.28997,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0097991,0.32902,0.31705,1,1
4,GO ESTROUS CYCLE,0.0073805,0.32883,0.31795,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.016296,0.32864,0.25541,1,1
4,GO REPRODUCTIVE BEHAVIOR,0.0035004,0.32846,0.25929,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.011648,0.32792,0.22538,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.02631,0.3276,0.31214,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0023626,0.32679,0.32945,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0022699,0.32669,0.25461,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.01857,0.32626,0.42937,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.011648,0.3249,0.31847,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00032527,0.32477,0.38173,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0094624,0.3247,0.27236,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.021799,0.3233,0.40783,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0049293,0.32317,0.30836,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00023453,0.32182,0.29992,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.00064092,0.32054,0.44313,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00069995,0.31891,0.29928,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0061556,0.31866,0.30331,1,1
4,GO PROTEIN DEMANNOSYLATION,0.0027694,0.31846,0.34459,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.011255,0.31749,0.26423,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0094624,0.31471,0.38161,1,1
4,GO BONE REMODELING,0.0020943,0.31399,0.29258,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.0035004,0.31395,0.24884,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.0138,0.31356,0.2601,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.004403,0.31317,0.27798,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0082164,0.31316,0.3254,1,1
4,GO DIET INDUCED THERMOGENESIS,0.0085133,0.31313,0.28559,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0018542,0.31263,0.31804,1,1
4,GO MAST CELL MEDIATED IMMUNITY,0.0037806,0.31225,0.28681,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.005311,0.3119,0.34522,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.010146,0.31117,0.21969,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0024588,0.31088,0.30881,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.028854,0.30861,0.26137,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.0022699,0.3083,0.32888,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.023963,0.30786,0.28348,1,1
4,GO RESPONSE TO THYROID HORMONE,0.029747,0.30725,0.24496,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.014755,0.30686,0.32177,1,1
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0174,0.30667,0.22795,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0076503,0.30622,0.29304,1,1
4,GO CELL KILLING,0.0022699,0.30592,0.25031,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.0017084,0.30564,0.27358,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.010874,0.3037,0.21251,1,1
4,GO REGULATION OF B CELL ACTIVATION,0.0010336,0.30327,0.28056,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0018542,0.30158,0.28167,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0032392,0.30156,0.36382,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0039282,0.30129,0.24454,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0049293,0.30094,0.25666,1,1
4,GO GASTRIC ACID SECRETION,0.024724,0.30029,0.23477,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.0026621,0.29997,0.32839,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0088198,0.29957,0.27189,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.01857,0.29903,0.23418,1,1
4,GO GLYCOSYLATION,0.00064092,0.29879,0.27915,1,1
4,GO TRANSPOSITION,0.021117,0.29851,0.30238,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0020943,0.29823,0.27081,1,1
4,GO WATER HOMEOSTASIS,0.0059338,0.29653,0.2721,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.010874,0.29554,0.25126,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.005311,0.29529,0.2405,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.0026621,0.29464,0.32554,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.011648,0.29402,0.2392,1,1
4,GO MUSCLE HYPERTROPHY,0.0094624,0.29281,0.22038,1,1
4,GO RESPIRATORY BURST,0.0047478,0.29266,0.30355,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0049293,0.29241,0.27003,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.01684,0.29139,0.22255,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0055117,0.29084,0.26206,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.010505,0.29011,0.27894,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0066217,0.28965,0.24393,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.0042393,0.28965,0.31706,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.01918,0.28783,0.19865,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.0031154,0.28766,0.23712,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0040811,0.28735,0.3073,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0045725,0.28731,0.33315,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0011254,0.28731,0.25769,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0097991,0.28648,0.26131,1,1
4,GO MAST CELL ACTIVATION,0.0033675,0.28578,0.28241,1,1
4,GO INTERLEUKIN 6 PRODUCTION,0.0018542,0.28571,0.24101,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.0025586,0.28516,0.33375,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0091361,0.28391,0.27402,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025586,0.28345,0.25078,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0071194,0.28335,0.27919,1,1
4,GO KERATINIZATION,0.0019312,0.28322,0.28072,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.004403,0.28111,0.26961,1,1
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.014755,0.28076,0.22038,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0031154,0.2805,0.2474,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.017977,0.28023,0.22327,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0029959,0.27996,0.25958,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0036381,0.27967,0.24598,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.015767,0.27901,0.29618,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0085133,0.27882,0.24263,1,1
4,GO LYTIC VACUOLE ORGANIZATION,0.00064092,0.27875,0.29716,1,1
4,GO NOTCH SIGNALING PATHWAY,0.0066217,0.27773,0.21966,1,1
4,GO CORNIFICATION,0.0035004,0.27741,0.29001,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0032392,0.27635,0.23173,1,1
4,GO ENDOCARDIUM DEVELOPMENT,0.028854,0.27541,0.29884,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.017977,0.27537,0.27271,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0174,0.27411,0.23707,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0040811,0.27374,0.24451,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0031154,0.27368,0.25242,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0029959,0.27282,0.3435,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.020453,0.27271,0.19777,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.019808,0.27263,0.26015,1,1
4,GO RESPONSE TO ALKALOID,0.0047478,0.27226,0.21872,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.00090875,0.27199,0.28176,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.015767,0.27008,0.22779,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.014755,0.26998,0.25755,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0055117,0.26973,0.25456,1,1
4,GO FUCOSYLATION,0.023222,0.26825,0.22757,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.0082164,0.26799,0.22275,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0036381,0.26721,0.29256,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0055117,0.26711,0.23883,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.0079288,0.26569,0.20614,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.022501,0.26537,0.24049,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.0066217,0.26533,0.24835,1,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.028854,0.26458,0.24522,1,1
4,GO EATING BEHAVIOR,0.0039282,0.2638,0.2464,1,1
4,GO AMINE METABOLIC PROCESS,0.0010786,0.26353,0.23432,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0039282,0.26288,0.2529,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0040811,0.26207,0.25175,1,1
4,GO RESPONSE TO METAL ION,0.0037806,0.2613,0.20917,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0082164,0.25897,0.30946,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0091361,0.25842,0.23063,1,1
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0047478,0.25796,0.22667,1,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0088198,0.25696,0.275,1,1
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.0094624,0.25662,0.201,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.0013321,0.25555,0.23689,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0010786,0.2552,0.23235,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.010505,0.25519,0.21084,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.010874,0.25498,0.22305,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0028806,0.25484,0.30601,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0085133,0.25434,0.20982,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0037806,0.25428,0.26725,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0073805,0.25337,0.24577,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0097991,0.25314,0.22045,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00069995,0.25241,0.25241,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.0040811,0.25237,0.23428,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.015767,0.25192,0.29619,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.01427,0.25171,0.22925,1,1
4,GO CELL CELL ADHESION,0.011255,0.25117,0.17678,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.023222,0.25106,0.22862,1,1
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.01857,0.25083,0.28106,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.022501,0.25076,0.21752,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0042393,0.25072,0.23686,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.01684,0.25045,0.19197,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.012053,0.25014,0.1851,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0020112,0.24999,0.22624,1,1
4,GO STEROL METABOLIC PROCESS,0.0029959,0.24947,0.20906,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0063849,0.24935,0.23403,1,1
4,GO RESPONSE TO GONADOTROPIN,0.013344,0.24912,0.22702,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,0.0019312,0.24845,0.28434,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.025507,0.24809,0.20625,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.010505,0.24778,0.25196,1,1
4,GO PHOSPHOLIPID TRANSPORT,0.0020112,0.2461,0.21984,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0063849,0.24569,0.21913,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.0028806,0.24442,0.21162,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0061556,0.24439,0.27582,1,1
4,GO DENDRITE EXTENSION,0.0026621,0.24399,0.35912,1,1
4,GO STEROID METABOLIC PROCESS,0.0036381,0.24388,0.20257,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.017977,0.24272,0.27508,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0016396,0.2426,0.23441,1,1
4,GO T CELL PROLIFERATION,0.014755,0.24196,0.1942,1,1
4,GO MEMBRANE DEPOLARIZATION,0.010146,0.24162,0.24313,1,1
4,GO MYOTUBE DIFFERENTIATION,0.0015733,0.24141,0.23755,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.024724,0.24036,0.16859,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0017084,0.2403,0.2708,1,1
4,GO LEUKOCYTE PROLIFERATION,0.0079288,0.24017,0.2042,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.021117,0.23912,0.17537,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0020112,0.23902,0.22111,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0012247,0.23883,0.1847,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0066217,0.23804,0.2827,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0015733,0.23786,0.23591,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0138,0.23753,0.26115,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.0079288,0.23732,0.20017,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.01427,0.23707,0.20918,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.0040811,0.23687,0.19143,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,0.0012773,0.23686,0.24223,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.011255,0.2366,0.18782,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.016296,0.23586,0.19088,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.02631,0.23563,0.18531,1,1
4,GO MALE GENITALIA DEVELOPMENT,0.023222,0.23361,0.23277,1,1
4,GO B CELL ACTIVATION,0.0032392,0.23244,0.19987,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.017977,0.23177,0.18814,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01427,0.2316,0.29168,1,1
4,GO CELLULAR RESPONSE TO STARVATION,0.0029959,0.23155,0.2175,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0091361,0.2309,0.18088,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0091361,0.23081,0.2441,1,1
4,GO STEROL HOMEOSTASIS,0.010146,0.23074,0.22364,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.0018542,0.23061,0.20616,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.0174,0.22981,0.19136,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.013344,0.2296,0.16807,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.0020112,0.2293,0.23515,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.0026621,0.2287,0.21436,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.020453,0.22866,0.22416,1,1
4,GO CARBOHYDRATE TRANSPORT,0.0036381,0.22861,0.18728,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.0013321,0.22856,0.22922,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0010336,0.2285,0.19534,1,1
4,GO DRUG METABOLIC PROCESS,0.0094624,0.22825,0.2842,1,1
4,GO TISSUE HOMEOSTASIS,0.005311,0.22773,0.17554,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.01918,0.22768,0.21081,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.028854,0.2272,0.20902,1,1
4,GO AMYLOID BETA FORMATION,0.025507,0.22697,0.18552,1,1
4,GO MEMBRANE FUSION,0.0073805,0.22514,0.18082,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.020453,0.22504,0.20039,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0059338,0.22501,0.21089,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032392,0.22467,0.24429,1,1
4,GO EPIDERMIS DEVELOPMENT,0.011255,0.22445,0.17492,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.010146,0.22422,0.22111,1,1
4,GO NEURON MATURATION,0.0036381,0.2237,0.26783,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0129,0.22327,0.1842,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0066217,0.22324,0.16971,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.0068665,0.22322,0.21061,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0085133,0.22316,0.2942,1,1
4,GO LIPID LOCALIZATION,0.0021804,0.22286,0.19933,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,0.0057193,0.22274,0.19217,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0174,0.22217,0.28382,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0055117,0.2206,0.21689,1,1
4,GO CHOLESTEROL STORAGE,0.0097991,0.22034,0.28734,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.012053,0.21943,0.20058,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.005311,0.21899,0.19152,1,1
4,GO HORMONE METABOLIC PROCESS,0.023963,0.21789,0.177,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.020453,0.21786,0.22653,1,1
4,GO RESPONSE TO STEROL,0.025507,0.21766,0.20962,1,1
4,GO PEPTIDE SECRETION,0.001448,0.21763,0.20112,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00083347,0.21753,0.21644,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.027136,0.21749,0.16063,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0055117,0.2173,0.21944,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0174,0.21673,0.1807,1,1
4,GO RESPONSE TO ALCOHOL,0.010505,0.21608,0.16292,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.014755,0.21411,0.18336,1,1
4,GO REGULATION OF PEPTIDE SECRETION,0.0011741,0.21328,0.20228,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0097991,0.21304,0.17363,1,1
4,GO MATING,0.010146,0.213,0.18897,1,1
4,GO ACID SECRETION,0.005311,0.21299,0.21306,1,1
4,GO FAT CELL DIFFERENTIATION,0.0045725,0.21293,0.21615,1,1
4,GO RESPONSE TO COCAINE,0.029747,0.21288,0.19052,1,1
4,GO GOLGI RIBBON FORMATION,0.020453,0.21276,0.18493,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0076503,0.21142,0.17852,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0045725,0.21091,0.21966,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.023222,0.2102,0.20536,1,1
4,GO RENAL SYSTEM PROCESS,0.016296,0.21003,0.16895,1,1
4,GO SODIUM ION HOMEOSTASIS,0.0063849,0.20987,0.19963,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0021804,0.20981,0.23799,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.0061556,0.20977,0.15632,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0076503,0.20848,0.18596,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0051169,0.20845,0.15983,1,1
4,GO HORMONE TRANSPORT,0.0015095,0.20843,0.22631,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00069995,0.20812,0.20159,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.029747,0.20803,0.15231,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0138,0.20766,0.20765,1,1
4,GO OOCYTE DIFFERENTIATION,0.0138,0.20764,0.16415,1,1
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0079288,0.2074,0.18771,1,1
4,GO CYTOKINE SECRETION,0.010505,0.20708,0.19699,1,1
4,GO REGULATION OF GLIOGENESIS,0.01684,0.20641,0.18029,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.017977,0.20632,0.25965,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.01857,0.20625,0.17848,1,1
4,GO ENERGY HOMEOSTASIS,0.016296,0.20609,0.23619,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.023222,0.20571,0.21157,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0020112,0.20464,0.25669,1,1
4,GO SKIN DEVELOPMENT,0.015254,0.20432,0.17437,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0027694,0.20301,0.20491,1,1
4,GO REGULATION OF APPETITE,0.0049293,0.20267,0.20225,1,1
4,GO REGULATION OF HORMONE LEVELS,0.0029959,0.20225,0.1984,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.010146,0.20194,0.18636,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.01684,0.20163,0.20939,1,1
4,GO ACTIN NUCLEATION,0.0057193,0.20137,0.18428,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.020453,0.20033,0.17809,1,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.010874,0.20029,0.21182,1,1
4,GO ADAPTIVE THERMOGENESIS,0.00083347,0.19946,0.22096,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.005311,0.19921,0.20718,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0036381,0.19871,0.19153,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0079288,0.19849,0.17099,1,1
4,GO INSULIN SECRETION,0.0022699,0.19848,0.2077,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.02631,0.19742,0.16392,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0017799,0.19656,0.23524,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.011255,0.19561,0.18308,1,1
4,GO PEPTIDE HORMONE SECRETION,0.0020112,0.19507,0.21849,1,1
4,GO BIOMINERALIZATION,0.01918,0.19488,0.17376,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.0097991,0.19458,0.18413,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027136,0.19422,0.1578,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.012053,0.1939,0.198,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.023963,0.19359,0.14062,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.023963,0.19328,0.35554,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.01427,0.19306,0.24542,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0042393,0.1925,0.20064,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0076503,0.19201,0.17498,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.005311,0.19011,0.16465,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.01684,0.18993,0.17953,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.028854,0.18952,0.24235,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.001448,0.18945,0.19223,1,1
4,GO EPITHELIUM DEVELOPMENT,0.01247,0.18914,0.14096,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0079288,0.18905,0.21721,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0042393,0.18883,0.18963,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.0037806,0.18821,0.1562,1,1
4,GO GLIAL CELL DEVELOPMENT,0.023222,0.18776,0.16124,1,1
4,GO VACUOLE ORGANIZATION,0.0029959,0.18567,0.17237,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.0031154,0.18541,0.19734,1,1
4,GO B CELL DIFFERENTIATION,0.0032392,0.18466,0.18535,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.010505,0.18413,0.18425,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.02631,0.1839,0.22097,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0032392,0.18359,0.17539,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0129,0.18358,0.16753,1,1
4,GO RESPONSE TO CALCIUM ION,0.027983,0.1835,0.1676,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0021804,0.18327,0.16917,1,1
4,GO SECRETION,0.0079288,0.18296,0.1497,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.024724,0.18291,0.16226,1,1
4,GO CHLORIDE TRANSPORT,0.0024588,0.18253,0.18142,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.0029959,0.18234,0.18095,1,1
4,GO MANNOSYLATION,0.011255,0.18209,0.21116,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.013344,0.18206,0.17192,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.027983,0.18191,0.1642,1,1
4,GO DETECTION OF STIMULUS,0.0017799,0.18161,0.15858,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0029959,0.18116,0.2041,1,1
4,GO REGULATION OF HORMONE SECRETION,0.0032392,0.1794,0.2019,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.025507,0.17881,0.17343,1,1
4,GO GLAND DEVELOPMENT,0.01684,0.17825,0.13917,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0059338,0.17746,0.21492,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029959,0.17744,0.19008,1,1
4,GO ORGANELLE FUSION,0.01918,0.17733,0.14527,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.015767,0.17667,0.2013,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.028854,0.17664,0.18302,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0094624,0.17663,0.21291,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.013344,0.17651,0.19691,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0059338,0.17527,0.17703,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0097991,0.17428,0.15965,1,1
4,GO VESICLE ORGANIZATION,0.027136,0.17428,0.12995,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0033675,0.17387,0.14801,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0015733,0.17367,0.20647,1,1
4,GO CHEMICAL HOMEOSTASIS,0.0039282,0.17338,0.14891,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0076503,0.17307,0.13264,1,1
4,GO METAL ION HOMEOSTASIS,0.0042393,0.17304,0.14256,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.014755,0.17299,0.14055,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0068665,0.17139,0.16192,1,1
4,GO ACTION POTENTIAL,0.01857,0.17081,0.19533,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.0049293,0.17074,0.14282,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.01857,0.17053,0.14857,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.021799,0.17027,0.1255,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0082164,0.17,0.13626,1,1
4,GO PROTEIN DESTABILIZATION,0.005311,0.16863,0.18914,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.01427,0.16855,0.13732,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.015767,0.1683,0.18551,1,1
4,GO REGULATION OF SECRETION,0.0035004,0.16782,0.16855,1,1
4,GO REGULATION OF CELL MATURATION,0.0174,0.16734,0.15787,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.01427,0.16624,0.16012,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.023222,0.16624,0.13404,1,1
4,GO CELL MATURATION,0.0033675,0.16462,0.16967,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.0088198,0.16419,0.13432,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.0040811,0.16407,0.15292,1,1
4,GO SIGNAL RELEASE,0.0073805,0.16279,0.16801,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.01857,0.16222,0.1703,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.023222,0.16217,0.13371,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.028854,0.16159,0.12768,1,1
4,GO REGULATION OF PH,0.0024588,0.16123,0.14765,1,1
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.015767,0.16122,0.16144,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.0026621,0.16027,0.14902,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.011648,0.15987,0.12609,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0097991,0.15967,0.15233,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.022501,0.15925,0.13615,1,1
4,GO ION HOMEOSTASIS,0.0059338,0.15904,0.13078,1,1
4,GO LIPID METABOLIC PROCESS,0.010505,0.15863,0.12913,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.025507,0.15851,0.12198,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0024588,0.15813,0.15127,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0057193,0.15801,0.17635,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.0040811,0.15765,0.16225,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.01918,0.15765,0.13745,1,1
4,GO HEART PROCESS,0.013344,0.15726,0.1468,1,1
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.02631,0.15575,0.18802,1,1
4,GO REGULATION OF OSSIFICATION,0.01684,0.15374,0.15617,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.010874,0.15297,0.12629,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.025507,0.15266,0.14584,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.010146,0.15241,0.14298,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.010505,0.15191,0.1285,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.010505,0.15091,0.12498,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,0.0085133,0.15048,0.15872,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0082164,0.14951,0.14084,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.0082164,0.1494,0.12633,1,1
4,GO LYSOSOME LOCALIZATION,0.027983,0.14899,0.15281,1,1
4,GO HOMEOSTATIC PROCESS,0.0076503,0.14895,0.11434,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.024724,0.14789,0.11536,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.027983,0.1478,0.11937,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.017977,0.14775,0.11557,1,1
4,GO REGULATION OF ION TRANSPORT,0.019808,0.14719,0.12922,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.010146,0.14719,0.13045,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.011648,0.14697,0.13472,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.012053,0.14629,0.12331,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0097991,0.14537,0.16499,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.012053,0.14297,0.12979,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.02631,0.14261,0.11016,1,1
4,GO ORGANIC ANION TRANSPORT,0.0091361,0.1426,0.12366,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.0039282,0.14135,0.14097,1,1
4,GO ANION TRANSPORT,0.0063849,0.14127,0.12357,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.020453,0.14014,0.12555,1,1
4,GO LIPID CATABOLIC PROCESS,0.016296,0.13923,0.12533,1,1
4,GO REGULATION OF TOR SIGNALING,0.0029959,0.13886,0.13712,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.015254,0.13861,0.1098,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.016296,0.13704,0.11363,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.020453,0.1359,0.12142,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.020453,0.13503,0.1336,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.0085133,0.13488,0.11983,1,1
4,GO ION TRANSPORT,0.0097991,0.13252,0.12504,1,1
4,GO SODIUM ION TRANSPORT,0.0174,0.13219,0.1542,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.01427,0.13121,0.13568,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.0063849,0.13102,0.12865,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.020453,0.1303,0.10985,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.012053,0.12784,0.12678,1,1
4,GO CIRCADIAN RHYTHM,0.0026621,0.12769,0.1617,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.01247,0.12751,0.10321,1,1
4,GO RESPONSE TO PEPTIDE,0.027983,0.1264,0.10922,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.012053,0.12607,0.11256,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.014755,0.12566,0.13475,1,1
4,GO REGULATION OF EXOCYTOSIS,0.025507,0.12498,0.13935,1,1
4,GO METAL ION TRANSPORT,0.029747,0.12333,0.10368,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.016296,0.12321,0.11739,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.02631,0.12076,0.097677,1,1
4,GO REGULATION OF TRANSPORT,0.023222,0.12014,0.102,1,1
4,GO RHYTHMIC PROCESS,0.028854,0.1179,0.10537,1,1
4,GO RESPONSE TO INSULIN,0.019808,0.11719,0.12797,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.027136,0.11521,0.1008,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.010874,0.11431,0.11155,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.01918,0.10776,0.095191,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.025507,0.10746,0.10536,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.028854,0.10729,0.11167,1,1
4,GO DEVELOPMENTAL MATURATION,0.02631,0.1068,0.12845,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.028854,0.10532,0.12489,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.023222,0.10477,0.1011,1,1
4,GO TOR SIGNALING,0.0039282,0.10247,0.10757,1,1
4,GO CELLULAR HOMEOSTASIS,0.024724,0.10167,0.094159,1,1
4,GO T CELL SELECTION,0.024724,0.095035,0.13191,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.021117,0.091739,0.11956,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0068665,1.1952,1.151,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0063849,1.0246,0.93631,1,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.022501,0.91884,0.62579,1,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0037806,0.86151,0.72241,1,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.0029959,0.85893,0.76611,1,0
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0042393,0.80042,0.67151,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.023963,0.62578,0.34945,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0138,0.6239,0.53497,1,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0045725,0.60693,0.50162,1,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.0097991,0.5837,0.44394,1,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.016296,0.58101,0.40769,1,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0019312,0.57938,0.55293,1,0
4,GO RESPONSE TO TYPE I INTERFERON,0.0022699,0.57261,0.53814,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.019808,0.5656,0.47511,1,0
4,GO RESPONSE TO INTERFERON BETA,0.01918,0.56018,0.45819,1,0
4,GO PROGESTERONE METABOLIC PROCESS,0.02631,0.54123,0.33643,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.013344,0.53303,0.36537,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.027983,0.53041,0.61617,1,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.0020112,0.52893,0.46737,1,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.027136,0.52435,0.38369,1,0
4,GO REGULATION OF VASCULOGENESIS,0.0031154,0.51443,0.51661,1,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.0073805,0.50604,0.41841,1,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090875,0.49518,0.51587,1,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0063849,0.4922,0.42473,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0022699,0.48629,0.48213,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017977,0.48512,0.36771,1,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.020453,0.46453,0.32351,1,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0012773,0.46108,0.40931,1,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.025507,0.45889,0.40393,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.010874,0.45748,0.36855,1,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.011255,0.45734,0.3848,1,0
4,GO NATURAL KILLER CELL PROLIFERATION,0.01247,0.45496,0.39643,1,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.010505,0.45429,0.36696,1,0
4,GO GERMINAL CENTER FORMATION,0.016296,0.45345,0.41157,1,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.0057193,0.45008,0.39598,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0085133,0.44702,0.39482,1,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0063849,0.44081,0.41072,1,0
4,GO RESPONSE TO DIETARY EXCESS,0.0027694,0.43884,0.45044,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.02631,0.43781,0.32086,1,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0088198,0.43455,0.44988,1,0
4,GO RESPONSE TO INTERLEUKIN 15,0.0019312,0.43336,0.36347,1,0
4,GO T CELL MEDIATED IMMUNITY,0.0097991,0.43283,0.28869,1,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.01857,0.43256,0.3685,1,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010786,0.43185,0.3987,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.01247,0.43097,0.35971,1,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012773,0.42939,0.38891,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010786,0.42831,0.36906,1,0
4,GO REGULATION OF MYOBLAST FUSION,0.0039282,0.42609,0.37747,1,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0174,0.4256,0.51209,1,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.024724,0.42385,0.44309,1,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0051169,0.42127,0.36212,1,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0097991,0.41967,0.32859,1,0
4,GO ZYMOGEN ACTIVATION,0.0051169,0.41774,0.36111,1,0
4,GO DNA DEAMINATION,0.027136,0.41748,0.38551,1,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0063849,0.41739,0.38202,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.01857,0.41512,0.31023,1,0
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.010146,0.41494,0.37962,1,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0013889,0.41272,0.36043,1,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0085133,0.41236,0.3255,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0085133,0.41201,0.34654,1,0
4,GO MYOBLAST FUSION,0.0029959,0.40949,0.32741,1,0
4,GO KETONE CATABOLIC PROCESS,0.0082164,0.40882,0.35738,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0061556,0.40836,0.33266,1,0
4,GO CELLULAR DEFENSE RESPONSE,0.0019312,0.40621,0.35299,1,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.010874,0.40484,0.29555,1,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0091361,0.40207,0.34763,1,0
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0040811,0.40192,0.42396,1,0
4,GO RESPONSE TO AMPHETAMINE,0.01427,0.39986,0.31734,1,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.019808,0.39273,0.25949,1,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.027983,0.38806,0.38546,1,0
4,GO RESPONSE TO FORSKOLIN,0.0040811,0.38781,0.42255,1,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.0047478,0.38681,0.38066,1,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0040811,0.38577,0.37271,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.025507,0.3844,0.33155,1,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0063849,0.38428,0.37671,1,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.012053,0.38406,0.2709,1,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00094871,0.38318,0.38963,1,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.01918,0.38253,0.33451,1,0
4,GO RESPONSE TO LITHIUM ION,0.00039093,0.37999,0.49145,1,0
4,GO BLOOD VESSEL REMODELING,0.0063849,0.37644,0.28444,1,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.023963,0.37631,0.32024,1,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0085133,0.37314,0.24452,1,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.025507,0.37073,0.26291,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0066217,0.37067,0.30098,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0088198,0.37,0.2801,1,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0068665,0.36899,0.40319,1,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0085133,0.36803,0.23975,1,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.011648,0.36585,0.27837,1,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.0045725,0.36446,0.33529,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0057193,0.36332,0.25254,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0029959,0.36213,0.31333,1,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.021117,0.36085,0.26163,1,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.016296,0.35922,0.28488,1,0
4,GO ZINC ION HOMEOSTASIS,0.028854,0.35642,0.31217,1,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0079288,0.35348,0.30729,1,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0039282,0.35177,0.38404,1,0
4,GO VIRAL GENOME REPLICATION,0.0094624,0.35118,0.26331,1,0
4,GO RESPONSE TO CADMIUM ION,0.025507,0.35011,0.25638,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0055117,0.34819,0.28103,1,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.021117,0.34723,0.29347,1,0
4,GO B CELL MEDIATED IMMUNITY,0.015254,0.34705,0.20664,1,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0013321,0.34582,0.28336,1,0
4,GO INTESTINAL LIPID ABSORPTION,0.0055117,0.34576,0.33894,1,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.027983,0.34231,0.33534,1,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0063849,0.34165,0.22448,1,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.0037806,0.33888,0.30267,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0042393,0.33885,0.32778,1,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.01918,0.3365,0.31784,1,0
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0049293,0.33425,0.39661,1,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0076503,0.33342,0.29657,1,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.010505,0.33319,0.25456,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.015767,0.33301,0.2207,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0129,0.33264,0.24463,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0079288,0.33218,0.25071,1,0
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0061556,0.33126,0.31594,1,0
4,GO RESPONSE TO INTERFERON GAMMA,0.0073805,0.32986,0.31892,1,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.010505,0.32916,0.21945,1,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0174,0.32857,0.19182,1,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.01918,0.32803,0.32051,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.010874,0.32787,0.22982,1,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.027136,0.32727,0.24715,1,0
4,GO DEFENSE RESPONSE TO VIRUS,0.0085133,0.32653,0.25713,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.012053,0.3261,0.23451,1,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0016396,0.32589,0.31496,1,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.023222,0.32501,0.30051,1,0
4,GO ENTRY INTO HOST,0.023963,0.32457,0.20143,1,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0079288,0.3237,0.24828,1,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.021117,0.32157,0.30513,1,0
4,GO OSTEOBLAST PROLIFERATION,0.0061556,0.31947,0.31016,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0049293,0.31762,0.23843,1,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0094624,0.31759,0.29412,1,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0028806,0.31661,0.28109,1,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.027136,0.31452,0.20452,1,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0040811,0.31314,0.25205,1,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0138,0.31166,0.24808,1,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.010874,0.31143,0.23489,1,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.01684,0.31092,0.24436,1,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.01247,0.31081,0.2665,1,0
4,GO ACUTE INFLAMMATORY RESPONSE,0.0045725,0.30758,0.27049,1,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0068665,0.30738,0.21652,1,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0026621,0.30569,0.26172,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.013344,0.30423,0.24725,1,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.028854,0.30415,0.18188,1,0
4,GO LIPID DIGESTION,0.017977,0.30407,0.27248,1,0
4,GO T CELL MIGRATION,0.0174,0.30287,0.21832,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.01427,0.29908,0.25089,1,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.028854,0.29881,0.28704,1,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0071194,0.2988,0.26305,1,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.017977,0.29742,0.52858,1,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0027694,0.29739,0.25989,1,0
4,GO PHOSPHOLIPID EFFLUX,0.027136,0.2972,0.24097,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.011255,0.29628,0.27488,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0073805,0.29592,0.22113,1,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.019808,0.29563,0.22861,1,0
4,GO TYPE I INTERFERON PRODUCTION,0.0045725,0.29523,0.25186,1,0
4,GO INTERLEUKIN 8 PRODUCTION,0.0082164,0.29477,0.26062,1,0
4,GO N GLYCAN PROCESSING,0.021117,0.29398,0.27631,1,0
4,GO MOVEMENT IN HOST ENVIRONMENT,0.024724,0.29339,0.18447,1,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0045725,0.29307,0.28826,1,0
4,GO METHIONINE METABOLIC PROCESS,0.0066217,0.29267,0.24496,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.021117,0.29238,0.18012,1,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.010146,0.29229,0.24024,1,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.023222,0.2919,0.21333,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.023963,0.29098,0.19314,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0029959,0.29064,0.28855,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.023222,0.29036,0.18229,1,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.020453,0.29011,0.33158,1,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0040811,0.29006,0.30778,1,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.015254,0.28964,0.20207,1,0
4,GO OPTIC NERVE DEVELOPMENT,0.0097991,0.28913,0.3575,1,0
4,GO B CELL HOMEOSTASIS,0.010146,0.28908,0.26605,1,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.01857,0.28883,0.18725,1,0
4,GO NECROTIC CELL DEATH,0.0088198,0.28873,0.28917,1,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.0082164,0.28873,0.21827,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0035004,0.28611,0.25337,1,0
4,GO SYNCYTIUM FORMATION,0.0066217,0.28559,0.22975,1,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0036381,0.28548,0.26442,1,0
4,GO RESPONSE TO MINERALOCORTICOID,0.0047478,0.28511,0.27428,1,0
4,GO LEUKOCYTE MIGRATION,0.0042393,0.2849,0.23023,1,0
4,GO PROGRAMMED NECROTIC CELL DEATH,0.013344,0.28446,0.29106,1,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0029959,0.28389,0.25879,1,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0033675,0.28368,0.23895,1,0
4,GO INTERLEUKIN 1 PRODUCTION,0.029747,0.28224,0.20788,1,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0073805,0.28154,0.25605,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.012053,0.2814,0.20844,1,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.027983,0.28066,0.21636,1,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0082164,0.2805,0.24125,1,0
4,GO MONOCYTE CHEMOTAXIS,0.029747,0.28038,0.19243,1,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0035004,0.27936,0.22593,1,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0068665,0.27748,0.26534,1,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0047478,0.27696,0.22592,1,0
4,GO ZYMOGEN INHIBITION,0.013344,0.2762,0.27937,1,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.021117,0.27306,0.26813,1,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0091361,0.27247,0.23545,1,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0023626,0.272,0.22875,1,0
4,GO HAIR CELL DIFFERENTIATION,0.011648,0.2718,0.19795,1,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0029959,0.27162,0.24948,1,0
4,GO INNATE IMMUNE RESPONSE,0.0042393,0.2702,0.21719,1,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.017977,0.26983,0.2672,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.02631,0.26911,0.218,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.020453,0.26841,0.23336,1,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0015095,0.26743,0.26015,1,0
4,GO RESPONSE TO VIRUS,0.0079288,0.2673,0.21943,1,0
4,GO CHEMOKINE PRODUCTION,0.0174,0.26723,0.20411,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0085133,0.26636,0.21396,1,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.019808,0.26634,0.1937,1,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.010505,0.2662,0.19027,1,0
4,GO DETECTION OF BIOTIC STIMULUS,0.01684,0.26595,0.24274,1,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.014755,0.26564,0.20056,1,0
4,GO RESPONSE TO GROWTH HORMONE,0.0059338,0.26563,0.2656,1,0
4,GO RESPONSE TO CORTICOSTERONE,0.0076503,0.26501,0.35223,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.01684,0.26404,0.2567,1,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0088198,0.26353,0.26545,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.015767,0.26343,0.26465,1,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0024588,0.26339,0.24724,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.023222,0.26338,0.25471,1,0
4,GO RESPONSE TO LEPTIN,0.01684,0.26245,0.20853,1,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.022501,0.26224,0.23822,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.014755,0.26192,0.20612,1,0
4,GO DIGESTION,0.0042393,0.26144,0.24112,1,0
4,GO RESPONSE TO UV B,0.028854,0.26114,0.23941,1,0
4,GO LIPID STORAGE,0.0020112,0.26084,0.26558,1,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.011255,0.25933,0.27886,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0097991,0.25875,0.16929,1,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0091361,0.25849,0.31083,1,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.015254,0.25814,0.19449,1,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0042393,0.25514,0.20922,1,0
4,GO PHAGOSOME ACIDIFICATION,0.0068665,0.25489,0.21683,1,0
4,GO ACUTE PHASE RESPONSE,0.01684,0.25285,0.22564,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0063849,0.25197,0.23507,1,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0174,0.25197,0.34714,1,0
4,GO CYTOPLASM ORGANIZATION,0.0047478,0.25189,0.25896,1,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.01857,0.25177,0.23349,1,0
4,GO PIRNA METABOLIC PROCESS,0.0138,0.25079,0.21925,1,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.02631,0.24937,0.16943,1,0
4,GO ICOSANOID METABOLIC PROCESS,0.0091361,0.24904,0.22139,1,0
4,GO IMMUNE EFFECTOR PROCESS,0.0076503,0.2488,0.20008,1,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0026621,0.24727,0.22163,1,0
4,GO TRANSFERRIN TRANSPORT,0.0025586,0.24675,0.21115,1,0
4,GO CELL CHEMOTAXIS,0.0040811,0.24575,0.20909,1,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0017799,0.24507,0.22986,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.028854,0.245,0.25327,1,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.016296,0.24495,0.25569,1,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02631,0.24469,0.1723,1,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0097991,0.24456,0.19457,1,0
4,GO LYMPHOCYTE MIGRATION,0.013344,0.24404,0.18117,1,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0079288,0.24396,0.20151,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02631,0.24384,0.27137,1,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.01247,0.24359,0.18934,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0091361,0.24281,0.20374,1,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0073805,0.24269,0.2024,1,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019808,0.24252,0.21678,1,0
4,GO POSITIVE CHEMOTAXIS,0.021799,0.24238,0.17454,1,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0023626,0.24225,0.2343,1,0
4,GO DEFENSE RESPONSE,0.0032392,0.24012,0.20374,1,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.022501,0.23933,0.19147,1,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0026621,0.23933,0.21964,1,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.024724,0.23931,0.23103,1,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.0085133,0.23895,0.20116,1,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.015254,0.23815,0.19331,1,0
4,GO CYTOKINE PRODUCTION,0.0073805,0.23805,0.19819,1,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.022501,0.23784,0.23235,1,0
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.020453,0.23717,0.26383,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.021799,0.23658,0.18623,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0018542,0.23586,0.22014,1,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0094624,0.2356,0.23223,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.023963,0.2351,0.23939,1,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.017977,0.23492,0.20941,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0047478,0.23477,0.2107,1,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0091361,0.2343,0.20226,1,0
4,GO INTERFERON BETA PRODUCTION,0.023222,0.23391,0.18852,1,0
4,GO NERVE DEVELOPMENT,0.021799,0.23389,0.21585,1,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0059338,0.23358,0.22597,1,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.015767,0.23336,0.17415,1,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.010505,0.23296,0.1857,1,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.02631,0.23277,0.23607,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0033675,0.23222,0.20852,1,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0085133,0.23068,0.22585,1,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.015767,0.23056,0.188,1,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0029959,0.23055,0.22917,1,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.010874,0.23012,0.19224,1,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.01684,0.22978,0.20947,1,0
4,GO SIGNAL PEPTIDE PROCESSING,0.0031154,0.22942,0.34844,1,0
4,GO PROTEIN PROCESSING,0.0013321,0.22889,0.23541,1,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.020453,0.22835,0.20067,1,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0051169,0.22808,0.18808,1,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.01427,0.22779,0.14687,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.012053,0.22743,0.19327,1,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0085133,0.22728,0.17671,1,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.0066217,0.22723,0.3056,1,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.021799,0.22651,0.16851,1,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010874,0.22561,0.20706,1,0
4,GO KERATAN SULFATE METABOLIC PROCESS,0.02631,0.22531,0.22336,1,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0066217,0.2251,0.20223,1,0
4,GO REGULATION OF RESPONSE TO FOOD,0.01684,0.22456,0.17556,1,0
4,GO INTERACTION WITH HOST,0.024724,0.22452,0.1539,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.0061556,0.2241,0.16476,1,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.011255,0.22403,0.26879,1,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0129,0.22382,0.16258,1,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.028854,0.22345,0.16213,1,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.011648,0.22322,0.18331,1,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.022501,0.22307,0.24089,1,0
4,GO DIOL METABOLIC PROCESS,0.0138,0.22239,0.21998,1,0
4,GO RESPONSE TO CYTOKINE,0.0097991,0.2223,0.17193,1,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.011255,0.22214,0.19722,1,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.016296,0.22135,0.15774,1,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.024724,0.22123,0.16365,1,0
4,GO VACUOLAR ACIDIFICATION,0.0082164,0.22121,0.20397,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION,0.020453,0.22058,0.17844,1,0
4,GO ENDOCRINE PROCESS,0.0039282,0.22041,0.2398,1,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0076503,0.22,0.17751,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.028854,0.2197,0.1661,1,0
4,GO RESPONSE TO BIOTIC STIMULUS,0.0063849,0.21962,0.17516,1,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.01684,0.21945,0.30945,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.0085133,0.21937,0.19018,1,0
4,GO VIRAL LIFE CYCLE,0.022501,0.21928,0.14912,1,0
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.013344,0.21764,0.18416,1,0
4,GO RESPONSE TO DSRNA,0.019808,0.21721,0.1622,1,0
4,GO PLATELET ACTIVATION,0.015254,0.21696,0.17855,1,0
4,GO POSITIVE REGULATION OF CELL SIZE,0.022501,0.21668,0.23676,1,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.028854,0.2163,0.19732,1,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0039282,0.21564,0.23195,1,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.01247,0.2152,0.17726,1,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.020453,0.21494,0.19337,1,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0097991,0.21485,0.1621,1,0
4,GO MYELOID LEUKOCYTE ACTIVATION,0.011648,0.21445,0.18743,1,0
4,GO UBIQUINONE METABOLIC PROCESS,0.027983,0.21417,0.15972,1,0
4,GO INFLAMMATORY RESPONSE,0.0049293,0.21411,0.19607,1,0
4,GO CELLULAR RESPONSE TO DSRNA,0.022501,0.2141,0.18054,1,0
4,GO INTERFERON ALPHA PRODUCTION,0.0094624,0.2141,0.2224,1,0
4,GO MYELOID LEUKOCYTE MIGRATION,0.0071194,0.21334,0.18375,1,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.011648,0.21267,0.19823,1,0
4,GO RESPONSE TO INTERLEUKIN 1,0.023222,0.21264,0.13323,1,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.027983,0.21184,0.18379,1,0
4,GO REGULATION OF DEFENSE RESPONSE,0.0049293,0.21184,0.18366,1,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.013344,0.21125,0.17452,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.017977,0.21121,0.16685,1,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.024724,0.21092,0.1826,1,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0042393,0.20995,0.18922,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.021117,0.20987,0.21007,1,0
4,GO GRANULOCYTE CHEMOTAXIS,0.010505,0.20976,0.1598,1,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0088198,0.20895,0.16501,1,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0036381,0.20854,0.25078,1,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.015254,0.20841,0.17601,1,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0063849,0.20839,0.1782,1,0
4,GO CELL ACTIVATION,0.014755,0.20823,0.15492,1,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.0073805,0.20735,0.19225,1,0
4,GO REGULATION OF IMMUNE RESPONSE,0.015254,0.20693,0.15074,1,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.0097991,0.20664,0.19456,1,0
4,GO PROTEIN DEGLYCOSYLATION,0.013344,0.20635,0.27453,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.016296,0.20611,0.19435,1,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.017977,0.20593,0.20285,1,0
4,GO BILE ACID METABOLIC PROCESS,0.015767,0.20589,0.19862,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.015767,0.20588,0.19444,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.014755,0.20482,0.19332,1,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.029747,0.20418,0.14227,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.01684,0.20341,0.18254,1,0
4,GO REGULATION OF LIPID STORAGE,0.0088198,0.20311,0.21794,1,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0094624,0.20293,0.21162,1,0
4,GO AMINOGLYCAN METABOLIC PROCESS,0.01857,0.20277,0.18767,1,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0076503,0.20255,0.15461,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0059338,0.20241,0.22283,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.024724,0.20219,0.16902,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0138,0.20109,0.1852,1,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0097991,0.20013,0.16054,1,0
4,GO CELLULAR RESPONSE TO VIRUS,0.0085133,0.19965,0.19228,1,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.023963,0.19955,0.23648,1,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0094624,0.19953,0.16623,1,0
4,GO DOPAMINE TRANSPORT,0.015254,0.19914,0.36145,1,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.015254,0.19892,0.14551,1,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.023222,0.19764,0.18474,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.01918,0.19706,0.18037,1,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0138,0.19705,0.213,1,0
4,GO REGULATION OF CELL ADHESION,0.020453,0.19659,0.16623,1,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.028854,0.19633,0.22721,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.021117,0.19611,0.15697,1,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.021117,0.19561,0.25075,1,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.0035004,0.19529,0.20214,1,0
4,GO REGULATION OF CELL ACTIVATION,0.021117,0.19502,0.15438,1,0
4,GO REGULATION OF T CELL ACTIVATION,0.019808,0.19474,0.16301,1,0
4,GO GRANULOCYTE MIGRATION,0.01857,0.19462,0.1533,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.01857,0.19441,0.13328,1,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.015767,0.1942,0.24894,1,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.01684,0.19391,0.16709,1,0
4,GO T CELL ACTIVATION,0.01247,0.19312,0.17011,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0039282,0.19242,0.19579,1,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.01918,0.19225,0.17293,1,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.02631,0.192,0.17762,1,0
4,GO ALPHA BETA T CELL ACTIVATION,0.0063849,0.19136,0.2143,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.005311,0.19099,0.17458,1,0
4,GO PROTEIN MATURATION,0.0045725,0.19098,0.17044,1,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.023222,0.19084,0.13507,1,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.017977,0.19071,0.16569,1,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0063849,0.19058,0.17833,1,0
4,GO REGULATION OF HEART RATE,0.0061556,0.1904,0.22989,1,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.015767,0.18809,0.26078,1,0
4,GO NEUTROPHIL MIGRATION,0.0079288,0.18774,0.14855,1,0
4,GO REGULATION OF HEMOPOIESIS,0.01247,0.18494,0.14155,1,0
4,GO RIG I SIGNALING PATHWAY,0.027983,0.18463,0.15567,1,0
4,GO NIK NF KAPPAB SIGNALING,0.023222,0.18434,0.13407,1,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0059338,0.18384,0.22666,1,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.020453,0.18342,0.20299,1,0
4,GO REGULATION OF WOUND HEALING,0.02631,0.18305,0.19821,1,0
4,GO EXOCYTOSIS,0.010874,0.18273,0.15605,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.015767,0.18223,0.18346,1,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.016296,0.18204,0.16993,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.027136,0.18085,0.19066,1,0
4,GO NATURAL KILLER CELL ACTIVATION,0.019808,0.18078,0.14817,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.017977,0.18026,0.18707,1,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.028854,0.17932,0.22444,1,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0055117,0.17931,0.17464,1,0
4,GO INTEGRIN ACTIVATION,0.013344,0.17902,0.23099,1,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0085133,0.1784,0.17526,1,0
4,GO MULTICELLULAR ORGANISM AGING,0.011648,0.17745,0.1778,1,0
4,GO RESPONSE TO STARVATION,0.0039282,0.17711,0.20178,1,0
4,GO GOLGI VESICLE BUDDING,0.025507,0.17585,0.1208,1,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.01857,0.17583,0.21288,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.024724,0.17571,0.18948,1,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.015767,0.17483,0.2289,1,0
4,GO LEUKOCYTE DIFFERENTIATION,0.0061556,0.17472,0.16051,1,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.023222,0.17294,0.23759,1,0
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.020453,0.1727,0.16716,1,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.028854,0.17175,0.13482,1,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.01857,0.1709,0.16276,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.028854,0.17072,0.13961,1,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.029747,0.17008,0.14842,1,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.028854,0.17005,0.18942,1,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.01684,0.16981,0.18483,1,0
4,GO ANDROGEN METABOLIC PROCESS,0.020453,0.16971,0.22455,1,0
4,GO RESPONSE TO BACTERIUM,0.013344,0.16957,0.16206,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.01857,0.16942,0.14602,1,0
4,GO LYMPHOCYTE ACTIVATION,0.013344,0.1692,0.14935,1,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0051169,0.16571,0.15837,1,0
4,GO REGULATION OF CHEMOTAXIS,0.027136,0.16349,0.1289,1,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0079288,0.16268,0.14721,1,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.023963,0.16237,0.12753,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0028806,0.16213,0.18388,1,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.024724,0.16191,0.13101,1,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.01247,0.16124,0.17779,1,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.015767,0.16104,0.15971,1,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.01918,0.16065,0.17864,1,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.013344,0.16026,0.13139,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.023222,0.16,0.15284,1,0
4,GO T CELL DIFFERENTIATION,0.0129,0.15895,0.15005,1,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0040811,0.15886,0.16457,1,0
4,GO RESPONSE TO CHEMOKINE,0.0059338,0.15885,0.14059,1,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.01247,0.15716,0.16424,1,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0174,0.15666,0.14124,1,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.01427,0.1565,0.1877,1,0
4,GO MYELOID CELL DIFFERENTIATION,0.01918,0.15646,0.13777,1,0
4,GO REGULATION OF CARDIAC CONDUCTION,0.021117,0.15631,0.16805,1,0
4,GO SENSORY PERCEPTION OF SMELL,0.0027694,0.15552,0.17043,1,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.015767,0.15381,0.18162,1,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0082164,0.15331,0.19915,1,0
4,GO NUCLEOTIDE TRANSPORT,0.028854,0.15308,0.13606,1,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.0079288,0.15248,0.23151,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019808,0.15157,0.14145,1,0
4,GO PROTEOLYSIS,0.022501,0.15126,0.10205,1,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0097991,0.15007,0.14089,1,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.01684,0.14784,0.19233,1,0
4,GO RESPONSE TO FUNGUS,0.005311,0.14782,0.19131,1,0
4,GO AGING,0.023222,0.14738,0.10183,1,0
4,GO REGULATION OF CELLULAR PH,0.0029959,0.14687,0.1419,1,0
4,GO PH REDUCTION,0.0091361,0.1447,0.15949,1,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.01684,0.14445,0.13641,1,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.023963,0.14342,0.1532,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012053,0.1433,0.14163,1,0
4,GO SULFUR COMPOUND TRANSPORT,0.013344,0.14154,0.14397,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.019808,0.13776,0.12425,1,0
4,GO INORGANIC ANION TRANSPORT,0.0033675,0.13772,0.14351,1,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.021117,0.13605,0.11351,1,0
4,GO REGULATION OF ANION TRANSPORT,0.010874,0.13508,0.16624,1,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.025507,0.13232,0.1275,1,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.029747,0.13222,0.12482,1,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0129,0.13181,0.14656,1,0
4,GO GLUCOSE METABOLIC PROCESS,0.0068665,0.12856,0.15286,1,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.014755,0.12736,0.14195,1,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0097991,0.12713,0.15447,1,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.01857,0.12397,0.17322,1,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.023963,0.12247,0.12467,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.01857,0.12024,0.11682,1,0
4,GO SENSORY PERCEPTION,0.024724,0.11938,0.094676,1,0
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0091361,0.1177,0.12504,1,0
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.027136,0.11571,0.09542,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.023963,0.11409,0.10434,1,0
4,GO CATION TRANSPORT,0.024724,0.11002,0.10994,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.022501,0.10601,0.1158,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.021117,0.10589,0.10792,1,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.029747,0.102,0.16105,1,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.015254,0.099082,0.1702,1,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.029747,0.0989,0.1295,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.011648,0.092232,0.094364,1,0
4,GO PROTEIN POLYUBIQUITINATION,0.017977,0.090621,0.097312,1,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.028854,0.088013,0.094268,1,0
4,GO REGULATION OF AUTOPHAGY,0.01918,0.086468,0.094346,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.019808,-0.074677,-0.12997,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0174,-0.08127,-0.10782,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.02631,-0.090912,-0.09381,1,0
4,GO BASE EXCISION REPAIR,0.0082164,-0.09214,-0.12872,1,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.023963,-0.092603,-0.16453,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.0174,-0.093522,-0.088878,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0091361,-0.098663,-0.12044,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0091361,-0.10138,-0.13922,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.027983,-0.1063,-0.10497,1,0
4,GO DNA DEPENDENT DNA REPLICATION,0.02631,-0.11248,-0.12837,1,0
4,GO REGULATION OF DNA REPAIR,0.0091361,-0.114,-0.12434,1,0
4,GO TELOMERE ORGANIZATION,0.0079288,-0.11434,-0.12429,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.021117,-0.11448,-0.11981,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.010505,-0.11489,-0.12551,1,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.024724,-0.1199,-0.14351,1,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.029747,-0.12091,-0.1737,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.027136,-0.12359,-0.14313,1,0
4,GO STRESS GRANULE ASSEMBLY,0.0129,-0.1248,-0.18936,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.0015095,-0.12814,-0.17287,1,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0035004,-0.12904,-0.15985,1,0
4,GO MITOCHONDRION LOCALIZATION,0.010874,-0.12908,-0.13368,1,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.0138,-0.13072,-0.1326,1,0
4,GO TRNA MODIFICATION,0.011648,-0.1316,-0.19258,1,0
4,GO TRNA PROCESSING,0.021799,-0.13291,-0.15793,1,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.019808,-0.13404,-0.15553,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.023222,-0.13416,-0.10361,1,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0013889,-0.13697,-0.16492,1,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0061556,-0.13999,-0.15234,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.023963,-0.14462,-0.15526,1,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.013344,-0.1461,-0.23411,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.01918,-0.14663,-0.15851,1,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.016296,-0.14986,-0.2773,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.022501,-0.15032,-0.16118,1,0
4,GO HISTONE DEUBIQUITINATION,0.0061556,-0.15056,-0.14032,1,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.024724,-0.15371,-0.18294,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.01427,-0.15908,-0.22693,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.027983,-0.16045,-0.17383,1,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.023963,-0.1611,-0.20318,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0129,-0.16112,-0.1997,1,0
4,GO RESPIRATORY SYSTEM PROCESS,0.0138,-0.16118,-0.20148,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.021799,-0.16264,-0.18456,1,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.015254,-0.16374,-0.2222,1,0
4,GO RESPONSE TO SALT STRESS,0.02631,-0.16591,-0.22798,1,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.024724,-0.1695,-0.18906,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00087036,-0.17369,-0.17603,1,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.024724,-0.17483,-0.14243,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0082164,-0.17592,-0.17176,1,0
4,GO MATURATION OF SSU RRNA,0.02631,-0.17594,-0.23853,1,0
4,GO RRNA TRANSCRIPTION,0.022501,-0.17647,-0.19997,1,0
4,GO AXO DENDRITIC TRANSPORT,0.0085133,-0.1803,-0.17037,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.010505,-0.18066,-0.14336,1,0
4,GO DNA REPLICATION INITIATION,0.0033675,-0.18075,-0.22763,1,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.028854,-0.18112,-0.25555,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0091361,-0.18154,-0.17614,1,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.020453,-0.18162,-0.22364,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.023222,-0.18172,-0.19113,1,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.029747,-0.182,-0.22979,1,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0076503,-0.18485,-0.2112,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00049043,-0.189,-0.184,1,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024588,-0.19056,-0.18392,1,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.027136,-0.19187,-0.24531,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0063849,-0.19217,-0.19722,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0042393,-0.19314,-0.28401,1,0
4,GO REPLICATION FORK PROCESSING,0.0047478,-0.19435,-0.2039,1,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.023222,-0.19569,-0.2282,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.027983,-0.19697,-0.27631,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00024585,-0.199,-0.18381,1,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0031154,-0.19902,-0.17947,1,0
4,GO SULFATION,0.015767,-0.20032,-0.22172,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0138,-0.20076,-0.31145,1,0
4,GO BLASTOCYST GROWTH,0.013344,-0.2017,-0.19307,1,0
4,GO RIBOSOME ASSEMBLY,0.028854,-0.20308,-0.25528,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.016296,-0.2039,-0.2103,1,0
4,GO AXONAL TRANSPORT,0.0035004,-0.20441,-0.20338,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.011255,-0.20667,-0.20947,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0042393,-0.20681,-0.26344,1,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0055117,-0.20694,-0.20711,1,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.011648,-0.21115,-0.31637,1,0
4,GO CHROMATIN DISASSEMBLY,0.016296,-0.21671,-0.23061,1,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.023222,-0.21989,-0.26181,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.01918,-0.22224,-0.26943,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.02631,-0.22283,-0.203,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.029747,-0.22355,-0.26475,1,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.015254,-0.22462,-0.20334,1,0
4,GO MRNA SPLICE SITE SELECTION,0.01857,-0.22529,-0.19925,1,0
4,GO ADULT HEART DEVELOPMENT,0.01247,-0.22864,-0.28575,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.0071194,-0.22974,-0.22938,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00079804,-0.23101,-0.23788,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.0045725,-0.23205,-0.28247,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.023222,-0.23588,-0.32098,1,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.0015095,-0.23712,-0.25899,1,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0129,-0.23766,-0.19924,1,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.023222,-0.24402,-0.21112,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0016396,-0.24617,-0.28003,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.023963,-0.24718,-0.2179,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.016296,-0.24747,-0.24661,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.01684,-0.24881,-0.20973,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.010146,-0.25178,-0.30831,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.0174,-0.25325,-0.34595,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.010146,-0.25775,-0.24309,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.022501,-0.25802,-0.3115,1,0
4,GO PRENYLATION,0.0031154,-0.25832,-0.2567,1,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.0079288,-0.25906,-0.23798,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0036381,-0.25924,-0.33497,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0036381,-0.25924,-0.27461,1,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.013344,-0.26081,-0.26794,1,0
4,GO VIRAL TRANSLATION,0.01857,-0.26196,-0.28287,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.010505,-0.26354,-0.26742,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.013344,-0.26584,-0.2617,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0129,-0.27795,-0.35143,1,0
4,GO SECRETORY GRANULE LOCALIZATION,0.025507,-0.27797,-0.30184,1,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.010874,-0.27976,-0.1932,1,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0129,-0.28012,-0.32295,1,0
4,GO TELOMERASE RNA LOCALIZATION,0.0047478,-0.28188,-0.34221,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0129,-0.28308,-0.31607,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0055117,-0.28914,-0.34727,1,0
4,GO GLYCINE METABOLIC PROCESS,0.0023626,-0.29992,-0.32863,1,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.023963,-0.30502,-0.30562,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.023963,-0.3065,-0.38771,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.012053,-0.31016,-0.25836,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,0.0085133,-0.32196,-0.24594,1,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0015095,-0.32277,-0.34899,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.025507,-0.32368,-0.32565,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0082164,-0.33528,-0.31457,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.011648,-0.336,-0.33521,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00013838,-0.33837,-0.3184,1,0
4,GO GTP METABOLIC PROCESS,0.0097991,-0.3546,-0.27938,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.020453,-0.35492,-0.39857,1,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0097991,-0.35785,-0.27461,1,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0138,-0.36008,-0.32894,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.0079288,-0.36091,-0.3294,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.017977,-0.36188,-0.31355,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.0063849,-0.36757,-0.42933,1,0
4,GO RETROGRADE AXONAL TRANSPORT,0.0023626,-0.36953,-0.34839,1,0
4,GO CARDIAC VENTRICLE FORMATION,0.0138,-0.39064,-0.42418,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.0042393,-0.39816,-0.41177,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.0068665,-0.39876,-0.37258,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.011648,-0.40112,-0.34734,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.021799,-0.42306,-0.39849,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.021117,-0.43017,-0.40435,1,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.015254,-0.43023,-0.39544,1,0
4,GO L SERINE METABOLIC PROCESS,0.024724,-0.43932,-0.35566,1,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0129,-0.457,-0.35578,1,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00069995,-0.46362,-0.50538,1,0
4,GO CARDIAC CHAMBER FORMATION,0.0076503,-0.46526,-0.47141,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.020453,-0.50372,-0.39091,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.001448,-0.56339,-0.50583,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.010874,-0.58078,-0.50904,1,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.041252,0.54298,0.34476,0,1
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.19971,0.50488,0.32269,0,1
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.15712,0.49009,0.25476,0,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.068115,0.47288,0.39931,0,1
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.033564,0.44122,0.33373,0,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.12771,0.4147,0.27734,0,1
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.047616,0.40647,0.29805,0,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.07572,0.4049,0.34042,0,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.030665,0.40192,0.27868,0,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.21712,0.38955,0.24498,0,1
4,GO FAT CELL PROLIFERATION,0.036694,0.38779,0.29896,0,1
4,GO RESPONSE TO WATER,0.071835,0.38597,0.25217,0,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.031606,0.38429,0.28288,0,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.15017,0.37559,0.22474,0,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.033564,0.36379,0.30373,0,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.033564,0.36309,0.27455,0,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13699,0.35981,0.24351,0,1
4,GO REGULATION OF RECEPTOR CLUSTERING,0.030665,0.35975,0.37795,0,1
4,GO ADHESION OF SYMBIONT TO HOST,0.034581,0.35729,0.35064,0,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.030665,0.34776,0.29287,0,1
4,GO NOTCH RECEPTOR PROCESSING,0.11892,0.34058,0.35116,0,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.11333,0.33971,0.20034,0,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.11061,0.33822,0.19557,0,1
4,GO CATECHOLAMINE UPTAKE,0.068115,0.33156,0.23509,0,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.25516,0.3249,0.20299,0,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.032572,0.32098,0.27274,0,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.048983,0.31881,0.32843,0,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.13699,0.31598,0.19682,0,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.047616,0.31571,0.20819,0,1
4,GO MUSCLE ATROPHY,0.10025,0.31489,0.21578,0,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.042464,0.31246,0.24823,0,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.031606,0.31048,0.21062,0,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.12472,0.30777,0.22661,0,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.38267,0.30492,0.10528,0,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.32642,0.29763,0.1218,0,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.033564,0.29714,0.25803,0,1
4,GO EPOXYGENASE P450 PATHWAY,0.095374,0.2923,0.25333,0,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.047616,0.29177,0.17407,0,1
4,GO KERATINOCYTE PROLIFERATION,0.033564,0.29139,0.23657,0,1
4,GO DETECTION OF TEMPERATURE STIMULUS,0.16068,0.2898,0.2174,0,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.047616,0.28901,0.21321,0,1
4,GO POLYOL TRANSPORT,0.035624,0.28249,0.22408,0,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.093006,0.28236,0.18058,0,1
4,GO ETHER METABOLIC PROCESS,0.056323,0.28063,0.17546,0,1
4,GO MAGNESIUM ION HOMEOSTASIS,0.11892,0.27504,0.18535,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.057895,0.27484,0.24656,0,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.11061,0.26853,0.2266,0,1
4,GO SERTOLI CELL DIFFERENTIATION,0.053284,0.26589,0.17897,0,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.041252,0.26583,0.21346,0,1
4,GO PARAXIAL MESODERM DEVELOPMENT,0.10277,0.26494,0.1965,0,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.034581,0.25712,0.16793,0,1
4,GO MEMBRANE HYPERPOLARIZATION,0.030665,0.25676,0.19912,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.035624,0.25624,0.39544,0,1
4,GO REGULATION OF ACTIN NUCLEATION,0.030665,0.25282,0.21773,0,1
4,GO DENDRITIC CELL MIGRATION,0.057895,0.25246,0.17288,0,1
4,GO STRIATED MUSCLE ADAPTATION,0.062834,0.25034,0.20013,0,1
4,GO BONE CELL DEVELOPMENT,0.037792,0.25022,0.20307,0,1
4,GO ASTROCYTE DIFFERENTIATION,0.090686,0.24995,0.16745,0,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.051817,0.24985,0.19796,0,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.19552,0.24751,0.22125,0,1
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.044978,0.24686,0.19314,0,1
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.26023,0.24492,0.10497,0,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.14347,0.24408,0.18232,0,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.1402,0.24311,0.16194,0,1
4,GO REGULATION OF DOPAMINE SECRETION,0.032572,0.24141,0.38644,0,1
4,GO LEFT RIGHT PATTERN FORMATION,0.4445,0.23953,0.071056,0,1
4,GO METANEPHROS MORPHOGENESIS,0.043706,0.23645,0.20915,0,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.032572,0.23465,0.21383,0,1
4,GO MUSCLE ADAPTATION,0.031606,0.23441,0.1718,0,1
4,GO SPHINGOID METABOLIC PROCESS,0.06115,0.23334,0.1566,0,1
4,GO SECRETORY GRANULE ORGANIZATION,0.043706,0.23332,0.16257,0,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.050383,0.23161,0.18809,0,1
4,GO MAINTENANCE OF CELL POLARITY,0.031606,0.23131,0.24147,0,1
4,GO DEFINITIVE HEMOPOIESIS,0.056323,0.23083,0.18345,0,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.079775,0.23019,0.2107,0,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.084004,0.22953,0.18723,0,1
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.33843,0.22807,0.09805,0,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.16068,0.22803,0.18788,0,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.081867,0.22747,0.13931,0,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.037792,0.2271,0.19047,0,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.088413,0.22485,0.16846,0,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.050383,0.22452,0.1616,0,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.15712,0.22447,0.1233,0,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.030665,0.22349,0.29312,0,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.090686,0.22057,0.18471,0,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037792,0.21982,0.21128,0,1
4,GO GLOMERULUS DEVELOPMENT,0.068115,0.21788,0.1833,0,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.048983,0.21626,0.17738,0,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.22622,0.21557,0.15792,0,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.15712,0.21502,0.13273,0,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.053284,0.21379,0.21185,0,1
4,GO LEUKOCYTE HOMEOSTASIS,0.059504,0.21288,0.13598,0,1
4,GO RETINOL METABOLIC PROCESS,0.053284,0.21285,0.14792,0,1
4,GO RESPONSE TO NUTRIENT,0.12472,0.21273,0.11294,0,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.056323,0.21249,0.14726,0,1
4,GO CELLULAR RESPONSE TO KETONE,0.12179,0.21144,0.12739,0,1
4,GO COPULATION,0.077726,0.20972,0.17851,0,1
4,GO BIOLOGICAL ADHESION,0.035624,0.20961,0.13862,0,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.07572,0.20754,0.14533,0,1
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.12771,0.20741,0.1499,0,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.084004,0.20651,0.15539,0,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.047616,0.20452,0.17181,0,1
4,GO RESPONSE TO IRON ION,0.064555,0.20382,0.15603,0,1
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.19971,0.20354,0.12127,0,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.034581,0.20332,0.14651,0,1
4,GO GLIAL CELL DIFFERENTIATION,0.054786,0.20215,0.13445,0,1
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.042464,0.20152,0.14763,0,1
4,GO RESPONSE TO AMYLOID BETA,0.09779,0.20145,0.14023,0,1
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.034581,0.20128,0.17325,0,1
4,GO PROTEIN ADP RIBOSYLATION,0.084004,0.20104,0.14837,0,1
4,GO CELL JUNCTION ASSEMBLY,0.036694,0.20096,0.1366,0,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.043706,0.19901,0.14465,0,1
4,GO BONE MINERALIZATION,0.034581,0.19875,0.16101,0,1
4,GO SECONDARY PALATE DEVELOPMENT,0.11333,0.19789,0.15978,0,1
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.14679,0.19594,0.15942,0,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.038917,0.19588,0.15808,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.04007,0.19436,0.17101,0,1
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.10794,0.19364,0.19762,0,1
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.13074,0.19349,0.11438,0,1
4,GO SECRETION BY TISSUE,0.10277,0.19194,0.15707,0,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.04007,0.19148,0.19366,0,1
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.19139,0.19112,0.10687,0,1
4,GO ISOPRENOID METABOLIC PROCESS,0.077726,0.19037,0.12402,0,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.069955,0.1899,0.16488,0,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.033564,0.18961,0.22375,0,1
4,GO EPITHELIAL CELL PROLIFERATION,0.036694,0.18825,0.13318,0,1
4,GO GLIAL CELL PROLIFERATION,0.10533,0.18703,0.13181,0,1
4,GO NEGATIVE REGULATION OF GROWTH,0.046281,0.18677,0.1259,0,1
4,GO EMBRYONIC AXIS SPECIFICATION,0.066316,0.18665,0.18404,0,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.043706,0.18496,0.13943,0,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.12179,0.184,0.14869,0,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.051817,0.18248,0.1875,0,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.11892,0.18215,0.15972,0,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.20396,0.18178,0.078363,0,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.071835,0.18084,0.20347,0,1
4,GO ENDOCYTIC RECYCLING,0.077726,0.18,0.11784,0,1
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.062834,0.17892,0.1162,0,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.043706,0.17885,0.144,0,1
4,GO REGULATION OF CHROMATIN BINDING,0.30892,0.17878,0.084131,0,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.088413,0.17875,0.21106,0,1
4,GO STEROID CATABOLIC PROCESS,0.13384,0.17807,0.16876,0,1
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.069955,0.1766,0.11769,0,1
4,GO ADULT BEHAVIOR,0.066316,0.17605,0.16136,0,1
4,GO DNA DEMETHYLATION,0.22164,0.17518,0.14892,0,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.037792,0.17492,0.201,0,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.034581,0.17452,0.14355,0,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.047616,0.17227,0.11356,0,1
4,GO GLIOGENESIS,0.079775,0.17162,0.11498,0,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.16798,0.17121,0.12259,0,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.030665,0.1681,0.21062,0,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.033564,0.16759,0.17385,0,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.069955,0.16675,0.21601,0,1
4,GO RESPONSE TO VITAMIN,0.46631,0.16659,0.058458,0,1
4,GO MUSCLE CELL DEVELOPMENT,0.069955,0.16609,0.11918,0,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.09779,0.16576,0.14052,0,1
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.30323,0.16573,0.15925,0,1
4,GO TERPENOID METABOLIC PROCESS,0.13074,0.16411,0.11379,0,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14679,0.1639,0.10071,0,1
4,GO TUBE DEVELOPMENT,0.06115,0.16199,0.10954,0,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.054786,0.16164,0.10803,0,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.066316,0.16125,0.12186,0,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.12771,0.16059,0.11596,0,1
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.19552,0.16054,0.085527,0,1
4,GO MYELOID CELL DEVELOPMENT,0.064555,0.16033,0.11189,0,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.069955,0.15975,0.11104,0,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.036694,0.15952,0.1387,0,1
4,GO RESPONSE TO DOPAMINE,0.12771,0.15911,0.1101,0,1
4,GO STRIATED MUSCLE CONTRACTION,0.044978,0.15878,0.11737,0,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.038917,0.15639,0.13542,0,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.17553,0.1555,0.1126,0,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.048983,0.15538,0.1116,0,1
4,GO T CELL HOMEOSTASIS,0.059504,0.15534,0.12546,0,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.043706,0.15476,0.1335,0,1
4,GO PHOTOTRANSDUCTION,0.064555,0.15432,0.074162,0,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.043706,0.15425,0.11586,0,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.16798,0.15402,0.1135,0,1
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.15712,0.15281,0.11735,0,1
4,GO SENSORY PERCEPTION OF PAIN,0.034581,0.15272,0.15598,0,1
4,GO JNK CASCADE,0.043706,0.15253,0.12566,0,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.033564,0.15242,0.1588,0,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.069955,0.15182,0.1462,0,1
4,GO DRUG CATABOLIC PROCESS,0.077726,0.15156,0.18351,0,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.043706,0.15121,0.10931,0,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.066316,0.15084,0.13538,0,1
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.090686,0.15033,0.10385,0,1
4,GO FATTY ACID METABOLIC PROCESS,0.037792,0.14974,0.11238,0,1
4,GO CELL MOTILITY,0.057895,0.14907,0.10924,0,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.093006,0.14899,0.14164,0,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.090686,0.14894,0.10021,0,1
4,GO MESONEPHROS DEVELOPMENT,0.054786,0.14794,0.13124,0,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.044978,0.1472,0.10379,0,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.04007,0.14464,0.11931,0,1
4,GO PROSTAGLANDIN TRANSPORT,0.13074,0.14459,0.1476,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.10533,0.14424,0.098741,0,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.069955,0.14416,0.11705,0,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.10277,0.144,0.09441,0,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.037792,0.14297,0.11959,0,1
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.24039,0.14219,0.072282,0,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.090686,0.14197,0.099565,0,1
4,GO MOLTING CYCLE,0.21712,0.14195,0.077154,0,1
4,GO LIPID HOMEOSTASIS,0.032572,0.14192,0.13238,0,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.041252,0.14167,0.11019,0,1
4,GO RESPONSE TO AXON INJURY,0.15712,0.14158,0.1091,0,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.034581,0.14107,0.10764,0,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.034581,0.14082,0.11548,0,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.33843,0.14,0.092476,0,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.034581,0.13908,0.111,0,1
4,GO CARDIAC MUSCLE CONTRACTION,0.093006,0.13866,0.10518,0,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.12179,0.13811,0.083147,0,1
4,GO MUSCLE CELL DIFFERENTIATION,0.081867,0.13801,0.096524,0,1
4,GO DETECTION OF LIGHT STIMULUS,0.10533,0.1361,0.056337,0,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.036694,0.13564,0.10973,0,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.066316,0.13467,0.11743,0,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.035624,0.13458,0.10875,0,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.069955,0.13407,0.1135,0,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.038917,0.13329,0.099181,0,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.059504,0.13329,0.084531,0,1
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.068115,0.13315,0.093766,0,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.038917,0.13203,0.10001,0,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.046281,0.13202,0.095493,0,1
4,GO TUMOR NECROSIS FACTOR SECRETION,0.36329,0.13189,0.060041,0,1
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.18733,0.13183,0.079614,0,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.046281,0.13108,0.093595,0,1
4,GO REGULATION OF GROWTH,0.057895,0.13051,0.091755,0,1
4,GO RESPONSE TO MONOSACCHARIDE,0.031606,0.12931,0.1164,0,1
4,GO RESPONSE TO ACID CHEMICAL,0.051817,0.12911,0.10555,0,1
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.15361,0.1283,0.13402,0,1
4,GO GLUCOSE IMPORT,0.11892,0.12806,0.11211,0,1
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.15361,0.12626,0.075843,0,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.077726,0.12625,0.10251,0,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.084004,0.12616,0.094442,0,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.069955,0.12363,0.12206,0,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.19552,0.1231,0.064133,0,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.13384,0.12296,0.084422,0,1
4,GO REPRODUCTION,0.057895,0.12245,0.091884,0,1
4,GO RESPONSE TO HORMONE,0.04007,0.12208,0.10373,0,1
4,GO PROTEIN PALMITOYLATION,0.20828,0.12194,0.092221,0,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.095374,0.12174,0.091202,0,1
4,GO CELL JUNCTION ORGANIZATION,0.1402,0.12074,0.077599,0,1
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.15017,0.12033,0.076251,0,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.051817,0.1196,0.10053,0,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.38267,0.11957,0.082796,0,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.068115,0.11951,0.095886,0,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.066316,0.11927,0.10803,0,1
4,GO REGULATION OF CELL DIFFERENTIATION,0.090686,0.11885,0.082854,0,1
4,GO SOMITOGENESIS,0.079775,0.11803,0.092004,0,1
4,GO CELL CELL SIGNALING,0.07572,0.11782,0.082617,0,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.29206,0.1176,0.1144,0,1
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.069955,0.11575,0.15529,0,1
4,GO ORGANIC ACID TRANSPORT,0.031606,0.11476,0.097847,0,1
4,GO BODY MORPHOGENESIS,0.34454,0.11449,0.058755,0,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.20828,0.11417,0.097389,0,1
4,GO ACTIN FILAMENT BASED PROCESS,0.1402,0.11227,0.07169,0,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.16798,0.11189,0.069601,0,1
4,GO BEHAVIOR,0.17173,0.11177,0.076566,0,1
4,GO MUSCLE SYSTEM PROCESS,0.11892,0.11128,0.070311,0,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.10794,0.11032,0.07739,0,1
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.18334,0.11015,0.080641,0,1
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.28658,0.11003,0.055219,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.069955,0.10958,0.076343,0,1
4,GO LIPID MODIFICATION,0.030665,0.10898,0.10317,0,1
4,GO DNA MODIFICATION,0.11333,0.10879,0.063839,0,1
4,GO GROWTH,0.16798,0.10859,0.061553,0,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.068115,0.1083,0.092421,0,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.054786,0.10808,0.092555,0,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.050383,0.1076,0.076977,0,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.030665,0.10753,0.10181,0,1
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.1643,0.1075,0.09302,0,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.16068,0.10736,0.064316,0,1
4,GO MEIOSIS I CELL CYCLE PROCESS,0.071835,0.10721,0.099333,0,1
4,GO MULTI ORGANISM PROCESS,0.077726,0.10691,0.078438,0,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.031606,0.10682,0.092664,0,1
4,GO RESPONSE TO CARBOHYDRATE,0.050383,0.10673,0.10294,0,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.073757,0.10669,0.085822,0,1
4,GO POLYOL METABOLIC PROCESS,0.081867,0.10601,0.089321,0,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.30892,0.10589,0.074533,0,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.035624,0.10574,0.1022,0,1
4,GO MUSCLE TISSUE DEVELOPMENT,0.20828,0.10557,0.050843,0,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.086186,0.10528,0.052227,0,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.036694,0.10493,0.10642,0,1
4,GO NEGATIVE REGULATION OF SECRETION,0.056323,0.10489,0.089412,0,1
4,GO LIPID PHOSPHORYLATION,0.26023,0.1048,0.057113,0,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.14679,0.10435,0.079919,0,1
4,GO DNA METHYLATION OR DEMETHYLATION,0.13699,0.10382,0.079924,0,1
4,GO IRON ION TRANSPORT,0.048983,0.10375,0.10772,0,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.073757,0.1034,0.073679,0,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.053284,0.10312,0.092165,0,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.12179,0.10202,0.07451,0,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.054786,0.10193,0.093778,0,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.16068,0.10161,0.061208,0,1
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.12179,0.10072,0.077681,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.19139,0.10054,0.055385,0,1
4,GO SEX DIFFERENTIATION,0.17553,0.10011,0.085781,0,1
4,GO REGULATION OF METAL ION TRANSPORT,0.17553,0.099953,0.066898,0,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.041252,0.098278,0.088879,0,1
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.19971,0.096873,0.059524,0,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.088413,0.096842,0.064361,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.051817,0.093853,0.081516,0,1
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.29206,0.093164,0.04164,0,1
4,GO CELL RECOGNITION,0.36329,0.093013,0.050626,0,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.084004,0.092878,0.089098,0,1
4,GO CELL CELL SIGNALING BY WNT,0.25516,0.092517,0.052197,0,1
4,GO REGULATION OF HISTONE MODIFICATION,0.11892,0.091923,0.055297,0,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.077726,0.091409,0.0657,0,1
4,GO PROTEIN AUTOPHOSPHORYLATION,0.10533,0.090378,0.077825,0,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.062834,0.089809,0.07756,0,1
4,GO REGULATION OF CELL DEVELOPMENT,0.30323,0.089528,0.043716,0,1
4,GO CELL GROWTH,0.11892,0.086974,0.067691,0,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.11333,0.086116,0.059647,0,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.26536,0.085685,0.062623,0,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.079775,0.085614,0.096077,0,1
4,GO SEXUAL REPRODUCTION,0.056323,0.084248,0.076911,0,1
4,GO EMBRYO DEVELOPMENT,0.33843,0.083469,0.035689,0,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.059504,0.083318,0.073636,0,1
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.38927,0.08262,0.043321,0,1
4,GO REGULATION OF GTPASE ACTIVITY,0.10025,0.078773,0.075601,0,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.10794,0.076795,0.057174,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.16798,0.072897,0.060206,0,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.11333,0.065213,0.054684,0,1
4,GO RESPONSE TO RADIATION,0.23088,0.064711,0.03366,0,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.19552,0.060315,0.052052,0,1
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.20828,0.060222,0.033886,0,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.30892,0.055803,0.033104,0,1
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.044978,1.0577,0.76672,0,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.043706,0.65647,0.38827,0,0
4,GO MEMBRANE RAFT ASSEMBLY,0.1161,0.57462,0.3076,0,0
4,GO RESPONSE TO HISTAMINE,0.066316,0.56977,0.49147,0,0
4,GO RESPONSE TO INTERFERON ALPHA,0.044978,0.56285,0.32205,0,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.034581,0.53857,0.30626,0,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.068115,0.52415,0.42906,0,0
4,GO MEMBRANE RAFT ORGANIZATION,0.037792,0.51966,0.31244,0,0
4,GO MUCUS SECRETION,0.046281,0.47883,0.41516,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.07572,0.47756,0.32509,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.069955,0.47521,0.37625,0,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.030665,0.433,0.32642,0,0
4,GO GLYCINE TRANSPORT,0.11892,0.41927,0.2588,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.11892,0.41626,0.19953,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.095374,0.40922,0.29491,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.1794,0.40708,0.3066,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.04007,0.40672,0.39103,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.38267,0.40036,0.1702,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.032572,0.39358,0.27606,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.34454,0.38718,0.1903,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.069955,0.38593,0.27559,0,0
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.037792,0.38375,0.17635,0,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.037792,0.38375,0.23106,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.051817,0.37513,0.41791,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.057895,0.37318,0.3228,0,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.037792,0.36932,0.26756,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.07572,0.36855,0.28341,0,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.031606,0.36215,0.2697,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.17173,0.36102,0.22536,0,0
4,GO REFLEX,0.086186,0.36064,0.28909,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.056323,0.35742,0.33171,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.19552,0.35724,0.38197,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.059504,0.35715,0.23433,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.22622,0.35339,0.25584,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.033564,0.34168,0.24006,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.20396,0.34133,0.18429,0,0
4,GO HEART INDUCTION,0.044978,0.33635,0.36867,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.054786,0.33533,0.23129,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.1402,0.33517,0.24637,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.16798,0.33472,0.21702,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.042464,0.33355,0.2989,0,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.041252,0.33279,0.22846,0,0
4,GO PLASMINOGEN ACTIVATION,0.069955,0.33086,0.18265,0,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.057895,0.32897,0.19139,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.032572,0.32673,0.2747,0,0
4,GO T CELL EXTRAVASATION,0.14347,0.32584,0.1946,0,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.088413,0.32549,0.29788,0,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.059504,0.32211,0.2702,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.079775,0.31973,0.21687,0,0
4,GO CERAMIDE CATABOLIC PROCESS,0.059504,0.31875,0.27955,0,0
4,GO MALE MEIOSIS I,0.050383,0.31594,0.28103,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.19139,0.31173,0.25089,0,0
4,GO RETINAL METABOLIC PROCESS,0.15017,0.31029,0.1587,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.16068,0.31016,0.18821,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.048983,0.3084,0.25329,0,0
4,GO HORMONE CATABOLIC PROCESS,0.056323,0.3081,0.20975,0,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.044978,0.30714,0.188,0,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.047616,0.30697,0.27907,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.12179,0.30671,0.27345,0,0
4,GO NEURON CELL CELL ADHESION,0.11333,0.30658,0.32895,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.069955,0.30636,0.24386,0,0
4,GO TRNA CATABOLIC PROCESS,0.036694,0.30598,0.36893,0,0
4,GO TYPE 2 IMMUNE RESPONSE,0.066316,0.30419,0.17462,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.081867,0.30281,0.23982,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.13699,0.29964,0.1502,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.11061,0.29872,0.20978,0,0
4,GO RESPONSE TO INTERLEUKIN 18,0.07572,0.29862,0.30591,0,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.15017,0.29852,0.12177,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.077726,0.298,0.27249,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.22164,0.29785,0.27291,0,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.10277,0.29678,0.27622,0,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.044978,0.29613,0.1963,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.046281,0.29332,0.1871,0,0
4,GO RESPONSE TO ZINC ION,0.051817,0.29268,0.22601,0,0
4,GO T CELL CYTOKINE PRODUCTION,0.038917,0.29261,0.17931,0,0
4,GO STEROID HORMONE SECRETION,0.035624,0.29252,0.23661,0,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.046281,0.2919,0.34347,0,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.051817,0.29185,0.27919,0,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.10277,0.28963,0.2352,0,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.32642,0.28938,0.014604,0,0
4,GO REGULATION OF TRANSPOSITION,0.057895,0.28869,0.26508,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.057895,0.28676,0.27112,0,0
4,GO REGULATION OF RECEPTOR BINDING,0.068115,0.28383,0.24605,0,0
4,GO L PHENYLALANINE METABOLIC PROCESS,0.09779,0.28275,0.16185,0,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.046281,0.28208,0.29954,0,0
4,GO GDP METABOLIC PROCESS,0.057895,0.28137,0.25104,0,0
4,GO GAP JUNCTION ASSEMBLY,0.079775,0.28073,0.21211,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.04007,0.27963,0.30445,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.1643,0.27932,0.18307,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.12771,0.27927,0.21826,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.1161,0.27911,0.17593,0,0
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15712,0.27754,0.13331,0,0
4,GO ALANINE TRANSPORT,0.15017,0.2767,0.1736,0,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.044978,0.27603,0.16539,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.093006,0.27505,0.30964,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.15017,0.27474,0.27022,0,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.11061,0.27429,0.27267,0,0
4,GO OLIGOPEPTIDE TRANSPORT,0.068115,0.27398,0.19014,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.051817,0.27396,0.35924,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036694,0.27195,0.21673,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.24525,0.27096,0.19374,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.036694,0.27022,0.18223,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.069955,0.26945,0.26049,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.17553,0.26896,0.26899,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.077726,0.26895,0.31591,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.056323,0.26832,0.24823,0,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.050383,0.2683,0.20198,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.32642,0.26826,0.22316,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.057895,0.2675,0.19704,0,0
4,GO BILE ACID AND BILE SALT TRANSPORT,0.073757,0.26712,0.16956,0,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.04007,0.266,0.18875,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.062834,0.26599,0.26743,0,0
4,GO SUPEROXIDE ANION GENERATION,0.037792,0.26557,0.21175,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.077726,0.26376,0.24084,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.062834,0.26354,0.26608,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.071835,0.26297,0.14896,0,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.044978,0.26258,0.22848,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.044978,0.26165,0.24139,0,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.35697,0.26139,0.13976,0,0
4,GO INTERLEUKIN 13 PRODUCTION,0.18733,0.26068,0.16392,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.17553,0.25975,0.21797,0,0
4,GO REGULATION OF COAGULATION,0.059504,0.25891,0.18546,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.21712,0.25803,0.17789,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.19971,0.25659,0.16038,0,0
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.04007,0.25589,0.22028,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.062834,0.2552,0.19774,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.35072,0.25473,0.2182,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.14347,0.25455,0.24871,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.095374,0.25416,0.18033,0,0
4,GO RETINA LAYER FORMATION,0.10794,0.25407,0.27422,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21267,0.25399,0.14856,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.13074,0.2521,0.23033,0,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.12771,0.25208,0.19369,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033564,0.25204,0.1775,0,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.037792,0.25182,0.19767,0,0
4,GO SECONDARY METABOLIC PROCESS,0.09779,0.25154,0.17924,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.036694,0.25106,0.23527,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.22164,0.25085,0.19272,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.044978,0.25079,0.21023,0,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.073757,0.25069,0.33549,0,0
4,GO SPINAL CORD PATTERNING,0.19139,0.25029,0.18886,0,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.064555,0.25014,0.17062,0,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.088413,0.24938,0.17609,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.25017,0.24926,0.11375,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.079775,0.24881,0.17631,0,0
4,GO GALACTOSE METABOLIC PROCESS,0.23088,0.24876,0.14923,0,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.033564,0.24747,0.17758,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.081867,0.24665,0.23152,0,0
4,GO RESPONSE TO AMINE,0.069955,0.24509,0.15877,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.10025,0.24489,0.13709,0,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.054786,0.24466,0.19108,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.033564,0.24452,0.2291,0,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.1794,0.24385,0.11287,0,0
4,GO AMELOGENESIS,0.068115,0.24361,0.2324,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.032572,0.24326,0.17284,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.031606,0.24315,0.23614,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.1402,0.2427,0.17353,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.29206,0.242,0.13831,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.12771,0.2415,0.17438,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.10277,0.2406,0.23191,0,0
4,GO SHORT TERM MEMORY,0.54313,0.24001,0.055439,0,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.12771,0.23997,0.21761,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.062834,0.23864,0.18534,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.11333,0.23859,0.14964,0,0
4,GO MATING BEHAVIOR,0.037792,0.23778,0.19021,0,0
4,GO GOLGI TO ENDOSOME TRANSPORT,0.13384,0.23714,0.11793,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.044978,0.23673,0.13656,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.58378,0.23663,0.070825,0,0
4,GO POSITIVE REGULATION OF COAGULATION,0.062834,0.23614,0.19945,0,0
4,GO REPLICATIVE SENESCENCE,0.057895,0.23471,0.19856,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.07572,0.23455,0.21549,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.069955,0.23434,0.14141,0,0
4,GO MEMBRANE FISSION,0.19971,0.23338,0.15661,0,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.077726,0.23272,0.1601,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.069955,0.23199,0.14747,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.11333,0.23089,0.13036,0,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.047616,0.23021,0.14163,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.057895,0.2299,0.29822,0,0
4,GO REGULATION OF ACTION POTENTIAL,0.07572,0.22987,0.15334,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.21712,0.22961,0.1048,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.17553,0.22802,0.13797,0,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.073757,0.22786,0.14608,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.12472,0.22757,0.21097,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.21712,0.22729,0.12616,0,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.18733,0.22667,0.1178,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.036694,0.22627,0.15802,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.1643,0.22588,0.2565,0,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.077726,0.22586,0.15894,0,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.086186,0.22557,0.1667,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.16068,0.2246,0.18737,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.12771,0.22413,0.15469,0,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.048983,0.22394,0.19607,0,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.11333,0.22281,0.16879,0,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.21267,0.22245,0.10323,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.093006,0.22243,0.15394,0,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.1402,0.22226,0.21458,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.1161,0.22223,0.15555,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.066316,0.22204,0.16934,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.32052,0.22185,0.11804,0,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.068115,0.22176,0.20148,0,0
4,GO STARTLE RESPONSE,0.10277,0.22165,0.17199,0,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.16068,0.22156,0.10157,0,0
4,GO RESPONSE TO TUMOR CELL,0.030665,0.22144,0.20111,0,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.032572,0.22091,0.22117,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.048983,0.22091,0.24488,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.14679,0.22088,0.18133,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.056323,0.22065,0.24072,0,0
4,GO ACTIN FILAMENT SEVERING,0.1794,0.22014,0.15757,0,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.030665,0.21954,0.16461,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.20828,0.21862,0.09932,0,0
4,GO BLASTODERM SEGMENTATION,0.60883,0.21859,0.040946,0,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.36329,0.21782,0.079049,0,0
4,GO RESPONSE TO INSECTICIDE,0.046281,0.21756,0.24988,0,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.057895,0.2174,0.13038,0,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.09779,0.2174,0.21611,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.093006,0.21732,0.18857,0,0
4,GO PANCREAS DEVELOPMENT,0.10794,0.21692,0.13531,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.32642,0.21688,0.088225,0,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.069955,0.2163,0.26918,0,0
4,GO AMMONIUM TRANSPORT,0.071835,0.21598,0.18491,0,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.24039,0.21588,0.19,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.093006,0.21577,0.19235,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.090686,0.21555,0.18983,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.053284,0.21509,0.26723,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.068115,0.215,0.12929,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.33239,0.21458,0.1349,0,0
4,GO AMYLOID FIBRIL FORMATION,0.04007,0.21415,0.21638,0,0
4,GO CELL FATE DETERMINATION,0.20828,0.21411,0.12914,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.29206,0.21387,0.22054,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.054786,0.21344,0.26254,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.057895,0.21289,0.18069,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.059504,0.21283,0.14448,0,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.11333,0.21215,0.19148,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.17173,0.21197,0.17663,0,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.090686,0.21194,0.12173,0,0
4,GO BLEB ASSEMBLY,0.32052,0.21186,0.030554,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.56735,0.21172,-0.0059659,0,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.077726,0.21129,0.37523,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.042464,0.21092,0.23407,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.51944,0.21088,0.045991,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.030665,0.21051,0.18197,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.062834,0.21033,0.14602,0,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.059504,0.20976,0.18984,0,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.27056,0.20964,0.10762,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.24039,0.2092,0.10484,0,0
4,GO HYALURONAN METABOLIC PROCESS,0.073757,0.20905,0.122,0,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.073757,0.20891,0.18497,0,0
4,GO RESPONSE TO TESTOSTERONE,0.056323,0.20799,0.15624,0,0
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.07572,0.20783,0.21852,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.068115,0.20719,0.31036,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.31468,0.20714,0.080248,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.09779,0.20707,0.15061,0,0
4,GO REGULATION OF FATTY ACID OXIDATION,0.054786,0.20671,0.16622,0,0
4,GO BASEMENT MEMBRANE ORGANIZATION,0.11892,0.20645,0.18793,0,0
4,GO BEHAVIORAL RESPONSE TO PAIN,0.32052,0.20607,0.11179,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.13699,0.20603,0.10916,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.15017,0.20587,0.18237,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.38927,0.20586,0.18578,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.12179,0.20546,0.16395,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.1643,0.2049,0.20974,0,0
4,GO RESPONSE TO KETONE,0.037792,0.20479,0.13229,0,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.043706,0.20477,0.13066,0,0
4,GO STEROID ESTERIFICATION,0.046281,0.20477,0.16603,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.047616,0.20453,0.20326,0,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.036694,0.20425,0.14051,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.16068,0.20424,0.17468,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.044978,0.2041,0.18092,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.073757,0.20399,0.23409,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.25516,0.20318,0.10258,0,0
4,GO CELL CELL RECOGNITION,0.062834,0.20313,0.14203,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.30892,0.20303,0.091724,0,0
4,GO AUTOPHAGOSOME MATURATION,0.032572,0.20277,0.16281,0,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.14679,0.20203,0.15063,0,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.035624,0.20197,0.14906,0,0
4,GO EPITHELIAL CELL MATURATION,0.11061,0.20167,0.18799,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.24525,0.20166,0.11585,0,0
4,GO QUINONE METABOLIC PROCESS,0.088413,0.20159,0.19404,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.13074,0.20131,0.14414,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.048983,0.20083,0.14045,0,0
4,GO RESPONSE TO PROTOZOAN,0.046281,0.20059,0.15157,0,0
4,GO THALAMUS DEVELOPMENT,0.093006,0.20037,0.23148,0,0
4,GO REGULATION OF LIGASE ACTIVITY,0.13074,0.2003,0.15759,0,0
4,GO ASYMMETRIC CELL DIVISION,0.26536,0.20027,0.12991,0,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.04007,0.20024,0.17407,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.15017,0.20015,0.12962,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.25017,0.19973,0.091193,0,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.042464,0.19946,0.14325,0,0
4,GO GLAND MORPHOGENESIS,0.11333,0.19914,0.13183,0,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.057895,0.1991,0.23443,0,0
4,GO REGULATION OF AMINO ACID TRANSPORT,0.071835,0.19901,0.1842,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.66904,0.19892,0.025008,0,0
4,GO CD40 SIGNALING PATHWAY,0.095374,0.19881,0.13295,0,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.10794,0.19861,0.14136,0,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.054786,0.1984,0.21314,0,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.042464,0.19838,0.17934,0,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.1643,0.19806,0.14132,0,0
4,GO MYELIN MAINTENANCE,0.16798,0.198,0.17039,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.38267,0.19792,0.097926,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.059504,0.19773,0.26325,0,0
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.037792,0.19767,0.12756,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.17173,0.19745,0.11127,0,0
4,GO MONONUCLEAR CELL MIGRATION,0.066316,0.19739,0.1266,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.11061,0.19724,0.10057,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.064555,0.19717,0.17699,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.048983,0.19641,0.15409,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.086186,0.19618,0.14266,0,0
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.10277,0.19612,0.14875,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.057895,0.19582,0.15777,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.13384,0.1955,0.14581,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.030665,0.19536,0.15113,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.053284,0.19524,0.12946,0,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.048983,0.1952,0.15427,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.07572,0.19496,0.14805,0,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.059504,0.19494,0.16465,0,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.27583,0.19482,0.11909,0,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.32052,0.19472,0.066382,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.30323,0.19448,0.10594,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.30892,0.19442,0.051017,0,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.081867,0.19426,0.12105,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.30892,0.19423,0.14055,0,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.093006,0.19416,0.12738,0,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.068115,0.1941,0.21465,0,0
4,GO PRESYNAPSE ORGANIZATION,0.22164,0.19394,0.11513,0,0
4,GO PLATELET AGGREGATION,0.053284,0.19331,0.15273,0,0
4,GO SYNAPSE MATURATION,0.33239,0.19324,0.14623,0,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.27583,0.19305,0.11744,0,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.044978,0.19287,0.15163,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.17173,0.19241,0.14562,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.13074,0.19229,0.18359,0,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.10025,0.19217,0.30738,0,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.07572,0.19216,0.11926,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.068115,0.19175,0.16552,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.077726,0.19174,0.24509,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.10794,0.19165,0.17491,0,0
4,GO PIGMENTATION,0.062834,0.19135,0.11277,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.042464,0.19122,0.17249,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.19139,0.19066,0.15941,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.71343,0.19058,-0.043374,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.43029,0.19047,0.089814,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.057895,0.19032,0.17254,0,0
4,GO PLATELET DEGRANULATION,0.13699,0.19028,0.11853,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.2356,0.18991,0.13663,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.04007,0.18972,0.17077,0,0
4,GO ENAMEL MINERALIZATION,0.30892,0.18939,0.14105,0,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.056323,0.18936,0.14561,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.19139,0.18918,0.14887,0,0
4,GO RECEPTOR CATABOLIC PROCESS,0.1794,0.1891,0.093281,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.10794,0.18895,0.12213,0,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.093006,0.18874,0.11034,0,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.068115,0.18857,0.11361,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.050383,0.18831,0.17174,0,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.11892,0.1882,0.13315,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.062834,0.18802,0.13633,0,0
4,GO VESICLE BUDDING FROM MEMBRANE,0.10533,0.18798,0.10684,0,0
4,GO REGULATION OF VESICLE FUSION,0.16798,0.18784,0.18091,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.25017,0.18752,0.10705,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.22164,0.18727,0.12412,0,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.036694,0.18717,0.14747,0,0
4,GO VAGINA DEVELOPMENT,0.32052,0.18662,0.081138,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.066316,0.1865,0.15051,0,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.064555,0.18629,0.15236,0,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.28117,0.18591,0.1254,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.064555,0.18575,0.15509,0,0
4,GO PODOSOME ASSEMBLY,0.29206,0.18575,0.068084,0,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.034581,0.18567,0.19917,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.064555,0.18565,0.18742,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.40947,0.18555,0.11961,0,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.042464,0.1854,0.3461,0,0
4,GO PLASMA MEMBRANE FUSION,0.088413,0.1848,0.15969,0,0
4,GO ORGANELLE INHERITANCE,0.064555,0.18478,0.093847,0,0
4,GO LOCOMOTOR RHYTHM,0.17553,0.18461,0.12384,0,0
4,GO STEROL TRANSPORT,0.042464,0.18446,0.13826,0,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.04007,0.18443,0.15843,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.053284,0.18432,0.14181,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.041252,0.1843,0.20176,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.21712,0.18411,0.083945,0,0
4,GO COAGULATION,0.069955,0.18386,0.10491,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.11061,0.18363,0.18073,0,0
4,GO GROOMING BEHAVIOR,0.033564,0.18359,0.27043,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.33843,0.18358,0.07748,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.093006,0.18342,0.14092,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.51167,0.1834,0.069135,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.12179,0.1833,0.14636,0,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.10025,0.18264,0.10998,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.036694,0.18214,0.1899,0,0
4,GO CYTOKINE METABOLIC PROCESS,0.051817,0.18212,0.1171,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.16068,0.18185,0.11931,0,0
4,GO CYTOKINETIC PROCESS,0.043706,0.18185,0.13692,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.086186,0.18168,0.18121,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.53518,0.18121,0.093842,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.06115,0.18107,0.13778,0,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.051817,0.18091,0.12875,0,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.042464,0.1807,0.11697,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.15361,0.18031,0.15358,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.086186,0.17947,0.10381,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.14679,0.17916,0.16525,0,0
4,GO NEURON FATE SPECIFICATION,0.4963,0.17884,0.17917,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.43736,0.17864,0.14804,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.17553,0.1786,0.19839,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.046281,0.17854,0.15799,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.071835,0.17836,0.16548,0,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.034581,0.17822,0.33396,0,0
4,GO TRABECULA FORMATION,0.14679,0.17786,0.12535,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.28117,0.17759,0.078448,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.068115,0.17723,0.1249,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.046281,0.17715,0.18896,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.066316,0.17712,0.1383,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.36968,0.17711,0.10791,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.10794,0.1767,0.13415,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.22622,0.17668,0.14103,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.25017,0.17622,0.11381,0,0
4,GO DEVELOPMENTAL PIGMENTATION,0.16068,0.17617,0.08245,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.036694,0.17617,0.20772,0,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.14679,0.17582,0.11775,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.19139,0.17577,0.13325,0,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10533,0.17516,0.19023,0,0
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.086186,0.17489,0.14668,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13074,0.17484,0.17163,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.18334,0.17461,0.1374,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.38267,0.17449,0.056073,0,0
4,GO INCLUSION BODY ASSEMBLY,0.36329,0.17428,0.083178,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.19139,0.17428,0.18372,0,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.15712,0.17424,0.12157,0,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.032572,0.17407,0.15245,0,0
4,GO FUCOSE METABOLIC PROCESS,0.26023,0.17406,0.1161,0,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.071835,0.17406,0.1203,0,0
4,GO CELL MATRIX ADHESION,0.066316,0.17382,0.1267,0,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.18733,0.17371,0.10857,0,0
4,GO MICROVILLUS ORGANIZATION,0.069955,0.1737,0.20305,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10533,0.17369,0.2767,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.07572,0.17369,0.12648,0,0
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.15361,0.17357,0.13844,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.17173,0.17355,0.15404,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.043706,0.17343,0.15079,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.51167,0.17339,0.0236,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.37614,0.17332,0.052255,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.24039,0.17326,0.070786,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.066316,0.17322,0.1656,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.13384,0.17314,0.10612,0,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.051817,0.17312,0.13905,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.8331,0.17253,-0.0044092,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.12771,0.17243,0.16086,0,0
4,GO RESPONSE TO ETHANOL,0.047616,0.1723,0.12691,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.15712,0.17218,0.10443,0,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.13384,0.17194,0.094024,0,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.033564,0.17168,0.15688,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.15361,0.17159,0.1167,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.23088,0.17154,0.094725,0,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.14679,0.17153,0.12002,0,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.043706,0.17123,0.21781,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.28117,0.17111,0.084725,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.24039,0.17108,0.13632,0,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.06115,0.17103,0.14235,0,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.2356,0.17096,0.067343,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.35072,0.17085,0.038661,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.048983,0.17078,0.17568,0,0
4,GO REGULATION OF BODY FLUID LEVELS,0.033564,0.17054,0.13102,0,0
4,GO PLACENTA DEVELOPMENT,0.23088,0.17031,0.093934,0,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.071835,0.17027,0.10912,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.29761,0.17022,0.098571,0,0
4,GO GONADOTROPIN SECRETION,0.13074,0.17017,0.15566,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.11061,0.17007,0.13025,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.046281,0.17003,0.14754,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.043706,0.16957,0.13831,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.25017,0.16951,0.13311,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.14679,0.16946,0.14375,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.031606,0.16942,0.17508,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.19139,0.16896,0.11495,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.056323,0.16875,0.14039,0,0
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.16798,0.16855,0.13483,0,0
4,GO OXALATE TRANSPORT,0.11892,0.16817,0.11552,0,0
4,GO ENDOTHELIAL CELL MIGRATION,0.053284,0.16807,0.15928,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.45898,0.1677,0.048736,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.18733,0.16765,0.12003,0,0
4,GO MICROVILLUS ASSEMBLY,0.14347,0.16763,0.19624,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.17173,0.16735,0.11872,0,0
4,GO RESPONSE TO OSMOTIC STRESS,0.21267,0.16732,0.087954,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.069955,0.16729,0.13173,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.29761,0.16717,0.012286,0,0
4,GO METANEPHROS DEVELOPMENT,0.14679,0.16691,0.11308,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.30323,0.16665,0.25625,0,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.15712,0.16651,0.12435,0,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.033564,0.16638,0.12892,0,0
4,GO COPPER ION HOMEOSTASIS,0.036694,0.16627,0.2038,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.064555,0.1659,0.13348,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.76799,0.16588,-0.053676,0,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.059504,0.16587,0.1888,0,0
4,GO REGULATION OF TUBE SIZE,0.030665,0.16584,0.11997,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.1402,0.16574,0.11937,0,0
4,GO ASTROCYTE DEVELOPMENT,0.14347,0.16565,0.14862,0,0
4,GO DEVELOPMENTAL INDUCTION,0.033564,0.16559,0.17454,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.1643,0.16558,0.19452,0,0
4,GO VESICLE TARGETING,0.10794,0.1654,0.11297,0,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.06115,0.1653,0.11088,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.36968,0.16508,0.059873,0,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.053284,0.16478,0.13141,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.07572,0.16467,0.14495,0,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.09779,0.16447,0.14895,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.27056,0.16421,0.058879,0,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.10025,0.16414,0.11377,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.042464,0.1641,0.18546,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.22164,0.16362,0.22997,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.43736,0.16355,0.047065,0,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.050383,0.16354,0.17233,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.55922,0.16348,0.049194,0,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.047616,0.16346,0.22996,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.093006,0.16331,0.12336,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.29206,0.16311,0.089092,0,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.059504,0.16309,0.1233,0,0
4,GO PROSTANOID METABOLIC PROCESS,0.2356,0.16285,0.074075,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.10533,0.16274,0.17622,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.041252,0.16259,0.22088,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.28117,0.16256,0.092503,0,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.051817,0.16253,0.14313,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.25516,0.16251,0.14055,0,0
4,GO NEPHRON DEVELOPMENT,0.079775,0.16247,0.11167,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.048983,0.16246,0.12691,0,0
4,GO AMINE TRANSPORT,0.031606,0.16244,0.23905,0,0
4,GO MALE SEX DETERMINATION,0.23088,0.16241,0.14737,0,0
4,GO VIRAL RELEASE FROM HOST CELL,0.1402,0.16232,0.10098,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.17553,0.16214,0.17823,0,0
4,GO POTASSIUM ION HOMEOSTASIS,0.042464,0.16203,0.16712,0,0
4,GO REGULATION OF CHLORIDE TRANSPORT,0.38267,0.16199,0.094808,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.25516,0.16139,0.14107,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.071835,0.16138,0.13072,0,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.16068,0.16134,0.11086,0,0
4,GO OSSIFICATION,0.046281,0.16115,0.11214,0,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.06115,0.16104,0.1123,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.06115,0.16094,0.18366,0,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.066316,0.16059,0.11761,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.13074,0.16031,0.1057,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.081867,0.16024,0.11888,0,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.14347,0.16021,0.08852,0,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.033564,0.15995,0.12813,0,0
4,GO ARACHIDONIC ACID SECRETION,0.048983,0.1596,0.11812,0,0
4,GO EAR DEVELOPMENT,0.20396,0.1596,0.085439,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.10025,0.15946,0.12217,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.030665,0.15932,0.20353,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.17173,0.15921,0.13653,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.28658,0.15901,0.046958,0,0
4,GO ENERGY RESERVE METABOLIC PROCESS,0.066316,0.15897,0.14527,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.41634,0.15892,0.13145,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.034581,0.15891,0.14208,0,0
4,GO CELL AGGREGATION,0.51944,0.15869,0.030371,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.27583,0.15854,0.095085,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.4445,0.1582,0.11541,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.042464,0.15815,0.14328,0,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25516,0.15801,0.10943,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.084004,0.15799,0.21277,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.044978,0.15784,0.11938,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.086186,0.15769,0.23508,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.43736,0.15761,0.10993,0,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.15017,0.15754,0.11027,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.50395,0.15753,0.048203,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.041252,0.15752,0.11899,0,0
4,GO TUBE MORPHOGENESIS,0.088413,0.15752,0.097446,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.07572,0.15742,0.12852,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.079775,0.15742,0.12261,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.14679,0.15736,0.13439,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.13384,0.15705,0.24166,0,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.06115,0.15695,0.15227,0,0
4,GO REGULATION OF PROTEIN BINDING,0.069955,0.15679,0.10539,0,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.048983,0.15662,0.1131,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10533,0.15618,0.097091,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.079775,0.15588,0.12696,0,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.18733,0.15573,0.10486,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.26023,0.15554,0.052582,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.10277,0.15542,0.10287,0,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.034581,0.15538,0.18386,0,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.064555,0.15534,0.26693,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.32052,0.15507,0.10696,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.12771,0.15494,0.16802,0,0
4,GO COPII COATED VESICLE BUDDING,0.048983,0.15446,0.10365,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.1794,0.1544,0.12464,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.077726,0.15438,0.16444,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.17553,0.15406,0.12424,0,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.21267,0.15405,0.067338,0,0
4,GO PROTEIN KINASE B SIGNALING,0.15361,0.15393,0.090676,0,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.073757,0.15384,0.10908,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.59207,0.15384,0.027559,0,0
4,GO WOUND HEALING,0.11892,0.15379,0.092136,0,0
4,GO EXOCYTIC PROCESS,0.077726,0.15351,0.15919,0,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.10794,0.15343,0.14569,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.090686,0.15315,0.095211,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.1402,0.15302,0.10873,0,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.053284,0.153,0.14942,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.1643,0.15286,0.12686,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.15361,0.15279,0.092004,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.32052,0.15275,0.094844,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.22164,0.15252,0.086648,0,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.1643,0.15237,0.12173,0,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.19139,0.15213,0.093398,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.35072,0.15199,0.080269,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.2356,0.15157,0.14355,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.24039,0.15133,0.073128,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.051817,0.15116,0.16574,0,0
4,GO RESPONSE TO DRUG,0.033564,0.15114,0.12487,0,0
4,GO REGULATION OF PROTEOLYSIS,0.033564,0.15113,0.11721,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.62578,0.15106,0.017935,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.044978,0.15102,0.14555,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.26536,0.15063,0.15505,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.15712,0.15058,0.11237,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.39593,0.15048,0.095781,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.58378,0.1504,0.056605,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.071835,0.15032,0.15009,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.071835,0.14984,0.19495,0,0
4,GO FLUID TRANSPORT,0.084004,0.14973,0.1073,0,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.043706,0.14972,0.10763,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.10794,0.14936,0.12576,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.06115,0.14921,0.12321,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.48118,0.14918,0.055814,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.1161,0.14847,0.10903,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.32642,0.14845,0.089914,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.054786,0.14833,0.15046,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.081867,0.14819,0.10584,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.33843,0.1477,0.10764,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.25017,0.14758,0.13466,0,0
4,GO RESPONSE TO PROGESTERONE,0.10277,0.14749,0.1298,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.19139,0.1474,0.16394,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23088,0.14728,0.10319,0,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.059504,0.14727,0.14049,0,0
4,GO RESPONSE TO WOUNDING,0.11061,0.14693,0.099459,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.062834,0.14678,0.10397,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.11333,0.14644,0.20298,0,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.10533,0.14642,0.11062,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.47371,0.14627,0.044313,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.43029,0.14622,0.029667,0,0
4,GO TRANSLESION SYNTHESIS,0.069955,0.14617,0.11669,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.21267,0.14606,0.15053,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.62578,0.14589,0.038502,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.057895,0.14583,0.12834,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.22164,0.14571,0.058971,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.21712,0.14559,0.1825,0,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.13699,0.14548,0.13686,0,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.030665,0.14546,0.1337,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.16068,0.14532,0.087696,0,0
4,GO MALE SEX DIFFERENTIATION,0.056323,0.14512,0.13059,0,0
4,GO TRABECULA MORPHOGENESIS,0.15017,0.14509,0.076965,0,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.057895,0.14486,0.17537,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.086186,0.14484,0.10233,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.52728,0.14469,0.13553,0,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.077726,0.14444,0.14793,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.066316,0.14431,0.11294,0,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.40267,0.14428,0.05175,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.13074,0.14428,0.091929,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.33239,0.14419,0.10937,0,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.035624,0.14404,0.11288,0,0
4,GO RESPONSE TO LIPID,0.057895,0.14381,0.11488,0,0
4,GO INNERVATION,0.39593,0.14381,0.16823,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.077726,0.14377,0.099652,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.30892,0.14356,0.20717,0,0
4,GO RRNA CATABOLIC PROCESS,0.032572,0.14337,0.19978,0,0
4,GO RENAL FILTRATION,0.41634,0.14333,0.12558,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11333,0.14319,0.18747,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.16798,0.14309,0.077301,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.23088,0.14288,0.06579,0,0
4,GO MEMBRANE REPOLARIZATION,0.068115,0.14276,0.1666,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.61728,0.14268,0.044708,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.088413,0.14262,0.088473,0,0
4,GO SEQUESTERING OF CALCIUM ION,0.035624,0.14262,0.1359,0,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.056323,0.14261,0.13903,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.093006,0.14237,0.14377,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.92804,0.14208,-0.058017,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.10533,0.14208,0.1291,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.32642,0.14185,0.063269,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.088413,0.14179,0.098623,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.33239,0.14158,0.073646,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.55115,0.14157,0.030653,0,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.2356,0.14153,0.089353,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.32052,0.14143,0.10177,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.78645,0.14136,-0.04171,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.22164,0.14135,0.10885,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.10794,0.14132,0.098343,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.33843,0.14132,0.11229,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.073757,0.14126,0.10289,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.22622,0.14123,0.098389,0,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.38267,0.14116,0.13335,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.53518,0.14102,0.072165,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.38267,0.141,0.04907,0,0
4,GO HINDBRAIN DEVELOPMENT,0.073757,0.14097,0.14157,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.40947,0.1409,-0.001113,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.09779,0.14071,0.10388,0,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.51167,0.14066,0.075415,0,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10533,0.14062,0.1736,0,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.13699,0.14062,0.087622,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.11333,0.14051,0.091559,0,0
4,GO REGIONALIZATION,0.059504,0.14043,0.1083,0,0
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.12179,0.14041,0.12306,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.068115,0.14041,0.20134,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.37614,0.14036,0.0914,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.45171,0.14025,0.057293,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.15712,0.14022,0.11277,0,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.15712,0.14017,0.10438,0,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.057895,0.14015,0.12352,0,0
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.038917,0.14013,0.10234,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.059504,0.13982,0.15634,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.28117,0.13972,0.077418,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.35697,0.13971,0.067509,0,0
4,GO AXONEME ASSEMBLY,0.17173,0.13964,0.11347,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.19552,0.13953,0.10874,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.093006,0.13952,0.06757,0,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.056323,0.1395,0.14198,0,0
4,GO SYMBIOTIC PROCESS,0.10025,0.13931,0.075897,0,0
4,GO RESPONSE TO OXYGEN RADICAL,0.047616,0.13909,0.14608,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.50395,0.13896,0.052659,0,0
4,GO VASCULATURE DEVELOPMENT,0.19552,0.1389,0.071875,0,0
4,GO VASCULOGENESIS,0.55922,0.1388,0.032785,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.22622,0.13872,0.14154,0,0
4,GO AXIS SPECIFICATION,0.1161,0.13869,0.12472,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.41634,0.13824,0.041041,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.85194,0.13822,-0.0041452,0,0
4,GO PREPULSE INHIBITION,0.55115,0.1382,0.1036,0,0
4,GO SEROTONIN SECRETION,0.30323,0.13813,0.13385,0,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.6603,0.1378,0.034587,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.25017,0.13771,0.10276,0,0
4,GO CELLULAR EXTRAVASATION,0.1643,0.13764,0.090972,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.17173,0.13763,0.10682,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17173,0.13763,0.13825,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.037792,0.13756,0.18852,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.24525,0.13753,0.089626,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.2356,0.1372,0.052755,0,0
4,GO EXPLORATION BEHAVIOR,0.33843,0.13708,0.038685,0,0
4,GO CYCLOOXYGENASE PATHWAY,0.35072,0.13693,0.082805,0,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.06115,0.13682,0.13438,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.066316,0.13676,0.20496,0,0
4,GO CALCIUM ION IMPORT,0.069955,0.13675,0.12094,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.74966,0.13671,-0.019225,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.10025,0.13661,0.19061,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.51944,0.1366,0.050856,0,0
4,GO FATTY ACID CATABOLIC PROCESS,0.084004,0.13655,0.10204,0,0
4,GO DETECTION OF MECHANICAL STIMULUS,0.081867,0.13653,0.11718,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.066316,0.13639,0.11136,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.07572,0.13631,0.14244,0,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.036694,0.13619,0.11625,0,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.086186,0.13612,0.10994,0,0
4,GO REGULATION OF RESPONSE TO STRESS,0.031606,0.136,0.098837,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.15712,0.13599,0.10026,0,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.042464,0.13596,0.12367,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.22164,0.13591,0.10579,0,0
4,GO ZINC ION TRANSPORT,0.15712,0.13582,0.089268,0,0
4,GO CAMP METABOLIC PROCESS,0.18334,0.13578,0.11547,0,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.031606,0.1357,0.11094,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.095374,0.1357,0.16351,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.55115,0.13548,0.059399,0,0
4,GO ER OVERLOAD RESPONSE,0.19971,0.13548,0.12327,0,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.20828,0.13542,0.088115,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.16068,0.13542,0.17533,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.12179,0.13504,0.11798,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.25017,0.13498,0.068902,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.24525,0.13496,0.1037,0,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.26023,0.13489,0.089672,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.1402,0.13487,0.10787,0,0
4,GO HEAT GENERATION,0.095374,0.13481,0.14805,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.20396,0.1347,0.10636,0,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.044978,0.13464,0.11749,0,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.11892,0.1346,0.10826,0,0
4,GO SLEEP,0.24039,0.1345,0.11257,0,0
4,GO MAMMARY GLAND DEVELOPMENT,0.062834,0.13436,0.11211,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.17173,0.1341,0.10034,0,0
4,GO MIDBODY ABSCISSION,0.051817,0.134,0.18015,0,0
4,GO CARDIAC CONDUCTION,0.095374,0.13395,0.1211,0,0
4,GO FATTY ACID TRANSPORT,0.069955,0.13393,0.094655,0,0
4,GO RESPONSE TO ETHER,0.14347,0.13386,0.08766,0,0
4,GO TISSUE REGENERATION,0.14679,0.13383,0.12753,0,0
4,GO SEGMENTATION,0.28658,0.13376,0.065916,0,0
4,GO AMYLOID BETA CLEARANCE,0.095374,0.13357,0.13525,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.40267,0.13345,0.085015,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.30892,0.13339,0.07823,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.037792,0.1333,0.14753,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.073757,0.13328,0.10544,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.41634,0.13317,0.017916,0,0
4,GO MAINTENANCE OF LOCATION,0.035624,0.13306,0.10953,0,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.077726,0.13297,0.092535,0,0
4,GO OOGENESIS,0.034581,0.13293,0.11213,0,0
4,GO KETONE BIOSYNTHETIC PROCESS,0.21712,0.13288,0.099338,0,0
4,GO SYNAPSE ASSEMBLY,0.19971,0.1328,0.118,0,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.20828,0.13224,0.12033,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.28658,0.13222,0.10164,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.062834,0.13214,0.11945,0,0
4,GO RESPONSE TO FATTY ACID,0.079775,0.13185,0.13029,0,0
4,GO AUTOPHAGY OF NUCLEUS,0.31468,0.13179,0.096489,0,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.40947,0.13167,0.10195,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.22164,0.13163,0.10935,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.47371,0.13132,0.054793,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.27583,0.1312,0.05243,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.26536,0.13118,0.19331,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.64294,0.13098,0.047672,0,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.068115,0.13089,0.11326,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.044978,0.13082,0.15342,0,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.056323,0.1308,0.12421,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.036694,0.13078,0.17009,0,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.2356,0.13047,0.10297,0,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.07572,0.1304,0.13818,0,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.1643,0.13031,0.19855,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.33843,0.1302,0.091816,0,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.20396,0.13019,0.072867,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.19552,0.13013,0.084185,0,0
4,GO FIBROBLAST MIGRATION,0.084004,0.13011,0.09746,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.32052,0.12995,0.074037,0,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.064555,0.12988,0.15423,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.19552,0.12978,0.17936,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.74966,0.12974,0.011353,0,0
4,GO CHYLOMICRON ASSEMBLY,0.36968,0.12974,0.051982,0,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.086186,0.1295,0.11808,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.36329,0.12928,0.04233,0,0
4,GO TISSUE MIGRATION,0.093006,0.12928,0.12253,0,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.084004,0.1292,0.098679,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.11892,0.12918,0.10913,0,0
4,GO LYMPH NODE DEVELOPMENT,0.12179,0.12907,0.13237,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.22164,0.12907,0.067344,0,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.035624,0.12902,0.1087,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.17553,0.12897,0.071281,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.10794,0.12892,0.073783,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.29761,0.1289,0.037213,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.15712,0.12887,0.077611,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.090686,0.12884,0.11559,0,0
4,GO FEEDING BEHAVIOR,0.084004,0.1286,0.10544,0,0
4,GO BICARBONATE TRANSPORT,0.18334,0.12844,0.11005,0,0
4,GO GENITALIA MORPHOGENESIS,0.16798,0.12813,0.17067,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.70447,0.12812,0.017904,0,0
4,GO ASTROCYTE ACTIVATION,0.1161,0.12802,0.14503,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.1161,0.12801,0.086416,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.14679,0.12789,0.18044,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.29761,0.12786,0.074092,0,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.050383,0.12744,0.13252,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.1402,0.12739,0.12101,0,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.1794,0.12714,0.08834,0,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.066316,0.1271,0.18666,0,0
4,GO MUSCLE CELL MIGRATION,0.18334,0.12701,0.090558,0,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.073757,0.12684,0.14916,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.29761,0.12664,0.12694,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.33843,0.1266,0.13606,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.40267,0.12655,0.076856,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.34454,0.12643,0.098811,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16798,0.12638,0.11595,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.12472,0.12632,0.11135,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.036694,0.12631,0.13281,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.22164,0.12629,0.19835,0,0
4,GO ARTERY MORPHOGENESIS,0.084004,0.12628,0.079888,0,0
4,GO MYELOID CELL HOMEOSTASIS,0.044978,0.12626,0.11949,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.064555,0.12618,0.1625,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.45171,0.12617,0.039938,0,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.041252,0.12616,0.10352,0,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.036694,0.12613,0.097992,0,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.15361,0.12606,0.16968,0,0
4,GO RESPONSE TO HYPEROXIA,0.60042,0.12598,0.024528,0,0
4,GO SUPEROXIDE METABOLIC PROCESS,0.10025,0.12591,0.12546,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.43029,0.12583,0.090528,0,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.059504,0.12581,0.099268,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.22164,0.12576,0.079598,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.1161,0.12576,0.10677,0,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.079775,0.12574,0.1437,0,0
4,GO PANCREATIC JUICE SECRETION,0.55115,0.12572,0.10958,0,0
4,GO RESPONSE TO OXYGEN LEVELS,0.044978,0.12571,0.11363,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.11333,0.12569,0.12443,0,0
4,GO MYELIN ASSEMBLY,0.15361,0.12553,0.14656,0,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.056323,0.1254,0.1343,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.16798,0.12529,0.19264,0,0
4,GO REGULATION OF LIPID LOCALIZATION,0.041252,0.1251,0.13315,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.51167,0.12507,0.05279,0,0
4,GO SPERM EGG RECOGNITION,0.23088,0.12504,0.071877,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.048983,0.12492,0.11627,0,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.13074,0.1249,0.16296,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.26023,0.12481,0.070514,0,0
4,GO PLATELET MORPHOGENESIS,0.4445,0.1246,0.050469,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.54313,0.12459,0.026708,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.10794,0.12451,0.098411,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.21267,0.12447,0.092332,0,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.22164,0.12437,0.1256,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21712,0.12427,0.10419,0,0
4,GO EXCRETION,0.081867,0.12424,0.10663,0,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.36968,0.12414,0.077706,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.066316,0.12405,0.10613,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.26023,0.12394,0.090039,0,0
4,GO KIDNEY MORPHOGENESIS,0.19139,0.12384,0.094267,0,0
4,GO CELL REDOX HOMEOSTASIS,0.1643,0.12372,0.10221,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.069955,0.12368,0.11138,0,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.059504,0.12343,0.16215,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.12179,0.1234,0.083691,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.19971,0.12331,0.13559,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.33843,0.12327,0.085282,0,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.15361,0.12327,0.083553,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.13699,0.12312,0.10985,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.32052,0.1231,0.11317,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.14347,0.1231,0.088653,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.19552,0.12304,0.23374,0,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.40947,0.12301,0.050225,0,0
4,GO POLYOL CATABOLIC PROCESS,0.038917,0.12292,0.16056,0,0
4,GO ESTROGEN METABOLIC PROCESS,0.31468,0.12277,0.073853,0,0
4,GO CELLULAR RESPONSE TO LIPID,0.086186,0.12267,0.098849,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.057895,0.12259,0.089285,0,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.048983,0.12252,0.10734,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.29761,0.12248,0.052778,0,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.041252,0.12232,0.096465,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.27056,0.12224,0.14989,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.19552,0.12223,0.085683,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.45898,0.12217,0.095288,0,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.39593,0.12214,0.061121,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.36329,0.12212,0.088947,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23088,0.12211,0.058883,0,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.035624,0.12195,0.11922,0,0
4,GO RESPONSE TO VITAMIN D,0.8331,0.12193,-0.013709,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.079775,0.12187,0.12524,0,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.1794,0.12174,0.090726,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.17553,0.12173,0.11609,0,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.21267,0.12169,0.082067,0,0
4,GO ANION HOMEOSTASIS,0.38267,0.12162,0.059046,0,0
4,GO VITAMIN METABOLIC PROCESS,0.35697,0.1213,0.079216,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.28658,0.12129,0.10247,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.26023,0.12124,0.060836,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.068115,0.12122,0.11045,0,0
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.12771,0.12116,0.084594,0,0
4,GO ANIMAL ORGAN REGENERATION,0.20396,0.12109,0.062267,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.051817,0.12096,0.11275,0,0
4,GO NEURON REMODELING,0.2356,0.12089,0.1473,0,0
4,GO FIBROBLAST PROLIFERATION,0.24525,0.12088,0.060228,0,0
4,GO REGULATION OF LIPID TRANSPORT,0.033564,0.12083,0.14864,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.53518,0.12066,0.019212,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.1643,0.12051,0.2273,0,0
4,GO LOCOMOTORY BEHAVIOR,0.16068,0.12051,0.11456,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.15361,0.12049,0.078418,0,0
4,GO TETRAPYRROLE METABOLIC PROCESS,0.35697,0.12049,0.057163,0,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.034581,0.12041,0.098601,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.13074,0.12031,0.092594,0,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.22622,0.12028,0.075363,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.13074,0.12028,0.15373,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.36968,0.12019,0.056624,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.20396,0.12018,0.099126,0,0
4,GO NUCLEOSIDE SALVAGE,0.55115,0.12011,0.018964,0,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.09779,0.12007,0.11808,0,0
4,GO AUTOPHAGOSOME ORGANIZATION,0.034581,0.12004,0.12457,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.15017,0.11993,0.095769,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.24525,0.11993,0.063662,0,0
4,GO SEX DETERMINATION,0.22622,0.11988,0.095254,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.1794,0.11988,0.088822,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.09779,0.11964,0.10226,0,0
4,GO CHOLESTEROL EFFLUX,0.16798,0.11944,0.088619,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.1402,0.11916,0.10365,0,0
4,GO REGULATION OF HEAT GENERATION,0.16798,0.11914,0.18092,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.23088,0.11911,0.18455,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.27056,0.11908,0.10208,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.60883,0.11895,0.062846,0,0
4,GO STRIATUM DEVELOPMENT,0.18733,0.11874,0.11921,0,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.09779,0.11874,0.094285,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.15361,0.11867,0.1113,0,0
4,GO REGULATION OF HAIR CYCLE,0.15712,0.11847,0.079663,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.36329,0.11846,0.045241,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.23088,0.11821,0.11093,0,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.30323,0.11817,0.053705,0,0
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.14679,0.11799,0.13577,0,0
4,GO MEMORY,0.16068,0.11792,0.096486,0,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.093006,0.1175,0.092268,0,0
4,GO REGULATION OF HEART GROWTH,0.81436,0.11748,0.0076922,0,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.21267,0.11747,0.095124,0,0
4,GO REGULATION OF CELL DEATH,0.056323,0.11739,0.088003,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.048983,0.11739,0.15632,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.85194,0.11713,0.01877,0,0
4,GO NEGATIVE T CELL SELECTION,0.10533,0.11695,0.051533,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.71343,0.11681,0.0226,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.066316,0.1166,0.16922,0,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.062834,0.11655,0.18764,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.28117,0.11647,0.053938,0,0
4,GO GLIAL CELL ACTIVATION,0.26023,0.11639,0.053863,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.12771,0.11638,0.11228,0,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.064555,0.11633,0.10553,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.61728,0.11625,0.0094858,0,0
4,GO CELL SUBSTRATE ADHESION,0.30323,0.11619,0.052286,0,0
4,GO PHAGOCYTOSIS,0.084004,0.11602,0.1051,0,0
4,GO OOCYTE MATURATION,0.19552,0.11591,0.065481,0,0
4,GO RESPONSE TO CORTICOSTEROID,0.14347,0.1157,0.098093,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.044978,0.11567,0.12577,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.11892,0.11551,0.18022,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.34454,0.11531,0.084559,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.12472,0.11528,0.087433,0,0
4,GO CGMP MEDIATED SIGNALING,0.53518,0.11526,0.043622,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.04007,0.11521,0.12919,0,0
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.60042,0.11521,0.0053651,0,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.034581,0.1151,0.12729,0,0
4,GO AXONAL FASCICULATION,0.70447,0.11505,0.011895,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.21267,0.1149,0.15927,0,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.051817,0.11483,0.16445,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.66904,0.1148,0.01805,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.051817,0.11472,0.18563,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.28658,0.11467,0.088829,0,0
4,GO HEART FIELD SPECIFICATION,0.36968,0.11464,0.13042,0,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.20396,0.11462,0.10974,0,0
4,GO POSITIVE REGULATION OF CELL DEATH,0.093006,0.11462,0.086834,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.073757,0.11461,0.15125,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.39593,0.11455,0.040051,0,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.10025,0.11449,0.08804,0,0
4,GO LIPID EXPORT FROM CELL,0.12472,0.11448,0.15871,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.069955,0.11444,0.080942,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.1794,0.11426,0.092326,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.068115,0.11421,0.11633,0,0
4,GO ACTIVATION OF MAPK ACTIVITY,0.032572,0.11414,0.11801,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.36329,0.11402,0.060311,0,0
4,GO REGULATION OF FIBRINOLYSIS,0.17553,0.11401,0.072119,0,0
4,GO POLYOL BIOSYNTHETIC PROCESS,0.13699,0.11393,0.077978,0,0
4,GO NADP METABOLIC PROCESS,0.53518,0.11386,0.032354,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.24039,0.1138,0.060149,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.95679,0.11376,-0.033822,0,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.064555,0.11375,0.11898,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.1402,0.11354,0.17611,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.10025,0.1135,0.095006,0,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.057895,0.11332,0.11631,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.077726,0.11311,0.13312,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.1402,0.11302,0.27209,0,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.077726,0.11272,0.12596,0,0
4,GO DNA DEALKYLATION,0.26536,0.1127,0.11967,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.19552,0.11265,0.10319,0,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.33843,0.11263,0.056442,0,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.45171,0.11262,0.065882,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.30323,0.1123,0.063817,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.086186,0.11218,0.10762,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.13384,0.112,0.086446,0,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.1643,0.11181,0.077832,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.8331,0.11177,0.024362,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.13699,0.11175,0.11804,0,0
4,GO REGULATION OF BINDING,0.13074,0.11173,0.081922,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.58378,0.11172,0.041463,0,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.25516,0.11171,0.081867,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.22164,0.1116,0.077163,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16068,0.11157,0.08635,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.66904,0.1115,0.10912,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.1794,0.11143,0.10074,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.07572,0.11127,0.34612,0,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.057895,0.11113,0.098504,0,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.42328,0.11112,0.082464,0,0
4,GO MONOAMINE TRANSPORT,0.073757,0.11111,0.23567,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.15712,0.11079,0.05381,0,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.14679,0.11076,0.087217,0,0
4,GO RECEPTOR RECYCLING,0.30892,0.11071,0.05816,0,0
4,GO ORGAN INDUCTION,0.1402,0.11061,0.095065,0,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.064555,0.1106,0.10912,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.24525,0.11055,0.078204,0,0
4,GO MACROPHAGE MIGRATION,0.34454,0.11042,0.049911,0,0
4,GO RESPONSE TO ABIOTIC STIMULUS,0.050383,0.11027,0.08445,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.20396,0.10991,0.10533,0,0
4,GO DRINKING BEHAVIOR,0.92804,0.10991,-0.036918,0,0
4,GO MEMBRANE ORGANIZATION,0.057895,0.10991,0.085235,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.066316,0.10979,0.17119,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.53518,0.10976,0.019669,0,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.047616,0.10975,0.099948,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.20828,0.10972,0.077443,0,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.11061,0.10957,0.083178,0,0
4,GO RESPONSE TO ESTRADIOL,0.19552,0.10939,0.061735,0,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.27583,0.10924,0.090949,0,0
4,GO AMINO ACID IMPORT,0.38927,0.10917,0.075745,0,0
4,GO REGULATION OF URINE VOLUME,0.50395,0.10916,0.032267,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.33239,0.10913,0.03588,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.16068,0.10912,0.091524,0,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.064555,0.10907,0.10774,0,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.046281,0.10906,0.099317,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.28117,0.10903,0.067072,0,0
4,GO TISSUE MORPHOGENESIS,0.14347,0.10877,0.065114,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.48871,0.10863,0.086916,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.051817,0.10861,0.092372,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.55115,0.10855,0.086437,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.22164,0.10851,0.10233,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.17553,0.10849,0.16546,0,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.037792,0.10846,0.12551,0,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.033564,0.10842,0.10997,0,0
4,GO AORTA MORPHOGENESIS,0.47371,0.10822,0.052562,0,0
4,GO CYTOLYSIS,0.35697,0.1082,0.058882,0,0
4,GO REGULATION OF STEROL TRANSPORT,0.19139,0.10815,0.090151,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.41634,0.10814,0.050689,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.26536,0.10771,0.12938,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.069955,0.10769,0.082384,0,0
4,GO RESPONSE TO STEROID HORMONE,0.079775,0.10767,0.09733,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.2356,0.10767,0.063736,0,0
4,GO FIBROBLAST ACTIVATION,1,0.10765,-0.045683,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.20828,0.10764,0.11176,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.10025,0.10763,0.086032,0,0
4,GO RESPONSE TO OXIDATIVE STRESS,0.086186,0.10754,0.079623,0,0
4,GO ORGANELLE DISASSEMBLY,0.054786,0.10753,0.093477,0,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.15712,0.10751,0.06686,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.04007,0.10744,0.14388,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.19139,0.10743,0.13858,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.19552,0.10733,0.060246,0,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.071835,0.10723,0.12435,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.28658,0.10721,0.072912,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.56735,0.10718,0.030834,0,0
4,GO ORGANIC CATION TRANSPORT,0.09779,0.10706,0.14766,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.4445,0.10705,0.071484,0,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.041252,0.10678,0.11831,0,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.07572,0.10664,0.088625,0,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.10277,0.10663,0.09942,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.12771,0.10662,0.068854,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.18733,0.10656,0.1003,0,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095374,0.10645,0.093833,0,0
4,GO RESPONSE TO BMP,0.15712,0.10634,0.091364,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.54313,0.10633,0.02205,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.28658,0.10633,0.032137,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.31468,0.10624,0.067675,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.31468,0.10622,0.10451,0,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.16798,0.10611,0.054207,0,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.25017,0.10593,0.068333,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.18733,0.1059,0.10123,0,0
4,GO POSTREPLICATION REPAIR,0.18733,0.10582,0.068188,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.1161,0.1058,0.15711,0,0
4,GO MEMBRANE BIOGENESIS,0.48118,0.10571,0.051691,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.26023,0.10547,0.1318,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.12179,0.10545,0.14632,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.51167,0.10543,0.054292,0,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.086186,0.10522,0.1052,0,0
4,GO REGENERATION,0.28658,0.10508,0.053314,0,0
4,GO MACROPHAGE ACTIVATION,0.095374,0.10483,0.11322,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.23088,0.10463,0.12823,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.39593,0.10463,0.067757,0,0
4,GO TRANSITION METAL ION TRANSPORT,0.064555,0.10462,0.082378,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.31468,0.10444,0.13834,0,0
4,GO CELLULAR PIGMENTATION,0.27056,0.10433,0.064619,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.82372,0.10432,0.005575,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.036694,0.10424,0.12445,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27056,0.10422,0.19766,0,0
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.079775,0.10416,0.10766,0,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.26023,0.10412,0.073554,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.35697,0.10399,0.044742,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10025,0.10396,0.25274,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.21712,0.10393,0.11201,0,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.044978,0.10388,0.17838,0,0
4,GO PRO B CELL DIFFERENTIATION,0.24039,0.10385,0.13522,0,0
4,GO RENAL WATER HOMEOSTASIS,0.31468,0.10383,0.056955,0,0
4,GO APOPTOTIC PROCESS,0.048983,0.10357,0.091778,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.8331,0.10356,-0.0074595,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.11333,0.10355,0.065799,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.29761,0.10351,0.070142,0,0
4,GO LIPID OXIDATION,0.10025,0.10351,0.089123,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.22622,0.1035,0.081661,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.11892,0.10341,0.11081,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.033564,0.10337,0.11263,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.36968,0.10305,0.1958,0,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.36329,0.10303,0.021649,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.059504,0.10294,0.10109,0,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.24525,0.10291,0.059352,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.6603,0.10268,0.049372,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.15361,0.10262,0.065604,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.1794,0.10254,0.079681,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.35697,0.10231,0.070664,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.044978,0.10226,0.13024,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60042,0.10203,0.058729,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.1643,0.10203,0.10697,0,0
4,GO MAST CELL MIGRATION,0.36329,0.10202,0.10669,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.13384,0.10199,0.082927,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.37614,0.10193,0.083121,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.45171,0.10185,0.023605,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.33239,0.10183,0.080327,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.30892,0.10181,0.078879,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.36968,0.1015,0.097157,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.26536,0.10134,0.055548,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.24525,0.10117,0.14295,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.10277,0.10106,0.10608,0,0
4,GO POSITIVE REGULATION OF CELL AGING,0.1794,0.10106,0.13554,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.18334,0.1009,0.12595,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.38927,0.10082,0.058763,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20828,0.10049,0.050162,0,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.073757,0.10034,0.080453,0,0
4,GO GERM CELL DEVELOPMENT,0.050383,0.10034,0.087022,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.19971,0.10028,0.097726,0,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.29206,0.10002,0.087494,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.27583,0.099975,0.048231,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.29206,0.099897,0.052554,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.25516,0.099877,0.065694,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.36329,0.099821,0.13347,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.057895,0.099812,0.12785,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.30323,0.099782,0.13672,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.20396,0.099756,0.11028,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.36329,0.099732,0.073949,0,0
4,GO PROTEIN O LINKED MANNOSYLATION,0.30892,0.099621,0.12602,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.1161,0.099571,0.10758,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.1643,0.099569,0.095428,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.23088,0.099338,0.067546,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.22622,0.099234,0.066999,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.19552,0.099212,0.099214,0,0
4,GO TAXIS,0.25017,0.09896,0.046709,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.090686,0.098752,0.089084,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12472,0.09869,0.073587,0,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.07572,0.098685,0.098461,0,0
4,GO LUNG MORPHOGENESIS,0.38267,0.098668,0.058852,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.09779,0.098613,0.11339,0,0
4,GO CENTROSOME SEPARATION,0.18334,0.09857,0.11641,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.87087,0.098541,0.010317,0,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.10533,0.098439,0.07619,0,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.12472,0.09841,0.084449,0,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.056323,0.098344,0.10483,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.07572,0.098308,0.072952,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.030665,0.098229,0.11532,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.73147,0.098181,-0.067855,0,0
4,GO REGULATION OF MAPK CASCADE,0.095374,0.097926,0.095319,0,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.30892,0.097863,0.07207,0,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.29761,0.097765,0.050145,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.18733,0.097744,0.14862,0,0
4,GO SARCOMERE ORGANIZATION,0.23088,0.097689,0.084016,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.8614,0.097623,-0.049943,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4445,0.097516,0.044941,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.26536,0.097329,0.06369,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.29206,0.097256,0.045962,0,0
4,GO VIRION ASSEMBLY,0.077726,0.097078,0.097641,0,0
4,GO NEURON RECOGNITION,0.72243,0.097037,0.034662,0,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.054786,0.096855,0.085761,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.32642,0.096837,0.079732,0,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.27583,0.096599,0.057884,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.26023,0.096596,0.042826,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.29206,0.09649,0.09501,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.053284,0.09648,0.10479,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.14347,0.096452,0.090798,0,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.1161,0.096391,0.10126,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.70447,0.096302,0.035619,0,0
4,GO METENCEPHALON DEVELOPMENT,0.33239,0.096298,0.097138,0,0
4,GO REGULATION OF PHOSPHORYLATION,0.056323,0.09623,0.086694,0,0
4,GO EYE MORPHOGENESIS,0.35697,0.096225,0.047932,0,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.12179,0.096179,0.074694,0,0
4,GO REGULATION OF CELL SHAPE,0.1402,0.096161,0.078415,0,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.31468,0.096043,0.058168,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.14347,0.095971,0.12526,0,0
4,GO CARNITINE SHUTTLE,0.10794,0.095881,0.15809,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.095374,0.095658,0.084989,0,0
4,GO XENOBIOTIC TRANSPORT,0.33843,0.095567,0.045007,0,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.07572,0.095541,0.091382,0,0
4,GO RUFFLE ORGANIZATION,0.16068,0.095302,0.091974,0,0
4,GO POSITIVE T CELL SELECTION,0.081867,0.095203,0.096164,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.40947,0.095199,0.036593,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.20828,0.09519,0.099605,0,0
4,GO THYMUS DEVELOPMENT,0.36329,0.095161,0.05237,0,0
4,GO DNA CATABOLIC PROCESS,0.07572,0.095147,0.10548,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.19552,0.095131,0.06425,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.35697,0.094923,0.080462,0,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.050383,0.094789,0.08925,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.16798,0.094785,0.086955,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.31468,0.094726,0.076566,0,0
4,GO NERVOUS SYSTEM PROCESS,0.069955,0.094696,0.075899,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.26536,0.094675,0.067726,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.12179,0.09466,0.18527,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.8614,0.094657,-0.016586,0,0
4,GO RESPONSE TO DEXAMETHASONE,0.18733,0.094618,0.094627,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.37614,0.094576,0.042276,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.1161,0.09432,0.15378,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.76799,0.09424,-0.00029566,0,0
4,GO RUFFLE ASSEMBLY,0.4445,0.094093,0.062481,0,0
4,GO OXIDATION REDUCTION PROCESS,0.079775,0.093814,0.083041,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.76799,0.093613,-0.0075565,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.36968,0.093579,0.058151,0,0
4,GO HISTONE H3 DEACETYLATION,0.74054,0.093508,0.0092804,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.043706,0.093438,0.091043,0,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.17173,0.09338,0.058282,0,0
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.037792,0.093357,0.11855,0,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.07572,0.093149,0.076836,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.33843,0.093121,0.10105,0,0
4,GO THYMIC T CELL SELECTION,0.1643,0.09307,0.070305,0,0
4,GO SPLEEN DEVELOPMENT,0.054786,0.092879,0.16203,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.19971,0.092779,0.058809,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.057895,0.092721,0.078712,0,0
4,GO ASSOCIATIVE LEARNING,0.39593,0.092711,0.051896,0,0
4,GO ADULT FEEDING BEHAVIOR,0.80503,0.09263,-0.027226,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.26023,0.092534,0.097957,0,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.056323,0.092403,0.091793,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.18733,0.092366,0.077998,0,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.11892,0.092269,0.091966,0,0
4,GO EXTRACELLULAR TRANSPORT,0.48871,0.092216,0.059003,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.33843,0.0922,0.067077,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.32052,0.092154,0.043877,0,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.073757,0.091981,0.065549,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.40947,0.091906,0.077474,0,0
4,GO FATTY ACID HOMEOSTASIS,0.52728,0.091868,0.057198,0,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.11061,0.091857,0.16938,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.31468,0.091839,0.063877,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.60042,0.091813,0.02172,0,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.23088,0.09181,0.053123,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.11061,0.09178,0.088131,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.29206,0.091753,0.044782,0,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.088413,0.091747,0.076687,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.22622,0.091664,0.058417,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.2356,0.091599,0.085012,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.6516,0.091382,-0.0027801,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.14679,0.091322,0.056934,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.059504,0.091287,0.084764,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.17173,0.091264,0.071806,0,0
4,GO POTASSIUM ION TRANSPORT,0.048983,0.091094,0.15601,0,0
4,GO HEART DEVELOPMENT,0.33843,0.090754,0.041067,0,0
4,GO FRUCTOSE METABOLIC PROCESS,0.30892,0.090665,0.16958,0,0
4,GO SEROTONIN TRANSPORT,0.35072,0.09066,0.1307,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.24039,0.090652,0.055528,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.18334,0.090647,0.1517,0,0
4,GO SPERM CAPACITATION,0.38267,0.090643,0.055924,0,0
4,GO PROTEIN CATABOLIC PROCESS,0.073757,0.090583,0.066009,0,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.16798,0.090576,0.14185,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.21267,0.090528,0.058797,0,0
4,GO DEPHOSPHORYLATION,0.1794,0.090487,0.056643,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.16798,0.090388,0.06121,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.30892,0.090155,0.030623,0,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.088413,0.090142,0.07461,0,0
4,GO HYPOTONIC RESPONSE,0.51944,0.090124,0.035914,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.33239,0.090123,0.061043,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.79572,0.090052,0.0089153,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.26536,0.089887,0.057301,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.15361,0.089853,0.10565,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.30323,0.089794,0.054284,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.51167,0.089778,0.038498,0,0
4,GO ACTIVATION OF GTPASE ACTIVITY,0.093006,0.089697,0.093988,0,0
4,GO GENITALIA DEVELOPMENT,0.1643,0.089646,0.096474,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.26023,0.089573,0.04715,0,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.10025,0.089435,0.0747,0,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.61728,0.089389,0.061593,0,0
4,GO CONVERGENT EXTENSION,0.74966,0.08935,0.023629,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.13074,0.089212,0.11137,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.1643,0.089125,0.22168,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.21712,0.089078,0.064638,0,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.38267,0.08907,0.12107,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.74966,0.089053,0.024813,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.47371,0.08893,0.039593,0,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.17553,0.088725,0.098908,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.12771,0.088719,0.069421,0,0
4,GO PROTEIN OXIDATION,0.80503,0.088579,-0.036678,0,0
4,GO MYOBLAST DIFFERENTIATION,0.32642,0.088499,0.037302,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.48118,0.088484,0.032685,0,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.26023,0.088464,0.045982,0,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.084004,0.088355,0.10097,0,0
4,GO AUTOPHAGY OF MITOCHONDRION,0.13699,0.088339,0.088917,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.37614,0.088296,0.12591,0,0
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.45171,0.088243,0.028855,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.69555,0.088143,0.030628,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.33239,0.088035,0.038477,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.32642,0.087976,0.077569,0,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.55922,0.087953,0.026549,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.19552,0.087946,0.074892,0,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.068115,0.087843,0.083555,0,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.32642,0.087837,0.066028,0,0
4,GO MITOTIC DNA REPLICATION,0.31468,0.087784,0.068338,0,0
4,GO MUSCLE CELL PROLIFERATION,0.32052,0.087753,0.054851,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.32052,0.087713,0.060224,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.9472,0.087632,-0.020437,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.39593,0.087574,0.18041,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.20828,0.087534,0.082341,0,0
4,GO VIRAL LATENCY,0.95679,0.08738,-0.032798,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.093006,0.087322,0.072288,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.60042,0.087173,0.064689,0,0
4,GO NEURON PROJECTION REGENERATION,0.62578,0.087166,0.030074,0,0
4,GO ENSHEATHMENT OF NEURONS,0.1402,0.087119,0.086439,0,0
4,GO MIDGUT DEVELOPMENT,0.58378,0.08711,0.069668,0,0
4,GO RHYTHMIC BEHAVIOR,0.18733,0.087095,0.10615,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.42328,0.087,0.030808,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.84251,0.086978,0.0059524,0,0
4,GO RELAXATION OF MUSCLE,0.45898,0.086923,0.060181,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.57554,0.086908,0.062102,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.32642,0.086889,0.11074,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.19139,0.086878,0.11041,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.54313,0.086873,0.10114,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.31468,0.086868,0.074737,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.068115,0.086788,0.083368,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.89939,0.086686,-0.017906,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.61728,0.086664,0.025767,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.18334,0.086559,0.13464,0,0
4,GO GLIAL CELL MIGRATION,0.47371,0.086554,0.023453,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.21712,0.086525,0.089525,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.38267,0.086454,0.06318,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.95679,0.086384,-0.01812,0,0
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.19552,0.086233,0.051395,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.26536,0.086221,0.045437,0,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.15017,0.086175,0.089888,0,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.084004,0.086159,0.075344,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.88036,0.085866,-0.017681,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.30323,0.085858,0.083595,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.46631,0.085772,0.042094,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.51944,0.085605,0.0042742,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.13699,0.085605,0.14322,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.23088,0.085496,0.11352,0,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.27583,0.08537,0.045838,0,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.29206,0.085316,0.056305,0,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.7588,0.085151,0.007033,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.82372,0.085081,0.0070583,0,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.29761,0.085039,0.058441,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.35697,0.085013,0.023598,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.9472,0.084962,0.04772,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.52728,0.084785,0.013363,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.29206,0.084775,0.051534,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.45898,0.084649,0.13935,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.27056,0.084373,0.036328,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.48118,0.084319,0.04503,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.17173,0.084259,0.12672,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.21712,0.084249,0.0699,0,0
4,GO HEART GROWTH,0.30323,0.083839,0.063906,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.19971,0.083784,0.11765,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.76799,0.083711,-0.019218,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.14347,0.083552,0.073037,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.43029,0.08352,0.038968,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.054786,0.083503,0.092417,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.26023,0.083496,0.047743,0,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.10533,0.083448,0.09482,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.42328,0.083384,0.048008,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.26536,0.083206,0.048074,0,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.48871,0.083165,0.066083,0,0
4,GO EAR MORPHOGENESIS,0.61728,0.083067,0.012069,0,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.1643,0.08295,0.062524,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.12771,0.082905,0.1343,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.91848,0.082898,-0.024184,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.084004,0.082869,0.087911,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.38267,0.082762,0.033937,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.26023,0.082729,0.075159,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.40947,0.082701,0.020791,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.10794,0.08248,0.071138,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.13384,0.082407,0.074857,0,0
4,GO NCRNA CATABOLIC PROCESS,0.26023,0.082389,0.080841,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.18334,0.082354,0.079084,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.15017,0.082266,0.062663,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.47371,0.082104,0.032983,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.19139,0.082088,0.089002,0,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.095374,0.081881,0.078141,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.11892,0.081864,0.13679,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.093006,0.08186,0.08189,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.12472,0.081793,0.13017,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.6516,0.081761,0.014002,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.27056,0.081656,0.059035,0,0
4,GO MUSCLE CONTRACTION,0.19552,0.081611,0.053586,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.19971,0.081582,0.11533,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.4445,0.081447,0.027329,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.22164,0.081323,0.07108,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.35072,0.081261,0.036815,0,0
4,GO REGULATION OF BEHAVIOR,0.68667,0.081073,-0.0021701,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.1402,0.081073,0.052144,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.13074,0.080822,0.13137,0,0
4,GO COCHLEA DEVELOPMENT,0.88987,0.080809,-0.01406,0,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.068115,0.080806,0.097496,0,0
4,GO RESPONSE TO UV C,0.32052,0.080752,0.064577,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.19971,0.080705,0.075041,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.18334,0.080605,0.059183,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.36329,0.080549,0.090005,0,0
4,GO CELL AGING,0.15017,0.080528,0.059667,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.52728,0.080388,0.041313,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.095374,0.080386,0.088207,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.46631,0.080296,0.040671,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.36968,0.080196,0.051547,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.21267,0.080157,0.07598,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.22622,0.080128,0.25317,0,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.30892,0.079989,0.058738,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.48118,0.079954,0.051552,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.29761,0.079929,0.078097,0,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.28117,0.079887,0.065525,0,0
4,GO MALE GAMETE GENERATION,0.10025,0.079822,0.070584,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.4963,0.079598,0.052989,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.30323,0.079489,0.12352,0,0
4,GO RNA INTERFERENCE,0.58378,0.079366,0.045934,0,0
4,GO GOLGI ORGANIZATION,0.051817,0.079355,0.089954,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.13074,0.079172,0.070519,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.04007,0.079135,0.11269,0,0
4,GO FACE DEVELOPMENT,0.91848,0.079096,-0.011854,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.36329,0.079079,0.088671,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.78645,0.079054,-0.016017,0,0
4,GO IMPORT INTO CELL,0.22622,0.079018,0.081741,0,0
4,GO CELL FATE COMMITMENT,0.29206,0.078945,0.038915,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.17553,0.078929,0.091102,0,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.63434,0.078833,0.0068568,0,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.32642,0.078823,0.033446,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.11333,0.078774,0.10476,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.29206,0.078744,0.051075,0,0
4,GO T CELL LINEAGE COMMITMENT,0.062834,0.078685,0.1092,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.45171,0.078504,0.041537,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.19552,0.078496,0.071839,0,0
4,GO FEMALE GAMETE GENERATION,0.18334,0.078395,0.062566,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.71343,0.078358,0.020887,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.4445,0.078047,0.10394,0,0
4,GO VISUAL BEHAVIOR,0.28117,0.078043,0.072187,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.51944,0.07804,0.014727,0,0
4,GO ARTERY DEVELOPMENT,0.84251,0.077998,-0.022779,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.68667,0.077914,0.05135,0,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.081867,0.077895,0.059658,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.80503,0.077886,0.0016741,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.88987,0.077742,-0.029113,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.34454,0.077608,0.045527,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.45171,0.07758,0.059162,0,0
4,GO SULFATE TRANSPORT,0.40267,0.07756,0.084436,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.20828,0.077497,0.090118,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.43029,0.07744,0.047773,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.69555,0.077395,0.041138,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.093006,0.077362,0.072286,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.67783,0.077071,0.027283,0,0
4,GO PLASMA MEMBRANE ORGANIZATION,0.11333,0.076905,0.11798,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.19971,0.076889,0.11607,0,0
4,GO CELL JUNCTION MAINTENANCE,0.70447,0.076836,0.0094055,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.047616,0.076832,0.094795,0,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.39593,0.076686,0.10617,0,0
4,GO HEAD DEVELOPMENT,0.28117,0.076619,0.050247,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.51167,0.076576,0.057082,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.29761,0.076522,0.10577,0,0
4,GO VESICLE DOCKING,0.56735,0.076476,0.034952,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.89939,0.076419,-0.011628,0,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.20828,0.07635,0.13911,0,0
4,GO ERAD PATHWAY,0.17553,0.076332,0.047897,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.7588,0.076281,-0.013109,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.38927,0.076273,0.072732,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.14679,0.076254,0.076778,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.18334,0.076219,0.051096,0,0
4,GO LYMPHANGIOGENESIS,0.59207,0.076208,-0.0992,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.42328,0.076166,0.078503,0,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.077726,0.076046,0.11622,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.15712,0.075862,0.076717,0,0
4,GO NUCLEOTIDE SALVAGE,0.84251,0.07586,-0.013899,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.53518,0.075841,0.039893,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.093006,0.075797,0.11583,0,0
4,GO MITOPHAGY,0.22622,0.07573,0.072928,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21267,0.075715,0.094317,0,0
4,GO EPITHELIAL TUBE FORMATION,0.33239,0.075646,0.032109,0,0
4,GO ANIMAL ORGAN MATURATION,0.20396,0.075622,0.09853,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.15712,0.075573,0.074865,0,0
4,GO DEVELOPMENTAL GROWTH,0.43736,0.075435,0.030037,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.25017,0.075366,0.04825,0,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.22164,0.075205,0.060871,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.39593,0.075174,0.050561,0,0
4,GO POSITIVE REGULATION OF BINDING,0.36968,0.07514,0.037003,0,0
4,GO RETINA HOMEOSTASIS,0.30892,0.074928,0.036447,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.059504,0.074909,0.077139,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.19971,0.074822,0.061718,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.20828,0.074797,0.057163,0,0
4,GO SPERMATID DIFFERENTIATION,0.073757,0.074751,0.083714,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.9472,0.074715,0.031875,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.22164,0.074713,0.058425,0,0
4,GO CYTOSOLIC TRANSPORT,0.32642,0.074707,0.028936,0,0
4,GO GAMETE GENERATION,0.10025,0.074682,0.068971,0,0
4,GO INNER EAR MORPHOGENESIS,0.76799,0.074519,0.0073889,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.26023,0.074461,0.065409,0,0
4,GO RESPONSE TO ACTIVITY,0.12179,0.074413,0.10164,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.6516,0.074346,0.011714,0,0
4,GO ENDOSOME ORGANIZATION,0.13384,0.074325,0.081252,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.38267,0.074295,0.029254,0,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.090686,0.074239,0.099839,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.61728,0.074233,-0.097098,0,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.20396,0.074216,0.055062,0,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.60883,0.07421,0.016403,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.47371,0.074138,0.09452,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.19552,0.074137,0.047738,0,0
4,GO NOSE DEVELOPMENT,0.51944,0.074125,0.17487,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.051817,0.074064,0.08343,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.74054,0.074044,0.031921,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.1161,0.074022,0.090461,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.55115,0.074013,0.021795,0,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.30323,0.073912,0.060149,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.11892,0.073787,0.071195,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.41634,0.073765,0.001358,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.38927,0.073709,0.039561,0,0
4,GO RESPONSE TO ISCHEMIA,0.17173,0.073694,0.089439,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.077726,0.073438,0.14088,0,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.064555,0.073389,0.062475,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.45898,0.073351,0.043783,0,0
4,GO NEURAL TUBE FORMATION,0.42328,0.073225,0.029345,0,0
4,GO HISTONE H3 K36 METHYLATION,0.46631,0.073185,0.048526,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10794,0.073043,0.13404,0,0
4,GO PHAGOSOME MATURATION,0.081867,0.072984,0.1312,0,0
4,GO ERBB SIGNALING PATHWAY,0.46631,0.072968,0.028344,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.14679,0.072904,0.073104,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.13384,0.072832,0.046074,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.30323,0.072825,0.024423,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.14679,0.072718,0.10029,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.51944,0.072711,0.036164,0,0
4,GO REGULATION OF DNA BINDING,0.27056,0.072678,0.069229,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.48118,0.072582,0.024266,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.43736,0.072581,0.024309,0,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.12771,0.072395,0.059125,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.22164,0.072366,0.062878,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.27583,0.072216,0.059712,0,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.18733,0.072211,0.13498,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.15712,0.072205,0.062163,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.20396,0.072196,0.077518,0,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.1402,0.072089,0.077832,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.12179,0.071856,0.14234,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.33239,0.071438,0.064319,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.57554,0.071379,0.041221,0,0
4,GO SPERM AXONEME ASSEMBLY,0.36968,0.071351,0.085083,0,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.15712,0.071248,0.092202,0,0
4,GO VASCULAR TRANSPORT,0.76799,0.071079,-0.016938,0,0
4,GO ORGAN GROWTH,0.76799,0.071004,-0.00047592,0,0
4,GO RESPONSE TO ESTROGEN,0.80503,0.071001,-0.0032009,0,0
4,GO HISTONE H3 K9 METHYLATION,0.55922,0.070989,0.034828,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.081867,0.07098,0.087318,0,0
4,GO INOSITOL METABOLIC PROCESS,0.46631,0.070641,0.069803,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.073757,0.070594,0.06251,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.37614,0.070324,0.044701,0,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.15712,0.07029,0.08007,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.6603,0.070053,0.0045012,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.29206,0.069994,0.11252,0,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.22164,0.069816,0.049783,0,0
4,GO NEUROGENESIS,0.41634,0.069715,0.028246,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.23088,0.069683,0.093156,0,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.2356,0.069682,0.13677,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.45171,0.069662,0.029436,0,0
4,GO RESPONSE TO LEUCINE,0.35072,0.069639,0.13183,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.48118,0.06959,0.037506,0,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.19139,0.069589,0.058669,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.45171,0.06957,0.11113,0,0
4,GO TORC1 SIGNALING,0.16798,0.069519,0.068132,0,0
4,GO REGULATION OF ORGAN GROWTH,0.93762,0.069382,-0.025267,0,0
4,GO BODY FLUID SECRETION,0.34454,0.069342,0.036774,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.9472,0.069325,0.0013886,0,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.51944,0.069311,0.044007,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.53518,0.069296,0.030256,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.96638,0.069236,-0.017351,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.90893,0.069193,-0.10387,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.70447,0.069091,0.019577,0,0
4,GO RESPONSE TO ACIDIC PH,0.60883,0.068966,0.073365,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.67783,0.068934,0.029855,0,0
4,GO STRESS FIBER ASSEMBLY,0.54313,0.068868,0.043825,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.27583,0.06886,0.043028,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.46631,0.068432,0.025117,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.25017,0.068345,0.052036,0,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.14347,0.068269,0.049697,0,0
4,GO NEURON DEATH,0.14679,0.068179,0.057673,0,0
4,GO COLLATERAL SPROUTING,0.64294,0.06798,0.040329,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.55115,0.067882,0.020226,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.1402,0.067876,0.059074,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.43029,0.06779,0.029616,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.66904,0.067723,-0.062287,0,0
4,GO PROSTAGLANDIN SECRETION,0.29761,0.067717,0.11911,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.36329,0.067626,0.034083,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.095374,0.067592,0.063478,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.35072,0.067446,0.03426,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.38927,0.067414,0.059541,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.29761,0.067318,0.098981,0,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.32642,0.067312,0.056531,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.32052,0.067302,0.034154,0,0
4,GO KERATINOCYTE MIGRATION,0.43029,0.067251,0.05057,0,0
4,GO AUTOPHAGIC CELL DEATH,0.19552,0.067205,0.11821,0,0
4,GO RESPONSE TO PH,0.30892,0.066988,0.080379,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.64294,0.066927,0.0050244,0,0
4,GO PEPTIDYL SERINE MODIFICATION,0.15361,0.066794,0.053757,0,0
4,GO PHOTOPERIODISM,0.30892,0.066771,0.10775,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.7588,0.066687,0.026294,0,0
4,GO PROTEIN HYDROXYLATION,0.52728,0.066626,0.090238,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.71343,0.066548,0.015346,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4963,0.066535,0.039723,0,0
4,GO SINGLE FERTILIZATION,0.30892,0.066497,0.04822,0,0
4,GO BLASTOCYST DEVELOPMENT,0.050383,0.066422,0.083029,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.84251,0.066368,0.010477,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.34454,0.066274,0.048598,0,0
4,GO ENDOSOMAL TRANSPORT,0.10533,0.066163,0.0546,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.9472,0.06612,-0.036484,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.7588,0.065931,0.010837,0,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.35072,0.065906,0.048885,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.066316,0.065903,0.062746,0,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.18733,0.06573,0.053228,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.14679,0.065634,0.066124,0,0
4,GO MEMBRANE INVAGINATION,0.26023,0.065556,0.076494,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.87087,0.065535,-0.039187,0,0
4,GO REGULATION OF CELL DIVISION,0.39593,0.065524,0.035644,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.45171,0.065498,0.054509,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.7588,0.065482,0.053404,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.25017,0.065252,0.073789,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.97598,0.06512,-0.024968,0,0
4,GO GENETIC IMPRINTING,0.18733,0.064998,0.11578,0,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.40267,0.064845,0.027344,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.35072,0.064775,0.062472,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.96638,0.064679,-0.049161,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.45171,0.064627,0.042958,0,0
4,GO ERK1 AND ERK2 CASCADE,0.52728,0.064612,0.029596,0,0
4,GO VACUOLAR TRANSPORT,0.15017,0.06456,0.057394,0,0
4,GO TUBE FORMATION,0.32052,0.064443,0.03675,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.50395,0.064396,0.031013,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.57554,0.064317,0.050525,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.85194,0.064309,-0.012283,0,0
4,GO PROTEIN POLYMERIZATION,0.33239,0.064306,0.033148,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17173,0.06423,0.073379,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.40947,0.064197,0.078028,0,0
4,GO SKIN MORPHOGENESIS,0.70447,0.064188,-0.16091,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.12472,0.06411,0.13052,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.27056,0.064041,0.067676,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.43029,0.063963,0.04644,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.74054,0.063822,0.0083939,0,0
4,GO ORGANIC ACID METABOLIC PROCESS,0.18334,0.063724,0.059328,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.33239,0.063613,0.039948,0,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.081867,0.063609,0.070568,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY,0.39593,0.063584,0.028609,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.33843,0.063554,0.087253,0,0
4,GO PROTEIN METHYLATION,0.31468,0.063544,0.015129,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12179,0.06352,0.091768,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.66904,0.063452,0.01121,0,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.27583,0.063374,0.070143,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.78645,0.06336,0.027863,0,0
4,GO NUCLEOSOME ASSEMBLY,0.69555,0.063219,0.012873,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.20828,0.063176,0.056962,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.20828,0.063158,0.14657,0,0
4,GO PROTEIN AUTOPROCESSING,0.20396,0.063124,0.051203,0,0
4,GO REGULATION OF CYTOKINESIS,0.56735,0.063097,0.036689,0,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.30892,0.063006,0.031174,0,0
4,GO COMPLEMENT ACTIVATION,0.4445,0.062979,0.031375,0,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.28117,0.062941,0.058603,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.15017,0.062879,0.080416,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.28117,0.062776,0.055244,0,0
4,GO NEURON DIFFERENTIATION,0.51167,0.062762,0.026329,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.29761,0.062572,0.051071,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.78645,0.062524,-0.047372,0,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.62578,0.062483,0.021443,0,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.4445,0.062361,0.066045,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.71343,0.062358,0.012782,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.50395,0.062335,0.031631,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.72243,0.062247,0.013149,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.39593,0.062234,0.050184,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.93762,0.062158,-0.007879,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.48118,0.062042,0.063342,0,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.30892,0.061906,0.08065,0,0
4,GO CGMP METABOLIC PROCESS,0.59207,0.061856,0.081846,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.4445,0.061789,0.030288,0,0
4,GO SYNAPTIC SIGNALING,0.69555,0.061756,0.034539,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.069955,0.061739,0.093519,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26536,0.061724,0.032521,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.13384,0.061722,0.07987,0,0
4,GO VOCALIZATION BEHAVIOR,0.91848,0.0617,0.044302,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.66904,0.061665,0.023006,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.88987,0.061648,0.005783,0,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.58378,0.061594,0.047945,0,0
4,GO MACROAUTOPHAGY,0.054786,0.061588,0.068988,0,0
4,GO ENDOCYTOSIS,0.24525,0.06147,0.06122,0,0
4,GO COGNITION,0.55922,0.061465,0.028618,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.40947,0.061446,0.064022,0,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.17173,0.06143,0.081521,0,0
4,GO DETOXIFICATION,0.63434,0.061262,0.037762,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.58378,0.060976,0.061634,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.68667,0.060963,0.010903,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.74054,0.060936,0.013297,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.2356,0.06092,0.095727,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.87087,0.0609,-0.04193,0,0
4,GO SELECTIVE AUTOPHAGY,0.24039,0.060847,0.056234,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.53518,0.06073,0.054664,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.93762,0.060627,-0.019033,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.40947,0.060538,0.044565,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27583,0.060535,0.052492,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.4963,0.060524,0.036282,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.72243,0.060423,-0.077546,0,0
4,GO VIRAL BUDDING,0.19139,0.060304,0.10159,0,0
4,GO RESPONSE TO CAMP,0.27056,0.060126,0.068945,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.79572,0.060108,0.042736,0,0
4,GO FOREBRAIN CELL MIGRATION,0.60883,0.0601,0.029475,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.35697,0.06007,0.047265,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.40947,0.06007,0.069513,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.96638,0.060038,-0.021889,0,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.31468,0.060025,0.053681,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.56735,0.059914,0.018089,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.42328,0.059857,0.068891,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.30892,0.059724,0.082071,0,0
4,GO FERTILIZATION,0.25516,0.059683,0.042578,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.4445,0.059554,0.090626,0,0
4,GO IRON ION HOMEOSTASIS,0.52728,0.05934,0.029747,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.30323,0.059301,0.038007,0,0
4,GO PEPTIDYL LYSINE METHYLATION,0.60883,0.059297,0.0084642,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.71343,0.059284,-0.0028989,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.43736,0.05921,0.086906,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.20396,0.059184,0.053843,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.78645,0.059132,0.0012453,0,0
4,GO RESPONSE TO FOOD,0.4963,0.059077,0.045732,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.59207,0.059059,0.033714,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.51167,0.058937,0.024368,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.81436,0.058859,-0.0051285,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.11061,0.058692,0.11246,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.95679,0.058617,-0.028649,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.45171,0.058614,0.064773,0,0
4,GO PROTEIN TARGETING TO VACUOLE,0.16068,0.058603,0.075685,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.24039,0.058527,0.097032,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.1161,0.058523,0.042889,0,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.32052,0.058482,0.050575,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.20828,0.058388,0.067265,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.50395,0.058269,0.076338,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.43736,0.058248,0.029289,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.85194,0.058164,0.016858,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.45898,0.05811,-0.021259,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.59207,0.057921,0.017428,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.30323,0.057853,0.10382,0,0
4,GO NEURON APOPTOTIC PROCESS,0.35697,0.057709,0.036045,0,0
4,GO WATER TRANSPORT,0.46631,0.057647,0.018228,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.18334,0.057598,0.057799,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.28658,0.057455,0.049111,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.22164,0.057358,0.072344,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.55115,0.057279,0.022286,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.8331,0.057217,0.015507,0,0
4,GO RESPONSE TO NICOTINE,0.20396,0.057102,0.12959,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.12771,0.057092,0.04067,0,0
4,GO REGULATION OF ATP METABOLIC PROCESS,0.48871,0.057035,0.03712,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.27056,0.057031,0.037187,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.98559,0.056984,-0.022221,0,0
4,GO HEART MORPHOGENESIS,0.57554,0.056918,0.0068149,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.6603,0.056866,0.005838,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.59207,0.056748,0.032693,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.35697,0.05656,0.053592,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.74966,0.056442,0.1177,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.6516,0.056298,0.06608,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.88987,0.056272,-0.02165,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.8331,0.056265,-0.056436,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.74054,0.056216,0.004896,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.27056,0.056194,0.12452,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.88987,0.056073,-0.011591,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.4445,0.055843,0.016697,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.42328,0.055785,0.086101,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.71343,0.055748,0.084421,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.39593,0.055627,0.04187,0,0
4,GO MEIOTIC CELL CYCLE,0.046281,0.055591,0.09011,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.55922,0.055461,0.016748,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.73147,0.055425,0.018408,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.50395,0.055393,0.025757,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.36968,0.055389,0.045171,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.9952,0.055216,-0.010895,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.73147,0.055118,0.010205,0,0
4,GO AMINE CATABOLIC PROCESS,0.42328,0.055087,0.062446,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.29761,0.055027,0.068669,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.30892,0.054752,0.030422,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.96638,0.054732,-0.030737,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.36329,0.054698,0.043668,0,0
4,GO NEURON DEVELOPMENT,0.55115,0.054668,0.023596,0,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.48118,0.054632,0.018178,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.68667,0.054408,0.010583,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.55115,0.054259,0.048235,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.54313,0.054251,-0.12568,0,0
4,GO NEUROMUSCULAR PROCESS,0.8614,0.054233,0.003066,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.96638,0.054204,-0.06273,0,0
4,GO REGULATION OF MITOPHAGY,0.51167,0.054126,0.04087,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.62578,0.054022,0.019023,0,0
4,GO EPIBOLY,0.90893,0.053978,-0.054702,0,0
4,GO ACROSOME REACTION,0.28658,0.053893,0.091075,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.24039,0.053845,0.070883,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.37614,0.053839,0.05485,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.62578,0.05369,0.041821,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.88987,0.053611,-0.0020519,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.82372,0.053567,0.015531,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.12472,0.053437,0.046725,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.30323,0.05334,0.05893,0,0
4,GO CELL PROJECTION ORGANIZATION,0.51167,0.053226,0.025899,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.15712,0.053191,0.10693,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.48118,0.053032,0.055339,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.90893,0.053001,0.014806,0,0
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.16798,0.052998,0.03782,0,0
4,GO REGULATION OF PROTEIN STABILITY,0.21267,0.052857,0.043209,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.88036,0.052845,0.047511,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.55922,0.052716,0.022464,0,0
4,GO REGULATION OF CATABOLIC PROCESS,0.36329,0.052632,0.030229,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.4963,0.052555,0.01958,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.63434,0.05255,0.022388,0,0
4,GO HYPEROSMOTIC RESPONSE,0.97598,0.0525,-0.050397,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.53518,0.05247,0.013143,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.32642,0.052456,0.1095,0,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.26023,0.052318,0.045938,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.97598,0.052193,0.0054677,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.18733,0.052143,0.072254,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55115,0.052129,0.070165,0,0
4,GO THIOESTER METABOLIC PROCESS,0.28658,0.051695,0.043732,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.58378,0.051664,-0.14567,0,0
4,GO PROTEIN NITROSYLATION,0.74966,0.051589,-0.030141,0,0
4,GO SUCKLING BEHAVIOR,1,0.051587,-0.024452,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.62578,0.051584,0.010457,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.38927,0.051536,0.052976,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.98559,0.051333,-0.029431,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.4445,0.051219,-0.16039,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.39593,0.051213,0.027435,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.22164,0.051212,0.073326,0,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.21712,0.051069,0.065996,0,0
4,GO COPPER ION TRANSPORT,0.26023,0.051042,0.10994,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.27056,0.050906,0.065473,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.24525,0.050742,0.085072,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.33239,0.050703,0.05901,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.50395,0.050447,0.054553,0,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.28117,0.050311,0.12308,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.73147,0.050264,0.15978,0,0
4,GO CYTOSKELETON ORGANIZATION,0.47371,0.05021,0.027189,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.68667,0.050163,0.066997,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.7772,0.049899,-0.053352,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.87087,0.049875,0.0017536,0,0
4,GO CYTOKINESIS,0.42328,0.049833,0.034274,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.18733,0.049743,0.094268,0,0
4,GO RESPONSE TO RETINOIC ACID,0.6516,0.049735,0.029238,0,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.057895,0.049634,0.12818,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.48118,0.049614,0.019875,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.85194,0.049517,-0.011719,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.53518,0.049468,0.02997,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.55115,0.049455,-0.077933,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.76799,0.04936,-0.073216,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.73147,0.049218,-0.11797,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.85194,0.049063,-0.044607,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.85194,0.048891,0.0034867,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.59207,0.048856,0.026768,0,0
4,GO LIPID IMPORT INTO CELL,0.51944,0.048851,0.074527,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.31468,0.04881,0.032461,0,0
4,GO HISTONE METHYLATION,0.43029,0.048608,0.0093238,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.37614,0.048541,0.048267,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.30323,0.048528,0.032038,0,0
4,GO CILIUM MOVEMENT,0.48871,0.048502,0.0219,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.58378,0.048466,0.036199,0,0
4,GO VESICLE LOCALIZATION,0.41634,0.048449,0.027315,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.85194,0.048347,-0.035021,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.91848,0.048316,-0.026315,0,0
4,GO LONG TERM MEMORY,0.96638,0.048256,-0.036312,0,0
4,GO SOMITE DEVELOPMENT,0.26023,0.04823,0.054931,0,0
4,GO TOXIN TRANSPORT,0.55115,0.048127,0.032861,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.47371,0.048025,0.028324,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.35697,0.047925,0.056785,0,0
4,GO AXIS ELONGATION,0.88036,0.047847,-0.0078253,0,0
4,GO CATECHOLAMINE SECRETION,0.19552,0.047818,0.22249,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.56735,0.047787,0.060439,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.28658,0.047755,0.071922,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.9472,0.047695,-0.014732,0,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.24525,0.047664,0.14051,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.56735,0.047642,0.012862,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.51944,0.047241,0.026692,0,0
4,GO L AMINO ACID TRANSPORT,0.69555,0.047229,-0.0026137,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.62578,0.047009,0.02641,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.79572,0.046958,-0.019004,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.56735,0.046852,0.035467,0,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.64294,0.04675,0.02252,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.73147,0.046698,0.032878,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.50395,0.046642,0.060168,0,0
4,GO ORGANELLE LOCALIZATION,0.41634,0.046548,0.028525,0,0
4,GO CELLULAR SENESCENCE,0.42328,0.046449,0.04499,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.84251,0.046361,-0.0051657,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.17173,0.046311,0.070642,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.38267,0.046231,0.031253,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.82372,0.046218,-0.070287,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.93762,0.046144,-0.057753,0,0
4,GO FILOPODIUM ASSEMBLY,0.96638,0.046062,-0.012667,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.71343,0.045962,-0.047046,0,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.45898,0.045902,0.038543,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.6603,0.045681,0.026168,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.24525,0.045371,0.02302,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.60042,0.045023,-0.1347,0,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.45171,0.044906,0.019761,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.22164,0.044854,0.031278,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.34454,0.04473,0.060924,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.43736,0.044579,0.02057,0,0
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.73147,0.04452,0.021056,0,0
4,GO CELL MORPHOGENESIS,0.72243,0.044517,0.0048649,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.33843,0.044455,0.052648,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.9952,0.044317,-0.015214,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.36968,0.044198,0.029324,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.25516,0.044131,0.048402,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.40947,0.044128,0.037905,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.51944,0.044098,0.025912,0,0
4,GO REGULATION OF GTP BINDING,0.78645,0.043926,-0.066763,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.71343,0.043712,0.041575,0,0
4,GO FATTY ACID BETA OXIDATION,0.55922,0.04369,0.016633,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.69555,0.043612,0.010894,0,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.22164,0.043514,0.035177,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.71343,0.04345,0.010173,0,0
4,GO REGULATION OF CELL CYCLE,0.28117,0.043426,0.029466,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.95679,0.043404,-0.017764,0,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.33239,0.043397,0.066476,0,0
4,GO SPECIFICATION OF SYMMETRY,0.98559,0.043173,-0.039656,0,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.67783,0.043156,0.022132,0,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.24039,0.043107,0.062304,0,0
4,GO CARNITINE METABOLIC PROCESS,0.48118,0.043106,0.10309,0,0
4,GO AORTA DEVELOPMENT,0.76799,0.042993,-0.071069,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.60042,0.042937,0.031733,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.58378,0.042795,0.014728,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.81436,0.042763,0.0050632,0,0
4,GO EMBRYO IMPLANTATION,0.91848,0.042758,-0.017238,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.88987,0.042634,-0.046193,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.2356,0.04262,0.0494,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.31468,0.042439,0.029929,0,0
4,GO GOLGI VESICLE TRANSPORT,0.22164,0.042424,0.042507,0,0
4,GO MANGANESE ION TRANSPORT,0.52728,0.042401,0.049391,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.8614,0.042225,0.028304,0,0
4,GO DENDRITE DEVELOPMENT,0.96638,0.04222,0.0047188,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.76799,0.04221,0.019473,0,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.40947,0.042198,0.027022,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.89939,0.042188,0.019485,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.4963,0.042165,0.1353,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.74054,0.042119,0.014659,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.81436,0.041996,0.0069107,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.88987,0.041808,-0.054457,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.60042,0.041788,0.032682,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.52728,0.041436,0.073932,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.9952,0.041386,-0.012503,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.84251,0.04136,0.00084839,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.45898,0.041284,0.084525,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.93762,0.041144,-0.019797,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.85194,0.041108,0.010305,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.46631,0.041095,0.15814,0,0
4,GO MITOCHONDRIAL TRANSPORT,0.38927,0.041031,0.025609,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.40947,0.040892,0.041102,0,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.12472,0.040867,0.062356,0,0
4,GO DNA METHYLATION,0.35072,0.040863,0.044378,0,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.50395,0.040811,0.040162,0,0
4,GO MESENCHYME DEVELOPMENT,0.9472,0.040712,-0.02973,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.28658,0.040678,0.06965,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.66904,0.040674,0.008325,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.51944,0.040555,0.018155,0,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.46631,0.04053,0.048655,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.8331,0.040485,-0.055146,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.36329,0.040449,0.05097,0,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.43736,0.040421,0.089891,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.32642,0.040361,0.057541,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.72243,0.040238,0.02891,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.9472,0.040127,-0.011491,0,0
4,GO OVULATION,0.88036,0.040041,-0.025675,0,0
4,GO PIGMENT GRANULE ORGANIZATION,0.55115,0.040014,0.024412,0,0
4,GO PEROXISOMAL TRANSPORT,0.45898,0.039909,0.039859,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.6603,0.039872,0.049496,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.52728,0.039833,0.066294,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.88987,0.03983,-0.045012,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.87087,0.039792,0.0083866,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.96638,0.03976,-0.0013218,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.6603,0.03947,-0.008279,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.43736,0.039432,0.02677,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.8331,0.039395,-0.0073231,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.48871,0.039315,0.041924,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.72243,0.039237,-0.0018941,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.4445,0.039196,0.037925,0,0
4,GO ORGANIC ACID CATABOLIC PROCESS,0.52728,0.039084,0.016133,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.61728,0.03905,0.019142,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.43736,0.03903,0.0335,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.40267,0.039004,0.040839,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.66904,0.038911,-0.065419,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.64294,0.038897,0.037958,0,0
4,GO APPENDAGE DEVELOPMENT,0.98559,0.038879,-0.0011506,0,0
4,GO MITOCHONDRIAL TRNA PROCESSING,0.82372,0.038826,-0.040359,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.87087,0.038765,-0.0015075,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.95679,0.038669,0.018149,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.32642,0.038649,0.068738,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.78645,0.038426,0.0075292,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.43736,0.038318,0.051658,0,0
4,GO ENDODERM DEVELOPMENT,0.97598,0.038278,-0.063681,0,0
4,GO ETHANOL OXIDATION,0.43736,0.038253,0.04468,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.98559,0.038246,-0.0030456,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.54313,0.038173,0.026128,0,0
4,GO CELL PROJECTION ASSEMBLY,0.60883,0.038096,0.033163,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36968,0.03804,0.065154,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.55922,0.038007,-0.14443,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.90893,0.037992,0.0013462,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.47371,0.037908,0.031004,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.69555,0.037838,-0.062949,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.97598,0.037672,-0.01686,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1,0.037634,-0.018555,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.84251,0.037625,0.0070157,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.7772,0.037437,-0.051025,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.73147,0.037425,0.014885,0,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.89939,0.037193,0.032545,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.37614,0.037116,0.072347,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.71343,0.036999,0.021299,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.45171,0.036964,0.050698,0,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.26536,0.036939,0.064852,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.55922,0.036883,0.006591,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.84251,0.036882,0.010752,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.70447,0.036843,-0.0039729,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.97598,0.036827,-0.016246,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.51167,0.036751,0.062625,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.81436,0.036733,0.018709,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.58378,0.036722,0.021695,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.6603,0.03672,0.022403,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.97598,0.036714,-0.005895,0,0
4,GO BONE MATURATION,0.89939,0.036701,-0.022878,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.64294,0.036548,0.012719,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.33239,0.0365,0.032772,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.85194,0.036388,-0.0056915,0,0
4,GO SYNAPSE ORGANIZATION,0.9952,0.036131,0.008431,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.82372,0.035867,0.00024704,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.7588,0.035856,-0.0010406,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.64294,0.035825,0.0018888,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.63434,0.035819,0.018938,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.68667,0.035786,0.0028772,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.91848,0.035722,-0.029406,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.9952,0.035721,0.057344,0,0
4,GO BRONCHUS DEVELOPMENT,0.90893,0.035709,-0.021159,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.92804,0.035703,-0.0076584,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.60042,0.035661,0.035302,0,0
4,GO DE NOVO PROTEIN FOLDING,0.63434,0.035652,0.02202,0,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.54313,0.035573,0.061833,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.98559,0.035389,-0.0053959,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.6603,0.035364,0.019637,0,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.82372,0.035302,-0.0083029,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.90893,0.035088,0.016188,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.87087,0.03497,-0.065252,0,0
4,GO TONGUE MORPHOGENESIS,0.69555,0.034844,-0.067356,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.91848,0.034669,-0.0071057,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.63434,0.034611,0.061263,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.53518,0.03451,0.013446,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.91848,0.034441,-0.0032666,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24525,0.034382,0.06482,0,0
4,GO LYSOSOMAL TRANSPORT,0.36329,0.034315,0.040268,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.62578,0.034257,-0.0072992,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.53518,0.034251,0.055872,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.51167,0.034242,0.075466,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.53518,0.034159,0.017773,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.98559,0.034156,-0.01242,0,0
4,GO RENAL SODIUM EXCRETION,0.52728,0.034125,0.041268,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.2356,0.034104,0.14674,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.76799,0.034023,-0.017509,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.70447,0.033999,-0.052722,0,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.53518,0.033993,0.021815,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.78645,0.033961,-0.016938,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.8614,0.033944,-0.017169,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.74966,0.033883,0.00062095,0,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.17173,0.033851,0.089286,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.56735,0.033702,0.034972,0,0
4,GO ACTIN CROSSLINK FORMATION,0.84251,0.033683,-0.034408,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.32052,0.033676,0.050779,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.98559,0.03365,-0.034434,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.97598,0.03364,-0.0015769,0,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.48118,0.033618,0.024594,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.91848,0.033611,-0.027928,0,0
4,GO RESPONSE TO INACTIVITY,0.29761,0.033491,0.11724,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.59207,0.033367,0.0041062,0,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.64294,0.033348,0.018778,0,0
4,GO HISTONE MONOUBIQUITINATION,0.36968,0.033294,0.040749,0,0
4,GO GENE SILENCING,0.55115,0.033107,-0.0026827,0,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.70447,0.033022,0.0026326,0,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.4963,0.032889,0.047096,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.80503,0.032807,-0.081285,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.55922,0.03273,0.046988,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.30323,0.032698,0.082611,0,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.41634,0.032679,0.033222,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.48118,0.032611,0.076198,0,0
4,GO PROTEIN TETRAMERIZATION,0.68667,0.032531,0.011517,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.97598,0.032529,-0.030036,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.76799,0.032522,-0.082266,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.32642,0.032492,0.065351,0,0
4,GO MISMATCH REPAIR,0.38267,0.032462,0.039623,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.55115,0.032447,0.1053,0,0
4,GO HEART FORMATION,0.87087,0.032347,0.01479,0,0
4,GO METHYLATION,0.72243,0.032196,-0.0051441,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.80503,0.032047,-0.012104,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.26023,0.031995,0.070356,0,0
4,GO GLUTAMATE METABOLIC PROCESS,0.50395,0.031731,0.05221,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.97598,0.031677,-0.038031,0,0
4,GO SPROUTING ANGIOGENESIS,0.64294,0.031604,0.018399,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.32642,0.031587,0.17909,0,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.32642,0.03151,0.093413,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.88036,0.031448,-0.035584,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.64294,0.031376,0.035411,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.52728,0.031359,0.059308,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.96638,0.031342,-0.030951,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.73147,0.031334,-0.010481,0,0
4,GO INTRACELLULAR TRANSPORT,0.4963,0.031204,0.01575,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.89939,0.031184,-0.012345,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.9952,0.031053,-0.01002,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.45898,0.031011,0.023039,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.91848,0.030902,-0.045015,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.62578,0.03088,0.021634,0,0
4,GO CELL CYCLE,0.55922,0.030861,0.015506,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.58378,0.030699,0.054107,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.79572,0.030682,-0.027779,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.92804,0.030679,-0.030116,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.56735,0.030403,0.01165,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.80503,0.030327,0.043095,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.70447,0.030022,0.015993,0,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.50395,0.030002,0.020291,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.89939,0.029973,0.0041311,0,0
4,GO SPINAL CORD DEVELOPMENT,0.74054,0.029887,0.024803,0,0
4,GO GASTRULATION,0.73147,0.029861,0.0043721,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.7588,0.029798,-0.038231,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.60042,0.029763,-0.097805,0,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.53518,0.02968,0.01947,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.82372,0.029587,-0.0044991,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.71343,0.029537,-0.036841,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.95679,0.029472,-0.036119,0,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.28117,0.029454,0.046421,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.73147,0.029071,0.026859,0,0
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.80503,0.028811,-0.067238,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.8614,0.028721,-0.034621,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.70447,0.028689,0.033527,0,0
4,GO AMINO ACID TRANSPORT,0.53518,0.028682,0.044564,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.87087,0.028564,0.0084739,0,0
4,GO REGULATION OF MACROAUTOPHAGY,0.27056,0.028468,0.044969,0,0
4,GO HISTONE H2B UBIQUITINATION,0.19971,0.028447,0.079051,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.70447,0.028429,-0.046535,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.82372,0.028357,-0.073118,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.76799,0.028161,-0.059125,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.80503,0.028155,-3.5056e-05,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.62578,0.028116,0.045835,0,0
4,GO AMP METABOLIC PROCESS,0.72243,0.028114,-0.067018,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.58378,0.028112,-0.070334,0,0
4,GO MEMBRANE DOCKING,0.53518,0.028044,0.03125,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.85194,0.028021,0.03248,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.72243,0.027803,0.0085322,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.87087,0.027617,0.0035118,0,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.43029,0.027614,0.036133,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.82372,0.027499,-0.027208,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.80503,0.027492,0.031241,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.64294,0.027482,0.059124,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.78645,0.027443,0.0058352,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.72243,0.027372,0.0244,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.8614,0.027309,-0.0028366,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.57554,0.027136,0.011718,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.9472,0.027119,0.0010939,0,0
4,GO ALCOHOL CATABOLIC PROCESS,0.45898,0.026945,0.030645,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.23088,0.026928,0.11279,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.91848,0.02682,-0.030229,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.79572,0.0268,0.019767,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.97598,0.026583,-0.010407,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.33239,0.026565,0.056287,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.40267,0.026513,0.030308,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.58378,0.026486,0.029975,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.55115,0.026367,-0.036111,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.97598,0.025931,-0.038896,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.93762,0.025818,-0.0085667,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.80503,0.025694,-0.024897,0,0
4,GO MESENCHYME MORPHOGENESIS,0.7772,0.025692,-0.018847,0,0
4,GO FEAR RESPONSE,0.20828,0.025659,0.096896,0,0
4,GO MYOFIBRIL ASSEMBLY,0.45171,0.025357,0.044826,0,0
4,GO CELLULAR RESPIRATION,0.73147,0.025349,0.0052454,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.39593,0.025272,0.10013,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.59207,0.02527,0.036466,0,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.64294,0.025161,0.01525,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.64294,0.025149,-0.040148,0,0
4,GO ODONTOGENESIS,0.87087,0.024969,-0.046289,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.30892,0.024947,0.11539,0,0
4,GO PROTEIN FOLDING,0.51944,0.024902,0.026358,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.74054,0.024818,0.012748,0,0
4,GO HISTONE EXCHANGE,0.89939,0.024684,0.00018256,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.55922,0.023984,0.042087,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.98559,0.023979,-0.021744,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.63434,0.023964,-0.059911,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.98559,0.023927,0.060073,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.96638,0.023718,-0.013114,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.6603,0.023714,-0.078622,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.91848,0.023599,0.0095493,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.51167,0.023424,0.045802,0,0
4,GO CELL PART MORPHOGENESIS,0.89939,0.023414,-0.028343,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.97598,0.023391,0.0030046,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.9952,0.023217,-0.013349,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.50395,0.023191,0.022249,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.9952,0.023171,-0.011225,0,0
4,GO KINETOCHORE ASSEMBLY,0.61728,0.023165,0.059402,0,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.89939,0.023097,-0.00051872,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.82372,0.022876,-0.05569,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.40267,0.022685,0.044501,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.58378,0.022646,0.069671,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.60883,0.022645,0.021012,0,0
4,GO T CELL APOPTOTIC PROCESS,0.59207,0.022565,0.047573,0,0
4,GO HEART VALVE DEVELOPMENT,0.80503,0.022555,-0.018093,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.56735,0.022466,0.028833,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.53518,0.02236,0.034608,0,0
4,GO STEROL IMPORT,0.89939,0.022349,-0.024588,0,0
4,GO PROTEIN ACETYLATION,0.87087,0.022248,0.0019579,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.57554,0.022234,0.037423,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.67783,0.022108,0.010532,0,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.79572,0.022057,0.015819,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.59207,0.022028,0.024662,0,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.48118,0.021853,0.06578,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.66904,0.021798,0.044201,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.64294,0.021785,0.031524,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.9952,0.021623,-0.0034089,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.62578,0.021577,-0.018165,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.73147,0.021461,0.042369,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.56735,0.021439,0.048744,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.76799,0.021413,-0.055458,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.47371,0.021342,0.036457,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.68667,0.021288,0.0069677,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.74054,0.021182,0.040822,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.76799,0.021182,-0.048017,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.30323,0.021172,0.059573,0,0
4,GO STEM CELL PROLIFERATION,0.84251,0.021075,0.018462,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.8614,0.021055,-0.0024699,0,0
4,GO PEROXISOME ORGANIZATION,0.45171,0.02092,0.037819,0,0
4,GO ORGANELLE FISSION,0.7772,0.020913,0.016635,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.66904,0.020904,0.013909,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.97598,0.020879,0.010782,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.90893,0.020793,-0.05075,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.84251,0.020773,0.024499,0,0
4,GO DECIDUALIZATION,0.8614,0.020767,-0.021227,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.74966,0.020737,0.014392,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.89939,0.020735,-0.0060407,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.6516,0.020617,0.013067,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.81436,0.020595,-0.061639,0,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.35072,0.020571,0.073068,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.47371,0.020472,0.026186,0,0
4,GO CELL FATE SPECIFICATION,0.71343,0.020352,0.034158,0,0
4,GO NEPHRON MORPHOGENESIS,0.58378,0.020309,0.034729,0,0
4,GO CELL DIVISION,0.8614,0.020119,0.0056942,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.84251,0.020022,-0.038106,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.88987,0.019861,-0.03031,0,0
4,GO PRIMARY MIRNA PROCESSING,0.85194,0.019718,-0.0091066,0,0
4,GO RESPONSE TO GLUCAGON,0.72243,0.019594,0.02796,0,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.35697,0.019277,0.094279,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.98559,0.019247,-0.0057632,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.74054,0.019194,-0.020612,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.9952,0.019188,-0.015996,0,0
4,GO AEROBIC RESPIRATION,0.82372,0.019171,-0.014166,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.74966,0.019011,0.011548,0,0
4,GO PROTEIN ACYLATION,0.55922,0.018997,0.011666,0,0
4,GO P38MAPK CASCADE,0.57554,0.018906,0.068068,0,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.72243,0.018769,0.030385,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.79572,0.018722,-0.031847,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.35697,0.018624,0.054356,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.73147,0.018611,0.012059,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.80503,0.018558,0.00038375,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.70447,0.018476,0.038517,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.66904,0.018354,0.018699,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.85194,0.018185,0.058359,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.73147,0.018154,0.061208,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.74966,0.018082,0.010171,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.71343,0.018047,-0.02866,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.97598,0.01799,-0.01893,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.96638,0.017969,-0.0014379,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.95679,0.017951,0.00059483,0,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.82372,0.017934,-0.0033633,0,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.54313,0.017927,0.027811,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.66904,0.017888,0.035381,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.98559,0.017887,-0.015784,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.53518,0.017869,-0.063891,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.9472,0.017805,0.008466,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.84251,0.017763,-0.024931,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.95679,0.017667,-0.0030846,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.9472,0.017648,-0.043621,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.74054,0.017527,0.0080523,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.90893,0.017501,-0.0089665,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.88036,0.017486,0.018221,0,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.59207,0.017404,-0.031631,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.89939,0.017321,-0.020931,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.74966,0.017288,0.020119,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.9952,0.017198,0.010705,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.62578,0.017188,0.12436,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.79572,0.017127,0.0095429,0,0
4,GO PEPTIDE CATABOLIC PROCESS,0.70447,0.017097,0.011704,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.91848,0.017086,-0.0080156,0,0
4,GO RRNA 3 END PROCESSING,0.72243,0.01695,-0.038371,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.68667,0.016933,-0.070386,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.88987,0.016902,-0.014551,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.82372,0.01683,0.0057995,0,0
4,GO NOTOCHORD DEVELOPMENT,1,0.016815,-0.051567,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.69555,0.016792,-0.11685,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.92804,0.016692,0.031633,0,0
4,GO ALDITOL METABOLIC PROCESS,0.9472,0.016602,-0.011886,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.81436,0.016566,-0.024408,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.71343,0.016305,-0.026754,0,0
4,GO MIDBRAIN DEVELOPMENT,0.6516,0.016263,0.015642,0,0
4,GO REGULATION OF ODONTOGENESIS,0.93762,0.016201,-0.050831,0,0
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.43029,0.016188,0.1462,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.98559,0.016078,0.030435,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.93762,0.015799,-0.021391,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.9952,0.015739,-0.03202,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.93762,0.015722,-0.086477,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.74966,0.015711,0.082587,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1,0.015634,-0.0061679,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.56735,0.015514,0.047526,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.73147,0.015473,-0.031991,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.92804,0.01536,-0.012832,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.78645,0.015251,-0.02451,0,0
4,GO RESPONSE TO LIGHT INTENSITY,0.7772,0.015037,0.033771,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.76799,0.014875,-0.0059238,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.93762,0.01486,-0.10459,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.88987,0.01485,0.0096606,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.8614,0.014839,0.014008,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.61728,0.014833,0.11669,0,0
4,GO LEARNING,0.8614,0.014678,-0.021,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.80503,0.01462,0.020691,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.8331,0.014523,0.034979,0,0
4,GO EXIT FROM MITOSIS,0.55922,0.014498,0.031251,0,0
4,GO SPERM MOTILITY,0.76799,0.014414,0.022219,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.62578,0.014205,-0.047492,0,0
4,GO RNA STABILIZATION,0.38927,0.014011,-0.078876,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.4445,0.013929,-0.19978,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.97598,0.013901,0.0018628,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.90893,0.013896,0.01186,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.66904,0.013546,0.010937,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.97598,0.013544,-0.044399,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.69555,0.013445,0.049209,0,0
4,GO GMP METABOLIC PROCESS,0.88987,0.012972,0.032601,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.84251,0.012915,-0.048722,0,0
4,GO FOREBRAIN DEVELOPMENT,0.81436,0.012875,0.022336,0,0
4,GO ORGANELLE ASSEMBLY,0.90893,0.012873,0.0052606,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.8614,0.012727,0.019018,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.8614,0.012686,-0.041733,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.4963,0.012622,0.059343,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.97598,0.012618,-0.0046396,0,0
4,GO RESPONSE TO SALT,0.71343,0.012577,0.020719,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.96638,0.012546,-0.01601,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.62578,0.012496,0.089566,0,0
4,GO STEM CELL DIVISION,0.90893,0.012459,0.0015446,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.30892,0.012277,0.052912,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.89939,0.012271,-0.0090981,0,0
4,GO MITOTIC CELL CYCLE,0.8614,0.012239,-0.0045166,0,0
4,GO MESODERM DEVELOPMENT,0.9952,0.012199,-0.019692,0,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.51944,0.01201,0.093769,0,0
4,GO RESPONSE TO ANGIOTENSIN,0.6603,0.011984,0.012774,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.8614,0.011954,0.014724,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.93762,0.01188,-0.017521,0,0
4,GO MITOCHONDRION ORGANIZATION,0.56735,0.01183,0.022326,0,0
4,GO REGULATION OF CELL SIZE,0.93762,0.011792,-0.0098071,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.91848,0.011762,-0.01154,0,0
4,GO TRANSCYTOSIS,0.71343,0.011327,0.024348,0,0
4,GO REGULATION OF ENDOCYTOSIS,0.85194,0.011253,0.0097992,0,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.90893,0.011206,0.071912,0,0
4,GO HISTONE DEACETYLATION,0.88987,0.011184,-0.0033366,0,0
4,GO PERICARDIUM DEVELOPMENT,0.57554,0.011167,-0.11627,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.9952,0.011134,-0.023585,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.82372,0.011133,0.023531,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.8614,0.011117,-0.012386,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.64294,0.011062,0.044524,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.97598,0.011006,0.0018578,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.74966,0.010997,-0.0065259,0,0
4,GO CHROMATIN ORGANIZATION,0.74966,0.010996,-0.01004,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.85194,0.010922,-0.047132,0,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.69555,0.010732,-0.026661,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.9472,0.010716,-0.027236,0,0
4,GO IMPORT INTO NUCLEUS,0.55115,0.01069,-0.049972,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.8614,0.010689,0.011654,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.58378,0.010131,0.025988,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.76799,0.01007,0.03491,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.80503,0.010049,-0.041963,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.91848,0.010048,0.0032218,0,0
4,GO TRNA 5 LEADER REMOVAL,0.8614,0.010027,-0.031027,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.52728,0.0099619,0.039701,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.84251,0.0098535,-0.028451,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.8331,0.0097774,0.074072,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85194,0.0094717,-0.002785,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.92804,0.0094525,-0.033341,0,0
4,GO APPENDAGE MORPHOGENESIS,0.97598,0.0093202,-0.011287,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.89939,0.0092331,-0.029306,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.92804,0.009197,-0.11344,0,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.64294,0.0091894,-0.041351,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.43736,0.0090792,-0.064728,0,0
4,GO DOSAGE COMPENSATION,0.88036,0.0089842,0.01252,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.70447,0.0088858,0.016508,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.55115,0.008872,0.21238,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.71343,0.0087639,-0.047528,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.91848,0.0087166,-0.0019106,0,0
4,GO HEAD MORPHOGENESIS,0.92804,0.0086596,-0.044624,0,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.9952,0.0086298,-0.0037168,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.9952,0.0085796,-0.0065122,0,0
4,GO HISTONE H3 K4 METHYLATION,0.82372,0.0085036,0.0044452,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.97598,0.008469,-0.0099481,0,0
4,GO CELL CYCLE PROCESS,0.79572,0.0084379,-0.0072018,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.79572,0.0084174,0.034496,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.64294,0.0082518,-0.018198,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.81436,0.0078319,0.021021,0,0
4,GO MESODERM MORPHOGENESIS,0.6603,0.0077175,0.018361,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,1,0.0076632,-0.038198,0,0
4,GO DEMETHYLATION,0.54313,0.0074727,0.031718,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.9952,0.0074028,-0.017503,0,0
4,GO MIRNA METABOLIC PROCESS,0.51944,0.0072994,-0.06443,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.90893,0.0072634,-0.0084255,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.58378,0.0072316,-0.05672,0,0
4,GO NUCLEUS ORGANIZATION,0.91848,0.0071703,-0.0074245,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.8331,0.0071118,0.026645,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.91848,0.0071114,-0.007114,0,0
4,GO STEM CELL DIFFERENTIATION,0.95679,0.0070865,-0.0084394,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.45898,0.0069594,0.070844,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.66904,0.0069303,-0.049012,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.9472,0.006812,-0.0034027,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.88987,0.0065174,-0.0019262,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.53518,0.0063726,-0.13931,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.51944,0.0059427,0.070452,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.68667,0.0059039,-0.0062963,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.90893,0.0058434,0.037063,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.85194,0.0057673,0.020797,0,0
4,GO OVULATION CYCLE,0.98559,0.0057536,0.0013142,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.64294,0.0057401,-0.032637,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.9952,0.0055907,-0.013009,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.59207,0.0054832,0.041332,0,0
4,GO PIGMENT METABOLIC PROCESS,0.76799,0.0054172,-0.040842,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.58378,0.0053018,0.020594,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,1,0.0052457,0.021035,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.62578,0.0052384,-0.066559,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.64294,0.0052359,-0.13836,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.66904,0.0051925,-0.052355,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.71343,0.0051549,-0.042372,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.88987,0.0050484,-0.015588,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.54313,0.005044,-0.062355,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.9472,0.0049661,-0.037176,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.62578,0.00482,-0.037899,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.63434,0.0047368,-0.052337,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.80503,0.0046339,-0.042531,0,0
4,GO DNA PACKAGING,0.74054,0.0046143,-0.019766,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.78645,0.0043599,-0.045381,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.60042,0.0041958,-0.088269,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.71343,0.004149,-0.028216,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.8614,0.0040794,0.0082775,0,0
4,GO NEURON FATE COMMITMENT,0.97598,0.0039162,0.035117,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.73147,0.0039074,-0.042519,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.67783,0.0039,-0.047088,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.53518,0.0038606,-0.083086,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.80503,0.0038522,-0.013123,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.85194,0.0037565,-0.0063952,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.76799,0.0035423,0.013842,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.90893,0.0035411,-0.00254,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.90893,0.0034601,-0.0001446,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.54313,0.0033154,0.036057,0,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.84251,0.0033152,-0.040977,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.88987,0.0033055,-0.0213,0,0
4,GO PROTEIN TARGETING,0.53518,0.0033041,-0.043985,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.81436,0.0031236,-0.032653,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.85194,0.0031186,0.016597,0,0
4,GO GOLGI LOCALIZATION,0.90893,0.0030965,0.0061161,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.6516,0.0030344,-0.029642,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.80503,0.0029927,-0.033734,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.85194,0.0029616,-0.017403,0,0
4,GO BLASTOCYST FORMATION,0.89939,0.002864,0.0038078,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9952,0.0028065,-0.0051567,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.89939,0.0027128,-0.011039,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.95679,0.0026865,-0.025048,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.48118,0.0026202,-0.066633,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.9472,0.002597,-0.0014004,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.8614,0.0025561,0.014513,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,1,0.0023389,-0.013748,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.7588,0.0021884,0.0081515,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.7772,0.0021072,-0.057902,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.80503,0.0021047,-0.042049,0,0
4,GO MITOTIC CYTOKINESIS,0.82372,0.0020523,0.010031,0,0
4,GO SOMATIC STEM CELL DIVISION,0.92804,0.0020515,0.0001183,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.51167,0.0020262,0.048712,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.8331,0.001878,0.0067109,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.58378,0.001807,-0.046942,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.54313,0.0017704,-0.046494,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.73147,0.0014836,0.0082621,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.62578,0.0013171,0.029197,0,0
4,GO T CELL CHEMOTAXIS,0.96638,0.0012771,-0.015962,0,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.95679,0.0011013,-0.01652,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.7588,0.0010918,0.025609,0,0
4,GO PROTEIN MANNOSYLATION,0.41634,0.0010595,0.11443,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.55115,0.0010554,0.038877,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.98559,0.0010312,-0.02282,0,0
4,GO ATP METABOLIC PROCESS,0.60883,0.0010237,0.020477,0,0
4,GO REGULATION OF CELL AGING,0.73147,0.0008619,-0.030958,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.46631,0.00078807,0.030399,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.81436,0.00072315,0.026596,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.55115,0.00069555,-0.061643,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.95679,0.00064911,-0.020036,0,0
4,GO SMOOTHENED SIGNALING PATHWAY,1,0.0006235,-0.0037224,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.7588,0.0005153,-0.010925,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.68667,0.0004088,0.038364,0,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.47371,0.00028269,-0.14151,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.80503,0.00024009,0.018725,0,0
4,GO PYRUVATE METABOLIC PROCESS,0.91848,0.0001742,0.00011207,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.8614,-1.9706e-05,0.011731,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.91848,-8.8606e-05,-0.051547,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.55115,-0.00010891,-0.1483,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.74054,-0.00019507,-0.00028914,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.8614,-0.00029745,-0.044597,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.76799,-0.00039619,0.017692,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.84251,-0.00040864,-0.02254,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.74054,-0.00041192,-0.014181,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.8614,-0.00053187,-0.043405,0,0
4,GO PIGMENT ACCUMULATION,0.78645,-0.00079011,-0.030151,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.61728,-0.0010695,-0.058228,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.9472,-0.001202,0.0034136,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.87087,-0.0012251,-0.0039611,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.78645,-0.0012342,-0.00054117,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.70447,-0.0012563,-0.0085068,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.8614,-0.0013532,-0.03323,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.98559,-0.0014327,0.0028313,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.55922,-0.0014335,-0.037437,0,0
4,GO RESPONSE TO POTASSIUM ION,0.81436,-0.0014534,-0.023397,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.69555,-0.0015731,0.075601,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.52728,-0.0015746,-0.044056,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.74966,-0.0016769,-0.040126,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.45171,-0.0017368,-0.053733,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.6603,-0.0018912,-0.041843,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.9952,-0.0019301,-0.079571,0,0
4,GO FIBRINOLYSIS,0.74966,-0.0022136,-0.11761,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.55115,-0.0023997,-0.080152,0,0
4,GO ARGININE METABOLIC PROCESS,0.80503,-0.0028209,0.0041333,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.88036,-0.002882,0.0077613,0,0
4,GO REGULATION OF CELLULAR RESPIRATION,0.90893,-0.0029305,0.012517,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.91848,-0.002949,-0.0054818,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.85194,-0.003046,-0.026401,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.9472,-0.0035054,-0.037985,0,0
4,GO NEUROTRANSMITTER SECRETION,0.88987,-0.0036791,0.038658,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.93762,-0.0039206,-0.016591,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.90893,-0.0040694,-0.021323,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.9472,-0.0040956,0.007155,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.54313,-0.0041257,-0.10952,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.93762,-0.0041643,0.0059267,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.8331,-0.0042114,-0.02973,0,0
4,GO DNA CONFORMATION CHANGE,0.35697,-0.0044016,-0.048888,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.97598,-0.0044945,-0.014409,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.92804,-0.0045767,0.007072,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.50395,-0.0046584,-0.043222,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.91848,-0.0046769,-0.0033261,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.88036,-0.0047549,-0.042323,0,0
4,GO GROWTH HORMONE SECRETION,0.8614,-0.0049312,0.065261,0,0
4,GO REGULATION OF AXONOGENESIS,0.92804,-0.0050118,-0.039094,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.74966,-0.0053213,-0.043983,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.90893,-0.0053533,-0.00826,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.98559,-0.0056803,0.0076108,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.6603,-0.0057667,-0.068986,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.60042,-0.0059419,-0.082521,0,0
4,GO MACROMOLECULE DEACYLATION,0.91848,-0.0060618,0.0042968,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.96638,-0.0063646,0.002657,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.72243,-0.0064421,0.014868,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.8614,-0.0064562,0.013528,0,0
4,GO VITAMIN TRANSPORT,0.60883,-0.0065607,0.059995,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.8331,-0.0065961,0.008295,0,0
4,GO CELLULAR RESPONSE TO ATP,0.78645,-0.0067409,-0.022706,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.80503,-0.0069909,-0.032811,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.76799,-0.0071558,0.0078362,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.6603,-0.0072692,-0.01724,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.76799,-0.0075461,-0.019657,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.6516,-0.00767,-0.055089,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.63434,-0.0077017,0.016686,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.72243,-0.0077908,0.026391,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.64294,-0.008023,0.12984,0,0
4,GO RECEPTOR INTERNALIZATION,0.68667,-0.0080523,-0.03505,0,0
4,GO PROTEIN STABILIZATION,0.93762,-0.0081935,-0.012775,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.79572,-0.0082217,-0.026808,0,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.66904,-0.008379,-0.0513,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.71343,-0.008477,-0.0030342,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.79572,-0.0085096,-0.036658,0,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.9952,-0.0085319,0.00056187,0,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.56735,-0.0086089,0.060744,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.95679,-0.0086143,-0.0013,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.51167,-0.0087247,-0.053272,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.6603,-0.0088023,-0.039476,0,0
4,GO METAPHASE PLATE CONGRESSION,0.73147,-0.0090037,0.030491,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.58378,-0.0091118,-0.11025,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.79572,-0.0091841,-0.031867,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.58378,-0.009286,-0.030898,0,0
4,GO RESPONSE TO VITAMIN A,0.87087,-0.0093038,-0.00042681,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.54313,-0.0096008,-0.067113,0,0
4,GO KINETOCHORE ORGANIZATION,0.80503,-0.0098784,0.049504,0,0
4,GO CENTROSOME DUPLICATION,0.8614,-0.0099355,0.013259,0,0
4,GO LACTATE METABOLIC PROCESS,0.67783,-0.0099752,-0.050128,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.42328,-0.010054,-0.1003,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.81436,-0.010099,0.011055,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.58378,-0.01017,-0.051106,0,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.68667,-0.010178,-0.045704,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.85194,-0.010186,-0.01656,0,0
4,GO NUCLEOSOME ORGANIZATION,0.51944,-0.010224,-0.035266,0,0
4,GO REGULATION OF DNA METHYLATION,0.78645,-0.010338,-0.018162,0,0
4,GO PROTEIN SUMOYLATION,0.54313,-0.010357,-0.032603,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.53518,-0.010366,-0.054642,0,0
4,GO NEGATIVE CHEMOTAXIS,0.50395,-0.01038,-0.11217,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.51944,-0.010398,-0.086681,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.9472,-0.010473,-0.034865,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.59207,-0.010655,-0.026832,0,0
4,GO NEPHRON TUBULE FORMATION,0.66904,-0.010659,-0.05105,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.92804,-0.010944,-0.0060939,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.97598,-0.011205,-0.0019228,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.93762,-0.011307,0.021683,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.85194,-0.011344,-0.016809,0,0
4,GO CARTILAGE DEVELOPMENT,0.92804,-0.011349,-0.0087739,0,0
4,GO AXON DEVELOPMENT,0.56735,-0.01146,-0.057999,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.69555,-0.011479,-0.033005,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.32052,-0.011489,-0.065273,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.88987,-0.011503,0.012013,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.81436,-0.011605,-0.013043,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.88036,-0.011663,-0.013079,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.9472,-0.01188,0.002241,0,0
4,GO LACTATION,0.78645,-0.011887,-0.026915,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.45171,-0.011971,-0.038605,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.96638,-0.012028,0.012001,0,0
4,GO CHROMATIN SILENCING,0.70447,-0.012087,-0.027681,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.88987,-0.01248,-0.0277,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.93762,-0.012494,-0.017924,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.9472,-0.012537,-0.019613,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.84251,-0.012777,-0.036538,0,0
4,GO PROTEIN IMPORT,0.32052,-0.013046,-0.055177,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.64294,-0.013073,-0.057042,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.8331,-0.013114,-0.015197,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.43029,-0.01316,-0.06509,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.72243,-0.013167,-0.054608,0,0
4,GO P BODY ASSEMBLY,0.8614,-0.013193,-0.02239,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.79572,-0.013288,-0.050844,0,0
4,GO CELL CYCLE ARREST,0.74054,-0.013312,0.018825,0,0
4,GO GANGLION DEVELOPMENT,0.7772,-0.01347,0.10566,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.84251,-0.013612,0.0044703,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.93762,-0.013637,-0.02116,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.90893,-0.013666,0.10065,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.98559,-0.013676,-0.00016223,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.38927,-0.013679,-0.041935,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.93762,-0.013708,0.0013923,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.62578,-0.013729,-0.063004,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.67783,-0.014118,-0.04794,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.8614,-0.014146,0.028156,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.72243,-0.014208,-0.047126,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.92804,-0.014311,-0.029457,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.52728,-0.014335,-0.093924,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.81436,-0.014403,-0.029749,0,0
4,GO HISTONE H3 ACETYLATION,0.80503,-0.014445,-0.010414,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.45898,-0.014618,-0.16121,0,0
4,GO DENDRITE MORPHOGENESIS,0.56735,-0.014652,-0.048758,0,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.30323,-0.014845,-0.070366,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.71343,-0.014918,-0.029292,0,0
4,GO NEURON MIGRATION,0.69555,-0.0152,-0.029108,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.70447,-0.015271,0.080647,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.64294,-0.015538,-0.044648,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.92804,-0.015578,-0.040235,0,0
4,GO ENDODERM FORMATION,0.81436,-0.015644,-0.098505,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.96638,-0.015694,-0.0094834,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.98559,-0.015877,0.032158,0,0
4,GO FOREGUT MORPHOGENESIS,0.48118,-0.016079,-0.10142,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.69555,-0.016129,-0.023531,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.9952,-0.016156,-0.0058555,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.89939,-0.016189,-0.0052878,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.64294,-0.016194,0.021765,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.55115,-0.0163,-0.041533,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.28658,-0.016412,-0.071207,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.89939,-0.016532,-0.019661,0,0
4,GO PHOSPHATE ION TRANSPORT,0.58378,-0.016701,0.067199,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.61728,-0.016725,-0.039806,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.88036,-0.016729,0.027081,0,0
4,GO NCRNA 3 END PROCESSING,0.78645,-0.01681,-0.067649,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.97598,-0.016823,-0.011628,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.62578,-0.01693,-0.031597,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.78645,-0.016988,0.014094,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.40267,-0.017104,-0.088184,0,0
4,GO ANIMAL ORGAN FORMATION,0.43736,-0.017221,-0.077838,0,0
4,GO MUSCLE FILAMENT SLIDING,0.55115,-0.017239,-0.069607,0,0
4,GO NEURON PROJECTION EXTENSION,0.93762,-0.017384,-0.020694,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.62578,-0.017542,-0.068639,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.59207,-0.017587,0.043356,0,0
4,GO FEVER GENERATION,0.8614,-0.017601,-0.02414,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.56735,-0.017626,-0.035907,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.38267,-0.017737,-0.081223,0,0
4,GO RESPONSE TO MISFOLDED PROTEIN,0.89939,-0.017791,-0.0096211,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.71343,-0.017817,-0.029333,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.71343,-0.017989,-0.089534,0,0
4,GO LYSINE METABOLIC PROCESS,0.76799,-0.018032,-0.063069,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.60883,-0.018068,-0.040621,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.82372,-0.018373,0.03521,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.61728,-0.01846,-0.070909,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.46631,-0.018625,-0.10027,0,0
4,GO HEART VALVE FORMATION,0.63434,-0.018684,-0.072685,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.97598,-0.018754,-0.0018895,0,0
4,GO CERAMIDE TRANSPORT,0.90893,-0.018846,-0.026143,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.48871,-0.018891,-0.0365,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.7588,-0.019027,-0.0057684,0,0
4,GO CRISTAE FORMATION,0.50395,-0.019058,-0.099149,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.69555,-0.019121,-0.038352,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.54313,-0.019155,-0.074988,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.4963,-0.019267,-0.037049,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.84251,-0.019295,-0.013493,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.43029,-0.019341,-0.057156,0,0
4,GO CHROMOSOME LOCALIZATION,0.7588,-0.019537,0.036827,0,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.97598,-0.019564,-0.012664,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.74966,-0.019681,-0.028273,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.84251,-0.019689,-0.053051,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.69555,-0.019756,-0.079591,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.73147,-0.020012,0.039239,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.70447,-0.020217,-0.10459,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.73147,-0.020278,-0.050485,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.88036,-0.020363,-0.087555,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.31468,-0.020383,-0.087566,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.55115,-0.020531,-0.040655,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.96638,-0.020641,0.03753,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.81436,-0.020674,-0.026942,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.57554,-0.020757,-0.07358,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.6516,-0.020897,-0.085689,0,0
4,GO REGULATION OF ERAD PATHWAY,0.71343,-0.020911,-0.02131,0,0
4,GO MRNA TRANSCRIPTION,0.28658,-0.02103,-0.094109,0,0
4,GO PINOCYTOSIS,0.66904,-0.021089,-0.073964,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.88987,-0.021321,0.0090345,0,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.40267,-0.021462,-0.085705,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.85194,-0.021573,-0.037598,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.7588,-0.021575,-0.018604,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.76799,-0.021617,-0.0087692,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.42328,-0.021681,-0.072376,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.9952,-0.021685,0.0046332,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.4963,-0.021693,-0.047931,0,0
4,GO CHROMOSOME ORGANIZATION,0.67783,-0.02178,-0.023993,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.88036,-0.021891,0.024958,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.79572,-0.022055,0.051333,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.53518,-0.022064,-0.094449,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.76799,-0.022233,-0.049886,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.61728,-0.022258,-0.17533,0,0
4,GO HISTONE H2A UBIQUITINATION,0.69555,-0.022667,-0.022821,0,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.36329,-0.022785,-0.081122,0,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.56735,-0.022793,-0.086796,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.71343,-0.022831,0.10238,0,0
4,GO BONE DEVELOPMENT,0.50395,-0.022969,-0.064337,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.68667,-0.022971,0.016726,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.76799,-0.023027,0.026946,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.64294,-0.02309,-0.055578,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.54313,-0.023333,-0.061568,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.27583,-0.02337,-0.08815,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.84251,-0.023415,0.0023842,0,0
4,GO DNA METABOLIC PROCESS,0.36968,-0.023508,-0.032743,0,0
4,GO COENZYME A METABOLIC PROCESS,0.81436,-0.023509,0.018898,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95679,-0.023619,-0.0043731,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.24525,-0.02362,-0.055759,0,0
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.62578,-0.023902,-0.10953,0,0
4,GO NEURON PROJECTION GUIDANCE,0.34454,-0.024132,-0.092093,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.55115,-0.02417,-0.049229,0,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.7772,-0.024215,-0.027188,0,0
4,GO HEME METABOLIC PROCESS,0.63434,-0.024233,-0.095525,0,0
4,GO NUCLEAR TRANSPORT,0.18733,-0.024447,-0.065034,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.25516,-0.024453,-0.15907,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.82372,-0.02453,-0.027016,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.54313,-0.024612,-0.054509,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.67783,-0.024889,-0.087728,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.57554,-0.024929,-0.055077,0,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.68667,-0.02521,-0.053685,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.93762,-0.025213,-0.0016241,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.48871,-0.025278,-0.086548,0,0
4,GO PALLIUM DEVELOPMENT,0.96638,-0.025587,0.0037901,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.72243,-0.025664,-0.011707,0,0
4,GO SNRNA TRANSCRIPTION,0.24039,-0.025777,-0.059933,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.4963,-0.025889,-0.068846,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.51944,-0.026098,-0.069402,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.51944,-0.026109,-0.069194,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.26023,-0.026168,-0.059185,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.28658,-0.026209,-0.083624,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.63434,-0.026238,-0.10194,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.4963,-0.026277,-0.11245,0,0
4,GO CELL CYCLE CHECKPOINT,0.72243,-0.026369,-0.0095707,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.71343,-0.026414,-0.026365,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.53518,-0.026445,-0.028023,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.30323,-0.026714,-0.055312,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.40947,-0.026731,-0.02652,0,0
4,GO ECTODERM DEVELOPMENT,0.90893,-0.026739,0.028083,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.48871,-0.02685,-0.082682,0,0
4,GO SPINDLE ASSEMBLY,0.4445,-0.026921,-0.032447,0,0
4,GO SNRNA PROCESSING,0.48871,-0.026971,-0.091236,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.55922,-0.026985,-0.036367,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.50395,-0.026998,-0.061505,0,0
4,GO PORE COMPLEX ASSEMBLY,0.61728,-0.027034,-0.043191,0,0
4,GO LIVER REGENERATION,0.56735,-0.027439,-0.098572,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.73147,-0.027494,0.016577,0,0
4,GO BIOLOGICAL PHASE,0.91848,-0.027643,-0.047121,0,0
4,GO CELL CYCLE DNA REPLICATION,0.48871,-0.027644,-0.06177,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.64294,-0.027687,-0.026977,0,0
4,GO REGULATION OF DNA REPLICATION,0.7588,-0.027854,-0.022472,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.7772,-0.027935,-0.0312,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.43736,-0.028008,-0.048679,0,0
4,GO THYROID GLAND DEVELOPMENT,0.79572,-0.028012,-0.014518,0,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.27056,-0.028052,-0.067973,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.35072,-0.028204,-0.076886,0,0
4,GO CILIUM ORGANIZATION,0.93762,-0.02823,0.012425,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.73147,-0.028391,-0.0044785,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.74054,-0.028486,-0.018941,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.70447,-0.028672,0.032552,0,0
4,GO CHROMATIN REMODELING,0.45898,-0.028798,-0.032378,0,0
4,GO RNA DESTABILIZATION,0.36329,-0.029125,-0.082913,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.43736,-0.029149,-0.07723,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.82372,-0.02922,-0.017142,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.78645,-0.029291,-0.038865,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.80503,-0.0295,-0.022114,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.57554,-0.029626,-0.16279,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.8614,-0.029746,0.03196,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.55922,-0.029757,-0.054878,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.64294,-0.029943,-0.040999,0,0
4,GO SISTER CHROMATID SEGREGATION,0.52728,-0.030074,-0.022363,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.79572,-0.030148,-0.017753,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.69555,-0.030173,-0.048229,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.66904,-0.030216,-0.043872,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.11892,-0.030284,-0.071492,0,0
4,GO ACETYL COA METABOLIC PROCESS,1,-0.03035,-0.016269,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.37614,-0.030539,-0.031372,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.52728,-0.03059,-0.063918,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.50395,-0.030813,-0.056177,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.60042,-0.031093,-0.056547,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.28658,-0.031394,-0.067755,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.8331,-0.031566,-0.028019,0,0
4,GO MICROTUBULE POLYMERIZATION,0.43736,-0.031595,-0.051087,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.8331,-0.031676,0.019127,0,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.20828,-0.031738,-0.074961,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.31468,-0.03179,-0.10519,0,0
4,GO SPINDLE LOCALIZATION,0.53518,-0.032176,-0.026354,0,0
4,GO PROTEIN REFOLDING,0.74966,-0.032188,0.027964,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.81436,-0.032372,-0.026711,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.38927,-0.032393,-0.08278,0,0
4,GO HISTONE PHOSPHORYLATION,0.53518,-0.032402,-0.052735,0,0
4,GO RNA CATABOLIC PROCESS,0.25017,-0.032517,-0.075409,0,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.93762,-0.032602,0.04125,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.70447,-0.032836,-0.019335,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.18334,-0.032867,-0.1043,0,0
4,GO RECEPTOR CLUSTERING,0.52728,-0.032938,-0.059289,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.46631,-0.033148,-0.045816,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.4963,-0.033442,-0.010487,0,0
4,GO GLUTAMATE SECRETION,0.74966,-0.033544,-0.020898,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.30892,-0.033595,-0.089277,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.38267,-0.03396,-0.079166,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.98559,-0.0341,0.017035,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.87087,-0.034219,-0.057362,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.35072,-0.034236,-0.10295,0,0
4,GO DNA REPLICATION CHECKPOINT,0.46631,-0.034263,-0.098488,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.55922,-0.034425,-0.055239,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.29761,-0.034443,-0.12632,0,0
4,GO HINDLIMB MORPHOGENESIS,0.45171,-0.034768,-0.094387,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.67783,-0.035225,-0.021814,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.63434,-0.035336,-0.038357,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.88036,-0.035968,0.023697,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.8331,-0.036095,-0.038947,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.8331,-0.036268,0.03349,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.30892,-0.036277,-0.14054,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.54313,-0.036297,-0.045256,0,0
4,GO RESPONSE TO HYDROXYUREA,0.81436,-0.036351,0.045164,0,0
4,GO HISTONE UBIQUITINATION,0.22164,-0.036373,-0.050654,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.72243,-0.036456,-0.017253,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.4963,-0.036459,-0.079255,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.46631,-0.036467,-0.036255,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.63434,-0.03663,-0.065004,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.33239,-0.036857,-0.069171,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.29206,-0.037516,-0.10518,0,0
4,GO RNA POLYADENYLATION,0.15361,-0.037519,-0.089325,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.29206,-0.03779,-0.060583,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.41634,-0.037862,-0.13286,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.56735,-0.03801,-0.03334,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.21267,-0.038261,-0.098483,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.47371,-0.038358,-0.042221,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.8614,-0.038598,0.022761,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.40267,-0.038647,-0.10685,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.38267,-0.039259,-0.087308,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.6603,-0.039289,-0.063348,0,0
4,GO TRNA 5 END PROCESSING,0.30892,-0.039622,-0.095885,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.28658,-0.03966,-0.040293,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.51944,-0.039846,-0.073125,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.45898,-0.039915,-0.031068,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.30323,-0.040027,-0.039263,0,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.48871,-0.040076,-0.038245,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.79572,-0.040536,-0.011895,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.62578,-0.040583,-0.072104,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.68667,-0.040669,-0.010525,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.6516,-0.040821,-0.075884,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.55115,-0.040885,-0.04153,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.63434,-0.041528,0.15663,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.63434,-0.041602,-0.032483,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.43029,-0.04171,-0.062475,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.80503,-0.041883,0.011096,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.97598,-0.041902,0.020096,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.4963,-0.042016,-0.085993,0,0
4,GO HISTONE H4 ACETYLATION,0.46631,-0.042133,-0.018398,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.45898,-0.04233,-0.02803,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.6516,-0.042477,-0.094499,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.68667,-0.042726,-0.050772,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.43029,-0.043088,-0.13026,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.79572,-0.043151,-0.047403,0,0
4,GO RESPONSE TO HEAT,0.35072,-0.043251,-0.053596,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.48871,-0.043335,-0.054143,0,0
4,GO SNRNA METABOLIC PROCESS,0.37614,-0.043628,-0.077188,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.22622,-0.043762,-0.11628,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.36968,-0.043858,-0.092216,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.31468,-0.044266,-0.047303,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.7772,-0.044334,-0.012384,0,0
4,GO REGULATION OF GENE SILENCING,0.26536,-0.044404,-0.092134,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.89939,-0.044473,0.011722,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.59207,-0.044606,-0.064874,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.21267,-0.044675,-0.1065,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.73147,-0.044862,-0.035376,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.37614,-0.044955,-0.088778,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.31468,-0.045124,-0.081723,0,0
4,GO TOOTH MINERALIZATION,1,-0.045132,-0.0019855,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.29206,-0.045208,-0.071778,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.32642,-0.045245,-0.076027,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.73147,-0.046124,-0.035093,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.35072,-0.046491,-0.04552,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.68667,-0.047107,-0.05574,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.56735,-0.047166,-0.048981,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.8614,-0.047269,-0.010122,0,0
4,GO MITOCHONDRIAL FUSION,0.51167,-0.047524,-0.04437,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.36968,-0.047614,-0.065501,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.1794,-0.047684,-0.050462,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.28658,-0.04773,-0.097045,0,0
4,GO NUCLEAR EXPORT,0.11892,-0.047899,-0.088969,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.4445,-0.047909,-0.056947,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.69555,-0.047954,-0.067676,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.69555,-0.048017,-0.12242,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.24525,-0.048018,-0.050443,0,0
4,GO TRNA METABOLIC PROCESS,0.15712,-0.048077,-0.094552,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.16798,-0.048401,-0.080857,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.17553,-0.048613,-0.12964,0,0
4,GO HISTONE H3 K9 ACETYLATION,0.36968,-0.048641,-0.044058,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.42328,-0.048769,-0.044465,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.22622,-0.048867,-0.079656,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.6603,-0.048905,-0.099904,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.71343,-0.049013,-0.014853,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.79572,-0.049037,-0.039674,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.61728,-0.04924,-0.0312,0,0
4,GO MRNA CLEAVAGE,0.16798,-0.04929,-0.074689,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.56735,-0.049323,-0.036815,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.33843,-0.049693,-0.052209,0,0
4,GO RNA 3 END PROCESSING,0.15017,-0.049712,-0.085941,0,0
4,GO DNA GEOMETRIC CHANGE,0.071835,-0.05004,-0.11031,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.82372,-0.05009,-0.056146,0,0
4,GO MRNA TRANSPORT,0.18733,-0.050641,-0.08202,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.24039,-0.050682,-0.05759,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.4445,-0.050844,-0.035303,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.55115,-0.050919,-0.048431,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.25017,-0.050933,-0.058552,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.4445,-0.051,-0.045288,0,0
4,GO DNA REPLICATION,0.33239,-0.051174,-0.047312,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.56735,-0.051531,-0.093829,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.72243,-0.051803,-0.063501,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.98559,-0.051888,0.023693,0,0
4,GO SIALYLATION,0.88036,-0.051929,0.023093,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.40267,-0.051962,-0.046736,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.45898,-0.051972,-0.066399,0,0
4,GO SPINDLE ORGANIZATION,0.24525,-0.052043,-0.046056,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.17173,-0.05212,-0.10392,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.19971,-0.052132,-0.13595,0,0
4,GO INTRACILIARY TRANSPORT,0.93762,-0.052166,0.03133,0,0
4,GO RESPONSE TO MANGANESE ION,0.45171,-0.052251,-0.073353,0,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.12771,-0.05236,-0.059963,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.1161,-0.052402,-0.089308,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.10277,-0.052531,-0.10226,0,0
4,GO MRNA 3 END PROCESSING,0.12472,-0.052682,-0.083607,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.61728,-0.052901,-0.087393,0,0
4,GO VESICLE CARGO LOADING,0.7588,-0.053029,-0.023314,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.42328,-0.053055,-0.016037,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.88036,-0.053368,-0.029537,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.48871,-0.053434,-0.046789,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.66904,-0.053602,-0.044587,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.24525,-0.053629,-0.15324,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.73147,-0.053783,-0.015604,0,0
4,GO RNA MODIFICATION,0.15361,-0.053864,-0.091516,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.42328,-0.054424,-0.11344,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.52728,-0.054646,-0.053383,0,0
4,GO TELOMERE CAPPING,0.20828,-0.05466,-0.051275,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.29761,-0.054941,-0.14126,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.79572,-0.055124,0.086523,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.46631,-0.055486,-0.045279,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.25017,-0.055529,-0.087457,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.19552,-0.055655,-0.089615,0,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.30323,-0.056068,-0.16537,0,0
4,GO MACROPHAGE PROLIFERATION,0.82372,-0.056222,-0.069752,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.68667,-0.056259,-0.005927,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.37614,-0.056313,-0.088517,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.25017,-0.05634,-0.11022,0,0
4,GO CENTRIOLE ASSEMBLY,0.43029,-0.056495,-0.045576,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.97598,-0.056758,-0.061703,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.58378,-0.056895,-0.11652,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.25017,-0.057084,-0.034601,0,0
4,GO ERYTHROCYTE MATURATION,0.17553,-0.057178,-0.1829,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.39593,-0.057245,-0.12951,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.88987,-0.05741,0.0079613,0,0
4,GO DNA RECOMBINATION,0.20396,-0.057499,-0.053645,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.46631,-0.057511,-0.095768,0,0
4,GO MICROTUBULE BASED PROCESS,0.28117,-0.057536,-0.034295,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.45898,-0.057539,-0.082261,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.48118,-0.057652,-0.091681,0,0
4,GO HAIR FOLLICLE MATURATION,0.60042,-0.057732,-0.10286,0,0
4,GO FORELIMB MORPHOGENESIS,0.45171,-0.05792,-0.096022,0,0
4,GO CHROMOSOME CONDENSATION,0.25017,-0.057996,-0.056226,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.79572,-0.058048,-0.046715,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.87087,-0.058139,-0.046742,0,0
4,GO TRNA TRANSPORT,0.16798,-0.058371,-0.13409,0,0
4,GO CHROMOSOME SEGREGATION,0.43029,-0.05854,-0.023053,0,0
4,GO PROTEIN TRIMERIZATION,0.88036,-0.05866,-0.045202,0,0
4,GO TRANSLATIONAL TERMINATION,0.53518,-0.058779,-0.065554,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.50395,-0.059264,-0.065695,0,0
4,GO MRNA PROCESSING,0.086186,-0.05936,-0.072162,0,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.19971,-0.059681,-0.074733,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72243,-0.059864,-0.03485,0,0
4,GO PIGMENT GRANULE MATURATION,0.31468,-0.059914,-0.14432,0,0
4,GO REGULATION OF GASTRULATION,0.59207,-0.060077,-0.063298,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.30323,-0.060235,-0.096946,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.30323,-0.060654,-0.070539,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.62578,-0.060731,-0.052599,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.76799,-0.060744,-0.0045992,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.073757,-0.060777,-0.12946,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.23088,-0.060853,-0.065954,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.26023,-0.061186,-0.092029,0,0
4,GO DNA REPAIR,0.14679,-0.061429,-0.055571,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.71343,-0.061523,-0.026482,0,0
4,GO INTERACTION WITH SYMBIONT,0.87087,-0.061674,-0.040373,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.21712,-0.061709,-0.14654,0,0
4,GO RESPONSE TO UV,0.18733,-0.061789,-0.060208,0,0
4,GO NEURON PROJECTION ORGANIZATION,0.20828,-0.061909,-0.10577,0,0
4,GO RNA LOCALIZATION,0.10277,-0.062141,-0.10176,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.88987,-0.062204,0.0057663,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.47371,-0.062243,-0.052008,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.73147,-0.062455,0.0021003,0,0
4,GO REGULATION OF RNA SPLICING,0.068115,-0.06249,-0.06732,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.34454,-0.06252,-0.04217,0,0
4,GO ACROSOME ASSEMBLY,0.48871,-0.062858,-0.062554,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.25516,-0.062976,-0.05556,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.48871,-0.063694,-0.035707,0,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.48118,-0.063705,-0.05823,0,0
4,GO PEPTIDE CROSS LINKING,0.92804,-0.063748,-0.031952,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.11333,-0.063875,-0.088303,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.33843,-0.064165,-0.16488,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.67783,-0.064176,-0.07455,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.19971,-0.064255,-0.13126,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.33239,-0.064543,-0.050341,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.78645,-0.06459,-0.0073962,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.89939,-0.064776,-0.030653,0,0
4,GO AXON EXTENSION,0.15361,-0.065214,-0.10659,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.91848,-0.065305,0.028365,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.25017,-0.06541,-0.16342,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.57554,-0.065437,-0.011442,0,0
4,GO ATP TRANSPORT,0.40267,-0.066239,-0.052118,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.51944,-0.066589,-0.13355,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.19552,-0.06669,-0.0772,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.50395,-0.06684,-0.05739,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.16068,-0.066849,-0.11146,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.79572,-0.066947,-0.053132,0,0
4,GO SYNAPTIC VESICLE PRIMING,1,-0.066957,0.0703,0,0
4,GO RESPONSE TO ATP,0.60042,-0.067114,-0.036277,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.23088,-0.067434,-0.14263,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.19139,-0.067588,-0.11016,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.20828,-0.067651,-0.092664,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.69555,-0.067688,-0.061037,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.12472,-0.067748,-0.063959,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.29206,-0.068211,-0.11003,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.25017,-0.068291,-0.078931,0,0
4,GO RNA SPLICING,0.068115,-0.068295,-0.075322,0,0
4,GO G0 TO G1 TRANSITION,0.40267,-0.06852,-0.041282,0,0
4,GO OVULATION CYCLE PROCESS,0.43029,-0.068732,-0.04841,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.38927,-0.068806,-0.11114,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.71343,-0.069025,-0.021383,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.54313,-0.069085,-0.058792,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.93762,-0.069091,-0.033131,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.18733,-0.069111,-0.082659,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.17553,-0.069194,-0.08707,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.67783,-0.069297,-0.073729,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.26536,-0.069332,-0.21878,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.30323,-0.069628,-0.064908,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.28658,-0.069771,-0.10612,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.38267,-0.069824,-0.095209,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.32052,-0.069836,-0.10602,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.55922,-0.06989,-0.067892,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.30892,-0.06994,-0.13564,0,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.12771,-0.070014,-0.073491,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.38267,-0.070107,-0.14529,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.26023,-0.070222,-0.15389,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.29206,-0.070223,-0.070139,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.28117,-0.070294,-0.097138,0,0
4,GO HISTONE H4 DEACETYLATION,0.40267,-0.07031,-0.07881,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.23088,-0.070375,-0.070329,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.43029,-0.07049,-0.061207,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.26536,-0.070652,-0.061651,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.23088,-0.070838,-0.23058,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.48118,-0.071,-0.076128,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.6516,-0.071083,0.061817,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.30892,-0.071111,-0.045463,0,0
4,GO VIRAL GENE EXPRESSION,0.29761,-0.071129,-0.12712,0,0
4,GO PROTEIN KINASE A SIGNALING,0.30323,-0.071158,-0.063258,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.34454,-0.071332,-0.15811,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.20828,-0.071561,-0.18343,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.15712,-0.071617,-0.10598,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.6603,-0.071699,-0.036696,0,0
4,GO REGULATION OF EXCRETION,0.95679,-0.071743,-0.0049827,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.84251,-0.07182,-0.030296,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.29761,-0.071879,-0.11266,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.40267,-0.072267,-0.063603,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.98559,-0.072296,0.014384,0,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.6516,-0.072454,-0.028833,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.73147,-0.072749,-0.03085,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.53518,-0.072826,-0.038273,0,0
4,GO NEUROBLAST PROLIFERATION,0.52728,-0.072837,-0.039591,0,0
4,GO MRNA METABOLIC PROCESS,0.068115,-0.072969,-0.08651,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.37614,-0.073302,-0.097012,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.14347,-0.073858,-0.10768,0,0
4,GO MITOTIC RECOMBINATION,0.26023,-0.073964,-0.10106,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.92804,-0.07416,0.014368,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.84251,-0.074245,0.0016045,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.25017,-0.074397,-0.10065,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.46631,-0.074677,-0.092387,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.33843,-0.074748,-0.076669,0,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.22622,-0.074761,-0.11492,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.36968,-0.074786,-0.086895,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.19139,-0.074845,-0.18012,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.079775,-0.075047,-0.11359,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.55922,-0.075112,-0.062271,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.09779,-0.075341,-0.080397,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.22164,-0.075411,-0.10658,0,0
4,GO MICROTUBULE NUCLEATION,0.19552,-0.075415,-0.076382,0,0
4,GO REGULATION OF PINOCYTOSIS,0.19139,-0.075444,-0.15776,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.31468,-0.075702,-0.08837,0,0
4,GO SISTER CHROMATID COHESION,0.97598,-0.075788,0.016706,0,0
4,GO RNA 5 END PROCESSING,0.21267,-0.075862,-0.11835,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.043706,-0.07621,-0.087996,0,0
4,GO RNA PROCESSING,0.042464,-0.076218,-0.10267,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.11892,-0.076473,-0.1037,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.27583,-0.076619,-0.17743,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.034581,-0.076817,-0.10193,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.43029,-0.076849,-0.068182,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.07572,-0.077066,-0.11165,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.35697,-0.07713,-0.076759,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.25516,-0.077495,-0.066824,0,0
4,GO FOREBRAIN REGIONALIZATION,0.43029,-0.077667,-0.063885,0,0
4,GO RNA METHYLATION,0.14347,-0.077707,-0.091782,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.43736,-0.077719,-0.071504,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.25017,-0.077844,-0.15133,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.52728,-0.077947,-0.073547,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.36329,-0.078184,-0.06937,0,0
4,GO REGULATION OF MYELINATION,0.26536,-0.07819,-0.056034,0,0
4,GO HISTONE ARGININE METHYLATION,0.26536,-0.078303,-0.077049,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.21712,-0.07832,-0.12481,0,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.035624,-0.078633,-0.13223,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.40267,-0.078687,-0.048915,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.26023,-0.079063,-0.11166,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.51167,-0.079261,-0.082545,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.29206,-0.079267,-0.10214,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.26536,-0.07959,-0.055635,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.46631,-0.079602,-0.11876,0,0
4,GO REGULATION OF OOGENESIS,0.33239,-0.079747,-0.0693,0,0
4,GO OXIDATIVE DEMETHYLATION,0.20396,-0.080529,-0.080531,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.51167,-0.080714,-0.094099,0,0
4,GO NCRNA METABOLIC PROCESS,0.12472,-0.081029,-0.11512,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.13699,-0.081081,-0.095014,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.30892,-0.08154,-0.10523,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.35072,-0.081633,-0.074908,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.34454,-0.08198,-0.096398,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.10277,-0.082092,-0.1304,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.54313,-0.082205,-0.1646,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.22164,-0.082391,-0.11677,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.31468,-0.083132,-0.11217,0,0
4,GO DNA STRAND ELONGATION,0.17173,-0.083215,-0.10721,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.37614,-0.083614,-0.093826,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.11892,-0.08363,-0.1288,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.9472,-0.083851,-0.001632,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.47371,-0.084112,-0.1095,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.58378,-0.084113,-0.052337,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.40947,-0.084497,-0.059932,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.32052,-0.084811,-0.081394,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.14679,-0.08484,-0.087506,0,0
4,GO MICROTUBULE ANCHORING,0.15017,-0.085064,-0.072904,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.41634,-0.085322,-0.081651,0,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.032572,-0.085638,-0.11591,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.35697,-0.085923,-0.072602,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.10533,-0.086066,-0.09728,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.13699,-0.086414,-0.11054,0,0
4,GO NCRNA TRANSCRIPTION,0.041252,-0.086594,-0.10953,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.33239,-0.0866,-0.055221,0,0
4,GO NEURAL CREST FORMATION,0.35697,-0.086731,-0.11614,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.55922,-0.087099,-0.043508,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.48118,-0.087492,-0.037478,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.52728,-0.087917,-0.077139,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.15017,-0.087959,-0.089552,0,0
4,GO REGULATION OF MRNA PROCESSING,0.047616,-0.088012,-0.096445,0,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.093006,-0.08803,-0.11278,0,0
4,GO MITOCHONDRIAL FISSION,0.19139,-0.088124,-0.083571,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.48871,-0.088223,-0.10435,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.15361,-0.08828,-0.089201,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.61728,-0.08828,-0.029969,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.1794,-0.088385,-0.08514,0,0
4,GO NODAL SIGNALING PATHWAY,0.57554,-0.088473,-0.023913,0,0
4,GO DIVALENT METAL ION EXPORT,0.84251,-0.088629,-0.047489,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.38927,-0.08884,-0.14,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16798,-0.088872,-0.10992,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.26536,-0.088921,-0.11842,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.23088,-0.089511,-0.10092,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.93762,-0.090076,0.025688,0,0
4,GO CHROMOSOME SEPARATION,0.14347,-0.090371,-0.081241,0,0
4,GO CELLULAR RESPONSE TO UV,0.10533,-0.090688,-0.089721,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.077726,-0.090912,-0.092284,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.9472,-0.091378,0.027194,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.24039,-0.091461,-0.15572,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.42328,-0.091552,-0.090493,0,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.24525,-0.091589,-0.1507,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.33239,-0.091686,-0.08161,0,0
4,GO PRE MIRNA PROCESSING,0.45898,-0.091766,-0.089586,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.54313,-0.092088,-0.07015,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.62578,-0.092198,-0.031112,0,0
4,GO TUBULIN DEACETYLATION,0.55922,-0.09247,-0.047958,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.30892,-0.09291,-0.11636,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.55115,-0.092978,-0.037775,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.19552,-0.093912,-0.10532,0,0
4,GO WALKING BEHAVIOR,0.1402,-0.09392,-0.13298,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.48871,-0.093949,-0.032723,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.55115,-0.094027,-0.060752,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.19139,-0.09462,-0.096574,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.10025,-0.094678,-0.14059,0,0
4,GO TRANSLATIONAL ELONGATION,0.27583,-0.095107,-0.095829,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.61728,-0.09551,-0.069823,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.17553,-0.095719,-0.10864,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.09779,-0.096631,-0.16614,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.17553,-0.096894,-0.18745,0,0
4,GO PROTEASOME ASSEMBLY,0.41634,-0.097105,-0.096569,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.047616,-0.097589,-0.10699,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.26536,-0.097731,-0.093261,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.33239,-0.098075,-0.063193,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.38267,-0.098295,-0.067462,0,0
4,GO HEXOSE CATABOLIC PROCESS,0.64294,-0.098638,-0.017966,0,0
4,GO NEURAL TUBE PATTERNING,0.09779,-0.098658,-0.14641,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.24525,-0.099183,-0.12777,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.033564,-0.099728,-0.12009,0,0
4,GO CARTILAGE MORPHOGENESIS,0.24525,-0.099771,-0.21844,0,0
4,GO DOUBLE STRAND BREAK REPAIR,0.053284,-0.0998,-0.096434,0,0
4,GO RNA SURVEILLANCE,0.088413,-0.10019,-0.12069,0,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.047616,-0.10092,-0.092428,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.069955,-0.10114,-0.18836,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.10533,-0.10145,-0.11271,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.081867,-0.10172,-0.13397,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.19139,-0.10175,-0.063274,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.069955,-0.10215,-0.15405,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.043706,-0.1023,-0.12885,0,0
4,GO REPLACEMENT OSSIFICATION,0.29206,-0.10231,-0.098673,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.32052,-0.10266,-0.088179,0,0
4,GO NAD METABOLIC PROCESS,0.32642,-0.10291,-0.080344,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.6603,-0.10303,-0.078256,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.6603,-0.10318,-0.091716,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.53518,-0.10331,-0.11775,0,0
4,GO AMINO ACID ACTIVATION,0.9472,-0.10362,-0.019234,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.4445,-0.10362,-0.072553,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.40267,-0.10372,-0.095101,0,0
4,GO MRNA METHYLATION,0.14679,-0.10394,-0.13029,0,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.10277,-0.10406,-0.11364,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.15361,-0.1042,-0.094669,0,0
4,GO TRANSLATIONAL INITIATION,0.15017,-0.10427,-0.18024,0,0
4,GO PROTEIN NEDDYLATION,0.22164,-0.10428,-0.091022,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.29761,-0.10441,-0.067203,0,0
4,GO RESPONSE TO X RAY,0.18733,-0.1046,-0.14058,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.15712,-0.10461,-0.20653,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.13074,-0.10638,-0.17411,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.16068,-0.10658,-0.099528,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.21267,-0.10663,-0.16759,0,0
4,GO TRNA METHYLATION,0.064555,-0.10675,-0.14237,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.16068,-0.10687,-0.076087,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.33843,-0.10697,-0.074682,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.10533,-0.10726,-0.14223,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.71343,-0.10754,-0.05044,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.036694,-0.10764,-0.11109,0,0
4,GO HEPARIN METABOLIC PROCESS,0.45171,-0.10819,-0.1243,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.26536,-0.10823,-0.11344,0,0
4,GO NUCLEUS LOCALIZATION,0.053284,-0.10859,-0.15972,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.47371,-0.10862,-0.071317,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.068115,-0.10911,-0.17652,0,0
4,GO BRAIN MORPHOGENESIS,0.057895,-0.10917,-0.13613,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.47371,-0.10924,-0.066243,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.12472,-0.10953,-0.087322,0,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.1402,-0.10994,-0.084993,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.64294,-0.11067,-0.040392,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.077726,-0.11113,-0.15916,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.13384,-0.11132,-0.15623,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.081867,-0.11155,-0.11555,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.38267,-0.1117,-0.15798,0,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.37614,-0.11182,-0.086446,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.1794,-0.11208,-0.21299,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.07572,-0.11209,-0.11961,0,0
4,GO RECOMBINATIONAL REPAIR,0.069955,-0.11291,-0.1039,0,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.11333,-0.11307,-0.098785,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.20828,-0.11319,-0.14268,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.45171,-0.11364,-0.12473,0,0
4,GO OTIC VESICLE MORPHOGENESIS,0.15017,-0.1138,-0.19753,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.07572,-0.1138,-0.11431,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.28658,-0.11383,-0.11952,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.31468,-0.11397,-0.11316,0,0
4,GO REGULATION OF LYASE ACTIVITY,0.095374,-0.11464,-0.12508,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.14679,-0.11492,-0.14985,0,0
4,GO RNA DECAPPING,0.1402,-0.11509,-0.077362,0,0
4,GO MEMBRANE DISASSEMBLY,0.037792,-0.11514,-0.20157,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.51944,-0.11556,-0.045122,0,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.24039,-0.11588,-0.11374,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.13699,-0.11659,-0.14761,0,0
4,GO RRNA METABOLIC PROCESS,0.086186,-0.11679,-0.1478,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.26536,-0.11709,-0.11429,0,0
4,GO SNORNA 3 END PROCESSING,0.11061,-0.11711,-0.14016,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.054786,-0.11721,-0.13888,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.69555,-0.11746,-0.019657,0,0
4,GO URETER DEVELOPMENT,0.40267,-0.11772,-0.10825,0,0
4,GO COCHLEA MORPHOGENESIS,0.17173,-0.11793,-0.14527,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.13699,-0.11795,-0.24863,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.12179,-0.11805,-0.116,0,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.031606,-0.11824,-0.11248,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.23088,-0.11875,-0.10071,0,0
4,GO RNA CAPPING,0.053284,-0.11879,-0.10124,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.10533,-0.11898,-0.18132,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.45898,-0.11908,-0.032521,0,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.051817,-0.11926,-0.16531,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.32642,-0.11947,-0.1463,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.10025,-0.11949,-0.13232,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.27583,-0.12087,-0.13701,0,0
4,GO UTERUS DEVELOPMENT,0.42328,-0.12215,-0.12834,0,0
4,GO CELLULAR RESPONSE TO PH,0.35072,-0.12237,-0.070213,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.52728,-0.1227,-0.041976,0,0
4,GO REGULATION OF RNA BINDING,0.10794,-0.12331,-0.14838,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.4963,-0.12331,-0.09608,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.050383,-0.12337,-0.15073,0,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.33239,-0.12352,-0.10133,0,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.090686,-0.12371,-0.15948,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.041252,-0.12384,-0.17384,0,0
4,GO REGULATION OF AXON GUIDANCE,0.10025,-0.1246,-0.15343,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.1402,-0.12463,-0.1872,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.27583,-0.12468,-0.10079,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.34454,-0.12486,-0.13628,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.32642,-0.12504,-0.1177,0,0
4,GO L GLUTAMATE IMPORT,0.32642,-0.12538,-0.10224,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.15017,-0.12538,-0.15302,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.19552,-0.12634,-0.10429,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.16798,-0.12648,-0.12084,0,0
4,GO MUSCLE CELL FATE COMMITMENT,0.15712,-0.12695,-0.19066,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.38267,-0.12699,-0.1163,0,0
4,GO HISTONE H3 K27 METHYLATION,0.29761,-0.12705,-0.061737,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.36329,-0.12734,-0.099738,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.42328,-0.12746,-0.095453,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.13699,-0.1275,-0.15241,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.051817,-0.12752,-0.15116,0,0
4,GO DENDRITIC TRANSPORT,0.18334,-0.12755,-0.15319,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.10794,-0.12771,-0.14187,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.073757,-0.12791,-0.11463,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.19139,-0.12808,-0.12617,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.45898,-0.12826,-0.13801,0,0
4,GO LEUKOCYTE AGGREGATION,0.52728,-0.12833,-0.16427,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.47371,-0.12873,-0.030067,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.064555,-0.12886,-0.18193,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.11061,-0.12927,-0.21566,0,0
4,GO NCRNA PROCESSING,0.046281,-0.12933,-0.15779,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.22164,-0.1295,-0.076183,0,0
4,GO NADH METABOLIC PROCESS,0.33843,-0.12979,-0.065325,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.12771,-0.12995,-0.15103,0,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.047616,-0.13007,-0.17305,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.079775,-0.13075,-0.14346,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.27056,-0.1316,-0.11527,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.20396,-0.13184,-0.20492,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.12179,-0.13195,-0.16523,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.1643,-0.13206,-0.13326,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.036694,-0.13225,-0.22157,0,0
4,GO ETHANOL METABOLIC PROCESS,0.78645,-0.13277,-0.05582,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.095374,-0.13278,-0.11672,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.04007,-0.13299,-0.22955,0,0
4,GO TRACHEA MORPHOGENESIS,0.16798,-0.13332,-0.14979,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.071835,-0.1335,-0.13022,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.70447,-0.13367,-0.048623,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.54313,-0.13379,-0.11955,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.69555,-0.13417,-0.10928,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15017,-0.13441,-0.13783,0,0
4,GO PENILE ERECTION,0.25516,-0.13453,-0.1437,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.19139,-0.13454,-0.1022,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.15017,-0.13475,-0.11223,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.37614,-0.1348,-0.094652,0,0
4,GO PENTOSE METABOLIC PROCESS,0.034581,-0.13491,-0.21415,0,0
4,GO NUCLEAR MIGRATION,0.068115,-0.13498,-0.16401,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.26023,-0.13521,-0.12287,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.26023,-0.13541,-0.17454,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.056323,-0.13544,-0.12577,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.088413,-0.13614,-0.12701,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.081867,-0.1367,-0.1788,0,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.10794,-0.13676,-0.12548,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.09779,-0.13757,-0.13145,0,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.14347,-0.13776,-0.10416,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.30892,-0.1382,-0.10619,0,0
4,GO PROTEIN DENEDDYLATION,0.1161,-0.13859,-0.14207,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.24039,-0.13891,-0.12368,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.11333,-0.13918,-0.27493,0,0
4,GO MYOBLAST PROLIFERATION,0.057895,-0.13952,-0.20751,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.18733,-0.13986,-0.23858,0,0
4,GO CARDIOBLAST PROLIFERATION,0.30892,-0.14003,-0.23112,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.28658,-0.14012,-0.18147,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.11892,-0.14047,-0.16167,0,0
4,GO V D J RECOMBINATION,0.10277,-0.14178,-0.17385,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.28117,-0.14277,-0.12382,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.28658,-0.14293,-0.18207,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.1402,-0.14323,-0.14118,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.11061,-0.14422,-0.23124,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.15712,-0.1447,-0.2379,0,0
4,GO RIBOSOME BIOGENESIS,0.053284,-0.14474,-0.17768,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.17553,-0.14485,-0.28261,0,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.030665,-0.14488,-0.12048,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.4445,-0.14573,-0.17448,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.079775,-0.14584,-0.19656,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.36968,-0.14592,-0.1238,0,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.17553,-0.14603,-0.11936,0,0
4,GO CYTOPLASMIC TRANSLATION,0.10277,-0.14615,-0.21306,0,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.15712,-0.14636,-0.19741,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.20396,-0.1465,-0.18483,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.077726,-0.14667,-0.16452,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26536,-0.14676,-0.14587,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.14679,-0.14693,-0.1893,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.32052,-0.1473,-0.061659,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.18733,-0.1474,-0.12902,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.78645,-0.14835,-0.037101,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.62578,-0.14906,-0.073945,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.073757,-0.14924,-0.17904,0,0
4,GO TONGUE DEVELOPMENT,0.32052,-0.14938,-0.14822,0,0
4,GO REGULATION OF MRNA BINDING,0.090686,-0.14942,-0.18968,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.40267,-0.14948,-0.12086,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.16798,-0.14952,-0.25433,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.13074,-0.14967,-0.095433,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.13699,-0.14967,-0.12858,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.4445,-0.1505,-0.11457,0,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.030665,-0.15057,-0.16439,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.51944,-0.15079,-0.094366,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.36329,-0.15082,-0.26184,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.33239,-0.1538,-0.068658,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.073757,-0.15438,-0.18862,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.042464,-0.15459,-0.11604,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.088413,-0.15489,-0.1911,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.030665,-0.15596,-0.12723,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.40947,-0.15604,-0.18221,0,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.079775,-0.15652,-0.17586,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.35697,-0.15663,-0.12489,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.43736,-0.15693,-0.10298,0,0
4,GO BONE MORPHOGENESIS,0.088413,-0.15721,-0.15731,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.044978,-0.15906,-0.24244,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.16068,-0.1596,-0.13451,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.030665,-0.15963,-0.25246,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25017,-0.15986,-0.10835,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.67783,-0.15996,-0.060443,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.07572,-0.15999,-0.13804,0,0
4,GO RESPONSE TO L GLUTAMATE,0.38267,-0.1611,-0.12076,0,0
4,GO RRNA MODIFICATION,0.084004,-0.16148,-0.16356,0,0
4,GO RRNA METHYLATION,0.11892,-0.16174,-0.12261,0,0
4,GO SEQUESTERING OF METAL ION,0.059504,-0.16175,-0.19714,0,0
4,GO POSTSYNAPSE ASSEMBLY,0.19139,-0.16175,-0.22819,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.27583,-0.16239,-0.098724,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.20396,-0.16252,-0.13572,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.071835,-0.16262,-0.19912,0,0
4,GO MITOCHONDRION DISTRIBUTION,0.050383,-0.16278,-0.13906,0,0
4,GO HISTONE H2A ACETYLATION,0.26536,-0.1628,-0.086014,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.062834,-0.16309,-0.22357,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.22622,-0.16311,-0.063966,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.52728,-0.16426,-0.10228,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.041252,-0.16538,-0.19873,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.28658,-0.16551,-0.093347,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.10794,-0.16553,-0.17385,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.1402,-0.16564,-0.14718,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.70447,-0.16585,-0.030353,0,0
4,GO MATURATION OF 5 8S RRNA,0.037792,-0.16619,-0.21139,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.43029,-0.16655,-0.09575,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.11892,-0.16667,-0.22367,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.12771,-0.16691,-0.093545,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.66904,-0.16759,-0.089301,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.12179,-0.16826,-0.17864,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.18334,-0.16871,-0.14983,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.15361,-0.16894,-0.10121,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.030665,-0.16944,-0.22418,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.07572,-0.16984,-0.27192,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.048983,-0.17179,-0.25002,0,0
4,GO HIPPO SIGNALING,0.081867,-0.17222,-0.22965,0,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.050383,-0.17269,-0.26602,0,0
4,GO DNA LIGATION,0.39593,-0.17272,-0.087949,0,0
4,GO IMMATURE T CELL PROLIFERATION,0.095374,-0.17354,-0.2567,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.16798,-0.17398,-0.16369,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.084004,-0.17424,-0.14489,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.07572,-0.17431,-0.22754,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.051817,-0.17467,-0.27269,0,0
4,GO SNORNA METABOLIC PROCESS,0.12771,-0.17468,-0.13902,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.28658,-0.17491,-0.12758,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.16068,-0.17677,-0.1996,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.10277,-0.177,-0.18053,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.13384,-0.178,-0.20043,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.24525,-0.17824,-0.25589,0,0
4,GO MATURATION OF LSU RRNA,0.069955,-0.17839,-0.25395,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.19139,-0.17846,-0.26841,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.048983,-0.18013,-0.22629,0,0
4,GO TRACHEA DEVELOPMENT,0.066316,-0.18028,-0.21901,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.50395,-0.18044,-0.080562,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.35697,-0.18067,-0.11011,0,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.60883,-0.18136,-0.04479,0,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.059504,-0.18178,-0.16979,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.25017,-0.18217,-0.11968,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.24039,-0.18238,-0.176,0,0
4,GO MRNA MODIFICATION,0.073757,-0.18335,-0.15972,0,0
4,GO MICROTUBULE SEVERING,0.46631,-0.18509,-0.094225,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.034581,-0.18606,-0.21551,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.033564,-0.18616,-0.19688,0,0
4,GO RESPONSE TO LEAD ION,0.047616,-0.18686,-0.15089,0,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.031606,-0.18708,-0.23564,0,0
4,GO REGULATION OF NEURON MIGRATION,0.090686,-0.18749,-0.17548,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.077726,-0.18751,-0.19275,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.45171,-0.18887,-0.077349,0,0
4,GO LATERAL MESODERM DEVELOPMENT,0.077726,-0.18888,-0.26497,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.10794,-0.18894,-0.12674,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.043706,-0.19186,-0.21527,0,0
4,GO NADPH REGENERATION,0.09779,-0.19299,-0.19541,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.064555,-0.19361,-0.24366,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.23088,-0.19377,-0.18353,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.28658,-0.19591,-0.13256,0,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.056323,-0.19909,-0.18954,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.088413,-0.19932,-0.25293,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.038917,-0.19982,-0.26864,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.27583,-0.20063,-0.11439,0,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.10533,-0.20076,-0.26009,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.073757,-0.20088,-0.25424,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.048983,-0.20096,-0.20241,0,0
4,GO PLASMA MEMBRANE REPAIR,0.40947,-0.20153,-0.14058,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.21267,-0.20165,-0.23021,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.2356,-0.20486,-0.18207,0,0
4,GO LIMB BUD FORMATION,0.088413,-0.20527,-0.29857,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.13699,-0.20628,-0.20691,0,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.035624,-0.20818,-0.2277,0,0
4,GO NEURAL CREST CELL MIGRATION,0.033564,-0.20948,-0.23245,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.28117,-0.20966,-0.073447,0,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.095374,-0.21072,-0.2068,0,0
4,GO CHONDROCYTE PROLIFERATION,0.13074,-0.21141,-0.19796,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.15712,-0.21185,-0.15359,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.25017,-0.21239,-0.25706,0,0
4,GO NEUROBLAST DIVISION,0.28658,-0.2124,-0.13407,0,0
4,GO GAS TRANSPORT,0.17173,-0.213,-0.25138,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.041252,-0.21341,-0.23439,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.081867,-0.21468,-0.16072,0,0
4,GO FOREBRAIN MORPHOGENESIS,0.046281,-0.21497,-0.20811,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.093006,-0.2166,-0.17495,0,0
4,GO PROSTATIC BUD FORMATION,0.077726,-0.21794,-0.28779,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.030665,-0.21906,-0.21798,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.054786,-0.21981,-0.22298,0,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.033564,-0.22044,-0.26467,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.12179,-0.22059,-0.14913,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.079775,-0.22318,-0.23921,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.044978,-0.22358,-0.23094,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.071835,-0.22491,-0.19425,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.15017,-0.22514,-0.14784,0,0
4,GO BONE GROWTH,0.035624,-0.22641,-0.24419,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.16798,-0.22845,-0.20624,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.095374,-0.22929,-0.2363,0,0
4,GO PROTEIN DEMETHYLATION,0.031606,-0.22972,-0.1786,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.034581,-0.23208,-0.31421,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.22164,-0.2334,-0.20775,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.066316,-0.23777,-0.23611,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.36968,-0.23982,-0.14548,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.053284,-0.24037,-0.32604,0,0
4,GO IMP METABOLIC PROCESS,0.10533,-0.24206,-0.238,0,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.051817,-0.24248,-0.17901,0,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.043706,-0.24303,-0.20863,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.062834,-0.24488,-0.26457,0,0
4,GO NOREPINEPHRINE SECRETION,0.09779,-0.24497,-0.17727,0,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.046281,-0.24635,-0.25664,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.033564,-0.24709,-0.31435,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.035624,-0.24801,-0.21707,0,0
4,GO MYOBLAST MIGRATION,0.10794,-0.24948,-0.25713,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.048983,-0.25115,-0.19664,0,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.1643,-0.2562,-0.14842,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.16798,-0.258,-0.25892,0,0
4,GO OXYGEN TRANSPORT,0.19971,-0.2585,-0.30114,0,0
4,GO DENDRITE SELF AVOIDANCE,0.13384,-0.25927,-0.2041,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.15017,-0.26804,-0.18162,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.14679,-0.27066,-0.21395,0,0
4,GO CARDIOBLAST DIFFERENTIATION,0.044978,-0.27442,-0.25532,0,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.037792,-0.27562,-0.29938,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.042464,-0.27705,-0.24857,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.1643,-0.27858,-0.25386,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.053284,-0.28258,-0.17075,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.071835,-0.28314,-0.26407,0,0
4,GO BONE TRABECULA FORMATION,0.11061,-0.28597,-0.33172,0,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.079775,-0.28629,-0.2723,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.043706,-0.29001,-0.30996,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.10277,-0.29116,-0.24585,0,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.084004,-0.29149,-0.19514,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.11061,-0.29409,-0.26157,0,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.033564,-0.29468,-0.29586,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.15712,-0.29685,-0.20965,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.047616,-0.29772,-0.19947,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.037792,-0.29866,-0.4087,0,0
4,GO PROSTATE GLAND GROWTH,0.038917,-0.29921,-0.28711,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.37614,-0.31471,-0.1276,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.051817,-0.32277,-0.31266,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.030665,-0.32545,-0.4299,0,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.042464,-0.33001,-0.32721,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.054786,-0.33124,-0.32031,0,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.044978,-0.33142,-0.25719,0,0
4,GO UV PROTECTION,0.035624,-0.3348,-0.26567,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.31468,-0.3371,-0.2418,0,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.11061,-0.35295,-0.36723,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.053284,-0.36558,-0.41027,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.069955,-0.39096,-0.30198,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.0047478,0.66148,0.77767,1,1
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0061556,0.60869,0.48932,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0047478,0.58625,0.5594,1,1
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0040811,0.56898,0.52536,1,1
5,GO CARDIAC CELL FATE COMMITMENT,0.0049293,0.53356,0.49408,1,1
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.016296,0.40065,0.38297,1,1
5,GO THALAMUS DEVELOPMENT,0.0085133,0.38434,0.36351,1,1
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.01918,0.37654,0.29377,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0059338,0.34899,0.28983,1,1
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0129,0.33486,0.30783,1,1
5,GO GENETIC IMPRINTING,0.0036381,0.32295,0.2749,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0079288,0.3149,0.35859,1,1
5,GO KINETOCHORE ORGANIZATION,0.023963,0.29084,0.19735,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0017084,0.28876,0.29764,1,1
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0040811,0.28492,0.44274,1,1
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0174,0.27076,0.29742,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.029747,0.26767,0.1833,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.012053,0.26709,0.23307,1,1
5,GO HISTONE H4 K16 ACETYLATION,0.00031055,0.26026,0.28122,1,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.016296,0.25353,0.30228,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0174,0.24344,0.2536,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.021117,0.24255,0.2468,1,1
5,GO HISTONE H4 K5 ACETYLATION,0.0026621,0.2377,0.24774,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,0.0035004,0.23121,0.24897,1,1
5,GO DENDRITIC TRANSPORT,0.01684,0.227,0.25568,1,1
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.020453,0.22064,0.18698,1,1
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0063849,0.2102,0.23369,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,0.0085133,0.20836,0.19669,1,1
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.028854,0.20767,0.20854,1,1
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0020112,0.20227,0.20738,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,0.0033675,0.19983,0.22291,1,1
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.010874,0.1915,0.193,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.010146,0.18261,0.22956,1,1
5,GO HISTONE H3 K4 METHYLATION,0.0036381,0.1824,0.19464,1,1
5,GO CENTROMERE COMPLEX ASSEMBLY,0.022501,0.18205,0.16848,1,1
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.0082164,0.1803,0.1502,1,1
5,GO HISTONE H3 K9 ACETYLATION,0.023222,0.16932,0.13421,1,1
5,GO REGULATION OF CILIUM ASSEMBLY,0.0071194,0.16809,0.16127,1,1
5,GO G0 TO G1 TRANSITION,0.0032392,0.16527,0.18513,1,1
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.023222,0.164,0.1839,1,1
5,GO HISTONE H3 K36 METHYLATION,0.024724,0.16169,0.1889,1,1
5,GO HISTONE H4 ACETYLATION,0.00040918,0.15932,0.17455,1,1
5,GO HISTONE H2A UBIQUITINATION,0.011255,0.15917,0.16053,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0026621,0.15645,0.18686,1,1
5,GO DOSAGE COMPENSATION,0.0138,0.15376,0.13797,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.027136,0.14622,0.14151,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,0.010874,0.1427,0.1194,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.028854,0.13942,0.11657,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0055117,0.13653,0.1699,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0020943,0.13625,0.15543,1,1
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.01427,0.13611,0.17167,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0021804,0.13292,0.16846,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,0.00031055,0.12779,0.1371,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.011648,0.12608,0.12113,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.01427,0.12246,0.11794,1,1
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.029747,0.11441,0.11789,1,1
5,GO NUCLEOSOME ORGANIZATION,0.01684,0.11011,0.11876,1,1
5,GO PEPTIDYL LYSINE METHYLATION,0.012053,0.10516,0.12217,1,1
5,GO HISTONE MONOUBIQUITINATION,0.012053,0.10283,0.12071,1,1
5,GO PROTEIN ACETYLATION,0.00031055,0.10113,0.11483,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,0.0068665,0.092637,0.072649,1,1
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.027136,0.092546,0.07628,1,1
5,GO DNA INTEGRITY CHECKPOINT,0.01857,0.090649,0.078575,1,1
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.01427,0.089114,0.11649,1,1
5,GO CHROMATIN ORGANIZATION,0.0085133,0.08739,0.076208,1,1
5,GO CELL CYCLE CHECKPOINT,0.013344,0.079864,0.079046,1,1
5,GO COVALENT CHROMATIN MODIFICATION,0.0088198,0.078068,0.072417,1,1
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.028854,0.52428,0.39779,1,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0094624,0.48844,0.55904,1,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.011648,0.42637,0.3937,1,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0076503,0.3989,0.48598,1,0
5,GO NEURON CELL CELL ADHESION,0.027136,0.39795,0.42001,1,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0024588,0.39433,0.47375,1,0
5,GO NEURON FATE SPECIFICATION,0.027136,0.38109,0.4063,1,0
5,GO RESPONSE TO FORSKOLIN,0.0071194,0.35547,0.37803,1,0
5,GO NOSE DEVELOPMENT,0.0059338,0.35518,0.52696,1,0
5,GO SPINAL CORD PATTERNING,0.011648,0.34575,0.36704,1,0
5,GO NEURON FATE COMMITMENT,0.0094624,0.34289,0.35514,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0174,0.33837,0.46259,1,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0042393,0.32686,0.37565,1,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0027694,0.32445,0.40159,1,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0085133,0.31614,0.35611,1,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0085133,0.27667,0.27541,1,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.016296,0.27579,0.24496,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.011255,0.26955,0.27482,1,0
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.01857,0.24999,0.25454,1,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.0138,0.24759,0.25477,1,0
5,GO MRNA SPLICE SITE SELECTION,0.0016396,0.24351,0.29425,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0079288,0.24155,0.26405,1,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0094624,0.2204,0.3068,1,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.005311,0.21759,0.23975,1,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.025507,0.21359,0.19821,1,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.0076503,0.20284,0.25414,1,0
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.015767,0.20221,0.18766,1,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.021117,0.20188,0.23856,1,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.01857,0.19858,0.22763,1,0
5,GO REGULATION OF MICROTUBULE BINDING,0.020453,0.19706,0.22957,1,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.017977,0.19392,0.21843,1,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.029747,0.19173,0.1859,1,0
5,GO INTRACILIARY TRANSPORT,0.011648,0.19047,0.27215,1,0
5,GO ACROSOME ASSEMBLY,0.0094624,0.18677,0.22143,1,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.011255,0.18445,0.2638,1,0
5,GO FOREBRAIN REGIONALIZATION,0.028854,0.18252,0.2426,1,0
5,GO HISTONE H3 K27 METHYLATION,0.020453,0.18002,0.14899,1,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.010146,0.17504,0.18124,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.019808,0.17279,0.17508,1,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0085133,0.17154,0.17305,1,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.020453,0.15355,0.1863,1,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.016296,0.15281,0.16492,1,0
5,GO RENAL WATER HOMEOSTASIS,0.027983,0.14844,0.17745,1,0
5,GO SPINAL CORD DEVELOPMENT,0.01427,0.14576,0.17092,1,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.024724,0.14249,0.14739,1,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.029747,0.14233,0.18374,1,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.028854,0.14093,0.17115,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.01857,0.13913,0.14938,1,0
5,GO CILIUM ORGANIZATION,0.024724,0.13201,0.13361,1,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.01684,0.13114,0.13397,1,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.019808,0.12738,0.12072,1,0
5,GO HISTONE H2A ACETYLATION,0.0129,0.12732,0.18867,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.029747,0.12653,0.17688,1,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.015767,0.12497,0.13963,1,0
5,GO CENTRIOLE ASSEMBLY,0.029747,0.1206,0.11764,1,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.028854,0.11488,0.19162,1,0
5,GO DEMETHYLATION,0.0097991,0.11166,0.11222,1,0
5,GO HISTONE H3 K9 MODIFICATION,0.027136,0.098916,0.13068,1,0
5,GO SISTER CHROMATID COHESION,0.01918,0.097088,0.13757,1,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.012053,0.091844,0.12104,1,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.021799,0.087668,0.089703,1,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.029747,0.085976,0.094254,1,0
5,GO TRANSPORT ALONG MICROTUBULE,0.025507,0.082352,0.10218,1,0
5,GO DNA PACKAGING,0.017977,0.075323,0.10055,1,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.028854,0.073678,0.10071,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.027136,0.072743,0.072833,1,0
5,GO PROTEIN ACYLATION,0.0019312,0.070568,0.08716,1,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0174,-0.05738,-0.088832,1,0
5,GO PROTEIN CATABOLIC PROCESS,0.017977,-0.057499,-0.079282,1,0
5,GO VESICLE ORGANIZATION,0.015767,-0.065506,-0.10101,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.027136,-0.066318,-0.079779,1,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.016296,-0.067405,-0.079503,1,0
5,GO LEUKOCYTE DIFFERENTIATION,0.028854,-0.067585,-0.1137,1,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.027136,-0.068373,-0.075681,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.019808,-0.070193,-0.095641,1,0
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.016296,-0.071001,-0.087144,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.028854,-0.072125,-0.090776,1,0
5,GO PROTEOLYSIS,0.022501,-0.072342,-0.090578,1,0
5,GO MACROAUTOPHAGY,0.020453,-0.073466,-0.086826,1,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.024724,-0.073567,-0.083713,1,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.021117,-0.075853,-0.10581,1,0
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0082164,-0.077644,-0.070436,1,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.020453,-0.077746,-0.11954,1,0
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.01857,-0.078015,-0.085633,1,0
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.015254,-0.078845,-0.09888,1,0
5,GO RESPONSE TO ABIOTIC STIMULUS,0.0071194,-0.079224,-0.10342,1,0
5,GO APOPTOTIC PROCESS,0.0085133,-0.079815,-0.10251,1,0
5,GO REGULATION OF HYDROLASE ACTIVITY,0.0097991,-0.080134,-0.10647,1,0
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.023963,-0.080597,-0.086889,1,0
5,GO CELLULAR RESPONSE TO KETONE,0.022501,-0.081379,-0.15049,1,0
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.02631,-0.081589,-0.10229,1,0
5,GO REGULATION OF CELL DEATH,0.0076503,-0.082389,-0.10422,1,0
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.010505,-0.082512,-0.099755,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.02631,-0.083239,-0.090608,1,0
5,GO PROTEIN IMPORT,0.01427,-0.083459,-0.11034,1,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.023963,-0.083801,-0.092996,1,0
5,GO ERAD PATHWAY,0.027983,-0.084033,-0.12191,1,0
5,GO RESPONSE TO MONOSACCHARIDE,0.02631,-0.084487,-0.098121,1,0
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.01247,-0.084947,-0.10371,1,0
5,GO RESPONSE TO CARBOHYDRATE,0.0097991,-0.085354,-0.10882,1,0
5,GO ENDOCYTOSIS,0.020453,-0.085381,-0.11442,1,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.01427,-0.085515,-0.11895,1,0
5,GO REGULATION OF BODY FLUID LEVELS,0.028854,-0.085526,-0.12173,1,0
5,GO BLOOD VESSEL MORPHOGENESIS,0.027136,-0.086239,-0.15817,1,0
5,GO VASCULATURE DEVELOPMENT,0.023222,-0.08661,-0.14989,1,0
5,GO NEGATIVE REGULATION OF CELL DEATH,0.010146,-0.086975,-0.11516,1,0
5,GO SECRETION,0.0073805,-0.087063,-0.11729,1,0
5,GO PROTEIN STABILIZATION,0.0129,-0.087836,-0.10954,1,0
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0082164,-0.088093,-0.097581,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0063849,-0.088269,-0.10732,1,0
5,GO RESPONSE TO NITROGEN COMPOUND,0.0068665,-0.088274,-0.10428,1,0
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0063849,-0.088318,-0.12075,1,0
5,GO ORGANELLE DISASSEMBLY,0.029747,-0.088422,-0.11177,1,0
5,GO REGULATION OF RESPONSE TO STRESS,0.023222,-0.08859,-0.10059,1,0
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.011648,-0.089304,-0.10455,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.011648,-0.089746,-0.12848,1,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0021804,-0.090372,-0.086992,1,0
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.017977,-0.09082,-0.10871,1,0
5,GO NEGATIVE REGULATION OF TRANSPORT,0.024724,-0.091131,-0.097459,1,0
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0079288,-0.091916,-0.11313,1,0
5,GO TRANSMEMBRANE TRANSPORT,0.0088198,-0.09278,-0.104,1,0
5,GO REGULATION OF GTPASE ACTIVITY,0.021117,-0.093013,-0.099978,1,0
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0076503,-0.093244,-0.11164,1,0
5,GO ION TRANSPORT,0.021799,-0.094494,-0.099886,1,0
5,GO REGULATION OF METAL ION TRANSPORT,0.0091361,-0.094962,-0.12294,1,0
5,GO MYELOID CELL DIFFERENTIATION,0.016296,-0.095079,-0.1092,1,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0097991,-0.095244,-0.153,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0076503,-0.095367,-0.097279,1,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.02631,-0.095703,-0.16009,1,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.025507,-0.09574,-0.1891,1,0
5,GO JNK CASCADE,0.01857,-0.095751,-0.11047,1,0
5,GO MEMBRANE ORGANIZATION,0.010874,-0.095793,-0.10072,1,0
5,GO POSITIVE REGULATION OF CELL DEATH,0.025507,-0.096044,-0.09534,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE,0.01427,-0.096249,-0.10176,1,0
5,GO REGULATION OF PHOSPHORYLATION,0.0129,-0.096316,-0.1019,1,0
5,GO TRANSITION METAL ION TRANSPORT,0.022501,-0.096346,-0.10372,1,0
5,GO BIOLOGICAL ADHESION,0.021799,-0.096693,-0.12449,1,0
5,GO APOPTOTIC SIGNALING PATHWAY,0.0129,-0.096822,-0.12117,1,0
5,GO GOLGI VESICLE TRANSPORT,0.028854,-0.096972,-0.0963,1,0
5,GO OSSIFICATION,0.015767,-0.096977,-0.14636,1,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.01247,-0.097482,-0.10475,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.020453,-0.09755,-0.099464,1,0
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0042393,-0.097608,-0.12207,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.01684,-0.097898,-0.1066,1,0
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.010505,-0.098064,-0.098431,1,0
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0079288,-0.098093,-0.10968,1,0
5,GO RESPONSE TO GROWTH FACTOR,0.021117,-0.098122,-0.11382,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0020943,-0.098414,-0.11584,1,0
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.013344,-0.098634,-0.16642,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.023222,-0.098764,-0.12267,1,0
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.023963,-0.099208,-0.10503,1,0
5,GO CELLULAR KETONE METABOLIC PROCESS,0.023222,-0.099398,-0.15121,1,0
5,GO INTRACELLULAR TRANSPORT,0.0021804,-0.099515,-0.089694,1,0
5,GO HOMEOSTATIC PROCESS,0.0021804,-0.099522,-0.10699,1,0
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0138,-0.099548,-0.10985,1,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.023222,-0.099715,-0.16748,1,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0051169,-0.099979,-0.13992,1,0
5,GO AGING,0.010505,-0.10027,-0.1349,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.029747,-0.10059,-0.11626,1,0
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.014755,-0.10127,-0.12324,1,0
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.024724,-0.10157,-0.10714,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.0055117,-0.10174,-0.15022,1,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0088198,-0.10206,-0.14964,1,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.01918,-0.10212,-0.10392,1,0
5,GO GLYCEROLIPID METABOLIC PROCESS,0.0068665,-0.1023,-0.1208,1,0
5,GO REGULATION OF PROTEIN STABILITY,0.0049293,-0.10235,-0.10723,1,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0138,-0.10242,-0.18231,1,0
5,GO RESPONSE TO METAL ION,0.01247,-0.10298,-0.13495,1,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.027136,-0.10298,-0.11822,1,0
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.010146,-0.10313,-0.1241,1,0
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.01247,-0.10402,-0.12378,1,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.025507,-0.1042,-0.12203,1,0
5,GO LIPID BIOSYNTHETIC PROCESS,0.0073805,-0.10434,-0.12653,1,0
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.0017799,-0.10448,-0.15085,1,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.005311,-0.10468,-0.11371,1,0
5,GO CELLULAR ION HOMEOSTASIS,0.0027694,-0.10488,-0.11949,1,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.01684,-0.10513,-0.12225,1,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.027983,-0.10519,-0.12047,1,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.020453,-0.10524,-0.10678,1,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.013344,-0.10529,-0.12246,1,0
5,GO STEROID BIOSYNTHETIC PROCESS,0.0091361,-0.10531,-0.16549,1,0
5,GO REGULATION OF CELL ADHESION,0.029747,-0.10569,-0.14472,1,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.029747,-0.10586,-0.13564,1,0
5,GO MITOCHONDRION ORGANIZATION,0.004403,-0.10608,-0.11439,1,0
5,GO REGULATION OF PROTEOLYSIS,0.0091361,-0.10609,-0.13049,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.017977,-0.10613,-0.19297,1,0
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0091361,-0.10617,-0.1155,1,0
5,GO RESPONSE TO PEPTIDE,0.0047478,-0.10625,-0.1146,1,0
5,GO REGULATION OF CELL AGING,0.027136,-0.1063,-0.14481,1,0
5,GO REGULATION OF AUTOPHAGY,0.0055117,-0.10666,-0.11456,1,0
5,GO RNA METHYLATION,0.019808,-0.10741,-0.13904,1,0
5,GO PROTEIN HOMOOLIGOMERIZATION,0.010505,-0.10809,-0.11523,1,0
5,GO GLUCOSE METABOLIC PROCESS,0.005311,-0.10809,-0.13507,1,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.01918,-0.10813,-0.12454,1,0
5,GO RNA MODIFICATION,0.011648,-0.10859,-0.14305,1,0
5,GO REGULATION OF DEFENSE RESPONSE,0.021799,-0.10874,-0.12654,1,0
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.011255,-0.10891,-0.12858,1,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.014755,-0.10936,-0.098758,1,0
5,GO CIRCULATORY SYSTEM PROCESS,0.015767,-0.10979,-0.1191,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,0.0011741,-0.11019,-0.11922,1,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.021117,-0.11028,-0.17238,1,0
5,GO PROTEIN PROCESSING,0.020453,-0.11035,-0.15031,1,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.011648,-0.11035,-0.13677,1,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0097991,-0.11058,-0.13992,1,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0032392,-0.11062,-0.14096,1,0
5,GO METAL ION HOMEOSTASIS,0.0027694,-0.1107,-0.12545,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.024724,-0.11083,-0.12397,1,0
5,GO LIPID MODIFICATION,0.0047478,-0.11085,-0.13636,1,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.017977,-0.1113,-0.16815,1,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.013344,-0.1114,-0.144,1,0
5,GO RESPONSE TO INSULIN,0.0029959,-0.11142,-0.12431,1,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0097991,-0.11195,-0.16305,1,0
5,GO EPITHELIAL CELL PROLIFERATION,0.023222,-0.11196,-0.14982,1,0
5,GO ANION TRANSPORT,0.0021804,-0.11199,-0.12835,1,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0025586,-0.11203,-0.098393,1,0
5,GO CHEMICAL HOMEOSTASIS,0.0027694,-0.11226,-0.12209,1,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.001448,-0.11238,-0.11602,1,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.01857,-0.11244,-0.17929,1,0
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0066217,-0.11244,-0.11155,1,0
5,GO CELL ACTIVATION,0.013344,-0.11249,-0.14407,1,0
5,GO NEGATIVE REGULATION OF GROWTH,0.012053,-0.11259,-0.1242,1,0
5,GO LEUKOCYTE MIGRATION,0.027983,-0.11263,-0.14992,1,0
5,GO ORGANIC ACID TRANSPORT,0.0016396,-0.11289,-0.14808,1,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.021799,-0.11306,-0.12303,1,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.028854,-0.11312,-0.11349,1,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.015254,-0.11315,-0.11388,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0138,-0.11321,-0.11629,1,0
5,GO RESPONSE TO INTERLEUKIN 1,0.0055117,-0.11323,-0.16696,1,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0129,-0.11356,-0.11961,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.01857,-0.11386,-0.14223,1,0
5,GO INFLAMMATORY RESPONSE,0.01247,-0.11392,-0.16959,1,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0059338,-0.11405,-0.13016,1,0
5,GO LIPID HOMEOSTASIS,0.010505,-0.11421,-0.15101,1,0
5,GO INORGANIC ANION TRANSPORT,0.0091361,-0.11431,-0.11235,1,0
5,GO CELLULAR HOMEOSTASIS,0.0019312,-0.11451,-0.12751,1,0
5,GO RESPONSE TO PEPTIDE HORMONE,0.004403,-0.11455,-0.11606,1,0
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0079288,-0.11456,-0.12266,1,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.0015733,-0.11466,-0.10245,1,0
5,GO CELLULAR LIPID METABOLIC PROCESS,0.0016396,-0.11486,-0.14788,1,0
5,GO ION HOMEOSTASIS,0.0017799,-0.11514,-0.13587,1,0
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0097991,-0.11547,-0.11598,1,0
5,GO MYELOID CELL HOMEOSTASIS,0.027983,-0.11558,-0.11727,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.0091361,-0.11579,-0.1678,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0094624,-0.11592,-0.13223,1,0
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.021117,-0.11613,-0.15234,1,0
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0094624,-0.11613,-0.11611,1,0
5,GO POSITIVE REGULATION OF JNK CASCADE,0.029747,-0.11617,-0.12011,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0057193,-0.11633,-0.11857,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.024724,-0.11648,-0.17272,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.022501,-0.11675,-0.11668,1,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.025507,-0.11676,-0.14103,1,0
5,GO RESPONSE TO NUTRIENT,0.020453,-0.11676,-0.16117,1,0
5,GO SMOOTH MUSCLE CONTRACTION,0.01918,-0.11678,-0.13473,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.011255,-0.11681,-0.095467,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.021799,-0.11727,-0.17611,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.011648,-0.11751,-0.11995,1,0
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.021117,-0.11761,-0.13167,1,0
5,GO RESPONSE TO ETHANOL,0.015767,-0.11799,-0.14908,1,0
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.010505,-0.11863,-0.13501,1,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0138,-0.11864,-0.13113,1,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.016296,-0.11878,-0.15702,1,0
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0071194,-0.11969,-0.15634,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0082164,-0.1197,-0.14087,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.027136,-0.11987,-0.16339,1,0
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.005311,-0.12043,-0.099664,1,0
5,GO EXOCYTOSIS,0.005311,-0.1208,-0.14868,1,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.01918,-0.1209,-0.13626,1,0
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0051169,-0.12093,-0.12532,1,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.028854,-0.12112,-0.20625,1,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.011255,-0.12129,-0.15184,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0055117,-0.12152,-0.13538,1,0
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0055117,-0.1216,-0.13043,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION,0.023222,-0.12178,-0.17026,1,0
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.01684,-0.12179,-0.11986,1,0
5,GO ANION TRANSMEMBRANE TRANSPORT,0.0037806,-0.12188,-0.13114,1,0
5,GO LIPID METABOLIC PROCESS,0.0017799,-0.1224,-0.14318,1,0
5,GO ORGANIC ANION TRANSPORT,0.0015095,-0.12244,-0.1443,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027983,-0.12244,-0.12771,1,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0138,-0.12272,-0.13381,1,0
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0021804,-0.12291,-0.13163,1,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0076503,-0.12311,-0.12571,1,0
5,GO LEUKOCYTE PROLIFERATION,0.017977,-0.12344,-0.1572,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0040811,-0.12367,-0.11217,1,0
5,GO ERYTHROCYTE HOMEOSTASIS,0.027136,-0.1238,-0.11604,1,0
5,GO VESICLE BUDDING FROM MEMBRANE,0.0031154,-0.12394,-0.16496,1,0
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0085133,-0.12405,-0.12398,1,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.021799,-0.12411,-0.19413,1,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.01857,-0.12415,-0.13943,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.024724,-0.12416,-0.15687,1,0
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.012053,-0.12421,-0.12344,1,0
5,GO REGULATION OF CATABOLIC PROCESS,0.0029959,-0.12429,-0.11162,1,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0071194,-0.12439,-0.13722,1,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.021117,-0.12461,-0.12548,1,0
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.015767,-0.12464,-0.15139,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.021799,-0.12465,-0.19673,1,0
5,GO OSTEOBLAST DIFFERENTIATION,0.0071194,-0.12479,-0.18288,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0051169,-0.12494,-0.15775,1,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.019808,-0.12555,-0.13727,1,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.021117,-0.12576,-0.12172,1,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.012053,-0.12586,-0.18649,1,0
5,GO DRUG CATABOLIC PROCESS,0.0094624,-0.12595,-0.21198,1,0
5,GO VESICLE TARGETING,0.011648,-0.12617,-0.1637,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.012053,-0.12631,-0.12965,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0174,-0.12636,-0.13548,1,0
5,GO RESPONSE TO KETONE,0.015254,-0.12677,-0.1382,1,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.029747,-0.12679,-0.14621,1,0
5,GO MUSCLE ADAPTATION,0.01247,-0.12701,-0.16608,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0061556,-0.12739,-0.23747,1,0
5,GO MUSCLE HYPERTROPHY,0.015254,-0.12749,-0.16368,1,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.021799,-0.12756,-0.12545,1,0
5,GO MITOCHONDRIAL TRANSPORT,0.0025586,-0.1276,-0.12401,1,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.01684,-0.12785,-0.13341,1,0
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0022699,-0.12835,-0.12984,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.024724,-0.12846,-0.16774,1,0
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.004403,-0.12847,-0.14251,1,0
5,GO CARBOHYDRATE HOMEOSTASIS,0.017977,-0.12855,-0.13159,1,0
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.017977,-0.12858,-0.14247,1,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.0035004,-0.12878,-0.18641,1,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0073805,-0.12899,-0.10757,1,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.01918,-0.12916,-0.1618,1,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.027136,-0.12926,-0.14388,1,0
5,GO CYTOKINE PRODUCTION,0.015767,-0.12943,-0.15056,1,0
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0061556,-0.1295,-0.13643,1,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.0091361,-0.12992,-0.14997,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0059338,-0.12995,-0.16521,1,0
5,GO PROTEIN MATURATION,0.0076503,-0.12998,-0.14932,1,0
5,GO SULFUR COMPOUND TRANSPORT,0.01247,-0.13002,-0.15517,1,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00066983,-0.13002,-0.14558,1,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0045725,-0.1302,-0.13482,1,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.019808,-0.13086,-0.16822,1,0
5,GO NUCLEOTIDE PHOSPHORYLATION,0.0071194,-0.13104,-0.15743,1,0
5,GO REGULATION OF PROTEIN BINDING,0.0082164,-0.1313,-0.142,1,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0079288,-0.13143,-0.18856,1,0
5,GO DEFENSE RESPONSE,0.011648,-0.13153,-0.14909,1,0
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0076503,-0.1318,-0.16481,1,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.027983,-0.13188,-0.15383,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0085133,-0.13197,-0.15005,1,0
5,GO RESPONSE TO BIOTIC STIMULUS,0.01427,-0.13199,-0.14659,1,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.010505,-0.13216,-0.15694,1,0
5,GO SYMBIOTIC PROCESS,0.0026621,-0.13216,-0.15576,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.014755,-0.13273,-0.11175,1,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.02631,-0.13292,-0.12841,1,0
5,GO REGULATION OF MAP KINASE ACTIVITY,0.0068665,-0.13323,-0.15827,1,0
5,GO RESPONSE TO LIPID,0.0031154,-0.1334,-0.15843,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.01857,-0.13343,-0.15249,1,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.010874,-0.13387,-0.17238,1,0
5,GO SPROUTING ANGIOGENESIS,0.021117,-0.13449,-0.18697,1,0
5,GO MAMMARY GLAND DEVELOPMENT,0.027136,-0.13465,-0.14156,1,0
5,GO GRANULOCYTE MIGRATION,0.01857,-0.13479,-0.16467,1,0
5,GO ERK1 AND ERK2 CASCADE,0.01857,-0.13499,-0.16471,1,0
5,GO ENDOTHELIAL CELL PROLIFERATION,0.013344,-0.13547,-0.1687,1,0
5,GO GLIAL CELL ACTIVATION,0.025507,-0.13591,-0.18016,1,0
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0016396,-0.13605,-0.16674,1,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0013321,-0.13613,-0.22132,1,0
5,GO REGULATION OF BONE MINERALIZATION,0.01427,-0.13615,-0.19338,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0037806,-0.13633,-0.17244,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0049293,-0.13646,-0.17575,1,0
5,GO CELL CHEMOTAXIS,0.015767,-0.13653,-0.17639,1,0
5,GO LAMELLIPODIUM ORGANIZATION,0.016296,-0.13663,-0.15784,1,0
5,GO BONE MINERALIZATION,0.01427,-0.13686,-0.1893,1,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.023963,-0.1369,-0.14902,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.013344,-0.13707,-0.16435,1,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.017977,-0.13715,-0.21117,1,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0079288,-0.13722,-0.15938,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.015767,-0.13735,-0.16538,1,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0063849,-0.1375,-0.14827,1,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.011648,-0.13776,-0.18136,1,0
5,GO MAINTENANCE OF LOCATION,0.0031154,-0.13787,-0.15092,1,0
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0029959,-0.13789,-0.1545,1,0
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.011255,-0.13793,-0.14365,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0088198,-0.13796,-0.19918,1,0
5,GO LIVER REGENERATION,0.01427,-0.13815,-0.24424,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0174,-0.1383,-0.18425,1,0
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.022501,-0.13856,-0.17282,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.022501,-0.13866,-0.18191,1,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.017977,-0.13877,-0.16584,1,0
5,GO REGULATION OF IMMUNE RESPONSE,0.01918,-0.13889,-0.13298,1,0
5,GO CELL MATRIX ADHESION,0.013344,-0.1389,-0.20359,1,0
5,GO RESPONSE TO HORMONE,0.0025586,-0.13898,-0.14251,1,0
5,GO DEFENSE RESPONSE TO BACTERIUM,0.027136,-0.13912,-0.14282,1,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.029747,-0.13919,-0.17476,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0019312,-0.13921,-0.18162,1,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.023222,-0.13925,-0.20225,1,0
5,GO REGULATION OF ENDOCYTOSIS,0.016296,-0.13927,-0.12635,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0016396,-0.13929,-0.12974,1,0
5,GO ARTERY DEVELOPMENT,0.012053,-0.1394,-0.17411,1,0
5,GO MACROPHAGE MIGRATION,0.015254,-0.13955,-0.20765,1,0
5,GO RESPONSE TO CYTOKINE,0.0088198,-0.13965,-0.16969,1,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.028854,-0.13966,-0.2007,1,0
5,GO MYELOID LEUKOCYTE MIGRATION,0.0068665,-0.13995,-0.1846,1,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.01684,-0.14002,-0.20604,1,0
5,GO RESPONSE TO HEAT,0.010505,-0.14006,-0.13879,1,0
5,GO VACUOLE ORGANIZATION,0.0049293,-0.14008,-0.14745,1,0
5,GO SCHWANN CELL DEVELOPMENT,0.015767,-0.14038,-0.14201,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.022501,-0.14047,-0.13125,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.017977,-0.14051,-0.18471,1,0
5,GO LIPID LOCALIZATION,0.0029959,-0.1406,-0.17247,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.025507,-0.14073,-0.21226,1,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.0022699,-0.14077,-0.16701,1,0
5,GO RESPONSE TO OXIDATIVE STRESS,0.0019312,-0.1408,-0.17231,1,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0042393,-0.14088,-0.11808,1,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.01918,-0.14089,-0.17961,1,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.01684,-0.14095,-0.16466,1,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.004403,-0.14106,-0.11948,1,0
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.016296,-0.1411,-0.16103,1,0
5,GO ADAPTIVE IMMUNE RESPONSE,0.027983,-0.14111,-0.17712,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.028854,-0.1414,-0.15331,1,0
5,GO REGULATION OF MAPK CASCADE,0.0071194,-0.14152,-0.15465,1,0
5,GO CELL SUBSTRATE ADHESION,0.012053,-0.14156,-0.19567,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.021799,-0.14195,-0.20905,1,0
5,GO MUSCLE SYSTEM PROCESS,0.0012773,-0.14211,-0.15718,1,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0059338,-0.1422,-0.18972,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.027983,-0.14224,-0.15272,1,0
5,GO RESPONSE TO RETINOIC ACID,0.0076503,-0.14225,-0.18795,1,0
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0042393,-0.14243,-0.14323,1,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.0028806,-0.14262,-0.17982,1,0
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0047478,-0.14296,-0.17764,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0082164,-0.14306,-0.18074,1,0
5,GO NIK NF KAPPAB SIGNALING,0.021799,-0.14306,-0.16488,1,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0174,-0.14343,-0.18003,1,0
5,GO RESPONSE TO PH,0.01684,-0.14346,-0.23281,1,0
5,GO OXALATE TRANSPORT,0.0138,-0.14349,-0.26714,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY,0.0010786,-0.14359,-0.13851,1,0
5,GO CELLULAR RESPONSE TO LIPID,0.0031154,-0.14367,-0.16398,1,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.01918,-0.14384,-0.12142,1,0
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.015767,-0.14391,-0.1752,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.025507,-0.1441,-0.20157,1,0
5,GO REGULATION OF LIPASE ACTIVITY,0.0023626,-0.14479,-0.18355,1,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.0088198,-0.1448,-0.18028,1,0
5,GO COPII COATED VESICLE CARGO LOADING,0.010505,-0.14529,-0.18824,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.019808,-0.14544,-0.19882,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0055117,-0.14553,-0.14762,1,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.010505,-0.14558,-0.19473,1,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.025507,-0.14562,-0.13091,1,0
5,GO RESPONSE TO OXYGEN LEVELS,0.0011741,-0.14579,-0.17763,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.015254,-0.14604,-0.18997,1,0
5,GO RRNA METHYLATION,0.01857,-0.14633,-0.18997,1,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.014755,-0.1464,-0.16372,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.011255,-0.14647,-0.17985,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0073805,-0.14655,-0.14,1,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0079288,-0.14657,-0.19041,1,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.015767,-0.14713,-0.18963,1,0
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0082164,-0.14717,-0.13647,1,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.019808,-0.14741,-0.17606,1,0
5,GO MUSCLE CONTRACTION,0.0022699,-0.14745,-0.15181,1,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0047478,-0.14747,-0.17349,1,0
5,GO REGULATION OF LIPID TRANSPORT,0.011648,-0.14775,-0.16926,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0068665,-0.14797,-0.16057,1,0
5,GO CARBOHYDRATE METABOLIC PROCESS,0.0013321,-0.14802,-0.15623,1,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.011648,-0.14914,-0.15476,1,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.016296,-0.14916,-0.16702,1,0
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.0051169,-0.1492,-0.16293,1,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0088198,-0.14931,-0.18624,1,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0088198,-0.14942,-0.17187,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.005311,-0.14971,-0.16485,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.010874,-0.1499,-0.17842,1,0
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0017799,-0.15022,-0.16001,1,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0037806,-0.15055,-0.18669,1,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0138,-0.15068,-0.18006,1,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0021804,-0.15073,-0.1842,1,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0021804,-0.15087,-0.18091,1,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.021799,-0.1509,-0.168,1,0
5,GO RESPONSE TO STEROL,0.023222,-0.15102,-0.20655,1,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.028854,-0.15112,-0.16565,1,0
5,GO INTERFERON GAMMA PRODUCTION,0.023963,-0.15135,-0.14465,1,0
5,GO LYTIC VACUOLE ORGANIZATION,0.020453,-0.15143,-0.18314,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0063849,-0.15172,-0.17671,1,0
5,GO INTERACTION WITH HOST,0.015767,-0.15176,-0.18939,1,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.020453,-0.1518,-0.17915,1,0
5,GO REGULATION OF VASCULAR PERMEABILITY,0.01857,-0.15193,-0.19858,1,0
5,GO REGULATION OF BIOMINERALIZATION,0.01857,-0.15205,-0.17862,1,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0076503,-0.15232,-0.18411,1,0
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0017799,-0.15286,-0.18193,1,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.01427,-0.15297,-0.1702,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.011255,-0.15332,-0.16225,1,0
5,GO CHOLESTEROL EFFLUX,0.01684,-0.15335,-0.18179,1,0
5,GO L AMINO ACID TRANSPORT,0.0091361,-0.15364,-0.18386,1,0
5,GO IMMUNE EFFECTOR PROCESS,0.0138,-0.15382,-0.16468,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.022501,-0.15397,-0.17824,1,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.022501,-0.15417,-0.23245,1,0
5,GO RESPONSE TO STARVATION,0.016296,-0.15427,-0.13934,1,0
5,GO GENITALIA DEVELOPMENT,0.01857,-0.15439,-0.16218,1,0
5,GO RESPONSE TO DRUG,0.0019312,-0.15445,-0.18933,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0033675,-0.15467,-0.18684,1,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.010874,-0.15477,-0.15897,1,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.01857,-0.15486,-0.17602,1,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0029959,-0.15512,-0.18797,1,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.028854,-0.15515,-0.17098,1,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0020112,-0.15553,-0.17199,1,0
5,GO REGULATION OF MUSCLE CONTRACTION,0.01247,-0.1558,-0.13846,1,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0045725,-0.15582,-0.19623,1,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.023222,-0.15627,-0.17917,1,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0032392,-0.15642,-0.14244,1,0
5,GO PROTEIN FOLDING,0.0019312,-0.15676,-0.17419,1,0
5,GO RESPONSE TO ACID CHEMICAL,0.010146,-0.15679,-0.14493,1,0
5,GO REGULATION OF ATP METABOLIC PROCESS,0.0076503,-0.15693,-0.13608,1,0
5,GO FATTY ACID TRANSPORT,0.0036381,-0.15712,-0.17609,1,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.015767,-0.15727,-0.17703,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.0042393,-0.15784,-0.1568,1,0
5,GO SELECTIVE AUTOPHAGY,0.012053,-0.15796,-0.16002,1,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.0010336,-0.15802,-0.17953,1,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0091361,-0.15861,-0.18253,1,0
5,GO ACTIN FILAMENT BASED MOVEMENT,0.023222,-0.15867,-0.15168,1,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0017799,-0.15926,-0.22342,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.01918,-0.15949,-0.19535,1,0
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.01918,-0.15951,-0.22888,1,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0037806,-0.15973,-0.15984,1,0
5,GO REGULATION OF MACROPHAGE MIGRATION,0.01427,-0.15989,-0.18568,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.0012773,-0.16016,-0.19775,1,0
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0010336,-0.16029,-0.14779,1,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0045725,-0.16032,-0.17213,1,0
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.019808,-0.16081,-0.20269,1,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00083347,-0.16116,-0.17594,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.028854,-0.16147,-0.1496,1,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0017799,-0.16148,-0.19184,1,0
5,GO REGENERATION,0.0079288,-0.16182,-0.18938,1,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.014755,-0.16185,-0.15268,1,0
5,GO REGULATION OF OSSIFICATION,0.010146,-0.16204,-0.17756,1,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0091361,-0.16224,-0.23186,1,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.021117,-0.16248,-0.13728,1,0
5,GO REGULATION OF BLOOD PRESSURE,0.0138,-0.16261,-0.14308,1,0
5,GO FEAR RESPONSE,0.0091361,-0.16266,-0.18712,1,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0015095,-0.16272,-0.23242,1,0
5,GO COPII COATED VESICLE BUDDING,0.0015733,-0.16355,-0.18918,1,0
5,GO STEROL HOMEOSTASIS,0.023963,-0.16393,-0.17907,1,0
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.0035004,-0.16396,-0.20144,1,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.02631,-0.16425,-0.16165,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.015254,-0.16433,-0.13471,1,0
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0017084,-0.16438,-0.15816,1,0
5,GO PYRUVATE METABOLIC PROCESS,0.0016396,-0.16469,-0.19585,1,0
5,GO MYELOID LEUKOCYTE ACTIVATION,0.0042393,-0.16469,-0.19739,1,0
5,GO TRNA MODIFICATION,0.015254,-0.16473,-0.16967,1,0
5,GO GOLGI VESICLE BUDDING,0.0011741,-0.16488,-0.18968,1,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.0138,-0.16502,-0.13619,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0035004,-0.16507,-0.20841,1,0
5,GO PLATELET MORPHOGENESIS,0.027983,-0.16521,-0.15844,1,0
5,GO TRNA PROCESSING,0.013344,-0.16527,-0.15985,1,0
5,GO RESPONSE TO BACTERIUM,0.0036381,-0.16531,-0.18939,1,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0055117,-0.16549,-0.21667,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.023963,-0.16563,-0.23275,1,0
5,GO RESPONSE TO PEPTIDOGLYCAN,0.028854,-0.16567,-0.19644,1,0
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0094624,-0.1657,-0.19201,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0036381,-0.16584,-0.22517,1,0
5,GO ESTROGEN METABOLIC PROCESS,0.0057193,-0.16624,-0.20848,1,0
5,GO RESPONSE TO STEROID HORMONE,0.0036381,-0.16655,-0.17653,1,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.023222,-0.16663,-0.22853,1,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.023222,-0.16677,-0.16718,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.013344,-0.16681,-0.22357,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.01857,-0.16699,-0.19605,1,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0049293,-0.16708,-0.1741,1,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.022501,-0.16711,-0.14735,1,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.010505,-0.16739,-0.13733,1,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0051169,-0.16753,-0.20133,1,0
5,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.028854,-0.16767,-0.19107,1,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0017084,-0.16777,-0.19525,1,0
5,GO INTERACTION WITH SYMBIONT,0.0063849,-0.1682,-0.17777,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.01247,-0.16849,-0.17952,1,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.022501,-0.16878,-0.12388,1,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0071194,-0.1689,-0.21039,1,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0012247,-0.16891,-0.22359,1,0
5,GO VITAMIN TRANSPORT,0.015767,-0.16905,-0.20086,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.010505,-0.16907,-0.23398,1,0
5,GO VITAMIN METABOLIC PROCESS,0.0091361,-0.16908,-0.16569,1,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.014755,-0.16909,-0.20325,1,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.027983,-0.16916,-0.15894,1,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0040811,-0.1692,-0.2105,1,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0031154,-0.16922,-0.20383,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0027694,-0.1697,-0.18828,1,0
5,GO IRON ION HOMEOSTASIS,0.010874,-0.17002,-0.17246,1,0
5,GO BIOMINERALIZATION,0.0073805,-0.17005,-0.18187,1,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.01247,-0.17038,-0.22095,1,0
5,GO STEROID METABOLIC PROCESS,0.0036381,-0.17048,-0.17971,1,0
5,GO ELECTRON TRANSPORT CHAIN,0.0049293,-0.17093,-0.21078,1,0
5,GO INTERLEUKIN 8 PRODUCTION,0.019808,-0.17129,-0.21745,1,0
5,GO ICOSANOID METABOLIC PROCESS,0.020453,-0.17163,-0.20493,1,0
5,GO PHAGOCYTOSIS,0.0061556,-0.17166,-0.19819,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.021799,-0.17168,-0.14618,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0091361,-0.17177,-0.18902,1,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0138,-0.17216,-0.16999,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.01427,-0.17221,-0.22111,1,0
5,GO BLASTOCYST FORMATION,0.024724,-0.17239,-0.15033,1,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.021799,-0.17244,-0.25776,1,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.005311,-0.17261,-0.17744,1,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0129,-0.17291,-0.20955,1,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.025507,-0.17299,-0.19497,1,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0094624,-0.17305,-0.23648,1,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011254,-0.17314,-0.16843,1,0
5,GO REGULATION OF TISSUE REMODELING,0.0049293,-0.17359,-0.2338,1,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0049293,-0.17372,-0.16765,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.005311,-0.17392,-0.19648,1,0
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00073133,-0.17416,-0.18013,1,0
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0033675,-0.17416,-0.18564,1,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0138,-0.17426,-0.23893,1,0
5,GO CELLULAR RESPIRATION,0.0036381,-0.17432,-0.23744,1,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0025586,-0.17436,-0.20266,1,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.01857,-0.1744,-0.16751,1,0
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0036381,-0.17454,-0.19906,1,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0129,-0.17465,-0.18039,1,0
5,GO PLASMA MEMBRANE ORGANIZATION,0.0174,-0.17491,-0.15791,1,0
5,GO COENZYME A METABOLIC PROCESS,0.01918,-0.17494,-0.17675,1,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00039093,-0.17495,-0.20438,1,0
5,GO PROTEIN TETRAMERIZATION,0.0097991,-0.17496,-0.1379,1,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0057193,-0.17529,-0.16287,1,0
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.0088198,-0.17529,-0.19816,1,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.021117,-0.17541,-0.18296,1,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0031154,-0.17557,-0.16257,1,0
5,GO ORGANIC ACID METABOLIC PROCESS,0.00039093,-0.17577,-0.19145,1,0
5,GO RESPONSE TO DSRNA,0.01427,-0.17581,-0.17793,1,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.01857,-0.17598,-0.21841,1,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.010874,-0.17635,-0.16289,1,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0032392,-0.17643,-0.22052,1,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.0066217,-0.1765,-0.20296,1,0
5,GO BODY FLUID SECRETION,0.00079804,-0.17658,-0.24251,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0012247,-0.17676,-0.15918,1,0
5,GO MEMBRANE INVAGINATION,0.0049293,-0.17727,-0.2197,1,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0009903,-0.17733,-0.1863,1,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0071194,-0.17748,-0.22653,1,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00049043,-0.1777,-0.20274,1,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.0025586,-0.1783,-0.18492,1,0
5,GO TRNA METABOLIC PROCESS,0.0049293,-0.17833,-0.18272,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.012053,-0.17849,-0.16233,1,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.027136,-0.17855,-0.15919,1,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00090875,-0.17877,-0.17436,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0011254,-0.17877,-0.1851,1,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.00094871,-0.17908,-0.17783,1,0
5,GO URONIC ACID METABOLIC PROCESS,0.027983,-0.17913,-0.16684,1,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0049293,-0.17951,-0.21013,1,0
5,GO LIPID OXIDATION,0.0012773,-0.18016,-0.22287,1,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0010336,-0.18064,-0.22507,1,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0068665,-0.18068,-0.17132,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.010505,-0.18072,-0.20719,1,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0071194,-0.18079,-0.16789,1,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0021804,-0.18102,-0.18198,1,0
5,GO RESPONSE TO CAMP,0.016296,-0.18107,-0.16848,1,0
5,GO CELLULAR RESPONSE TO DRUG,0.0035004,-0.18138,-0.17503,1,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0057193,-0.18156,-0.22779,1,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.011648,-0.18166,-0.21803,1,0
5,GO SPERM EGG RECOGNITION,0.0024588,-0.18169,-0.20804,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.014755,-0.18174,-0.24708,1,0
5,GO POLYOL METABOLIC PROCESS,0.0009903,-0.18219,-0.17616,1,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.01684,-0.18242,-0.27531,1,0
5,GO REGULATION OF LIPID LOCALIZATION,0.0026621,-0.1831,-0.20163,1,0
5,GO APOPTOTIC CELL CLEARANCE,0.01247,-0.18329,-0.2786,1,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0051169,-0.18339,-0.28365,1,0
5,GO MACROPHAGE CHEMOTAXIS,0.0129,-0.18388,-0.21955,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.015254,-0.18393,-0.23527,1,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0040811,-0.18406,-0.28592,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0061556,-0.18457,-0.17315,1,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0055117,-0.1849,-0.18267,1,0
5,GO HORMONE METABOLIC PROCESS,0.0088198,-0.1851,-0.16807,1,0
5,GO SEQUESTERING OF CALCIUM ION,0.0055117,-0.18531,-0.17491,1,0
5,GO POSITIVE CHEMOTAXIS,0.01918,-0.18541,-0.1939,1,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.01427,-0.1858,-0.23939,1,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.017977,-0.18605,-0.18936,1,0
5,GO FATTY ACID BETA OXIDATION,0.0018542,-0.18607,-0.2317,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.012053,-0.18623,-0.24262,1,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.01684,-0.1867,-0.2058,1,0
5,GO CHEMOSENSORY BEHAVIOR,0.0061556,-0.18685,-0.22888,1,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0063849,-0.18699,-0.14852,1,0
5,GO STEROL METABOLIC PROCESS,0.019808,-0.18707,-0.16571,1,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0031154,-0.18716,-0.20445,1,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0040811,-0.18744,-0.25498,1,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.010146,-0.18777,-0.26114,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0071194,-0.18793,-0.23864,1,0
5,GO RESPONSE TO GONADOTROPIN,0.01918,-0.18815,-0.22924,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,0.004403,-0.18826,-0.19255,1,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.016296,-0.18834,-0.20397,1,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.0059338,-0.18845,-0.2992,1,0
5,GO NCRNA CATABOLIC PROCESS,0.024724,-0.18879,-0.17837,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.017977,-0.18885,-0.1897,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0049293,-0.18892,-0.24574,1,0
5,GO DIOL METABOLIC PROCESS,0.01684,-0.18911,-0.21355,1,0
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.011648,-0.18916,-0.19385,1,0
5,GO FATTY ACID METABOLIC PROCESS,0.00046881,-0.18949,-0.21575,1,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0088198,-0.18986,-0.19385,1,0
5,GO BONE RESORPTION,0.0174,-0.18998,-0.20515,1,0
5,GO OXIDATIVE PHOSPHORYLATION,0.004403,-0.19008,-0.24376,1,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0013889,-0.19025,-0.2282,1,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.013344,-0.1907,-0.20771,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0073805,-0.19071,-0.22989,1,0
5,GO BLOOD VESSEL REMODELING,0.0079288,-0.19074,-0.25262,1,0
5,GO KERATINOCYTE MIGRATION,0.022501,-0.19104,-0.20174,1,0
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0045725,-0.19105,-0.23266,1,0
5,GO TRANSLATIONAL TERMINATION,0.0037806,-0.19143,-0.27058,1,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0020112,-0.19158,-0.21724,1,0
5,GO ATP METABOLIC PROCESS,0.00087036,-0.19167,-0.18522,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.00073133,-0.19167,-0.19363,1,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.023963,-0.19182,-0.3193,1,0
5,GO STEROL TRANSPORT,0.0045725,-0.19197,-0.22327,1,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.028854,-0.19223,-0.19228,1,0
5,GO RESPONSE TO CHEMOKINE,0.0016396,-0.19223,-0.19823,1,0
5,GO VESICLE CARGO LOADING,0.0031154,-0.19252,-0.22489,1,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.019808,-0.19283,-0.23253,1,0
5,GO AUTOPHAGY OF NUCLEUS,0.025507,-0.19313,-0.20226,1,0
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0022699,-0.19314,-0.17895,1,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00037344,-0.19316,-0.19116,1,0
5,GO NUCLEOSIDE SALVAGE,0.01427,-0.19347,-0.24465,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0031154,-0.19353,-0.18117,1,0
5,GO T CELL APOPTOTIC PROCESS,0.01918,-0.19359,-0.19408,1,0
5,GO PENTOSE METABOLIC PROCESS,0.01684,-0.19384,-0.26269,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.014755,-0.194,-0.21096,1,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00032527,-0.19403,-0.18322,1,0
5,GO LIPID CATABOLIC PROCESS,0.00042822,-0.19433,-0.20438,1,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.027136,-0.19484,-0.28612,1,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.0066217,-0.19484,-0.23082,1,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.021799,-0.19492,-0.17699,1,0
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.0042393,-0.19504,-0.21446,1,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.015254,-0.19507,-0.21515,1,0
5,GO POSITIVE REGULATION OF BINDING,0.005311,-0.19546,-0.14817,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.0039282,-0.1955,-0.28606,1,0
5,GO ZYMOGEN ACTIVATION,0.012053,-0.19555,-0.32551,1,0
5,GO ACETYL COA METABOLIC PROCESS,0.0063849,-0.19558,-0.22468,1,0
5,GO TISSUE REGENERATION,0.0073805,-0.19559,-0.23752,1,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0049293,-0.1957,-0.19061,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0045725,-0.19616,-0.24944,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00073133,-0.19635,-0.19643,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.00025768,-0.19637,-0.19216,1,0
5,GO TRABECULA FORMATION,0.027983,-0.19661,-0.29013,1,0
5,GO TISSUE MIGRATION,0.0042393,-0.19677,-0.21762,1,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0061556,-0.19717,-0.22107,1,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.025507,-0.19754,-0.22438,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0066217,-0.19764,-0.23352,1,0
5,GO ALCOHOL METABOLIC PROCESS,0.0032392,-0.19779,-0.18213,1,0
5,GO AORTA DEVELOPMENT,0.021799,-0.19802,-0.19905,1,0
5,GO METHIONINE METABOLIC PROCESS,0.023222,-0.1981,-0.17219,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.02631,-0.19812,-0.18065,1,0
5,GO ENTRY INTO HOST,0.0085133,-0.19822,-0.26096,1,0
5,GO RRNA MODIFICATION,0.012053,-0.19823,-0.22642,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0036381,-0.19889,-0.22437,1,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00039093,-0.19903,-0.19744,1,0
5,GO LIPID STORAGE,0.023222,-0.19918,-0.19589,1,0
5,GO TISSUE REMODELING,0.019808,-0.1996,-0.20407,1,0
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0049293,-0.19979,-0.17123,1,0
5,GO NCRNA METABOLIC PROCESS,0.0028806,-0.19985,-0.21024,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.029747,-0.20007,-0.20058,1,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.004403,-0.20015,-0.19412,1,0
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.011255,-0.20066,-0.22288,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0085133,-0.20072,-0.26284,1,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023222,-0.20136,-0.22857,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0061556,-0.20137,-0.21162,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.0057193,-0.20138,-0.25737,1,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0055117,-0.20144,-0.25218,1,0
5,GO PIGMENT GRANULE MATURATION,0.014755,-0.20146,-0.27397,1,0
5,GO ORGANIC ACID CATABOLIC PROCESS,0.00040918,-0.20179,-0.23856,1,0
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.005311,-0.20191,-0.24886,1,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0057193,-0.20201,-0.24834,1,0
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.021799,-0.20224,-0.22741,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0035004,-0.20246,-0.22624,1,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.005311,-0.20256,-0.24904,1,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.023222,-0.20273,-0.24089,1,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.005311,-0.20274,-0.23628,1,0
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0026621,-0.20274,-0.2259,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.022501,-0.20304,-0.21775,1,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.021799,-0.20313,-0.2121,1,0
5,GO REGULATION OF BONE DEVELOPMENT,0.015767,-0.20328,-0.21145,1,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00073133,-0.20347,-0.22941,1,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.0039282,-0.20351,-0.29064,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0071194,-0.20382,-0.20134,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.00044809,-0.20397,-0.20879,1,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.0094624,-0.20402,-0.29317,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.020453,-0.20414,-0.29031,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0063849,-0.20414,-0.23383,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0088198,-0.20434,-0.22707,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0085133,-0.20442,-0.23523,1,0
5,GO SPHINGOID METABOLIC PROCESS,0.0079288,-0.20465,-0.22613,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0097991,-0.20477,-0.22657,1,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.0026621,-0.20502,-0.26875,1,0
5,GO T CELL MEDIATED IMMUNITY,0.013344,-0.20527,-0.25169,1,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0091361,-0.20534,-0.25241,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0051169,-0.20544,-0.21287,1,0
5,GO OXIDATION REDUCTION PROCESS,0.00034064,-0.20568,-0.20474,1,0
5,GO PLATELET DEGRANULATION,0.0059338,-0.20574,-0.26689,1,0
5,GO DRUG METABOLIC PROCESS,0.0094624,-0.20576,-0.23607,1,0
5,GO MITOCHONDRIAL TRANSLATION,0.0032392,-0.2058,-0.26346,1,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0015095,-0.20615,-0.23069,1,0
5,GO REGULATION OF FIBRINOLYSIS,0.0020943,-0.20654,-0.36616,1,0
5,GO INTRACELLULAR LIPID TRANSPORT,0.010874,-0.20661,-0.20029,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.027983,-0.20671,-0.25697,1,0
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0138,-0.20677,-0.22791,1,0
5,GO PROTEIN DEGLYCOSYLATION,0.01918,-0.20727,-0.24404,1,0
5,GO CARDIAC CELL DEVELOPMENT,0.0033675,-0.20736,-0.19737,1,0
5,GO POLYOL TRANSPORT,0.019808,-0.20823,-0.24803,1,0
5,GO RESPONSE TO CADMIUM ION,0.021799,-0.20829,-0.23862,1,0
5,GO PEPTIDE CATABOLIC PROCESS,0.0045725,-0.20867,-0.23483,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.01857,-0.209,-0.19878,1,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.004403,-0.20926,-0.24694,1,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.021117,-0.20944,-0.26379,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.017977,-0.20948,-0.23934,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.01918,-0.20981,-0.21865,1,0
5,GO ENDOTHELIAL CELL MIGRATION,0.0061556,-0.20995,-0.22358,1,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.011255,-0.21031,-0.16203,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.019808,-0.21031,-0.27312,1,0
5,GO PROTEASOME ASSEMBLY,0.0059338,-0.21072,-0.23282,1,0
5,GO RESPONSE TO CORTICOSTEROID,0.0029959,-0.21093,-0.24266,1,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.00046881,-0.21093,-0.22564,1,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.01684,-0.21124,-0.239,1,0
5,GO SYNCYTIUM FORMATION,0.0049293,-0.2119,-0.26821,1,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0010786,-0.21208,-0.21272,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0029959,-0.21215,-0.23232,1,0
5,GO RESPONSE TO PROTOZOAN,0.0129,-0.21221,-0.23264,1,0
5,GO TRANSLATIONAL ELONGATION,0.0049293,-0.21238,-0.25005,1,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.020453,-0.21238,-0.17873,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0085133,-0.21269,-0.3154,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.011255,-0.21296,-0.25633,1,0
5,GO COLLAGEN CATABOLIC PROCESS,0.010505,-0.21303,-0.24417,1,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0024588,-0.21312,-0.20587,1,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0042393,-0.21327,-0.24252,1,0
5,GO ETHER METABOLIC PROCESS,0.01427,-0.21347,-0.25833,1,0
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.01247,-0.21349,-0.21748,1,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0066217,-0.21352,-0.21278,1,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.00011376,-0.21356,-0.21856,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,0.0027694,-0.21382,-0.21161,1,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.011648,-0.214,-0.25002,1,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.024724,-0.21416,-0.20624,1,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.017977,-0.21441,-0.22835,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.01427,-0.21447,-0.2586,1,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0037806,-0.21469,-0.25372,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0066217,-0.21486,-0.2674,1,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0088198,-0.21501,-0.26675,1,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0063849,-0.21502,-0.22666,1,0
5,GO DETOXIFICATION,0.0045725,-0.21527,-0.23357,1,0
5,GO ANION HOMEOSTASIS,0.029747,-0.21552,-0.18408,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00042822,-0.21592,-0.27305,1,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.019808,-0.216,-0.19677,1,0
5,GO DE NOVO PROTEIN FOLDING,0.0049293,-0.21632,-0.21582,1,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0071194,-0.21638,-0.2464,1,0
5,GO FOLIC ACID METABOLIC PROCESS,0.01918,-0.21644,-0.21601,1,0
5,GO NCRNA PROCESSING,0.0051169,-0.21652,-0.22034,1,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0049293,-0.21653,-0.2371,1,0
5,GO SUPEROXIDE METABOLIC PROCESS,0.023963,-0.21665,-0.18307,1,0
5,GO REGULATION OF AMYLOID BETA FORMATION,0.01427,-0.21692,-0.22319,1,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.00053648,-0.21799,-0.2579,1,0
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.00034064,-0.21804,-0.22974,1,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0017799,-0.21805,-0.19414,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.015254,-0.21814,-0.26901,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.010874,-0.21822,-0.26766,1,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.005311,-0.21845,-0.19826,1,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.014755,-0.21869,-0.23965,1,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.012053,-0.21881,-0.18947,1,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0040811,-0.2189,-0.25324,1,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00039093,-0.21934,-0.25928,1,0
5,GO REGULATION OF CELL MATRIX ADHESION,0.0076503,-0.22014,-0.24799,1,0
5,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0097991,-0.22017,-0.24692,1,0
5,GO ORGAN INDUCTION,0.005311,-0.22029,-0.24175,1,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.005311,-0.2205,-0.27118,1,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0013889,-0.22073,-0.22398,1,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0055117,-0.22088,-0.28947,1,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028806,-0.22102,-0.29264,1,0
5,GO PROTEIN TARGETING,0.00040918,-0.22104,-0.22505,1,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0055117,-0.22184,-0.22499,1,0
5,GO GLIAL CELL MIGRATION,0.020453,-0.22192,-0.19832,1,0
5,GO BONE REMODELING,0.0088198,-0.2223,-0.2361,1,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.014755,-0.22277,-0.19217,1,0
5,GO KERATAN SULFATE METABOLIC PROCESS,0.0071194,-0.22288,-0.26506,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00058654,-0.22292,-0.23655,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0076503,-0.22328,-0.22856,1,0
5,GO FUCOSYLATION,0.0076503,-0.22348,-0.25771,1,0
5,GO FIBROBLAST PROLIFERATION,0.017977,-0.22428,-0.24284,1,0
5,GO AMINO ACID IMPORT,0.0026621,-0.22438,-0.26719,1,0
5,GO HAIR FOLLICLE MATURATION,0.011648,-0.22455,-0.31181,1,0
5,GO RESPONSE TO INTERFERON GAMMA,0.010874,-0.22457,-0.28895,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.010505,-0.2246,-0.25135,1,0
5,GO CELL CELL RECOGNITION,0.0015733,-0.22491,-0.22588,1,0
5,GO RNA 5 END PROCESSING,0.0025586,-0.22538,-0.24873,1,0
5,GO TRICARBOXYLIC ACID CYCLE,0.0082164,-0.22594,-0.2471,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0037806,-0.22657,-0.19408,1,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0088198,-0.22661,-0.28935,1,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.01684,-0.22666,-0.21878,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0071194,-0.22679,-0.21136,1,0
5,GO ACUTE INFLAMMATORY RESPONSE,0.0040811,-0.22729,-0.28345,1,0
5,GO PEPTIDE METABOLIC PROCESS,0.0001255,-0.22737,-0.23273,1,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0010786,-0.22772,-0.24217,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.00025768,-0.22781,-0.22723,1,0
5,GO PROTEIN AUTOPROCESSING,0.0088198,-0.22792,-0.23487,1,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0033675,-0.22845,-0.19411,1,0
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00079804,-0.22847,-0.22351,1,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0051169,-0.22861,-0.32156,1,0
5,GO RESPONSE TO INTERLEUKIN 4,0.0082164,-0.22865,-0.19797,1,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0138,-0.23006,-0.28404,1,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0079288,-0.23061,-0.24745,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0059338,-0.23091,-0.25177,1,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.0049293,-0.23096,-0.26518,1,0
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.011255,-0.23133,-0.25853,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0023626,-0.23136,-0.28849,1,0
5,GO RESPONSE TO ESTROGEN,0.00079804,-0.23158,-0.2675,1,0
5,GO NADP METABOLIC PROCESS,0.021117,-0.23186,-0.22529,1,0
5,GO KETONE BIOSYNTHETIC PROCESS,0.0129,-0.23236,-0.22382,1,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.0011254,-0.23246,-0.31827,1,0
5,GO MYOBLAST FUSION,0.0021804,-0.23302,-0.32175,1,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.011648,-0.2333,-0.2806,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.016296,-0.23363,-0.22767,1,0
5,GO FATTY ACID CATABOLIC PROCESS,0.00064092,-0.23396,-0.23684,1,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0049293,-0.23399,-0.30845,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.0061556,-0.23414,-0.31446,1,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.0091361,-0.23436,-0.25984,1,0
5,GO CD40 SIGNALING PATHWAY,0.00083347,-0.23469,-0.33854,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0068665,-0.23481,-0.26579,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.023963,-0.23498,-0.23865,1,0
5,GO RESPONSE TO SALT,0.0055117,-0.23553,-0.18743,1,0
5,GO RNA CATABOLIC PROCESS,0.0013889,-0.23577,-0.217,1,0
5,GO MONONUCLEAR CELL MIGRATION,0.0015733,-0.236,-0.26839,1,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0021804,-0.23614,-0.2494,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0022699,-0.23702,-0.27317,1,0
5,GO REGULATION OF LIPID STORAGE,0.0063849,-0.23706,-0.24858,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0049293,-0.2372,-0.27093,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.027983,-0.23724,-0.16743,1,0
5,GO SEQUESTERING OF TRIGLYCERIDE,0.028854,-0.2373,-0.30148,1,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0068665,-0.23749,-0.24642,1,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0073805,-0.23763,-0.43066,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0027694,-0.23775,-0.22836,1,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.014755,-0.23789,-0.25293,1,0
5,GO THIOESTER METABOLIC PROCESS,0.0013889,-0.23828,-0.24414,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0174,-0.23831,-0.19933,1,0
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0020112,-0.23846,-0.24095,1,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00056099,-0.23861,-0.26007,1,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.00073133,-0.23876,-0.27629,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0039282,-0.23884,-0.23137,1,0
5,GO REGULATION OF BONE REMODELING,0.010146,-0.23909,-0.24889,1,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0076503,-0.23917,-0.30321,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0012247,-0.23932,-0.2933,1,0
5,GO RESPONSE TO DEXAMETHASONE,0.0016396,-0.23953,-0.30177,1,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0039282,-0.24011,-0.23899,1,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0063849,-0.24043,-0.27933,1,0
5,GO PEROXISOME ORGANIZATION,0.00046881,-0.24064,-0.24555,1,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.016296,-0.24107,-0.22003,1,0
5,GO HOMOTYPIC CELL CELL ADHESION,0.021799,-0.24177,-0.2317,1,0
5,GO RRNA METABOLIC PROCESS,0.0020112,-0.24288,-0.2705,1,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0020943,-0.24356,-0.29874,1,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.013344,-0.24358,-0.25848,1,0
5,GO REGULATION OF MYOBLAST FUSION,0.0082164,-0.24369,-0.36033,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0063849,-0.24426,-0.26241,1,0
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.01857,-0.24468,-0.26167,1,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0055117,-0.245,-0.22229,1,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0019312,-0.24523,-0.24078,1,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0032392,-0.24551,-0.2644,1,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0073805,-0.24573,-0.23083,1,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.015254,-0.246,-0.24675,1,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.0012773,-0.24605,-0.27957,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0025586,-0.24619,-0.23407,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.010874,-0.24634,-0.26776,1,0
5,GO COLLAGEN METABOLIC PROCESS,0.019808,-0.24639,-0.26545,1,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0024588,-0.24643,-0.22466,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0063849,-0.24644,-0.28457,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0063849,-0.24644,-0.26904,1,0
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0029959,-0.24655,-0.28688,1,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0013321,-0.24658,-0.24908,1,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0025586,-0.24692,-0.28611,1,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0015733,-0.24706,-0.26777,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.021117,-0.24756,-0.22972,1,0
5,GO KETONE BODY METABOLIC PROCESS,0.014755,-0.24771,-0.28927,1,0
5,GO HEART TRABECULA FORMATION,0.017977,-0.24788,-0.31079,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0019312,-0.24845,-0.25568,1,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0020943,-0.24866,-0.33908,1,0
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.004403,-0.24898,-0.21152,1,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.028854,-0.2491,-0.21293,1,0
5,GO ALDITOL METABOLIC PROCESS,0.0071194,-0.2491,-0.26178,1,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.00079804,-0.24911,-0.2787,1,0
5,GO ADHESION OF SYMBIONT TO HOST,0.027136,-0.2495,-0.28537,1,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0015733,-0.24963,-0.28351,1,0
5,GO HEXOSE CATABOLIC PROCESS,0.0037806,-0.2498,-0.29659,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0012247,-0.25011,-0.2126,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0055117,-0.25057,-0.26773,1,0
5,GO PHOSPHOLIPID EFFLUX,0.015254,-0.2511,-0.2962,1,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0082164,-0.25118,-0.29137,1,0
5,GO BICARBONATE TRANSPORT,0.004403,-0.25145,-0.22448,1,0
5,GO ETHANOL METABOLIC PROCESS,0.029747,-0.25147,-0.27358,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.016296,-0.25283,-0.37449,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.0066217,-0.25285,-0.3472,1,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019808,-0.25287,-0.30912,1,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.0138,-0.25325,-0.32071,1,0
5,GO NECROTIC CELL DEATH,0.0061556,-0.25346,-0.2601,1,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.027983,-0.25355,-0.32351,1,0
5,GO RESPONSE TO AMINE,0.0010336,-0.25366,-0.30023,1,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.022501,-0.25392,-0.31415,1,0
5,GO LACTATION,0.011648,-0.25403,-0.22275,1,0
5,GO LIPID IMPORT INTO CELL,0.013344,-0.25442,-0.24542,1,0
5,GO ONE CARBON METABOLIC PROCESS,0.00058654,-0.25502,-0.26313,1,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.015254,-0.25522,-0.24719,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0024588,-0.25537,-0.27548,1,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.011648,-0.25614,-0.27689,1,0
5,GO DETECTION OF BIOTIC STIMULUS,0.0085133,-0.25621,-0.30079,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0061556,-0.25655,-0.28264,1,0
5,GO MITOCHONDRIAL DEPOLARIZATION,0.027136,-0.25685,-0.25697,1,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00058654,-0.25697,-0.29025,1,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.01427,-0.25698,-0.25555,1,0
5,GO EMBRYO IMPLANTATION,0.021117,-0.25741,-0.21929,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0066217,-0.25768,-0.27506,1,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0042393,-0.25831,-0.28217,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.016296,-0.2585,-0.27274,1,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.01918,-0.25922,-0.26507,1,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.01857,-0.25944,-0.26141,1,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.029747,-0.2597,-0.29686,1,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.023222,-0.25993,-0.3597,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0037806,-0.25995,-0.29419,1,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.01857,-0.25995,-0.26801,1,0
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.015254,-0.2601,-0.23858,1,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0049293,-0.26042,-0.26068,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.01918,-0.26082,-0.21318,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00053648,-0.26091,-0.35401,1,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.025507,-0.26106,-0.23841,1,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.0042393,-0.2619,-0.24851,1,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.022501,-0.26201,-0.34537,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.004403,-0.26204,-0.34427,1,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.0017799,-0.26205,-0.27144,1,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.0138,-0.26222,-0.30056,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0071194,-0.26333,-0.28375,1,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0085133,-0.26343,-0.33142,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0029959,-0.26383,-0.39065,1,0
5,GO PEPTIDYL HISTIDINE MODIFICATION,0.0079288,-0.26417,-0.24147,1,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.015767,-0.26418,-0.29883,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0026621,-0.26481,-0.27942,1,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0024588,-0.26485,-0.27832,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0024588,-0.26493,-0.24283,1,0
5,GO RIBOSOME BIOGENESIS,0.0027694,-0.26559,-0.28268,1,0
5,GO PEROXISOMAL TRANSPORT,0.00034064,-0.26561,-0.26724,1,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.015254,-0.26584,-0.24787,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0012773,-0.26599,-0.29099,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066217,-0.26637,-0.31211,1,0
5,GO TRNA 5 LEADER REMOVAL,0.0037806,-0.26689,-0.27143,1,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0040811,-0.26798,-0.24774,1,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.004403,-0.26853,-0.39692,1,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0039282,-0.26872,-0.25594,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.027136,-0.26877,-0.35152,1,0
5,GO SECRETION BY TISSUE,0.019808,-0.26926,-0.23852,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.0066217,-0.26933,-0.31383,1,0
5,GO RESPONSE TO GROWTH HORMONE,0.0055117,-0.26935,-0.266,1,0
5,GO TRNA 5 END PROCESSING,0.0061556,-0.26995,-0.23348,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0018542,-0.27004,-0.38531,1,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0011741,-0.27035,-0.29238,1,0
5,GO CELL REDOX HOMEOSTASIS,0.0032392,-0.27037,-0.27185,1,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0026621,-0.27119,-0.29503,1,0
5,GO GLOMERULUS DEVELOPMENT,0.021117,-0.27131,-0.25071,1,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0079288,-0.27184,-0.25595,1,0
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0026621,-0.27186,-0.30944,1,0
5,GO TYPE 2 IMMUNE RESPONSE,0.0094624,-0.27242,-0.3013,1,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0028806,-0.27262,-0.33283,1,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0088198,-0.27269,-0.2501,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0019312,-0.27299,-0.30139,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.01684,-0.27316,-0.28196,1,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0020943,-0.27334,-0.29003,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0061556,-0.27337,-0.42948,1,0
5,GO STEROID ESTERIFICATION,0.011648,-0.27382,-0.32932,1,0
5,GO RESPONSE TO ACIDIC PH,0.015767,-0.27417,-0.33384,1,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.027983,-0.27625,-0.2561,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,0.0025586,-0.27635,-0.25997,1,0
5,GO TETRAPYRROLE METABOLIC PROCESS,0.0009903,-0.27648,-0.28354,1,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.00079804,-0.27672,-0.30073,1,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0055117,-0.27682,-0.24859,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.01427,-0.2774,-0.29055,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0063849,-0.27858,-0.26522,1,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0028806,-0.27893,-0.31993,1,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00035669,-0.27929,-0.29514,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0016396,-0.2796,-0.31731,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.028854,-0.28025,-0.31332,1,0
5,GO ZYMOGEN INHIBITION,0.016296,-0.28057,-0.32006,1,0
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.01684,-0.28081,-0.40382,1,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0085133,-0.2809,-0.35179,1,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.021799,-0.28112,-0.29597,1,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0138,-0.28136,-0.29378,1,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0055117,-0.28149,-0.27116,1,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.005311,-0.2819,-0.26199,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0013321,-0.2819,-0.33112,1,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.0061556,-0.28197,-0.2503,1,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0015095,-0.28239,-0.35682,1,0
5,GO NADPH REGENERATION,0.029747,-0.2824,-0.25042,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0028806,-0.28244,-0.30725,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.012053,-0.28245,-0.28791,1,0
5,GO VASODILATION,0.010505,-0.28246,-0.29392,1,0
5,GO RESPONSE TO TESTOSTERONE,0.027136,-0.28251,-0.20477,1,0
5,GO FIBRINOLYSIS,0.0088198,-0.28281,-0.37702,1,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0047478,-0.28282,-0.29329,1,0
5,GO RETINOL METABOLIC PROCESS,0.0061556,-0.28327,-0.28107,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0057193,-0.28383,-0.3598,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0039282,-0.28401,-0.26489,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.021117,-0.28435,-0.21922,1,0
5,GO MONOCYTE CHEMOTAXIS,0.0012247,-0.28527,-0.31065,1,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0039282,-0.28679,-0.29778,1,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.015767,-0.28788,-0.2317,1,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.01918,-0.28812,-0.23459,1,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0066217,-0.28908,-0.32933,1,0
5,GO ACTIN MEDIATED CELL CONTRACTION,0.0091361,-0.2894,-0.20969,1,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0013889,-0.28984,-0.32269,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0015733,-0.29049,-0.32972,1,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.010146,-0.29062,-0.34024,1,0
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.016296,-0.29149,-0.34335,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.013344,-0.29216,-0.26014,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.0097991,-0.29228,-0.35727,1,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0094624,-0.29264,-0.27983,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0051169,-0.29281,-0.34278,1,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.0018542,-0.29282,-0.2949,1,0
5,GO PROTEIN REFOLDING,0.010874,-0.29369,-0.24734,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0045725,-0.29421,-0.37812,1,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.014755,-0.29422,-0.31257,1,0
5,GO RESPONSE TO PAIN,0.01427,-0.29447,-0.32584,1,0
5,GO STEROL IMPORT,0.0051169,-0.29467,-0.31451,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0029959,-0.29468,-0.36415,1,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.016296,-0.29529,-0.38365,1,0
5,GO AEROBIC RESPIRATION,0.00053648,-0.29545,-0.28621,1,0
5,GO SUPEROXIDE ANION GENERATION,0.021117,-0.29546,-0.31622,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0045725,-0.29578,-0.29309,1,0
5,GO RESPONSE TO TUMOR CELL,0.0047478,-0.29713,-0.32141,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0018542,-0.29722,-0.27796,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0085133,-0.29724,-0.35638,1,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.00069995,-0.29732,-0.37329,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0018542,-0.29733,-0.26188,1,0
5,GO COPPER ION HOMEOSTASIS,0.0047478,-0.29756,-0.29083,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0029959,-0.29781,-0.29497,1,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0085133,-0.29851,-0.4156,1,0
5,GO TOLERANCE INDUCTION,0.0138,-0.29855,-0.42747,1,0
5,GO RELAXATION OF MUSCLE,0.0063849,-0.2987,-0.30379,1,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0018542,-0.2992,-0.38339,1,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0138,-0.29949,-0.35229,1,0
5,GO AMINO ACID ACTIVATION,0.005311,-0.30185,-0.27909,1,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0129,-0.30212,-0.3214,1,0
5,GO AMP METABOLIC PROCESS,0.0028806,-0.30218,-0.39385,1,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.024724,-0.30269,-0.34594,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0020112,-0.3028,-0.33015,1,0
5,GO RESPONSE TO ZINC ION,0.019808,-0.3034,-0.27083,1,0
5,GO NAD METABOLIC PROCESS,0.0042393,-0.30429,-0.32704,1,0
5,GO RESPONSE TO INTERLEUKIN 12,0.0018542,-0.30448,-0.29363,1,0
5,GO PROTEIN OXIDATION,0.0024588,-0.30473,-0.36261,1,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.027983,-0.30478,-0.25893,1,0
5,GO GLYCINE METABOLIC PROCESS,0.0076503,-0.30574,-0.3656,1,0
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.019808,-0.30575,-0.35096,1,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0068665,-0.30583,-0.37232,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00037344,-0.30592,-0.38084,1,0
5,GO ANIMAL ORGAN REGENERATION,0.0035004,-0.30594,-0.26459,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0017799,-0.3063,-0.38004,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.023963,-0.30778,-0.40278,1,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0019312,-0.30843,-0.35449,1,0
5,GO ACTIN FILAMENT SEVERING,0.0088198,-0.30859,-0.36362,1,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.021117,-0.31039,-0.30573,1,0
5,GO OLIGOPEPTIDE TRANSPORT,0.02631,-0.31069,-0.34269,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.0055117,-0.31115,-0.30559,1,0
5,GO PIGMENT METABOLIC PROCESS,0.0019312,-0.31131,-0.28019,1,0
5,GO CERAMIDE CATABOLIC PROCESS,0.0082164,-0.31133,-0.33735,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0051169,-0.31148,-0.31961,1,0
5,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0028806,-0.31151,-0.32794,1,0
5,GO CYCLOOXYGENASE PATHWAY,0.0066217,-0.31298,-0.4759,1,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.016296,-0.31344,-0.34223,1,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0059338,-0.31352,-0.28307,1,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0071194,-0.31401,-0.37145,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.020453,-0.31488,-0.37044,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0017084,-0.31669,-0.31027,1,0
5,GO RESPONSE TO CAFFEINE,0.01247,-0.31687,-0.26105,1,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.011648,-0.31766,-0.26195,1,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0082164,-0.3182,-0.33427,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0022699,-0.31874,-0.41181,1,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.013344,-0.31911,-0.36519,1,0
5,GO NEURON REMODELING,0.020453,-0.31938,-0.26961,1,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0082164,-0.31995,-0.40637,1,0
5,GO MATURATION OF 5 8S RRNA,0.0039282,-0.32042,-0.30637,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.004403,-0.32089,-0.29816,1,0
5,GO GLUCOSE CATABOLIC PROCESS,0.0049293,-0.32207,-0.31683,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0088198,-0.32304,-0.35259,1,0
5,GO MATURATION OF SSU RRNA,0.0013321,-0.32322,-0.35726,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0138,-0.32347,-0.32301,1,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0138,-0.32442,-0.36934,1,0
5,GO NEUROBLAST DIVISION,0.0085133,-0.3248,-0.34053,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.015767,-0.32556,-0.32713,1,0
5,GO PROTEIN TRIMERIZATION,0.0055117,-0.32642,-0.39058,1,0
5,GO INCLUSION BODY ASSEMBLY,0.0088198,-0.32675,-0.30075,1,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.010146,-0.32692,-0.31898,1,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0082164,-0.32695,-0.37603,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0028806,-0.32705,-0.30195,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.012053,-0.32783,-0.37547,1,0
5,GO RIBOSOME ASSEMBLY,0.0019312,-0.32839,-0.39264,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0012773,-0.32851,-0.42055,1,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0013889,-0.3293,-0.4258,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.022501,-0.32969,-0.33649,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.02631,-0.3298,-0.3156,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.014755,-0.33021,-0.31023,1,0
5,GO RESPONSE TO THYROID HORMONE,0.0036381,-0.33039,-0.35348,1,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0079288,-0.33186,-0.34865,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0073805,-0.33337,-0.44764,1,0
5,GO COPPER ION TRANSPORT,0.00076401,-0.33368,-0.35417,1,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.0024588,-0.33386,-0.32361,1,0
5,GO EOSINOPHIL MIGRATION,0.010505,-0.33439,-0.35298,1,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0025586,-0.33611,-0.41318,1,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0032392,-0.33615,-0.38181,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0013321,-0.33679,-0.33871,1,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.025507,-0.33821,-0.33605,1,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0020943,-0.33842,-0.3532,1,0
5,GO PULMONARY VALVE DEVELOPMENT,0.0085133,-0.33906,-0.44411,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0027694,-0.33919,-0.29639,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00066983,-0.33925,-0.38221,1,0
5,GO NADH METABOLIC PROCESS,0.0055117,-0.33931,-0.30395,1,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0040811,-0.33995,-0.36109,1,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0129,-0.34324,-0.29501,1,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.023963,-0.34404,-0.27593,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0055117,-0.34406,-0.37,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0068665,-0.34426,-0.42769,1,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0032392,-0.34439,-0.37372,1,0
5,GO MATURE B CELL DIFFERENTIATION,0.0031154,-0.34573,-0.38484,1,0
5,GO EOSINOPHIL CHEMOTAXIS,0.016296,-0.34631,-0.37395,1,0
5,GO VIRAL GENE EXPRESSION,0.0011254,-0.34669,-0.36266,1,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.004403,-0.34777,-0.30435,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.028854,-0.34781,-0.33602,1,0
5,GO TROPHOBLAST CELL MIGRATION,0.0035004,-0.34858,-0.41388,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.004403,-0.34949,-0.39568,1,0
5,GO GTP METABOLIC PROCESS,0.010146,-0.35007,-0.28044,1,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0129,-0.35044,-0.35976,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.016296,-0.35079,-0.28905,1,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0028806,-0.35083,-0.4121,1,0
5,GO VIRAL TRANSLATION,0.0040811,-0.35084,-0.35947,1,0
5,GO RESPONSE TO MANGANESE ION,0.0033675,-0.35146,-0.30636,1,0
5,GO INTERLEUKIN 13 PRODUCTION,0.022501,-0.35222,-0.29962,1,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00087036,-0.3525,-0.38783,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0174,-0.35266,-0.41721,1,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.015767,-0.35482,-0.36766,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0082164,-0.35543,-0.49894,1,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0057193,-0.35741,-0.37404,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0037806,-0.35747,-0.38734,1,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0039282,-0.35757,-0.30291,1,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0028806,-0.35807,-0.36292,1,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0061556,-0.3585,-0.37224,1,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0032392,-0.35952,-0.32477,1,0
5,GO EPOXYGENASE P450 PATHWAY,0.012053,-0.35986,-0.32282,1,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.023222,-0.36036,-0.49081,1,0
5,GO MATURATION OF LSU RRNA,0.0042393,-0.36049,-0.36079,1,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.00051298,-0.36073,-0.40001,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00073133,-0.36303,-0.44402,1,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0071194,-0.36329,-0.37339,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00064092,-0.36395,-0.42234,1,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0059338,-0.36542,-0.31262,1,0
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0085133,-0.36712,-0.35314,1,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0016396,-0.36747,-0.40527,1,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0018542,-0.36894,-0.42932,1,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.023222,-0.36969,-0.45038,1,0
5,GO GALACTOSE METABOLIC PROCESS,0.0061556,-0.37003,-0.43534,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0049293,-0.3712,-0.43243,1,0
5,GO PLASMINOGEN ACTIVATION,0.0013321,-0.37143,-0.42412,1,0
5,GO L PHENYLALANINE METABOLIC PROCESS,0.0059338,-0.37145,-0.34762,1,0
5,GO CYSTEINE METABOLIC PROCESS,0.0018542,-0.37157,-0.49911,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0010336,-0.37307,-0.43717,1,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.017977,-0.37413,-0.35263,1,0
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0031154,-0.37814,-0.36323,1,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.012053,-0.37864,-0.50395,1,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0025586,-0.37984,-0.35692,1,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.023222,-0.38129,-0.47587,1,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00090875,-0.3813,-0.38886,1,0
5,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0040811,-0.38131,-0.37595,1,0
5,GO HEPARIN METABOLIC PROCESS,0.0059338,-0.38172,-0.3958,1,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0085133,-0.38256,-0.36632,1,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.029747,-0.38287,-0.33489,1,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.023222,-0.38452,-0.3903,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.023963,-0.38648,-0.43769,1,0
5,GO MEMBRANE RAFT ORGANIZATION,0.0036381,-0.38858,-0.48969,1,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.01427,-0.38905,-0.32587,1,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0049293,-0.38905,-0.34059,1,0
5,GO GLYCINE TRANSPORT,0.0071194,-0.39098,-0.43175,1,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0012247,-0.39224,-0.40091,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00090875,-0.39324,-0.42576,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.013344,-0.39332,-0.39711,1,0
5,GO FATTY ACID HOMEOSTASIS,0.0031154,-0.39378,-0.39069,1,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0055117,-0.39411,-0.44035,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.015767,-0.39678,-0.32924,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0037806,-0.39769,-0.61472,1,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.001448,-0.39839,-0.40487,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00076401,-0.39921,-0.45731,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.0047478,-0.39932,-0.39603,1,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.00064092,-0.39947,-0.36966,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.021117,-0.39952,-0.37773,1,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.0021804,-0.40018,-0.53371,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015733,-0.40124,-0.38385,1,0
5,GO NEGATIVE REGULATION OF CELL KILLING,0.028854,-0.40208,-0.43655,1,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.00069995,-0.40434,-0.3905,1,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.0032392,-0.40701,-0.43632,1,0
5,GO ARGININE METABOLIC PROCESS,0.0025586,-0.40868,-0.43042,1,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.01857,-0.40989,-0.36419,1,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00069995,-0.41213,-0.40428,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010336,-0.41345,-0.53145,1,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0026621,-0.4137,-0.51852,1,0
5,GO HEME METABOLIC PROCESS,0.0011254,-0.41517,-0.42234,1,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0024588,-0.41658,-0.40907,1,0
5,GO CYTOPLASMIC TRANSLATION,0.0031154,-0.41663,-0.3839,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0012247,-0.41976,-0.47038,1,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.01427,-0.41979,-0.4481,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00051298,-0.42025,-0.40997,1,0
5,GO TRANSLATIONAL INITIATION,0.00083347,-0.42174,-0.40908,1,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0049293,-0.42411,-0.50232,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.005311,-0.42739,-0.44097,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.012053,-0.42834,-0.35194,1,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0035004,-0.43392,-0.48957,1,0
5,GO RESPONSE TO COPPER ION,0.0036381,-0.43904,-0.41017,1,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.0027694,-0.44258,-0.44734,1,0
5,GO BIOLOGICAL PHASE,0.0040811,-0.44373,-0.54918,1,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.010146,-0.44476,-0.45555,1,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0025586,-0.44559,-0.43829,1,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0082164,-0.44672,-0.39213,1,0
5,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.023222,-0.45058,-0.41448,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0017084,-0.45179,-0.42844,1,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.00025768,-0.45622,-0.47862,1,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.0039282,-0.45626,-0.5617,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.022501,-0.45713,-0.39389,1,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.015254,-0.45732,-0.52905,1,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.0071194,-0.45864,-0.4611,1,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.0017084,-0.46247,-0.47544,1,0
5,GO PROTEIN HYDROXYLATION,0.0079288,-0.46507,-0.42594,1,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.010146,-0.46675,-0.45366,1,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.01427,-0.4712,-0.38354,1,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0079288,-0.47374,-0.4277,1,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.027136,-0.47555,-0.39509,1,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0013321,-0.47658,-0.55823,1,0
5,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.0011254,-0.47743,-0.53989,1,0
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0013889,-0.48301,-0.5985,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0022699,-0.48561,-0.46414,1,0
5,GO MUCUS SECRETION,0.0174,-0.48575,-0.57571,1,0
5,GO NUCLEOTIDE SALVAGE,0.00058654,-0.48903,-0.51988,1,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0029959,-0.4963,-0.50853,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00046881,-0.50413,-0.4657,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00083347,-0.51845,-0.54128,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.025507,-0.52265,-0.43038,1,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0045725,-0.53995,-0.5538,1,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00037344,-0.5477,-0.49536,1,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00061317,-0.54917,-0.57889,1,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.01918,-0.56243,-0.39143,1,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0032392,-0.5634,-0.55739,1,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0012247,-0.57089,-0.58593,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00073133,-0.61238,-0.58704,1,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.0021804,-0.62104,-0.54743,1,0
5,GO MEMBRANE RAFT ASSEMBLY,0.0012773,-0.64486,-0.84096,1,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.054786,0.43829,0.30206,0,1
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.43736,0.35956,0.11367,0,1
5,GO PARENTAL BEHAVIOR,0.046281,0.34703,0.39898,0,1
5,GO OTIC VESICLE DEVELOPMENT,0.1643,0.33599,0.19483,0,1
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.093006,0.32324,0.26663,0,1
5,GO CAMP BIOSYNTHETIC PROCESS,0.095374,0.30529,0.2011,0,1
5,GO GDP METABOLIC PROCESS,0.057895,0.3019,0.22908,0,1
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.093006,0.29031,0.26068,0,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.057895,0.27216,0.3674,0,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.093006,0.25568,0.17509,0,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.050383,0.25209,0.38412,0,1
5,GO V D J RECOMBINATION,0.041252,0.24395,0.24874,0,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18733,0.24131,0.14391,0,1
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.079775,0.23012,0.17117,0,1
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.036694,0.22866,0.16521,0,1
5,GO REGULATION OF GLUTAMATE SECRETION,0.081867,0.22842,0.32981,0,1
5,GO RESPONSE TO HYDROXYUREA,0.037792,0.22618,0.20224,0,1
5,GO MEGAKARYOCYTE DEVELOPMENT,0.095374,0.21351,0.21272,0,1
5,GO HISTONE H3 K9 TRIMETHYLATION,0.030665,0.20358,0.16797,0,1
5,GO KINETOCHORE ASSEMBLY,0.042464,0.20161,0.17642,0,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.051817,0.18633,0.14923,0,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.030665,0.18305,0.18063,0,1
5,GO MICROTUBULE SEVERING,0.11061,0.18273,0.14243,0,1
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.031606,0.17057,0.19158,0,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.079775,0.16993,0.12997,0,1
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.032572,0.1694,0.16223,0,1
5,GO REGULATION OF CHROMATIN BINDING,0.095374,0.1561,0.11884,0,1
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.090686,0.14116,0.093935,0,1
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.1161,0.13842,0.10341,0,1
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.073757,0.13363,0.11159,0,1
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.11892,0.12133,0.11245,0,1
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.26536,0.11745,0.08714,0,1
5,GO G2 DNA DAMAGE CHECKPOINT,0.20828,0.11423,0.089997,0,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.030665,0.10906,0.1461,0,1
5,GO DNA REPLICATION CHECKPOINT,0.090686,0.10768,0.10712,0,1
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.038917,0.10603,0.10123,0,1
5,GO P BODY ASSEMBLY,0.1643,0.08932,0.073933,0,1
5,GO RECOMBINATIONAL REPAIR,0.030665,0.079256,0.085478,0,1
5,GO DNA REPLICATION,0.050383,0.057029,0.070388,0,1
5,GO CARDIOBLAST PROLIFERATION,0.030665,0.49998,0.46637,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.10533,0.39417,0.28589,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.095374,0.36692,0.32183,0,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.053284,0.34768,0.33794,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.054786,0.34341,0.30361,0,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.033564,0.33408,0.35197,0,0
5,GO SIALYLATION,0.10277,0.32257,0.21654,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.051817,0.32059,0.37331,0,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.044978,0.31851,0.24746,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.036694,0.31746,0.22784,0,0
5,GO VOCALIZATION BEHAVIOR,0.053284,0.3145,0.36526,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.21712,0.28573,0.3115,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.12179,0.27965,0.23428,0,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.21267,0.27407,0.14026,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.068115,0.27221,0.26606,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.19971,0.26978,0.19486,0,0
5,GO CELL MIGRATION IN HINDBRAIN,0.043706,0.26818,0.23799,0,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.048983,0.26624,0.3498,0,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.044978,0.26491,0.29779,0,0
5,GO RESPONSE TO UV B,0.1794,0.26276,0.14835,0,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.04007,0.26212,0.20688,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.12472,0.26082,0.26562,0,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.090686,0.25926,0.27443,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10794,0.255,0.19645,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.034581,0.24636,0.27928,0,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.10794,0.24476,0.23409,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.20396,0.24003,0.12173,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.7772,0.23868,0.065911,0,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.077726,0.23693,0.15753,0,0
5,GO OTIC VESICLE MORPHOGENESIS,0.60042,0.23651,0.070357,0,0
5,GO ESTROUS CYCLE,0.10794,0.23408,0.19624,0,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.19971,0.23322,0.17127,0,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.55922,0.23277,0.051048,0,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.041252,0.23021,0.42394,0,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.073757,0.2281,0.18232,0,0
5,GO POSTSYNAPSE ASSEMBLY,0.23088,0.22654,0.17599,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.18334,0.22647,0.42889,0,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.088413,0.22498,0.17265,0,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.031606,0.21961,0.20679,0,0
5,GO NEURON PROJECTION ARBORIZATION,0.030665,0.21746,0.21201,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.077726,0.21681,0.25941,0,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.19971,0.21585,0.19012,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.27583,0.21562,0.15655,0,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.062834,0.21523,0.20123,0,0
5,GO ATRIAL SEPTUM DEVELOPMENT,0.15361,0.2151,0.1889,0,0
5,GO REGULATION OF RECEPTOR CLUSTERING,0.24039,0.21428,0.21269,0,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.15361,0.2138,0.23702,0,0
5,GO CARDIAC CHAMBER FORMATION,0.068115,0.2131,0.34468,0,0
5,GO NATURAL KILLER CELL PROLIFERATION,0.16798,0.21112,0.15051,0,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.059504,0.20887,0.17222,0,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.069955,0.20738,0.2164,0,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.24525,0.20394,0.2064,0,0
5,GO LIMB BUD FORMATION,0.21267,0.20368,0.16338,0,0
5,GO NEURAL NUCLEUS DEVELOPMENT,0.048983,0.20347,0.20058,0,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.36968,0.20346,0.15417,0,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.13699,0.202,0.14059,0,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.15361,0.2011,0.20172,0,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.10794,0.20001,0.23533,0,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.093006,0.19793,0.17357,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.21712,0.19741,0.23791,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.093006,0.1965,0.19501,0,0
5,GO CARDIAC VENTRICLE FORMATION,0.035624,0.1965,0.42611,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.63434,0.19533,0.056921,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.064555,0.19496,0.14633,0,0
5,GO LATERAL MESODERM DEVELOPMENT,0.39593,0.19478,0.070783,0,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.19139,0.19406,0.1389,0,0
5,GO FORELIMB MORPHOGENESIS,0.030665,0.19405,0.21205,0,0
5,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.32642,0.19395,0.088159,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.34454,0.19266,0.14435,0,0
5,GO MEMBRANE FISSION,0.11333,0.19219,0.18652,0,0
5,GO GAMMA DELTA T CELL ACTIVATION,0.1402,0.19114,0.19257,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.1161,0.1899,0.18251,0,0
5,GO CELL JUNCTION MAINTENANCE,0.11333,0.18906,0.17122,0,0
5,GO NEURON RECOGNITION,0.30323,0.18903,0.10738,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.06115,0.18811,0.16973,0,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.17173,0.18765,0.18609,0,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.057895,0.18513,0.16324,0,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.064555,0.18322,0.26968,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.088413,0.18315,0.20337,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.47371,0.18229,0.10622,0,0
5,GO EPITHELIAL CELL MATURATION,0.13384,0.18164,0.17409,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.14347,0.18117,0.25819,0,0
5,GO CARDIOBLAST DIFFERENTIATION,0.13699,0.18073,0.16598,0,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.36329,0.18053,0.063952,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.13384,0.17961,0.14117,0,0
5,GO THYROID GLAND DEVELOPMENT,0.52728,0.17875,0.048758,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.037792,0.17769,0.18744,0,0
5,GO DENDRITE SELF AVOIDANCE,0.11892,0.1761,0.16897,0,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.079775,0.17601,0.13877,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.45171,0.17343,0.0438,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.1161,0.17279,0.18157,0,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.11333,0.17144,0.15044,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.064555,0.17128,0.15793,0,0
5,GO GANGLION DEVELOPMENT,0.36329,0.1703,0.20289,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.15712,0.17013,0.14949,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.50395,0.16997,0.06063,0,0
5,GO DNA DEMETHYLATION,0.090686,0.16965,0.12492,0,0
5,GO ENDOCARDIUM DEVELOPMENT,0.12771,0.16735,0.21701,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.33843,0.16575,0.28609,0,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.090686,0.16571,0.1746,0,0
5,GO VIRAL LATENCY,0.13699,0.16492,0.17312,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.47371,0.16401,0.12015,0,0
5,GO PENILE ERECTION,0.45171,0.16394,0.15954,0,0
5,GO CELL FATE SPECIFICATION,0.038917,0.16376,0.16756,0,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.12771,0.16332,0.11777,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.2356,0.16271,0.20716,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.25516,0.1619,0.1341,0,0
5,GO RESPONSE TO ACETYLCHOLINE,0.10533,0.16189,0.15921,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.25017,0.16158,0.24264,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.066316,0.161,0.12296,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.20828,0.16083,0.18,0,0
5,GO DENDRITE MORPHOGENESIS,0.037792,0.1606,0.16219,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.16068,0.16014,0.22635,0,0
5,GO SPERM AXONEME ASSEMBLY,0.11892,0.15932,0.17879,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.43029,0.15889,0.11067,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.38927,0.1588,0.12741,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.06115,0.15819,0.139,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.53518,0.1578,0.07796,0,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.19139,0.15779,0.11598,0,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.07572,0.15724,0.12,0,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.046281,0.15718,0.17364,0,0
5,GO NEURAL TUBE PATTERNING,0.031606,0.15708,0.17267,0,0
5,GO ERYTHROCYTE MATURATION,0.37614,0.1569,0.071538,0,0
5,GO REGULATION OF STEM CELL DIVISION,0.088413,0.1547,0.16065,0,0
5,GO RETROGRADE AXONAL TRANSPORT,0.042464,0.15468,0.19564,0,0
5,GO INSEMINATION,0.2356,0.15437,0.10415,0,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.042464,0.15425,0.17775,0,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.22622,0.15232,0.11811,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.1643,0.15183,0.17009,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.31468,0.15165,0.13579,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.58378,0.1499,0.051902,0,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.077726,0.14976,0.1693,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.17553,0.1495,0.19281,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.095374,0.1494,0.13509,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.07572,0.1493,0.16429,0,0
5,GO PROTEIN DEMETHYLATION,0.047616,0.14854,0.13497,0,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.12771,0.14808,0.16203,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.32052,0.14784,0.12069,0,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.26536,0.1461,0.088041,0,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.068115,0.14555,0.15364,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.32642,0.14554,0.159,0,0
5,GO NEURON PROJECTION ORGANIZATION,0.15017,0.14471,0.094561,0,0
5,GO DECIDUALIZATION,0.6516,0.14464,0.027378,0,0
5,GO COPULATION,0.12472,0.14432,0.15147,0,0
5,GO REGULATION OF TRANSPOSITION,0.36968,0.14399,0.091727,0,0
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.30323,0.14364,0.065297,0,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.2356,0.14352,0.14995,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.084004,0.14299,0.12501,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.41634,0.14274,0.088629,0,0
5,GO NOTCH RECEPTOR PROCESSING,0.038917,0.14269,0.20091,0,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.12771,0.14251,0.098916,0,0
5,GO FOREBRAIN MORPHOGENESIS,0.6603,0.14249,0.0084652,0,0
5,GO PYRAMIDAL NEURON DIFFERENTIATION,0.54313,0.14176,0.072363,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.19139,0.13989,0.13957,0,0
5,GO GROOMING BEHAVIOR,0.43736,0.13965,0.144,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.15017,0.1391,0.1553,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.38927,0.13889,0.10059,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.10533,0.1385,0.13399,0,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.09779,0.13766,0.1577,0,0
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.40267,0.13759,0.10499,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.19552,0.13702,0.17672,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.29761,0.13685,0.17438,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.13699,0.13633,0.098919,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING,0.12179,0.13626,0.10725,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.12179,0.1362,0.16923,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.35697,0.1357,0.18663,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.088413,0.13456,0.12837,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.1161,0.13436,0.11755,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.056323,0.13408,0.15019,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.068115,0.13376,0.13334,0,0
5,GO MYOTUBE CELL DEVELOPMENT,0.19139,0.13373,0.096606,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.073757,0.13352,0.13439,0,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.6516,0.13319,0.051105,0,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.37614,0.13272,0.10469,0,0
5,GO MECHANOSENSORY BEHAVIOR,0.53518,0.13241,0.14735,0,0
5,GO MICROTUBULE BUNDLE FORMATION,0.059504,0.13101,0.15973,0,0
5,GO TRANSPOSITION,0.32052,0.13084,0.10458,0,0
5,GO NUCLEOSOME ASSEMBLY,0.035624,0.13039,0.14769,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.056323,0.12989,0.10115,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.62578,0.12979,0.050571,0,0
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.60883,0.12915,0.049628,0,0
5,GO EMBRYONIC EYE MORPHOGENESIS,0.20396,0.1291,0.10017,0,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.26536,0.12878,0.1224,0,0
5,GO CENTRIOLE CENTRIOLE COHESION,0.093006,0.12815,0.1499,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.1161,0.12809,0.11006,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.42328,0.12796,0.062065,0,0
5,GO AXONEME ASSEMBLY,0.11333,0.12765,0.19095,0,0
5,GO GANGLIOSIDE METABOLIC PROCESS,0.20828,0.12737,0.10865,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.066316,0.12711,0.11863,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.22622,0.12682,0.17728,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.12179,0.12613,0.12455,0,0
5,GO FAT CELL PROLIFERATION,0.28117,0.12553,0.14946,0,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.21267,0.1251,0.14835,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.15017,0.12455,0.081121,0,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.38267,0.12447,0.11839,0,0
5,GO DNA DEAMINATION,0.7772,0.12436,-0.0063627,0,0
5,GO CELLULAR RESPONSE TO VITAMIN D,0.55115,0.12372,0.017437,0,0
5,GO LONG TERM SYNAPTIC POTENTIATION,0.2356,0.1235,0.085762,0,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.13074,0.12239,0.18257,0,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.55115,0.12201,0.084764,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.37614,0.12146,0.069064,0,0
5,GO HISTONE EXCHANGE,0.077726,0.12066,0.10019,0,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.27056,0.12038,0.14098,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.33843,0.11914,0.1047,0,0
5,GO POSTSYNAPSE ORGANIZATION,0.24525,0.11914,0.093091,0,0
5,GO REGULATION OF FIBROBLAST MIGRATION,0.38267,0.11906,0.037872,0,0
5,GO SPERM CAPACITATION,0.16798,0.11876,0.086149,0,0
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.45898,0.11854,0.103,0,0
5,GO RESPONSE TO DOPAMINE,0.062834,0.1181,0.12053,0,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.24525,0.11806,0.14665,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.64294,0.11785,0.077277,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.27056,0.11781,0.16663,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.09779,0.1176,0.11343,0,0
5,GO REGULATION OF SYNAPSE MATURATION,0.81436,0.11749,0.0050872,0,0
5,GO REGULATION OF NEURON MIGRATION,0.14679,0.11742,0.12203,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.48118,0.1173,0.066161,0,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.38927,0.11707,0.074293,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.04007,0.11672,0.23774,0,0
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.10794,0.1165,0.15345,0,0
5,GO DNA DEALKYLATION,0.16798,0.11527,0.080992,0,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.093006,0.11497,0.10378,0,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.80503,0.11478,0.017099,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.090686,0.11473,0.10422,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.35697,0.11459,0.093469,0,0
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.16068,0.11436,0.098094,0,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.11061,0.11428,0.10395,0,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.13074,0.11418,0.11572,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.27583,0.11367,0.072483,0,0
5,GO QUINONE METABOLIC PROCESS,0.8614,0.11354,-0.071529,0,0
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.20828,0.11323,0.12097,0,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.41634,0.11312,0.055276,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.10794,0.11288,0.29299,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.70447,0.11225,0.096073,0,0
5,GO ERYTHROCYTE DEVELOPMENT,0.30323,0.11208,0.0577,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.6516,0.11187,0.055146,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.21712,0.1118,0.10345,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.086186,0.11173,0.19062,0,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.97598,0.11118,-0.062832,0,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.4445,0.11053,0.038816,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.17553,0.11032,0.14575,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.21712,0.10949,0.16859,0,0
5,GO HISTONE H3 K9 METHYLATION,0.081867,0.1094,0.12525,0,0
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.41634,0.10923,0.049449,0,0
5,GO RETINA LAYER FORMATION,0.29761,0.1089,0.14769,0,0
5,GO PANCREAS DEVELOPMENT,0.35697,0.10874,0.082193,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.40947,0.10818,0.038165,0,0
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.24039,0.10805,0.10897,0,0
5,GO DNA STRAND ELONGATION,0.10277,0.10781,0.090721,0,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.13699,0.10726,0.1268,0,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.18733,0.10702,0.17055,0,0
5,GO PERICARDIUM DEVELOPMENT,0.9952,0.10698,-0.014569,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.084004,0.10689,0.12946,0,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.12771,0.10668,0.0997,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.031606,0.10663,0.093999,0,0
5,GO PROSTATE GLAND MORPHOGENESIS,0.64294,0.10662,0.036935,0,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.15712,0.10645,0.19722,0,0
5,GO CELL CYCLE DNA REPLICATION,0.035624,0.10641,0.10306,0,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.051817,0.10635,0.15392,0,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.30892,0.10604,0.11425,0,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.37614,0.10597,0.049536,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.46631,0.10565,0.082408,0,0
5,GO SEGMENT SPECIFICATION,0.30892,0.10531,0.14297,0,0
5,GO SYNAPTIC VESICLE MATURATION,0.36329,0.10523,0.17044,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.050383,0.10505,0.11281,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.11333,0.10503,0.12127,0,0
5,GO MITRAL VALVE DEVELOPMENT,0.26536,0.10494,0.079819,0,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.40947,0.10476,0.017313,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.33239,0.10431,0.10308,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.51167,0.10401,0.087855,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.071835,0.10387,0.14846,0,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.88987,0.10384,0.002532,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.19971,0.10364,0.12867,0,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.47371,0.10182,0.075627,0,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.11892,0.1018,0.12388,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12179,0.10162,0.10643,0,0
5,GO APICAL PROTEIN LOCALIZATION,0.11892,0.10122,0.13099,0,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.1643,0.10106,0.14351,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.090686,0.10095,0.11018,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.34454,0.10088,0.078398,0,0
5,GO HISTONE UBIQUITINATION,0.034581,0.10043,0.092982,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.1161,0.10033,0.14912,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.54313,0.099981,0.079582,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.043706,0.099914,0.098314,0,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.20396,0.099712,0.08651,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.38927,0.099707,0.06894,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.58378,0.099401,0.028277,0,0
5,GO CENTROSOME DUPLICATION,0.048983,0.099056,0.12384,0,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.10025,0.098622,0.085301,0,0
5,GO MYOBLAST MIGRATION,0.68667,0.098323,0.018201,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.030665,0.098102,0.094404,0,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.62578,0.097732,0.068871,0,0
5,GO AXONAL FASCICULATION,0.52728,0.096564,0.055733,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.51167,0.096383,0.10978,0,0
5,GO PROTEIN ADP RIBOSYLATION,0.42328,0.096268,0.078158,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.047616,0.096122,0.074911,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.14679,0.095993,0.10346,0,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.28117,0.095962,0.12665,0,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.17553,0.095713,0.091765,0,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.48871,0.095626,0.030787,0,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.79572,0.0956,-0.019004,0,0
5,GO DNA REPLICATION INITIATION,0.18733,0.095553,0.073317,0,0
5,GO AXONAL TRANSPORT,0.066316,0.095515,0.12273,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.69555,0.094945,0.056609,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12472,0.094809,0.10598,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.19139,0.094599,0.10334,0,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.31468,0.094514,0.090575,0,0
5,GO NEURON MIGRATION,0.15361,0.094313,0.14243,0,0
5,GO STRIATUM DEVELOPMENT,0.56735,0.093805,0.029441,0,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.11061,0.093765,0.093472,0,0
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.57554,0.093196,0.03228,0,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.036694,0.092905,0.080763,0,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.69555,0.092839,0.0067854,0,0
5,GO DENDRITE DEVELOPMENT,0.10794,0.09272,0.10921,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.48871,0.092451,0.15123,0,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.12472,0.092398,0.076058,0,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.98559,0.092125,-0.031199,0,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.30892,0.092053,0.14867,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.20396,0.09199,0.06703,0,0
5,GO RECEPTOR CLUSTERING,0.32642,0.091862,0.08745,0,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.053284,0.091346,0.12044,0,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.14347,0.091337,0.098654,0,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.06115,0.091019,0.10529,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.14679,0.090749,0.13294,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.45171,0.090741,0.096541,0,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.43736,0.090497,0.047421,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.20828,0.089231,0.098598,0,0
5,GO OOGENESIS,0.33843,0.088721,0.051953,0,0
5,GO N GLYCAN PROCESSING,0.37614,0.088223,0.096078,0,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.53518,0.088036,0.057252,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.31468,0.087963,0.09688,0,0
5,GO PROGESTERONE METABOLIC PROCESS,0.6516,0.087954,-0.077242,0,0
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.53518,0.087398,0.037285,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.2356,0.087182,0.1426,0,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.20828,0.086875,0.083176,0,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.85194,0.086846,0.0074676,0,0
5,GO NUCLEUS LOCALIZATION,0.88036,0.086351,0.011804,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.64294,0.086246,0.13177,0,0
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.39593,0.086166,0.06246,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.36329,0.086087,0.035766,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.27056,0.085839,0.088892,0,0
5,GO SMOOTHENED SIGNALING PATHWAY,0.079775,0.085782,0.086169,0,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.31468,0.085779,0.11757,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.35072,0.085633,0.13651,0,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.53518,0.08475,0.0025305,0,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.31468,0.084559,0.071083,0,0
5,GO REPLICATION FORK PROCESSING,0.10277,0.08425,0.084639,0,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.26536,0.083996,0.11982,0,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.51944,0.083632,0.15589,0,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.12771,0.083628,0.080117,0,0
5,GO SHORT TERM MEMORY,0.40267,0.082982,0.10184,0,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.28658,0.082656,0.10896,0,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.19139,0.082608,0.10647,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.1402,0.082517,0.092437,0,0
5,GO VIRAL RNA GENOME REPLICATION,0.72243,0.082398,0.0072135,0,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.64294,0.082177,0.045504,0,0
5,GO DENDRITIC SPINE MAINTENANCE,0.40267,0.082154,0.05611,0,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.038917,0.082152,0.091051,0,0
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.28658,0.082106,0.095436,0,0
5,GO REGULATION OF MRNA PROCESSING,0.041252,0.081485,0.091841,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.19971,0.081097,0.099209,0,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.8614,0.081063,-0.062153,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.51944,0.080967,0.058775,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.19971,0.080355,0.054903,0,0
5,GO EMBRYONIC BODY MORPHOGENESIS,0.35072,0.080202,0.089674,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.2356,0.0801,0.067855,0,0
5,GO POSITIVE T CELL SELECTION,0.24039,0.080096,0.060787,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.38267,0.079945,0.12446,0,0
5,GO REGULATION OF DNA REPAIR,0.064555,0.079818,0.064368,0,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.13699,0.079791,0.098859,0,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.63434,0.079674,0.032616,0,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.30892,0.079611,0.058289,0,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.18334,0.079575,0.084285,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.80503,0.079545,-0.042968,0,0
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.36968,0.079401,0.10926,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.1794,0.079325,0.12682,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.056323,0.079204,0.087727,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.55922,0.079078,0.10157,0,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.36968,0.079035,0.040784,0,0
5,GO SYNAPTIC MEMBRANE ADHESION,0.68667,0.078793,0.048833,0,0
5,GO AXO DENDRITIC TRANSPORT,0.1402,0.078674,0.10392,0,0
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.55922,0.078594,0.030655,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.62578,0.078422,0.0331,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.39593,0.078363,0.03862,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.45171,0.078207,0.072225,0,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.60883,0.078142,0.0097487,0,0
5,GO NEURON PROJECTION REGENERATION,0.93762,0.077788,-0.0004998,0,0
5,GO ADHERENS JUNCTION ASSEMBLY,0.89939,0.077659,0.012889,0,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.30323,0.077656,0.14569,0,0
5,GO METENCEPHALON DEVELOPMENT,0.1402,0.077655,0.10839,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.14679,0.077392,0.10504,0,0
5,GO MICROTUBULE BASED MOVEMENT,0.084004,0.077289,0.074748,0,0
5,GO DENDRITIC SPINE DEVELOPMENT,0.24039,0.077199,0.074376,0,0
5,GO ACTIN CROSSLINK FORMATION,0.51167,0.076943,0.047021,0,0
5,GO CHROMATIN DISASSEMBLY,0.36329,0.076804,0.076757,0,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.18733,0.076739,0.095552,0,0
5,GO CHROMATIN REMODELING,0.030665,0.076656,0.07889,0,0
5,GO CELLULAR RESPONSE TO VITAMIN,0.30892,0.076416,0.040791,0,0
5,GO AMINE TRANSPORT,0.7588,0.07639,0.071564,0,0
5,GO CYTOPLASM ORGANIZATION,0.87087,0.076186,-0.0049885,0,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.35697,0.075899,0.054953,0,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.16068,0.075638,0.054243,0,0
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.22622,0.075566,0.082116,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.14679,0.075513,0.057937,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.10533,0.074944,0.085444,0,0
5,GO CHONDROCYTE PROLIFERATION,0.98559,0.074751,-0.051965,0,0
5,GO SEROTONIN SECRETION,0.4445,0.074626,0.1153,0,0
5,GO SECRETORY GRANULE LOCALIZATION,0.8331,0.074619,0.036791,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.84251,0.074462,-0.048444,0,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.45171,0.07432,0.047632,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.035624,0.074274,0.064848,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.030665,0.073872,0.10144,0,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.32642,0.073747,0.091348,0,0
5,GO RESPIRATORY SYSTEM PROCESS,0.42328,0.07324,0.083535,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.73147,0.073217,-0.12755,0,0
5,GO PH REDUCTION,0.37614,0.072397,0.040268,0,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.76799,0.072287,0.013873,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.15361,0.071972,0.09983,0,0
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.85194,0.071836,-0.014783,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.12771,0.071815,0.087674,0,0
5,GO RENAL FILTRATION,0.40947,0.071764,0.12466,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.88036,0.071501,-0.029229,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.32642,0.071429,0.04614,0,0
5,GO CRANIAL NERVE DEVELOPMENT,0.80503,0.07126,0.013572,0,0
5,GO ADULT LOCOMOTORY BEHAVIOR,0.7588,0.071108,0.037652,0,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.16068,0.071027,0.098537,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.1161,0.070972,0.10305,0,0
5,GO REGULATION OF MITOPHAGY,0.19552,0.070923,0.1003,0,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.16798,0.070898,0.053869,0,0
5,GO REPRODUCTIVE BEHAVIOR,0.74054,0.070485,0.02205,0,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.13074,0.07039,0.12628,0,0
5,GO MICROTUBULE ANCHORING,0.17173,0.07032,0.07473,0,0
5,GO OXIDATIVE DEMETHYLATION,0.14347,0.070277,0.091308,0,0
5,GO GLIAL CELL FATE COMMITMENT,0.32052,0.069887,0.20196,0,0
5,GO HINDBRAIN MORPHOGENESIS,0.24525,0.069807,0.067965,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.37614,0.069554,0.054777,0,0
5,GO MICROTUBULE BASED PROCESS,0.041252,0.069283,0.069208,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.26536,0.068888,0.055515,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.04007,0.068629,0.077915,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.67783,0.068182,0.041232,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.36329,0.068095,0.040418,0,0
5,GO T CELL SELECTION,0.17173,0.067655,0.069157,0,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.32642,0.067431,0.080657,0,0
5,GO MITOCHONDRION LOCALIZATION,0.10533,0.067283,0.091032,0,0
5,GO LIPID DROPLET FORMATION,0.82372,0.067187,0.018017,0,0
5,GO REGULATION OF AXONOGENESIS,0.26536,0.067109,0.072912,0,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.30892,0.067036,0.18648,0,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.48871,0.066963,0.073256,0,0
5,GO NEURON PROJECTION GUIDANCE,0.32642,0.0669,0.055928,0,0
5,GO HINDBRAIN DEVELOPMENT,0.11333,0.066587,0.11195,0,0
5,GO DNA LIGATION,0.60042,0.066339,0.049004,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.37614,0.066195,0.10488,0,0
5,GO REGULATION OF EXCRETION,0.64294,0.066125,0.044776,0,0
5,GO DNA DEPENDENT DNA REPLICATION,0.15017,0.065954,0.069264,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.36968,0.065922,0.076341,0,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.25516,0.065889,0.04487,0,0
5,GO SISTER CHROMATID SEGREGATION,0.095374,0.065858,0.063368,0,0
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.97598,0.065766,0.010113,0,0
5,GO MICROTUBULE NUCLEATION,0.4963,0.065722,0.027248,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.71343,0.065611,0.020975,0,0
5,GO MRNA EXPORT FROM NUCLEUS,0.36968,0.065146,0.044136,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.72243,0.065062,0.047554,0,0
5,GO SKELETAL MUSCLE ADAPTATION,0.6603,0.064833,0.060329,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.13074,0.064786,0.19204,0,0
5,GO LEARNING,0.38267,0.064741,0.077902,0,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.9952,0.064604,-0.033031,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.35072,0.064557,0.075546,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.23088,0.064376,0.090981,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.45898,0.064024,0.063422,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.88987,0.063682,-0.036021,0,0
5,GO HEART FORMATION,0.7772,0.06348,0.027659,0,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.7588,0.063405,0.011419,0,0
5,GO CHROMOSOME SEGREGATION,0.07572,0.063399,0.055468,0,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.80503,0.063115,0.071988,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.4445,0.063068,0.034066,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.60042,0.062952,0.071287,0,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.55115,0.062883,0.074886,0,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.17173,0.062576,0.059019,0,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.6516,0.062447,-0.0066001,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.26536,0.062317,0.076704,0,0
5,GO CHROMOSOME LOCALIZATION,0.19971,0.062278,0.046489,0,0
5,GO MICROTUBULE POLYMERIZATION,0.41634,0.062277,0.041996,0,0
5,GO TONGUE DEVELOPMENT,0.98559,0.062214,-0.028545,0,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.33239,0.061973,0.10809,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.62578,0.061705,0.0054641,0,0
5,GO RESPONSE TO AUDITORY STIMULUS,0.25017,0.061599,0.18776,0,0
5,GO DNA CONFORMATION CHANGE,0.13074,0.061588,0.052751,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.47371,0.061302,0.042259,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.068115,0.06116,0.10098,0,0
5,GO SODIUM ION HOMEOSTASIS,0.51944,0.061158,0.044937,0,0
5,GO COCHLEA DEVELOPMENT,0.35072,0.060627,0.079238,0,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.35697,0.060416,0.05302,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.1402,0.06037,0.083438,0,0
5,GO SYNAPSE MATURATION,0.6516,0.060258,0.069735,0,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.81436,0.060213,0.012127,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.37614,0.060004,0.12935,0,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.32642,0.059977,0.22136,0,0
5,GO MICROTUBULE BASED TRANSPORT,0.10025,0.059761,0.080583,0,0
5,GO MULTICELLULAR ORGANISM AGING,0.33239,0.059441,0.048217,0,0
5,GO GERM CELL DEVELOPMENT,0.066316,0.059129,0.072327,0,0
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.81436,0.059086,0.0044699,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.11892,0.059065,0.067439,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.58378,0.059012,0.031829,0,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.23088,0.058908,0.10023,0,0
5,GO SPINDLE ORGANIZATION,0.11061,0.058772,0.045088,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.32052,0.058735,0.14093,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.26536,0.058585,0.052043,0,0
5,GO APPENDAGE MORPHOGENESIS,0.35697,0.058197,0.043258,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.48118,0.057701,0.045069,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.89939,0.05753,-0.0094353,0,0
5,GO SPERM MOTILITY,0.35072,0.057453,0.047677,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.31468,0.057327,0.084723,0,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.68667,0.057304,0.013871,0,0
5,GO NOREPINEPHRINE SECRETION,0.45171,0.057079,0.077384,0,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.97598,0.057042,-0.02188,0,0
5,GO BRAIN MORPHOGENESIS,0.2356,0.056671,0.072543,0,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.30892,0.056497,0.053041,0,0
5,GO REGULATION OF HEAT GENERATION,0.69555,0.056354,0.079465,0,0
5,GO EMBRYONIC HEMOPOIESIS,0.41634,0.056347,0.088374,0,0
5,GO CENTROSOME SEPARATION,0.32052,0.056281,0.11708,0,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.40267,0.055962,0.058917,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.57554,0.055941,0.033915,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.55922,0.055745,-0.1687,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.2356,0.055461,0.064569,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,1,0.055354,-0.038162,0,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.81436,0.055348,0.037879,0,0
5,GO ADULT BEHAVIOR,0.41634,0.055307,0.083548,0,0
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.88987,0.055209,0.0083334,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.32052,0.055151,0.078224,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.29761,0.054883,0.074363,0,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.92804,0.054853,-0.031536,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.60042,0.054685,0.051771,0,0
5,GO METAPHASE PLATE CONGRESSION,0.36968,0.054597,0.034646,0,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.22622,0.05457,0.044098,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.60883,0.054425,0.027607,0,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.28117,0.054414,0.059485,0,0
5,GO MAINTENANCE OF CELL NUMBER,0.91848,0.054344,-0.03033,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.079775,0.054321,0.052753,0,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.76799,0.054144,0.0012386,0,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.62578,0.054135,0.12029,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.7772,0.05398,0.035874,0,0
5,GO CHROMOSOME CONDENSATION,0.1402,0.053927,0.081146,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.6516,0.053891,0.021988,0,0
5,GO PROTEIN MONOUBIQUITINATION,0.06115,0.053853,0.06106,0,0
5,GO LOCALIZATION WITHIN MEMBRANE,0.55115,0.053831,0.034754,0,0
5,GO CELL FATE DETERMINATION,0.46631,0.053667,0.055244,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.18334,0.05356,0.06731,0,0
5,GO REGULATION OF CIRCADIAN RHYTHM,0.073757,0.05348,0.066566,0,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.74054,0.053434,-0.015077,0,0
5,GO REGULATION OF RNA SPLICING,0.07572,0.053331,0.061519,0,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.56735,0.053228,0.019221,0,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.73147,0.053194,0.03346,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.31468,0.053027,0.046125,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.43029,0.052815,0.033894,0,0
5,GO PHOTOPERIODISM,0.69555,0.052772,0.0089788,0,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.63434,0.052768,0.038719,0,0
5,GO DNA CATABOLIC PROCESS,0.073757,0.052757,0.066702,0,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1,0.052741,-0.013612,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.43736,0.052716,0.046604,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.27583,0.052548,0.059118,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.6516,0.052533,0.024411,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.36968,0.052509,0.089775,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.34454,0.052074,0.08233,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.33239,0.051909,0.067275,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.056323,0.051896,0.07298,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.71343,0.05183,0.033946,0,0
5,GO ER OVERLOAD RESPONSE,0.61728,0.051535,0.063024,0,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.24525,0.051398,0.050042,0,0
5,GO CHROMATIN SILENCING,0.12472,0.051245,0.079722,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.21712,0.051161,0.036763,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.9472,0.051044,0.12945,0,0
5,GO TELENCEPHALON DEVELOPMENT,0.39593,0.05101,0.04298,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.85194,0.050807,0.016241,0,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.40947,0.050504,0.048153,0,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.39593,0.050408,0.050017,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.066316,0.05036,0.059875,0,0
5,GO PALLIUM DEVELOPMENT,0.53518,0.050187,0.041947,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.50395,0.050135,0.054343,0,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.64294,0.050056,0.067324,0,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.90893,0.049818,-0.012821,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.92804,0.049634,-0.040002,0,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.26023,0.049617,0.049858,0,0
5,GO NATURAL KILLER CELL ACTIVATION,0.59207,0.049395,0.0083137,0,0
5,GO SEROTONIN TRANSPORT,0.92804,0.049082,0.00027378,0,0
5,GO NUCLEAR MIGRATION,0.74054,0.048983,0.010656,0,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.41634,0.04878,0.048267,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.33843,0.048733,0.041249,0,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.61728,0.048421,0.023612,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.61728,0.04827,0.018802,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.25516,0.048256,0.081038,0,0
5,GO CHROMOSOME ORGANIZATION,0.056323,0.048211,0.041167,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.73147,0.047643,0.018765,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.81436,0.047155,-0.0052078,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.07572,0.04704,0.10227,0,0
5,GO CELLULAR RESPONSE TO NUTRIENT,0.54313,0.046921,0.022104,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.31468,0.046859,0.053723,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.61728,0.046435,-0.0045782,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.91848,0.046433,-0.022073,0,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.66904,0.046383,0.10191,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.13384,0.046275,0.045835,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.82372,0.046206,-0.058661,0,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.88987,0.046143,-0.03959,0,0
5,GO SPINDLE ASSEMBLY,0.22622,0.046098,0.034122,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.41634,0.045758,0.037617,0,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.45171,0.045694,0.066059,0,0
5,GO TRANSCYTOSIS,0.7772,0.045671,0.0015901,0,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.51944,0.045598,0.02103,0,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.41634,0.045561,0.092926,0,0
5,GO IMMATURE B CELL DIFFERENTIATION,0.88036,0.045461,-0.00030294,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.25017,0.045305,0.066351,0,0
5,GO RESPONSE TO CATECHOLAMINE,0.39593,0.045247,0.051746,0,0
5,GO NEPHRON TUBULE FORMATION,0.8614,0.045213,0.010001,0,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.73147,0.045094,0.05984,0,0
5,GO GLUTAMATE SECRETION,0.71343,0.045084,0.065445,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.50395,0.044894,0.028132,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.36968,0.044883,0.05861,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.95679,0.044871,-0.016008,0,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.39593,0.044821,0.051364,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.26536,0.044808,0.05388,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.43736,0.044763,0.071611,0,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.50395,0.044712,-0.16025,0,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.88036,0.044633,0.0052098,0,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.29761,0.044541,0.11773,0,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.45171,0.044508,0.011805,0,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.6603,0.043812,-0.089782,0,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.28117,0.043717,0.055554,0,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.40947,0.043703,0.063741,0,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.61728,0.043688,0.014603,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.8331,0.043674,0.077999,0,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.36968,0.043431,0.056481,0,0
5,GO HIPPO SIGNALING,0.7588,0.043362,-0.032716,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.11061,0.04319,0.066518,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.43029,0.043054,0.085935,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.12472,0.043031,0.048216,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.71343,0.043007,0.0060951,0,0
5,GO REGULATION OF CYTOKINESIS,0.24039,0.042905,0.036432,0,0
5,GO WATER TRANSPORT,0.48118,0.042841,0.10343,0,0
5,GO REGULATION OF GLUCOSE IMPORT,0.82372,0.042553,0.0081482,0,0
5,GO CELL PROJECTION ASSEMBLY,0.60042,0.042466,0.032038,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.76799,0.042405,-0.049765,0,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.87087,0.042391,-0.0027185,0,0
5,GO REGULATION OF CILIUM MOVEMENT,0.17553,0.042266,0.08344,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.33843,0.042182,0.043433,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.38927,0.042174,0.032486,0,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.8331,0.042148,-0.02334,0,0
5,GO RESPONSE TO ETHER,0.39593,0.041977,0.057515,0,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.19139,0.041956,0.09138,0,0
5,GO CELL PART MORPHOGENESIS,0.35072,0.041611,0.052435,0,0
5,GO CYTIDINE TO URIDINE EDITING,0.66904,0.041498,-0.13452,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.33239,0.041226,0.055429,0,0
5,GO RESPONSE TO POTASSIUM ION,0.43736,0.041191,0.13485,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.60883,0.041162,0.026609,0,0
5,GO EATING BEHAVIOR,0.98559,0.040704,-0.0012994,0,0
5,GO ENERGY HOMEOSTASIS,0.80503,0.040669,-0.040177,0,0
5,GO HISTONE H3 ACETYLATION,0.27583,0.040626,0.035215,0,0
5,GO HISTONE METHYLATION,0.12771,0.040321,0.076603,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.60883,0.040184,0.03789,0,0
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.48118,0.039855,-0.19401,0,0
5,GO POSITIVE REGULATION OF CELL GROWTH,0.72243,0.039659,0.010574,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.09779,0.03962,0.1112,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.96638,0.039552,-0.019098,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.85194,0.039522,0.024039,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.6603,0.039499,0.0028381,0,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.46631,0.039484,0.11182,0,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.59207,0.03945,0.043578,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.40947,0.039189,0.066247,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.11333,0.03898,0.047462,0,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.40947,0.038974,0.041039,0,0
5,GO PROSTATIC BUD FORMATION,0.58378,0.038957,-0.14973,0,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.67783,0.03875,-0.054952,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.81436,0.038712,-0.019535,0,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.74054,0.038639,0.04669,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.35697,0.03839,0.018119,0,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.33239,0.03839,0.04984,0,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.58378,0.038223,0.024623,0,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.28658,0.038094,0.048388,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.47371,0.038072,0.033176,0,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.60883,0.038031,0.0232,0,0
5,GO STEM CELL PROLIFERATION,0.36968,0.037933,0.044439,0,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.9952,0.037703,-0.018183,0,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.50395,0.037605,0.069309,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.90893,0.03737,-0.059178,0,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.74966,0.037349,0.039864,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.24039,0.037185,0.065123,0,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.50395,0.037133,0.039521,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.93762,0.037029,0.0073914,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.82372,0.036982,-0.005806,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.36968,0.036752,0.037948,0,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.35072,0.036655,0.041738,0,0
5,GO REGULATION OF GLIOGENESIS,0.43736,0.03663,0.037134,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.92804,0.036564,-0.022077,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.40947,0.036519,0.094786,0,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.16068,0.036351,0.058276,0,0
5,GO DNA REPAIR,0.13699,0.036351,0.035727,0,0
5,GO MYELOID CELL DEVELOPMENT,0.51944,0.036282,0.031291,0,0
5,GO PROTEIN SUMOYLATION,0.70447,0.036029,0.013057,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.51944,0.035999,0.05672,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.53518,0.035879,0.015373,0,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.30892,0.035808,0.022938,0,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.67783,0.035756,0.031679,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.6603,0.035753,0.10893,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.29761,0.035673,0.043368,0,0
5,GO BONE CELL DEVELOPMENT,0.89939,0.03565,-0.001119,0,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.74054,0.035553,0.065772,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.12771,0.035506,0.059474,0,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.79572,0.035412,0.020981,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.70447,0.034943,0.038778,0,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.79572,0.034941,0.028614,0,0
5,GO LUNG CELL DIFFERENTIATION,0.64294,0.03487,0.1167,0,0
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.98559,0.034824,0.046253,0,0
5,GO RENAL ABSORPTION,0.76799,0.034737,-0.12135,0,0
5,GO CRANIAL NERVE MORPHOGENESIS,1,0.034612,-0.012695,0,0
5,GO RESPONSE TO UV C,0.88987,0.034556,0.0023576,0,0
5,GO MITOCHONDRIAL FUSION,0.81436,0.034211,-0.023046,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.91848,0.034129,0.024863,0,0
5,GO PATTERN SPECIFICATION PROCESS,0.47371,0.034111,0.030002,0,0
5,GO PRO B CELL DIFFERENTIATION,0.79572,0.034086,0.035416,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.9952,0.034078,-0.0091425,0,0
5,GO HISTONE DEUBIQUITINATION,0.29761,0.0339,0.055707,0,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.72243,0.03389,-0.076994,0,0
5,GO CELL FATE COMMITMENT,0.51167,0.033686,0.023935,0,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.1794,0.033681,0.053599,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.53518,0.033567,0.017682,0,0
5,GO KETONE CATABOLIC PROCESS,0.8614,0.03342,-0.077425,0,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1,0.033292,-0.035054,0,0
5,GO SYNAPSE ASSEMBLY,0.8331,0.033281,0.052259,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.93762,0.033245,-0.025018,0,0
5,GO AXON EXTENSION,0.47371,0.033131,0.03278,0,0
5,GO PROTEIN METHYLATION,0.25017,0.032906,0.053167,0,0
5,GO FOREBRAIN DEVELOPMENT,0.30323,0.032691,0.054953,0,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.6603,0.032543,0.031508,0,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.79572,0.032379,0.012943,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.58378,0.032329,0.044106,0,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.78645,0.032184,-0.048331,0,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.6603,0.032116,-0.083885,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.60883,0.03211,0.017059,0,0
5,GO EYE MORPHOGENESIS,0.38927,0.032007,0.034407,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.68667,0.031868,0.024748,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.24039,0.031603,0.046381,0,0
5,GO T CELL LINEAGE COMMITMENT,0.38927,0.031597,0.051759,0,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.57554,0.031317,0.01929,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.91848,0.030981,0.0094998,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.91848,0.030904,-0.004378,0,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.91848,0.030889,-0.0011277,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.8331,0.030635,-0.025505,0,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.31468,0.030635,0.019775,0,0
5,GO SPERMATID DIFFERENTIATION,0.093006,0.030545,0.088497,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.85194,0.030395,0.045203,0,0
5,GO PROTEIN LOCALIZATION TO AXON,0.73147,0.030215,0.089147,0,0
5,GO RESPONSE TO UV,0.56735,0.030153,0.011126,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.80503,0.030152,0.036777,0,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.56735,0.030148,0.060668,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.69555,0.030057,0.042711,0,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.71343,0.030028,0.043377,0,0
5,GO EPITHELIAL CELL MORPHOGENESIS,0.6603,0.030008,-0.049982,0,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.88987,0.029997,-9.1921e-05,0,0
5,GO REGULATION OF DNA REPLICATION,0.29761,0.029847,0.040601,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.56735,0.029803,0.021424,0,0
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.95679,0.029799,-0.0068529,0,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.55922,0.029696,0.0088013,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.57554,0.029667,0.027005,0,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.40267,0.029606,0.13447,0,0
5,GO PIGMENT GRANULE LOCALIZATION,0.60042,0.02958,0.027863,0,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.61728,0.029574,0.035433,0,0
5,GO SYNAPTIC SIGNALING,0.64294,0.029437,0.056038,0,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.9952,0.029334,0.0038739,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.71343,0.02925,0.011374,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.51944,0.029173,0.03068,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.79572,0.029155,0.018897,0,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.51167,0.029123,0.027185,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.9952,0.028772,-0.016503,0,0
5,GO RESPONSE TO LITHIUM ION,0.51167,0.028577,0.14946,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.80503,0.028445,0.01906,0,0
5,GO RESPONSE TO GLUCAGON,0.64294,0.028365,0.024396,0,0
5,GO CGMP METABOLIC PROCESS,0.61728,0.02832,0.064051,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.24525,0.028315,0.046005,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.8614,0.028126,0.010102,0,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,1,0.028097,-0.00048169,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.38267,0.027922,0.14288,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.48871,0.027807,0.033038,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.84251,0.027805,-0.040276,0,0
5,GO REGULATION OF DNA BINDING,0.63434,0.027786,0.021593,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.50395,0.027713,0.05142,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.82372,0.027529,0.00139,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.60042,0.027173,0.026088,0,0
5,GO DETECTION OF ABIOTIC STIMULUS,0.56735,0.027135,0.025773,0,0
5,GO MALE GAMETE GENERATION,0.35072,0.027076,0.03036,0,0
5,GO GAMETE GENERATION,0.23088,0.027019,0.034899,0,0
5,GO VASCULAR WOUND HEALING,0.88987,0.026945,0.031827,0,0
5,GO REGULATION OF NEURON DIFFERENTIATION,0.55115,0.02648,0.038857,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.6516,0.026311,0.026423,0,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.68667,0.026278,0.067985,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.56735,0.026218,0.020788,0,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.80503,0.026187,0.081901,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.78645,0.025773,0.07249,0,0
5,GO RNA SPLICING,0.54313,0.025772,0.02782,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.81436,0.025714,0.011153,0,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.9952,0.025298,-0.022299,0,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.59207,0.025289,0.058818,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.60042,0.025032,0.034365,0,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.25017,0.02503,0.10165,0,0
5,GO TELOMERE CAPPING,0.30323,0.025008,0.047194,0,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.51944,0.024975,0.028564,0,0
5,GO MATING BEHAVIOR,0.6516,0.024897,-0.053515,0,0
5,GO MEMORY,0.73147,0.024679,0.023591,0,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.82372,0.024667,0.0028771,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.71343,0.024667,0.027508,0,0
5,GO TUMOR NECROSIS FACTOR SECRETION,0.47371,0.024461,0.029591,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.66904,0.024391,-0.10113,0,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.89939,0.024383,-0.0073497,0,0
5,GO AXON DEVELOPMENT,0.47371,0.024375,0.046526,0,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.9952,0.024353,-0.0043466,0,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.72243,0.02411,0.029939,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.82372,0.023862,0.0087383,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.73147,0.023851,0.016752,0,0
5,GO FOREGUT MORPHOGENESIS,0.79572,0.023776,0.0031774,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.68667,0.023727,0.018287,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.37614,0.023727,0.068104,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.37614,0.023528,0.038866,0,0
5,GO REGULATION OF CELL DIVISION,0.63434,0.023488,0.010581,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.78645,0.023454,0.020199,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.80503,0.023412,-0.0023913,0,0
5,GO BONE MATURATION,0.9472,0.023254,-0.022152,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.4963,0.023229,0.028046,0,0
5,GO MEMBRANE DOCKING,0.25017,0.023183,0.044461,0,0
5,GO PHAGOSOME ACIDIFICATION,0.7588,0.022939,-0.044405,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.88987,0.022812,-0.013201,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.82372,0.022758,0.042352,0,0
5,GO MRNA TRANSPORT,0.8331,0.022601,0.0091087,0,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.78645,0.02255,0.020604,0,0
5,GO AXIS SPECIFICATION,0.87087,0.022522,0.0077745,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.89939,0.022487,-0.0041911,0,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.89939,0.022466,0.0050873,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.54313,0.022403,0.021094,0,0
5,GO CYTOKINESIS,0.88036,0.022359,-0.0056445,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.72243,0.02233,0.0071442,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.54313,0.022168,0.035873,0,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.39593,0.022097,0.026156,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.7588,0.02199,0.019507,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.53518,0.021883,0.033868,0,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.46631,0.02177,0.04441,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.6603,0.02172,-0.058497,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.74054,0.021497,0.019025,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.8331,0.021483,-0.029498,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22164,0.021369,0.043352,0,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.4445,0.021336,0.040447,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.23088,0.021323,0.041354,0,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.80503,0.020625,0.025542,0,0
5,GO REGIONALIZATION,0.74054,0.020495,0.013308,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95679,0.020454,-0.018475,0,0
5,GO DNA METABOLIC PROCESS,0.51167,0.020447,0.011578,0,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.66904,0.02039,0.022677,0,0
5,GO DNA RECOMBINATION,0.22164,0.020334,0.041516,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.90893,0.020271,0.00023498,0,0
5,GO RESPONSE TO INTERLEUKIN 6,0.90893,0.020247,-0.011351,0,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.60883,0.020212,0.025115,0,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.4445,0.020183,0.069808,0,0
5,GO ECTODERM DEVELOPMENT,0.54313,0.020182,0.018671,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.53518,0.019692,0.011146,0,0
5,GO MRNA PROCESSING,0.54313,0.01958,0.024835,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.9952,0.019569,-0.023895,0,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.8331,0.019553,-0.029716,0,0
5,GO SEQUESTERING OF METAL ION,0.70447,0.019501,-0.054002,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.7772,0.019412,-0.042597,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.58378,0.019367,-0.080754,0,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.72243,0.019284,-0.019415,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.8614,0.019265,0.0035905,0,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.76799,0.01922,0.021074,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.71343,0.019107,0.03885,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.81436,0.019082,0.016901,0,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.8614,0.018863,-0.0059107,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.55922,0.018657,-0.076905,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.6603,0.018531,0.036228,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.7588,0.018472,0.021221,0,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.51167,0.018259,-0.21399,0,0
5,GO GRANULOCYTE DIFFERENTIATION,0.40947,0.018183,-0.09881,0,0
5,GO RESPONSE TO COCAINE,0.95679,0.01813,0.013192,0,0
5,GO MRNA METHYLATION,0.92804,0.018022,-0.018714,0,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.85194,0.01796,-0.040898,0,0
5,GO POSTREPLICATION REPAIR,0.88987,0.017866,0.00066726,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1,0.017854,-0.022009,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.85194,0.017844,-0.0082197,0,0
5,GO FEMALE GAMETE GENERATION,0.88036,0.017713,-0.016913,0,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.79572,0.017519,0.086207,0,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.45171,0.017458,-0.090368,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.88036,0.01733,-0.0028141,0,0
5,GO REGULATION OF BEHAVIOR,0.74054,0.017242,-0.04093,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.64294,0.017207,0.066002,0,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.97598,0.0172,0.0039482,0,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.96638,0.017074,-0.049144,0,0
5,GO CELL PROJECTION ORGANIZATION,0.67783,0.017046,0.021844,0,0
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.67783,0.016973,-0.05535,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.40947,0.016952,0.057208,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.79572,0.016884,0.021252,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.90893,0.016742,-0.0067195,0,0
5,GO EPIDERMIS MORPHOGENESIS,0.88036,0.016581,-0.035712,0,0
5,GO NEUROTRANSMITTER SECRETION,0.88036,0.016563,0.064993,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.71343,0.016528,0.025448,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.68667,0.016434,0.048087,0,0
5,GO CELL DIVISION,0.51167,0.016405,0.016402,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.85194,0.0164,0.011093,0,0
5,GO CARTILAGE MORPHOGENESIS,0.67783,0.016352,0.047246,0,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.80503,0.016343,-0.0038689,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.24039,0.016271,0.041552,0,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.38927,0.016216,0.089229,0,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.67783,0.016069,0.019456,0,0
5,GO REGULATION OF PINOCYTOSIS,0.70447,0.016067,-0.10699,0,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.81436,0.016066,-0.0012013,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.61728,0.016017,-0.037756,0,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.85194,0.015959,-0.069889,0,0
5,GO SENSORY ORGAN MORPHOGENESIS,0.96638,0.015896,-0.0053822,0,0
5,GO LIPID TRANSLOCATION,0.52728,0.015619,-0.065373,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.91848,0.015483,-0.02949,0,0
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.72243,0.01545,0.025442,0,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.79572,0.015386,0.013907,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.84251,0.01533,-0.065957,0,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.92804,0.01519,-0.032179,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.43736,0.015126,0.036272,0,0
5,GO BASE EXCISION REPAIR,0.84251,0.015063,-0.0074859,0,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.98559,0.014927,-0.03383,0,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.7772,0.014859,-0.016882,0,0
5,GO NEURON DIFFERENTIATION,0.48871,0.01484,0.03986,0,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.98559,0.014747,-0.0021305,0,0
5,GO HEAD DEVELOPMENT,0.60883,0.014695,0.028797,0,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.43736,0.014626,0.019411,0,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.60042,0.014559,0.023203,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.71343,0.014553,0.0019507,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.61728,0.014541,-0.089104,0,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.55922,0.014439,-0.099156,0,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.8614,0.014411,0.0030905,0,0
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.93762,0.014384,0.0061738,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.55922,0.014377,-0.074428,0,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.58378,0.014334,0.1043,0,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.84251,0.014217,0.034425,0,0
5,GO NEURON DEVELOPMENT,0.60883,0.014042,0.030169,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.7772,0.01402,0.011489,0,0
5,GO REGULATION OF APPETITE,0.8331,0.013896,-0.016359,0,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.32642,0.013895,0.051471,0,0
5,GO FOREBRAIN CELL MIGRATION,0.92804,0.013836,0.00040245,0,0
5,GO ORGANELLE LOCALIZATION,0.42328,0.013796,0.016564,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.46631,0.013732,0.065919,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.79572,0.013693,0.018146,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.69555,0.013406,0.029185,0,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.7588,0.013268,0.0042191,0,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.57554,0.013262,-0.088959,0,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.40947,0.013256,0.14522,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.82372,0.012982,-0.027606,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.98559,0.012976,0.00055659,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.9952,0.012854,-0.013449,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.82372,0.012721,0.018227,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.98559,0.012606,-0.0043927,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.9952,0.012461,-0.033642,0,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.6603,0.012358,-0.078466,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.55115,0.012283,0.060415,0,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.9472,0.012219,0.0032692,0,0
5,GO CELLULAR RESPONSE TO RADIATION,0.9472,0.012216,-0.0071198,0,0
5,GO MITOTIC CELL CYCLE,0.7588,0.012199,0.0021077,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.54313,0.012028,0.048792,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.90893,0.011989,-0.043683,0,0
5,GO SULFATION,0.90893,0.011922,0.0081559,0,0
5,GO HISTONE H3 DEACETYLATION,0.98559,0.011863,0.0043197,0,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.74054,0.011701,0.0051887,0,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.7772,0.011663,0.031385,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.40947,0.011584,0.03299,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.91848,0.011477,-0.0060062,0,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.8331,0.011423,0.050668,0,0
5,GO SPINDLE LOCALIZATION,0.60883,0.011378,-0.025224,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.76799,0.011339,0.014487,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.74966,0.011286,0.032303,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.82372,0.011201,-0.031609,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.74966,0.01119,-0.033037,0,0
5,GO TORC1 SIGNALING,0.48871,0.01117,0.024629,0,0
5,GO RESPONSE TO LIGHT STIMULUS,0.80503,0.011161,-0.0009717,0,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.57554,0.011095,0.063843,0,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.88987,0.011069,-0.0037689,0,0
5,GO WATER HOMEOSTASIS,0.7772,0.011043,0.018562,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.9952,0.010755,-0.0037202,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.80503,0.01072,-0.06478,0,0
5,GO CILIUM MOVEMENT,0.58378,0.010643,0.04418,0,0
5,GO APPENDAGE DEVELOPMENT,0.73147,0.010598,0.0049174,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.7772,0.010495,0.030167,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.78645,0.010439,0.0030109,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.95679,0.010404,0.081631,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.62578,0.01039,0.031459,0,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.7772,0.010369,-0.02081,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.95679,0.010365,0.034292,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.74966,0.010359,0.010318,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.87087,0.01033,0.0044607,0,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.4963,0.010288,0.061639,0,0
5,GO SUCKLING BEHAVIOR,1,0.010251,0.0065811,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.40267,0.0099016,0.089039,0,0
5,GO ACTIVATION OF MAPKK ACTIVITY,0.95679,0.0098273,-0.016594,0,0
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.4445,0.0098229,0.035208,0,0
5,GO MONOAMINE TRANSPORT,0.8331,0.0097074,0.038258,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.7588,0.0095856,-0.01352,0,0
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.8331,0.0095074,-0.027053,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.67783,0.0094083,0.024375,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.6603,0.0093508,-0.039147,0,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.81436,0.0092985,0.01197,0,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.89939,0.0092587,-0.0014021,0,0
5,GO VISUAL BEHAVIOR,0.93762,0.0092512,0.0092666,0,0
5,GO ACROSOME REACTION,0.88036,0.009239,-0.0006672,0,0
5,GO PHOTOTRANSDUCTION,0.78645,0.0092171,-0.0011008,0,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.89939,0.0090712,-0.0073666,0,0
5,GO COGNITION,0.43736,0.0090377,0.04631,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.72243,0.0090325,-0.037533,0,0
5,GO CORNIFICATION,0.54313,0.0090324,-0.07885,0,0
5,GO NEURAL TUBE DEVELOPMENT,0.69555,0.0089721,-0.0025923,0,0
5,GO DNA METHYLATION,0.8331,0.0089622,0.015038,0,0
5,GO LIPID PHOSPHORYLATION,0.9952,0.0089617,-0.0018616,0,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.30892,0.0088129,-0.21984,0,0
5,GO LYMPHOCYTE COSTIMULATION,0.73147,0.0085909,0.005814,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.72243,0.008501,0.060289,0,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.66904,0.0083903,-0.036036,0,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.67783,0.0082188,0.001758,0,0
5,GO DNA MODIFICATION,0.67783,0.0080803,0.013433,0,0
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.93762,0.0078703,-0.036021,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.91848,0.0078669,-0.024852,0,0
5,GO CELLULAR RESPONSE TO UV,0.81436,0.0078603,0.0027687,0,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.81436,0.0077582,0.014033,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.72243,0.0077203,0.013258,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.95679,0.0074477,-0.0113,0,0
5,GO NODAL SIGNALING PATHWAY,0.95679,0.0071977,0.0035988,0,0
5,GO REGULATION OF CELL CYCLE,0.78645,0.0071216,0.0012293,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.98559,0.0069897,0.039146,0,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.90893,0.0067186,0.024962,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.76799,0.0067182,-0.049071,0,0
5,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.62578,0.0066623,0.075143,0,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.46631,0.0064656,0.058812,0,0
5,GO MITOPHAGY,0.92804,0.0064074,0.01114,0,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.70447,0.0062224,-0.011472,0,0
5,GO NEURONAL ACTION POTENTIAL,0.8331,0.0061942,-0.017317,0,0
5,GO AMMONIUM TRANSPORT,0.71343,0.0061931,0.056336,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,1,0.0061258,-0.0082482,0,0
5,GO CALCINEURIN MEDIATED SIGNALING,0.90893,0.0061131,0.0011116,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.8614,0.006109,-0.022497,0,0
5,GO MRNA 3 END PROCESSING,0.70447,0.0060647,0.015958,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.73147,0.0058299,-0.014824,0,0
5,GO RESPONSE TO FOOD,0.82372,0.0058176,0.010086,0,0
5,GO RESPONSE TO LEAD ION,0.85194,0.0057244,-0.025577,0,0
5,GO POST EMBRYONIC DEVELOPMENT,0.91848,0.0056657,0.0073369,0,0
5,GO CELL CYCLE,0.91848,0.0056602,0.0014334,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.98559,0.0056301,-0.0039194,0,0
5,GO SNRNA TRANSCRIPTION,0.8614,0.0055566,0.001985,0,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.78645,0.0052748,-0.0045764,0,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.73147,0.0051527,-0.046597,0,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.85194,0.005044,0.0026022,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.52728,0.0050054,-0.052103,0,0
5,GO RNA EXPORT FROM NUCLEUS,1,0.004941,-0.0030568,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.38927,0.0047241,0.025633,0,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.60883,0.0046828,0.016059,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.93762,0.0046133,0.0020904,0,0
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.95679,0.0044124,-0.016929,0,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.95679,0.0042058,-0.018794,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.76799,0.0041259,0.016205,0,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.85194,0.0040725,-0.031288,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.9472,0.0040562,-0.00028623,0,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.91848,0.0040389,0.03182,0,0
5,GO DEFINITIVE HEMOPOIESIS,0.90893,0.0040102,0.018925,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.81436,0.0038873,0.031783,0,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.95679,0.0037921,0.0078966,0,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.4963,0.0036164,0.019843,0,0
5,GO NEURON PROJECTION EXTENSION,0.82372,0.0034906,0.019048,0,0
5,GO SEXUAL REPRODUCTION,0.62578,0.003428,0.010843,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.92804,0.0033937,0.0079838,0,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.76799,0.0032628,-0.023628,0,0
5,GO ADULT FEEDING BEHAVIOR,0.95679,0.0031759,-0.045877,0,0
5,GO HISTONE H4 DEACETYLATION,0.8614,0.0031445,0.0019825,0,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.93762,0.0031318,0.0042487,0,0
5,GO MITOCHONDRION DISTRIBUTION,0.60042,0.0027675,0.067688,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.98559,0.0027334,-0.017635,0,0
5,GO LOCOMOTORY BEHAVIOR,0.6603,0.0026754,0.046649,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.82372,0.0024344,0.036196,0,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.8614,0.0023564,-0.00275,0,0
5,GO RESPONSE TO LEUCINE,0.69555,0.002262,0.078273,0,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.92804,0.0021807,-0.011601,0,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.8331,0.0020774,-0.0011639,0,0
5,GO CELL MATURATION,0.6516,0.001604,0.025538,0,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.96638,0.0011073,-0.00014457,0,0
5,GO NEURON DEATH,0.66904,0.0010639,-0.018885,0,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.9472,0.00083014,-0.026677,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.39593,0.00080925,-0.11044,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.74966,0.00063966,-0.0024755,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.28117,0.00054805,0.042031,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.55922,0.00052326,-0.073273,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.74054,0.00049403,0.14532,0,0
5,GO NEUROGENESIS,0.7772,0.00047096,0.018726,0,0
5,GO POSITIVE REGULATION OF CELL MATURATION,0.92804,0.00042524,-0.036175,0,0
5,GO THYMUS DEVELOPMENT,0.4963,0.00038251,0.058638,0,0
5,GO TONGUE MORPHOGENESIS,0.79572,0.00036326,0.043826,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.95679,0.00023987,-0.0036437,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.85194,0.00021558,-0.045079,0,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.7588,0.00017737,-0.032844,0,0
5,GO MALE MEIOSIS I,0.7772,0.00015913,-0.069168,0,0
5,GO DRINKING BEHAVIOR,0.91848,6.6435e-05,-0.044876,0,0
5,GO REGULATION OF VASOCONSTRICTION,0.95679,1.318e-05,-0.031861,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.63434,-5.2568e-05,0.080229,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.6516,-9.3238e-05,0.078268,0,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.93762,-0.00010702,-0.014265,0,0
5,GO KERATINIZATION,0.7588,-0.00018172,-0.039075,0,0
5,GO THYMIC T CELL SELECTION,0.87087,-0.00032982,-0.01626,0,0
5,GO PREPULSE INHIBITION,0.6603,-0.00041704,0.095365,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.74054,-0.00052924,0.052761,0,0
5,GO HEAT GENERATION,0.98559,-0.00085357,0.016408,0,0
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.88987,-0.0010761,-0.031202,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.54313,-0.0010773,0.025078,0,0
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.78645,-0.0011875,-0.035537,0,0
5,GO MISMATCH REPAIR,0.90893,-0.0012572,-0.0096937,0,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.84251,-0.0012786,-0.040474,0,0
5,GO ORGANELLE FISSION,0.74054,-0.0013201,0.0039694,0,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.90893,-0.0014666,0.0043002,0,0
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.66904,-0.0014857,-0.039,0,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.72243,-0.0016076,-0.08544,0,0
5,GO GENE SILENCING,0.69555,-0.0016479,-0.012723,0,0
5,GO ANATOMICAL STRUCTURE MATURATION,0.95679,-0.0016489,0.0043784,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.68667,-0.0016496,-0.078751,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.84251,-0.0016829,-0.016826,0,0
5,GO GMP METABOLIC PROCESS,0.74966,-0.0017925,0.03311,0,0
5,GO DIENCEPHALON DEVELOPMENT,0.9952,-0.0018012,0.012029,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.92804,-0.0019302,0.028356,0,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.41634,-0.0020352,-0.08962,0,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.70447,-0.0024276,0.036461,0,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.92804,-0.0024814,0.047158,0,0
5,GO CELL CYCLE PROCESS,0.90893,-0.0025053,-0.007489,0,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.84251,-0.0025723,-0.018754,0,0
5,GO REGULATION OF CELL DEVELOPMENT,0.89939,-0.0026287,0.0051241,0,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,1,-0.002651,0.0074595,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.91848,-0.0027733,-0.018559,0,0
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.81436,-0.002818,-0.086138,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.78645,-0.002853,-0.056113,0,0
5,GO INNER EAR MORPHOGENESIS,0.78645,-0.0029633,-0.026151,0,0
5,GO NEUROBLAST PROLIFERATION,0.51167,-0.0030177,0.056367,0,0
5,GO REGULATION OF ANION TRANSPORT,0.6516,-0.0031031,-0.044344,0,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.8614,-0.0031442,0.011559,0,0
5,GO CHROMOSOME SEPARATION,0.97598,-0.0031588,0.0022096,0,0
5,GO POSITIVE REGULATION OF CELL DIVISION,0.87087,-0.0033273,-0.0090632,0,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.64294,-0.0035446,0.097492,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.93762,-0.0036577,0.0017675,0,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.80503,-0.0036673,-0.01294,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.95679,-0.0037232,0.023426,0,0
5,GO DETECTION OF LIGHT STIMULUS,0.74966,-0.0037999,0.0052554,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.88036,-0.0038234,0.015527,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.93762,-0.0038875,0.021609,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.53518,-0.0040814,0.06348,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.45171,-0.0042294,-0.083375,0,0
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.70447,-0.004236,-0.019395,0,0
5,GO COLLATERAL SPROUTING,0.63434,-0.0043095,-0.043403,0,0
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.7772,-0.0043163,-0.032456,0,0
5,GO SPECIFICATION OF SYMMETRY,0.70447,-0.0046168,0.029721,0,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.80503,-0.0047456,-0.030145,0,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.9472,-0.0047889,-0.010432,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.51944,-0.0048122,0.044844,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.7772,-0.0048433,0.051071,0,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.90893,-0.0048793,0.0066562,0,0
5,GO MITOTIC DNA REPLICATION,0.88036,-0.0048958,0.01739,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.55922,-0.0049849,-0.01956,0,0
5,GO ORGANELLE ASSEMBLY,0.8614,-0.0049886,-0.0023225,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.78645,-0.0051483,-0.055624,0,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.7588,-0.0051606,-0.028187,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.88987,-0.0051686,-0.017423,0,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.43029,-0.0053014,-0.064346,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.95679,-0.0053044,0.016439,0,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.85194,-0.0053875,-0.019092,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.66904,-0.0054404,-0.042854,0,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.81436,-0.0055769,-0.018417,0,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.72243,-0.0056215,-0.020435,0,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.63434,-0.0057945,-0.070351,0,0
5,GO POTASSIUM ION HOMEOSTASIS,0.66904,-0.0059322,0.043863,0,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.55922,-0.0059585,-0.060715,0,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.88036,-0.0059721,-0.085451,0,0
5,GO DNA GEOMETRIC CHANGE,0.71343,-0.0060347,0.017864,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.78645,-0.0060631,-0.03238,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.87087,-0.0061187,-0.02153,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.8331,-0.0061904,-0.014681,0,0
5,GO SOMITE DEVELOPMENT,0.53518,-0.0062508,-0.048294,0,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.76799,-0.0063535,0.03036,0,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.40947,-0.0064694,-0.11528,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.97598,-0.0066119,-0.014685,0,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.36329,-0.0066169,-0.079371,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.7772,-0.0066707,0.11967,0,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.80503,-0.006723,0.01696,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.56735,-0.0067268,-0.092612,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.73147,-0.0067948,-0.035526,0,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.78645,-0.0069189,0.0054988,0,0
5,GO SENSORY SYSTEM DEVELOPMENT,0.80503,-0.0070535,-0.014194,0,0
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.46631,-0.0070836,-0.046508,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.87087,-0.0072405,0.0028747,0,0
5,GO EAR DEVELOPMENT,0.79572,-0.0072526,-0.029386,0,0
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.57554,-0.0072834,-0.028856,0,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.84251,-0.0074556,-0.015933,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.62578,-0.00775,-0.081059,0,0
5,GO VACUOLAR ACIDIFICATION,0.34454,-0.0080422,-0.10672,0,0
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.6603,-0.0080965,-0.038604,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.72243,-0.0081885,-0.034402,0,0
5,GO MULTICELLULAR ORGANISM GROWTH,0.56735,-0.0082519,-0.029019,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.78645,-0.008257,-0.021966,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.4963,-0.0082913,-0.076209,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.73147,-0.0084205,-0.053857,0,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.90893,-0.008538,-0.011991,0,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.79572,-0.0087225,-0.023592,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.53518,-0.0087283,-0.11447,0,0
5,GO RUFFLE ASSEMBLY,0.6516,-0.0087397,-0.037171,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.68667,-0.0087628,-0.045471,0,0
5,GO PEPTIDYL SERINE MODIFICATION,0.37614,-0.0087965,-0.035144,0,0
5,GO RESPONSE TO VITAMIN D,0.91848,-0.0088059,-0.021031,0,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.9472,-0.0088516,-0.012477,0,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.9952,-0.0090787,-0.023486,0,0
5,GO SENSORY ORGAN DEVELOPMENT,0.87087,-0.0091308,-0.015748,0,0
5,GO VESICLE LOCALIZATION,0.87087,-0.0091511,-0.0088274,0,0
5,GO SPLEEN DEVELOPMENT,0.70447,-0.0091888,-0.032718,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.81436,-0.0093571,0.0081209,0,0
5,GO MEIOTIC CELL CYCLE,0.79572,-0.0093658,0.0066853,0,0
5,GO RESPONSE TO PROSTAGLANDIN,0.63434,-0.0093804,-0.050737,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.98559,-0.0094903,-0.0097296,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.78645,-0.0094991,-0.013381,0,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.63434,-0.0095363,-0.034582,0,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.82372,-0.0096506,0.03737,0,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.89939,-0.0097461,-0.034795,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.9952,-0.0097609,0.004548,0,0
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.81436,-0.0098375,-0.012968,0,0
5,GO LYMPHANGIOGENESIS,0.58378,-0.0098835,-0.079154,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.66904,-0.0099249,-0.02447,0,0
5,GO DEVELOPMENTAL MATURATION,0.96638,-0.0099738,0.015094,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.91848,-0.010072,-0.0087828,0,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.60883,-0.010201,-0.020267,0,0
5,GO PROTEIN POLYUBIQUITINATION,0.67783,-0.010355,-0.025432,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.81436,-0.01037,-0.04892,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.88036,-0.010396,0.045827,0,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.80503,-0.010404,-0.041061,0,0
5,GO RNA DECAPPING,0.29206,-0.010453,-0.075806,0,0
5,GO NEURON APOPTOTIC PROCESS,0.68667,-0.010658,0.017419,0,0
5,GO SYNAPSE ORGANIZATION,0.98559,-0.010673,0.01749,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.87087,-0.010689,-0.022758,0,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.91848,-0.010725,-0.0033577,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.50395,-0.01077,-0.016239,0,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.71343,-0.010896,-0.049094,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.92804,-0.01097,-0.010328,0,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.27056,-0.011058,-0.16631,0,0
5,GO CELLULAR RESPONSE TO ALKALOID,0.82372,-0.011104,-0.015985,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.82372,-0.011137,-0.0093584,0,0
5,GO CHONDROCYTE DEVELOPMENT,0.45898,-0.011332,0.050399,0,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.68667,-0.011332,-0.018268,0,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.74054,-0.011459,-0.037376,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.8331,-0.011561,-0.011644,0,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.79572,-0.011646,0.029881,0,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.27583,-0.011728,-0.09141,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.91848,-0.011802,0.041502,0,0
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.66904,-0.011849,-0.029155,0,0
5,GO CYTOSKELETON ORGANIZATION,0.48118,-0.011862,-0.024876,0,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.84251,-0.011932,-0.033305,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.51167,-0.012276,-0.014755,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.4445,-0.012278,0.099476,0,0
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.74054,-0.012351,-0.036388,0,0
5,GO ASTROCYTE ACTIVATION,0.6603,-0.01241,-0.056949,0,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.73147,-0.012417,-0.02449,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.42328,-0.012758,-0.042534,0,0
5,GO MITOTIC CYTOKINESIS,0.72243,-0.012934,-0.024749,0,0
5,GO SIGNAL RELEASE,0.58378,-0.012936,-0.0082955,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.60883,-0.012987,-0.056224,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.48118,-0.013057,-0.10331,0,0
5,GO PRESYNAPSE ORGANIZATION,0.93762,-0.013188,0.027973,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.8331,-0.013329,-0.031954,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.96638,-0.013357,-0.0012064,0,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.81436,-0.013371,-0.014021,0,0
5,GO DETECTION OF MECHANICAL STIMULUS,0.88987,-0.013509,0.026781,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.51167,-0.013541,-0.13155,0,0
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.93762,-0.013551,0.006526,0,0
5,GO CELL CELL SIGNALING,0.6516,-0.013578,-0.014794,0,0
5,GO PLACENTA DEVELOPMENT,0.53518,-0.013585,-0.051807,0,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.51944,-0.013648,0.080006,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.51167,-0.013742,-0.075067,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.56735,-0.014007,-0.034401,0,0
5,GO O GLYCAN PROCESSING,0.48871,-0.014015,-0.13531,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.79572,-0.014123,-0.019488,0,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.69555,-0.014308,-0.032927,0,0
5,GO INTERLEUKIN 6 PRODUCTION,0.6603,-0.014323,-0.037883,0,0
5,GO REGULATION OF HORMONE SECRETION,0.55115,-0.014326,-0.033644,0,0
5,GO BODY MORPHOGENESIS,0.48871,-0.014416,-0.065379,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.97598,-0.014447,0.03263,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.61728,-0.014519,-0.019627,0,0
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.72243,-0.014541,-0.024421,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.67783,-0.014639,-0.018869,0,0
5,GO POSITIVE THYMIC T CELL SELECTION,0.68667,-0.014881,-0.033221,0,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.29206,-0.015035,-0.20506,0,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.9952,-0.015064,-0.019269,0,0
5,GO REGULATION OF COLLATERAL SPROUTING,0.88987,-0.015089,-0.0067184,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.81436,-0.015115,-0.030398,0,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.58378,-0.015189,-0.030653,0,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.92804,-0.015284,-0.018582,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.62578,-0.015333,-0.032983,0,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.60883,-0.01545,0.050824,0,0
5,GO REGULATION OF EXOCYTOSIS,0.7588,-0.015489,0.010996,0,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.78645,-0.01558,-0.033366,0,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.81436,-0.015593,0.026075,0,0
5,GO RESPONSE TO WATER,0.74054,-0.015594,-0.040554,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION,0.59207,-0.015674,-0.053381,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.72243,-0.015681,-0.0059753,0,0
5,GO RESPONSE TO INSECTICIDE,0.8331,-0.015685,-0.011806,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.78645,-0.015704,-0.028309,0,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.29761,-0.015746,-0.094964,0,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.38927,-0.015869,-0.085079,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.69555,-0.015893,-0.016093,0,0
5,GO MAST CELL MIGRATION,0.95679,-0.015923,0.010399,0,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.78645,-0.015988,-0.013052,0,0
5,GO GLIAL CELL DIFFERENTIATION,0.42328,-0.016019,-0.058542,0,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.97598,-0.016049,0.0043563,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.51944,-0.016089,-0.041812,0,0
5,GO CELL MORPHOGENESIS,0.97598,-0.016121,-0.0028657,0,0
5,GO RESPONSE TO X RAY,0.68667,-0.016208,-0.069764,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.36968,-0.016411,-0.12989,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.43029,-0.016431,-0.020524,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.48871,-0.016434,-0.028691,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.88036,-0.016475,-0.020961,0,0
5,GO ENDOCRINE HORMONE SECRETION,0.7588,-0.016524,-0.04074,0,0
5,GO RENAL SYSTEM PROCESS,0.98559,-0.016736,-0.0020995,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.70447,-0.016877,-0.032804,0,0
5,GO REPLICATIVE SENESCENCE,0.50395,-0.016881,-0.11135,0,0
5,GO GOLGI RIBBON FORMATION,0.67783,-0.016884,-0.03926,0,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.33843,-0.017128,-0.1163,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.82372,-0.017133,-0.03873,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.91848,-0.017206,0.032921,0,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.76799,-0.017219,0.024613,0,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.67783,-0.017238,-0.012259,0,0
5,GO CAMERA TYPE EYE DEVELOPMENT,0.7588,-0.017311,-0.0183,0,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.50395,-0.017319,-0.077198,0,0
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.64294,-0.0176,-0.04823,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.71343,-0.017721,0.032297,0,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.6603,-0.017777,-0.057728,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.26023,-0.017869,-0.053119,0,0
5,GO NEGATIVE T CELL SELECTION,0.63434,-0.018051,-0.076765,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.42328,-0.018159,-0.12184,0,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.47371,-0.018184,-0.055025,0,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.73147,-0.018285,-0.035921,0,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.51167,-0.018389,-0.071417,0,0
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.80503,-0.018403,-0.012685,0,0
5,GO BONE MORPHOGENESIS,0.50395,-0.018406,-0.078807,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.37614,-0.018409,-0.1635,0,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.87087,-0.01844,0.0090984,0,0
5,GO REPRODUCTION,0.51944,-0.018468,-0.026453,0,0
5,GO REGULATION OF SECRETION,0.38267,-0.018659,-0.038855,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.9952,-0.018689,0.014156,0,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.72243,-0.018807,0.016239,0,0
5,GO REGULATION OF ERAD PATHWAY,0.79572,-0.018819,-0.017514,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.53518,-0.018867,-0.056505,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.9952,-0.018889,0.017789,0,0
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.71343,-0.018897,-0.024023,0,0
5,GO MIDBRAIN DEVELOPMENT,1,-0.018946,-0.0068249,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.82372,-0.018977,-0.043659,0,0
5,GO POSITIVE REGULATION OF SECRETION,0.40267,-0.019071,-0.041076,0,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.85194,-0.019151,-0.014821,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.74054,-0.019213,0.048679,0,0
5,GO POSITIVE REGULATION OF NEURON DEATH,0.88036,-0.019328,0.00050539,0,0
5,GO RESPONSE TO BMP,0.64294,-0.019392,-0.04956,0,0
5,GO OPTIC NERVE DEVELOPMENT,0.98559,-0.019486,-0.0065806,0,0
5,GO LEFT RIGHT PATTERN FORMATION,0.95679,-0.019493,0.0031723,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.60883,-0.019513,-0.055732,0,0
5,GO REGULATION OF ATPASE ACTIVITY,0.55922,-0.019578,-0.025554,0,0
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.63434,-0.019795,-0.024793,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.95679,-0.019859,0.0080487,0,0
5,GO MALE SEX DETERMINATION,0.95679,-0.019877,0.018242,0,0
5,GO LIPOPROTEIN METABOLIC PROCESS,0.48118,-0.019891,-0.051222,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.95679,-0.019968,0.0020152,0,0
5,GO ACTIVATION OF GTPASE ACTIVITY,0.19552,-0.019983,-0.079843,0,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.88987,-0.020057,-0.035349,0,0
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.88036,-0.020108,-0.012138,0,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.61728,-0.020139,0.039342,0,0
5,GO VIRAL GENOME REPLICATION,0.72243,-0.020144,-0.07484,0,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.69555,-0.020199,-0.049513,0,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.64294,-0.020267,-0.08714,0,0
5,GO CIRCADIAN RHYTHM,0.60883,-0.020329,-0.020148,0,0
5,GO REGULATION OF GLIAL CELL MIGRATION,0.7772,-0.02052,0.018454,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.88036,-0.02059,-0.044694,0,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.9472,-0.020661,-0.041237,0,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.97598,-0.0208,-0.0076097,0,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.80503,-0.020848,0.051131,0,0
5,GO ACTIVATED T CELL PROLIFERATION,0.85194,-0.020963,-0.016567,0,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.4445,-0.020975,-0.048027,0,0
5,GO REGULATION OF CELL MORPHOGENESIS,0.9952,-0.02103,-0.0016353,0,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.57554,-0.021092,-0.055967,0,0
5,GO EAR MORPHOGENESIS,0.74966,-0.021142,-0.036489,0,0
5,GO NEURAL TUBE FORMATION,0.6516,-0.021146,-0.039928,0,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.81436,-0.021291,0.017602,0,0
5,GO CHEMOKINE PRODUCTION,0.2356,-0.021393,-0.13902,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.9952,-0.021584,-0.0089311,0,0
5,GO MULTI ORGANISM PROCESS,0.33239,-0.02166,-0.028497,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.69555,-0.021727,-0.059873,0,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.4963,-0.021775,-0.02794,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.4445,-0.021783,-0.09799,0,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.8614,-0.021843,-0.017823,0,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.7772,-0.021849,-0.05298,0,0
5,GO REGULATION OF GASTRULATION,0.51944,-0.021934,-0.074935,0,0
5,GO BRONCHUS DEVELOPMENT,0.7588,-0.021939,-0.068164,0,0
5,GO TELOMERIC LOOP DISASSEMBLY,0.89939,-0.021991,0.011517,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.56735,-0.022117,-0.043568,0,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.35072,-0.022132,-0.036044,0,0
5,GO REGULATION OF TOR SIGNALING,0.55922,-0.022172,-0.025822,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.81436,-0.022201,-0.035401,0,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.91848,-0.022251,-0.029978,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.6603,-0.022554,-0.024008,0,0
5,GO ACTIVATION OF JNKK ACTIVITY,0.93762,-0.022632,-0.0079558,0,0
5,GO REGULATION OF JUN KINASE ACTIVITY,0.28117,-0.022653,-0.079151,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.43736,-0.022676,-0.083821,0,0
5,GO STRESS GRANULE ASSEMBLY,0.27583,-0.022699,-0.085321,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.60883,-0.022885,-0.072416,0,0
5,GO GOLGI LOCALIZATION,0.48871,-0.022886,-0.061627,0,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.59207,-0.022908,-0.036784,0,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.79572,-0.023086,-0.038836,0,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.34454,-0.023178,-0.17385,0,0
5,GO HEART VALVE FORMATION,0.8331,-0.023216,-0.040781,0,0
5,GO NCRNA TRANSCRIPTION,0.48871,-0.023262,-0.024523,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.62578,-0.023425,-0.1113,0,0
5,GO RENAL SODIUM EXCRETION,0.84251,-0.023514,-0.022209,0,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.61728,-0.023536,-0.013035,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.82372,-0.023557,-0.022885,0,0
5,GO FIBROBLAST MIGRATION,0.81436,-0.023604,-0.025715,0,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.45171,-0.023722,-0.082382,0,0
5,GO EXIT FROM MITOSIS,0.81436,-0.02378,-0.019272,0,0
5,GO MESENCHYMAL CELL PROLIFERATION,0.9952,-0.023816,-0.042695,0,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.22622,-0.023852,-0.053122,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.35072,-0.024062,-0.079662,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.71343,-0.024079,-0.031134,0,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.85194,-0.024447,-0.013113,0,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.70447,-0.024658,-0.077232,0,0
5,GO CYTOSOLIC TRANSPORT,0.24039,-0.024865,-0.055617,0,0
5,GO BLASTOCYST GROWTH,0.46631,-0.024887,-0.065184,0,0
5,GO PROTEIN PALMITOYLATION,0.87087,-0.024892,0.0076558,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.40267,-0.024992,-0.1212,0,0
5,GO NEURAL CREST FORMATION,0.9952,-0.024997,0.0048843,0,0
5,GO CELL JUNCTION ASSEMBLY,0.27583,-0.024999,-0.06319,0,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.97598,-0.025001,-0.013125,0,0
5,GO RESPONSE TO RADIATION,0.71343,-0.025347,-0.017683,0,0
5,GO REGULATION OF CELLULAR PH,0.29761,-0.02555,-0.058263,0,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.38267,-0.02555,-0.037658,0,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.60042,-0.025572,-0.044646,0,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.84251,-0.025633,-0.019977,0,0
5,GO RESPONSE TO FUNGUS,0.82372,-0.025709,-0.011925,0,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.60883,-0.025788,-0.062556,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.84251,-0.025824,-0.019921,0,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.74054,-0.025848,-0.061569,0,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.59207,-0.025899,-0.022331,0,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.96638,-0.025911,0.046076,0,0
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.7588,-0.025945,-0.012333,0,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.4963,-0.025962,-0.05329,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.68667,-0.026222,-0.036172,0,0
5,GO CELLULAR SENESCENCE,0.28658,-0.026275,-0.058205,0,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.40267,-0.026278,-0.076922,0,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.53518,-0.026288,-0.040537,0,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.53518,-0.026321,-0.060937,0,0
5,GO REGULATION OF CELL MATURATION,0.71343,-0.026363,-0.019897,0,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.36968,-0.026461,-0.077655,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.72243,-0.026506,-0.029909,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.68667,-0.026545,-0.031217,0,0
5,GO POLYAMINE METABOLIC PROCESS,0.50395,-0.026572,-0.055999,0,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.35072,-0.026636,-0.041145,0,0
5,GO DEVELOPMENTAL CELL GROWTH,0.73147,-0.026637,-0.017786,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.54313,-0.026669,-0.12533,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.56735,-0.026672,-0.077141,0,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.72243,-0.026781,-0.067497,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.8614,-0.026813,-0.0046031,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.53518,-0.026863,-0.033978,0,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.40947,-0.027029,-0.12162,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.25017,-0.02712,-0.092516,0,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.51944,-0.027199,-0.059237,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.56735,-0.02721,-0.018957,0,0
5,GO MAGNESIUM ION TRANSPORT,0.7772,-0.027345,-0.037673,0,0
5,GO T CELL DIFFERENTIATION IN THYMUS,0.8331,-0.027386,-0.029253,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.89939,-0.027401,-0.012155,0,0
5,GO SEGMENTATION,0.45171,-0.027416,-0.060133,0,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.9952,-0.027447,0.00071808,0,0
5,GO PROTEIN KINASE A SIGNALING,0.41634,-0.027481,-0.046884,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.48871,-0.027494,-0.056313,0,0
5,GO METHYLATION,0.19552,-0.027649,-0.036861,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.78645,-0.027798,-0.050992,0,0
5,GO PROTEIN AUTOUBIQUITINATION,0.50395,-0.028212,-0.027558,0,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.67783,-0.028216,-0.032071,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.7772,-0.028224,-0.10712,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.7588,-0.028268,-0.036426,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.39593,-0.028281,-0.10829,0,0
5,GO BONE DEVELOPMENT,0.30323,-0.028301,-0.07456,0,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.37614,-0.028317,-0.034643,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.40947,-0.028383,-0.035359,0,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.57554,-0.028417,-0.027468,0,0
5,GO MESODERM DEVELOPMENT,0.27583,-0.028533,-0.087289,0,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.29761,-0.028683,-0.037647,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.50395,-0.028723,-0.094,0,0
5,GO LIPID DIGESTION,0.34454,-0.028735,-0.15304,0,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.42328,-0.028752,-0.060928,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.39593,-0.028813,-0.096418,0,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.6516,-0.028992,0.034154,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.88036,-0.029005,0.033643,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.74054,-0.02902,-0.035791,0,0
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.19971,-0.029101,-0.088977,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.90893,-0.029117,0.0071919,0,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.30323,-0.029207,-0.10839,0,0
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.33239,-0.029218,-0.088608,0,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.55115,-0.029238,-0.098332,0,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.7588,-0.029263,-0.078417,0,0
5,GO LIMBIC SYSTEM DEVELOPMENT,0.92804,-0.029282,0.013943,0,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.80503,-0.029305,-0.016521,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.58378,-0.029364,-0.05299,0,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.4445,-0.029367,-0.0699,0,0
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.42328,-0.029386,-0.12435,0,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.48118,-0.029455,-0.038152,0,0
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.30892,-0.029457,-0.048287,0,0
5,GO TRANSLESION SYNTHESIS,0.7772,-0.029676,-0.017729,0,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.76799,-0.029741,-0.03592,0,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.7588,-0.02983,-0.084486,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.1794,-0.029856,-0.055788,0,0
5,GO RETINA HOMEOSTASIS,0.76799,-0.029928,-0.021598,0,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.29761,-0.029991,-0.073331,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.68667,-0.030112,-0.064411,0,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.48871,-0.030222,-0.036959,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.21712,-0.030277,-0.067178,0,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.42328,-0.030462,-0.060228,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.74054,-0.030485,-0.01914,0,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.55922,-0.030536,-0.080747,0,0
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.76799,-0.030648,-0.026164,0,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.32052,-0.03066,-0.079163,0,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.87087,-0.030936,0.036497,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.32052,-0.03109,-0.10445,0,0
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.57554,-0.031301,-0.033898,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.31468,-0.031322,-0.034727,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.85194,-0.031349,-0.01182,0,0
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.67783,-0.031433,-0.0355,0,0
5,GO WHITE FAT CELL DIFFERENTIATION,0.50395,-0.031457,-0.064033,0,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.7588,-0.031544,-0.090402,0,0
5,GO MAST CELL ACTIVATION,0.57554,-0.031753,-0.048419,0,0
5,GO ANIMAL ORGAN FORMATION,0.20828,-0.031905,-0.1125,0,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.67783,-0.031934,-0.0064696,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.47371,-0.032066,-0.052081,0,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.45171,-0.03213,-0.03161,0,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.51944,-0.03218,-0.073962,0,0
5,GO SULFATE TRANSPORT,0.17553,-0.032225,-0.12579,0,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.25017,-0.032244,-0.058066,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.52728,-0.032246,-0.10519,0,0
5,GO REGULATION OF RESPONSE TO FOOD,0.48118,-0.032261,-0.071232,0,0
5,GO EPIDERMIS DEVELOPMENT,0.25017,-0.032279,-0.096038,0,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.8331,-0.032323,-0.04486,0,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.28117,-0.032449,-0.15532,0,0
5,GO STRIATED MUSCLE ADAPTATION,0.48118,-0.032476,-0.055679,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.82372,-0.032502,0.0023764,0,0
5,GO REGULATION OF CELL DIFFERENTIATION,0.29761,-0.032625,-0.037224,0,0
5,GO NUCLEAR EXPORT,0.40947,-0.03263,-0.038819,0,0
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.32642,-0.032899,-0.050389,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.82372,-0.032899,0.01999,0,0
5,GO REGULATION OF PH,0.38927,-0.032923,-0.051696,0,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.71343,-0.032983,-0.050153,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.35072,-0.033064,-0.040222,0,0
5,GO RNA LOCALIZATION,0.26536,-0.033194,-0.056399,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION,0.1402,-0.033367,-0.050729,0,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.64294,-0.033438,-0.030406,0,0
5,GO OOCYTE DIFFERENTIATION,0.59207,-0.03344,-0.039771,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.87087,-0.033459,-0.025423,0,0
5,GO EMBRYO DEVELOPMENT,0.59207,-0.033473,-0.02672,0,0
5,GO PROTEIN DESTABILIZATION,0.42328,-0.033639,-0.046268,0,0
5,GO HAIR CELL DIFFERENTIATION,0.4445,-0.033654,-0.082358,0,0
5,GO NUCLEUS ORGANIZATION,0.45898,-0.0337,-0.024225,0,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.66904,-0.033762,-0.03916,0,0
5,GO REGULATION OF OOGENESIS,0.64294,-0.033887,-0.050134,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.87087,-0.033897,-0.030288,0,0
5,GO BLASTOCYST DEVELOPMENT,0.25516,-0.033947,-0.045618,0,0
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.8331,-0.033965,-0.023801,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.96638,-0.034056,0.016024,0,0
5,GO REGULATION OF MYELINATION,0.64294,-0.034061,-0.026026,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.43029,-0.034069,-0.037719,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.6516,-0.034395,-0.042814,0,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.45171,-0.034396,-0.071711,0,0
5,GO REGULATION OF URINE VOLUME,0.32642,-0.034521,-0.064452,0,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.36968,-0.034553,-0.063882,0,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.56735,-0.034579,-0.054244,0,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.1161,-0.034582,-0.045143,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.43029,-0.034624,-0.10786,0,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.39593,-0.034669,-0.068728,0,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.14679,-0.034892,-0.035953,0,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.21267,-0.034947,-0.048446,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.4445,-0.034959,-0.069896,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.33843,-0.035012,-0.081586,0,0
5,GO TISSUE HOMEOSTASIS,0.24525,-0.035027,-0.080717,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.22622,-0.035043,-0.034638,0,0
5,GO AMELOGENESIS,0.32642,-0.035229,-0.1243,0,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.6603,-0.035235,-0.10244,0,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.36968,-0.035316,-0.28248,0,0
5,GO T CELL HOMEOSTASIS,0.74966,-0.035318,-0.016075,0,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.45171,-0.035476,-0.075603,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.8614,-0.035633,-0.028596,0,0
5,GO LONG TERM MEMORY,0.8331,-0.035687,0.036665,0,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.55922,-0.035782,-0.069394,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.33843,-0.035845,-0.067725,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.8331,-0.035864,-0.012959,0,0
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.26023,-0.035878,-0.061564,0,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.45171,-0.03588,-0.069996,0,0
5,GO HISTONE PHOSPHORYLATION,0.39593,-0.03596,-0.062396,0,0
5,GO PROTEIN POLYMERIZATION,0.34454,-0.036031,-0.035015,0,0
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.97598,-0.036057,-0.023881,0,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.54313,-0.036136,-0.042003,0,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.36968,-0.036182,-0.044237,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.66904,-0.036418,-0.014671,0,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.4445,-0.036524,-0.12475,0,0
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.46631,-0.036545,-0.04429,0,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.54313,-0.036591,-0.07418,0,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.53518,-0.036599,-0.10502,0,0
5,GO ENDOTHELIUM DEVELOPMENT,0.6603,-0.036665,-0.040433,0,0
5,GO MOTOR NEURON AXON GUIDANCE,0.4445,-0.036786,-0.058439,0,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.32052,-0.036877,-0.037998,0,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.74054,-0.036987,-0.080579,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.98559,-0.037031,-0.010172,0,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.45171,-0.037125,-0.054348,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.82372,-0.037166,-0.0095827,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.93762,-0.037214,0.02203,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.9952,-0.037219,0.0099364,0,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.34454,-0.037322,-0.079778,0,0
5,GO GLUCOSE IMPORT,0.67783,-0.037327,-0.024448,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.55922,-0.037353,-0.043252,0,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.29761,-0.037486,-0.074617,0,0
5,GO LACTATE METABOLIC PROCESS,0.8614,-0.037516,0.0024981,0,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.79572,-0.03758,-0.014784,0,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.33239,-0.037585,-0.065171,0,0
5,GO THYROID HORMONE METABOLIC PROCESS,0.79572,-0.037626,-0.013022,0,0
5,GO HORMONE TRANSPORT,0.52728,-0.037633,-0.03437,0,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.43029,-0.03764,-0.10034,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.58378,-0.037707,-0.027879,0,0
5,GO MANGANESE ION TRANSPORT,0.4963,-0.037748,-0.060237,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.10794,-0.037783,-0.055401,0,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.11061,-0.037828,-0.05489,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.30323,-0.0379,-0.067081,0,0
5,GO SKIN EPIDERMIS DEVELOPMENT,0.32052,-0.037913,-0.11083,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.9952,-0.03792,0.067807,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.34454,-0.038008,-0.088799,0,0
5,GO INTERLEUKIN 10 PRODUCTION,0.48118,-0.03802,-0.056865,0,0
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.59207,-0.038039,-0.031076,0,0
5,GO PROTEIN DENEDDYLATION,0.74966,-0.038062,-0.025685,0,0
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.28658,-0.038189,-0.055346,0,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.85194,-0.038392,0.034044,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.19139,-0.03843,-0.088979,0,0
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.16798,-0.038431,-0.1512,0,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.73147,-0.038449,-0.03149,0,0
5,GO HINDLIMB MORPHOGENESIS,0.85194,-0.03848,0.0025567,0,0
5,GO REGULATION OF GENE SILENCING,0.17553,-0.038498,-0.072102,0,0
5,GO CELL GROWTH,0.17553,-0.038627,-0.053974,0,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.72243,-0.038665,-0.010473,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.74054,-0.038711,-0.02495,0,0
5,GO TOR SIGNALING,0.23088,-0.038835,-0.041024,0,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.14679,-0.038837,-0.044752,0,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.15361,-0.038876,-0.076555,0,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.45898,-0.038925,-0.069483,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.6603,-0.03893,0.097654,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.1161,-0.038937,-0.042501,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.59207,-0.039004,-0.05681,0,0
5,GO SENSORY PERCEPTION OF SMELL,0.21267,-0.039095,-0.077235,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.45898,-0.039113,-0.030793,0,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.35697,-0.039131,-0.084324,0,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.29206,-0.039177,-0.050458,0,0
5,GO GLYCOSYLATION,0.18733,-0.039201,-0.097783,0,0
5,GO REGULATION OF SYSTEM PROCESS,0.21712,-0.039208,-0.061673,0,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.28117,-0.03926,-0.03384,0,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.82372,-0.039289,0.00086898,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.43029,-0.039325,-0.08458,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.55115,-0.039386,-0.056533,0,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1,-0.039454,0.038409,0,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.36329,-0.039523,-0.048392,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.70447,-0.039532,-0.017485,0,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.89939,-0.039534,-0.030126,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.51167,-0.03956,-0.033247,0,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.16798,-0.039613,-0.046167,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.35072,-0.039647,-0.07046,0,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.46631,-0.039698,-0.060431,0,0
5,GO CELL JUNCTION ORGANIZATION,0.35072,-0.039729,-0.04957,0,0
5,GO EPITHELIAL TUBE FORMATION,0.61728,-0.039851,-0.038411,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.40947,-0.039942,-0.13061,0,0
5,GO NERVOUS SYSTEM PROCESS,0.71343,-0.039973,-0.0084952,0,0
5,GO REGULATION OF CELL SIZE,0.69555,-0.040093,-0.014275,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.56735,-0.040149,-0.031128,0,0
5,GO DENDRITE EXTENSION,0.84251,-0.04023,0.10868,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.50395,-0.040263,-0.051734,0,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.42328,-0.040292,-0.11822,0,0
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.17173,-0.040354,-0.088546,0,0
5,GO RESPONSE TO ALKALOID,0.2356,-0.040363,-0.079147,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.60042,-0.040432,-0.019014,0,0
5,GO REGULATION OF CALCIUM ION IMPORT,0.29206,-0.04047,-0.097633,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE,0.35697,-0.040524,-0.051409,0,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.8614,-0.040555,-0.015867,0,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.06115,-0.040581,-0.066076,0,0
5,GO NERVE DEVELOPMENT,0.78645,-0.040604,-0.01999,0,0
5,GO MATING,0.43736,-0.040673,-0.051582,0,0
5,GO EMBRYONIC MORPHOGENESIS,0.41634,-0.040691,-0.043429,0,0
5,GO REGULATION OF AXON GUIDANCE,0.89939,-0.040777,-0.014042,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.34454,-0.040901,-0.061928,0,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.48871,-0.040918,-0.044812,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.43736,-0.041112,-0.081933,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.1794,-0.041227,-0.052055,0,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.36329,-0.041238,-0.03614,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.7772,-0.041306,-0.017896,0,0
5,GO REGULATION OF ICOSANOID SECRETION,0.84251,-0.04152,-0.012918,0,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.67783,-0.041551,-0.021769,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.22164,-0.041594,-0.063883,0,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.6603,-0.041605,-0.019003,0,0
5,GO INTERFERON ALPHA PRODUCTION,0.93762,-0.041688,0.013147,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.24525,-0.041703,-0.097066,0,0
5,GO NEURON MATURATION,1,-0.04177,0.039727,0,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32642,-0.041797,-0.053393,0,0
5,GO CELL VOLUME HOMEOSTASIS,0.43736,-0.04192,-0.036985,0,0
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.29761,-0.041994,-0.067144,0,0
5,GO LYMPHOCYTE DIFFERENTIATION,0.20396,-0.042136,-0.073781,0,0
5,GO REGULATION OF T CELL MIGRATION,0.38267,-0.042143,-0.068813,0,0
5,GO REGULATION OF PROTEIN MATURATION,0.12472,-0.042255,-0.13951,0,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.32642,-0.042484,-0.10078,0,0
5,GO SKIN DEVELOPMENT,0.21267,-0.042532,-0.10735,0,0
5,GO BEHAVIOR,0.9472,-0.042564,0.011488,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.23088,-0.042594,-0.058715,0,0
5,GO NEGATIVE REGULATION OF BINDING,0.23088,-0.042642,-0.047052,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.87087,-0.042692,-0.0087703,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.69555,-0.043012,-0.013976,0,0
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.35697,-0.043016,-0.051003,0,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.25017,-0.043079,-0.10855,0,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.30323,-0.043153,-0.10485,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.30323,-0.043212,-0.043497,0,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.69555,-0.043229,-0.093234,0,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.12472,-0.043231,-0.088356,0,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.57554,-0.043238,-0.051005,0,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.31468,-0.043304,-0.094458,0,0
5,GO ZINC ION TRANSPORT,0.20396,-0.043442,-0.10432,0,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.63434,-0.043576,-0.042569,0,0
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.56735,-0.043614,-0.026914,0,0
5,GO RNA DESTABILIZATION,0.91848,-0.043617,-0.018399,0,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.87087,-0.043725,0.068489,0,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.63434,-0.043755,-0.043448,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.43736,-0.043767,-0.081635,0,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.25017,-0.043767,-0.091547,0,0
5,GO VACUOLAR TRANSPORT,0.25516,-0.043801,-0.070501,0,0
5,GO RESPONSE TO PROGESTERONE,0.40267,-0.043891,-0.1013,0,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.7772,-0.043908,-0.030582,0,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.39593,-0.043944,-0.042777,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.47371,-0.043975,-0.090737,0,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.60042,-0.044016,-0.049739,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.36968,-0.044136,-0.047246,0,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.66904,-0.044141,-0.023707,0,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.12179,-0.044154,-0.055869,0,0
5,GO RESPONSE TO ANTIBIOTIC,0.46631,-0.044243,-0.045325,0,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.32052,-0.044341,-0.062393,0,0
5,GO PROTEIN O LINKED GLYCOSYLATION,0.30323,-0.044398,-0.11708,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.58378,-0.044423,-0.035207,0,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.26536,-0.044564,-0.082069,0,0
5,GO REGULATION OF DNA METHYLATION,0.51944,-0.044814,-0.052092,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.090686,-0.044835,-0.051121,0,0
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.30323,-0.044838,-0.099522,0,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.50395,-0.0449,-0.036767,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.24525,-0.044955,-0.04327,0,0
5,GO PRE MIRNA PROCESSING,0.60883,-0.044966,-0.062084,0,0
5,GO RNA 3 END PROCESSING,0.53518,-0.045115,-0.039717,0,0
5,GO REGULATION OF FATTY ACID TRANSPORT,0.57554,-0.045161,-0.059018,0,0
5,GO TAXIS,0.13699,-0.045254,-0.068193,0,0
5,GO MITOTIC CELL CYCLE ARREST,0.89939,-0.04541,0.021041,0,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.13699,-0.045461,-0.069148,0,0
5,GO CATECHOLAMINE SECRETION,0.8331,-0.045478,0.063977,0,0
5,GO ENDOSOMAL TRANSPORT,0.26023,-0.045574,-0.040396,0,0
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.62578,-0.045636,-0.067465,0,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.70447,-0.045708,-0.032224,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14347,-0.045837,-0.045786,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.17173,-0.045878,-0.052675,0,0
5,GO RHYTHMIC BEHAVIOR,0.16068,-0.046018,-0.079663,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.7772,-0.046038,-0.043034,0,0
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.27583,-0.046095,-0.056639,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.78645,-0.046132,-0.015175,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.6603,-0.046145,-0.048602,0,0
5,GO GLIOGENESIS,0.19971,-0.046191,-0.082041,0,0
5,GO PROTEIN POLYGLUTAMYLATION,0.93762,-0.046208,-0.03386,0,0
5,GO DETECTION OF STIMULUS,0.15712,-0.046407,-0.04852,0,0
5,GO CALCIUM ION IMPORT,0.50395,-0.046452,-0.034937,0,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.35697,-0.046477,-0.11943,0,0
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.4963,-0.046608,-0.151,0,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.50395,-0.046636,-0.11379,0,0
5,GO INNERVATION,0.96638,-0.04672,0.036992,0,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.36329,-0.046777,-0.10314,0,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.38927,-0.046782,-0.054894,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.35697,-0.046814,-0.067338,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.25017,-0.046825,-0.19939,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.34454,-0.046848,-0.038971,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.84251,-0.046975,-0.020741,0,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.45171,-0.047054,-0.062693,0,0
5,GO NEURAL CREST CELL MIGRATION,0.35072,-0.047059,-0.10252,0,0
5,GO REGULATION OF ODONTOGENESIS,0.43736,-0.047103,-0.10243,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.9952,-0.04716,0.005985,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.53518,-0.047203,-0.023863,0,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.20396,-0.04723,-0.057948,0,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.16068,-0.047234,-0.11354,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.31468,-0.047358,-0.044799,0,0
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.51167,-0.047434,-0.073652,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.79572,-0.047448,-0.0083133,0,0
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.13384,-0.047469,-0.037887,0,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.79572,-0.047497,0.053281,0,0
5,GO EPITHELIUM DEVELOPMENT,0.21712,-0.047529,-0.07283,0,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.19971,-0.047619,-0.06728,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.28117,-0.047766,-0.054245,0,0
5,GO REGULATION OF PEPTIDE SECRETION,0.18733,-0.047852,-0.069429,0,0
5,GO PEPTIDE HORMONE SECRETION,0.48118,-0.047871,-0.033117,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.50395,-0.047963,-0.072196,0,0
5,GO MIRNA METABOLIC PROCESS,0.19552,-0.048006,-0.083295,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.43736,-0.048476,-0.098108,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.93762,-0.048515,0.04438,0,0
5,GO REGULATION OF MEMBRANE POTENTIAL,0.45898,-0.04856,-0.030943,0,0
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.056323,-0.048801,-0.073363,0,0
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.29206,-0.048827,-0.046016,0,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.30323,-0.048866,-0.063717,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.31468,-0.048922,-0.11974,0,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.43029,-0.048998,-0.066803,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.32642,-0.049208,-0.073427,0,0
5,GO TRANSMISSION OF NERVE IMPULSE,0.78645,-0.049259,-0.00052206,0,0
5,GO PROTEIN DEPHOSPHORYLATION,0.22164,-0.049283,-0.040666,0,0
5,GO SINGLE FERTILIZATION,0.19139,-0.0494,-0.064638,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.95679,-0.049422,0.023352,0,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.53518,-0.049459,-0.059788,0,0
5,GO POSITIVE REGULATION OF GROWTH,0.36329,-0.049527,-0.039827,0,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.59207,-0.049559,-0.065776,0,0
5,GO POSITIVE REGULATION OF TRANSPORT,0.077726,-0.049639,-0.066679,0,0
5,GO REGULATION OF T CELL ACTIVATION,0.17173,-0.049661,-0.092666,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.30323,-0.049773,-0.08242,0,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.19139,-0.049859,-0.086449,0,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.32642,-0.050122,-0.09676,0,0
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.1643,-0.050277,-0.14832,0,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.090686,-0.050326,-0.062177,0,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.13699,-0.050328,-0.098859,0,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.32052,-0.050337,-0.097576,0,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.78645,-0.05069,-0.028912,0,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.057895,-0.050866,-0.06677,0,0
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.30323,-0.050894,-0.044219,0,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.7588,-0.050922,-0.027136,0,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.9952,-0.05101,0.014745,0,0
5,GO PEPTIDE SECRETION,0.13699,-0.051136,-0.077015,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.45898,-0.051207,-0.01764,0,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.10794,-0.05122,-0.086992,0,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.45898,-0.051276,-0.034631,0,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.29206,-0.051456,-0.079485,0,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.40947,-0.051522,-0.058991,0,0
5,GO ADIPOSE TISSUE DEVELOPMENT,0.32642,-0.051574,-0.078465,0,0
5,GO NUCLEAR TRANSPORT,0.11333,-0.051587,-0.055999,0,0
5,GO CELL CELL SIGNALING BY WNT,0.1643,-0.051594,-0.063247,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.52728,-0.05161,-0.091611,0,0
5,GO INOSITOL METABOLIC PROCESS,0.7588,-0.051615,-0.014541,0,0
5,GO ESTABLISHMENT OF CELL POLARITY,0.28117,-0.051622,-0.050532,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32052,-0.05167,-0.093954,0,0
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.079775,-0.051851,-0.069437,0,0
5,GO FEVER GENERATION,0.25516,-0.051899,-0.14203,0,0
5,GO T CELL DIFFERENTIATION,0.4445,-0.051951,-0.06217,0,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.12179,-0.052069,-0.11011,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.22622,-0.052128,-0.035748,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.7588,-0.05214,-0.03367,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.036694,-0.052179,-0.084645,0,0
5,GO BONE TRABECULA FORMATION,0.28117,-0.05242,-0.30409,0,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.58378,-0.052492,-0.044934,0,0
5,GO STEM CELL DIFFERENTIATION,0.21267,-0.052515,-0.060908,0,0
5,GO PARTURITION,0.89939,-0.052528,-0.034142,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.85194,-0.052545,-0.010933,0,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.13699,-0.052682,-0.10182,0,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.35697,-0.052734,-0.12534,0,0
5,GO GOLGI ORGANIZATION,0.051817,-0.052813,-0.084557,0,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.51944,-0.052929,-0.1049,0,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20396,-0.05298,-0.10132,0,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.92804,-0.052998,0.022977,0,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.32642,-0.053062,-0.093951,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.54313,-0.053062,-0.035759,0,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.85194,-0.053139,-0.0083452,0,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.15017,-0.053176,-0.052288,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.7588,-0.053222,-0.017608,0,0
5,GO RHYTHMIC PROCESS,0.31468,-0.05329,-0.033088,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.16798,-0.053308,-0.099897,0,0
5,GO RESPONSE TO IRON ION,0.35697,-0.053336,-0.064782,0,0
5,GO MAST CELL MEDIATED IMMUNITY,0.55922,-0.053384,-0.037616,0,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.35072,-0.053384,-0.037352,0,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.51167,-0.053416,-0.16428,0,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.48871,-0.053432,-0.063898,0,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.088413,-0.053442,-0.10224,0,0
5,GO REGULATION OF CELLULAR LOCALIZATION,0.1643,-0.053479,-0.043987,0,0
5,GO MACROPHAGE DIFFERENTIATION,0.20828,-0.053585,-0.1297,0,0
5,GO LIPID DROPLET ORGANIZATION,0.33843,-0.05359,-0.090241,0,0
5,GO CELL CELL JUNCTION ORGANIZATION,0.26023,-0.053617,-0.0962,0,0
5,GO PROTEIN MANNOSYLATION,0.55922,-0.053642,-0.02972,0,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.60042,-0.053656,-0.040139,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.11061,-0.05382,-0.076632,0,0
5,GO ENDOSOME ORGANIZATION,0.30323,-0.053837,-0.057729,0,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.36968,-0.053965,-0.10214,0,0
5,GO INTERLEUKIN 12 PRODUCTION,0.48871,-0.053973,-0.054753,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.78645,-0.054027,-0.025497,0,0
5,GO PLASMA MEMBRANE REPAIR,0.4445,-0.054034,-0.083007,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.54313,-0.05419,-0.030049,0,0
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.15712,-0.054196,-0.079732,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.38267,-0.054213,-0.076466,0,0
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.20828,-0.054218,-0.073767,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.55115,-0.054263,-0.097717,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.11892,-0.054344,-0.06478,0,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.52728,-0.054366,-0.026942,0,0
5,GO REGULATION OF PEPTIDE TRANSPORT,0.14347,-0.054516,-0.05413,0,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.24039,-0.054579,-0.084087,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.30323,-0.054584,-0.098873,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.36329,-0.054635,-0.049573,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.30323,-0.05467,-0.15689,0,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.47371,-0.054708,-0.076437,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.74966,-0.054763,-0.0094199,0,0
5,GO REGULATION OF FERTILIZATION,0.35697,-0.054799,-0.079928,0,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.34454,-0.054818,-0.091746,0,0
5,GO MITOCHONDRIAL FISSION,0.12472,-0.054869,-0.10745,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.38927,-0.054913,-0.056062,0,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.13074,-0.054921,-0.094426,0,0
5,GO ORGAN GROWTH,0.19139,-0.055002,-0.071395,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION,0.24039,-0.055004,-0.078486,0,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.22164,-0.055121,-0.10205,0,0
5,GO REGULATION OF DENDRITE EXTENSION,0.57554,-0.055136,0.024289,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.46631,-0.055158,-0.0258,0,0
5,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.9952,-0.055211,-0.0148,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.61728,-0.055259,-0.069769,0,0
5,GO NUCLEAR PORE ORGANIZATION,0.48871,-0.055292,-0.07153,0,0
5,GO EPIDERMAL CELL DIFFERENTIATION,0.27056,-0.055311,-0.086099,0,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.24039,-0.055409,-0.096377,0,0
5,GO DETECTION OF CALCIUM ION,0.97598,-0.055795,0.015301,0,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.54313,-0.055812,-0.057442,0,0
5,GO CELL CELL ADHESION,0.069955,-0.055823,-0.10352,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.15017,-0.055858,-0.11646,0,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.17553,-0.055884,-0.099651,0,0
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.17553,-0.055941,-0.069608,0,0
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.12771,-0.056021,-0.080022,0,0
5,GO REGULATION OF ENDOCRINE PROCESS,0.1794,-0.056147,-0.092853,0,0
5,GO PLATELET ACTIVATION,0.13384,-0.056224,-0.11085,0,0
5,GO CARBOHYDRATE TRANSPORT,0.066316,-0.056384,-0.09729,0,0
5,GO RESPONSE TO INTERFERON ALPHA,0.9472,-0.056439,-0.12419,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.31468,-0.056458,-0.074255,0,0
5,GO REGULATION OF GTP BINDING,0.45898,-0.056546,-0.096153,0,0
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.071835,-0.05655,-0.10072,0,0
5,GO SOMATIC STEM CELL DIVISION,0.60042,-0.056591,0.15304,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.97598,-0.056612,0.00084152,0,0
5,GO VESICLE DOCKING,0.30892,-0.056623,-0.053197,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.51944,-0.056658,-0.045213,0,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.28658,-0.056693,-0.08071,0,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.21267,-0.056865,-0.083868,0,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.62578,-0.056874,-0.11435,0,0
5,GO FERTILIZATION,0.12179,-0.05691,-0.069055,0,0
5,GO REGULATION OF DEPHOSPHORYLATION,0.26536,-0.056953,-0.033718,0,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.24039,-0.056975,-0.064044,0,0
5,GO TRACHEA MORPHOGENESIS,0.55115,-0.056982,-0.081083,0,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.069955,-0.057001,-0.087248,0,0
5,GO LYSOSOME LOCALIZATION,0.55115,-0.057054,-0.020387,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.18334,-0.057131,-0.094458,0,0
5,GO SECONDARY PALATE DEVELOPMENT,0.62578,-0.057231,-0.043668,0,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.24039,-0.05727,-0.090418,0,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.26023,-0.057274,-0.095253,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.19552,-0.057357,-0.14028,0,0
5,GO REGULATION OF ION TRANSPORT,0.1402,-0.057398,-0.077292,0,0
5,GO CATECHOLAMINE UPTAKE,0.34454,-0.057503,-0.13214,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.48118,-0.057517,-0.074986,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.27583,-0.057584,-0.069665,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.29761,-0.057584,-0.084985,0,0
5,GO RESPONSE TO ACTIVITY,0.10533,-0.057589,-0.091719,0,0
5,GO ACTIN FILAMENT BASED PROCESS,0.051817,-0.057634,-0.08939,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.1794,-0.057726,-0.108,0,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.33843,-0.057801,-0.090833,0,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.043706,-0.057814,-0.10488,0,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.28117,-0.05782,-0.184,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.28117,-0.057871,-0.08004,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.51944,-0.057926,-0.065311,0,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.60042,-0.058001,-0.062992,0,0
5,GO RNA POLYADENYLATION,0.19971,-0.058036,-0.07638,0,0
5,GO MUSCLE CELL FATE COMMITMENT,0.21712,-0.058087,-0.17707,0,0
5,GO DEVELOPMENTAL GROWTH,0.18733,-0.058107,-0.054127,0,0
5,GO REGULATION OF HAIR CYCLE,0.19552,-0.05815,-0.13624,0,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.64294,-0.05815,-0.044306,0,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.17173,-0.058191,-0.059612,0,0
5,GO CELLULAR RESPONSE TO ALCOHOL,0.43736,-0.058213,-0.056652,0,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.22622,-0.05826,-0.12725,0,0
5,GO MALE SEX DIFFERENTIATION,0.16798,-0.058266,-0.085434,0,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.43736,-0.058451,-0.05754,0,0
5,GO CALCIUM MEDIATED SIGNALING,0.12472,-0.058479,-0.065953,0,0
5,GO CELL RECOGNITION,0.12472,-0.058521,-0.085879,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.64294,-0.05856,-0.10038,0,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.4963,-0.058575,-0.057732,0,0
5,GO DIVALENT METAL ION EXPORT,0.88036,-0.058679,0.022243,0,0
5,GO PHAGOSOME MATURATION,0.18334,-0.058841,-0.11227,0,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.50395,-0.058897,-0.043526,0,0
5,GO IMPORT INTO NUCLEUS,0.037792,-0.059065,-0.087669,0,0
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.42328,-0.059133,-0.078012,0,0
5,GO ORGANELLE INHERITANCE,0.15361,-0.059239,-0.076471,0,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.10025,-0.05928,-0.10614,0,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.21267,-0.059404,-0.077006,0,0
5,GO REGULATION OF B CELL DIFFERENTIATION,0.57554,-0.059434,-0.063754,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.66904,-0.059487,-0.025796,0,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.14347,-0.059498,-0.10108,0,0
5,GO CELL CELL JUNCTION ASSEMBLY,0.21712,-0.059523,-0.1047,0,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.69555,-0.059528,-0.025956,0,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.11061,-0.059567,-0.094734,0,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.34454,-0.059593,-0.10174,0,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.26536,-0.059621,-0.079125,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.40947,-0.059672,-0.13942,0,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.43029,-0.059729,-0.10368,0,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.1402,-0.059855,-0.057358,0,0
5,GO REGULATION OF CELL ACTIVATION,0.11333,-0.059889,-0.10514,0,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.34454,-0.059938,-0.083338,0,0
5,GO DEPHOSPHORYLATION,0.1161,-0.06,-0.05409,0,0
5,GO EXECUTION PHASE OF APOPTOSIS,0.62578,-0.060043,-0.021251,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.25017,-0.060059,-0.047361,0,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.52728,-0.060123,-0.05855,0,0
5,GO GROWTH,0.07572,-0.060176,-0.065036,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.17553,-0.060194,-0.24316,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.15361,-0.060473,-0.17237,0,0
5,GO NUCLEOTIDE TRANSPORT,0.46631,-0.060488,-0.052051,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.7588,-0.060551,-0.062347,0,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.12179,-0.060579,-0.058076,0,0
5,GO OOCYTE MATURATION,0.4445,-0.060585,-0.041811,0,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.46631,-0.060618,-0.10412,0,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.073757,-0.060646,-0.059795,0,0
5,GO HEART MORPHOGENESIS,0.28658,-0.060806,-0.078592,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.13699,-0.060813,-0.10287,0,0
5,GO INTERFERON BETA PRODUCTION,0.54313,-0.061109,-0.058685,0,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.29761,-0.061223,-0.095968,0,0
5,GO HISTONE DEACETYLATION,0.23088,-0.061268,-0.053395,0,0
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.030665,-0.061304,-0.0993,0,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.27583,-0.06147,-0.1025,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.96638,-0.061531,0.0053248,0,0
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.8614,-0.061539,-0.066329,0,0
5,GO MRNA CLEAVAGE,0.17173,-0.061703,-0.06925,0,0
5,GO CYTOKINE SECRETION,0.38267,-0.061727,-0.066266,0,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.15712,-0.061729,-0.074423,0,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.36968,-0.061734,-0.080056,0,0
5,GO BILE ACID METABOLIC PROCESS,0.71343,-0.061788,-0.050449,0,0
5,GO VIRAL BUDDING,0.54313,-0.061803,-0.018377,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.22164,-0.061892,-0.075912,0,0
5,GO OLIGODENDROCYTE DEVELOPMENT,0.13699,-0.061894,-0.11462,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.81436,-0.06191,-0.009782,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.19139,-0.062004,-0.085174,0,0
5,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.32052,-0.062019,-0.17653,0,0
5,GO L GLUTAMATE IMPORT,0.52728,-0.062177,-0.071928,0,0
5,GO TISSUE MORPHOGENESIS,0.10533,-0.062288,-0.087781,0,0
5,GO MITOTIC RECOMBINATION,0.6516,-0.062313,-0.028729,0,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.27056,-0.06256,-0.09306,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.16798,-0.062734,-0.12848,0,0
5,GO RESPONSE TO LEPTIN,0.32642,-0.062765,-0.074465,0,0
5,GO ALPHA BETA T CELL ACTIVATION,0.19971,-0.063042,-0.09833,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.31468,-0.063074,-0.10006,0,0
5,GO HORMONE CATABOLIC PROCESS,0.7772,-0.063114,-0.023338,0,0
5,GO REGULATION OF RESPIRATORY BURST,0.34454,-0.06319,-0.10536,0,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.13699,-0.063263,-0.08031,0,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.093006,-0.063275,-0.1066,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.036694,-0.063352,-0.055561,0,0
5,GO REGULATION OF TRANSPORT,0.068115,-0.063369,-0.069104,0,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.68667,-0.063458,-0.062936,0,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.29206,-0.063487,-0.1228,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.20828,-0.063528,-0.14109,0,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.20396,-0.063545,-0.1138,0,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.34454,-0.063603,-0.053878,0,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.090686,-0.063649,-0.12556,0,0
5,GO PIRNA METABOLIC PROCESS,0.25017,-0.063762,-0.13768,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.13699,-0.063775,-0.15393,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.1643,-0.063838,-0.070613,0,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.27583,-0.063842,-0.072878,0,0
5,GO HISTONE H2B UBIQUITINATION,0.7772,-0.063928,-0.029433,0,0
5,GO SOMITOGENESIS,0.18334,-0.063984,-0.088441,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.45171,-0.063991,-0.067427,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.16068,-0.064037,-0.10083,0,0
5,GO SNORNA 3 END PROCESSING,0.6603,-0.064053,-0.040949,0,0
5,GO LENS FIBER CELL DIFFERENTIATION,0.35697,-0.064057,-0.090183,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.17173,-0.064076,-0.16816,0,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.30892,-0.06409,-0.087619,0,0
5,GO WALKING BEHAVIOR,0.80503,-0.064109,-0.00049746,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.17173,-0.064182,-0.12062,0,0
5,GO MUSCLE CELL DIFFERENTIATION,0.086186,-0.064219,-0.081608,0,0
5,GO ENDOCYTIC RECYCLING,0.29206,-0.064313,-0.067453,0,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.43736,-0.064431,-0.036618,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.32052,-0.064538,-0.083247,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.82372,-0.064558,-0.026334,0,0
5,GO PROTEIN KINASE B SIGNALING,0.10277,-0.06457,-0.10437,0,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.41634,-0.064673,-0.059912,0,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.38927,-0.064678,-0.086299,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.66904,-0.064758,-0.04272,0,0
5,GO TELOMERE ORGANIZATION,0.20396,-0.06478,-0.057259,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.67783,-0.06479,-0.03808,0,0
5,GO SENSORY PERCEPTION,0.12179,-0.064793,-0.061312,0,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.24525,-0.06484,-0.14597,0,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.55115,-0.065093,-0.026889,0,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.67783,-0.065095,-0.059503,0,0
5,GO ASSOCIATIVE LEARNING,0.80503,-0.0651,-0.011937,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.57554,-0.065114,-0.046462,0,0
5,GO KERATINOCYTE DIFFERENTIATION,0.23088,-0.065119,-0.10532,0,0
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.1643,-0.065152,-0.072914,0,0
5,GO REGULATION OF LYASE ACTIVITY,0.38927,-0.065304,-0.063139,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.13074,-0.065337,-0.11461,0,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.35072,-0.065452,-0.08556,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.25516,-0.065496,-0.070126,0,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.6603,-0.065504,-0.069286,0,0
5,GO B CELL DIFFERENTIATION,0.11333,-0.065523,-0.1079,0,0
5,GO EXOCYTIC PROCESS,0.62578,-0.065605,-0.0030868,0,0
5,GO SLEEP,0.18334,-0.065646,-0.097658,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.42328,-0.065686,-0.069307,0,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.10794,-0.065735,-0.12715,0,0
5,GO MOLTING CYCLE,0.19139,-0.065786,-0.097036,0,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.57554,-0.066008,-0.090368,0,0
5,GO TRANSFERRIN TRANSPORT,0.21712,-0.066096,-0.095054,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.22622,-0.06614,-0.09818,0,0
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.16068,-0.066164,-0.092035,0,0
5,GO SCHWANN CELL DIFFERENTIATION,0.10794,-0.066291,-0.11063,0,0
5,GO ANIMAL ORGAN MATURATION,0.36968,-0.066303,-0.073163,0,0
5,GO POTASSIUM ION TRANSPORT,0.41634,-0.066327,-0.037705,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.6603,-0.066335,-0.084915,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.25017,-0.066368,-0.039704,0,0
5,GO LYMPHOCYTE MIGRATION,0.09779,-0.066387,-0.11548,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.51944,-0.066392,-0.040388,0,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.64294,-0.066393,-0.044757,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.32052,-0.066402,-0.10581,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.4445,-0.066537,-0.029803,0,0
5,GO MUSCLE TISSUE DEVELOPMENT,0.13384,-0.066561,-0.073843,0,0
5,GO TOOTH MINERALIZATION,0.39593,-0.06672,-0.11395,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.36968,-0.066726,-0.10657,0,0
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.064555,-0.066752,-0.091732,0,0
5,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.33239,-0.066806,-0.13595,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.4963,-0.066896,-0.091782,0,0
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.071835,-0.066927,-0.074221,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.14679,-0.066948,-0.11922,0,0
5,GO STARTLE RESPONSE,0.64294,-0.066961,-0.061186,0,0
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.031606,-0.066974,-0.10326,0,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.086186,-0.067023,-0.084975,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.12472,-0.067039,-0.072534,0,0
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.20828,-0.06713,-0.066913,0,0
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.1161,-0.067317,-0.085173,0,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.079775,-0.067379,-0.11171,0,0
5,GO RESPONSE TO IONIZING RADIATION,0.29761,-0.067396,-0.058903,0,0
5,GO METANEPHROS MORPHOGENESIS,0.6603,-0.067445,-0.029891,0,0
5,GO CANONICAL WNT SIGNALING PATHWAY,0.10277,-0.067501,-0.083972,0,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.31468,-0.067632,-0.078199,0,0
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.13074,-0.067761,-0.065351,0,0
5,GO TUBE DEVELOPMENT,0.1161,-0.067823,-0.094984,0,0
5,GO RNA INTERFERENCE,0.21712,-0.067846,-0.11373,0,0
5,GO POSITIVE REGULATION OF SIGNALING,0.042464,-0.067865,-0.079699,0,0
5,GO GONADOTROPIN SECRETION,0.9952,-0.067867,0.032193,0,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.48118,-0.067918,-0.033155,0,0
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.13384,-0.067937,-0.13806,0,0
5,GO SENSORY PERCEPTION OF PAIN,0.28117,-0.067999,-0.059607,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.077726,-0.068029,-0.071831,0,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.035624,-0.068056,-0.079019,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.96638,-0.068058,-0.0083502,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.38927,-0.068094,-0.071103,0,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.46631,-0.068348,-0.056131,0,0
5,GO SKELETAL SYSTEM DEVELOPMENT,0.10794,-0.068361,-0.08355,0,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.093006,-0.068408,-0.090106,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.13699,-0.068596,-0.10929,0,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.10794,-0.068674,-0.065678,0,0
5,GO NEUROINFLAMMATORY RESPONSE,0.29761,-0.06868,-0.090954,0,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.4445,-0.068755,-0.08822,0,0
5,GO CARTILAGE DEVELOPMENT,0.15361,-0.068806,-0.10698,0,0
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.10277,-0.068829,-0.067466,0,0
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.086186,-0.068899,-0.076109,0,0
5,GO OSTEOCLAST DIFFERENTIATION,0.21712,-0.068914,-0.076858,0,0
5,GO PRIMARY MIRNA PROCESSING,0.22164,-0.068915,-0.12518,0,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.71343,-0.068952,-0.020003,0,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.43029,-0.068959,-0.091382,0,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.35072,-0.069002,-0.10283,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.98559,-0.06906,-0.0042358,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.52728,-0.069115,-0.04319,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.29206,-0.069126,-0.16017,0,0
5,GO ENSHEATHMENT OF NEURONS,0.24039,-0.069252,-0.061971,0,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.073757,-0.069375,-0.080841,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.048983,-0.069378,-0.091322,0,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.034581,-0.069538,-0.075334,0,0
5,GO LYSOSOMAL TRANSPORT,0.17553,-0.069547,-0.08219,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.55115,-0.069605,-0.08881,0,0
5,GO PORE COMPLEX ASSEMBLY,0.22164,-0.069619,-0.098227,0,0
5,GO TUBE MORPHOGENESIS,0.050383,-0.069756,-0.11809,0,0
5,GO ANIMAL ORGAN MORPHOGENESIS,0.15017,-0.069767,-0.072653,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.042464,-0.069787,-0.086793,0,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.52728,-0.069853,-0.08085,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.28117,-0.069859,-0.10292,0,0
5,GO NEGATIVE REGULATION OF SIGNALING,0.032572,-0.069927,-0.082133,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.19139,-0.070003,-0.10657,0,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.10533,-0.070189,-0.093418,0,0
5,GO LYMPH VESSEL DEVELOPMENT,0.18733,-0.070267,-0.14891,0,0
5,GO PROTEIN N LINKED GLYCOSYLATION,0.077726,-0.070292,-0.11799,0,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.15361,-0.070384,-0.072324,0,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.030665,-0.07044,-0.076458,0,0
5,GO TUBE FORMATION,0.51167,-0.070459,-0.047434,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.70447,-0.070502,-0.027654,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.7588,-0.070553,-0.030272,0,0
5,GO ADRENAL GLAND DEVELOPMENT,0.63434,-0.070601,-0.10587,0,0
5,GO CERAMIDE METABOLIC PROCESS,0.088413,-0.070672,-0.095099,0,0
5,GO MECHANORECEPTOR DIFFERENTIATION,0.38927,-0.070703,-0.088457,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.11061,-0.070705,-0.07188,0,0
5,GO MUSCLE FIBER DEVELOPMENT,0.26536,-0.07074,-0.068204,0,0
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.33843,-0.070761,-0.123,0,0
5,GO IMMUNE SYSTEM DEVELOPMENT,0.069955,-0.070853,-0.080941,0,0
5,GO REGULATION OF PLATELET AGGREGATION,0.40267,-0.070877,-0.13838,0,0
5,GO CELL CYCLE ARREST,0.11892,-0.070901,-0.054423,0,0
5,GO MRNA TRANSCRIPTION,0.80503,-0.070902,-0.02765,0,0
5,GO LYMPH NODE DEVELOPMENT,0.51167,-0.070946,-0.061486,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.50395,-0.070961,-0.068639,0,0
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.42328,-0.070982,-0.059865,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.82372,-0.070989,-0.073053,0,0
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.037792,-0.070989,-0.090439,0,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.27583,-0.070995,-0.075513,0,0
5,GO ADULT HEART DEVELOPMENT,0.79572,-0.071057,-0.046905,0,0
5,GO INSULIN SECRETION,0.41634,-0.071165,-0.049246,0,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.15017,-0.071193,-0.11435,0,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.24039,-0.071241,-0.081934,0,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.11892,-0.071241,-0.091227,0,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.60042,-0.071293,-0.11199,0,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.53518,-0.071337,-0.070274,0,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.22164,-0.071478,-0.17398,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.15017,-0.071485,-0.062707,0,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.38267,-0.071652,-0.11967,0,0
5,GO PIGMENTATION,0.036694,-0.071672,-0.11317,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.45898,-0.071777,-0.052551,0,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.056323,-0.071828,-0.10503,0,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.10277,-0.071838,-0.095976,0,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.069955,-0.071941,-0.129,0,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.48871,-0.07198,-0.10399,0,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.18733,-0.072033,-0.099906,0,0
5,GO REGULATION OF INSULIN SECRETION,0.33843,-0.072044,-0.051979,0,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.1794,-0.072115,-0.085292,0,0
5,GO REGULATION OF DOPAMINE SECRETION,0.78645,-0.072148,0.046769,0,0
5,GO ARACHIDONIC ACID SECRETION,0.09779,-0.072214,-0.12725,0,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.15017,-0.072277,-0.082359,0,0
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.28117,-0.072306,-0.087339,0,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.71343,-0.072362,-0.064669,0,0
5,GO EPITHELIAL CELL CELL ADHESION,0.4445,-0.072381,-0.086751,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.36968,-0.072399,-0.085999,0,0
5,GO REGULATION OF ACROSOME REACTION,0.62578,-0.072419,-0.062888,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.1794,-0.072584,-0.064077,0,0
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.51167,-0.072589,-0.0774,0,0
5,GO CELL MOTILITY,0.071835,-0.07261,-0.093072,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47371,-0.072676,-0.042677,0,0
5,GO GASTRULATION,0.13074,-0.072744,-0.12956,0,0
5,GO B CELL ACTIVATION,0.050383,-0.072766,-0.11997,0,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.054786,-0.072833,-0.10383,0,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.12771,-0.072869,-0.089129,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.17553,-0.072948,-0.11516,0,0
5,GO CHONDROCYTE DIFFERENTIATION,0.22164,-0.073019,-0.10195,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.21712,-0.073098,-0.12679,0,0
5,GO REGULATION OF PROTEIN TARGETING,0.1794,-0.073131,-0.054488,0,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.48871,-0.073173,-0.053839,0,0
5,GO DOPAMINE TRANSPORT,0.4445,-0.073194,-0.014127,0,0
5,GO REGULATION OF B CELL PROLIFERATION,0.079775,-0.073244,-0.15742,0,0
5,GO MIDBODY ABSCISSION,0.31468,-0.073285,-0.051986,0,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.6603,-0.07335,-0.02779,0,0
5,GO RNA PROCESSING,0.071835,-0.073534,-0.083083,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10025,-0.073538,-0.13292,0,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.27056,-0.073612,-0.10444,0,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.25017,-0.07389,-0.059452,0,0
5,GO MANNOSYLATION,0.43736,-0.074013,-0.059756,0,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.33843,-0.074038,-0.061696,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.17173,-0.074046,-0.067178,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.26023,-0.074146,-0.053469,0,0
5,GO RESPONSE TO ALCOHOL,0.041252,-0.074166,-0.11842,0,0
5,GO RUFFLE ORGANIZATION,0.26536,-0.074193,-0.070335,0,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.073757,-0.074197,-0.20007,0,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.12771,-0.074229,-0.11032,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.1161,-0.074268,-0.15289,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.1643,-0.074357,-0.15203,0,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.081867,-0.074388,-0.11941,0,0
5,GO I KAPPAB PHOSPHORYLATION,0.15017,-0.074402,-0.14227,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.38927,-0.074412,-0.06223,0,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.17173,-0.074415,-0.091181,0,0
5,GO EPITHELIAL CELL DEVELOPMENT,0.22164,-0.074441,-0.095251,0,0
5,GO ACTIN FILAMENT ORGANIZATION,0.044978,-0.074453,-0.098527,0,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.23088,-0.074586,-0.082604,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.6603,-0.074593,-0.057253,0,0
5,GO MYOBLAST PROLIFERATION,0.37614,-0.074594,-0.098581,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.1643,-0.074633,-0.066922,0,0
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.1643,-0.074638,-0.10469,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.31468,-0.074658,-0.073955,0,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.25017,-0.074731,-0.060469,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.47371,-0.074811,-0.071898,0,0
5,GO REGULATION OF B CELL ACTIVATION,0.15361,-0.074812,-0.10934,0,0
5,GO SEX DIFFERENTIATION,0.11061,-0.074839,-0.076161,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.12472,-0.074926,-0.12499,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.6603,-0.074931,-0.034006,0,0
5,GO RESPONSE TO MECHANICAL STIMULUS,0.19971,-0.074957,-0.089722,0,0
5,GO PROSTATE GLAND DEVELOPMENT,0.38927,-0.075014,-0.12428,0,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.6603,-0.075452,-0.026355,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.88987,-0.075477,0.076362,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.12179,-0.075619,-0.12303,0,0
5,GO CHLORIDE ION HOMEOSTASIS,0.51167,-0.075631,-0.063847,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.12472,-0.075638,-0.13511,0,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.68667,-0.075648,-0.051593,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.41634,-0.075725,-0.051269,0,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.38267,-0.075741,-0.11354,0,0
5,GO RNA CAPPING,0.15712,-0.075744,-0.08005,0,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.31468,-0.075894,-0.04301,0,0
5,GO INTERLEUKIN 4 PRODUCTION,0.20828,-0.075912,-0.093464,0,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.095374,-0.076046,-0.13743,0,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.057895,-0.076199,-0.12942,0,0
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.073757,-0.076442,-0.14306,0,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.71343,-0.076481,-0.036743,0,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.90893,-0.076487,-0.031807,0,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.1161,-0.076517,-0.099692,0,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.062834,-0.076722,-0.10404,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.050383,-0.076797,-0.093112,0,0
5,GO CELLULAR PIGMENTATION,0.10277,-0.076832,-0.09913,0,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.28658,-0.076844,-0.060768,0,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.24525,-0.076856,-0.11978,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.57554,-0.076903,-0.05406,0,0
5,GO RESPONSE TO ESTRADIOL,0.051817,-0.076911,-0.10444,0,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.14347,-0.076912,-0.082768,0,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17553,-0.07699,-0.087984,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.15017,-0.077007,-0.12021,0,0
5,GO REFLEX,0.6516,-0.077098,-0.074871,0,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.37614,-0.077111,-0.061227,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.42328,-0.077325,-0.10658,0,0
5,GO VIRION ASSEMBLY,0.13699,-0.077327,-0.087042,0,0
5,GO HEART DEVELOPMENT,0.077726,-0.077347,-0.093734,0,0
5,GO RESPONSE TO NICOTINE,0.84251,-0.077416,0.0037712,0,0
5,GO PSEUDOPODIUM ORGANIZATION,0.51167,-0.077461,-0.11321,0,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.31468,-0.077615,-0.075536,0,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.032572,-0.077626,-0.12877,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.81436,-0.077668,-0.0572,0,0
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.14679,-0.077699,-0.09689,0,0
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.11061,-0.07771,-0.076853,0,0
5,GO LIPOPROTEIN LOCALIZATION,0.11333,-0.077712,-0.14496,0,0
5,GO MACROMOLECULE DEACYLATION,0.093006,-0.077773,-0.059599,0,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.63434,-0.077837,-0.1206,0,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.12179,-0.077906,-0.088322,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.40947,-0.077907,-0.060739,0,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16068,-0.078035,-0.1127,0,0
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.13699,-0.078037,-0.078751,0,0
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.18334,-0.078171,-0.14766,0,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.55115,-0.078183,-0.059437,0,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.081867,-0.078261,-0.079305,0,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.17173,-0.078337,-0.11314,0,0
5,GO COAGULATION,0.041252,-0.078562,-0.13447,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.14679,-0.078605,-0.10327,0,0
5,GO COMPLEMENT ACTIVATION,0.11061,-0.07873,-0.13812,0,0
5,GO MYOFIBRIL ASSEMBLY,0.11333,-0.078777,-0.094695,0,0
5,GO MUSCLE ORGAN MORPHOGENESIS,0.14679,-0.078832,-0.10799,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.4445,-0.078939,-0.061185,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.80503,-0.079036,-0.029174,0,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.78645,-0.079073,-0.025313,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.25516,-0.079088,-0.13473,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.74966,-0.079147,-0.023254,0,0
5,GO B CELL MEDIATED IMMUNITY,0.25017,-0.079203,-0.1148,0,0
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.034581,-0.079249,-0.11476,0,0
5,GO NEGATIVE REGULATION OF SECRETION,0.066316,-0.079279,-0.084339,0,0
5,GO SARCOMERE ORGANIZATION,0.21712,-0.079391,-0.084805,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.22622,-0.079425,-0.10482,0,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.19971,-0.079427,-0.07262,0,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.32642,-0.079496,-0.10476,0,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.16068,-0.079509,-0.17742,0,0
5,GO REGULATION OF GROWTH,0.088413,-0.079573,-0.06763,0,0
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035624,-0.079632,-0.097116,0,0
5,GO AMINE METABOLIC PROCESS,0.035624,-0.079743,-0.13229,0,0
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.58378,-0.079765,-0.024305,0,0
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.046281,-0.079786,-0.077356,0,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.11061,-0.079823,-0.10818,0,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.34454,-0.079842,-0.13362,0,0
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.06115,-0.079846,-0.088075,0,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.1402,-0.079871,-0.13429,0,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.29761,-0.079893,-0.08172,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.80503,-0.079967,-0.059225,0,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.16798,-0.080063,-0.12044,0,0
5,GO CGMP MEDIATED SIGNALING,0.12179,-0.080086,-0.14387,0,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.038917,-0.080091,-0.13252,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.23088,-0.080111,-0.10278,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.64294,-0.080254,-0.10146,0,0
5,GO CELLULAR RESPONSE TO DSRNA,0.35072,-0.080416,-0.11399,0,0
5,GO TRNA TRANSPORT,0.16798,-0.080529,-0.079414,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.31468,-0.080586,-0.06817,0,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.39593,-0.080605,-0.062471,0,0
5,GO MESENCHYME MORPHOGENESIS,0.16798,-0.080684,-0.15945,0,0
5,GO LEUKOCYTE AGGREGATION,0.76799,-0.080687,-0.058118,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.13074,-0.080735,-0.12815,0,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.40267,-0.080753,-0.092409,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.78645,-0.080833,-0.052421,0,0
5,GO CELLULAR DEFENSE RESPONSE,0.10277,-0.080835,-0.16927,0,0
5,GO BONE GROWTH,0.46631,-0.080898,-0.11032,0,0
5,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.69555,-0.080952,-0.056918,0,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.043706,-0.080974,-0.15409,0,0
5,GO MEMBRANE REPOLARIZATION,0.29761,-0.081118,-0.09786,0,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.047616,-0.081145,-0.12858,0,0
5,GO REGULATION OF BINDING,0.050383,-0.081214,-0.083489,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.15361,-0.081227,-0.13327,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.12472,-0.081277,-0.1254,0,0
5,GO RNA STABILIZATION,0.28658,-0.081422,-0.070952,0,0
5,GO AUTOPHAGIC CELL DEATH,0.30892,-0.081443,-0.09123,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.032572,-0.081523,-0.10322,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.27056,-0.081569,-0.16436,0,0
5,GO REGULATION OF MACROAUTOPHAGY,0.036694,-0.081571,-0.076955,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.6516,-0.081573,-0.062753,0,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.19971,-0.081598,-0.12556,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.10794,-0.081643,-0.13001,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.11333,-0.081678,-0.16699,0,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.1402,-0.081704,-0.12289,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.12771,-0.081724,-0.10468,0,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.19552,-0.081738,-0.075886,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.15361,-0.081783,-0.1167,0,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.30892,-0.081786,-0.13056,0,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.11333,-0.081862,-0.10945,0,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.1161,-0.081869,-0.090495,0,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.068115,-0.081935,-0.088489,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.73147,-0.081951,-0.019899,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.20396,-0.082126,-0.06572,0,0
5,GO DEFENSE RESPONSE TO VIRUS,0.58378,-0.082147,-0.085775,0,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.15361,-0.082158,-0.097147,0,0
5,GO REGULATION OF MUSCLE ADAPTATION,0.053284,-0.082188,-0.12744,0,0
5,GO MUSCLE ORGAN DEVELOPMENT,0.053284,-0.082199,-0.089595,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.15712,-0.08232,-0.0751,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.43029,-0.082357,-0.036532,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.26023,-0.082357,-0.05698,0,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.054786,-0.082431,-0.13241,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.18334,-0.082472,-0.10213,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.36968,-0.082495,-0.11099,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.6603,-0.082538,-0.060486,0,0
5,GO FILOPODIUM ASSEMBLY,0.52728,-0.082552,-0.047125,0,0
5,GO LIPOXYGENASE PATHWAY,0.30892,-0.082569,-0.18539,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.33843,-0.082571,-0.16128,0,0
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.071835,-0.082573,-0.098569,0,0
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.054786,-0.082693,-0.098527,0,0
5,GO MESENCHYME DEVELOPMENT,0.086186,-0.082784,-0.11188,0,0
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.053284,-0.082788,-0.086609,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.24525,-0.082802,-0.15511,0,0
5,GO RESPONSE TO AMYLOID BETA,0.37614,-0.082892,-0.061681,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.06115,-0.082919,-0.13606,0,0
5,GO FIBROBLAST ACTIVATION,0.43029,-0.082949,-0.08553,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.086186,-0.082982,-0.23793,0,0
5,GO REGULATION OF HORMONE LEVELS,0.16798,-0.082986,-0.076501,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32642,-0.083319,-0.15876,0,0
5,GO CARDIAC CONDUCTION,0.26023,-0.083339,-0.08658,0,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.19552,-0.083351,-0.1235,0,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.073757,-0.08339,-0.12866,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.14679,-0.083423,-0.10233,0,0
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.054786,-0.08354,-0.08415,0,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.073757,-0.083561,-0.12564,0,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.050383,-0.083644,-0.087445,0,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.64294,-0.083659,-0.042576,0,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.8614,-0.083675,0.002732,0,0
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.51944,-0.08368,-0.074229,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.13384,-0.083701,-0.08979,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.21267,-0.08374,-0.1658,0,0
5,GO NEUTROPHIL CHEMOTAXIS,0.20828,-0.083807,-0.085157,0,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.10533,-0.083855,-0.14317,0,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.12179,-0.083879,-0.10662,0,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15361,-0.083966,-0.099294,0,0
5,GO PROTEIN NEDDYLATION,0.28117,-0.084125,-0.077867,0,0
5,GO CATION TRANSPORT,0.062834,-0.084158,-0.083862,0,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.088413,-0.084174,-0.074324,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.50395,-0.084199,-0.045413,0,0
5,GO LEUKOCYTE CELL CELL ADHESION,0.06115,-0.08427,-0.13153,0,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.73147,-0.084307,-0.018361,0,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.044978,-0.084308,-0.10084,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.15361,-0.084363,-0.10067,0,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.55922,-0.084512,-0.048101,0,0
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.22622,-0.084694,-0.11626,0,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.15017,-0.084725,-0.11585,0,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.13074,-0.08475,-0.11556,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.04007,-0.084798,-0.13866,0,0
5,GO CATION TRANSMEMBRANE TRANSPORT,0.064555,-0.084813,-0.087023,0,0
5,GO CELL AGGREGATION,0.67783,-0.084823,-0.035274,0,0
5,GO ASTROCYTE DIFFERENTIATION,0.24039,-0.084828,-0.10926,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.97598,-0.084866,-0.0044847,0,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.55922,-0.084906,-0.044835,0,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.10533,-0.084977,-0.14621,0,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.086186,-0.084998,-0.12341,0,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24039,-0.085005,-0.12165,0,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.16798,-0.085013,-0.10177,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.1794,-0.085017,-0.13992,0,0
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.26536,-0.085064,-0.22068,0,0
5,GO RESPONSE TO SALT STRESS,0.60042,-0.085075,-0.047965,0,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.13074,-0.085124,-0.11947,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.17173,-0.085167,-0.11222,0,0
5,GO PROTEIN TARGETING TO VACUOLE,0.1161,-0.085262,-0.10984,0,0
5,GO LYMPHOCYTE ACTIVATION,0.056323,-0.08527,-0.10615,0,0
5,GO AMYLOID FIBRIL FORMATION,0.4445,-0.085287,-0.092193,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.15017,-0.085395,-0.074803,0,0
5,GO BLASTODERM SEGMENTATION,0.48871,-0.085456,-0.11022,0,0
5,GO MESODERM MORPHOGENESIS,0.17173,-0.085531,-0.13531,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.46631,-0.085574,-0.090343,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.37614,-0.0858,-0.075442,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.059504,-0.085821,-0.14832,0,0
5,GO METAL ION TRANSPORT,0.04007,-0.085871,-0.095061,0,0
5,GO IRON ION TRANSPORT,0.044978,-0.085872,-0.10362,0,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.1402,-0.08588,-0.1265,0,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.09779,-0.086122,-0.14874,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.13699,-0.086246,-0.14511,0,0
5,GO ACTIN NUCLEATION,0.054786,-0.086302,-0.11055,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.12771,-0.086341,-0.098522,0,0
5,GO CYTOKINE METABOLIC PROCESS,0.044978,-0.086395,-0.17783,0,0
5,GO T CELL ACTIVATION,0.13384,-0.086472,-0.10646,0,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.034581,-0.086715,-0.12855,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.22164,-0.086715,-0.12148,0,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.18334,-0.086725,-0.096389,0,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.056323,-0.08677,-0.10215,0,0
5,GO ION TRANSMEMBRANE TRANSPORT,0.035624,-0.086839,-0.090335,0,0
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.044978,-0.086933,-0.12564,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.45898,-0.086993,-0.073523,0,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.60042,-0.086996,-0.030547,0,0
5,GO FEEDING BEHAVIOR,0.31468,-0.087006,-0.054754,0,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.21267,-0.087104,-0.13728,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.059504,-0.08711,-0.09465,0,0
5,GO AMINO ACID TRANSPORT,0.13074,-0.08713,-0.085353,0,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.037792,-0.087187,-0.10779,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.27583,-0.087297,-0.050883,0,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.28658,-0.087441,-0.084181,0,0
5,GO CELLULAR EXTRAVASATION,0.15361,-0.0875,-0.10104,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.050383,-0.087506,-0.09172,0,0
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.40947,-0.087612,-0.12396,0,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.70447,-0.087657,-0.14518,0,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.084004,-0.087817,-0.089374,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.88036,-0.087998,0.049606,0,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.17553,-0.088007,-0.066953,0,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.12771,-0.088061,-0.072945,0,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.064555,-0.088124,-0.11993,0,0
5,GO RESPONSE TO VITAMIN,0.16068,-0.088181,-0.1203,0,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.56735,-0.0883,-0.11379,0,0
5,GO MYOBLAST DIFFERENTIATION,0.18733,-0.088311,-0.11695,0,0
5,GO SPHINGOLIPID METABOLIC PROCESS,0.057895,-0.088494,-0.12229,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.041252,-0.088547,-0.08891,0,0
5,GO PROSTAGLANDIN TRANSPORT,0.15017,-0.088559,-0.12319,0,0
5,GO SENSORY PERCEPTION OF TASTE,0.10277,-0.088575,-0.11823,0,0
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.036694,-0.088634,-0.09107,0,0
5,GO MEMBRANE DISASSEMBLY,0.33239,-0.08871,-0.091635,0,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.12771,-0.088713,-0.1113,0,0
5,GO LEUKOCYTE HOMEOSTASIS,0.044978,-0.088759,-0.12258,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.30892,-0.088809,-0.096502,0,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.033564,-0.088824,-0.11305,0,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.28658,-0.088858,-0.081511,0,0
5,GO HEART GROWTH,0.18733,-0.088879,-0.074814,0,0
5,GO ACTIVATION OF MAPK ACTIVITY,0.035624,-0.088883,-0.10534,0,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.15017,-0.088906,-0.18809,0,0
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.06115,-0.088964,-0.097496,0,0
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.10277,-0.088986,-0.10069,0,0
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.15361,-0.089121,-0.08885,0,0
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.1161,-0.089354,-0.10931,0,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.20396,-0.089362,-0.15518,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.057895,-0.089388,-0.099747,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.31468,-0.089408,-0.060335,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.72243,-0.089456,-0.038354,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.64294,-0.089634,-0.045064,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.14679,-0.089998,-0.083684,0,0
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.041252,-0.090082,-0.11672,0,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.28117,-0.090112,-0.15104,0,0
5,GO REGULATION OF HEART GROWTH,0.24525,-0.09017,-0.07996,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.48871,-0.090242,-0.0099238,0,0
5,GO PHOSPHOLIPID TRANSPORT,0.04007,-0.090244,-0.13185,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.40947,-0.090297,-0.079717,0,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.030665,-0.090321,-0.092125,0,0
5,GO LAMELLIPODIUM ASSEMBLY,0.071835,-0.09036,-0.10891,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.24039,-0.090389,-0.14608,0,0
5,GO ORGANELLE MEMBRANE FUSION,0.057895,-0.090451,-0.12757,0,0
5,GO REGULATION OF BLOOD CIRCULATION,0.1402,-0.090472,-0.086938,0,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.21712,-0.090479,-0.11664,0,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.19139,-0.090568,-0.11897,0,0
5,GO FAT CELL DIFFERENTIATION,0.081867,-0.090801,-0.10893,0,0
5,GO POLYOL CATABOLIC PROCESS,0.33239,-0.090913,-0.045445,0,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.066316,-0.090954,-0.13339,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.47371,-0.091048,-0.11362,0,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.20828,-0.091108,-0.13294,0,0
5,GO PEPTIDYL TYROSINE MODIFICATION,0.050383,-0.091141,-0.11788,0,0
5,GO POSITIVE REGULATION OF CELL KILLING,0.43736,-0.091154,-0.09006,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.34454,-0.091221,-0.065981,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.24525,-0.091333,-0.1351,0,0
5,GO KIDNEY MORPHOGENESIS,0.67783,-0.091337,-0.02302,0,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.088413,-0.091403,-0.084335,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.48871,-0.091405,-0.071277,0,0
5,GO BASIC AMINO ACID TRANSPORT,0.22164,-0.091517,-0.15921,0,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.17173,-0.091519,-0.12725,0,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.19552,-0.091567,-0.11896,0,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.1643,-0.091615,-0.10131,0,0
5,GO CARDIAC SEPTUM DEVELOPMENT,0.18733,-0.091652,-0.12228,0,0
5,GO REGULATION OF HEMOPOIESIS,0.053284,-0.091872,-0.10161,0,0
5,GO REGULATION OF VIRAL LIFE CYCLE,0.40267,-0.091906,-0.12983,0,0
5,GO LYSINE METABOLIC PROCESS,0.33843,-0.092051,-0.13392,0,0
5,GO ATP TRANSPORT,0.24039,-0.092136,-0.07682,0,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.19139,-0.092293,-0.1023,0,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.090686,-0.092355,-0.18529,0,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.1161,-0.092466,-0.16173,0,0
5,GO CYTOKINETIC PROCESS,0.051817,-0.092599,-0.14673,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.32052,-0.092676,-0.13291,0,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.10533,-0.092682,-0.075302,0,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.35697,-0.092723,-0.081652,0,0
5,GO GROWTH HORMONE SECRETION,0.69555,-0.092766,-0.0022692,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.095374,-0.092842,-0.14958,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.46631,-0.092885,-0.074358,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.35697,-0.092981,-0.13409,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.22164,-0.092985,-0.083692,0,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.030665,-0.092993,-0.10025,0,0
5,GO LENS FIBER CELL DEVELOPMENT,0.21267,-0.093,-0.14499,0,0
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.037792,-0.093027,-0.12377,0,0
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.042464,-0.093105,-0.11063,0,0
5,GO SEX DETERMINATION,0.43029,-0.093142,-0.063396,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.70447,-0.093188,0.11449,0,0
5,GO RESPONSE TO VIRUS,0.33239,-0.093192,-0.106,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.041252,-0.093349,-0.10139,0,0
5,GO LUNG ALVEOLUS DEVELOPMENT,0.43029,-0.093422,-0.067585,0,0
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.45171,-0.093623,-0.13652,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.066316,-0.093776,-0.15097,0,0
5,GO NEUTROPHIL MIGRATION,0.066316,-0.093795,-0.12622,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.19139,-0.093885,-0.07812,0,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.22622,-0.09391,-0.11992,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.10277,-0.094027,-0.14676,0,0
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.035624,-0.094033,-0.11781,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.079775,-0.094034,-0.18035,0,0
5,GO MYOTUBE DIFFERENTIATION,0.051817,-0.094058,-0.13275,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.39593,-0.094074,-0.083082,0,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.19971,-0.094078,-0.17545,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.30323,-0.094113,-0.12817,0,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.09779,-0.094215,-0.088155,0,0
5,GO AUTOPHAGOSOME ORGANIZATION,0.12179,-0.094247,-0.10444,0,0
5,GO T CELL MIGRATION,0.064555,-0.094264,-0.15144,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.09779,-0.094286,-0.12034,0,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.09779,-0.094376,-0.096142,0,0
5,GO GASTRIC ACID SECRETION,0.64294,-0.094402,-0.046151,0,0
5,GO ACID SECRETION,0.26023,-0.094432,-0.06223,0,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.22164,-0.094435,-0.063397,0,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.032572,-0.094552,-0.098036,0,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.30892,-0.094592,-0.094815,0,0
5,GO REGULATORY T CELL DIFFERENTIATION,0.59207,-0.094604,-0.079691,0,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.1794,-0.094605,-0.084547,0,0
5,GO REGULATION OF CELL SHAPE,0.21712,-0.094678,-0.089549,0,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.14679,-0.094704,-0.092304,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.88987,-0.094777,-0.047181,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.78645,-0.094807,-0.029134,0,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.1161,-0.09485,-0.11092,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.31468,-0.094864,-0.050589,0,0
5,GO LYMPHOCYTE CHEMOTAXIS,0.12771,-0.094951,-0.11277,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.13699,-0.094994,-0.15643,0,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.13074,-0.095133,-0.14824,0,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.10277,-0.095416,-0.16377,0,0
5,GO STEROID HORMONE SECRETION,0.43029,-0.09549,-0.1138,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.12179,-0.095494,-0.14536,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.28117,-0.0955,-0.18387,0,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.09779,-0.095591,-0.11243,0,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.068115,-0.095591,-0.10257,0,0
5,GO TOXIN METABOLIC PROCESS,0.30892,-0.095638,-0.12535,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38927,-0.095746,-0.10899,0,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.1161,-0.095781,-0.12175,0,0
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.037792,-0.095788,-0.11423,0,0
5,GO VIRAL RELEASE FROM HOST CELL,0.12179,-0.095832,-0.11431,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.6603,-0.095873,-0.03351,0,0
5,GO TYPE I INTERFERON PRODUCTION,0.16798,-0.095969,-0.12232,0,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.031606,-0.096013,-0.098199,0,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.13384,-0.096109,-0.19303,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.31468,-0.096117,-0.060832,0,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.20828,-0.09629,-0.1121,0,0
5,GO LEUKOTRIENE METABOLIC PROCESS,0.073757,-0.096326,-0.18661,0,0
5,GO STORE OPERATED CALCIUM ENTRY,0.32642,-0.096348,-0.11572,0,0
5,GO RECEPTOR INTERNALIZATION,0.10025,-0.096374,-0.083594,0,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.11333,-0.096479,-0.13341,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.084004,-0.096571,-0.10825,0,0
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.04007,-0.096625,-0.09816,0,0
5,GO REGULATION OF EXOSOMAL SECRETION,0.28658,-0.096651,-0.13557,0,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.15017,-0.096666,-0.16736,0,0
5,GO INTERLEUKIN 1 PRODUCTION,0.07572,-0.096747,-0.18707,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.53518,-0.096752,-0.064851,0,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.13384,-0.096792,-0.16914,0,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.079775,-0.096902,-0.09661,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.30892,-0.096929,-0.065614,0,0
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.032572,-0.097043,-0.10768,0,0
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.11333,-0.097052,-0.082473,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.050383,-0.097074,-0.16741,0,0
5,GO VIRAL LIFE CYCLE,0.086186,-0.097078,-0.14123,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.059504,-0.097141,-0.10292,0,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.42328,-0.097206,-0.10112,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.39593,-0.097427,-0.10699,0,0
5,GO CONVERGENT EXTENSION,0.47371,-0.097461,-0.080808,0,0
5,GO SMOOTH MUSCLE CELL MIGRATION,0.079775,-0.097477,-0.19738,0,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.22164,-0.097519,-0.1298,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.086186,-0.097536,-0.069762,0,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.45898,-0.09757,-0.047714,0,0
5,GO REGULATION OF CELL CELL ADHESION,0.044978,-0.097596,-0.13621,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.51944,-0.097716,-0.084517,0,0
5,GO SERTOLI CELL DEVELOPMENT,0.60883,-0.097725,-0.061728,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.1794,-0.097744,-0.15658,0,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.17553,-0.097761,-0.13271,0,0
5,GO REGULATION OF SYMBIOTIC PROCESS,0.21267,-0.097811,-0.12438,0,0
5,GO LYMPHOCYTE HOMEOSTASIS,0.057895,-0.097881,-0.10164,0,0
5,GO TRANSEPITHELIAL TRANSPORT,0.084004,-0.097885,-0.13891,0,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.2356,-0.097922,-0.11431,0,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.18334,-0.097944,-0.20161,0,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.15361,-0.098008,-0.12699,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.032572,-0.098043,-0.097278,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.38927,-0.098077,-0.15557,0,0
5,GO PEPTIDE CROSS LINKING,0.088413,-0.098147,-0.23853,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.077726,-0.098152,-0.17886,0,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.04007,-0.098249,-0.097398,0,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.19971,-0.098261,-0.096952,0,0
5,GO IMMUNOGLOBULIN SECRETION,0.11892,-0.098323,-0.17202,0,0
5,GO TUBULIN DEACETYLATION,0.33239,-0.098392,-0.076134,0,0
5,GO EXCRETION,0.11892,-0.098396,-0.10868,0,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.16068,-0.098421,-0.10185,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.046281,-0.098524,-0.12754,0,0
5,GO HYPEROSMOTIC RESPONSE,0.48871,-0.098545,-0.064261,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.51167,-0.098753,-0.015829,0,0
5,GO ALPHA BETA T CELL PROLIFERATION,0.48871,-0.098831,-0.087266,0,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.30323,-0.098876,-0.10015,0,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.077726,-0.09893,-0.14993,0,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.73147,-0.099034,-0.035535,0,0
5,GO RESPONSE TO COLD,0.11892,-0.099072,-0.19237,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.88987,-0.099078,-0.00037412,0,0
5,GO SNRNA METABOLIC PROCESS,0.12472,-0.099094,-0.12518,0,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.27583,-0.099096,-0.16539,0,0
5,GO REGULATION OF PROTEIN DEACETYLATION,0.1643,-0.099152,-0.079335,0,0
5,GO DEVELOPMENTAL PIGMENTATION,0.071835,-0.099173,-0.10494,0,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.048983,-0.099289,-0.1526,0,0
5,GO METANEPHROS DEVELOPMENT,0.18733,-0.099487,-0.098683,0,0
5,GO CELL AGING,0.034581,-0.09962,-0.11278,0,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.042464,-0.099665,-0.096884,0,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.031606,-0.099736,-0.1004,0,0
5,GO NEUROMUSCULAR PROCESS,0.33843,-0.099746,-0.05508,0,0
5,GO MEMBRANE FUSION,0.050383,-0.099811,-0.10975,0,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.086186,-0.099925,-0.13498,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.032572,-0.10008,-0.1279,0,0
5,GO RESPONSE TO L GLUTAMATE,1,-0.10027,0.0072535,0,0
5,GO CELLULAR RESPONSE TO VIRUS,0.26023,-0.10037,-0.093,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.70447,-0.10045,-0.018233,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.19552,-0.1005,-0.10166,0,0
5,GO CELLULAR RESPONSE TO FATTY ACID,0.16068,-0.10051,-0.13068,0,0
5,GO HEART PROCESS,0.073757,-0.10058,-0.10437,0,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.044978,-0.10058,-0.14982,0,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.37614,-0.10073,-0.10698,0,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.10277,-0.10077,-0.11255,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.050383,-0.10087,-0.1251,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.079775,-0.10087,-0.18159,0,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.27056,-0.10088,-0.165,0,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.069955,-0.10088,-0.16924,0,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.34454,-0.10094,-0.081667,0,0
5,GO GLAND DEVELOPMENT,0.047616,-0.10101,-0.10467,0,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.066316,-0.10105,-0.122,0,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.21712,-0.10113,-0.14851,0,0
5,GO RESPONSE TO AXON INJURY,0.21267,-0.10113,-0.088372,0,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.14679,-0.10117,-0.14946,0,0
5,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.54313,-0.1013,-0.048545,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.084004,-0.10136,-0.12111,0,0
5,GO AUTOPHAGOSOME MATURATION,0.086186,-0.10136,-0.13358,0,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.30323,-0.10144,-0.13023,0,0
5,GO ELASTIC FIBER ASSEMBLY,0.27056,-0.10145,-0.25088,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.19139,-0.10147,-0.093536,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.1794,-0.10147,-0.090878,0,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.35072,-0.10172,-0.14685,0,0
5,GO MUSCLE CELL DEVELOPMENT,0.037792,-0.10174,-0.11452,0,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.19139,-0.10193,-0.14505,0,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.11061,-0.10199,-0.13056,0,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.081867,-0.10202,-0.11951,0,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.43736,-0.10207,-0.11745,0,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.13699,-0.10212,-0.079298,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.11892,-0.10213,-0.13485,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.29761,-0.10216,-0.095699,0,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.35697,-0.10229,-0.12315,0,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.095374,-0.10229,-0.09679,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.13699,-0.10235,-0.26428,0,0
5,GO MRNA MODIFICATION,0.12179,-0.10241,-0.12895,0,0
5,GO REGULATION OF PHAGOCYTOSIS,0.10533,-0.10247,-0.13688,0,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.21712,-0.10256,-0.18827,0,0
5,GO MULTI ORGANISM LOCALIZATION,0.048983,-0.10269,-0.12261,0,0
5,GO RECEPTOR METABOLIC PROCESS,0.054786,-0.10272,-0.093093,0,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.037792,-0.10272,-0.15872,0,0
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.034581,-0.10277,-0.11765,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.09779,-0.10295,-0.098665,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.51167,-0.10309,-0.10949,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.032572,-0.10313,-0.099517,0,0
5,GO SECONDARY METABOLIC PROCESS,0.24039,-0.10316,-0.13428,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.050383,-0.10319,-0.14008,0,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.12179,-0.10321,-0.11857,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.16068,-0.10321,-0.17124,0,0
5,GO REGULATION OF TUBE SIZE,0.068115,-0.10343,-0.11064,0,0
5,GO MACROPHAGE ACTIVATION,0.030665,-0.10351,-0.14823,0,0
5,GO RECEPTOR RECYCLING,0.037792,-0.10377,-0.12603,0,0
5,GO SODIUM ION TRANSPORT,0.06115,-0.10382,-0.12064,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.53518,-0.10384,-0.07486,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.19971,-0.10396,-0.15189,0,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.038917,-0.104,-0.10721,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.048983,-0.10405,-0.1173,0,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.27056,-0.10413,-0.07456,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.55115,-0.10417,-0.056902,0,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.21712,-0.10423,-0.13492,0,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.18733,-0.10424,-0.21627,0,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.27583,-0.10427,-0.12236,0,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.6516,-0.10431,-0.065409,0,0
5,GO REGULATION OF CHEMOTAXIS,0.064555,-0.10452,-0.12723,0,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.09779,-0.10459,-0.11869,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.46631,-0.10465,-0.10702,0,0
5,GO REGULATION OF CELL KILLING,0.17553,-0.10467,-0.13003,0,0
5,GO RNA SURVEILLANCE,0.28117,-0.10478,-0.079408,0,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.20396,-0.10485,-0.10714,0,0
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.10533,-0.1049,-0.16711,0,0
5,GO ACYLGLYCEROL HOMEOSTASIS,0.046281,-0.10517,-0.16911,0,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.16068,-0.10518,-0.12249,0,0
5,GO ORGANIC CATION TRANSPORT,0.19552,-0.10537,-0.096023,0,0
5,GO DENDRITIC CELL DIFFERENTIATION,0.12472,-0.10544,-0.21414,0,0
5,GO T CELL PROLIFERATION,0.044978,-0.10556,-0.13141,0,0
5,GO REGULATION OF ORGAN GROWTH,0.12472,-0.10558,-0.10048,0,0
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.051817,-0.10572,-0.1572,0,0
5,GO REGULATION OF GLUCONEOGENESIS,0.1794,-0.10576,-0.079407,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.74966,-0.10576,-0.086976,0,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.43736,-0.1058,-0.091234,0,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.25516,-0.10592,-0.079798,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.36329,-0.10592,-0.086781,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.12472,-0.10596,-0.13844,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.046281,-0.10609,-0.16427,0,0
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.066316,-0.10611,-0.12629,0,0
5,GO MUSCLE CELL PROLIFERATION,0.032572,-0.10624,-0.15582,0,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.19139,-0.10638,-0.19312,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.046281,-0.10639,-0.085036,0,0
5,GO GAP JUNCTION ASSEMBLY,0.36329,-0.10642,-0.15511,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.38267,-0.10659,-0.14904,0,0
5,GO T CELL CHEMOTAXIS,0.27056,-0.10661,-0.078843,0,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.2356,-0.10667,-0.10523,0,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.035624,-0.10685,-0.12512,0,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.21712,-0.10692,-0.10518,0,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.33239,-0.10732,-0.11544,0,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.036694,-0.10743,-0.14892,0,0
5,GO PROTEIN TARGETING TO LYSOSOME,0.10794,-0.10747,-0.15558,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.11892,-0.10753,-0.17515,0,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.062834,-0.10768,-0.1337,0,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.059504,-0.10769,-0.13015,0,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.059504,-0.10794,-0.1699,0,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.090686,-0.10796,-0.18157,0,0
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.15361,-0.10807,-0.09918,0,0
5,GO ANATOMICAL STRUCTURE REGRESSION,0.26536,-0.10809,-0.15111,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.081867,-0.10818,-0.17602,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.037792,-0.10818,-0.11519,0,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.1161,-0.1083,-0.11669,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.92804,-0.10833,0.0064742,0,0
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.11892,-0.1084,-0.14225,0,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.21712,-0.10845,-0.19605,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.17173,-0.10855,-0.07672,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.15017,-0.10858,-0.13346,0,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.12472,-0.10862,-0.17377,0,0
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.069955,-0.10863,-0.10852,0,0
5,GO TRNA METHYLATION,0.077726,-0.10886,-0.14216,0,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.093006,-0.1089,-0.10175,0,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.16798,-0.109,-0.1675,0,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.11892,-0.10905,-0.18965,0,0
5,GO LEUKOCYTE CHEMOTAXIS,0.035624,-0.10908,-0.14496,0,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.30323,-0.10914,-0.13844,0,0
5,GO HUMORAL IMMUNE RESPONSE,0.037792,-0.10923,-0.12268,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.33239,-0.10926,-0.079888,0,0
5,GO TEMPERATURE HOMEOSTASIS,0.047616,-0.10932,-0.10186,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.054786,-0.10935,-0.20304,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.32642,-0.10937,-0.072338,0,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.041252,-0.10954,-0.1446,0,0
5,GO RESPONSE TO NITRIC OXIDE,0.10025,-0.10968,-0.095224,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.43736,-0.10974,-0.083742,0,0
5,GO RESPONSE TO WOUNDING,0.038917,-0.10974,-0.14881,0,0
5,GO WOUND HEALING,0.04007,-0.10988,-0.15853,0,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.1402,-0.10995,-0.10597,0,0
5,GO PANCREATIC JUICE SECRETION,0.1794,-0.10999,-0.12122,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.28117,-0.11004,-0.083587,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.25017,-0.11011,-0.072436,0,0
5,GO HEAD MORPHOGENESIS,0.26536,-0.11028,-0.095964,0,0
5,GO CELLULAR RESPONSE TO PH,0.15712,-0.11029,-0.13998,0,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.13074,-0.11043,-0.16403,0,0
5,GO LUNG MORPHOGENESIS,0.1402,-0.11046,-0.1465,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.037792,-0.11047,-0.11831,0,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.042464,-0.11048,-0.19806,0,0
5,GO CARDIOCYTE DIFFERENTIATION,0.035624,-0.11048,-0.13858,0,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.32642,-0.11058,-0.073583,0,0
5,GO LIPID EXPORT FROM CELL,0.13384,-0.11064,-0.11206,0,0
5,GO ERBB SIGNALING PATHWAY,0.030665,-0.11082,-0.13864,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.25516,-0.11082,-0.1874,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.15712,-0.11087,-0.14043,0,0
5,GO PROTEIN KINASE C SIGNALING,0.43029,-0.11101,-0.059706,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.38927,-0.11113,-0.15646,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.36968,-0.1113,-0.12185,0,0
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.22164,-0.11132,-0.10746,0,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.086186,-0.11133,-0.11803,0,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.043706,-0.11134,-0.18076,0,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.048983,-0.11136,-0.25974,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.11333,-0.11141,-0.093232,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.1402,-0.11143,-0.19915,0,0
5,GO SEROTONIN METABOLIC PROCESS,0.78645,-0.11147,-0.028557,0,0
5,GO RESPIRATORY BURST,0.13384,-0.11153,-0.15222,0,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.053284,-0.1116,-0.13988,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.10277,-0.11174,-0.11228,0,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.26023,-0.11182,-0.15036,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.12771,-0.11186,-0.16335,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.15017,-0.1121,-0.14049,0,0
5,GO NCRNA 3 END PROCESSING,0.12179,-0.11211,-0.13098,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.095374,-0.11213,-0.11713,0,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.23088,-0.11214,-0.12902,0,0
5,GO MRNA METABOLIC PROCESS,0.041252,-0.11214,-0.090933,0,0
5,GO CELL KILLING,0.043706,-0.1122,-0.13562,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.077726,-0.11221,-0.1283,0,0
5,GO PHOSPHOLIPID HOMEOSTASIS,0.1794,-0.11226,-0.16117,0,0
5,GO TRACHEA DEVELOPMENT,0.22164,-0.11244,-0.15871,0,0
5,GO PROTEIN DEMANNOSYLATION,0.33843,-0.11248,-0.11559,0,0
5,GO GLIAL CELL DEVELOPMENT,0.081867,-0.11255,-0.12653,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.15017,-0.11256,-0.14248,0,0
5,GO REGULATION OF RNA BINDING,0.20828,-0.11261,-0.12851,0,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.22164,-0.11263,-0.10995,0,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33239,-0.11263,-0.094963,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.21267,-0.11264,-0.16663,0,0
5,GO CRISTAE FORMATION,0.036694,-0.11276,-0.19916,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.038917,-0.11286,-0.14319,0,0
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.032572,-0.11293,-0.13583,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.24039,-0.11294,-0.11997,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.66904,-0.11297,-0.062594,0,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.12771,-0.11327,-0.16285,0,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.15712,-0.11329,-0.20748,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.15712,-0.11344,-0.14876,0,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.51167,-0.11351,-0.03365,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.088413,-0.11352,-0.13358,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.24525,-0.11352,-0.094147,0,0
5,GO NEGATIVE REGULATION OF CELL SIZE,0.11892,-0.11357,-0.12477,0,0
5,GO HISTONE ARGININE METHYLATION,0.15361,-0.1136,-0.097996,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.18733,-0.11361,-0.12754,0,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.056323,-0.11369,-0.23267,0,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.032572,-0.11385,-0.11534,0,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.17173,-0.11397,-0.14593,0,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.053284,-0.11413,-0.15013,0,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.19139,-0.11415,-0.14363,0,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.037792,-0.11417,-0.13296,0,0
5,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.43029,-0.11425,-0.15371,0,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.11892,-0.11432,-0.11945,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.034581,-0.11434,-0.14949,0,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.11061,-0.11446,-0.13504,0,0
5,GO CYTOLYSIS,0.27583,-0.11446,-0.14687,0,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.095374,-0.11469,-0.10971,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.053284,-0.11471,-0.16034,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.36329,-0.11475,-0.12778,0,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.35072,-0.11477,-0.086279,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.064555,-0.11481,-0.19928,0,0
5,GO REGULATION OF HISTONE DEACETYLATION,0.20396,-0.11513,-0.093205,0,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.09779,-0.11519,-0.14806,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.031606,-0.11523,-0.12347,0,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.33843,-0.11527,-0.1164,0,0
5,GO DEVELOPMENTAL INDUCTION,0.1402,-0.11529,-0.10882,0,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.22622,-0.11535,-0.10402,0,0
5,GO RESPONSE TO ATP,0.066316,-0.11558,-0.12315,0,0
5,GO RESPONSE TO MUSCLE STRETCH,0.20828,-0.1156,-0.18469,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.20396,-0.11575,-0.11581,0,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.24525,-0.11581,-0.10008,0,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.090686,-0.11589,-0.17141,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.17173,-0.1159,-0.12467,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.1161,-0.11598,-0.20132,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.1402,-0.11603,-0.15292,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.18334,-0.11613,-0.2262,0,0
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.26536,-0.11627,-0.14365,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.068115,-0.11628,-0.16899,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.15712,-0.11639,-0.13542,0,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.40947,-0.11639,-0.046319,0,0
5,GO ODONTOGENESIS,0.095374,-0.11641,-0.13923,0,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.054786,-0.11656,-0.16025,0,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.33239,-0.11657,-0.22634,0,0
5,GO DORSAL AORTA DEVELOPMENT,0.27056,-0.11701,-0.11059,0,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.13699,-0.1171,-0.14317,0,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.42328,-0.11712,-0.083791,0,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.10025,-0.11719,-0.1519,0,0
5,GO RESPONSE TO INTERLEUKIN 2,0.55922,-0.11721,-0.044967,0,0
5,GO FOAM CELL DIFFERENTIATION,0.15361,-0.11729,-0.17203,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.033564,-0.11742,-0.16575,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.068115,-0.11743,-0.18373,0,0
5,GO STRESS FIBER ASSEMBLY,0.043706,-0.11745,-0.14312,0,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.054786,-0.11746,-0.38324,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.14679,-0.11756,-0.12749,0,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.13699,-0.11756,-0.15282,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.11892,-0.1176,-0.17798,0,0
5,GO CHLORIDE TRANSPORT,0.088413,-0.11788,-0.096065,0,0
5,GO NOTCH SIGNALING PATHWAY,0.053284,-0.118,-0.12313,0,0
5,GO RESPONSE TO OSMOTIC STRESS,0.04007,-0.11808,-0.13598,0,0
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.032572,-0.11822,-0.11661,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.48871,-0.11823,-0.072334,0,0
5,GO ALANINE TRANSPORT,0.21712,-0.11824,-0.13374,0,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.069955,-0.11827,-0.15385,0,0
5,GO RESPONSE TO FATTY ACID,0.038917,-0.11842,-0.15716,0,0
5,GO RESPONSE TO CORTICOSTERONE,0.42328,-0.11892,-0.12511,0,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.10794,-0.11894,-0.14322,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.28117,-0.11899,-0.098762,0,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.14679,-0.11907,-0.15893,0,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.42328,-0.11914,-0.072628,0,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.17173,-0.11927,-0.138,0,0
5,GO EPITHELIAL CELL FATE COMMITMENT,0.47371,-0.11927,-0.080058,0,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.050383,-0.11933,-0.17336,0,0
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.086186,-0.11934,-0.13314,0,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.36968,-0.11943,-0.13742,0,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.043706,-0.11952,-0.098167,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.037792,-0.11955,-0.16376,0,0
5,GO HYALURONAN METABOLIC PROCESS,0.032572,-0.11961,-0.18452,0,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.068115,-0.11968,-0.1715,0,0
5,GO INNATE IMMUNE RESPONSE,0.043706,-0.11969,-0.1397,0,0
5,GO SNORNA METABOLIC PROCESS,0.38927,-0.11991,-0.091938,0,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.051817,-0.12004,-0.17776,0,0
5,GO MEMBRANE BIOGENESIS,0.38267,-0.12008,-0.067327,0,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.068115,-0.12019,-0.11473,0,0
5,GO OVULATION CYCLE,0.1402,-0.12031,-0.098068,0,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.071835,-0.12032,-0.17629,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.16068,-0.12035,-0.2042,0,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.07572,-0.12039,-0.19747,0,0
5,GO ISOPRENOID METABOLIC PROCESS,0.068115,-0.1204,-0.13522,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.2356,-0.1204,-0.14214,0,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.034581,-0.12042,-0.1879,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.2356,-0.12044,-0.21371,0,0
5,GO LIVER MORPHOGENESIS,0.33843,-0.12059,-0.12809,0,0
5,GO ENDODERM DEVELOPMENT,0.095374,-0.12075,-0.19951,0,0
5,GO REGULATION OF SODIUM ION TRANSPORT,0.086186,-0.12085,-0.13143,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.9952,-0.12092,0.025065,0,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.068115,-0.12098,-0.17139,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.069955,-0.121,-0.12524,0,0
5,GO HEART VALVE DEVELOPMENT,0.24039,-0.12101,-0.13584,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.079775,-0.1212,-0.13521,0,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.10277,-0.12126,-0.12848,0,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.32052,-0.12147,-0.052612,0,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.069955,-0.12154,-0.13849,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.086186,-0.12159,-0.12136,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.13074,-0.12163,-0.11957,0,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.13699,-0.12163,-0.17561,0,0
5,GO RESPONSE TO OXYGEN RADICAL,0.12472,-0.12176,-0.10404,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.51167,-0.12191,-0.087061,0,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.59207,-0.12206,-0.046327,0,0
5,GO ONE CARBON COMPOUND TRANSPORT,0.1643,-0.1222,-0.12888,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.10794,-0.12223,-0.13742,0,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.059504,-0.12223,-0.23552,0,0
5,GO ADAPTIVE THERMOGENESIS,0.032572,-0.12224,-0.11437,0,0
5,GO P38MAPK CASCADE,0.04007,-0.12233,-0.16816,0,0
5,GO RESPONSE TO VITAMIN A,0.4963,-0.12234,-0.049066,0,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.22164,-0.12236,-0.11771,0,0
5,GO STEROID CATABOLIC PROCESS,0.19971,-0.12238,-0.11436,0,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.04007,-0.12239,-0.14107,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.07572,-0.12245,-0.13939,0,0
5,GO LINOLEIC ACID METABOLIC PROCESS,0.1643,-0.12252,-0.2385,0,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.090686,-0.12252,-0.13292,0,0
5,GO AORTA MORPHOGENESIS,0.22164,-0.12257,-0.11291,0,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.12179,-0.12264,-0.12228,0,0
5,GO FOCAL ADHESION ASSEMBLY,0.032572,-0.12268,-0.18294,0,0
5,GO APICAL JUNCTION ASSEMBLY,0.20828,-0.12271,-0.11073,0,0
5,GO NEUROTRANSMITTER UPTAKE,0.21712,-0.12285,-0.12352,0,0
5,GO T CELL CYTOKINE PRODUCTION,0.069955,-0.12286,-0.17077,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.090686,-0.12289,-0.11378,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.20396,-0.12301,-0.09057,0,0
5,GO PHOSPHATE ION TRANSPORT,0.048983,-0.12318,-0.10617,0,0
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.036694,-0.12321,-0.14843,0,0
5,GO UV PROTECTION,0.4445,-0.12321,-0.10231,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.11333,-0.12325,-0.15812,0,0
5,GO GLUTAMATE METABOLIC PROCESS,0.12179,-0.12325,-0.10746,0,0
5,GO RIG I SIGNALING PATHWAY,0.086186,-0.12358,-0.15409,0,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.28658,-0.12359,-0.11178,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.85194,-0.12362,0.0098776,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.054786,-0.12384,-0.14697,0,0
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.51167,-0.12389,-0.099266,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.1794,-0.124,-0.13201,0,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.084004,-0.12403,-0.14341,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.090686,-0.12409,-0.13189,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.22622,-0.12412,-0.12484,0,0
5,GO NEPHRON DEVELOPMENT,0.09779,-0.12424,-0.11615,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.050383,-0.12428,-0.15687,0,0
5,GO DOPAMINE METABOLIC PROCESS,0.9472,-0.12449,0.0182,0,0
5,GO TERPENOID METABOLIC PROCESS,0.071835,-0.12472,-0.12933,0,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.084004,-0.12476,-0.11706,0,0
5,GO REGULATION OF RUFFLE ASSEMBLY,0.081867,-0.12479,-0.14325,0,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.24525,-0.12507,-0.11033,0,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.13699,-0.12509,-0.1364,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.33239,-0.1253,-0.11183,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.059504,-0.12534,-0.18777,0,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.18334,-0.12541,-0.15428,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.14347,-0.12543,-0.1444,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.034581,-0.12546,-0.13631,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.1161,-0.12558,-0.18022,0,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.10025,-0.12562,-0.16406,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.16798,-0.12568,-0.11812,0,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.093006,-0.12569,-0.23095,0,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.37614,-0.12578,-0.085526,0,0
5,GO REVERSE CHOLESTEROL TRANSPORT,0.14347,-0.12586,-0.18988,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.17553,-0.12587,-0.11371,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.04007,-0.12602,-0.17271,0,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.12472,-0.12616,-0.12259,0,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.10794,-0.1263,-0.13148,0,0
5,GO CORTICOSTEROID HORMONE SECRETION,0.28117,-0.12635,-0.15968,0,0
5,GO PARAXIAL MESODERM DEVELOPMENT,0.18733,-0.12641,-0.16655,0,0
5,GO MEMBRANE DEPOLARIZATION,0.25017,-0.12642,-0.098529,0,0
5,GO STEM CELL DIVISION,0.16798,-0.12643,-0.1136,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.095374,-0.12646,-0.11819,0,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.40947,-0.12655,-0.1187,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.41634,-0.12681,-0.087386,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.60883,-0.12683,-0.11694,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.26536,-0.12693,-0.1334,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.36329,-0.12703,-0.098388,0,0
5,GO OVULATION CYCLE PROCESS,0.046281,-0.12706,-0.15288,0,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.13384,-0.12706,-0.17239,0,0
5,GO CELLULAR RESPONSE TO CAMP,0.25017,-0.1271,-0.092557,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.85194,-0.12711,0.0069788,0,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.066316,-0.12716,-0.11052,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.27056,-0.12719,-0.12039,0,0
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.033564,-0.12722,-0.11762,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.069955,-0.12733,-0.1954,0,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.43736,-0.1274,-0.074932,0,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.74054,-0.12757,-0.060983,0,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.1643,-0.1276,-0.23567,0,0
5,GO RRNA CATABOLIC PROCESS,0.38927,-0.12762,-0.065663,0,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.077726,-0.12762,-0.12518,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.47371,-0.12778,-0.0039606,0,0
5,GO AMYLOID BETA CLEARANCE,0.17553,-0.12787,-0.15506,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.053284,-0.128,-0.16072,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.35072,-0.12804,-0.21327,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.19552,-0.12812,-0.1065,0,0
5,GO INTESTINAL ABSORPTION,0.20828,-0.12829,-0.15109,0,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.081867,-0.12844,-0.12032,0,0
5,GO GLAND MORPHOGENESIS,0.1794,-0.12856,-0.16327,0,0
5,GO TOXIN TRANSPORT,0.06115,-0.12859,-0.12573,0,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.39593,-0.12886,-0.079462,0,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.13384,-0.12886,-0.1087,0,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.079775,-0.12887,-0.18494,0,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.10533,-0.1289,-0.15978,0,0
5,GO INTERLEUKIN 2 PRODUCTION,0.093006,-0.12903,-0.13294,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.10794,-0.1292,-0.13834,0,0
5,GO RESPONSE TO CALCIUM ION,0.053284,-0.12922,-0.1217,0,0
5,GO AMINOGLYCAN METABOLIC PROCESS,0.077726,-0.12925,-0.14731,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.12771,-0.12926,-0.25708,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.2356,-0.12931,-0.14511,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.088413,-0.12947,-0.14663,0,0
5,GO GRANULOCYTE CHEMOTAXIS,0.059504,-0.12959,-0.13807,0,0
5,GO ORGANELLE FUSION,0.041252,-0.12964,-0.11368,0,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.047616,-0.12974,-0.19002,0,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.07572,-0.12974,-0.21175,0,0
5,GO ENERGY RESERVE METABOLIC PROCESS,0.030665,-0.1299,-0.12968,0,0
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.062834,-0.12996,-0.11433,0,0
5,GO UTERUS DEVELOPMENT,0.85194,-0.12998,-0.0081704,0,0
5,GO CELLULAR RESPONSE TO IRON ION,0.19552,-0.1301,-0.1361,0,0
5,GO FLUID TRANSPORT,0.20828,-0.13021,-0.072005,0,0
5,GO PRENYLATION,0.18334,-0.1305,-0.10612,0,0
5,GO ENAMEL MINERALIZATION,0.30323,-0.13052,-0.18906,0,0
5,GO MESONEPHROS DEVELOPMENT,0.27583,-0.13069,-0.10484,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.034581,-0.13083,-0.13331,0,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.086186,-0.13086,-0.15265,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.20396,-0.13088,-0.16394,0,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.13699,-0.13092,-0.11701,0,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.1402,-0.13113,-0.1136,0,0
5,GO ACTION POTENTIAL,0.13384,-0.13114,-0.11043,0,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27056,-0.1315,-0.11667,0,0
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.050383,-0.13152,-0.14692,0,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.050383,-0.13154,-0.18491,0,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.037792,-0.13164,-0.12725,0,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.064555,-0.13171,-0.14505,0,0
5,GO RESPONSE TO ISCHEMIA,0.077726,-0.13208,-0.12667,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.051817,-0.13213,-0.13654,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.16068,-0.13214,-0.10541,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.068115,-0.13231,-0.12825,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.036694,-0.13281,-0.16551,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.051817,-0.13298,-0.13225,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.046281,-0.1331,-0.11288,0,0
5,GO DIGESTIVE SYSTEM PROCESS,0.079775,-0.13313,-0.12116,0,0
5,GO MYELIN MAINTENANCE,0.17553,-0.13316,-0.17132,0,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.26536,-0.13321,-0.11047,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.036694,-0.1333,-0.17955,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.041252,-0.13331,-0.11365,0,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.06115,-0.13355,-0.13564,0,0
5,GO PIGMENT ACCUMULATION,0.084004,-0.13357,-0.16835,0,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.043706,-0.13357,-0.20224,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.06115,-0.13369,-0.17031,0,0
5,GO STRIATED MUSCLE CONTRACTION,0.048983,-0.13382,-0.12786,0,0
5,GO RRNA TRANSCRIPTION,0.069955,-0.13413,-0.14366,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,0.11061,-0.1344,-0.1765,0,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.19139,-0.13455,-0.16265,0,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.042464,-0.13471,-0.15585,0,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.066316,-0.1348,-0.12951,0,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.051817,-0.13486,-0.12383,0,0
5,GO ACTIVATION OF IMMUNE RESPONSE,0.032572,-0.13491,-0.12027,0,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12179,-0.13501,-0.21244,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.16798,-0.13512,-0.16731,0,0
5,GO HEPATOCYTE DIFFERENTIATION,0.43736,-0.13553,-0.095343,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.031606,-0.13562,-0.18413,0,0
5,GO ALCOHOL CATABOLIC PROCESS,0.11892,-0.13564,-0.11714,0,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.15361,-0.13578,-0.1149,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.23088,-0.13582,-0.15098,0,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.079775,-0.1359,-0.1622,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.088413,-0.136,-0.15529,0,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.093006,-0.13602,-0.19277,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.50395,-0.13604,-0.090499,0,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.053284,-0.13608,-0.21618,0,0
5,GO MUSCLE CELL MIGRATION,0.10533,-0.13612,-0.16145,0,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.047616,-0.13613,-0.19214,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.095374,-0.13617,-0.29528,0,0
5,GO GLIAL CELL PROLIFERATION,0.19139,-0.13622,-0.10494,0,0
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.081867,-0.13644,-0.13228,0,0
5,GO SKELETAL MUSCLE CONTRACTION,0.1402,-0.13661,-0.11619,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.069955,-0.13663,-0.15902,0,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.088413,-0.1367,-0.12871,0,0
5,GO INTEGRIN ACTIVATION,0.12771,-0.13679,-0.14595,0,0
5,GO CELLULAR RESPONSE TO STARVATION,0.054786,-0.13686,-0.11031,0,0
5,GO HEART TRABECULA MORPHOGENESIS,0.050383,-0.13688,-0.19013,0,0
5,GO B CELL PROLIFERATION,0.035624,-0.13738,-0.16831,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.12472,-0.1375,-0.14858,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.047616,-0.13787,-0.16688,0,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.1643,-0.13793,-0.18188,0,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.10277,-0.13798,-0.19191,0,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.35697,-0.13801,-0.083779,0,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.030665,-0.13809,-0.20008,0,0
5,GO EXTRACELLULAR TRANSPORT,0.48118,-0.13822,-0.051139,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.19971,-0.13828,-0.10767,0,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.15361,-0.13842,-0.10275,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.079775,-0.13843,-0.13717,0,0
5,GO PLATELET AGGREGATION,0.04007,-0.13847,-0.19478,0,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.1402,-0.13847,-0.15184,0,0
5,GO CHYLOMICRON ASSEMBLY,0.04007,-0.13857,-0.17473,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.13384,-0.13871,-0.094404,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.28117,-0.13883,-0.096785,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.030665,-0.13887,-0.16511,0,0
5,GO RESPONSE TO HISTAMINE,0.33239,-0.13889,-0.18836,0,0
5,GO INTERLEUKIN 17 PRODUCTION,0.030665,-0.1391,-0.18769,0,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.19552,-0.13917,-0.18415,0,0
5,GO ACUTE PHASE RESPONSE,0.06115,-0.13922,-0.16347,0,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.033564,-0.13933,-0.14127,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.086186,-0.13936,-0.11606,0,0
5,GO REGULATION OF RECEPTOR BINDING,0.093006,-0.13938,-0.23892,0,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.12472,-0.13939,-0.1161,0,0
5,GO RESPONSE TO INTERLEUKIN 15,0.04007,-0.13944,-0.2237,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.19971,-0.13944,-0.15405,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.093006,-0.13982,-0.16154,0,0
5,GO PROTEIN NITROSYLATION,0.046281,-0.13985,-0.21654,0,0
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.09779,-0.1399,-0.12461,0,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.12472,-0.1399,-0.1277,0,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.2356,-0.13997,-0.12976,0,0
5,GO SNRNA PROCESSING,0.086186,-0.13999,-0.1648,0,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.21267,-0.14035,-0.10702,0,0
5,GO AMYLOID BETA METABOLIC PROCESS,0.042464,-0.14054,-0.16624,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.054786,-0.14061,-0.19861,0,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.1402,-0.14063,-0.14754,0,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.1643,-0.14076,-0.18725,0,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.04007,-0.14078,-0.16795,0,0
5,GO ARTERY MORPHOGENESIS,0.10025,-0.14096,-0.12114,0,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.034581,-0.14102,-0.18751,0,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.26023,-0.14111,-0.10399,0,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.032572,-0.1412,-0.14779,0,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.10533,-0.14128,-0.16218,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.16068,-0.1414,-0.12361,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.068115,-0.14141,-0.15538,0,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.10533,-0.14147,-0.17859,0,0
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.30892,-0.14156,-0.1588,0,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.062834,-0.14159,-0.15419,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.090686,-0.14162,-0.27755,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.45171,-0.14174,-0.071874,0,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.11333,-0.14199,-0.21193,0,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.20828,-0.14205,-0.10046,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.048983,-0.14208,-0.14972,0,0
5,GO NEPHRON MORPHOGENESIS,0.22164,-0.14209,-0.079057,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.22164,-0.1421,-0.11602,0,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.036694,-0.14222,-0.1129,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.25017,-0.14227,-0.12947,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.043706,-0.14228,-0.1434,0,0
5,GO EPIBOLY,0.14679,-0.14232,-0.22499,0,0
5,GO DENDRITIC CELL MIGRATION,0.068115,-0.14239,-0.2025,0,0
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.06115,-0.14244,-0.17281,0,0
5,GO NEUTROPHIL HOMEOSTASIS,0.09779,-0.14253,-0.28145,0,0
5,GO REGULATION OF MAST CELL ACTIVATION,0.21267,-0.14262,-0.10014,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.032572,-0.14298,-0.12591,0,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.16068,-0.143,-0.18349,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.93762,-0.14316,0.058208,0,0
5,GO REGULATION OF WOUND HEALING,0.034581,-0.1432,-0.2031,0,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.031606,-0.14323,-0.12331,0,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.031606,-0.14342,-0.15094,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.19139,-0.14356,-0.14398,0,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.1402,-0.14371,-0.19784,0,0
5,GO CERAMIDE TRANSPORT,0.095374,-0.14376,-0.17447,0,0
5,GO RESPONSE TO MINERALOCORTICOID,0.09779,-0.14387,-0.1753,0,0
5,GO REGULATION OF CARDIAC CONDUCTION,0.051817,-0.14389,-0.13997,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.66904,-0.14389,-0.0040691,0,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.036694,-0.14393,-0.14904,0,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.18733,-0.14397,-0.14052,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.16068,-0.14404,-0.15946,0,0
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.069955,-0.14407,-0.16738,0,0
5,GO DIGESTION,0.07572,-0.1441,-0.13139,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.37614,-0.14412,-0.11356,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.1794,-0.14427,-0.11438,0,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.15361,-0.14436,-0.14241,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.051817,-0.14439,-0.23737,0,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.071835,-0.14446,-0.15349,0,0
5,GO LOCOMOTOR RHYTHM,0.40947,-0.14471,-0.085548,0,0
5,GO PROTEIN ACTIVATION CASCADE,0.066316,-0.14504,-0.20694,0,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.1161,-0.14506,-0.18325,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.18334,-0.14527,-0.1001,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.030665,-0.14537,-0.18677,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.51167,-0.14537,-0.029268,0,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.12179,-0.14555,-0.24451,0,0
5,GO ENDOCRINE PROCESS,0.086186,-0.14567,-0.13651,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.059504,-0.14589,-0.24411,0,0
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.29761,-0.14612,-0.13079,0,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.11061,-0.14618,-0.18433,0,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.059504,-0.14622,-0.20074,0,0
5,GO FACIAL NERVE MORPHOGENESIS,0.9472,-0.14642,0.043822,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.11061,-0.14654,-0.21348,0,0
5,GO CAMP METABOLIC PROCESS,0.19139,-0.1466,-0.14964,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.1794,-0.1468,-0.21033,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.18334,-0.14692,-0.12989,0,0
5,GO VITAMIN D METABOLIC PROCESS,0.15712,-0.14697,-0.16934,0,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.086186,-0.14705,-0.12089,0,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.07572,-0.14719,-0.18093,0,0
5,GO PINOCYTOSIS,0.050383,-0.14721,-0.17788,0,0
5,GO FEMALE SEX DIFFERENTIATION,0.056323,-0.14735,-0.12623,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.046281,-0.14764,-0.16646,0,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.036694,-0.14764,-0.13152,0,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.064555,-0.14786,-0.17192,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.081867,-0.14809,-0.16611,0,0
5,GO MUSCLE FILAMENT SLIDING,0.056323,-0.14815,-0.16686,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.046281,-0.1483,-0.19835,0,0
5,GO REGULATION OF ACTION POTENTIAL,0.11061,-0.1483,-0.14233,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.38927,-0.14848,-0.10716,0,0
5,GO POSITIVE REGULATION OF COAGULATION,0.12771,-0.1485,-0.15554,0,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.10025,-0.14856,-0.16589,0,0
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.034581,-0.14859,-0.14347,0,0
5,GO PEPTIDYL ARGININE METHYLATION,0.071835,-0.14863,-0.13618,0,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.084004,-0.14882,-0.14463,0,0
5,GO POSITIVE REGULATION OF MYELINATION,0.07572,-0.14885,-0.1402,0,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.035624,-0.14892,-0.16272,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.21267,-0.14897,-0.13548,0,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.09779,-0.14904,-0.1935,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.057895,-0.14907,-0.15185,0,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.10794,-0.14948,-0.17258,0,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.038917,-0.14964,-0.18044,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.2356,-0.14994,-0.13057,0,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054786,-0.15023,-0.17728,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.16798,-0.1504,-0.12794,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.036694,-0.15046,-0.20714,0,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43736,-0.15062,-0.085679,0,0
5,GO REGULATION OF RESPONSE TO WOUNDING,0.095374,-0.15066,-0.16035,0,0
5,GO AMYLOID BETA FORMATION,0.051817,-0.15091,-0.15429,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.042464,-0.15093,-0.15352,0,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.17553,-0.15103,-0.097635,0,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.068115,-0.15108,-0.16599,0,0
5,GO HYALURONAN CATABOLIC PROCESS,0.068115,-0.15128,-0.2985,0,0
5,GO RESPONSE TO INTERLEUKIN 7,0.038917,-0.15169,-0.16224,0,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.093006,-0.15188,-0.12345,0,0
5,GO FACE DEVELOPMENT,0.073757,-0.15193,-0.14916,0,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.043706,-0.1521,-0.14802,0,0
5,GO OSTEOBLAST PROLIFERATION,0.19139,-0.15271,-0.15575,0,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.39593,-0.15279,-0.096648,0,0
5,GO IMPORT INTO CELL,0.033564,-0.15293,-0.12934,0,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.069955,-0.15296,-0.12931,0,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.050383,-0.15301,-0.17953,0,0
5,GO ENGULFMENT OF APOPTOTIC CELL,0.066316,-0.15301,-0.17678,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.14679,-0.1531,-0.15286,0,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.066316,-0.15319,-0.20094,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.43029,-0.15341,-0.08299,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.29761,-0.1537,-0.16469,0,0
5,GO RENAL TUBULE DEVELOPMENT,0.10025,-0.15376,-0.12694,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.32052,-0.15388,-0.0873,0,0
5,GO PROSTAGLANDIN SECRETION,0.04007,-0.15403,-0.17905,0,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.33239,-0.15462,-0.10868,0,0
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.14679,-0.15467,-0.12662,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.90893,-0.15473,-0.00078204,0,0
5,GO REGULATION OF NEURON MATURATION,0.32642,-0.15484,-0.10023,0,0
5,GO FEMALE GENITALIA DEVELOPMENT,0.14679,-0.15485,-0.13544,0,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.059504,-0.15519,-0.20381,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.18334,-0.15521,-0.1414,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.51944,-0.15524,-0.13665,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.1161,-0.15532,-0.19587,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.14347,-0.15608,-0.13292,0,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.10794,-0.15614,-0.13018,0,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.12179,-0.15622,-0.28863,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.35697,-0.15636,-0.14345,0,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.20828,-0.15642,-0.20357,0,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.042464,-0.15643,-0.17059,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.46631,-0.15653,-0.081248,0,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18334,-0.1569,-0.17166,0,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.17553,-0.15731,-0.14702,0,0
5,GO HYPOTONIC RESPONSE,0.041252,-0.15755,-0.21136,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.14347,-0.15781,-0.13182,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.030665,-0.15787,-0.15827,0,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.13074,-0.1579,-0.2335,0,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.11061,-0.15803,-0.13752,0,0
5,GO TRABECULA MORPHOGENESIS,0.056323,-0.15813,-0.17822,0,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.14679,-0.15823,-0.23362,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.033564,-0.15834,-0.23723,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.06115,-0.15841,-0.27239,0,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.39593,-0.15843,-0.11946,0,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.062834,-0.15865,-0.18542,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.043706,-0.15869,-0.15965,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.35697,-0.15881,-0.097556,0,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.1161,-0.15905,-0.2165,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.034581,-0.15915,-0.26662,0,0
5,GO ANOIKIS,0.21712,-0.15916,-0.13126,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.30323,-0.15941,-0.12849,0,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.10533,-0.15962,-0.17753,0,0
5,GO MALE GENITALIA DEVELOPMENT,0.048983,-0.15989,-0.21149,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.17553,-0.15991,-0.14255,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.031606,-0.16028,-0.20893,0,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.044978,-0.16033,-0.16574,0,0
5,GO PLASMA MEMBRANE TUBULATION,0.13384,-0.16051,-0.1539,0,0
5,GO CELLULAR ANION HOMEOSTASIS,0.12771,-0.16053,-0.14116,0,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.035624,-0.16057,-0.17887,0,0
5,GO MYELIN ASSEMBLY,0.095374,-0.16063,-0.151,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.37614,-0.16079,-0.069132,0,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.13074,-0.16094,-0.092048,0,0
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.34454,-0.16103,-0.12443,0,0
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17553,-0.16114,-0.17191,0,0
5,GO CELLULAR RESPONSE TO STEROL,0.059504,-0.16128,-0.19766,0,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.07572,-0.1614,-0.23656,0,0
5,GO VITAMIN CATABOLIC PROCESS,0.25017,-0.16141,-0.16162,0,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.22164,-0.16161,-0.17361,0,0
5,GO CARDIAC MUSCLE CONTRACTION,0.053284,-0.16196,-0.13159,0,0
5,GO REPLACEMENT OSSIFICATION,0.19139,-0.16208,-0.15247,0,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.10025,-0.16221,-0.17862,0,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.11333,-0.16228,-0.16697,0,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32642,-0.16231,-0.11422,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.054786,-0.16235,-0.19086,0,0
5,GO AMINE CATABOLIC PROCESS,0.041252,-0.16244,-0.26127,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.037792,-0.16247,-0.13958,0,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.056323,-0.16267,-0.30906,0,0
5,GO POSITIVE REGULATION OF CELL SIZE,0.21712,-0.16284,-0.12632,0,0
5,GO CELLULAR RESPONSE TO ATP,0.13074,-0.16307,-0.12436,0,0
5,GO DIET INDUCED THERMOGENESIS,0.062834,-0.1631,-0.18984,0,0
5,GO RECEPTOR CATABOLIC PROCESS,0.036694,-0.16313,-0.19635,0,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15712,-0.16319,-0.15111,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.10025,-0.16349,-0.22642,0,0
5,GO DISACCHARIDE METABOLIC PROCESS,0.12472,-0.16365,-0.16482,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.1402,-0.16383,-0.2631,0,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.088413,-0.16426,-0.25574,0,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.18334,-0.16432,-0.15506,0,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.044978,-0.1645,-0.2564,0,0
5,GO ENDODERM FORMATION,0.051817,-0.16454,-0.25584,0,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.069955,-0.16471,-0.12214,0,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.050383,-0.16482,-0.18815,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.10277,-0.16496,-0.21581,0,0
5,GO T CELL EXTRAVASATION,0.10277,-0.16503,-0.30714,0,0
5,GO KERATINOCYTE PROLIFERATION,0.077726,-0.16511,-0.19577,0,0
5,GO NEGATIVE CHEMOTAXIS,0.079775,-0.16535,-0.20087,0,0
5,GO REGULATION OF PLATELET ACTIVATION,0.06115,-0.1657,-0.23438,0,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.062834,-0.16576,-0.19292,0,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.12179,-0.16581,-0.17191,0,0
5,GO REGULATION OF CHLORIDE TRANSPORT,0.077726,-0.16633,-0.19934,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.14347,-0.16639,-0.14756,0,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.031606,-0.1669,-0.19461,0,0
5,GO PROSTATE GLAND GROWTH,0.036694,-0.16703,-0.27154,0,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.086186,-0.16705,-0.14439,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.16068,-0.16734,-0.15131,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.15361,-0.16739,-0.22335,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.19971,-0.16833,-0.15931,0,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.035624,-0.16865,-0.18599,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.04007,-0.1687,-0.2166,0,0
5,GO XENOBIOTIC TRANSPORT,0.050383,-0.16876,-0.17628,0,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.041252,-0.16927,-0.15321,0,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.24525,-0.16947,-0.15666,0,0
5,GO VASCULOGENESIS,0.088413,-0.16978,-0.20725,0,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.18334,-0.17004,-0.19846,0,0
5,GO RESPONSE TO DIETARY EXCESS,0.23088,-0.17006,-0.15572,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.036694,-0.17021,-0.18546,0,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.033564,-0.17045,-0.17525,0,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.33843,-0.17066,-0.32558,0,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.030665,-0.17076,-0.14889,0,0
5,GO B CELL HOMEOSTASIS,0.037792,-0.17077,-0.15898,0,0
5,GO REGULATION OF TUBULIN DEACETYLATION,0.16798,-0.17115,-0.14497,0,0
5,GO BROWN FAT CELL DIFFERENTIATION,0.081867,-0.1713,-0.14138,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.038917,-0.17136,-0.20349,0,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033564,-0.1717,-0.15984,0,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.21712,-0.17171,-0.16739,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.15017,-0.172,-0.20056,0,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.07572,-0.17206,-0.18884,0,0
5,GO REGULATION OF COAGULATION,0.034581,-0.17223,-0.24018,0,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.044978,-0.17223,-0.18179,0,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.079775,-0.17242,-0.18689,0,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.054786,-0.17243,-0.15195,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.1794,-0.17245,-0.19311,0,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.035624,-0.1725,-0.13565,0,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.030665,-0.17274,-0.27689,0,0
5,GO RESPONSE TO ANGIOTENSIN,0.041252,-0.17275,-0.20702,0,0
5,GO IMMATURE T CELL PROLIFERATION,0.09779,-0.17284,-0.17956,0,0
5,GO HEART FIELD SPECIFICATION,0.74054,-0.17301,-0.032553,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.11892,-0.17323,-0.16813,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.035624,-0.17331,-0.18321,0,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.04007,-0.17388,-0.20439,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.07572,-0.17397,-0.2604,0,0
5,GO MITOCHONDRIAL TRNA PROCESSING,0.11333,-0.17409,-0.19553,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.17553,-0.17414,-0.21092,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.1402,-0.17448,-0.2585,0,0
5,GO EXPLORATION BEHAVIOR,0.24039,-0.17495,-0.12419,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.066316,-0.17537,-0.14631,0,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.042464,-0.17548,-0.27315,0,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.1794,-0.17555,-0.13381,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.077726,-0.17562,-0.15154,0,0
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.036694,-0.17614,-0.16987,0,0
5,GO ASTROCYTE DEVELOPMENT,0.081867,-0.17626,-0.1878,0,0
5,GO RRNA 3 END PROCESSING,0.11061,-0.17629,-0.14807,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15712,-0.17645,-0.24163,0,0
5,GO REGULATION OF GONAD DEVELOPMENT,0.26023,-0.17646,-0.11989,0,0
5,GO GLUTAMINE METABOLIC PROCESS,0.04007,-0.17647,-0.16204,0,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.035624,-0.17658,-0.27303,0,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.13384,-0.17679,-0.18794,0,0
5,GO ASYMMETRIC CELL DIVISION,0.033564,-0.17688,-0.21068,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046281,-0.17716,-0.19282,0,0
5,GO SERTOLI CELL DIFFERENTIATION,0.12179,-0.1772,-0.16123,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.079775,-0.17764,-0.18846,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.16798,-0.17766,-0.20176,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.084004,-0.17766,-0.20529,0,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.048983,-0.17766,-0.16142,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.038917,-0.17796,-0.17585,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.034581,-0.1781,-0.23795,0,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.12472,-0.17814,-0.17615,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.033564,-0.17829,-0.25182,0,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.090686,-0.17869,-0.14077,0,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.24039,-0.17882,-0.11952,0,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.056323,-0.17888,-0.2204,0,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.07572,-0.17989,-0.22483,0,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.21267,-0.18031,-0.16006,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.077726,-0.18039,-0.22477,0,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.1402,-0.1809,-0.22333,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.15361,-0.18101,-0.21487,0,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.084004,-0.18135,-0.25233,0,0
5,GO RESPONSE TO INACTIVITY,0.12472,-0.18141,-0.15519,0,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.09779,-0.18151,-0.18613,0,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.56735,-0.18163,-0.039609,0,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.12179,-0.18164,-0.18388,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.09779,-0.18187,-0.16245,0,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.06115,-0.18227,-0.17721,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.035624,-0.18247,-0.1773,0,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.36329,-0.1825,-0.098132,0,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.24525,-0.18268,-0.14941,0,0
5,GO REGULATION OF MRNA BINDING,0.064555,-0.18321,-0.21197,0,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.053284,-0.18327,-0.19734,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.033564,-0.18334,-0.23719,0,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.11333,-0.18344,-0.2135,0,0
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.10025,-0.1835,-0.2462,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.04007,-0.18372,-0.19397,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.077726,-0.18394,-0.19565,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.20396,-0.18445,-0.15547,0,0
5,GO MAMMARY GLAND MORPHOGENESIS,0.051817,-0.18513,-0.21722,0,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.24039,-0.18553,-0.15973,0,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.19139,-0.1859,-0.23197,0,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.030665,-0.18635,-0.20108,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.29206,-0.18643,-0.16881,0,0
5,GO PROSTANOID METABOLIC PROCESS,0.048983,-0.18661,-0.28711,0,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.033564,-0.18672,-0.24524,0,0
5,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.034581,-0.18712,-0.23235,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.047616,-0.18719,-0.16992,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.16798,-0.18745,-0.16162,0,0
5,GO REGULATION OF TOLERANCE INDUCTION,0.1794,-0.18797,-0.22789,0,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.059504,-0.18889,-0.29371,0,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.20396,-0.18937,-0.2473,0,0
5,GO RESPONSE TO AMPHETAMINE,0.032572,-0.18966,-0.23239,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.043706,-0.19019,-0.23797,0,0
5,GO URETER DEVELOPMENT,0.079775,-0.19029,-0.20346,0,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.12179,-0.19031,-0.15054,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.042464,-0.19039,-0.20487,0,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.030665,-0.1909,-0.24487,0,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.032572,-0.19239,-0.17762,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.057895,-0.19266,-0.1957,0,0
5,GO SIGNAL PEPTIDE PROCESSING,0.15361,-0.19278,-0.16318,0,0
5,GO POSITIVE REGULATION OF WOUND HEALING,0.064555,-0.19311,-0.17873,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.12179,-0.19328,-0.1552,0,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.06115,-0.19348,-0.1868,0,0
5,GO OSTEOCLAST DEVELOPMENT,0.084004,-0.19353,-0.1912,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.053284,-0.19357,-0.17837,0,0
5,GO GERMINAL CENTER FORMATION,0.041252,-0.19366,-0.35393,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.053284,-0.19368,-0.16793,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.29206,-0.19403,-0.15399,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.1161,-0.19436,-0.21667,0,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.15017,-0.19461,-0.2067,0,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.04007,-0.19476,-0.20051,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.068115,-0.19706,-0.18193,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.056323,-0.19725,-0.18289,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.30892,-0.19761,-0.13504,0,0
5,GO PEPTIDYL ARGININE N METHYLATION,0.04007,-0.19778,-0.20776,0,0
5,GO RESPONSE TO TYPE I INTERFERON,0.27056,-0.19838,-0.20609,0,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.1643,-0.19878,-0.15173,0,0
5,GO FUCOSE METABOLIC PROCESS,0.056323,-0.19901,-0.22236,0,0
5,GO B CELL APOPTOTIC PROCESS,0.10794,-0.19904,-0.16821,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.07572,-0.19947,-0.24556,0,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.053284,-0.1997,-0.19516,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.068115,-0.19976,-0.20771,0,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.037792,-0.20034,-0.1544,0,0
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.25017,-0.20046,-0.16488,0,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.13384,-0.20115,-0.14184,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.58378,-0.2012,-0.070656,0,0
5,GO MIDGUT DEVELOPMENT,0.1402,-0.20124,-0.20617,0,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.090686,-0.20187,-0.15381,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16068,-0.20188,-0.19879,0,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.031606,-0.20203,-0.19944,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.064555,-0.20237,-0.22479,0,0
5,GO CARNITINE METABOLIC PROCESS,0.16068,-0.20253,-0.12981,0,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.10025,-0.20308,-0.18831,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.09779,-0.20314,-0.25863,0,0
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.1402,-0.20323,-0.15592,0,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.24525,-0.20334,-0.14201,0,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.10794,-0.20347,-0.20484,0,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.041252,-0.20356,-0.20589,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.1643,-0.20385,-0.2471,0,0
5,GO HISTAMINE SECRETION,0.07572,-0.20389,-0.27568,0,0
5,GO HISTAMINE TRANSPORT,0.047616,-0.20431,-0.2827,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046281,-0.20448,-0.2132,0,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.047616,-0.20461,-0.2095,0,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.071835,-0.20508,-0.21119,0,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.15712,-0.20513,-0.24089,0,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.1643,-0.20515,-0.20493,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.071835,-0.20557,-0.26805,0,0
5,GO AORTIC VALVE DEVELOPMENT,0.057895,-0.20559,-0.29036,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.07572,-0.20594,-0.23686,0,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.26023,-0.20599,-0.20569,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.038917,-0.20611,-0.16168,0,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.034581,-0.20622,-0.18404,0,0
5,GO SNARE COMPLEX ASSEMBLY,0.068115,-0.20656,-0.19353,0,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.07572,-0.20675,-0.20538,0,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.088413,-0.20699,-0.12864,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16798,-0.20708,-0.12568,0,0
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.40947,-0.20786,-0.11561,0,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.054786,-0.20811,-0.20459,0,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.034581,-0.20869,-0.19537,0,0
5,GO GENITALIA MORPHOGENESIS,0.11061,-0.20909,-0.22151,0,0
5,GO RESPONSE TO MUSCLE ACTIVITY,0.035624,-0.20911,-0.24565,0,0
5,GO RESPONSE TO HYPEROXIA,0.033564,-0.20938,-0.28561,0,0
5,GO DETECTION OF OTHER ORGANISM,0.086186,-0.20977,-0.23457,0,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.40947,-0.21009,-0.11218,0,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.15361,-0.21083,-0.11932,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.033564,-0.2115,-0.23711,0,0
5,GO REGULATION OF ANOIKIS,0.044978,-0.21163,-0.27584,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11061,-0.21177,-0.14728,0,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.032572,-0.21189,-0.16777,0,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.11892,-0.21239,-0.23092,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.11333,-0.21253,-0.21246,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.041252,-0.21341,-0.23923,0,0
5,GO RESPONSE TO MAGNESIUM ION,0.10025,-0.2137,-0.28412,0,0
5,GO REGULATION OF FATTY ACID OXIDATION,0.036694,-0.21372,-0.18801,0,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.047616,-0.21384,-0.23762,0,0
5,GO CHOLESTEROL STORAGE,0.09779,-0.21445,-0.17816,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.36329,-0.21481,-0.13875,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.068115,-0.21503,-0.24088,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.036694,-0.2151,-0.21552,0,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.10794,-0.21543,-0.16017,0,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.1794,-0.21626,-0.11052,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.09779,-0.21628,-0.26807,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.11061,-0.21691,-0.38488,0,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.037792,-0.21694,-0.21643,0,0
5,GO REGULATION OF HEART RATE,0.071835,-0.21697,-0.14425,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.032572,-0.21716,-0.19263,0,0
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.21267,-0.21742,-0.30303,0,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.035624,-0.21788,-0.20946,0,0
5,GO CARNITINE SHUTTLE,0.09779,-0.21803,-0.18017,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.062834,-0.21817,-0.16799,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.086186,-0.21848,-0.16655,0,0
5,GO NEGATIVE REGULATION OF ANOIKIS,0.066316,-0.21874,-0.3104,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.034581,-0.21878,-0.32675,0,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.04007,-0.21969,-0.20056,0,0
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.090686,-0.22003,-0.22498,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.10533,-0.2201,-0.17378,0,0
5,GO COCHLEA MORPHOGENESIS,0.11892,-0.22021,-0.18421,0,0
5,GO MUSCLE ATROPHY,0.23088,-0.22046,-0.14098,0,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.13074,-0.2211,-0.22512,0,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.035624,-0.22166,-0.26113,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.1643,-0.22182,-0.17632,0,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.048983,-0.22195,-0.2073,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.12179,-0.22298,-0.21576,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.068115,-0.22337,-0.16237,0,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.081867,-0.22368,-0.21928,0,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.050383,-0.22417,-0.23375,0,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.035624,-0.22493,-0.19369,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.15017,-0.22591,-0.23844,0,0
5,GO RESPONSE TO REDOX STATE,0.036694,-0.22593,-0.19755,0,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.1161,-0.22627,-0.18175,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.034581,-0.22642,-0.33076,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.051817,-0.22656,-0.20862,0,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.036694,-0.22659,-0.20652,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.033564,-0.22682,-0.21463,0,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.032572,-0.22696,-0.24157,0,0
5,GO RESPONSE TO LIGHT INTENSITY,0.050383,-0.22697,-0.17352,0,0
5,GO RESPONSE TO STEROL DEPLETION,0.053284,-0.2284,-0.20404,0,0
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.048983,-0.22867,-0.20344,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.10533,-0.22896,-0.22117,0,0
5,GO ZINC ION HOMEOSTASIS,0.073757,-0.22932,-0.24244,0,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.059504,-0.22984,-0.26288,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11061,-0.23056,-0.19929,0,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.077726,-0.23105,-0.28152,0,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.095374,-0.23145,-0.25312,0,0
5,GO RETINAL METABOLIC PROCESS,0.13699,-0.23146,-0.26226,0,0
5,GO PIGMENT GRANULE ORGANIZATION,0.030665,-0.23157,-0.18605,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.038917,-0.23184,-0.26755,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.15712,-0.23384,-0.1637,0,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.077726,-0.23472,-0.18245,0,0
5,GO AXIS ELONGATION,0.081867,-0.23486,-0.18749,0,0
5,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.057895,-0.23532,-0.23308,0,0
5,GO SKIN MORPHOGENESIS,0.13384,-0.23774,-0.25871,0,0
5,GO POSITIVE REGULATION OF HEART RATE,0.06115,-0.23824,-0.21494,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.088413,-0.23838,-0.21153,0,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.04007,-0.23921,-0.22774,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.050383,-0.23969,-0.29781,0,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.11061,-0.23993,-0.28012,0,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.042464,-0.24114,-0.2274,0,0
5,GO MACROPHAGE PROLIFERATION,0.10794,-0.24144,-0.24395,0,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.042464,-0.24148,-0.26567,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.077726,-0.24168,-0.30047,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.10025,-0.24178,-0.22397,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.035624,-0.2418,-0.21162,0,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.062834,-0.24195,-0.36356,0,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.033564,-0.24218,-0.31367,0,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.10794,-0.24276,-0.21079,0,0
5,GO MICROVILLUS ASSEMBLY,0.09779,-0.24378,-0.20202,0,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.077726,-0.24407,-0.30369,0,0
5,GO PODOSOME ASSEMBLY,0.066316,-0.24514,-0.2042,0,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.037792,-0.2455,-0.24234,0,0
5,GO RESPONSE TO MUSCLE INACTIVITY,0.10794,-0.24616,-0.14655,0,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.10277,-0.24637,-0.27373,0,0
5,GO ANDROGEN METABOLIC PROCESS,0.054786,-0.2468,-0.21019,0,0
5,GO OVULATION,0.057895,-0.24688,-0.20883,0,0
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.032572,-0.2485,-0.24241,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.12179,-0.24859,-0.24265,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.033564,-0.24894,-0.23252,0,0
5,GO LEYDIG CELL DIFFERENTIATION,0.12179,-0.24947,-0.24338,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.095374,-0.24982,-0.16064,0,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.042464,-0.24994,-0.25219,0,0
5,GO SALIVARY GLAND DEVELOPMENT,0.04007,-0.25013,-0.26942,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.053284,-0.25104,-0.15984,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.45898,-0.25105,-0.11476,0,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.031606,-0.25132,-0.31628,0,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.030665,-0.25156,-0.42015,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.056323,-0.25227,-0.29287,0,0
5,GO VAGINA DEVELOPMENT,0.032572,-0.2535,-0.26286,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.030665,-0.25378,-0.27564,0,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.053284,-0.2539,-0.23211,0,0
5,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.11892,-0.2545,-0.30085,0,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.034581,-0.25512,-0.27477,0,0
5,GO NOTOCHORD DEVELOPMENT,0.04007,-0.25717,-0.29027,0,0
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.28658,-0.25749,-0.17468,0,0
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.030665,-0.2581,-0.30237,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.1161,-0.25854,-0.22314,0,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.15361,-0.25862,-0.1854,0,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.042464,-0.25911,-0.33845,0,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.031606,-0.25925,-0.2999,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.036694,-0.26052,-0.25103,0,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.054786,-0.26105,-0.30159,0,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.18334,-0.26134,-0.27454,0,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.030665,-0.26205,-0.22469,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.053284,-0.26248,-0.19132,0,0
5,GO REGULATION OF VESICLE FUSION,0.044978,-0.26357,-0.3103,0,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.069955,-0.26414,-0.33091,0,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.19552,-0.26551,-0.22261,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.19139,-0.26553,-0.1526,0,0
5,GO PHAGOCYTOSIS RECOGNITION,0.034581,-0.26609,-0.28251,0,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.034581,-0.26634,-0.25965,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.084004,-0.26682,-0.21455,0,0
5,GO RRNA PSEUDOURIDINE SYNTHESIS,0.032572,-0.2674,-0.29412,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.14679,-0.26789,-0.20305,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10794,-0.26808,-0.20541,0,0
5,GO VASCULAR TRANSPORT,0.046281,-0.26914,-0.34276,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.14679,-0.26984,-0.20014,0,0
5,GO PLASMA MEMBRANE FUSION,0.068115,-0.26997,-0.26542,0,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.14679,-0.27282,-0.26804,0,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.064555,-0.27375,-0.22517,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.050383,-0.27435,-0.27152,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.044978,-0.27486,-0.25205,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.036694,-0.27635,-0.28642,0,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.12771,-0.27727,-0.17293,0,0
5,GO INTERLEUKIN 5 PRODUCTION,0.031606,-0.27784,-0.26169,0,0
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.13699,-0.27809,-0.27946,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.079775,-0.27877,-0.41531,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.030665,-0.281,-0.24499,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.054786,-0.2812,-0.18676,0,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.043706,-0.28291,-0.22082,0,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.18733,-0.28374,-0.17295,0,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.19971,-0.28404,-0.21803,0,0
5,GO MICROVILLUS ORGANIZATION,0.034581,-0.28504,-0.23692,0,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.064555,-0.2857,-0.26719,0,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.046281,-0.28682,-0.28694,0,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.043706,-0.28736,-0.28748,0,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.17173,-0.28759,-0.16119,0,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10277,-0.28981,-0.29724,0,0
5,GO RESPONSE TO INTERFERON BETA,0.079775,-0.29003,-0.35311,0,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.086186,-0.29004,-0.25935,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.086186,-0.29205,-0.58287,0,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.11061,-0.29265,-0.34749,0,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.11061,-0.29582,-0.25489,0,0
5,GO MACROPHAGE APOPTOTIC PROCESS,0.030665,-0.29613,-0.24894,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.044978,-0.29619,-0.28828,0,0
5,GO HEMIDESMOSOME ASSEMBLY,0.10794,-0.29903,-0.30189,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.079775,-0.29951,-0.26579,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.047616,-0.29977,-0.29192,0,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.032572,-0.29994,-0.3883,0,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.038917,-0.30028,-0.28138,0,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.046281,-0.30161,-0.31969,0,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.079775,-0.3074,-0.24388,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.11892,-0.30829,-0.22725,0,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.07572,-0.30841,-0.3618,0,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.14679,-0.30842,-0.18124,0,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.035624,-0.31144,-0.27369,0,0
5,GO BLEB ASSEMBLY,0.046281,-0.31147,-0.48975,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.034581,-0.31186,-0.31609,0,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.095374,-0.3121,-0.26649,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.22164,-0.31941,-0.13226,0,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.030665,-0.32004,-0.31685,0,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.15712,-0.32373,-0.25453,0,0
5,GO ETHANOL OXIDATION,0.033564,-0.32525,-0.41913,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.056323,-0.32575,-0.26297,0,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.093006,-0.32627,-0.24504,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.071835,-0.32644,-0.2523,0,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.084004,-0.33163,-0.32681,0,0
5,GO REGULATION OF VASCULOGENESIS,0.057895,-0.3319,-0.318,0,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.035624,-0.3345,-0.28395,0,0
5,GO L SERINE METABOLIC PROCESS,0.042464,-0.33766,-0.29663,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.044978,-0.34109,-0.32644,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.064555,-0.34245,-0.21967,0,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.046281,-0.34334,-0.22983,0,0
5,GO RESPONSE TO INTERLEUKIN 18,0.071835,-0.34627,-0.36935,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.038917,-0.34886,-0.36471,0,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.054786,-0.35064,-0.26396,0,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.038917,-0.351,-0.27658,0,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.19552,-0.36131,-0.24728,0,0
5,GO TRNA CATABOLIC PROCESS,0.1161,-0.36186,-0.25754,0,0
5,GO GAS TRANSPORT,0.088413,-0.36357,-0.26028,0,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.042464,-0.36409,-0.29397,0,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.1161,-0.36551,-0.22248,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.046281,-0.36684,-0.23721,0,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.52728,-0.3675,-0.12659,0,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.069955,-0.36901,-0.34344,0,0
5,GO IMP METABOLIC PROCESS,0.04007,-0.36938,-0.2967,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.17173,-0.36955,-0.19283,0,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.036694,-0.37642,-0.38181,0,0
5,GO OXYGEN TRANSPORT,0.17553,-0.37737,-0.28352,0,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.034581,-0.3831,-0.29124,0,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.054786,-0.38787,-0.25772,0,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.054786,-0.38793,-0.46185,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.053284,-0.3912,-0.42465,0,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.042464,-0.39244,-0.31896,0,0
5,GO RESPONSE TO EPINEPHRINE,0.064555,-0.42539,-0.30409,0,0
5,GO HEART INDUCTION,0.054786,-0.44985,-0.31392,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.14347,-0.45376,-0.46622,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.09779,-0.79585,-0.64033,0,0
